{"meta":{"query_hash":"685268ecd29a","filters":{"venue":"Haematologica"},"cohort_total":466,"direct_labels_cover":0,"predictions_cover":466,"exported":466,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/685268ecd29a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Haematologica"},"results":[{"id":"W1792060848","doi":"10.3324/haematol.2014.117721","title":"Aging and malignant hemopathies","year":2015,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Incidence (geometry); Session (web analytics); Medicine; Gerontology; Plenary session; Library science; Computer science; Mathematics","score_opus":0.030407990995152814,"score_gpt":0.33102798289917235,"score_spread":0.30061999190401956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1792060848","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016804036,0.026631745,0.000027991664,0.0011711468,0.93111956,0.00140317,0.00010971458,0.0005494472,0.022183176],"genre_scores_gemma":[0.01726362,0.004259409,0.0014981679,0.0002565823,0.9608753,0.0001691374,0.0005070864,0.00015977262,0.015010941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969205,0.0001006141,0.00039541707,0.0006792654,0.0013203479,0.0005838533],"domain_scores_gemma":[0.9976534,0.00074360723,0.00015155069,0.00064626645,0.0004320786,0.0003730433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077564374,0.00036818287,0.0011601761,0.00017844464,0.00009216969,0.00006884705,0.00022198143,0.0010759278,0.000118301665],"category_scores_gemma":[0.0036064142,0.00025694992,0.00010623273,0.00016307828,0.00036342102,0.00004698945,0.0004406748,0.0009413794,0.0002449332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001636191,0.000039053873,0.000019590245,0.0012581496,0.00006720995,0.0054667643,0.00013208743,1.3815861e-7,0.000013474609,0.00014481721,0.9921,0.000595087],"study_design_scores_gemma":[0.005528907,0.00031731228,0.000004922585,0.00079058774,0.00014904185,0.0023959721,0.00010227213,0.00017159362,0.00018517935,0.0005271005,0.9895395,0.00028761802],"about_ca_topic_score_codex":0.0001967368,"about_ca_topic_score_gemma":0.000012644687,"teacher_disagreement_score":0.029755712,"about_ca_system_score_codex":0.0035332842,"about_ca_system_score_gemma":0.008902553,"threshold_uncertainty_score":0.99998826},"labels":[],"label_agreement":null},{"id":"W1833477067","doi":"10.3324/haematol.2015.130898","title":"Response to comments from Drs. Alter and Rosenberg","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Psychoanalysis; Psychology; Gerontology; Internal medicine; Bone marrow","score_opus":0.056557573008704586,"score_gpt":0.3344096317781854,"score_spread":0.2778520587694808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1833477067","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13804837,0.0004909379,0.000027940181,0.85688853,0.00020420394,0.0009962785,0.00021400863,0.00014766025,0.0029820453],"genre_scores_gemma":[0.008407388,0.000062745734,0.0034922985,0.9708491,0.0010227099,0.00015834419,0.00074779225,0.0001020063,0.015157644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99654853,0.0005920952,0.00043593097,0.00084660784,0.0008438095,0.0007330185],"domain_scores_gemma":[0.9972319,0.0008851038,0.00012495692,0.0010801954,0.00022042336,0.0004574072],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066955783,0.0004629177,0.0012387874,0.00030666366,0.00009103779,0.000072530536,0.00038602488,0.001224711,0.00068162516],"category_scores_gemma":[0.0012221677,0.0003403931,0.00011416655,0.00020838407,0.00020576704,0.000047031284,0.00064266846,0.0022370878,0.0019202246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021136836,0.000033318556,0.000641343,0.00008242559,0.00014377291,0.014714696,0.00023716869,6.53982e-8,0.00042403725,0.000003312932,0.98112994,0.00047622717],"study_design_scores_gemma":[0.001708361,0.0005212594,0.0014149188,0.00024991803,0.00010753152,0.0009391841,0.000046840705,0.000015536485,0.0004430765,0.0003158702,0.9938927,0.00034477946],"about_ca_topic_score_codex":0.0002452567,"about_ca_topic_score_gemma":0.0000064573837,"teacher_disagreement_score":0.12964098,"about_ca_system_score_codex":0.00041156454,"about_ca_system_score_gemma":0.0003552692,"threshold_uncertainty_score":0.9999048},"labels":[],"label_agreement":null},{"id":"W1859347718","doi":"10.3324/haematol.2015.126656","title":"Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Kreftforeningen","keywords":"Lymphocytosis; Bone marrow; Monoclonal; Lymphoma; Pathology; Diffuse large B-cell lymphoma; Medicine; Monoclonal antibody; Immunology; Antibody","score_opus":0.018170999321482813,"score_gpt":0.23208852591256693,"score_spread":0.21391752659108412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859347718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8712737,0.006596628,0.000002262872,0.08504054,0.00030288106,0.0026312682,0.0008633464,0.00079794286,0.032491423],"genre_scores_gemma":[0.7463533,0.00057713897,0.0005326536,0.22941925,0.0003441028,0.0011258961,0.013204518,0.00030826664,0.008134864],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936526,0.0004879024,0.0011807949,0.0015115133,0.0016185076,0.0015486975],"domain_scores_gemma":[0.995777,0.0008239919,0.0013783828,0.0011301757,0.0003685994,0.00052184484],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00039183247,0.0014407997,0.0031534643,0.00042410963,0.00029529608,0.00012756887,0.0006209856,0.0028919235,0.00030004967],"category_scores_gemma":[0.000108602784,0.0009721526,0.00065082614,0.0006031916,0.00034204702,0.00012352009,0.0003469439,0.0010157054,0.0009187658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006676223,0.019379202,0.045315564,0.0007242029,0.0015603222,0.026357038,0.00032689353,5.166371e-7,0.00002446009,0.00003136342,0.9053036,0.0003092317],"study_design_scores_gemma":[0.20432426,0.008679971,0.103982426,0.004517444,0.011887515,0.007232531,0.0001750152,0.00014811095,0.008776724,0.0008233835,0.6445019,0.004950712],"about_ca_topic_score_codex":0.000111648194,"about_ca_topic_score_gemma":0.000025025429,"teacher_disagreement_score":0.26080167,"about_ca_system_score_codex":0.002317366,"about_ca_system_score_gemma":0.0014957645,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W1865125576","doi":"10.3324/haematol.2015.127175","title":"PACE4 (PCSK6): another proprotein convertase link to iron homeostasis?","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Proprotein convertase; Iron homeostasis; PCSK9; Hepcidin; Proprotein Convertases; Medicine; Internal medicine; Cholesterol; Inflammation; LDL receptor; Lipoprotein; Metabolism","score_opus":0.04962170253058388,"score_gpt":0.2819668294353916,"score_spread":0.23234512690480771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1865125576","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047219465,0.0011264798,0.00017826477,0.97950727,0.0011516347,0.0027197436,0.00012266956,0.000486606,0.00998541],"genre_scores_gemma":[0.004129137,0.00010327629,0.001778691,0.9646492,0.0033913748,0.00041990352,0.0009335169,0.00012494378,0.02446996],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970455,0.0002786924,0.0005319987,0.0009167283,0.00051524135,0.00071185204],"domain_scores_gemma":[0.99801034,0.00011368005,0.00026950205,0.0010425341,0.0002980052,0.00026593445],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022846257,0.0006028843,0.001527434,0.00027890003,0.00009209993,0.000030238032,0.00024266525,0.0019253585,0.003653974],"category_scores_gemma":[0.00038136513,0.0004250744,0.00026851546,0.00022285245,0.00019015552,0.000039770275,0.00013761668,0.0018698013,0.007824733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046591484,0.00007269126,0.00007449092,0.00065558957,0.00007267186,0.0055496716,0.00014175387,5.6873e-7,0.00057522533,0.000022300648,0.9882669,0.004102218],"study_design_scores_gemma":[0.0011627921,0.0016572115,0.00014287984,0.0002979629,0.0001532386,0.0013205305,0.000033479377,0.0000052400123,0.0014414062,0.000189208,0.9930885,0.00050757395],"about_ca_topic_score_codex":0.00004942023,"about_ca_topic_score_gemma":0.000008966431,"teacher_disagreement_score":0.014858048,"about_ca_system_score_codex":0.00012868791,"about_ca_system_score_gemma":0.00028084836,"threshold_uncertainty_score":0.9998201},"labels":[],"label_agreement":null},{"id":"W1865212210","doi":"10.3324/haematol.2015.126227","title":"Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Samsung; Chonnam National University Hwasun Hospital; National Research Foundation of Korea; Kyungpook National University Hospital; Korea Research Institute of Bioscience and Biotechnology; National Research Foundation; University of Toronto; Ministry of Education, Science and Technology; Kyungpook National University; Catholic University of Korea; Chonnam National University; Dong-A University","keywords":"Myeloid leukemia; Karyotype; Medicine; Oncology; Internal medicine; Mutation; Adverse effect; Cancer research; Genetics; Biology; Gene; Chromosome","score_opus":0.013902527992961034,"score_gpt":0.26301818645545605,"score_spread":0.249115658462495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1865212210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988521,0.00011119663,0.0000043020486,0.00566301,0.00015879217,0.0030726816,0.00027001443,0.000037402053,0.002161645],"genre_scores_gemma":[0.99372274,0.00013223544,0.0002161376,0.00440791,0.00012350346,0.00019647759,0.0007927074,0.000074380725,0.0003339297],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9952756,0.0011941751,0.0011067842,0.00051349617,0.0013666427,0.00054329325],"domain_scores_gemma":[0.99458027,0.0024571165,0.0012599663,0.0010015478,0.000609069,0.00009205483],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012734135,0.0004878861,0.0017957411,0.00055529736,0.00004699847,0.0000046064356,0.0005485376,0.0010980214,0.000111175876],"category_scores_gemma":[0.0040930263,0.000280929,0.0003346314,0.0006714525,0.00057767256,0.0000668656,0.00022460605,0.0027560582,0.00009161866],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013569128,0.00056601,0.32929847,0.0064530787,0.0020857388,0.01027413,0.0012836359,0.00013605604,0.00023422543,0.000056905392,0.6333159,0.0027267148],"study_design_scores_gemma":[0.06646083,0.106554106,0.7003718,0.015865743,0.014201311,0.0031427222,0.00052739383,0.0023471517,0.06579079,0.001273459,0.020160764,0.0033039204],"about_ca_topic_score_codex":0.00030041995,"about_ca_topic_score_gemma":0.0000069097305,"teacher_disagreement_score":0.6131551,"about_ca_system_score_codex":0.00069182576,"about_ca_system_score_gemma":0.00082433363,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W1880343369","doi":"10.3324/haematol.2014.121384","title":"The international prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"Novo Nordisk","keywords":"Recombinant factor VIIa; Medicine; Platelet; Recombinant DNA; Glanzmann's thrombasthenia; Platelet transfusion; Thrombasthenia; Surgery; Internal medicine; Biochemistry","score_opus":0.03133696005214449,"score_gpt":0.3189892173289682,"score_spread":0.2876522572768237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880343369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986498,0.0006130821,0.0000034625336,0.0034694525,0.00009525191,0.0003275615,0.000004881478,0.000030544208,0.008957792],"genre_scores_gemma":[0.9981228,0.00018313022,0.000095973446,0.000034891338,0.000011401626,0.000072932744,0.000020270158,0.00000494325,0.0014536711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993854,0.00002950311,0.00016275008,0.00017675129,0.00011507607,0.00013052435],"domain_scores_gemma":[0.99965686,0.000062055115,0.000056231576,0.00012751657,0.00003350089,0.000063828156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010839748,0.00010617442,0.00027397246,0.000031221218,0.000044680663,0.000028951701,0.000055366818,0.000051413277,0.00001780709],"category_scores_gemma":[0.00007830493,0.000051931132,0.000058737,0.00004611652,0.000079378966,0.000037968734,0.00003749831,0.00005903474,0.000023906543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060064154,0.0007785626,0.9841914,0.000005441681,0.00018220276,0.0022015364,0.00031802055,3.903866e-7,0.0000029355626,0.0034070904,0.00037525094,0.007936493],"study_design_scores_gemma":[0.022032522,0.0025231312,0.90674305,0.00012401032,0.000117497766,0.0060094045,0.0021119302,0.00025331456,0.00031144154,0.015373891,0.044155736,0.00024408451],"about_ca_topic_score_codex":0.00013776211,"about_ca_topic_score_gemma":0.00027186665,"teacher_disagreement_score":0.0774484,"about_ca_system_score_codex":0.00011641052,"about_ca_system_score_gemma":0.000022106507,"threshold_uncertainty_score":0.21176901},"labels":[],"label_agreement":null},{"id":"W1895738210","doi":"10.3324/haematol.2015.128025","title":"Clinical profile and treatment outcome of older (&gt;75 years) patients with systemic AL amyloidosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"McKnight Foundation","keywords":"Medicine; Amyloidosis; AL amyloidosis; Internal medicine; Systemic therapy; Survival analysis; Surgery; Cancer; Immunology","score_opus":0.03333785387169814,"score_gpt":0.30934787938295527,"score_spread":0.27601002551125714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895738210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978623,0.0007855718,0.000032435928,0.00011075267,0.000108355736,0.000686471,0.000069821865,0.000029301551,0.00031502417],"genre_scores_gemma":[0.99745816,0.00021815118,0.0014845938,0.00024074133,0.000030208175,0.00017622575,0.00012660309,0.000027432765,0.00023789797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834144,0.00014451162,0.0005191938,0.0005185349,0.0002017811,0.00027455675],"domain_scores_gemma":[0.99885935,0.000056854755,0.00029143758,0.00047078726,0.00012582072,0.00019577467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001602904,0.00027069822,0.00062526675,0.000044590106,0.000038100472,0.000015296382,0.00015402227,0.00021918348,0.00002409173],"category_scores_gemma":[0.00012396982,0.00017762149,0.00013328323,0.000075550255,0.00019633071,0.000006547352,0.00012829286,0.0000596111,0.000034476063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019478568,0.0006300408,0.9947903,0.000024003411,0.00022004767,0.000020462823,0.000062754,0.0000019637862,0.00013603654,0.000040661635,0.001562379,0.0023165268],"study_design_scores_gemma":[0.006042659,0.004119731,0.98086125,0.00006640276,0.00020847474,0.00006364316,0.00018189145,0.000006685454,0.004085888,0.0000095669775,0.003997267,0.0003565344],"about_ca_topic_score_codex":0.000031490385,"about_ca_topic_score_gemma":0.00001769528,"teacher_disagreement_score":0.013929081,"about_ca_system_score_codex":0.000036483703,"about_ca_system_score_gemma":0.00004985391,"threshold_uncertainty_score":0.7243194},"labels":[],"label_agreement":null},{"id":"W1963911253","doi":"10.3324/haematol.11938","title":"Acute pancreatitis preceding thrombotic thrombocytopenic Purpura","year":2007,"lang":"en","type":"letter","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Acute pancreatitis; Medicine; Pancreatitis; Purpura (gastropod); Internal medicine; Gastroenterology; Platelet; Pediatrics","score_opus":0.03978107334847369,"score_gpt":0.29077815494818815,"score_spread":0.25099708159971446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963911253","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.146171,0.036686584,0.001138702,0.59961796,0.023594074,0.012058639,0.0030513683,0.0055608987,0.17212076],"genre_scores_gemma":[0.2894608,0.0009669689,0.00084831496,0.6535052,0.0021199272,0.0009737013,0.011365349,0.00038041337,0.040379286],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957738,0.00051065837,0.0010199327,0.0011235853,0.00017654404,0.0013954631],"domain_scores_gemma":[0.99715364,0.0007980843,0.00066004717,0.0012076107,0.0001377918,0.00004283789],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029959233,0.00083372416,0.0019648564,0.0002648208,0.0008037247,0.00018699969,0.0012562558,0.00212789,0.012637575],"category_scores_gemma":[0.00016039869,0.0006871391,0.0005101866,0.00026634004,0.0004772868,0.00013037777,0.0005360277,0.0020160694,0.008267636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038272497,0.000054293174,0.0010105196,0.00029093606,0.0013369947,0.0026359286,0.00005502751,2.266607e-7,0.001635172,0.00027277638,0.992468,0.0002018392],"study_design_scores_gemma":[0.0009588003,0.0002749777,0.0010971065,0.00053908845,0.0010355124,0.0055016293,0.00007128703,5.89405e-7,0.004355663,0.0005553121,0.984603,0.0010070386],"about_ca_topic_score_codex":0.00008866256,"about_ca_topic_score_gemma":0.000024719127,"teacher_disagreement_score":0.1432898,"about_ca_system_score_codex":0.00017715906,"about_ca_system_score_gemma":0.00011753897,"threshold_uncertainty_score":0.999558},"labels":[],"label_agreement":null},{"id":"W1968450817","doi":"10.3324/haematol.2014.117408","title":"Hb S/ +-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the   locus control region","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hospital for Sick Children","funders":"","keywords":"Thalassemia; Locus control region; Hemolytic anemia; Mutation; Hemoglobinopathy; Locus (genetics); Hemoglobin; Medicine; Genetics; Biology; Immunology; Gene; Internal medicine","score_opus":0.02048328375029363,"score_gpt":0.23344891697009704,"score_spread":0.2129656332198034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968450817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74444234,0.0018245644,0.00033177904,0.25045288,0.00012252804,0.0012835134,0.00007564941,0.000037485974,0.0014292566],"genre_scores_gemma":[0.93199015,0.0001432246,0.00016711555,0.067156285,0.000109850924,0.000019105844,0.00004184503,0.000028568906,0.00034384732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985172,0.00011767272,0.00040926918,0.00037713014,0.00030674884,0.00027195885],"domain_scores_gemma":[0.9986625,0.00023453722,0.0003445234,0.00034302927,0.0003074976,0.000107945314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018102977,0.00028944685,0.001060094,0.00011923633,0.000061265906,0.0000090407775,0.00008623045,0.0008964755,0.000009212796],"category_scores_gemma":[0.00049784046,0.00016960588,0.00012895097,0.00018041242,0.00041693953,0.00002633374,0.00009596836,0.0006966328,0.0000051297216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001353337,0.0003934039,0.004487993,0.0028106829,0.00072888733,0.0052244104,0.0020697652,0.00001553394,0.025328469,0.00077823846,0.95497614,0.0018331145],"study_design_scores_gemma":[0.054615468,0.012228784,0.029331708,0.020139573,0.012205444,0.11638552,0.012592123,0.0030655586,0.03819828,0.004146327,0.6920051,0.005086098],"about_ca_topic_score_codex":0.00008171227,"about_ca_topic_score_gemma":0.000007809666,"teacher_disagreement_score":0.26297104,"about_ca_system_score_codex":0.000032310596,"about_ca_system_score_gemma":0.000092570015,"threshold_uncertainty_score":0.6916327},"labels":[],"label_agreement":null},{"id":"W1969714279","doi":"10.3324/haematol.2009.017814","title":"Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenstrom's macroglobulinemia. Results of a retrospective analysis of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Celgene","keywords":"Medicine; Hematopoietic stem cell transplantation; Macroglobulinemia; Transplantation; Stem cell; Haematopoiesis; Hematopoietic cell; Retrospective cohort study; Oncology; Immunology; Internal medicine; Multiple myeloma; Biology; Genetics","score_opus":0.013381095656380645,"score_gpt":0.2815847595531309,"score_spread":0.26820366389675027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969714279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774504,0.0003874031,0.00043350484,0.00042377168,0.00002861694,0.0006698029,0.00014369449,0.000029247954,0.0001389487],"genre_scores_gemma":[0.99750775,0.00067723286,0.0016132973,0.00006410819,0.000011263185,0.000029524506,0.00004074433,0.000018760575,0.00003730052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973833,0.000557817,0.000683033,0.00048521423,0.00044641254,0.00044420757],"domain_scores_gemma":[0.99796957,0.0006191891,0.00040832633,0.000695603,0.00014357224,0.00016375475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015788544,0.00022877066,0.00086812663,0.00012995122,0.00009692356,0.000012264082,0.00027931904,0.00034220912,0.000057339246],"category_scores_gemma":[0.00019174362,0.00015272341,0.00029136604,0.0006205842,0.00046716863,0.000039773087,0.00008632428,0.0006287666,9.96929e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013225478,0.00031808382,0.7590835,0.0009952992,0.00031764893,0.00026113665,0.0062964344,0.00025588772,0.23067021,0.00008537028,0.000032767926,0.00036108727],"study_design_scores_gemma":[0.00889836,0.00021436354,0.8300619,0.00021781719,0.0008794115,0.0003631698,0.00019670143,0.011118526,0.14751545,0.00038171254,0.0000035709468,0.00014899508],"about_ca_topic_score_codex":0.0015919459,"about_ca_topic_score_gemma":0.0011659589,"teacher_disagreement_score":0.083154775,"about_ca_system_score_codex":0.001274018,"about_ca_system_score_gemma":0.0012789236,"threshold_uncertainty_score":0.622788},"labels":[],"label_agreement":null},{"id":"W1976649109","doi":"10.3324/haematol.12199","title":"Surgical treatment of a foscavir-resistant atypical Cytomegalovirus pneumonia in an allogeneic stem cell transplant recipient","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Cytomegalovirus; Stem cell; Medicine; Pneumonia; Transplantation; Aspergillosis; Immunology; Cytomegalovirus infections; Human cytomegalovirus; Herpesviridae; Internal medicine; Viral disease; Virus; Biology","score_opus":0.07233178469757054,"score_gpt":0.31791116742100717,"score_spread":0.24557938272343663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976649109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952008,0.0018589685,0.000013475723,0.0003092328,0.00004434875,0.000851648,0.00006641885,0.00007517582,0.0015799174],"genre_scores_gemma":[0.99674857,0.0022140911,0.00025299884,0.000075482516,0.00004596488,0.00012933304,0.00004462143,0.00003417196,0.0004547643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679565,0.00036676295,0.0008184634,0.00073036697,0.00058507227,0.0007036841],"domain_scores_gemma":[0.9983251,0.00025297992,0.00012324442,0.00076486205,0.000081846185,0.0004519803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041352364,0.0003521678,0.0012387929,0.0003219335,0.00012550472,0.000013001513,0.00022016441,0.00031714776,0.0003205694],"category_scores_gemma":[0.000012955104,0.0002448754,0.0003095546,0.00044909865,0.000292046,0.000070558664,0.000038235878,0.0002589619,0.00008470626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03880949,0.017226592,0.6365925,0.0005761834,0.00022072157,0.07498185,0.00514802,0.00004085597,0.19480799,0.00095263676,0.00033702079,0.030306157],"study_design_scores_gemma":[0.01940198,0.026864806,0.7521694,0.00040222032,0.00023281125,0.007833518,0.0005524739,0.0010874957,0.113302454,0.000094351686,0.07688831,0.0011701967],"about_ca_topic_score_codex":0.00027729187,"about_ca_topic_score_gemma":0.0002892424,"teacher_disagreement_score":0.1155769,"about_ca_system_score_codex":0.00025320816,"about_ca_system_score_gemma":0.00023847494,"threshold_uncertainty_score":0.99857295},"labels":[],"label_agreement":null},{"id":"W1977314095","doi":"10.3324/haematol.2009.013318","title":"Lymphoma stem cells: enough evidence to support their existence?","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Deutsche Krebshilfe; Ministerio de Ciencia e Innovación; Terry Fox Foundation","keywords":"Stem cell; Lymphoma; Medicine; Cancer research; Biology; Immunology; Genetics","score_opus":0.21763087573801798,"score_gpt":0.3831264085353868,"score_spread":0.16549553279736884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977314095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012802708,0.9902219,0.000035341076,0.00024237968,0.0011127007,0.002165098,0.0001069689,0.00018430297,0.0058032726],"genre_scores_gemma":[0.00010310399,0.99092406,0.00215127,0.00073936145,0.00031386522,0.0005114329,0.00003544422,0.00008781626,0.0051336256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656606,0.00016048944,0.0010340998,0.0010637001,0.00045778896,0.00071786373],"domain_scores_gemma":[0.99684274,0.0004412986,0.00048741256,0.0014882947,0.00015191532,0.000588361],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00054135843,0.00078106695,0.004231289,0.00023146131,0.00012223773,0.00006626128,0.00065391796,0.0007283018,0.0013686828],"category_scores_gemma":[0.000111523164,0.0004735018,0.0011230089,0.0005764445,0.0001468539,0.00007214941,0.00030706462,0.0005451379,0.0024659168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033684348,0.00011824111,0.0000017963074,0.01666858,0.000099311015,0.0009687372,0.00011247231,1.6682252e-8,0.000012251447,0.00018136913,0.008046441,0.9737571],"study_design_scores_gemma":[0.00020242778,0.0005293451,0.0000013421314,0.017704822,0.0011711437,0.0039620735,0.00006593652,1.6259531e-7,0.0004304814,0.000013673587,0.9754351,0.00048348962],"about_ca_topic_score_codex":0.000032029147,"about_ca_topic_score_gemma":0.00002184905,"teacher_disagreement_score":0.97327363,"about_ca_system_score_codex":0.00018346286,"about_ca_system_score_gemma":0.0010307272,"threshold_uncertainty_score":0.99977165},"labels":[],"label_agreement":null},{"id":"W1978101826","doi":"10.3324/haematol.2010.027086","title":" -catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Cancer research; Lymphoma; Biology; Cell growth; Cell culture; Catenin; Signal transduction; Pathology; Wnt signaling pathway; Medicine; Cell biology; Immunology; Biochemistry","score_opus":0.007329888307830495,"score_gpt":0.22679528598100795,"score_spread":0.21946539767317746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978101826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676436,0.00015519153,0.0009547322,0.000058856633,0.0001357036,0.00026729575,0.00012349758,0.000028750137,0.0015116023],"genre_scores_gemma":[0.9980726,0.00008159081,0.0010046473,0.00031580843,0.00005295433,0.0000918893,0.00019184772,0.000020393873,0.00016823616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846756,0.000088620174,0.00028095115,0.0005915807,0.00016800886,0.0004033017],"domain_scores_gemma":[0.99925715,0.00013830201,0.00017248325,0.00018787902,0.00011659293,0.00012757137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000121827026,0.00028955936,0.0003028946,0.00011376607,0.00019087772,0.00004308501,0.00017798608,0.0003070243,0.000103594],"category_scores_gemma":[0.00023207637,0.00025027382,0.00005334269,0.00016650438,0.00026305576,0.000022080587,0.00017220975,0.00011038818,0.000019379544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020014876,0.000949624,0.017130723,0.000074085314,0.00007537968,0.00011710347,0.0005240724,0.000006678943,0.97132033,0.00065678,0.0038126141,0.0033311304],"study_design_scores_gemma":[0.0030450718,0.00028791378,0.03715231,0.0000918188,0.000021595888,0.00007309295,0.00037933062,0.00006001132,0.9552038,0.00024289808,0.0030399566,0.000402255],"about_ca_topic_score_codex":0.000065290435,"about_ca_topic_score_gemma":0.000110564266,"teacher_disagreement_score":0.020021586,"about_ca_system_score_codex":0.00003367822,"about_ca_system_score_gemma":0.00021721757,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W1981684224","doi":"10.3324/haematol.2010.036343","title":"T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Vlaamse regering; Fonds Wetenschappelijk Onderzoek","keywords":"Stem cell; Haematopoiesis; Bone marrow; Cord blood; Biology; CD34; Immunology; Myeloid; Umbilical cord; Hematopoietic stem cell; Cell biology","score_opus":0.03731440278706067,"score_gpt":0.22382441689651528,"score_spread":0.1865100141094546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981684224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974464,0.00033514874,0.000071230344,0.00030633062,0.00028165066,0.0011340082,0.00012717291,0.000054874326,0.0002431572],"genre_scores_gemma":[0.9983792,0.00008991782,0.0009616675,0.00028329203,0.00003442259,0.00006131973,0.00004546992,0.000038486385,0.00010625971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99698865,0.00040251066,0.0009368822,0.0007232475,0.0005610788,0.0003876044],"domain_scores_gemma":[0.9986075,0.00012400367,0.00031612723,0.0006991154,0.00008477494,0.00016844615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024920207,0.00035973123,0.0010183068,0.00014398783,0.000056879067,0.000028141734,0.00025411384,0.00040890666,0.0005171233],"category_scores_gemma":[0.000013010947,0.00021981471,0.00014961082,0.00029516994,0.00020335818,0.00011851771,0.00008783446,0.00030596042,0.000028343258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020977214,0.001470605,0.09426607,0.00039798665,0.0001088882,0.0003190486,0.007128564,3.8278614e-7,0.89314115,0.000045277877,0.000060093596,0.0009641959],"study_design_scores_gemma":[0.003738654,0.00021213465,0.16409129,0.0003743017,0.00032861906,0.00013766879,0.0004428778,0.00019887749,0.8296339,0.0005878399,0.000011216478,0.00024263117],"about_ca_topic_score_codex":0.001975697,"about_ca_topic_score_gemma":0.00015946147,"teacher_disagreement_score":0.06982522,"about_ca_system_score_codex":0.000052941767,"about_ca_system_score_gemma":0.00007401932,"threshold_uncertainty_score":0.8963784},"labels":[],"label_agreement":null},{"id":"W1984003054","doi":"10.3324/haematol.2013.085340","title":"Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Sinai Health System; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; Genome Canada","keywords":"MCL1; Apoptosis; Biology; Programmed cell death; Leukemia; Gene; Cancer research; Allele; Haematopoiesis; Immunology; Genetics; Downregulation and upregulation; Stem cell","score_opus":0.0176132477233794,"score_gpt":0.2675597047388014,"score_spread":0.249946457015422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984003054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960315,0.000037781625,0.000017579441,0.0011392876,0.00006986928,0.0015718932,0.000031572185,0.000024821878,0.0010756877],"genre_scores_gemma":[0.9993368,0.000014473085,0.0001904165,0.00016849698,0.000021667294,0.000093290975,0.000004514388,0.000033408152,0.0001369455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997069,0.00025111408,0.0010241438,0.0003538261,0.0007890423,0.0005129016],"domain_scores_gemma":[0.9971645,0.0007342813,0.0005584082,0.001189823,0.00022213935,0.00013088924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039400812,0.00032432895,0.0010808416,0.00026190907,0.00005670608,0.0000102355625,0.00066977576,0.00026159117,0.00053068757],"category_scores_gemma":[0.0011461395,0.0001399327,0.0004718973,0.00086712214,0.0006773706,0.00007090315,0.00033084504,0.0003710921,0.0000548128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013528032,0.0022720958,0.8912413,0.00053226773,0.001506041,0.000092444556,0.0034374148,0.00014019692,0.08403941,0.007241559,0.0033884563,0.00475598],"study_design_scores_gemma":[0.0024475232,0.0011756176,0.88147515,0.0004976752,0.00010778936,0.00023499863,0.00010536305,0.00037041676,0.11274835,0.0006814095,0.000005850715,0.00014983071],"about_ca_topic_score_codex":0.00074396236,"about_ca_topic_score_gemma":0.000007971691,"teacher_disagreement_score":0.028708937,"about_ca_system_score_codex":0.00070893654,"about_ca_system_score_gemma":0.0008600234,"threshold_uncertainty_score":0.58106565},"labels":[],"label_agreement":null},{"id":"W1989402731","doi":"10.3324/haematol.11203","title":"Pediatric acute myeloid leukemia: towards high-quality cure of all patients","year":2007,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Myeloid leukemia; Pharmacogenomics; Minimal residual disease; Oncology; Disease; Internal medicine; Leukemia; Intensive care medicine; Pharmacology","score_opus":0.11254359432220473,"score_gpt":0.41814936660063895,"score_spread":0.3056057722784342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989402731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047082063,0.98586726,0.000051938678,0.000108608976,0.000416178,0.0030601092,0.00045157815,0.0002337531,0.0051023453],"genre_scores_gemma":[0.00043157238,0.9936695,0.0023655738,0.00027437607,0.00041524554,0.00018159422,0.001567387,0.00014247448,0.00095227105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927104,0.0005902381,0.002572817,0.0012174546,0.0016674411,0.0012416573],"domain_scores_gemma":[0.99480426,0.0007184472,0.0015651044,0.0016266258,0.0007008262,0.0005847335],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014496509,0.0010574578,0.0068245544,0.0008976778,0.000102005,0.0000269752,0.0010500015,0.0022265653,0.0005924144],"category_scores_gemma":[0.0009990656,0.00071093295,0.0014173493,0.0014981071,0.00033134417,0.000098293545,0.0007655521,0.0024572543,0.0007122534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029750846,0.00072292204,0.0010956974,0.09601409,0.0017342812,0.0023025607,0.00009106655,1.2381064e-7,0.0000013105388,0.0012075377,0.041508675,0.8550242],"study_design_scores_gemma":[0.0019132288,0.00072338193,0.0017469595,0.0029698797,0.0050511598,0.0007061191,0.000014025281,8.215052e-7,0.000025044907,0.00010099355,0.98597986,0.0007685518],"about_ca_topic_score_codex":0.0001739431,"about_ca_topic_score_gemma":0.0000042906254,"teacher_disagreement_score":0.9444712,"about_ca_system_score_codex":0.001620417,"about_ca_system_score_gemma":0.0028407096,"threshold_uncertainty_score":0.99984413},"labels":[],"label_agreement":null},{"id":"W1994932701","doi":"10.3324/haematol.2011.055269","title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; U.S. Public Health Service; Bernische Krebsliga; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Dyskeratosis congenita; Telomere; Bone marrow failure; Fluorescence in situ hybridization; Dyskeratosis; Aplastic anemia; Telomerase; Biology; Medicine; Pathology; Genetics; Bone marrow; Hyperkeratosis; Gene; Chromosome; Stem cell","score_opus":0.047812147767898446,"score_gpt":0.24638318339641127,"score_spread":0.19857103562851283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994932701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996364,0.0006430625,0.000014243855,0.00052348705,0.000025219499,0.00049772556,0.00002900313,0.0001459855,0.0017572748],"genre_scores_gemma":[0.9971534,0.00022052591,0.0011061926,0.0011112114,0.000014479346,0.000052981988,0.000025420579,0.000027180908,0.00028861844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998417,0.00008694348,0.00029941354,0.00051080005,0.00026969676,0.00041614723],"domain_scores_gemma":[0.9989269,0.000111498295,0.00012341252,0.0003642109,0.00012210691,0.00035188964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014093377,0.00030110055,0.0006916853,0.00012958242,0.000110597146,0.000024100362,0.000113957314,0.00014053575,0.00023181713],"category_scores_gemma":[0.00022208727,0.00018873284,0.00004586515,0.00041191163,0.0004091721,0.00012539663,0.000050256178,0.00025280277,0.000017251497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013807219,0.0004988779,0.9882449,0.00012614405,0.00011798686,0.0067095235,0.001380892,9.032568e-8,0.00006566555,0.000272909,0.00030339486,0.00089892495],"study_design_scores_gemma":[0.0021468608,0.00044503677,0.99403906,0.00036969938,0.0001886,0.000380301,0.00050444313,0.000044357454,0.0010440181,0.00021638753,0.00027465745,0.00034659682],"about_ca_topic_score_codex":0.00013749638,"about_ca_topic_score_gemma":0.00082128606,"teacher_disagreement_score":0.0063292226,"about_ca_system_score_codex":0.00003215224,"about_ca_system_score_gemma":0.00010812415,"threshold_uncertainty_score":0.7696302},"labels":[],"label_agreement":null},{"id":"W2003181078","doi":"10.3324/haematol.2014.104109","title":"Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bortezomib; Cyclophosphamide; Dexamethasone; Internal medicine; AL amyloidosis; Regimen; Cohort; Amyloidosis; Surgery; Chemotherapy; Multiple myeloma; Immunology","score_opus":0.007995014435383987,"score_gpt":0.24747480473891004,"score_spread":0.23947979030352606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003181078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975158,0.0009769788,0.000054963664,0.00009823017,0.00009109707,0.0007971585,0.00015860128,0.000029719391,0.00027746896],"genre_scores_gemma":[0.9943616,0.002908935,0.0019115969,0.00017814829,0.000024363517,0.00018899124,0.00022342887,0.000041240324,0.00016172096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773115,0.0003138221,0.0005318872,0.00078094285,0.00019896189,0.00044323283],"domain_scores_gemma":[0.9981837,0.00046918195,0.00045769484,0.0006550572,0.00008146141,0.00015290146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021598884,0.00043418788,0.000950927,0.000091807924,0.00009268042,0.000018583229,0.00018965901,0.0002666726,0.000048273017],"category_scores_gemma":[0.000425231,0.0003109763,0.00018234475,0.00017093855,0.00028297532,0.000010240526,0.00013779962,0.00011797794,0.000015436524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084822025,0.000836202,0.99226815,0.00001994928,0.0003962017,0.00001123341,0.000116412,0.000022202423,0.00052949553,0.000061050894,0.0002356545,0.0046552066],"study_design_scores_gemma":[0.008921955,0.0029035206,0.94913304,0.000041331343,0.0002478351,0.0000026922467,0.00014658539,0.000005564473,0.035423495,0.00002540471,0.0027637794,0.0003848011],"about_ca_topic_score_codex":0.0006705015,"about_ca_topic_score_gemma":0.00015717122,"teacher_disagreement_score":0.043135133,"about_ca_system_score_codex":0.00004947733,"about_ca_system_score_gemma":0.000047240894,"threshold_uncertainty_score":0.99993426},"labels":[],"label_agreement":null},{"id":"W2007027997","doi":"10.3324/haematol.13326","title":"Gene expression signatures in follicular lymphoma: are they ready for the clinic?","year":2008,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Follicular lymphoma; SNP array; Gene expression profiling; Single-nucleotide polymorphism; Biology; Computational biology; SNP; Genetics; Gene expression; Gene; Genome; Lymphoma; Genotype; Immunology","score_opus":0.03799693587896399,"score_gpt":0.3181259929605036,"score_spread":0.2801290570815396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007027997","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033623107,0.08098301,0.000036957485,0.0027124484,0.86916035,0.008713261,0.0011243088,0.0004192503,0.0032272835],"genre_scores_gemma":[0.22110942,0.049095098,0.0033532127,0.0011922262,0.7091938,0.008373877,0.0031039042,0.00027764586,0.004300819],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718577,0.00013497239,0.0006762894,0.00079756987,0.0007029,0.0005024808],"domain_scores_gemma":[0.99433297,0.0038575658,0.00051634264,0.00093972695,0.00022751454,0.00012589709],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032851592,0.0005432576,0.001469073,0.00011551706,0.00025622072,0.00003435783,0.0003628899,0.0016760055,0.00008086514],"category_scores_gemma":[0.0016685043,0.0002701069,0.00051971193,0.000107879765,0.000109612614,0.000035390898,0.00012980553,0.00034795352,0.000073310955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007587074,0.0010659682,0.0012663447,0.00017771467,0.00020976092,0.0023469967,0.00011310656,0.00000529953,0.000019544625,0.000022175116,0.9931793,0.0008350345],"study_design_scores_gemma":[0.007691014,0.00056310254,0.004083296,0.0009150139,0.00047166643,0.00011726808,0.00010635345,0.000014493627,0.0022942093,0.00017912888,0.9832,0.00036443578],"about_ca_topic_score_codex":0.00016302991,"about_ca_topic_score_gemma":0.0000786473,"teacher_disagreement_score":0.18748632,"about_ca_system_score_codex":0.00026231646,"about_ca_system_score_gemma":0.0003622417,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2010567185","doi":"10.3324/haematol.2010.022210","title":"CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"Multiple myeloma; Internal medicine; Oncology; Expression (computer science); Overall survival; Medicine; Adverse effect; Cancer research","score_opus":0.01226226489713932,"score_gpt":0.24420793155145465,"score_spread":0.23194566665431532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010567185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981081,0.000013189472,0.0000108589775,0.000053793556,0.000040846688,0.0010001542,0.00008419467,0.00006402898,0.00062485714],"genre_scores_gemma":[0.99648976,0.000012251028,0.0032146026,0.000071978466,0.000009196415,0.00003467492,0.0000890974,0.000031971256,0.000046462177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981824,0.00010329603,0.00028071346,0.00051038637,0.00056204107,0.00036111794],"domain_scores_gemma":[0.99870956,0.00010578189,0.00017771732,0.00044403505,0.0002170892,0.00034583296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010916754,0.00026061016,0.00053512026,0.00016853963,0.00011167433,0.000010938685,0.00011838831,0.00023735102,0.0003674304],"category_scores_gemma":[0.00015623754,0.00015198083,0.000035657184,0.00023481353,0.0003217073,0.00024766772,0.000110627196,0.0004225225,0.000017338858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012714961,0.0011749354,0.9758252,0.00008703792,0.0000640792,0.00029303398,0.001618736,0.0000018379291,0.0070931707,0.000007597622,0.00016957492,0.0009498625],"study_design_scores_gemma":[0.01585904,0.0031884727,0.95320284,0.00045445375,0.000046276462,0.0000437238,0.0007764142,0.0015214207,0.024610795,0.000012159405,0.000105021725,0.00017935569],"about_ca_topic_score_codex":0.00014979126,"about_ca_topic_score_gemma":0.000073869815,"teacher_disagreement_score":0.022622306,"about_ca_system_score_codex":0.0000262242,"about_ca_system_score_gemma":0.00006094289,"threshold_uncertainty_score":0.61975986},"labels":[],"label_agreement":null},{"id":"W2016011302","doi":"10.3324/haematol.2009.011692","title":"Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medizinische Universität Graz; Austrian Science Fund; Karl-Franzens-Universität Graz; Deutsche Forschungsgemeinschaft; Stem Cell Network","keywords":"Mesenchymal stem cell; Senescence; Stromal cell; Biology; Cell biology; Cell culture; Cancer research; Cell growth; Bone marrow; Cell cycle; Cell; Immunology; Genetics","score_opus":0.039794263361792856,"score_gpt":0.32236559266328285,"score_spread":0.28257132930149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016011302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925623,0.0001219329,0.00004401632,0.0031208186,0.00015974151,0.0010147215,0.00007908407,0.00014005089,0.0027573125],"genre_scores_gemma":[0.9967466,0.00013558505,0.00057246105,0.00024434758,0.00007707887,0.00021767954,0.00015480936,0.000027134707,0.001824331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997384,0.00024911278,0.00037230522,0.00069803005,0.00062825944,0.0006682647],"domain_scores_gemma":[0.9982856,0.00024029257,0.00024073373,0.00065252883,0.00023131577,0.0003495311],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028724884,0.0003227167,0.00074076967,0.00017520561,0.000205496,0.0000344252,0.0002675621,0.0005159904,0.0015203129],"category_scores_gemma":[0.00048574127,0.00021574258,0.00012146347,0.00038223094,0.00025050866,0.00006140736,0.00020087355,0.0010421203,0.000102265876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102592494,0.0006257781,0.048141077,0.00007693322,0.000033123448,0.0005962988,0.0003107247,0.0000027689787,0.94675475,0.0003722346,0.002944559,0.000039170773],"study_design_scores_gemma":[0.0013312564,0.00044074596,0.21481422,0.0003032469,0.00003879689,0.00019987901,0.0011533487,0.00013976585,0.7801652,0.0006318737,0.0004918118,0.00028987744],"about_ca_topic_score_codex":0.0000271531,"about_ca_topic_score_gemma":0.00047132836,"teacher_disagreement_score":0.16667314,"about_ca_system_score_codex":0.00010915374,"about_ca_system_score_gemma":0.00006634921,"threshold_uncertainty_score":0.99939245},"labels":[],"label_agreement":null},{"id":"W2024119815","doi":"10.3324/haematol.2011.054361","title":"Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Lady Tata Memorial Trust; European Hematology Association","keywords":"CEBPA; Germline mutation; Germline; Myeloid leukemia; Cancer research; Monosomy; Mutation; Chromosome 7 (human); Myelodysplastic syndromes; Biology; Genetics; Acute leukemia; Leukemia; Medicine; Immunology; Karyotype; Chromosome; Gene; Bone marrow","score_opus":0.029065012473407464,"score_gpt":0.28838651818110395,"score_spread":0.25932150570769646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024119815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641097,0.0006660965,0.0008055788,0.00073714467,0.00006934867,0.0008008591,0.00002252708,0.00008743166,0.0004000681],"genre_scores_gemma":[0.9937243,0.00010529243,0.005675308,0.00013840853,0.00005351004,0.0000813418,0.00013872133,0.000029712823,0.00005344659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792004,0.00024991005,0.0004448513,0.0004152465,0.00038478052,0.0005851986],"domain_scores_gemma":[0.9985878,0.00068406865,0.00015558355,0.00019818169,0.00008857667,0.00028580858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064572995,0.0002726409,0.0006258802,0.00026870304,0.00014194584,0.000042681582,0.00007648379,0.00020960985,0.00007415264],"category_scores_gemma":[0.00065772276,0.00020448316,0.000031015963,0.00037532044,0.00033416835,0.00033986027,0.0000820807,0.00029464476,0.0000305633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078030634,0.0011431563,0.9012378,0.0020869875,0.0005130663,0.02159268,0.004526492,0.00012726437,0.013339311,0.0018548366,0.00036817262,0.045407172],"study_design_scores_gemma":[0.0067462334,0.002198515,0.93766534,0.0003653646,0.00018633514,0.037207387,0.0025009254,0.010469597,0.001925759,0.00022972627,0.000047297017,0.00045753483],"about_ca_topic_score_codex":0.00011102908,"about_ca_topic_score_gemma":0.000053549644,"teacher_disagreement_score":0.044949636,"about_ca_system_score_codex":0.00010774716,"about_ca_system_score_gemma":0.00015713306,"threshold_uncertainty_score":0.83385813},"labels":[],"label_agreement":null},{"id":"W2024483006","doi":"10.3324/haematol.2014.121079","title":"The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Dysplasia; Medicine; Myeloid; Bone marrow; Myeloid leukemia; Chromosomal translocation; Gastroenterology; Population; Megakaryocyte; CEBPA; Internal medicine; Pathology; Biology; Gene; Genetics; Haematopoiesis","score_opus":0.06178628481314611,"score_gpt":0.31755517810562645,"score_spread":0.2557688932924803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024483006","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11191013,0.027429063,0.000007170916,0.8313161,0.0009962419,0.0067274505,0.0006930764,0.0012650054,0.019655757],"genre_scores_gemma":[0.044299923,0.027081635,0.0061602765,0.7072727,0.0059636775,0.0017998,0.0124927545,0.0009747148,0.19395454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933452,0.00087289035,0.0010017398,0.0016249196,0.0014625419,0.0016927201],"domain_scores_gemma":[0.9956511,0.001134786,0.0005449873,0.001561494,0.00066595955,0.00044164545],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0011130308,0.0010978078,0.0020481192,0.00028446986,0.0008965042,0.0003113146,0.0011117844,0.0037117363,0.0005818981],"category_scores_gemma":[0.002692539,0.0005493625,0.0003742031,0.00064005767,0.0009766446,0.0001425186,0.0010940853,0.0066329935,0.00030858384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012448564,0.000030360367,0.0006198836,0.00047447518,0.0010827394,0.034989722,0.0003511799,2.9574997e-7,0.00014043004,0.000039957034,0.9576828,0.0033433232],"study_design_scores_gemma":[0.003135239,0.0010207077,0.0011427428,0.0010864743,0.0006478086,0.027218506,0.00043244415,0.000033571603,0.00012474632,0.00066278747,0.9636216,0.00087335537],"about_ca_topic_score_codex":0.000072510484,"about_ca_topic_score_gemma":0.000013733243,"teacher_disagreement_score":0.17429878,"about_ca_system_score_codex":0.001016198,"about_ca_system_score_gemma":0.0011917748,"threshold_uncertainty_score":0.9996958},"labels":[],"label_agreement":null},{"id":"W2026548922","doi":"10.3324/haematol.2011.040402","title":"Genomic profiles of MALT lymphomas: variability across anatomical sites","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Associazione Italiana per la Ricerca sul Cancro; Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Biology; Chromosome; Comparative genomic hybridization; MALT lymphoma; Chromosomal translocation; Genetics; Pathology; Evolutionary biology; Gene; Medicine","score_opus":0.05047863974647793,"score_gpt":0.2929303381884109,"score_spread":0.24245169844193298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026548922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989351,0.00029095422,0.000014334849,0.00012317361,0.000050775237,0.00045341667,0.000040243795,0.000085058986,0.009591042],"genre_scores_gemma":[0.9947828,0.000051423474,0.00483042,0.00014607988,0.000019438134,0.000089690795,0.000023218512,0.000011559999,0.00004539222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987425,0.000071541166,0.00038660318,0.00034731635,0.00014555197,0.00030649244],"domain_scores_gemma":[0.9990591,0.00013535278,0.00013472405,0.0004554813,0.00008275147,0.00013260212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023004896,0.00017591617,0.000594972,0.00003268237,0.000062091334,0.000004713372,0.00011964557,0.00015484376,0.0010781985],"category_scores_gemma":[0.00016776247,0.00011558949,0.00017111823,0.00011048074,0.00023633767,0.000037740294,0.00010807285,0.000052679115,0.00013582948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028934103,0.001543887,0.98511076,0.00014594551,0.000117107564,0.000275568,0.0005658718,7.774389e-8,0.0013794014,0.009063702,0.00028329185,0.0012250695],"study_design_scores_gemma":[0.0014861994,0.00036000894,0.9282975,0.000042394124,0.00009727847,0.00042498444,0.0001586199,0.000031746524,0.06688721,0.0018395509,0.00025799926,0.00011650492],"about_ca_topic_score_codex":0.00010065021,"about_ca_topic_score_gemma":0.000007345572,"teacher_disagreement_score":0.06550781,"about_ca_system_score_codex":0.00009423296,"about_ca_system_score_gemma":0.00008069123,"threshold_uncertainty_score":0.99983495},"labels":[],"label_agreement":null},{"id":"W2029993391","doi":"10.3324/haematol.2014.115709","title":"Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Skånes universitetssjukhus; Hospital for Sick Children; Lunds Universitet","keywords":"Medicine; Clotting factor; Haemophilia; Factor IX; Arthropathy; Hemarthrosis; Coagulopathy; Surgery; Pediatrics; Prophylactic treatment; Factor VIIa; Intensive care medicine; Internal medicine; Coagulation; Alternative medicine; Osteoarthritis","score_opus":0.03848889974916503,"score_gpt":0.32662392638426047,"score_spread":0.28813502663509544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029993391","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30614457,0.0008260746,0.000006559954,0.6812829,0.00027237288,0.0019266425,0.000024672225,0.0002495966,0.009266625],"genre_scores_gemma":[0.8534981,0.00011167195,0.00028990358,0.13829114,0.002366479,0.00029131523,0.0004550046,0.00012331817,0.0045730793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957413,0.00021689697,0.0007140889,0.0010871947,0.0009735645,0.0012669747],"domain_scores_gemma":[0.9983157,0.00033558716,0.00020962655,0.00086273503,0.00005163095,0.00022471423],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00039488822,0.00073349284,0.0017925951,0.00063721684,0.00016015358,0.000077677265,0.00044642945,0.0019542663,0.0010013795],"category_scores_gemma":[0.00018528973,0.0004779951,0.00040640033,0.00053070945,0.0003402383,0.000095396455,0.00020174462,0.0036266968,0.00067490153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003689925,0.00042668552,0.13083865,0.004155062,0.00047295113,0.060503554,0.00066037383,0.0000023631032,0.000030639265,0.0017077612,0.79805124,0.0027817134],"study_design_scores_gemma":[0.008825289,0.003712448,0.024990385,0.003798658,0.00046976912,0.007785238,0.00004987595,0.00017187237,0.00037287685,0.030871848,0.91716814,0.0017836168],"about_ca_topic_score_codex":0.00010695066,"about_ca_topic_score_gemma":0.000045693836,"teacher_disagreement_score":0.5473535,"about_ca_system_score_codex":0.00028418115,"about_ca_system_score_gemma":0.00020876319,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W2032532029","doi":"10.3324/haematol.11572","title":"Hb Evora [ 2 35, Ser-&gt;Pro], a novel hemoglobin variant associated with an  -thalassemia phenotype","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Missense mutation; Phenotype; Thalassemia; Genetics; Mutation; Hemoglobinopathy; Biology; Hemoglobin; Amino acid substitution; Gene; Molecular biology; Hemolytic anemia; Immunology; Biochemistry","score_opus":0.019544050927914,"score_gpt":0.26202194499075593,"score_spread":0.24247789406284193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032532029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645812,0.00050232717,0.0032042346,0.0011611208,0.0002029097,0.0008023599,0.000014709139,0.0005486122,0.028982509],"genre_scores_gemma":[0.9931238,0.00004709918,0.0040825633,0.001443193,0.000063148516,0.000020413565,0.00012310655,0.000059759222,0.001036882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973498,0.00006450761,0.0005440774,0.00063582906,0.00051709823,0.00088870974],"domain_scores_gemma":[0.9983197,0.00015007117,0.00025255195,0.00058344484,0.00023458632,0.00045968892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070629566,0.0004044081,0.000796659,0.0001561638,0.0002391118,0.000041491134,0.00022299205,0.0006420851,0.0003517778],"category_scores_gemma":[0.00037764476,0.00026751254,0.0001312156,0.0007761014,0.00021483685,0.00012739461,0.00007120408,0.0006057111,0.00013283578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03606067,0.05682747,0.33112818,0.0031681617,0.0097221155,0.13438115,0.01794387,0.00089271757,0.1693935,0.12710649,0.0556206,0.057755087],"study_design_scores_gemma":[0.07567775,0.031423967,0.67055196,0.0074906456,0.004836524,0.04701114,0.01665194,0.01574012,0.025504163,0.004982413,0.09139226,0.008737097],"about_ca_topic_score_codex":0.00008276994,"about_ca_topic_score_gemma":0.000115025265,"teacher_disagreement_score":0.3394238,"about_ca_system_score_codex":0.00013297757,"about_ca_system_score_gemma":0.00020640907,"threshold_uncertainty_score":0.9999777},"labels":[],"label_agreement":null},{"id":"W2033482115","doi":"10.3324/haematol.2013.092114","title":"Commemorating Professor Renzo Galanello (July 21st 1948 - May 13th 2013)","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Francophone University Association","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; University of Toronto","keywords":"Battle; Wife; Medicine; Classics; Art; History; Ancient history; Philosophy; Theology","score_opus":0.036464433359462846,"score_gpt":0.30915243486372146,"score_spread":0.2726880015042586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033482115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83752996,0.00052524096,0.00035837007,0.036409453,0.00041043718,0.0030848011,0.000017485998,0.00070922734,0.120955005],"genre_scores_gemma":[0.97732383,0.00007448954,0.0053903107,0.0020590713,0.00019201673,0.00031280564,0.00006984219,0.000050825456,0.01452678],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973431,0.00018658706,0.00053722254,0.0005081973,0.00059158535,0.0008333006],"domain_scores_gemma":[0.99799925,0.00046061198,0.00017929322,0.0007496459,0.00022841818,0.00038276237],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00035827467,0.00031171416,0.00072653743,0.00013653608,0.00023713672,0.00007950636,0.00035788343,0.0003108082,0.0024309258],"category_scores_gemma":[0.0007183131,0.00021179461,0.00012141905,0.00034652487,0.00029290724,0.00016452676,0.0002584146,0.00060857245,0.009267136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016567236,0.00038088462,0.015758915,0.0003798958,0.00013383853,0.0009597421,0.0005168876,0.000002651248,0.003940228,0.0012449884,0.97393346,0.002582858],"study_design_scores_gemma":[0.037222546,0.0068952763,0.1360174,0.004062671,0.000964243,0.030994477,0.011309049,0.035073392,0.059640568,0.009492824,0.66336054,0.004967003],"about_ca_topic_score_codex":0.00044898302,"about_ca_topic_score_gemma":0.000016583588,"teacher_disagreement_score":0.3105729,"about_ca_system_score_codex":0.00023475969,"about_ca_system_score_gemma":0.0003119433,"threshold_uncertainty_score":0.998481},"labels":[],"label_agreement":null},{"id":"W2034781156","doi":"10.3324/haematol.2012.068288","title":"CD20 has no prognostic significance in children with precursor B-cell acute lymphoblastic leukemia","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; University of Toronto","keywords":"Medicine; Minimal residual disease; Internal medicine; Oncology; Log-rank test; Lymphoblastic Leukemia; Proportional hazards model; Survival analysis; Leukemia; Pediatrics","score_opus":0.01863836450510044,"score_gpt":0.2576372170730993,"score_spread":0.23899885256799883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034781156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670095,0.0005405077,0.00080337503,0.00031530284,0.00010746792,0.0022585508,0.000023798513,0.0002427518,0.009007264],"genre_scores_gemma":[0.9909799,0.000069512826,0.0062118983,0.0003962141,0.00019112021,0.00048181278,0.000067681394,0.000077379314,0.0015244667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645656,0.00015849534,0.0005175911,0.0006650861,0.0007583569,0.0014439252],"domain_scores_gemma":[0.99789476,0.00048025078,0.00018965903,0.0006699804,0.00018356249,0.0005817867],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035709975,0.0004720129,0.0008696947,0.00024766446,0.0001440298,0.00005844337,0.00038466178,0.0003194614,0.0003957448],"category_scores_gemma":[0.00052451814,0.0003200404,0.00010867962,0.0007107774,0.00053811213,0.00024160711,0.00017490855,0.00051687774,0.0022555778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001723342,0.0012071021,0.98305625,0.0003070622,0.00031482574,0.0008204791,0.00046672605,0.000032679087,0.0026454448,0.00026753425,0.008697697,0.0004608574],"study_design_scores_gemma":[0.019489368,0.003503977,0.93534005,0.00084933796,0.0009016602,0.012763707,0.00016990652,0.0023310988,0.020347096,0.000104493476,0.0028828527,0.001316461],"about_ca_topic_score_codex":0.000110537745,"about_ca_topic_score_gemma":0.00001111285,"teacher_disagreement_score":0.04771621,"about_ca_system_score_codex":0.0011730175,"about_ca_system_score_gemma":0.0014562223,"threshold_uncertainty_score":0.9999252},"labels":[],"label_agreement":null},{"id":"W2039543380","doi":"10.3324/haematol.2011.051433","title":"Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada; University of Bern; National Science Foundation; National Institutes of Health; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"ADAMTS13; Autoantibody; Thrombotic thrombocytopenic purpura; Medicine; Immunology; Von Willebrand factor; Internal medicine; Antibody; Platelet","score_opus":0.1554405688723648,"score_gpt":0.32904417117447626,"score_spread":0.17360360230211147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039543380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858476,0.008574118,0.00015789506,0.00007256113,0.00041781037,0.0013860057,0.00007609038,0.000103618426,0.0006271718],"genre_scores_gemma":[0.99887836,0.00025027327,0.00048718794,0.000024740919,0.0000098176915,0.00026256675,0.00002301404,0.000017608929,0.00004645252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771893,0.0003863596,0.00066900504,0.00053218415,0.00007714532,0.0006163895],"domain_scores_gemma":[0.99822676,0.00061702466,0.00044165633,0.0005565608,0.00012291445,0.000035108358],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044969047,0.0003117039,0.0010071162,0.00017804407,0.00015571585,0.000012995424,0.0005997907,0.0002098468,0.0013025496],"category_scores_gemma":[0.00046576004,0.00025631028,0.00023695735,0.00021296287,0.0003474512,0.00029767884,0.00031458156,0.00019919072,0.0001525057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002344169,0.0024526124,0.50655013,0.0012708523,0.00055607286,0.000055409593,0.0034149878,0.000009326529,0.46071827,0.013630354,0.0020723958,0.006925421],"study_design_scores_gemma":[0.0014134803,0.0009442723,0.8178985,0.00097197405,0.00015104603,0.00012521831,0.00077197305,0.000043780215,0.17494352,0.0017377511,0.00055672985,0.00044174196],"about_ca_topic_score_codex":0.00029747162,"about_ca_topic_score_gemma":0.00027348916,"teacher_disagreement_score":0.31134838,"about_ca_system_score_codex":0.00005629235,"about_ca_system_score_gemma":0.00011268957,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W2044240154","doi":"10.3324/haematol.2015.124008","title":"Tumor-associated macrophages in diffuse large B-cell lymphoma","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of British Columbia; Ligue Genevoise Contre le Cancer; Michael Smith Health Research BC","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Refractory (planetary science); Internal medicine; Disease; Oncology; Pathology; Biology","score_opus":0.024532070276834118,"score_gpt":0.26239133987691127,"score_spread":0.23785926960007714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044240154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7212471,0.0064432886,8.7843824e-7,0.24701943,0.0005484882,0.0015520084,0.0003724383,0.00041542083,0.022400972],"genre_scores_gemma":[0.5911464,0.00027544374,0.00011713576,0.40127283,0.0003720533,0.00035797752,0.0012977844,0.00009014347,0.0050702197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967571,0.00022294186,0.00062753283,0.00078546396,0.0006428069,0.00096418156],"domain_scores_gemma":[0.9983474,0.00024635092,0.0003622949,0.00071765075,0.00014087572,0.00018542852],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024021445,0.00064379076,0.0017502555,0.00027216328,0.00007508894,0.000050941668,0.00026154297,0.0011330857,0.0002789704],"category_scores_gemma":[0.0002508529,0.0004565949,0.00033486707,0.0003107473,0.00008844446,0.00004405452,0.00017364856,0.000588537,0.0011240824],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005884586,0.009745623,0.016659912,0.0002520269,0.00012461466,0.105672784,0.00009578342,3.3849187e-8,0.0000029104158,0.000022541744,0.86714005,0.00022485064],"study_design_scores_gemma":[0.05021192,0.00072401203,0.027002547,0.00073000917,0.0005090636,0.0017547752,0.00007554112,0.000022073205,0.0005306593,0.0003286044,0.9173633,0.000747532],"about_ca_topic_score_codex":0.00017783293,"about_ca_topic_score_gemma":0.000046012345,"teacher_disagreement_score":0.15425342,"about_ca_system_score_codex":0.00084323995,"about_ca_system_score_gemma":0.00032200382,"threshold_uncertainty_score":0.9997886},"labels":[],"label_agreement":null},{"id":"W2046217643","doi":"10.3324/haematol.11604","title":"Rapid desensitization for chlorambucil drug fever","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; Health Sciences Centre; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Chlorambucil; Desensitization (medicine); Drug; Medicine; Pharmacology; Internal medicine; Chemotherapy","score_opus":0.04447659047139698,"score_gpt":0.3122120784271372,"score_spread":0.26773548795574026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046217643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7937379,0.000277222,0.02881103,0.00488635,0.0008930481,0.0019895327,0.000015046335,0.0007682731,0.16862161],"genre_scores_gemma":[0.98907125,0.00002822753,0.0076667746,0.0008257844,0.0001408141,0.00002433983,0.00005624556,0.000021492593,0.0021650675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990294,0.000015136447,0.0002396122,0.00024066499,0.00016364935,0.00031156567],"domain_scores_gemma":[0.99913627,0.00022472905,0.00008479838,0.00024652274,0.00016977008,0.00013791723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003471858,0.00012667417,0.0002817798,0.000117546995,0.00012671108,0.0000116191495,0.000047004418,0.00011615459,0.000044003627],"category_scores_gemma":[0.00039567743,0.000101777216,0.0001177024,0.00021409661,0.000057549863,0.00007847314,0.000020173262,0.00012426788,0.00020465006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007273373,0.0025556264,0.012140341,0.0011480026,0.0007052569,0.0030690085,0.0027385666,0.000050276343,0.06783664,0.10228025,0.046415176,0.76033354],"study_design_scores_gemma":[0.0036566637,0.0000943095,0.06408658,0.00018274375,0.00032644105,0.0033833873,0.0018883321,0.0005974826,0.104279615,0.0021880881,0.8187856,0.0005307403],"about_ca_topic_score_codex":0.000011248106,"about_ca_topic_score_gemma":0.000016652413,"teacher_disagreement_score":0.77237046,"about_ca_system_score_codex":0.00008035024,"about_ca_system_score_gemma":0.000053416567,"threshold_uncertainty_score":0.41503543},"labels":[],"label_agreement":null},{"id":"W2048293097","doi":"10.3324/haematol.2014.112557","title":"Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver General Hospital","funders":"Erasmus Medisch Centrum; King's College London; University of Alberta; Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Multiple myeloma; Refractory (planetary science); Internal medicine; Oncology; Quality of life (healthcare); Lenalidomide","score_opus":0.1214802133070783,"score_gpt":0.3563383526192474,"score_spread":0.2348581393121691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048293097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8995694,0.0036481805,0.000025569581,0.09101031,0.00064222515,0.0044098063,0.00047909096,0.00010336817,0.00011204972],"genre_scores_gemma":[0.9715612,0.0009933084,0.004085286,0.020625751,0.0005254647,0.0003816957,0.0014326089,0.00012501283,0.00026969644],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98799,0.004884328,0.00316007,0.0012916208,0.0015218068,0.0011521648],"domain_scores_gemma":[0.9741691,0.020642478,0.0024825472,0.0019595101,0.00025784568,0.00048853917],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0027793108,0.0008969902,0.005237701,0.00042158758,0.00016631807,0.000029361023,0.00066252175,0.0019055392,0.00042344254],"category_scores_gemma":[0.020966828,0.00054961705,0.0005372541,0.0006428209,0.0010041863,0.00007948965,0.0003362693,0.003020977,0.000050343035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87051713,0.0028973164,0.01244624,0.003331734,0.0033962647,0.0046918164,0.0011651207,0.000013106418,0.0006069644,0.00010011045,0.0894315,0.011402689],"study_design_scores_gemma":[0.82443,0.014714605,0.13996336,0.0035257626,0.00080695504,0.00021624583,0.0005239732,0.0006186472,0.0008860882,0.0005098617,0.012359789,0.0014447207],"about_ca_topic_score_codex":0.023706013,"about_ca_topic_score_gemma":0.0016231044,"teacher_disagreement_score":0.12751712,"about_ca_system_score_codex":0.00046528166,"about_ca_system_score_gemma":0.0012539313,"threshold_uncertainty_score":0.99969554},"labels":[],"label_agreement":null},{"id":"W2049141040","doi":"10.3324/haematol.2013.100818","title":"R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Medicine; CHOP; Rituximab; Internal medicine; Vincristine; Gastroenterology; Hazard ratio; Diffuse large B-cell lymphoma; Bevacizumab; Lymphoma; Surgery; Confidence interval; Oncology; Cyclophosphamide; Chemotherapy","score_opus":0.014153833998881038,"score_gpt":0.25063564342900474,"score_spread":0.2364818094301237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049141040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594426,0.000046728008,0.000018304074,0.00018077427,0.000028924604,0.0025518695,0.000014953037,0.00014004322,0.0010741461],"genre_scores_gemma":[0.9977048,0.0000101660935,0.00065031956,0.00039193066,0.0000107032765,0.00043628845,0.000056107052,0.000044480817,0.0006952139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756837,0.0001873816,0.0004401175,0.0006571714,0.0005090343,0.0006379419],"domain_scores_gemma":[0.99861825,0.00018484824,0.0002041875,0.0006719085,0.00009938126,0.0002214321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017928696,0.00048069766,0.0012438894,0.00015299166,0.00012911478,0.00004147306,0.0001545593,0.00012334908,0.00010765515],"category_scores_gemma":[0.00009085879,0.00022232057,0.00007578472,0.00032889287,0.00007694383,0.00008507935,0.000078066136,0.00009709049,0.00009404263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004994751,0.047562283,0.9441427,0.00007920355,0.00018607438,0.0012523571,0.0006142702,8.5723104e-7,3.5911813e-7,0.00006226416,0.00014726938,0.0009576376],"study_design_scores_gemma":[0.14270648,0.009391142,0.8462236,0.00018006428,0.00038165433,0.00011953592,0.00034783274,0.000038862483,0.00005082033,0.000008269524,0.00026788795,0.00028385286],"about_ca_topic_score_codex":0.00019045279,"about_ca_topic_score_gemma":0.0011215704,"teacher_disagreement_score":0.13771173,"about_ca_system_score_codex":0.00023343426,"about_ca_system_score_gemma":0.00012634991,"threshold_uncertainty_score":0.90659696},"labels":[],"label_agreement":null},{"id":"W2055338669","doi":"10.3324/haematol.12320","title":"Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondation Pour La Conservation Du Saumon Atlantique","keywords":"D-dimer; Medicine; Venous thromboembolism; Discontinuation; Antagonism; Internal medicine; Hazard ratio; Gastroenterology; Vitamin k; Surgery; Confidence interval; Thrombosis","score_opus":0.04675828547302436,"score_gpt":0.3609892755392832,"score_spread":0.3142309900662589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055338669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939768,0.001593505,0.0003323058,0.0005994425,0.00019006479,0.0027469243,0.000070564325,0.000030402867,0.00046001893],"genre_scores_gemma":[0.9960089,0.0008486194,0.0027267495,0.00015509108,0.000014913914,0.00019255324,0.000007416509,0.000016914728,0.000028868059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641526,0.0012387354,0.0009194542,0.00043120046,0.0006856894,0.00030968472],"domain_scores_gemma":[0.9966992,0.0008215772,0.0008445412,0.0010900666,0.00045788704,0.000086684435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011574203,0.000282873,0.0023230421,0.0003045296,0.00022351126,0.0000059528256,0.0005395883,0.00009842534,0.00010767103],"category_scores_gemma":[0.0010498249,0.00013202688,0.0005922107,0.0014064256,0.00050800235,0.00003756175,0.0003703271,0.00026147385,0.0000034675766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017257024,0.02694892,0.76321286,0.00067530276,0.03375033,0.00008180276,0.15098234,0.0012576941,0.0022052154,0.0055856183,0.0036731272,0.009901065],"study_design_scores_gemma":[0.00059020263,0.0055118934,0.97330797,0.00014300195,0.009458427,0.000012455243,0.0069064717,0.00038550844,0.0032024058,0.00026015978,0.000090295005,0.00013120926],"about_ca_topic_score_codex":0.00046366424,"about_ca_topic_score_gemma":0.00013506268,"teacher_disagreement_score":0.21009508,"about_ca_system_score_codex":0.000029121591,"about_ca_system_score_gemma":0.00007498052,"threshold_uncertainty_score":0.53839},"labels":[],"label_agreement":null},{"id":"W2057046347","doi":"10.3324/haematol.2012.071068","title":"Mutations in the telomere capping complex in bone marrow failure and related syndromes","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Wellcome Trust","keywords":"Dyskeratosis congenita; Telomere; Phenotype; Biology; Telomere-binding protein; Genetics; Mutation; Bone marrow failure; Shelterin; DNA; Gene; Stem cell; Haematopoiesis","score_opus":0.04760938936269726,"score_gpt":0.2877051440021218,"score_spread":0.24009575463942456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057046347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867145,0.003277859,0.0000050298027,0.0068448326,0.000053322095,0.00044190924,0.000006754197,0.00006118703,0.0025946216],"genre_scores_gemma":[0.99815995,0.00011637254,0.0010130526,0.00048285484,0.000019110461,0.00003012734,0.000056923513,0.00001102204,0.00011060227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861753,0.00015901131,0.00037259774,0.00025941915,0.0001884702,0.0004029702],"domain_scores_gemma":[0.9991312,0.00026338585,0.000081070124,0.00040552247,0.000023748096,0.00009509485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004835289,0.00015813127,0.00043338412,0.00019196789,0.00009905153,0.000019494493,0.00016425028,0.00013981175,0.00018135842],"category_scores_gemma":[0.00030041844,0.00010271073,0.00003303814,0.0005485192,0.00018431337,0.000159524,0.000073350144,0.00033761715,0.000048151767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071533934,0.00063416647,0.9625403,0.00038721372,0.0000546593,0.003043229,0.013255335,0.0000049345686,0.0026083242,0.008701094,0.004695076,0.004004103],"study_design_scores_gemma":[0.0011228605,0.00006612756,0.97377175,0.00021933905,0.00004719827,0.009862009,0.008757048,0.00034891567,0.00006341087,0.0006793781,0.004846648,0.00021528424],"about_ca_topic_score_codex":0.00011718536,"about_ca_topic_score_gemma":0.00019708046,"teacher_disagreement_score":0.01144545,"about_ca_system_score_codex":0.000025053903,"about_ca_system_score_gemma":0.00002928782,"threshold_uncertainty_score":0.4188422},"labels":[],"label_agreement":null},{"id":"W2058663390","doi":"10.3324/haematol.10317","title":"APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival","year":2007,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Universidad de Jaén; Fondation de France; Association pour la Recherche sur le Cancer","keywords":"B-cell activating factor; Chronic lymphocytic leukemia; Clinical significance; Medicine; Immunology; CD20; Leukemia; Lymphocyte; Internal medicine; Oncology; B cell; Antibody","score_opus":0.0689201530676397,"score_gpt":0.32353673284256834,"score_spread":0.25461657977492863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058663390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.907982,0.0076933894,0.0012864537,0.059951343,0.0015270533,0.014779572,0.0019950145,0.0008268432,0.00395832],"genre_scores_gemma":[0.8839802,0.0006385795,0.0027207967,0.10190806,0.0029290207,0.0012182292,0.0007064257,0.00044894972,0.0054497398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.991187,0.00040667492,0.0021070424,0.0018075291,0.0020349545,0.0024567968],"domain_scores_gemma":[0.9897414,0.0060746316,0.00114291,0.0019684301,0.0007383578,0.00033427268],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017812126,0.0011503081,0.0038323181,0.0009190558,0.0001455923,0.00004905679,0.0011199911,0.003298144,0.0003487943],"category_scores_gemma":[0.006627173,0.00097588694,0.00072291086,0.001017168,0.0009287563,0.00011614392,0.00046472123,0.0027853448,0.0001943685],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009678117,0.00059056113,0.003811165,0.11346727,0.0022449107,0.115315095,0.00053919,0.0009730139,0.0044414536,0.00060328486,0.74159276,0.0067431736],"study_design_scores_gemma":[0.23872906,0.007907297,0.023481065,0.03433136,0.0038476768,0.022811374,0.00074046676,0.08613311,0.11595598,0.002279769,0.4555043,0.008278555],"about_ca_topic_score_codex":0.0017989031,"about_ca_topic_score_gemma":0.0004180705,"teacher_disagreement_score":0.28608847,"about_ca_system_score_codex":0.11898234,"about_ca_system_score_gemma":0.061396066,"threshold_uncertainty_score":0.9995153},"labels":[],"label_agreement":null},{"id":"W2059117184","doi":"10.3324/haematol.2012.062059","title":"Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Cancer Institute; CellGenix; Genentech; Health Resources and Services Administration; Sigma-Tau Pharmaceuticals; Therakos; Kiadis Pharma; Amgen; Otsuka America Pharmaceutical; National Heart, Lung, and Blood Institute; Blue Cross and Blue Shield Association; Otsuka America; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; WellPoint; Celgene; Takeda Oncology; Ariad Pharmaceuticals; GlaxoSmithKline; Swedish Orphan Biovitrum; Office of Naval Research; Be The Match Foundation; Medical College of Wisconsin; U.S. Department of Health and Human Services","keywords":"Medicine; Cumulative incidence; Transplantation; Myeloid leukemia; Bone marrow; Internal medicine; Leukemia; Gastroenterology; Incidence (geometry); Surgery","score_opus":0.07775151225751975,"score_gpt":0.36749665238917967,"score_spread":0.2897451401316599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059117184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893765,0.00030019038,0.0028488792,0.0023508149,0.00038921766,0.0034389198,0.00081851275,0.00007662762,0.00040034248],"genre_scores_gemma":[0.98925716,0.0018988304,0.0055207354,0.000119514254,0.00032519436,0.0007979877,0.0019306687,0.000044325043,0.00010557643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667794,0.00035213033,0.000767408,0.0006613775,0.0007467066,0.0007944291],"domain_scores_gemma":[0.9955942,0.0033238942,0.00016623226,0.00035769827,0.00032753832,0.00023044524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017033288,0.00030478544,0.000538619,0.0002951755,0.00047080984,0.00010253707,0.00039618972,0.00032022208,0.000066490815],"category_scores_gemma":[0.0004074049,0.00022752534,0.00014334201,0.00034135516,0.00022714387,0.00028886786,0.000040704388,0.0006910941,0.000010092898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13898896,0.006473757,0.66147864,0.006221606,0.0036109926,0.005691745,0.058003355,0.00012322827,0.106297135,0.002278147,0.0067581367,0.0040742788],"study_design_scores_gemma":[0.18925844,0.007895164,0.6861075,0.002237273,0.009981399,0.007948237,0.014089803,0.010954984,0.06321819,0.0012376349,0.005247785,0.0018235688],"about_ca_topic_score_codex":0.0003020368,"about_ca_topic_score_gemma":0.0004860088,"teacher_disagreement_score":0.05026949,"about_ca_system_score_codex":0.00026200552,"about_ca_system_score_gemma":0.00022196547,"threshold_uncertainty_score":0.9278214},"labels":[],"label_agreement":null},{"id":"W2064638441","doi":"10.3324/haematol.12152","title":"Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Microalbuminuria; Disease; Acute chest syndrome; Priapism; Chest pain; Sickle cell anemia; Internal medicine; Surgery","score_opus":0.04890125592743564,"score_gpt":0.35497936767394583,"score_spread":0.3060781117465102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064638441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95252496,0.0027934215,0.0023415831,0.022694238,0.00023391737,0.0022768606,0.000097175354,0.00027003017,0.01676779],"genre_scores_gemma":[0.9932843,0.0014314844,0.003138544,0.0013369295,0.000029143452,0.00007365173,0.000088853194,0.000026828395,0.0005902624],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981354,0.00036007955,0.0007011658,0.0003886091,0.00012453807,0.0002902458],"domain_scores_gemma":[0.99667567,0.0018501685,0.0003506349,0.0004726693,0.00037650988,0.00027436332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008678805,0.00017530704,0.00054352597,0.00006976677,0.00021423835,0.000005433875,0.00013729584,0.00026583346,0.000120831515],"category_scores_gemma":[0.0056865667,0.0001306565,0.00025782335,0.00036316074,0.00039715972,0.00007682506,0.00004574097,0.00031705486,0.000061927654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008848357,0.01728913,0.4291217,0.0014701706,0.0014081965,0.0023919332,0.0041867094,0.00010618838,0.0037812828,0.042521562,0.4811526,0.007722194],"study_design_scores_gemma":[0.01352179,0.003998833,0.8287199,0.00033833127,0.002102267,0.0011653831,0.0062562916,0.0014386179,0.0016385072,0.009446542,0.13034312,0.001030385],"about_ca_topic_score_codex":0.000012155221,"about_ca_topic_score_gemma":0.0000010966771,"teacher_disagreement_score":0.39959824,"about_ca_system_score_codex":0.000027768885,"about_ca_system_score_gemma":0.0002820487,"threshold_uncertainty_score":0.68077624},"labels":[],"label_agreement":null},{"id":"W2066523152","doi":"10.3324/haematol.2010.037408","title":"High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Medicine; Rituximab; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Microvessel; Oncology; Pathology; Cohort; Proportional hazards model; Angiogenesis","score_opus":0.011536105414878135,"score_gpt":0.21269570766142515,"score_spread":0.20115960224654703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066523152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989582,0.00017339944,0.00023862772,0.000019718815,0.00002680838,0.00029841575,0.000028304208,0.000028256929,0.00022831648],"genre_scores_gemma":[0.9971092,0.00004355797,0.0018196317,0.0005445783,0.000019994246,0.00004833045,0.000078743455,0.000034804652,0.00030120637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987968,0.00004090897,0.0002338067,0.00045507506,0.00011050633,0.00036287404],"domain_scores_gemma":[0.9993346,0.0000071129098,0.00014283527,0.0003500528,0.00009133433,0.00007409968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054090433,0.00027568833,0.00042793382,0.000047215242,0.00006815931,0.000014073963,0.00019585725,0.0001887851,0.000039494214],"category_scores_gemma":[0.0000074666477,0.00017440834,0.0000743538,0.00011491784,0.0000922126,0.000006178516,0.00006341247,0.000040664054,0.0000122622505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002291105,0.0033150318,0.9902736,0.000034992332,0.000056170837,0.000061751874,0.00006975224,3.349279e-7,0.0032888374,0.00002233394,0.00017939124,0.00040672693],"study_design_scores_gemma":[0.03022286,0.0011048341,0.77477854,0.00002949142,0.000046534245,0.000039201128,0.00004864979,0.000009645262,0.19244404,0.000009143576,0.0007819515,0.00048512992],"about_ca_topic_score_codex":0.00013408129,"about_ca_topic_score_gemma":0.00019595378,"teacher_disagreement_score":0.21549505,"about_ca_system_score_codex":0.000026397338,"about_ca_system_score_gemma":0.000038427133,"threshold_uncertainty_score":0.71121657},"labels":[],"label_agreement":null},{"id":"W2067685415","doi":"10.3324/haematol.2008.001024","title":"CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Rituximab; CD20; Epitope; CHOP; Lymphoma; Diffuse large B-cell lymphoma; Medicine; B cell; Immunophenotyping; Cancer research; Antigen; Immunology; Pathology; Antibody","score_opus":0.0215030188867451,"score_gpt":0.2558321422840284,"score_spread":0.2343291233972833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067685415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869326,0.002189097,0.000006531228,0.0097804135,0.000029086059,0.0006726226,0.000069976006,0.000052578995,0.00026714316],"genre_scores_gemma":[0.99756366,0.0005429934,0.0003379339,0.0013374931,0.00002044029,0.000097149925,0.00002568722,0.000012515825,0.000062129104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856764,0.00010474939,0.00040801405,0.00035867476,0.0002300959,0.0003307973],"domain_scores_gemma":[0.99882376,0.0002957922,0.00026046688,0.0004106196,0.000088717585,0.000120621386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013815648,0.00023577761,0.0006754508,0.00011265335,0.00014884559,0.000032516138,0.00011696844,0.0001424765,0.000044061264],"category_scores_gemma":[0.00024043849,0.00012749742,0.00010901864,0.00026228582,0.00010818203,0.000071168215,0.000057393656,0.00012370071,0.000019556855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038775502,0.025620224,0.94871503,0.0004505367,0.00016163116,0.007910205,0.0040899795,0.0000055022933,0.0019079256,0.0047841226,0.0041424516,0.0018246068],"study_design_scores_gemma":[0.022980213,0.00040481836,0.9585598,0.00060610916,0.0002687012,0.0005497225,0.0050056074,0.00019046973,0.009469562,0.00058060646,0.001120518,0.00026387267],"about_ca_topic_score_codex":0.000063011685,"about_ca_topic_score_gemma":0.00023562707,"teacher_disagreement_score":0.025215406,"about_ca_system_score_codex":0.000081762235,"about_ca_system_score_gemma":0.000062888226,"threshold_uncertainty_score":0.5199194},"labels":[],"label_agreement":null},{"id":"W2071134744","doi":"10.3324/haematol.2011.047670","title":"Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Salvage therapy; Chemotherapy; Medicine; Gemcitabine; Oncology; Internal medicine; Lymphoma; Refractory (planetary science); Cisplatin; Transplantation; Surgery; Materials science","score_opus":0.02961090295293868,"score_gpt":0.2552838877525562,"score_spread":0.22567298479961756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071134744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032176,0.00028633713,0.0010480818,0.0013951332,0.0001101815,0.0028084882,0.00023013623,0.00027319923,0.00352668],"genre_scores_gemma":[0.9795793,0.00016528991,0.014229581,0.004527847,0.00009049047,0.00072011555,0.00025065825,0.00010726589,0.0003294257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997295,0.000039507082,0.00066713215,0.0008349763,0.0003876236,0.0007757532],"domain_scores_gemma":[0.9982712,0.00023851548,0.000265546,0.00065590703,0.00019414931,0.00037462733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020549753,0.00059867406,0.0011877166,0.00017974373,0.0002589087,0.00004027379,0.00024341546,0.00025651566,0.0009669896],"category_scores_gemma":[0.00004349667,0.00039805434,0.00026373737,0.00028570992,0.00009303496,0.00010931269,0.000028784683,0.00009215449,0.00006404957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09951002,0.016118186,0.7821785,0.0015370831,0.0031163385,0.0025362489,0.015764207,0.000012655933,0.0016242306,0.0041332296,0.011356133,0.06211313],"study_design_scores_gemma":[0.06957195,0.024111763,0.76046336,0.0012812178,0.00057889527,0.0002923199,0.00030625134,0.00009663109,0.1051405,0.000634841,0.036112864,0.0014094342],"about_ca_topic_score_codex":0.00010207199,"about_ca_topic_score_gemma":0.0002803991,"teacher_disagreement_score":0.103516266,"about_ca_system_score_codex":0.00019696042,"about_ca_system_score_gemma":0.0001088072,"threshold_uncertainty_score":0.99994624},"labels":[],"label_agreement":null},{"id":"W2075574622","doi":"10.3324/haematol.2011.040121","title":"Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia","year":2011,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fondation Charles-Bruneau; Leukemia and Lymphoma Society of Canada; Mersin Üniversitesi; Kay Kendall Leukaemia Fund; Canadian Institutes of Health Research; Compagnia di San Paolo; Leukemia and Lymphoma Society","keywords":"Medicine; Acute lymphocytic leukemia; Leukemia; Penetrance; Genome-wide association study; Single-nucleotide polymorphism; Childhood leukemia; Genetics; Immunology; Oncology; Lymphoblastic Leukemia; Biology; Gene; Genotype; Phenotype","score_opus":0.09014294134175513,"score_gpt":0.3820084439961173,"score_spread":0.2918655026543622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075574622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19131121,0.675604,0.01867882,0.00048516697,0.0029086175,0.103649125,0.002560582,0.001459526,0.0033429894],"genre_scores_gemma":[0.026615595,0.8860978,0.058410577,0.0023511436,0.0014207432,0.019888269,0.0024546492,0.0005707018,0.0021905587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946688,0.00041625428,0.0015457871,0.0017452961,0.00078220887,0.00084169366],"domain_scores_gemma":[0.9957459,0.0006986137,0.00037411696,0.0015167533,0.00069379556,0.000970796],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063657644,0.0008396951,0.002982974,0.00064578856,0.00021773498,0.000100528334,0.0012215199,0.00055918837,0.00086835463],"category_scores_gemma":[0.0020915882,0.0006326897,0.00054163765,0.0007430548,0.00015017409,0.00010971303,0.00062091154,0.00042608337,0.00094060804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029908072,0.008790953,0.0018603052,0.010596281,0.0072876406,0.002243804,0.0038807602,0.000019722549,0.00003806987,0.000818285,0.01735631,0.94411707],"study_design_scores_gemma":[0.008183956,0.013132428,0.014315476,0.004967213,0.006093764,0.0066241045,0.00048855593,0.0002128978,0.000028154223,0.0002473895,0.9437547,0.0019513803],"about_ca_topic_score_codex":0.00005860853,"about_ca_topic_score_gemma":0.000056757966,"teacher_disagreement_score":0.9421657,"about_ca_system_score_codex":0.0023094963,"about_ca_system_score_gemma":0.0031245898,"threshold_uncertainty_score":0.9998373},"labels":[],"label_agreement":null},{"id":"W2090582630","doi":"10.3324/haematol.2010.029678","title":"Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Cancer Institute; Institut National Du Cancer; Fondation de France; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale","keywords":"Polycythemia vera; clone (Java method); Biology; Haematopoiesis; Somatic cell; Mutation; Progenitor cell; Cancer research; CD34; Germline mutation; Myeloproliferative neoplasm; Molecular biology; Genetics; Stem cell; Immunology; Myelofibrosis; Gene; Bone marrow","score_opus":0.0431385331944375,"score_gpt":0.27588322941015275,"score_spread":0.23274469621571525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090582630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881014,0.0008880596,0.00006736319,0.00072214135,0.000051536328,0.00065318675,0.000017463935,0.000038449052,0.009460401],"genre_scores_gemma":[0.9966443,0.00015938311,0.002394369,0.00026411668,0.000007426694,0.0002954077,0.00004318673,0.000013061609,0.00017871345],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874747,0.000049344984,0.00045560228,0.00028546335,0.00021544707,0.00024668773],"domain_scores_gemma":[0.9993153,0.000092654176,0.00013159518,0.0002821203,0.00006393241,0.000114369075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010982847,0.0001825191,0.00051924284,0.00010547726,0.000044216507,0.0000050043527,0.00008042112,0.00009271461,0.0012742487],"category_scores_gemma":[0.00006479166,0.00013064146,0.000100551624,0.0001823911,0.00011333558,0.000038901286,0.00004313924,0.00011264225,0.000082515515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005122832,0.008281128,0.9429608,0.00050347624,0.00034195348,0.0009878431,0.00807981,0.000002658643,0.008543644,0.021897983,0.005605938,0.002282458],"study_design_scores_gemma":[0.005680726,0.0022428422,0.26917362,0.0007288376,0.00028763307,0.0005050566,0.0023602142,0.00007033435,0.7107545,0.005868457,0.0018785766,0.00044917795],"about_ca_topic_score_codex":0.00014029519,"about_ca_topic_score_gemma":0.000035255605,"teacher_disagreement_score":0.70221084,"about_ca_system_score_codex":0.000065843524,"about_ca_system_score_gemma":0.000055974226,"threshold_uncertainty_score":0.99963874},"labels":[],"label_agreement":null},{"id":"W2095913486","doi":"10.3324/haematol.2010.025338","title":"Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Research Institute; Cancer Research Institute","keywords":"IGHV@; Internal medicine; Randomization; Oncology; Randomized controlled trial; Medicine; Beta-2 microglobulin; Chronic lymphocytic leukemia; Relative risk; Progression-free survival; Overall survival; Leukemia; Confidence interval","score_opus":0.05414269921170813,"score_gpt":0.32897521799457874,"score_spread":0.2748325187828706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095913486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586135,0.000107581036,0.000065844535,0.0002794783,0.00021325174,0.0026198076,0.0000068744057,0.00004017664,0.0008056148],"genre_scores_gemma":[0.99928534,0.000088424735,0.00012250635,0.000030478623,0.000057858648,0.00029913193,0.000036991176,0.000013910831,0.0000653301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808466,0.00019004654,0.0005085746,0.00033723886,0.00054330064,0.00033617494],"domain_scores_gemma":[0.99797934,0.00090526236,0.00021732139,0.0007218344,0.00008969337,0.00008655299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080165005,0.00018891793,0.0004971537,0.00014371649,0.00008001316,0.000029123326,0.0002958136,0.0002247689,0.00021323976],"category_scores_gemma":[0.0014665154,0.00009794925,0.0001439449,0.00030503355,0.00020377076,0.000056168927,0.00006316384,0.00039428836,0.00005907442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030950459,0.009695374,0.8912869,0.0008900875,0.00087776966,0.0020721748,0.0141700655,0.00005403287,0.012239301,0.022568151,0.0015412562,0.0136544425],"study_design_scores_gemma":[0.2259939,0.0070517063,0.7320438,0.00019324488,0.0006987768,0.0011851622,0.0031300255,0.004398383,0.017128045,0.006817279,0.00085521437,0.0005044514],"about_ca_topic_score_codex":0.0021745686,"about_ca_topic_score_gemma":0.0033965039,"teacher_disagreement_score":0.19504344,"about_ca_system_score_codex":0.0012508633,"about_ca_system_score_gemma":0.0014101255,"threshold_uncertainty_score":0.39942545},"labels":[],"label_agreement":null},{"id":"W2095934415","doi":"10.3324/haematol.2014.120857","title":"Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Budd–Chiari syndrome; Calreticulin; Medicine; Portal vein thrombosis; Thrombosis; Internal medicine; Gastroenterology; Inferior vena cava; Biology; Genetics","score_opus":0.02343537249997888,"score_gpt":0.260084234927091,"score_spread":0.2366488624271121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095934415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961034,0.00010147939,0.000019182162,0.0010376049,0.000032171447,0.0006956991,0.0000116824085,0.00004270753,0.0019560403],"genre_scores_gemma":[0.99729186,0.000011018795,0.0022414168,0.00016340417,0.0000050218764,0.00015529676,0.00008635382,0.00001252376,0.000033101507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989607,0.000051566087,0.0002593431,0.0002700268,0.00024981052,0.0002086089],"domain_scores_gemma":[0.99937946,0.00008214059,0.00008097723,0.0001690549,0.000091847854,0.00019650513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007946804,0.00017476604,0.00048682696,0.0000900037,0.000054123495,0.000019992696,0.000035558758,0.000081999824,0.0001490932],"category_scores_gemma":[0.00010866967,0.000107658074,0.000029530564,0.0001652253,0.00010703343,0.00006958698,0.00002907377,0.000107674794,0.000056726647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059877842,0.00090062886,0.99652493,0.000048279522,0.00007630163,0.0006795661,0.0005335161,0.000005912154,0.0000016322907,0.00083842233,0.00016980704,0.00016110983],"study_design_scores_gemma":[0.0037581422,0.0015269592,0.99286383,0.00017963065,0.00012198656,0.0004513587,0.0003123792,0.00010041358,0.0001137186,0.0004012806,0.00003380703,0.00013648815],"about_ca_topic_score_codex":0.00004403466,"about_ca_topic_score_gemma":0.000066651795,"teacher_disagreement_score":0.0036982642,"about_ca_system_score_codex":0.000043078715,"about_ca_system_score_gemma":0.00007148976,"threshold_uncertainty_score":0.43901688},"labels":[],"label_agreement":null},{"id":"W2096179016","doi":"10.3324/haematol.2014.108563","title":"Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centre Hospitalier Universitaire de Nantes; Ligue Contre le Cancer; National Cancer Institute; Institut National Du Cancer; Fondation de France; Association pour la Recherche sur le Cancer","keywords":"Busulfan; Clofarabine; Medicine; Myeloid leukemia; Internal medicine; Transplantation; Regimen; Gastroenterology; Leukemia; Cumulative incidence; Acute leukemia; Surgery; Hematopoietic stem cell transplantation; Cytarabine","score_opus":0.03173495571091613,"score_gpt":0.29545310455945895,"score_spread":0.26371814884854283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096179016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97617704,0.00008841471,0.0054510124,0.0022811156,0.00041747993,0.003437118,0.00018674076,0.00026821543,0.011692888],"genre_scores_gemma":[0.99514085,0.000044873785,0.0021672077,0.00088854413,0.00035405194,0.0005083282,0.00039310052,0.000040829196,0.00046219755],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966359,0.00042969492,0.0010017744,0.0008711444,0.000568031,0.00049343007],"domain_scores_gemma":[0.997365,0.0010757706,0.00040505143,0.0006927201,0.00018178673,0.0002796724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008975177,0.0003849796,0.00082935824,0.00013274126,0.00038420223,0.00006915544,0.0002872976,0.00026341336,0.00014477482],"category_scores_gemma":[0.00018733178,0.0002668672,0.00019981843,0.00041985227,0.00012697361,0.00010460337,0.000025090409,0.0003692699,0.00023168589],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6781632,0.00506297,0.003741833,0.0015162766,0.00126416,0.0034361004,0.09616603,0.00046003493,0.16966243,0.011654176,0.008914721,0.01995809],"study_design_scores_gemma":[0.29520294,0.012377795,0.022826927,0.0012279057,0.0021359934,0.0014879673,0.004353319,0.000792148,0.65142363,0.0014804445,0.0052513587,0.0014395661],"about_ca_topic_score_codex":0.00007111814,"about_ca_topic_score_gemma":0.000026484056,"teacher_disagreement_score":0.48176122,"about_ca_system_score_codex":0.00011303648,"about_ca_system_score_gemma":0.00014367481,"threshold_uncertainty_score":0.99997836},"labels":[],"label_agreement":null},{"id":"W2097367878","doi":"10.3324/haematol.2012.072090","title":"Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant","year":2013,"lang":"en","type":"review","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centre Léon Bérard; Centre hospitalier universitaire Sainte-Justine; Institut Gustave-Roussy","keywords":"Medicine; Lymphoma; Oncology; Internal medicine; Salvage therapy; Autologous stem-cell transplantation; Transplantation; Refractory (planetary science); Clinical trial; Brentuximab vedotin; Hodgkin lymphoma; Classical Hodgkin lymphoma; Chemotherapy","score_opus":0.10536846001959649,"score_gpt":0.3775607193242865,"score_spread":0.27219225930469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097367878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012471358,0.9677778,0.000030120967,0.0014676823,0.0005432681,0.01686502,0.00048875296,0.00014190265,0.00021410683],"genre_scores_gemma":[0.003481208,0.980536,0.0009737504,0.0005765632,0.00025290163,0.012554863,0.000778926,0.000083271545,0.0007625444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966069,0.00023620322,0.0013158057,0.00081754214,0.0004801302,0.00054341234],"domain_scores_gemma":[0.9951097,0.002218885,0.0009464843,0.0005545129,0.0009900996,0.00018036568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004771361,0.000693629,0.002857058,0.00012101877,0.0003445491,0.00009192074,0.00023191675,0.0006974637,0.000015693866],"category_scores_gemma":[0.0016211948,0.00034036988,0.00081248564,0.00015669737,0.000062550636,0.00007195909,0.000060279224,0.0000909946,0.00004408647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020107228,0.0040493426,0.003123883,0.0053129364,0.0013652749,0.000039743038,0.00015559446,2.3185374e-8,7.7594066e-8,0.00035624654,0.06969885,0.915697],"study_design_scores_gemma":[0.012056761,0.0027161397,0.0032238136,0.0035982335,0.006870681,0.00011156434,0.00011242286,0.000020600566,0.0000035194405,0.00009046025,0.97077763,0.00041819204],"about_ca_topic_score_codex":0.0000689336,"about_ca_topic_score_gemma":0.000026069598,"teacher_disagreement_score":0.9152788,"about_ca_system_score_codex":0.0006583108,"about_ca_system_score_gemma":0.00031065725,"threshold_uncertainty_score":0.9999048},"labels":[],"label_agreement":null},{"id":"W2098189184","doi":"10.3324/haematol.2012.062885","title":"Variations in non-pharmacological anti-infective measures in childhood leukemia - results of an international survey","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Myeloid leukemia; Childhood leukemia; Leukemia; Acute leukemia; Environmental health; Family medicine; Intensive care medicine; Pediatrics; Internal medicine; Lymphoblastic Leukemia","score_opus":0.04053151650102109,"score_gpt":0.3491545487385964,"score_spread":0.3086230322375753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098189184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925371,0.000033965243,0.00027683686,0.00019562777,0.00018144624,0.00057992904,0.000076544384,0.00003654574,0.006082046],"genre_scores_gemma":[0.99834746,0.00005922627,0.0011317685,0.00013392745,0.00007989555,0.000060303813,0.00015103628,0.000013473684,0.000022927125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760324,0.00047763056,0.00061795797,0.00033419416,0.0004889568,0.00047800128],"domain_scores_gemma":[0.99837315,0.00081153295,0.00015918876,0.00025709014,0.00020591363,0.00019311493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019888235,0.0001738274,0.00055524847,0.00038789975,0.00003490426,0.000011084247,0.0002671382,0.0002467156,0.0001519757],"category_scores_gemma":[0.003689467,0.00013186099,0.00006262996,0.00060378795,0.00013961823,0.00026486538,0.00014411857,0.00042963453,0.000045373465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012901509,0.0024249584,0.98938435,0.00002407947,0.00011270196,0.00029607187,0.0013444349,0.00013289943,0.0027022872,0.00055021077,0.000520106,0.0012177327],"study_design_scores_gemma":[0.0061422945,0.00025077353,0.98693246,0.00005833488,0.000021808215,0.0002336589,0.00008293823,0.0023292624,0.0036780564,0.00009044202,0.000055381373,0.00012459485],"about_ca_topic_score_codex":0.0012320991,"about_ca_topic_score_gemma":0.00026012733,"teacher_disagreement_score":0.0060591185,"about_ca_system_score_codex":0.00077160104,"about_ca_system_score_gemma":0.0004491927,"threshold_uncertainty_score":0.53771347},"labels":[],"label_agreement":null},{"id":"W2098388627","doi":"10.3324/haematol.10937","title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":350,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Hospital for Sick Children; U.S. Public Health Service; Wellcome Trust","keywords":"Medicine; Pediatrics; Interquartile range; Cohort; Sepsis; Pneumococcal conjugate vaccine; Thalassemia; Confidence interval; Transcranial Doppler; Sickle cell anemia; Streptococcus pneumoniae; Internal medicine; Disease","score_opus":0.009462221804418917,"score_gpt":0.26449165945301717,"score_spread":0.25502943764859826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098388627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690366,0.0007980284,0.000039681294,0.00035013858,0.000051315423,0.0007637917,0.0000037132784,0.000052550713,0.0010371096],"genre_scores_gemma":[0.9988906,0.0002192025,0.0002968313,0.00040041842,0.000019262505,0.000020422662,0.000020178919,0.000017873925,0.00011522366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816555,0.00010174923,0.0006323453,0.00040447628,0.00021809187,0.0004778075],"domain_scores_gemma":[0.99915665,0.00024165049,0.00009219128,0.00025801238,0.00001930099,0.00023216906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081265095,0.0002021205,0.0006736567,0.00023091907,0.000027341877,0.000008992359,0.000109916415,0.00023273859,0.00007632759],"category_scores_gemma":[0.00035595195,0.00013204914,0.000093463736,0.0003596068,0.00012867412,0.000053420834,0.000067847475,0.0006274645,0.000036418416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048504755,0.00090703706,0.9924617,0.00003803571,0.000023279048,0.0027403145,0.000419646,0.000021362624,0.0000014031625,0.000026811793,0.000014023188,0.0028613624],"study_design_scores_gemma":[0.004263788,0.00020879772,0.99422073,0.0002775744,0.000034845234,0.0001744628,0.00034088624,0.000087119435,0.0000058658793,0.000033624096,0.00017457349,0.0001777512],"about_ca_topic_score_codex":0.00036393185,"about_ca_topic_score_gemma":0.0014579217,"teacher_disagreement_score":0.0037787405,"about_ca_system_score_codex":0.000049162172,"about_ca_system_score_gemma":0.000089697336,"threshold_uncertainty_score":0.5384808},"labels":[],"label_agreement":null},{"id":"W2099016852","doi":"10.3324/haematol.2010.038281","title":"Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring","year":2011,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Macrocytic anemia; Somatic evolution in cancer; Myeloid leukemia; Myeloid; Biology; Cytogenetics; Chromosome; Anemia; Medicine; Immunology; Genetics; Internal medicine; Gene; Bone marrow","score_opus":0.03348741278418695,"score_gpt":0.2733394353099151,"score_spread":0.23985202252572815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099016852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94152457,0.0031670183,0.00056705205,0.051880706,0.00021934145,0.0014890858,0.000022014015,0.0001103894,0.0010198256],"genre_scores_gemma":[0.98453474,0.00027929718,0.0029437826,0.010638989,0.00048746623,0.00024008327,0.00006539539,0.00009237269,0.00071785407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707556,0.00020086585,0.0007076799,0.0005897721,0.00070876384,0.00071733247],"domain_scores_gemma":[0.9980606,0.0004166615,0.00041394393,0.00080274045,0.00022671328,0.00007935977],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00025530084,0.00042105926,0.0010532003,0.00033891952,0.00008156493,0.000013689748,0.00050085335,0.0008816415,0.00021770422],"category_scores_gemma":[0.00022556368,0.0002380386,0.00012845652,0.0005908103,0.00046809387,0.00005083394,0.00014964303,0.0026383772,0.00007382316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010179896,0.00012747989,0.8813846,0.0016307925,0.00044594164,0.028195081,0.00030055572,0.000023134387,0.00020248337,0.00011052818,0.0863767,0.00018468656],"study_design_scores_gemma":[0.0027550654,0.0020594173,0.9594148,0.003047463,0.00057621254,0.021599228,0.0002336613,0.0007228922,0.00030789882,0.0007744145,0.0077261217,0.00078285555],"about_ca_topic_score_codex":0.00019807782,"about_ca_topic_score_gemma":0.00002247036,"teacher_disagreement_score":0.07865058,"about_ca_system_score_codex":0.0004004377,"about_ca_system_score_gemma":0.00054356456,"threshold_uncertainty_score":0.9996626},"labels":[],"label_agreement":null},{"id":"W2099825600","doi":"10.3324/haematol.2009.017079","title":"PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":368,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Gertrude von Meissner-Stiftung; Karolinska Institutet; VINNOVA; Novartis Foundation; Krebsliga Beider Basel; Stiftelsen för Strategisk Forskning; Knut och Alice Wallenbergs Stiftelse; National Research Foundation; Genome Canada; GlaxoSmithKline; Ontario Innovation Trust; Wellcome Trust","keywords":"PIM1; Kinase; Biology; Cancer research; AKT3; Kinome; Serine; Threonine; Cell biology; Phosphorylation","score_opus":0.06871072317786502,"score_gpt":0.3507607535035781,"score_spread":0.2820500303257131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099825600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033792995,0.9644004,0.000006404425,0.0002440165,0.0001001735,0.0012385282,0.000040433326,0.000031436044,0.00014557279],"genre_scores_gemma":[0.007811766,0.9909807,0.00034432585,0.00036582357,0.0000471004,0.00036696583,0.000019960218,0.000032393174,0.00003099215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998281,0.00014455112,0.0006047971,0.00045714257,0.00020397213,0.0003085607],"domain_scores_gemma":[0.9987445,0.00025411285,0.0003977073,0.00047725177,0.000052995038,0.00007342169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035819088,0.0004476992,0.0026420227,0.00016189665,0.000074115356,0.00002285416,0.00020089906,0.00041602805,0.000103148974],"category_scores_gemma":[0.000058040216,0.00022615836,0.0002241921,0.0002964577,0.00036922307,0.000030647327,0.000066229084,0.00037827878,0.0000019162785],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015330984,0.00018184571,0.00037083114,0.012975593,0.00016844437,0.00088692096,0.00042040064,1.12668644e-7,0.0003921875,0.0057116663,0.00016115549,0.97857755],"study_design_scores_gemma":[0.0013062592,0.0010875748,0.00069638697,0.008771162,0.0003828457,0.010516734,0.0003108591,0.0000032525695,0.000374545,0.0011943529,0.9748265,0.00052948954],"about_ca_topic_score_codex":0.000093104965,"about_ca_topic_score_gemma":0.00010815144,"teacher_disagreement_score":0.978048,"about_ca_system_score_codex":0.00002644515,"about_ca_system_score_gemma":0.00020187111,"threshold_uncertainty_score":0.922247},"labels":[],"label_agreement":null},{"id":"W2100197564","doi":"10.3324/haematol.2009.007203","title":"Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Deutsche Forschungsgemeinschaft; Michael Smith Health Research BC; Lymphoma Research Foundation","keywords":"CHOP; BCL6; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Medicine; Vincristine; Cancer research; Outcome (game theory); Rituximab; Oncology; Gastroenterology; B cell; Chemotherapy; Immunology; Mathematics; Cyclophosphamide; Antibody","score_opus":0.0197562111914154,"score_gpt":0.2564587346492451,"score_spread":0.23670252345782972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100197564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603534,0.00010843751,0.000016589935,0.00062045973,0.000011363822,0.0010082404,0.000035450088,0.0000851176,0.0020790068],"genre_scores_gemma":[0.99829555,0.000038806964,0.00059731264,0.00041933055,0.000012016551,0.00008069518,0.000117048265,0.000016014721,0.00042320887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986439,0.000042157597,0.00032575757,0.00038050555,0.00025841073,0.00034931028],"domain_scores_gemma":[0.9992299,0.00009861844,0.00012423747,0.0003099791,0.00006128525,0.0001759807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006268527,0.000266164,0.0006145284,0.00012786813,0.00010715625,0.000025575211,0.000056499048,0.000112399815,0.00006711558],"category_scores_gemma":[0.000028924322,0.0001354593,0.0000400475,0.00027452293,0.000051040395,0.00007531565,0.00002381687,0.00006658275,0.000034443965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009253996,0.006977381,0.98857576,0.000027483295,0.00006548579,0.0004705695,0.00014942532,4.5879526e-7,0.0000012595567,0.00008499103,0.00018507314,0.0025366903],"study_design_scores_gemma":[0.046801604,0.002765118,0.94908553,0.00014136375,0.00025612273,0.000038465263,0.000067671936,0.000012331744,0.000055023298,0.000010903702,0.00058547256,0.00018040874],"about_ca_topic_score_codex":0.00005675882,"about_ca_topic_score_gemma":0.00005130133,"teacher_disagreement_score":0.045876205,"about_ca_system_score_codex":0.00013525251,"about_ca_system_score_gemma":0.000036648922,"threshold_uncertainty_score":0.55238694},"labels":[],"label_agreement":null},{"id":"W2100545079","doi":"10.3324/haematol.2014.108191","title":"Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University College London; University of Alberta","keywords":"AL amyloidosis; Amyloidosis; Autologous stem-cell transplantation; Transplantation; Medicine; Selection (genetic algorithm); Stem cell; Immunoglobulin light chain; Oncology; Surgery; Internal medicine; Immunology; Computer science; Biology","score_opus":0.007206170657029226,"score_gpt":0.21388401350753683,"score_spread":0.2066778428505076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100545079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621314,0.0025321748,0.000078482684,0.033362333,0.00019624394,0.0014958883,0.00004391372,0.000045961307,0.000113599934],"genre_scores_gemma":[0.95872337,0.00089284347,0.0001911936,0.038304076,0.00010285872,0.0014150499,0.00020461499,0.000053417225,0.000112599264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965565,0.000804381,0.000817568,0.0009388544,0.00028874658,0.00059392245],"domain_scores_gemma":[0.998741,0.00022133945,0.0004876098,0.0004598493,0.000043835393,0.00004638663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034606477,0.00061804027,0.0008256694,0.00022158929,0.00010322433,0.00007305544,0.00029412567,0.00116235,0.0000067415544],"category_scores_gemma":[0.000036318903,0.00041909167,0.00020215433,0.00013594922,0.00006392703,0.000009919022,0.000077382094,0.00069624954,0.000012959487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007614662,0.0008850134,0.88658124,0.004387478,0.0006340293,0.003464063,0.0066790446,0.0001758975,0.02605045,0.000023805087,0.058998175,0.011359333],"study_design_scores_gemma":[0.015699688,0.009159982,0.6370319,0.004324913,0.002620869,0.008566656,0.00663668,0.00063620997,0.21284446,0.00021925099,0.09374854,0.008510864],"about_ca_topic_score_codex":0.00011477841,"about_ca_topic_score_gemma":0.00021790824,"teacher_disagreement_score":0.24954936,"about_ca_system_score_codex":0.00012568271,"about_ca_system_score_gemma":0.000049290713,"threshold_uncertainty_score":0.9998261},"labels":[],"label_agreement":null},{"id":"W2103945928","doi":"10.3324/haematol.2012.066068","title":"Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34+ cells from patients with del(5q) myelodysplastic syndrome","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Celgene","keywords":"Lenalidomide; CD34; Myelodysplastic syndromes; Progenitor cell; Haematopoiesis; Medicine; Stem cell; microRNA; Cancer research; Gene knockdown; Immunology; Internal medicine; Bone marrow; Oncology; Biology; Cell culture; Multiple myeloma; Gene; Cell biology","score_opus":0.02584716796054585,"score_gpt":0.3004767009760496,"score_spread":0.27462953301550375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103945928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766153,0.00012283358,0.00071352965,0.00045825276,0.0000926349,0.00084330916,0.000038193844,0.00003742163,0.00003227912],"genre_scores_gemma":[0.997216,0.000026586109,0.0023554408,0.00008065169,0.000022068047,0.000044785087,0.00011804291,0.000027054177,0.00010938055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967185,0.0012478008,0.0007824108,0.00038761896,0.0005045126,0.00035913344],"domain_scores_gemma":[0.99653673,0.002326958,0.0003909987,0.00032826597,0.0001868767,0.00023014104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018677318,0.00021525525,0.000688293,0.00023915982,0.000066669905,0.000013507293,0.000082519655,0.00032655074,0.00007846883],"category_scores_gemma":[0.0018603853,0.00014316324,0.00003901349,0.0003838433,0.00031385818,0.00030642966,0.000054861524,0.00051527884,0.000038946637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15239373,0.0006306137,0.8355618,0.00005546825,0.00008426174,0.00017365123,0.0005599271,0.000017625114,0.00928677,0.000015748992,0.0008099502,0.0004104752],"study_design_scores_gemma":[0.007329023,0.0025986629,0.98462427,0.00027498664,0.00010057225,0.00029422608,0.0002618229,0.00041320774,0.003720568,0.000013916462,0.00019503392,0.0001737397],"about_ca_topic_score_codex":0.00011777527,"about_ca_topic_score_gemma":0.000020063959,"teacher_disagreement_score":0.14906245,"about_ca_system_score_codex":0.00017154471,"about_ca_system_score_gemma":0.0002511911,"threshold_uncertainty_score":0.58380276},"labels":[],"label_agreement":null},{"id":"W2104952531","doi":"10.3324/haematol.2014.120220","title":"Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute; Institut National Du Cancer","keywords":"Chemoimmunotherapy; Medicine; Vincristine; Dexamethasone; Internal medicine; Blinatumomab; Oncology; Lymphoblastic Leukemia; Refractory (planetary science); Leukemia; Chemotherapy; Chronic lymphocytic leukemia; Cyclophosphamide; Biology","score_opus":0.024572678894894274,"score_gpt":0.3097826535611139,"score_spread":0.2852099746662196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104952531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8797088,0.0010422902,0.007208535,0.088410944,0.0015178204,0.017774273,0.00090461754,0.001044934,0.0023877574],"genre_scores_gemma":[0.5954887,0.00026778545,0.00851934,0.3709018,0.0038206023,0.0045797983,0.00437301,0.0008449222,0.011204014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99225897,0.00054606394,0.001542055,0.002307239,0.0015871014,0.0017585593],"domain_scores_gemma":[0.99267083,0.0031525816,0.0008854867,0.0018097729,0.00093742885,0.0005438742],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00075596094,0.0014126251,0.00324622,0.0006880246,0.0006754111,0.00013978199,0.00074321986,0.0022655195,0.0004087262],"category_scores_gemma":[0.00351795,0.001080809,0.00045932553,0.00048478998,0.00069054804,0.00017356755,0.0007663915,0.0026288496,0.00018215926],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029005161,0.0024405383,0.00061108154,0.0016335145,0.0013189834,0.0056467066,0.0004986639,6.4247365e-7,0.00005847359,0.000025806483,0.98080057,0.0040645166],"study_design_scores_gemma":[0.104480475,0.05058001,0.0014950255,0.0013893379,0.005583549,0.0042734714,0.0002784577,0.0024407194,0.00013376196,0.00023698396,0.82680815,0.002300034],"about_ca_topic_score_codex":0.000106885,"about_ca_topic_score_gemma":0.000005945603,"teacher_disagreement_score":0.2842201,"about_ca_system_score_codex":0.0026295534,"about_ca_system_score_gemma":0.0017900468,"threshold_uncertainty_score":0.9998624},"labels":[],"label_agreement":null},{"id":"W2105830018","doi":"10.3324/haematol.2011.044933","title":"Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"St. Antonius Ziekenhuis; Universidad de Navarra; Erasmus Universitair Medisch Centrum Rotterdam; Universiteit van Amsterdam; Medisch Spectrum Twente","keywords":"Acute promyelocytic leukemia; Tandem exon duplication; Anthracycline; Gene duplication; Internal medicine; Oncology; Biology; Medicine; Cancer research; Retinoic acid; Immunology; Cancer; Genetics; Gene","score_opus":0.009622277325783102,"score_gpt":0.223581109928651,"score_spread":0.21395883260286788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105830018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978312,0.00026836933,0.0007893572,0.00002107071,0.000008184149,0.0005589743,0.000012520727,0.000020653652,0.0004896371],"genre_scores_gemma":[0.99399513,0.00017933518,0.0054838248,0.00004204718,0.0000068684294,0.00007864019,0.00015467167,0.000025488154,0.000034007033],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890244,0.00006055232,0.0002742171,0.00039418842,0.00012577683,0.00024283049],"domain_scores_gemma":[0.99939084,0.000015023578,0.00015950018,0.0002573368,0.00011438691,0.00006289035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069883085,0.00022140732,0.00030527505,0.000055722612,0.000045371125,0.000009275454,0.0001529126,0.00016672644,0.000017673823],"category_scores_gemma":[0.000033853543,0.00014728868,0.000031578995,0.00016348461,0.00031011007,0.0000091971915,0.000027705979,0.00010247035,0.0000010265452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021382247,0.00045255577,0.93214417,0.00020329487,0.00030386364,0.000106601656,0.0006554332,0.000023267661,0.06312467,0.000116631374,0.000017511255,0.0007137566],"study_design_scores_gemma":[0.003306498,0.0031015577,0.21840811,0.00012825876,0.00017388933,0.00011440168,0.00011400082,0.00009326985,0.7740208,0.000156348,0.00004248766,0.00034041406],"about_ca_topic_score_codex":0.000026029173,"about_ca_topic_score_gemma":0.000014568646,"teacher_disagreement_score":0.71373606,"about_ca_system_score_codex":0.00001756601,"about_ca_system_score_gemma":0.00011860962,"threshold_uncertainty_score":0.6006258},"labels":[],"label_agreement":null},{"id":"W2106429556","doi":"10.3324/haematol.2012.076349","title":"Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Chugai Pharmaceutical; Merck Sharp and Dohme; IC Design Education Center; Astellas Pharma; Eisai; Genentech; CellGenix; Bayer HealthCare; Otsuka America; American Society for Blood and Marrow Transplantation; National Institutes of Health; BioMarin Pharmaceutical; Kiadis Pharma; Therakos; Les Laboratories Pierre Fabre; WellPoint; Teva Pharmaceutical Industries; HistoGenetics; Medical College of Wisconsin; StemCyte; Sanofi; Enzon Pharmaceuticals; Alexion Pharmaceuticals; Health Resources and Services Administration; Viropharma; U.S. Navy; Centers for Disease Control and Prevention; Osiris Therapeutics; Celgene; Pfizer; Biogen; Baxter International; U.S. Public Health Service; U.S. Department of Defense; U.S. Department of Health and Human Services; Astellas Pharma US; National Research Foundation; Otsuka America Pharmaceutical; Amgen; Blue Cross and Blue Shield Association; Be The Match Foundation; National Cancer Institute; Gilead Sciences","keywords":"Transplantation; Medicine; Population; Hematopoietic stem cell transplantation; Leukemia; Myelodysplastic syndromes; Stem cell; Hematopoietic stem cell; Internal medicine; Immunology; Haematopoiesis; Environmental health; Bone marrow; Biology","score_opus":0.18392094977762818,"score_gpt":0.3623463507827868,"score_spread":0.17842540100515863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106429556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997695,0.00024926563,0.00041763188,0.0003437439,0.00002163174,0.00071468705,0.000041998035,0.000027283386,0.00048872473],"genre_scores_gemma":[0.99642825,0.00010471102,0.0032022626,0.000048729573,0.0000026616144,0.00011554275,0.000022010014,0.0000072146727,0.00006860462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834144,0.00030210626,0.00056294265,0.00032939925,0.0002863879,0.00017772976],"domain_scores_gemma":[0.9986049,0.00089255034,0.00015882295,0.0001247728,0.00012363106,0.00009532503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023429329,0.00019006114,0.000623779,0.00013015911,0.000042826498,0.000029951203,0.00005231422,0.000092450966,0.00009117576],"category_scores_gemma":[0.00002797159,0.00014431134,0.000036635287,0.00036265232,0.00018780914,0.00022527087,0.000013924537,0.000094944065,0.000006925023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003090289,0.00056339154,0.92721707,0.0009508267,0.000055283122,0.00012809347,0.061977506,8.772118e-7,0.00048754306,0.007959306,0.000018843406,0.00033225756],"study_design_scores_gemma":[0.0020733988,0.00092150405,0.9489692,0.00022612729,0.00010774457,0.0002514974,0.04579653,0.00017577237,0.000438766,0.0009001436,6.1994194e-7,0.00013873738],"about_ca_topic_score_codex":0.00029854727,"about_ca_topic_score_gemma":0.000109478155,"teacher_disagreement_score":0.021752117,"about_ca_system_score_codex":0.000018354069,"about_ca_system_score_gemma":0.00002930246,"threshold_uncertainty_score":0.5884846},"labels":[],"label_agreement":null},{"id":"W2106592889","doi":"10.3324/haematol.11201","title":"Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Juvenile myelomonocytic leukemia; Cancer research; Mutation; Myeloid leukemia; Myeloid; Biology; Molecular biology; Gene; Genetics; Haematopoiesis; Stem cell","score_opus":0.02223505742380733,"score_gpt":0.3065633143863526,"score_spread":0.28432825696254527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106592889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791591,0.000102166974,0.0014771568,0.0000841536,0.000022393575,0.00055636547,0.0000040323903,0.000026156733,0.018568486],"genre_scores_gemma":[0.9981789,0.00001655778,0.0016317022,0.000044368076,0.000014563407,0.00001701666,0.00002497241,0.000009054694,0.00006284005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852306,0.00005853963,0.00056705973,0.00021690168,0.00037171275,0.00026272415],"domain_scores_gemma":[0.9989276,0.00031853965,0.0002488635,0.00022398388,0.0002056866,0.000075334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065033074,0.000116876225,0.00049051654,0.0003679352,0.000025282498,0.000003036975,0.000109068766,0.00020174679,0.00011336178],"category_scores_gemma":[0.0006545318,0.00009814432,0.000065582564,0.0004675369,0.00025009117,0.00009091557,0.000060595034,0.00029285756,0.000021481026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006075006,0.0009906373,0.18643801,0.00097618875,0.00026473563,0.0015522076,0.0069325063,0.0005076582,0.6845401,0.052203868,0.0003849594,0.059134167],"study_design_scores_gemma":[0.002402066,0.00035539165,0.19524568,0.00023384758,0.000029452212,0.0002902689,0.0031505525,0.0010288921,0.7951117,0.0019300055,0.000113939874,0.00010818364],"about_ca_topic_score_codex":0.0003456061,"about_ca_topic_score_gemma":0.000056823283,"teacher_disagreement_score":0.11057165,"about_ca_system_score_codex":0.00066601386,"about_ca_system_score_gemma":0.0006075937,"threshold_uncertainty_score":0.40022093},"labels":[],"label_agreement":null},{"id":"W2107091218","doi":"10.3324/haematol.2010.030171","title":"Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Breakage; Fusion; Lymphoma; Bridge (graph theory); Cancer research; Medicine; Biology; Pathology; Internal medicine; Computer science; Philosophy","score_opus":0.007803453761874171,"score_gpt":0.2271145058532765,"score_spread":0.21931105209140234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107091218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987665,0.000078670986,0.00007217624,0.0003044687,0.00023306477,0.00018985511,0.000008909986,0.000032309483,0.0003140923],"genre_scores_gemma":[0.99549,0.000016465501,0.0038921288,0.00045073722,0.00006284634,0.0000068785944,0.00003312806,0.000026680927,0.00002113893],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99895275,0.000030840518,0.00019114334,0.00045355302,0.00012474562,0.00024699658],"domain_scores_gemma":[0.9995079,0.000010082143,0.00007535169,0.0002752892,0.000040761155,0.00009061181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011908062,0.00017078512,0.00021313378,0.000069828806,0.00014658162,0.00003240264,0.00012477055,0.0002386343,0.000053502245],"category_scores_gemma":[0.00007068165,0.00015002201,0.00004727948,0.000082520775,0.000057276695,0.000007953249,0.0002295323,0.00012149045,0.0000274819],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031804762,0.00007129367,0.013742375,0.00003181114,0.000019402247,0.00015945066,0.00007126136,0.00008895992,0.9589852,0.00015859034,0.000540199,0.025813382],"study_design_scores_gemma":[0.0011655936,0.0002992687,0.9795622,0.00010488357,0.000020361924,0.0014366992,0.000069072186,0.005879922,0.00623077,0.0006192774,0.0041500507,0.0004618708],"about_ca_topic_score_codex":0.00006906346,"about_ca_topic_score_gemma":0.0009692001,"teacher_disagreement_score":0.96581984,"about_ca_system_score_codex":0.000011356347,"about_ca_system_score_gemma":0.000015978578,"threshold_uncertainty_score":0.611772},"labels":[],"label_agreement":null},{"id":"W2107224115","doi":"10.3324/haematol.2014.109884","title":"Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Transplantation; Hazard ratio; Biology; Internal medicine; Medicine","score_opus":0.017828787608152145,"score_gpt":0.28316256882311425,"score_spread":0.2653337812149621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107224115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942429,0.00026257554,0.0004956973,0.0004747751,0.0002716539,0.00045440983,0.000040326715,0.00013066726,0.0036269706],"genre_scores_gemma":[0.9977918,0.00045382345,0.0013432004,0.00008009187,0.000029619458,0.00002173888,0.00007808849,0.00002266772,0.0001789693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986971,0.00010642417,0.00043543658,0.0003167365,0.00021579216,0.00022851834],"domain_scores_gemma":[0.99896383,0.00024930367,0.00016231164,0.0002637982,0.000059615963,0.0003011161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025339916,0.00019330457,0.0005292504,0.00010074812,0.000048193626,0.0000059668523,0.000084593776,0.00010099071,0.00028073887],"category_scores_gemma":[0.00008399788,0.00014916951,0.000101705424,0.00016167198,0.00017050882,0.00004980739,0.000030665215,0.00012963521,0.00004550491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01483412,0.0011975891,0.7166723,0.0048981123,0.0041472684,0.0026701828,0.0026545422,0.000027696602,0.23085,0.017771179,0.0014330805,0.0028439562],"study_design_scores_gemma":[0.028173681,0.0019254022,0.76916915,0.00093248085,0.010598508,0.001751761,0.00023505637,0.0042691366,0.17594415,0.0014439586,0.0045307493,0.0010259509],"about_ca_topic_score_codex":0.000009790324,"about_ca_topic_score_gemma":6.7054737e-7,"teacher_disagreement_score":0.05490584,"about_ca_system_score_codex":0.000016544029,"about_ca_system_score_gemma":0.00003485917,"threshold_uncertainty_score":0.6082956},"labels":[],"label_agreement":null},{"id":"W2108495564","doi":"10.3324/haematol.2010.030296","title":"Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Heidelberg; Deutsche Forschungsgemeinschaft; Stem Cell Network","keywords":"Multiple myeloma; Beta-2 microglobulin; Internal medicine; Oncology; Cancer research; Medicine; Chemotherapy; Proliferation index; Hematology; Bone marrow; Biology; Immunohistochemistry","score_opus":0.040330963112175724,"score_gpt":0.3031161525604666,"score_spread":0.2627851894482909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108495564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548465,0.00029667767,0.00014366677,0.0005116176,0.000038109152,0.0032656975,0.00016570002,0.0000469017,0.000046951907],"genre_scores_gemma":[0.99170625,0.00019369589,0.0070211473,0.000037630645,0.00003119323,0.0007106111,0.00009780585,0.0000151956365,0.00018648284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987167,0.000060177845,0.00021898074,0.00039875362,0.0001870287,0.00041832172],"domain_scores_gemma":[0.9991787,0.0002574776,0.000077127996,0.00014693383,0.00006371256,0.00027606272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000857098,0.0002081226,0.00041655707,0.000104197476,0.00013992612,0.000039282128,0.000035064382,0.0001553479,0.0001307579],"category_scores_gemma":[0.0006287023,0.00013660786,0.000060364597,0.00006892905,0.00010438473,0.00006465499,0.000027169353,0.00017204066,0.0000059163485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00139091,0.0005133096,0.9853867,0.000089630375,0.00012146307,0.00016716316,0.0010186802,1.5225977e-7,0.0017345324,0.00014402258,0.000027767905,0.0094056185],"study_design_scores_gemma":[0.012186631,0.0014627088,0.97176915,0.0000341788,0.0000714059,0.0002614455,0.00014522846,0.006467138,0.0058654053,0.00018526193,0.0014093891,0.00014207848],"about_ca_topic_score_codex":0.00018110083,"about_ca_topic_score_gemma":0.0006879955,"teacher_disagreement_score":0.013617621,"about_ca_system_score_codex":0.00005320734,"about_ca_system_score_gemma":0.00008741628,"threshold_uncertainty_score":0.5570707},"labels":[],"label_agreement":null},{"id":"W2108880951","doi":"10.3324/haematol.2013.098103","title":"p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Celgene","keywords":"Myelodysplastic syndromes; Oncology; Internal medicine; Medicine; Outcome (game theory); Protein expression; Biology; Genetics; Gene; Bone marrow","score_opus":0.01351225560887367,"score_gpt":0.24831775188288377,"score_spread":0.2348054962740101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108880951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947863,0.000030276418,0.0010325478,0.00025415266,0.00004910395,0.002091292,0.000013079429,0.00018445114,0.0015588022],"genre_scores_gemma":[0.9953802,0.0000053348313,0.003440516,0.00012474299,0.000030705134,0.00028787082,0.000038303388,0.000061563376,0.0006307699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660516,0.0002770206,0.00048116522,0.0007269118,0.001141585,0.0007681687],"domain_scores_gemma":[0.99820495,0.00021097503,0.00027115442,0.0007467722,0.00021635449,0.00034982208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045764097,0.0004049349,0.00089379546,0.00033012935,0.00014071562,0.00003969311,0.00033608964,0.00030409,0.00022521784],"category_scores_gemma":[0.0008912978,0.00022846175,0.00006150531,0.00047669947,0.00024375127,0.00018887526,0.00020501226,0.00094544404,0.00019518398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034809972,0.00057464687,0.99352956,0.00027608854,0.000055347886,0.0008310881,0.00009773495,0.000050373274,0.000096796226,0.000089703404,0.0002956919,0.0006220018],"study_design_scores_gemma":[0.012771764,0.0061570294,0.97621846,0.0013102255,0.000097535325,0.00034622182,0.00008404303,0.00083789503,0.0011893056,0.0000946531,0.00044460382,0.0004482373],"about_ca_topic_score_codex":0.00005913424,"about_ca_topic_score_gemma":0.000041869032,"teacher_disagreement_score":0.017311044,"about_ca_system_score_codex":0.00022444889,"about_ca_system_score_gemma":0.00017591885,"threshold_uncertainty_score":0.93163997},"labels":[],"label_agreement":null},{"id":"W2109183702","doi":"10.3324/haematol.2008.002691","title":"CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research","keywords":"Immunosuppression; Medicine; Lymphoma; Incidence (geometry); Systemic therapy; Internal medicine; Hodgkin lymphoma; Non-Hodgkin's lymphoma; Antiretroviral therapy; Immunology; Human immunodeficiency virus (HIV); Oncology; Cancer; Viral load; Breast cancer","score_opus":0.008002461004428946,"score_gpt":0.23790424278778194,"score_spread":0.229901781783353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109183702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98143774,0.0016985055,0.000009647475,0.0012089208,0.000012615547,0.00037419316,0.0000063860057,0.000007886813,0.015244109],"genre_scores_gemma":[0.9985341,0.0006540042,0.000033624776,0.0007052674,0.000006707186,0.000020685335,0.000002898089,0.0000030802516,0.000039664083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935246,0.00010006932,0.00016592513,0.00010402147,0.000151553,0.00012596733],"domain_scores_gemma":[0.999602,0.00010474403,0.00011499154,0.00014712573,0.000016168979,0.000014943968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042060218,0.00007626363,0.00030420301,0.00004230836,0.00002918288,0.0000079687325,0.00008598368,0.000070255184,0.00001815734],"category_scores_gemma":[0.00007421919,0.000032339216,0.000026637756,0.00018902755,0.000104411825,0.000013999774,0.000008873244,0.00009028105,0.000006897036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040958507,0.000107404565,0.9828204,0.00006218739,0.000049675775,0.00007894824,0.0040505244,0.000016672093,0.000010481469,0.0030773657,0.0061667906,0.0031499544],"study_design_scores_gemma":[0.01229112,0.00037516872,0.97721595,0.0005260743,0.00012587175,0.0002670122,0.0055987295,0.0001284346,0.000032411062,0.0027958357,0.0005219381,0.00012142868],"about_ca_topic_score_codex":0.0001144818,"about_ca_topic_score_gemma":0.000039053288,"teacher_disagreement_score":0.017096331,"about_ca_system_score_codex":0.000021036805,"about_ca_system_score_gemma":0.000040205217,"threshold_uncertainty_score":0.13187549},"labels":[],"label_agreement":null},{"id":"W2110734772","doi":"10.3324/haematol.2010.029389","title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"Bundesministerium für Bildung und Forschung; European Commission","keywords":"Hemophagocytic lymphohistiocytosis; Immunology; CD8; Cytotoxic T cell; Natural killer cell; Degranulation; Biology; Medicine; Disease; Immune system; Pathology; Internal medicine; Genetics; In vitro","score_opus":0.010981373341857016,"score_gpt":0.2641260837821603,"score_spread":0.2531447104403033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110734772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949062,0.00068512204,0.0001245717,0.00081781356,0.000054436663,0.00063110585,0.000014413176,0.000082298764,0.0026840477],"genre_scores_gemma":[0.9980622,0.000045048226,0.0009416889,0.0005160117,0.0000171593,0.00013272326,0.00003705014,0.000018599685,0.00022953724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998515,0.00005042561,0.00033756398,0.00037791114,0.00033570777,0.00038340426],"domain_scores_gemma":[0.99915135,0.00014073397,0.00005612678,0.0003659814,0.00009785071,0.0001879514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001353368,0.00018808345,0.0005417048,0.00020388998,0.00016647507,0.000033871147,0.00013699291,0.00013044725,0.00020731149],"category_scores_gemma":[0.00042297054,0.0001350561,0.000054845426,0.00039891177,0.00034858342,0.00011012536,0.00011562138,0.00031699176,0.000093528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009417154,0.0033316822,0.8667996,0.0012814159,0.00016895027,0.0075408756,0.0022805436,0.00008112892,0.046025638,0.015034624,0.0018639116,0.046174463],"study_design_scores_gemma":[0.0023287965,0.0005337896,0.9931197,0.00009302196,0.000049284266,0.0009590996,0.00047973,0.0002754474,0.00049251184,0.0002935299,0.0011516662,0.00022339915],"about_ca_topic_score_codex":0.00008128898,"about_ca_topic_score_gemma":0.000053583524,"teacher_disagreement_score":0.12632011,"about_ca_system_score_codex":0.00008267569,"about_ca_system_score_gemma":0.00042181826,"threshold_uncertainty_score":0.5507428},"labels":[],"label_agreement":null},{"id":"W2110993734","doi":"10.3324/haematol.2009.010306","title":"Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Australian Government","keywords":"CD20; Medicine; Cumulative incidence; Internal medicine; White blood cell; Rituximab; Lymphoblastic Leukemia; Oncology; Philadelphia chromosome; Incidence (geometry); Acute lymphocytic leukemia; Immunology; Leukemia; Gastroenterology; Lymphoma; Biology; Gene; Cohort","score_opus":0.012023147265197131,"score_gpt":0.2584060356743247,"score_spread":0.24638288840912756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110993734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144536,0.00020249454,0.00081988,0.0006674784,0.00004632088,0.0025645862,0.000037623344,0.0001517046,0.004064528],"genre_scores_gemma":[0.9914268,0.00011834259,0.007660215,0.00021591577,0.000048035097,0.00023494857,0.000038726736,0.000039929262,0.00021706673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99657774,0.00016770046,0.000741717,0.0008337154,0.0008718577,0.0008072866],"domain_scores_gemma":[0.99759203,0.00073036127,0.00040080934,0.00063605217,0.00030534962,0.00033537636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002000799,0.00046565916,0.0010862141,0.00032734402,0.000079960395,0.000012014833,0.00038852805,0.0003251697,0.00018018807],"category_scores_gemma":[0.0006597181,0.00031648547,0.00012893787,0.0009585421,0.00045898763,0.00019740008,0.00010151175,0.0004530548,0.000105577994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12985279,0.015163321,0.08004477,0.011048373,0.0009872122,0.051831376,0.019190723,0.003357716,0.6635469,0.001493545,0.018029952,0.0054533207],"study_design_scores_gemma":[0.05381077,0.018089853,0.13015908,0.0140917385,0.00066152774,0.003440142,0.0022746138,0.011156904,0.76342154,0.0011160505,0.00019025571,0.0015875249],"about_ca_topic_score_codex":0.000037250888,"about_ca_topic_score_gemma":0.00001364297,"teacher_disagreement_score":0.09987463,"about_ca_system_score_codex":0.0008695675,"about_ca_system_score_gemma":0.0014660425,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W2111099034","doi":"10.3324/haematol.2010.026682","title":"Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Health Resources and Services Administration; U.S. Department of Health and Human Services","keywords":"Medicine; Transplantation; Sibling; Aplastic anemia; Internal medicine; Proportional hazards model; Pediatrics; Surgery; Bone marrow","score_opus":0.03377049944666958,"score_gpt":0.32443012832120066,"score_spread":0.29065962887453106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111099034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911138,0.000020872294,0.007135979,0.000101654194,0.00022015492,0.0009604158,0.00007998153,0.000090912166,0.00027622134],"genre_scores_gemma":[0.9846754,0.000020814809,0.01490917,0.000082128434,0.000035652334,0.00008214358,0.00011629064,0.00003666477,0.000041706393],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99840134,0.00004257936,0.0005931615,0.0003354766,0.00027541543,0.00035200772],"domain_scores_gemma":[0.9986128,0.00062464725,0.00021646674,0.00030332414,0.0001000758,0.00014268208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002366225,0.00027700097,0.00079213624,0.00025662084,0.000065127344,0.000018514527,0.000085209045,0.0002789022,0.00027700322],"category_scores_gemma":[0.00015287692,0.00019853319,0.00032561453,0.00019712841,0.000103593695,0.00008457699,0.000006529316,0.00015620052,0.000017925742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050471784,0.0004282696,0.30910528,0.003197913,0.00018136903,0.00108411,0.0019507202,0.00020167892,0.6780877,0.00038049114,0.000039881725,0.00029541634],"study_design_scores_gemma":[0.0093448805,0.0014576971,0.81965035,0.0012492895,0.0014190542,0.0030442842,0.00025363662,0.0027626501,0.15940405,0.00068700296,0.000015309748,0.0007117648],"about_ca_topic_score_codex":0.000046106055,"about_ca_topic_score_gemma":0.0000408751,"teacher_disagreement_score":0.5186836,"about_ca_system_score_codex":0.000040082978,"about_ca_system_score_gemma":0.00008041,"threshold_uncertainty_score":0.80959487},"labels":[],"label_agreement":null},{"id":"W2111181123","doi":"10.3324/haematol.13359","title":"Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre; University Health Network; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Diamond–Blackfan anemia; Erythropoiesis; Biology; Ineffective erythropoiesis; Alternative splicing; Haematopoiesis; Cell biology; Myeloid; Myelopoiesis; Anemia; Cancer research; Stem cell; Genetics; Gene; RNA; Gene isoform; Internal medicine; Medicine","score_opus":0.02931776947713871,"score_gpt":0.2814989816257482,"score_spread":0.2521812121486095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111181123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885081,0.00073936617,0.009922938,0.0002711613,0.00009806267,0.0002531693,0.00002368534,0.0000056361155,0.00017787509],"genre_scores_gemma":[0.9984336,0.0005918439,0.00061021396,0.00009064354,0.00004604956,0.000108829234,0.0000146632965,0.000009550986,0.00009461176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924254,0.00005297436,0.00017174338,0.00028931553,0.00008744532,0.00015600273],"domain_scores_gemma":[0.99948686,0.00004604593,0.000107509884,0.00025724142,0.00006827587,0.000034084653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007070447,0.000110303525,0.0001786333,0.000024251824,0.00014773973,0.000007254094,0.000112916954,0.00011902857,0.000011333612],"category_scores_gemma":[0.00012586567,0.000074701486,0.00006119541,0.00006234582,0.000246535,0.000006823395,0.00007960395,0.00005900112,6.3285853e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016975282,0.00007269665,0.0110244835,0.00005902178,0.0000108481645,0.000003193027,0.00022780133,0.00005098604,0.9871627,0.00026056584,0.0005199194,0.00043799554],"study_design_scores_gemma":[0.00039302764,0.0001095247,0.046528865,0.00005491654,0.000013465718,0.000029457982,0.00033915276,0.00008155162,0.9516102,0.00039973445,0.0003304492,0.00010962615],"about_ca_topic_score_codex":0.000018337507,"about_ca_topic_score_gemma":0.000031425,"teacher_disagreement_score":0.03555251,"about_ca_system_score_codex":0.000010669058,"about_ca_system_score_gemma":0.000020795655,"threshold_uncertainty_score":0.3046238},"labels":[],"label_agreement":null},{"id":"W2111606093","doi":"10.3324/haematol.2013.085175","title":"Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Leukaemia and Lymphoma Research; Kay Kendall Leukaemia Fund","keywords":"CDKN2A; Cytogenetics; Leukemia; Biology; Multiplex ligation-dependent probe amplification; Acute lymphocytic leukemia; Copy-number variation; CDKN2B; Karyotype; Chromosomal translocation; Immunophenotyping; Cancer research; Oncology; Immunology; Genetics; Gene; Chromosome; Medicine; Lymphoblastic Leukemia; Flow cytometry","score_opus":0.012997858226794204,"score_gpt":0.2749340297644282,"score_spread":0.261936171537634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111606093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946294,0.00077843305,0.00015297774,0.0012339979,0.00006361554,0.0012196256,0.000014019959,0.000111572095,0.0017963549],"genre_scores_gemma":[0.99152654,0.0010472166,0.0055991844,0.0007594465,0.00007992747,0.00012704676,0.000042084666,0.000043848093,0.0007747026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732554,0.0002501629,0.00060272403,0.0005719271,0.00058070547,0.0006689407],"domain_scores_gemma":[0.9976888,0.0010677959,0.0002591306,0.00040479205,0.00025123174,0.0003282614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036327218,0.0003191531,0.00085205823,0.00016749959,0.00010235754,0.00007438741,0.0002125489,0.0005913827,0.000094911054],"category_scores_gemma":[0.0005762543,0.0002166633,0.00009389963,0.0003771774,0.00021923559,0.00010083082,0.00017963118,0.0005800245,0.00018966197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063745416,0.0008416868,0.9759591,0.00016728653,0.00046255777,0.00092942145,0.00027167107,0.000023198903,0.0009844231,0.00008513208,0.013234232,0.0064038406],"study_design_scores_gemma":[0.0112584075,0.001989837,0.97709924,0.0002003296,0.00040780037,0.0019723135,0.00017769964,0.0021627718,0.0037010403,0.00017674193,0.0004713692,0.00038246924],"about_ca_topic_score_codex":0.00017351868,"about_ca_topic_score_gemma":0.00011271772,"teacher_disagreement_score":0.012762862,"about_ca_system_score_codex":0.00085484324,"about_ca_system_score_gemma":0.000731024,"threshold_uncertainty_score":0.8835273},"labels":[],"label_agreement":null},{"id":"W2112000215","doi":"10.3324/haematol.2013.087650","title":"Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Placebo; Adverse effect; Myelofibrosis; Quality of life (healthcare); Internal medicine; Surgery; Pathology; Bone marrow; Alternative medicine","score_opus":0.18569937186375002,"score_gpt":0.4288866127252391,"score_spread":0.24318724086148907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112000215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749355,0.019467255,0.000009770095,0.0021485223,0.00002569627,0.0029668936,0.000019442736,0.0000067798696,0.00042016816],"genre_scores_gemma":[0.9849796,0.012080112,0.0006161206,0.00012230009,0.000012686158,0.0020324124,0.000010203391,0.0000063283455,0.00014019711],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914485,0.00006115283,0.00034818577,0.00016645508,0.00012839526,0.00015095905],"domain_scores_gemma":[0.9979629,0.0014865794,0.00018906107,0.00023937397,0.00009522485,0.000026892696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001298627,0.00015507602,0.0007160726,0.00003696839,0.0001005085,0.000009641752,0.00006463264,0.000046445253,0.00013822765],"category_scores_gemma":[0.000054447763,0.000059001577,0.00008889551,0.00008893445,0.00021688773,0.00002596255,0.000011478839,0.000036119895,0.000008442805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020394619,0.017015884,0.91045856,0.00028463363,0.0012466045,0.000014271756,0.015248712,0.0000080908285,0.001070542,0.002060554,0.014239388,0.036313303],"study_design_scores_gemma":[0.08957989,0.12356494,0.23028693,0.0010096367,0.0020438682,0.00025581825,0.0677244,0.003597436,0.38383964,0.0016801928,0.095679596,0.0007376593],"about_ca_topic_score_codex":0.00013378508,"about_ca_topic_score_gemma":0.000049939983,"teacher_disagreement_score":0.6801716,"about_ca_system_score_codex":0.000022482234,"about_ca_system_score_gemma":0.000020475421,"threshold_uncertainty_score":0.24060145},"labels":[],"label_agreement":null},{"id":"W2112114252","doi":"10.3324/haematol.10625","title":"IL-7 mediated protection against minor antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"FOXP3; IL-2 receptor; Bone marrow; Immunology; Transplantation; T cell; Medicine; Antigen; Immune system; Interleukin-7 receptor; Regulatory T cell; Internal medicine","score_opus":0.018650206912109692,"score_gpt":0.24035733135030435,"score_spread":0.22170712443819465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112114252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98332536,0.000060877046,0.010020771,0.00016022711,0.0001823304,0.0013162845,0.000021300486,0.00026518392,0.0046476605],"genre_scores_gemma":[0.99702877,0.00011794078,0.0019692814,0.0002719026,0.000028922346,0.000046705536,0.00011095088,0.000038038364,0.00038750353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773026,0.00011684222,0.00074483984,0.0004549723,0.00053964823,0.00041341886],"domain_scores_gemma":[0.99835116,0.0002547617,0.00055523496,0.00036529207,0.00032607865,0.00014749731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007778009,0.00027494816,0.00072898844,0.00026330145,0.00009343527,0.000009972874,0.00008847089,0.00045393308,0.00012690158],"category_scores_gemma":[0.00019706941,0.00021790425,0.00014164507,0.0006529335,0.00015357658,0.00009461168,0.000012361787,0.0002551014,0.00004128501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013670443,0.0003893905,0.0028222392,0.00043844327,0.00025410156,0.00022828004,0.0010567559,0.000012816372,0.99206233,0.000013388404,0.0003462161,0.0010090182],"study_design_scores_gemma":[0.0020429678,0.00077025755,0.03131168,0.0007434669,0.00013964131,0.00018685109,0.0004581045,0.00008732415,0.9638208,0.00004335218,0.00015068,0.00024488792],"about_ca_topic_score_codex":0.000035962883,"about_ca_topic_score_gemma":0.00006002049,"teacher_disagreement_score":0.028489439,"about_ca_system_score_codex":0.00011795935,"about_ca_system_score_gemma":0.000105425985,"threshold_uncertainty_score":0.8885877},"labels":[],"label_agreement":null},{"id":"W2112325849","doi":"10.3324/haematol.2011.041277","title":"Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Central nervous system; Lymphoma; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Pathology","score_opus":0.021197024169364427,"score_gpt":0.2162208885891669,"score_spread":0.1950238644198025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112325849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968988,0.0005105596,0.000016365255,0.000106597756,0.0000733863,0.00058881886,0.000067732835,0.000034847904,0.0017029349],"genre_scores_gemma":[0.99894565,0.0001787521,0.00059666147,0.000114106086,0.000007171331,0.000046497036,0.000005839281,0.000014388499,0.000090940805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988141,0.000081039674,0.00039613497,0.00022792367,0.00022193458,0.00025887904],"domain_scores_gemma":[0.99886894,0.0000540724,0.00035396655,0.00049358583,0.00005754537,0.00017191606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012036393,0.00017937829,0.00058253604,0.00004112482,0.00007145944,0.000004017771,0.00010452741,0.00008401731,0.000029650464],"category_scores_gemma":[0.000048660313,0.00008450331,0.0001329552,0.0001146006,0.00013780089,0.000022805467,0.00010256504,0.00004932885,0.0000049718055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026576172,0.004526269,0.98882884,0.00058973196,0.00020090198,0.00019614247,0.0007493133,1.1203215e-7,0.000041355215,0.0039859535,0.00020370571,0.00041190014],"study_design_scores_gemma":[0.010901137,0.0006709076,0.97392297,0.0003656062,0.00076096837,0.00028172942,0.0010256728,0.000033135744,0.011669075,0.000024685609,0.00024276844,0.0001013444],"about_ca_topic_score_codex":0.00047679112,"about_ca_topic_score_gemma":0.000050949715,"teacher_disagreement_score":0.014905884,"about_ca_system_score_codex":0.0000645582,"about_ca_system_score_gemma":0.00006274459,"threshold_uncertainty_score":0.34459448},"labels":[],"label_agreement":null},{"id":"W2112843683","doi":"10.3324/haematol.2008.005348","title":"Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review","year":2009,"lang":"en","type":"review","venue":"Haematologica","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; McMaster University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Thrombocytopenic purpura; Internal medicine; Helicobacter pylori; Odds ratio; Adverse effect; Immune system; Hematology; Immunology; Gastroenterology; Randomized controlled trial; Platelet","score_opus":0.0305027893274073,"score_gpt":0.3056950531228374,"score_spread":0.2751922637954301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112843683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044061907,0.93839484,0.0000065775557,0.00073811354,0.000087453096,0.016413862,0.00003451293,0.00017050913,0.00009220148],"genre_scores_gemma":[0.0024473048,0.9929066,0.0002775874,0.00068234117,0.00002531922,0.0032449989,0.00013423817,0.00009882894,0.00018281788],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9945902,0.0010454735,0.0018700883,0.0011505586,0.00053553254,0.0008081517],"domain_scores_gemma":[0.996891,0.00027449004,0.0009969368,0.001223667,0.00030505323,0.000308805],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007602231,0.0013259088,0.010491272,0.00052019994,0.00015648035,0.00004920634,0.00022465829,0.00047381816,0.000026816566],"category_scores_gemma":[0.0004222985,0.0006791451,0.00028606114,0.0010372793,0.0002174599,0.000121978024,0.00013293717,0.00072466803,0.0001365225],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007995278,0.0017681643,0.03614146,0.9226488,0.006608302,0.0023773783,0.00049675535,7.475378e-7,1.9077625e-7,0.000018175511,0.0003083577,0.021636402],"study_design_scores_gemma":[0.006195184,0.018870786,0.025783828,0.86755705,0.011983445,0.005475535,0.000023962659,3.6745396e-7,6.869338e-7,0.0000019091426,0.06326847,0.000838785],"about_ca_topic_score_codex":0.00004020965,"about_ca_topic_score_gemma":0.00008050009,"teacher_disagreement_score":0.06296011,"about_ca_system_score_codex":0.0008919635,"about_ca_system_score_gemma":0.00029992807,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W2114908650","doi":"10.3324/haematol.2011.054254","title":"Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; CRIS Cancer Foundation; University of Toronto; Ontario Institute for Cancer Research; University Health Network","keywords":"Clonogenic assay; Cytotoxicity; Cancer research; Multiple myeloma; Lymphokine-activated killer cell; Bone marrow; Biology; Natural killer cell; Immunology; Progenitor cell; Cell culture; Stem cell; Interleukin 21; T cell; In vitro; Cell biology; Immune system","score_opus":0.03143935893418044,"score_gpt":0.2802471565983891,"score_spread":0.24880779766420869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114908650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411404,0.0030717065,0.00007081036,0.00028199842,0.0002009623,0.001722761,0.000046591525,0.00015099498,0.00034013225],"genre_scores_gemma":[0.9880443,0.0008069572,0.008487329,0.0002378042,0.00008577513,0.00030021253,0.00019859946,0.000053466898,0.0017855231],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969202,0.00016047563,0.00059421535,0.0006407477,0.00047120926,0.0012131149],"domain_scores_gemma":[0.9979302,0.00018216622,0.00014731065,0.0005528526,0.00011255978,0.0010748666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002389052,0.0005245681,0.00080350676,0.0003225576,0.00015693098,0.000049427847,0.0001901144,0.00026544774,0.00014508255],"category_scores_gemma":[0.00023812531,0.0003728194,0.00021562411,0.00024988342,0.00017359435,0.00019841241,0.00028037647,0.00038821867,0.00013896196],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067734746,0.0123908995,0.7164525,0.0013939333,0.0006812457,0.0009869118,0.0022361611,0.00007639042,0.24490039,0.00028076966,0.0026947588,0.011132586],"study_design_scores_gemma":[0.024039429,0.0011582663,0.2566133,0.00032822764,0.00037703587,0.00044053607,0.0004363875,0.034443807,0.6776495,0.000080829646,0.0030986331,0.0013340267],"about_ca_topic_score_codex":0.00014889901,"about_ca_topic_score_gemma":0.00018194404,"teacher_disagreement_score":0.45983917,"about_ca_system_score_codex":0.00014373631,"about_ca_system_score_gemma":0.00012612704,"threshold_uncertainty_score":0.9998724},"labels":[],"label_agreement":null},{"id":"W2115551074","doi":"10.3324/haematol.2010.023929","title":"Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Fanconi anemia; Savior sibling; Medicine; Transplantation; Hematopoietic stem cell transplantation; Stem cell; Anemia; Pregnancy; Internal medicine; Biology","score_opus":0.01211538388308938,"score_gpt":0.2371111986478861,"score_spread":0.22499581476479671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115551074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972754,0.00088664546,0.000023762612,0.00010442772,0.00020199204,0.00058986293,0.000009928712,0.000041124633,0.00086683774],"genre_scores_gemma":[0.9993172,0.000093314746,0.00024563167,0.00010033268,0.0000073107153,0.00009298945,0.000024129527,0.0000075831213,0.00011149863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987816,0.00009509246,0.00030643062,0.0005070127,0.00008855966,0.0002212613],"domain_scores_gemma":[0.9993876,0.00006167612,0.000068758105,0.00034578016,0.00005761635,0.000078554476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017387439,0.00015633713,0.000352313,0.000052183605,0.000042099367,0.000006470673,0.000056558718,0.00027306762,0.000113346854],"category_scores_gemma":[0.000043197582,0.00011461399,0.000052839157,0.00008409468,0.00016606363,0.000077282646,0.000023215243,0.0003038578,0.000023308841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018258938,0.00031874748,0.9899675,0.0004939837,0.000006364492,0.00011276707,0.00040635385,8.967825e-8,0.0036521265,0.000011923057,0.0000069930634,0.003197213],"study_design_scores_gemma":[0.00084823347,0.00021406202,0.9834753,0.00010172413,0.00003217047,0.000054713626,0.00003225894,0.000001759904,0.014604991,0.00049532857,0.00002687899,0.000112530375],"about_ca_topic_score_codex":0.0000105859,"about_ca_topic_score_gemma":0.00006122424,"teacher_disagreement_score":0.010952865,"about_ca_system_score_codex":0.0000148493755,"about_ca_system_score_gemma":0.000026824522,"threshold_uncertainty_score":0.46738228},"labels":[],"label_agreement":null},{"id":"W2117793275","doi":"10.3324/haematol.13422","title":"STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Malaria Research and Control","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Reticulocytosis; Parasitemia; Plasmodium chabaudi; STAT6; Erythropoiesis; Biology; Cytokine; Immunology; Erythropoietin; Anemia; STAT protein; Endocrinology; Internal medicine; Interleukin 4; STAT3; Medicine; Malaria; Plasmodium falciparum; Signal transduction; Cell biology","score_opus":0.05273893510853034,"score_gpt":0.3191013224765463,"score_spread":0.266362387368016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117793275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978645,0.00021370196,0.000087428576,0.00037158013,0.00002676443,0.00038504737,0.000027415084,0.000024472769,0.0009991187],"genre_scores_gemma":[0.99809384,0.000056297642,0.0016443765,0.00003958045,0.000015433068,0.00003279569,0.000041748688,0.000009376627,0.000066574576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870795,0.00009925128,0.00037783541,0.00020252833,0.00035604203,0.00025642174],"domain_scores_gemma":[0.999317,0.000073041505,0.000100624464,0.00027689993,0.00009199267,0.00014047665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000135595,0.00011211069,0.0005324793,0.00013286775,0.000033191187,0.0000021586204,0.00011863341,0.00014441942,0.0006633105],"category_scores_gemma":[0.00019602031,0.000081136524,0.000069018424,0.00013750257,0.00024305902,0.000081074344,0.00005881851,0.00015633508,0.0000062075756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006917989,0.0020507718,0.036868893,0.00020620546,0.000027951792,0.000733798,0.0012662723,0.00015730137,0.9484908,0.001974033,0.0012006128,0.000105365456],"study_design_scores_gemma":[0.015594291,0.004008052,0.068006925,0.00023075179,0.00004548268,0.00041497202,0.0016497532,0.06185863,0.84736145,0.00046694986,0.000033587854,0.00032913574],"about_ca_topic_score_codex":0.00009836236,"about_ca_topic_score_gemma":0.000009132196,"teacher_disagreement_score":0.10112934,"about_ca_system_score_codex":0.000024421646,"about_ca_system_score_gemma":0.00015369944,"threshold_uncertainty_score":0.7262785},"labels":[],"label_agreement":null},{"id":"W2119156186","doi":"10.3324/haematol.2014.109306","title":"Erythrocytosis associated with a novel missense mutation in the BPGM gene","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biotechnology and Biological Sciences Research Council; Centre National de la Recherche Scientifique; Queen's University; NIHR Oxford Biomedical Research Centre; University of Oxford; Imperial College London; Wellcome Trust; British Heart Foundation; Academy of Medical Sciences; National Institute for Health and Care Research","keywords":"Missense mutation; Mutation; Gene isoform; Gene; Biology; Transcription factor; Mutant; Hydroxylation; Hypoxia-inducible factors; Genetics; Molecular biology; Biochemistry; Enzyme","score_opus":0.022586502556323412,"score_gpt":0.24084943204490347,"score_spread":0.21826292948858006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119156186","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.617338,0.009219582,0.0030967167,0.3594093,0.0020071312,0.0029278223,0.00042270194,0.00014217576,0.0054365806],"genre_scores_gemma":[0.2850028,0.00078934507,0.00082608004,0.70232975,0.005183167,0.0004912401,0.003844824,0.00010783873,0.0014249608],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981525,0.0002483612,0.0003308066,0.00055769127,0.00029174626,0.00041891445],"domain_scores_gemma":[0.9988986,0.000095555355,0.00032589902,0.0005406101,0.00010726728,0.000032013995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033583678,0.0003586178,0.00062852,0.00007451475,0.00009136737,0.00005008906,0.00036404832,0.0009963071,0.000020660133],"category_scores_gemma":[0.00025542435,0.0002199904,0.00017855722,0.0001610521,0.00013643896,0.000002430613,0.00005108037,0.00058665086,0.0000106944735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013365083,0.000101504826,0.00005627046,0.00006672267,0.00019936048,0.00033344884,0.0001593112,0.00002168835,0.012066417,0.00002651184,0.98657215,0.0002629682],"study_design_scores_gemma":[0.0013990409,0.00023586981,0.0006129126,0.000078135585,0.0001741593,0.0015888392,0.000053603737,0.000014658063,0.00513739,0.00005557007,0.99018604,0.00046378473],"about_ca_topic_score_codex":0.000054649445,"about_ca_topic_score_gemma":0.00017591218,"teacher_disagreement_score":0.34292045,"about_ca_system_score_codex":0.000019967732,"about_ca_system_score_gemma":0.00010048388,"threshold_uncertainty_score":0.8970948},"labels":[],"label_agreement":null},{"id":"W2121399230","doi":"10.3324/haematol.11644","title":"Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Thalidomide; Dexamethasone; Internal medicine; Vincristine; Complete response; Adverse effect; Melphalan; Multiple myeloma; Randomized controlled trial; Gastroenterology; Chemotherapy; Induction chemotherapy; Urology; Cyclophosphamide","score_opus":0.029433587298597613,"score_gpt":0.3032299416468039,"score_spread":0.27379635434820626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121399230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960208,0.00092283374,0.0000030186925,0.0009438339,0.000039184262,0.001943605,0.0000164853,0.00006026644,0.00004997277],"genre_scores_gemma":[0.9983387,0.0006088511,0.0001442729,0.00014863489,0.00004607038,0.0005023588,0.000051219627,0.000022503886,0.00013740383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746764,0.00083386747,0.00042463184,0.00044232636,0.00021910015,0.000612445],"domain_scores_gemma":[0.9982439,0.0010316981,0.0000906117,0.0003857783,0.000045883582,0.00020210422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001173839,0.00029867212,0.0005377147,0.00026520246,0.0001011524,0.00003342924,0.00007899139,0.00018118495,0.00008514963],"category_scores_gemma":[0.00065966166,0.00015936785,0.000080247024,0.0003693127,0.0001945095,0.000106800784,0.000051684456,0.00020464486,0.000029334296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08341423,0.0011938536,0.8770288,0.00002053573,0.00011854225,0.0063217427,0.00088746834,0.0000023376836,0.0013252398,0.000029413584,0.000011572145,0.029646268],"study_design_scores_gemma":[0.014924808,0.0025279713,0.9712399,0.00011344568,0.00003257968,0.00044972808,0.00029441455,0.00008375784,0.009857447,0.00009408624,0.00025396614,0.0001278966],"about_ca_topic_score_codex":0.0030494265,"about_ca_topic_score_gemma":0.006714441,"teacher_disagreement_score":0.094211094,"about_ca_system_score_codex":0.00025989272,"about_ca_system_score_gemma":0.00010777335,"threshold_uncertainty_score":0.6498832},"labels":[],"label_agreement":null},{"id":"W2121578398","doi":"10.3324/haematol.2014.103580","title":"Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Aplastic anemia; Bone marrow; Mesenchymal stem cell; Stem cell; Bone marrow failure; Haematopoiesis; Immunology; Pancytopenia; Medicine; Hematopoietic stem cell; Clinical uses of mesenchymal stem cells; CD34; Pathogenesis; Cancer research; Biology; Pathology; Adult stem cell; Endothelial stem cell; Cell biology; In vitro","score_opus":0.021340504857120596,"score_gpt":0.20780888934172143,"score_spread":0.18646838448460082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121578398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532306,0.0007767653,0.00022591898,0.002233514,0.0000692638,0.001179388,0.00009728061,0.000017487255,0.00007729336],"genre_scores_gemma":[0.9992016,0.000021624457,0.00011195715,0.00023247629,0.000032824362,0.00008248469,0.000010900942,0.000015000404,0.00029113397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980973,0.00030246217,0.00029942946,0.0003548621,0.00064093235,0.00030498923],"domain_scores_gemma":[0.99851334,0.00046511347,0.000121965524,0.00044390335,0.00020048887,0.00025521265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041354916,0.00019040503,0.00044017995,0.000043946722,0.0002117193,0.00003654651,0.00013962106,0.00007095985,0.0001029108],"category_scores_gemma":[0.00035370636,0.00007930194,0.000052339514,0.00015356444,0.00032788966,0.00003495658,0.00026442425,0.0001631526,0.000016416545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013785465,0.0005152037,0.8857643,0.001071259,0.00022075194,0.00022796827,0.0005424516,0.00008939628,0.08764164,0.0021417374,0.000977649,0.0070221485],"study_design_scores_gemma":[0.001925739,0.000542178,0.9836581,0.00032526138,0.00016236797,0.00004999185,0.00020192475,0.00034523968,0.011928083,0.000094056166,0.00060888607,0.00015820903],"about_ca_topic_score_codex":0.00005297481,"about_ca_topic_score_gemma":0.00001742364,"teacher_disagreement_score":0.09789374,"about_ca_system_score_codex":0.00002659027,"about_ca_system_score_gemma":0.000067792695,"threshold_uncertainty_score":0.32338393},"labels":[],"label_agreement":null},{"id":"W2121970890","doi":"10.3324/haematol.2014.108258","title":"Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of Allergy and Infectious Diseases; Universitetet i Oslo; Medical Center, University of Rochester; Tampereen Yliopisto; Gentofte Hospital; Karolinska Institutet; University of Texas MD Anderson Cancer Center; Cancer Care Ontario; National Cancer Institute; University of Toronto; University of Rochester; U.S. Department of Veterans Affairs; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Lymphoma; Radiation therapy; Internal medicine; Hodgkin lymphoma; Oncology; Adverse effect; Cancer; Esophageal cancer","score_opus":0.02342477348110182,"score_gpt":0.30883694137542916,"score_spread":0.28541216789432733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121970890","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10463284,0.023331294,0.014200286,0.8477339,0.0024757003,0.0035345517,0.0003073844,0.00040939092,0.0033746285],"genre_scores_gemma":[0.112950444,0.0015089905,0.009262138,0.86785156,0.004566112,0.0005292783,0.00040536586,0.0001586882,0.002767421],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832046,0.000113715345,0.0004832748,0.0004132058,0.00029373358,0.000375618],"domain_scores_gemma":[0.9985186,0.00042041476,0.00049429835,0.0004424557,0.00006673351,0.000057495694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025334515,0.0003012278,0.0012307002,0.00018181124,0.00008936687,0.000020182515,0.00019545709,0.0005784799,0.00027489424],"category_scores_gemma":[0.00020730664,0.00022809183,0.0006209079,0.00012241636,0.00007061602,0.000046363617,0.000015893593,0.00035924092,0.00001291007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007804732,0.00003150674,0.011198621,0.00046155517,0.0007000825,0.00035327888,0.00010681019,0.000004997241,0.00007810421,0.00003087607,0.96997374,0.016982371],"study_design_scores_gemma":[0.0027468915,0.00020641132,0.002700756,0.00031434954,0.0006734121,0.00019067658,0.000008653198,0.0008923739,0.0016926485,0.00019191172,0.9901117,0.0002702124],"about_ca_topic_score_codex":0.00009412113,"about_ca_topic_score_gemma":0.0000014393368,"teacher_disagreement_score":0.021822304,"about_ca_system_score_codex":0.00009103707,"about_ca_system_score_gemma":0.00013712862,"threshold_uncertainty_score":0.93013144},"labels":[],"label_agreement":null},{"id":"W2122398847","doi":"10.3324/haematol.2013.096859","title":"The importance of calcium in the regulation of megakaryocyte function","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"National Institute of Biomedical Imaging and Bioengineering","keywords":"Megakaryocyte; Cell biology; Extracellular; ORAI1; Calcium; Calcium in biology; Thrombopoiesis; Calcium signaling; Chemistry; Phospholipase C; Intracellular; Biochemistry; Biology; Voltage-dependent calcium channel; Signal transduction; Stem cell; Progenitor cell","score_opus":0.024897050955237598,"score_gpt":0.27351114469430304,"score_spread":0.24861409373906546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122398847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332684,0.00035324827,0.00024085466,0.00059689576,0.000031625805,0.0001951048,7.1551307e-7,0.0000068908485,0.005247797],"genre_scores_gemma":[0.9996689,0.000026329277,0.00009927513,0.00010967219,0.000006306052,0.000013314346,0.0000071695995,0.0000024196484,0.000066639564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994784,0.000057279318,0.00019400142,0.00007430194,0.000117546355,0.00007845948],"domain_scores_gemma":[0.9994732,0.00016413044,0.0001204213,0.00020373854,0.000028639406,0.000009865245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024560664,0.00004924246,0.00018273715,0.00001931961,0.000036431906,0.000002130343,0.000051981522,0.000040653802,0.000014197256],"category_scores_gemma":[0.00010367938,0.00002130946,0.000042351596,0.00010739875,0.0000637716,0.000018034405,0.000008241804,0.00004420499,0.0000036982942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000993045,0.0004193414,0.9294002,0.00014357641,0.000070334194,0.000032334116,0.00039999775,0.000025167854,0.0021023054,0.058633953,0.0014310384,0.0063486765],"study_design_scores_gemma":[0.0008576525,0.00029060757,0.98425704,0.000033344088,0.000046265024,0.000084039624,0.00017666206,0.00047902614,0.0019357307,0.010393751,0.0014147366,0.000031151758],"about_ca_topic_score_codex":0.000020134576,"about_ca_topic_score_gemma":0.00007726186,"teacher_disagreement_score":0.054856803,"about_ca_system_score_codex":0.0000058338364,"about_ca_system_score_gemma":0.000010503287,"threshold_uncertainty_score":0.08689746},"labels":[],"label_agreement":null},{"id":"W2123152742","doi":"10.3324/haematol.13733","title":"Shwachman-Diamond syndrome neutrophils have altered chemoattractant-induced F-actin polymerization and polarization characteristics","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Universiteit van Amsterdam","keywords":"Chemotaxis; Actin; Cytoskeleton; Immunology; Neutropenia; Wiskott–Aldrich syndrome; Cell biology; Medicine; Biology; Internal medicine; Cell; Gene; Genetics","score_opus":0.011989963666442966,"score_gpt":0.23998011514518044,"score_spread":0.22799015147873747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123152742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997919,0.00041751532,0.0002825245,0.0004958161,0.00007849327,0.00024196944,0.000019968456,0.000032707914,0.0005119943],"genre_scores_gemma":[0.9983568,0.00016610962,0.00029280945,0.00049274927,0.000048047106,0.000012067927,0.0004879442,0.000015898082,0.00012754694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990083,0.00004194053,0.00022985201,0.0003804943,0.00009187038,0.00024752758],"domain_scores_gemma":[0.99947447,0.000006827798,0.0001522905,0.00024216672,0.0000375122,0.00008674474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041568157,0.00020924931,0.00025624878,0.000042330783,0.00013240939,0.00005127953,0.00009342242,0.00022088946,0.000014339305],"category_scores_gemma":[0.000043090087,0.00018750016,0.00005083947,0.000067152374,0.00003678604,0.0000113160795,0.00003693208,0.000075156924,0.000006916767],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013459405,0.0004398032,0.026180992,0.000022075455,0.00007945567,0.00008635398,0.000059668753,5.41426e-7,0.95925856,0.0004224354,0.000083557956,0.013231947],"study_design_scores_gemma":[0.0020007319,0.001956236,0.54439056,0.0000372047,0.00012816461,0.001010211,0.00009229347,0.0001290883,0.4482565,0.0005478821,0.0007865102,0.0006646414],"about_ca_topic_score_codex":0.000009679017,"about_ca_topic_score_gemma":0.0000033725523,"teacher_disagreement_score":0.5182096,"about_ca_system_score_codex":0.000006490761,"about_ca_system_score_gemma":0.000021191601,"threshold_uncertainty_score":0.7646035},"labels":[],"label_agreement":null},{"id":"W2123303925","doi":"10.3324/haematol.2014.112821","title":"Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity","year":2015,"lang":"en","type":"review","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Grifols; Swedish Orphan Biovitrum; Biogen; Pfizer","keywords":"Von Willebrand factor; Immunogenicity; Immunology; Antibody; Factor IX; Antigen; Immune system; Recombinant DNA; Medicine; Biology; Internal medicine; Genetics; Gene; Platelet","score_opus":0.10232411967621508,"score_gpt":0.37984142754775707,"score_spread":0.277517307871542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123303925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16999449,0.8244678,9.67102e-7,0.00034766734,0.00010350297,0.0040321243,0.00013279881,0.000052853593,0.0008677937],"genre_scores_gemma":[0.34655055,0.65241337,0.000087027765,0.00004396095,0.000069517824,0.00025515413,0.00007009492,0.000068814734,0.00044149146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954027,0.0006745763,0.0015010171,0.0007507833,0.0008309717,0.0008399737],"domain_scores_gemma":[0.99738914,0.0007371836,0.00046657224,0.0009945725,0.00018053516,0.00023197137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056637934,0.00078299525,0.004198858,0.0005717602,0.00011374031,0.000039887535,0.000633007,0.00073531363,0.00036582208],"category_scores_gemma":[0.00052852806,0.00039755862,0.00066894846,0.0008996603,0.0002564036,0.00008401722,0.00035767132,0.0009814885,0.00014475397],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005408269,0.0007839109,0.032515325,0.010467475,0.00091195316,0.0004302141,0.0031736363,0.0000011461387,0.000609801,0.00020337375,0.000104615014,0.9502577],"study_design_scores_gemma":[0.0058044153,0.0019156263,0.030456826,0.041561972,0.001120483,0.0010797991,0.0016430024,0.00007729376,0.0025610388,0.0011833617,0.9102766,0.0023195997],"about_ca_topic_score_codex":0.0001573503,"about_ca_topic_score_gemma":0.000106312575,"teacher_disagreement_score":0.94793814,"about_ca_system_score_codex":0.00036815548,"about_ca_system_score_gemma":0.00052980985,"threshold_uncertainty_score":0.99984765},"labels":[],"label_agreement":null},{"id":"W2123967889","doi":"10.3324/haematol.12212","title":"Characterization of compound 584, an Abl kinase inhibitor with lasting effects","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Centre National de la Recherche Scientifique; European Commission","keywords":"Nilotinib; Dasatinib; Tyrosine kinase; Imatinib; ABL; Chemistry; LYN; Kinase; Bosutinib; Proto-oncogene tyrosine-protein kinase Src; Tyrosine-kinase inhibitor; Pharmacology; Imatinib mesylate; IC50; Cancer research; Molecular biology; Biochemistry; Biology; In vitro; Signal transduction","score_opus":0.02235335089522569,"score_gpt":0.24931301543303974,"score_spread":0.22695966453781405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123967889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791473,0.000049013335,0.00019450765,0.00006871864,0.000057202655,0.00048826332,0.0000049103337,0.000113455826,0.0011092161],"genre_scores_gemma":[0.9971874,0.000021364895,0.002311147,0.00010985058,0.00006009577,0.000033183558,0.00012649516,0.000019403498,0.00013110545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990407,0.000056874407,0.00023129376,0.000250061,0.00021581186,0.00020524565],"domain_scores_gemma":[0.9992717,0.0000866719,0.00016693788,0.00028055452,0.00008090493,0.00011323894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053751446,0.00016140635,0.00045701006,0.00006686888,0.00009598961,0.000004996516,0.00005753919,0.000090255795,0.00006260074],"category_scores_gemma":[0.000073394884,0.00010952274,0.000039835628,0.00016771462,0.0001353671,0.000096965414,0.00002625724,0.00010538231,0.000030222078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014527576,0.0019611611,0.31969813,0.0014390319,0.00023541453,0.010473654,0.0015845979,0.000008426368,0.6595056,0.00055558764,0.00017124707,0.0029143959],"study_design_scores_gemma":[0.008380678,0.0036322647,0.44566944,0.0009851631,0.00020946265,0.008042007,0.00006691654,0.00052856153,0.53145576,0.000026041893,0.0006766614,0.0003270749],"about_ca_topic_score_codex":0.000026126092,"about_ca_topic_score_gemma":0.0000057301754,"teacher_disagreement_score":0.12804988,"about_ca_system_score_codex":0.000110849905,"about_ca_system_score_gemma":0.00012630633,"threshold_uncertainty_score":0.4466208},"labels":[],"label_agreement":null},{"id":"W2124881596","doi":"10.3324/haematol.2014.110742","title":"Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Izaak Walton Killam Health Centre; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Nova Scotia Health Research Foundation; Terry Fox Foundation; Beatrice Hunter Cancer Research Institute; California HIV/AIDS Research Program; Cancer Research Institute","keywords":"Zebrafish; Xenotransplantation; Leukemia; CRISPR; Cancer research; Cancer; Lymphoblastic Leukemia; Computational biology; PI3K/AKT/mTOR pathway; Medicine; Sanger sequencing; Genome editing; Mutation; Synthetic lethality; Biology; Bioinformatics; Immunology; Transplantation; Gene; Genetics; Internal medicine; Signal transduction; Mutant","score_opus":0.03345092067895968,"score_gpt":0.32917707558063475,"score_spread":0.2957261549016751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124881596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82974035,0.00008608981,0.16850464,0.00017720615,0.00007059399,0.0007288966,0.00004870308,0.000044012006,0.0005995211],"genre_scores_gemma":[0.98488474,0.00013593813,0.0130507415,0.00092878944,0.00021836285,0.00022147836,0.0004117983,0.000041884377,0.000106241685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805105,0.00008103871,0.00050823315,0.00061264343,0.00023098437,0.0005160722],"domain_scores_gemma":[0.99864894,0.00032261419,0.00016776442,0.0004669156,0.00011698741,0.0002767588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046202284,0.0002313321,0.00034984972,0.000045877525,0.00015530261,0.000049473263,0.00047420216,0.0004817151,0.000038210343],"category_scores_gemma":[0.00040098294,0.00019886726,0.00021434748,0.000120429584,0.00030095186,0.000008046944,0.000109704255,0.0001691328,0.00005299824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091428845,0.00022834254,0.00025001288,0.00009514768,0.00015941999,0.0000058988226,0.00003780655,0.000024250829,0.99020964,0.0013138575,0.0012973085,0.005464002],"study_design_scores_gemma":[0.006054046,0.0020036404,0.0010263976,0.000045352546,0.00032893082,0.00028953044,0.000031725005,0.028368134,0.9136939,0.009546163,0.037848856,0.0007633233],"about_ca_topic_score_codex":0.000012805193,"about_ca_topic_score_gemma":0.0000064962132,"teacher_disagreement_score":0.1554539,"about_ca_system_score_codex":0.00007611663,"about_ca_system_score_gemma":0.0003550208,"threshold_uncertainty_score":0.8109572},"labels":[],"label_agreement":null},{"id":"W2125213800","doi":"10.3324/haematol.11680","title":"Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib","year":2008,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Jewish General Hospital; Agenzia Italiana del Farmaco, Ministero della Salute; McGill University","keywords":"Imatinib; Myeloid leukemia; Creatine kinase; Medicine; Creatine; Internal medicine; Cholesterol; Endocrinology; Cancer research","score_opus":0.012412933668236417,"score_gpt":0.23054926538786524,"score_spread":0.21813633171962882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125213800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844185,0.0016559825,0.0000042787146,0.009544511,0.00005727776,0.0028463416,0.0000727813,0.0001348362,0.0012654945],"genre_scores_gemma":[0.9502953,0.004790874,0.0058215708,0.022290519,0.0010516543,0.002870908,0.0065342626,0.0003932365,0.005951672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964364,0.0001392553,0.0007835896,0.0011517493,0.000571962,0.00091701135],"domain_scores_gemma":[0.9983447,0.00019904002,0.00040326468,0.00080166355,0.0001011865,0.00015014624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006294626,0.0009585415,0.0017890754,0.00046500188,0.00017841798,0.000046723715,0.0001506906,0.0006275347,0.00020070124],"category_scores_gemma":[0.00004563089,0.000608884,0.00009840343,0.00042986142,0.00031150336,0.0001621174,0.000079229845,0.0010372243,0.000041506963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046746554,0.0017603483,0.9307976,0.0027437424,0.0011330931,0.039550632,0.002079435,0.00024999992,0.000047404148,0.000016884433,0.01362197,0.0033242432],"study_design_scores_gemma":[0.09007514,0.015134191,0.8397603,0.008926489,0.0009953459,0.0038185345,0.00007485716,0.0004183256,0.0019222328,0.000029737836,0.036618933,0.0022258763],"about_ca_topic_score_codex":0.0008474815,"about_ca_topic_score_gemma":0.00051347533,"teacher_disagreement_score":0.09103726,"about_ca_system_score_codex":0.006481319,"about_ca_system_score_gemma":0.0011194354,"threshold_uncertainty_score":0.99963623},"labels":[],"label_agreement":null},{"id":"W2125502424","doi":"10.3324/haematol.2012.083063","title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries","year":2013,"lang":"en","type":"letter","venue":"Haematologica","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Merck Sharp and Dohme; Robert Koch Institut; Masarykova Univerzita; Universität zu Köln; Julius-Maximilians-Universität Würzburg; Celgene; Universität des Saarlandes; Astellas Pharma; Universitätsklinikum Köln; Bundesministerium für Bildung und Forschung; Pfizer Pharmaceuticals; McGill University; Deutsches Zentrum für Infektionsforschung; BioCryst; Central European Institute of Technology; Gilead Sciences; Pfizer; Viropharma; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","keywords":"Mucormycosis; Antifungal; Amphotericin B; Medicine; Internal medicine; Hematologic Neoplasms; Hematopoietic stem cell transplantation; Leukemia; Intensive care medicine; Transplantation; Surgery; Dermatology","score_opus":0.02397617729043418,"score_gpt":0.23985988686912169,"score_spread":0.2158837095786875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125502424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382521,0.0041157077,0.00021362325,0.049671162,0.00008499219,0.006786588,0.00063695555,0.000050258815,0.00018859231],"genre_scores_gemma":[0.97856677,0.00070633966,0.00081192155,0.015473215,0.0001178503,0.001142453,0.002634609,0.00004170201,0.00050511776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974137,0.00016300331,0.00076194876,0.00080013834,0.0004462547,0.00041496003],"domain_scores_gemma":[0.9953433,0.0023616843,0.00069556496,0.001264592,0.00026621413,0.000068616304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014606194,0.0005013889,0.0016040016,0.000054915632,0.00018835237,0.00004916918,0.00027037796,0.00048347886,0.00005308412],"category_scores_gemma":[0.0006059815,0.0001999483,0.00026079235,0.0001889816,0.00084283645,0.00006293483,0.000065835105,0.00041470764,0.0000029675682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016521069,0.0007837223,0.8593471,0.0006031046,0.00043189144,0.0005223292,0.00024783492,4.0620384e-7,0.0000017787518,0.000029611836,0.13619797,0.00018215588],"study_design_scores_gemma":[0.00514894,0.0032946405,0.97665983,0.0006163393,0.001642934,0.000103908205,0.0013391529,0.000042111304,0.000125416,0.00031357873,0.01026452,0.00044860513],"about_ca_topic_score_codex":0.00045623299,"about_ca_topic_score_gemma":0.000050138937,"teacher_disagreement_score":0.12593344,"about_ca_system_score_codex":0.000090238485,"about_ca_system_score_gemma":0.00022568429,"threshold_uncertainty_score":0.8153655},"labels":[],"label_agreement":null},{"id":"W2125523937","doi":"10.3324/haematol.2011.056531","title":"A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada; University of Alberta","funders":"","keywords":"International Prognostic Index; Medicine; Epoch (astronomy); Rituximab; Vincristine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Etoposide; Cancer; Germinal center; Single Center; Prednisone; Oncology; Cyclophosphamide; B cell; Chemotherapy; Immunology","score_opus":0.03265571834827629,"score_gpt":0.280381009607812,"score_spread":0.24772529125953568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125523937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981018,0.00094525225,0.000021437269,0.00001891639,0.000011058665,0.00063459703,0.00007055458,0.0000223341,0.00017408592],"genre_scores_gemma":[0.999238,0.000121606594,0.00032607387,0.00008540571,0.0000011006787,0.00013397493,0.000049138675,0.000015974338,0.000028692482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985706,0.00007489574,0.00049198396,0.00039372485,0.00021063641,0.00025812205],"domain_scores_gemma":[0.9991513,0.00004216972,0.00025237765,0.00038014908,0.00007409037,0.000099933204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008655569,0.00023997435,0.0012080562,0.0002564801,0.000025733747,0.0000057517163,0.00008676606,0.00010139275,0.000056803296],"category_scores_gemma":[0.000017582954,0.00014855199,0.000106174986,0.0005782241,0.00008226948,0.00003605361,0.000065310145,0.00004612184,0.000002340474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063843455,0.070458755,0.92462474,0.00008906149,0.0013377438,0.0010735898,0.0012900343,6.8314256e-7,0.00023585102,0.00006154179,0.000017752343,0.00017182926],"study_design_scores_gemma":[0.086407416,0.0013801964,0.9037953,0.000071571994,0.0027092665,0.000028997154,0.00076420157,0.00029090693,0.004380634,0.0000029112946,0.000011924315,0.00015669793],"about_ca_topic_score_codex":0.006135767,"about_ca_topic_score_gemma":0.0027118078,"teacher_disagreement_score":0.085768975,"about_ca_system_score_codex":0.00012284194,"about_ca_system_score_gemma":0.00003304482,"threshold_uncertainty_score":0.9275485},"labels":[],"label_agreement":null},{"id":"W2125610771","doi":"10.3324/haematol.11755","title":"Inflammation and oxidant-stress in  -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Center for Research Resources; Translational Cancer Research Network; Children's Hospital of Philadelphia; University College London; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; New England Research Institutes","keywords":"Deferasirox; Malondialdehyde; Deferoxamine; Ferritin; Oxidative stress; Transferrin saturation; Medicine; Internal medicine; Transferrin; Deferiprone; Thalassemia; Gastroenterology; Serum ferritin","score_opus":0.020414249651859954,"score_gpt":0.24101753036686246,"score_spread":0.22060328071500251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125610771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752617,0.00009386565,0.0000011305906,0.00006526172,0.000049605573,0.0019686036,0.000006866565,0.000050853814,0.00023766581],"genre_scores_gemma":[0.9996257,0.00011104787,0.000054491604,0.000025920612,0.000016162205,0.00005854966,0.00002203042,0.000020761936,0.00006534324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982885,0.00018079473,0.0005452362,0.00034541424,0.00036756755,0.0002724916],"domain_scores_gemma":[0.9991013,0.000071522554,0.0002359434,0.0003743633,0.00010870103,0.00010816272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012823741,0.00023940092,0.0005629359,0.00012301515,0.00014574126,0.00000900496,0.00010999893,0.00024657504,0.000025758358],"category_scores_gemma":[0.00017560592,0.00011993628,0.000045458833,0.00052412244,0.00018177331,0.000107144064,0.000057253936,0.00026782916,0.0000023274515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011477094,0.0018883438,0.9825688,0.00008497111,0.000046465455,0.0003286033,0.0023320075,0.000026368438,0.0004772865,0.000008906924,0.000017964747,0.0007431773],"study_design_scores_gemma":[0.047736697,0.0061237845,0.9396802,0.00018240271,0.00013764204,0.00038144347,0.0021277652,0.00010489534,0.0033061083,0.0000036645417,0.000020930158,0.00019447517],"about_ca_topic_score_codex":0.00018932452,"about_ca_topic_score_gemma":0.00038695664,"teacher_disagreement_score":0.04288862,"about_ca_system_score_codex":0.00004287075,"about_ca_system_score_gemma":0.00007302927,"threshold_uncertainty_score":0.48908594},"labels":[],"label_agreement":null},{"id":"W2126532431","doi":"10.3324/haematol.2014.119545","title":"A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Ruxolitinib; Medicine; Hazard ratio; Internal medicine; Myelofibrosis; Placebo; Survival analysis; Confidence interval; Crossover study; Proportional hazards model; Surgery; Pathology","score_opus":0.1259945300572344,"score_gpt":0.39007178443101137,"score_spread":0.26407725437377694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126532431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188477,0.0028060465,0.00030150294,0.00059372565,0.000050545023,0.003573129,0.00040969325,0.000011295095,0.00036929006],"genre_scores_gemma":[0.9960652,0.001676832,0.0011252962,0.000046739035,0.000016193067,0.00080267736,0.00018180539,0.000010031705,0.000075212],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705535,0.00045930812,0.0016883506,0.0002775105,0.0002979438,0.00022154569],"domain_scores_gemma":[0.99324584,0.0050979354,0.00096326414,0.0003499198,0.0002207142,0.00012233706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020403108,0.0002578518,0.0050873416,0.00029081287,0.000050532326,0.0000064272454,0.00007583545,0.000115557785,0.00012321984],"category_scores_gemma":[0.0010355738,0.00012600237,0.0008786019,0.000353648,0.0003031916,0.000030057388,0.000031192227,0.000040579078,1.8939913e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67675847,0.02320636,0.18197092,0.0005704511,0.050214775,0.000085174586,0.011894346,0.00032686003,0.0014033405,0.04175377,0.000591236,0.011224299],"study_design_scores_gemma":[0.89753747,0.010121814,0.0126213385,0.00023597028,0.034513235,0.000021325865,0.0013609906,0.007119356,0.033833254,0.0013309593,0.0010433458,0.00026091287],"about_ca_topic_score_codex":0.00062298594,"about_ca_topic_score_gemma":0.00019420189,"teacher_disagreement_score":0.22077903,"about_ca_system_score_codex":0.000052961397,"about_ca_system_score_gemma":0.00010991532,"threshold_uncertainty_score":0.51382273},"labels":[],"label_agreement":null},{"id":"W2127765975","doi":"10.3324/haematol.2013.101386","title":"Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Hector Stiftung; Deutsche Krebshilfe; José Carreras Leukämie-Stiftung; Bundesministerium für Bildung und Forschung; Medizinischen Hochschule Hannover; Deutsche Forschungsgemeinschaft","keywords":"Decitabine; Myeloid leukemia; DNA methylation; Myelodysplastic syndromes; Internal medicine; Azacitidine; Medicine; Hypomethylating agent; Biology; Leukemia; Oncology; Cancer research; Bone marrow; Gene expression; Genetics; Gene","score_opus":0.024916716205095293,"score_gpt":0.33503992879084227,"score_spread":0.310123212585747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127765975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603695,0.00011649406,0.0002844934,0.00032600583,0.000025267196,0.00051215856,0.0000050957774,0.000054681783,0.002638871],"genre_scores_gemma":[0.99766845,0.00014265688,0.001879537,0.00009183843,0.00003483238,0.000024976349,0.000029252345,0.000021794709,0.00010668315],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830574,0.00020332185,0.0004080085,0.00038250562,0.00034391443,0.00035650676],"domain_scores_gemma":[0.99850446,0.0006403781,0.00014497933,0.00044190197,0.000087659595,0.00018060366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005353202,0.00021300423,0.00068331003,0.00032566529,0.00005032869,0.000011956866,0.00013573564,0.00023259658,0.00014519785],"category_scores_gemma":[0.0010529247,0.00013747106,0.00010063294,0.00034719415,0.00014213643,0.0000815794,0.00011394704,0.00037737843,0.000044140877],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005195315,0.0004525039,0.060376197,0.00021613593,0.00016091691,0.00029167035,0.0007859216,0.00012910375,0.8952859,0.0012445026,0.0028134638,0.033048347],"study_design_scores_gemma":[0.006070717,0.0024466198,0.8755822,0.00036684697,0.00005497077,0.00025199787,0.000033118908,0.0019293227,0.11213782,0.00072743866,0.0002036704,0.00019527708],"about_ca_topic_score_codex":0.00006134486,"about_ca_topic_score_gemma":0.0000029033974,"teacher_disagreement_score":0.815206,"about_ca_system_score_codex":0.00033232066,"about_ca_system_score_gemma":0.00014841904,"threshold_uncertainty_score":0.56059074},"labels":[],"label_agreement":null},{"id":"W2128185662","doi":"10.3324/haematol.2012.079012","title":"HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Blood Cancer UK; Queen's University","keywords":"Myeloid leukemia; Leukemia; Gene knockdown; Cancer research; Gene signature; Biology; Myeloid; Microarray analysis techniques; Chemotherapy; Gene; Microarray; Acute leukemia; Induction chemotherapy; Oncology; Immunology; Gene expression; Medicine; Genetics","score_opus":0.011518499260826579,"score_gpt":0.2593300131477613,"score_spread":0.2478115138869347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128185662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804855,0.00015861604,0.00037231535,0.010682663,0.00007842476,0.0015967956,0.000017308226,0.00027217244,0.006336234],"genre_scores_gemma":[0.9729067,0.0006011217,0.017698513,0.0070860405,0.00016061327,0.00016242257,0.000020468187,0.00007057691,0.001293561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970569,0.00009171754,0.00050111255,0.000763294,0.0005344649,0.0010525322],"domain_scores_gemma":[0.9978488,0.0002211799,0.000091094735,0.0006237696,0.00029433618,0.0009207869],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002473181,0.0004524357,0.0009124351,0.00024524936,0.00019718567,0.00011560677,0.00030155524,0.00037145996,0.0011772183],"category_scores_gemma":[0.00017478182,0.00033421608,0.0001617505,0.0004407444,0.0003654181,0.00013902031,0.00034218593,0.000529373,0.0016281802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011489287,0.00018802339,0.014243711,0.00032608263,0.0005195381,0.0016617823,0.0010644154,0.000006989577,0.8978495,0.000819406,0.071955964,0.010215634],"study_design_scores_gemma":[0.005938236,0.0028022625,0.15047972,0.00017612311,0.0002415188,0.0070794895,0.00060739287,0.0012507847,0.824973,0.00076930574,0.0045524463,0.0011297613],"about_ca_topic_score_codex":0.00031886727,"about_ca_topic_score_gemma":0.000007330937,"teacher_disagreement_score":0.136236,"about_ca_system_score_codex":0.00023458546,"about_ca_system_score_gemma":0.00032682557,"threshold_uncertainty_score":0.999911},"labels":[],"label_agreement":null},{"id":"W2128816533","doi":"10.3324/haematol.2009.017178","title":"Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council; Cancer Research UK","keywords":"Mesenchymal stem cell; Myeloid leukemia; Cancer research; Imatinib; Stromal cell; Bone marrow; Progenitor cell; Leukemia; Imatinib mesylate; Stem cell; Immunology; Biology; Cell biology","score_opus":0.014258445648139571,"score_gpt":0.24676444514542967,"score_spread":0.2325059994972901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128816533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899568,0.0002617319,0.00030841038,0.0009106673,0.00088363775,0.0036675795,0.00007555393,0.00038888896,0.0035467157],"genre_scores_gemma":[0.98962796,0.00007127603,0.0074848747,0.0003168872,0.00062408554,0.0008882241,0.00010136811,0.0001256144,0.0007596915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99497247,0.00026737482,0.0010099666,0.0013767325,0.0009524041,0.001421066],"domain_scores_gemma":[0.9963851,0.0005906736,0.0006140639,0.0017652971,0.00016654829,0.00047833956],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005348166,0.00093989936,0.0015390102,0.00018876635,0.00057727634,0.00011471862,0.0007544493,0.00082780124,0.002587195],"category_scores_gemma":[0.00020934567,0.00061885564,0.00053157413,0.0005487046,0.00043214572,0.00021662883,0.00034224094,0.0021135926,0.0020240555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042390818,0.00032510958,0.001276572,0.00016293315,0.00042233992,0.0003405571,0.0005130567,0.0000066224725,0.9863181,0.000047706857,0.002650416,0.007512689],"study_design_scores_gemma":[0.0053109587,0.0013722492,0.014873363,0.00017887614,0.00045327717,0.0006589424,0.00012803772,0.00216491,0.97225845,0.0002497108,0.001668449,0.0006827972],"about_ca_topic_score_codex":0.0015396097,"about_ca_topic_score_gemma":0.00042834392,"teacher_disagreement_score":0.014059661,"about_ca_system_score_codex":0.0017877477,"about_ca_system_score_gemma":0.0015223855,"threshold_uncertainty_score":0.9996263},"labels":[],"label_agreement":null},{"id":"W2129355608","doi":"10.3324/haematol.11606","title":"Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Leids Universitair Medisch Centrum; KWF Kankerbestrijding; Universiteit Leiden","keywords":"Haematopoiesis; Mobilization; Granulocyte colony-stimulating factor; Granulocyte; Progenitor cell; Interleukin 3; Hematopoietic growth factor; Stem cell; Internal medicine; Interleukin; Biology; Immunology; Endocrinology; Medicine; Cytokine; Cell biology; Chemotherapy; Antigen","score_opus":0.03270150285625094,"score_gpt":0.25546805348595286,"score_spread":0.2227665506297019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129355608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878067,0.00030370842,0.000052315016,0.000026184183,0.000047813748,0.0006147849,0.0000024272535,0.00004601761,0.00012609169],"genre_scores_gemma":[0.9996326,0.000040529772,0.00020925708,0.000012187167,0.000029813677,0.000028139122,0.000007579769,0.000019261328,0.000020636078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987345,0.000058468046,0.00045988406,0.00032843763,0.0001948494,0.00022390476],"domain_scores_gemma":[0.9993905,0.00011682478,0.00016522344,0.00015496374,0.000066531036,0.0001059839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006480055,0.00019965805,0.00065050484,0.00012554419,0.00007443887,0.00001141667,0.000053761574,0.00018122462,0.000054730204],"category_scores_gemma":[0.000046327365,0.00015710063,0.00006230485,0.00015332153,0.000064303415,0.00005574543,0.00007347256,0.00018334798,0.0000015562996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015109598,0.00021150056,0.37698364,0.000395921,0.000017294395,0.000056313198,0.0025497284,0.0000024755989,0.61824864,0.00004012148,0.0000032479006,0.0013399862],"study_design_scores_gemma":[0.0026002214,0.0006133336,0.06458694,0.00031259938,0.000054264565,0.0005279821,0.0010242054,0.0042739916,0.92567664,0.0000808524,0.000008192165,0.00024075063],"about_ca_topic_score_codex":0.00004548785,"about_ca_topic_score_gemma":0.0000093103345,"teacher_disagreement_score":0.3123967,"about_ca_system_score_codex":0.000033644596,"about_ca_system_score_gemma":0.000037351736,"threshold_uncertainty_score":0.64063776},"labels":[],"label_agreement":null},{"id":"W2131236362","doi":"10.3324/haematol.10616","title":"A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Hospital for Sick Children; Austrian Science Fund","keywords":"Medicine; Prospective cohort study; Heparin; Thrombosis; Incidence (geometry); Cohort; Cohort study; Internal medicine; Surgery; Major bleeding","score_opus":0.03307020865336616,"score_gpt":0.3408378763714658,"score_spread":0.3077676677180996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131236362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411964,0.00005591925,0.001477633,0.00015785873,0.00006504539,0.0016798927,0.0000018229919,0.00006732003,0.002374853],"genre_scores_gemma":[0.99718076,0.00003502502,0.002430569,0.0002627806,0.00001642178,0.000040062696,0.0000036617105,0.000014822608,0.00001589229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765044,0.00012901137,0.0011062876,0.0003950135,0.00045494284,0.00026431362],"domain_scores_gemma":[0.997881,0.00062611495,0.00034361557,0.0002882049,0.0007682294,0.0000928355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017542897,0.00016776194,0.00085634645,0.00021636562,0.000048054455,0.0000076538345,0.00013962445,0.00015671283,0.00014839621],"category_scores_gemma":[0.0018247333,0.00013315596,0.000098851575,0.00057167065,0.00015785499,0.000074844815,0.00006763354,0.00029682423,0.000005988323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047127806,0.0020395496,0.97933173,0.00004963626,0.00018943117,0.000055264205,0.0004769071,0.0000038271683,0.013344654,0.0031876403,0.0000020300888,0.000848023],"study_design_scores_gemma":[0.0014017185,0.0016852627,0.9789277,0.00024528973,0.0001737173,0.00007393957,0.0013124592,0.00009804438,0.014464702,0.0014929306,7.473998e-7,0.00012351999],"about_ca_topic_score_codex":0.00013493565,"about_ca_topic_score_gemma":0.000051902716,"teacher_disagreement_score":0.0030611097,"about_ca_system_score_codex":0.000051904364,"about_ca_system_score_gemma":0.00008575071,"threshold_uncertainty_score":0.54299426},"labels":[],"label_agreement":null},{"id":"W2132410859","doi":"10.3324/haematol.2010.037978","title":"Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stem Cell Network","keywords":"Antigen; Cancer; Multiple myeloma; Internal medicine; Medicine; Oncology; Immunotherapy; Cancer research; Biology; Immunology","score_opus":0.018509287959409152,"score_gpt":0.23985335944651587,"score_spread":0.22134407148710672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132410859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93984306,0.058088843,0.00027185504,0.00018885515,0.00037957422,0.001012717,0.000046905243,0.000081338934,0.00008682636],"genre_scores_gemma":[0.99122435,0.0063735554,0.0013437816,0.00019569123,0.000008861977,0.0004071292,0.000027925487,0.000030383733,0.0003883452],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983887,0.00024922052,0.00038938943,0.00042538022,0.000028015162,0.00051928195],"domain_scores_gemma":[0.9989201,0.000626551,0.00015135395,0.00022425517,0.000052834497,0.000024925565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002723727,0.00028210378,0.00051344396,0.00014935115,0.00027528603,0.00001984811,0.00016887925,0.00034167283,0.00034485458],"category_scores_gemma":[0.00034512536,0.00022863597,0.00008041895,0.00011610065,0.00046024765,0.00012360876,0.0000659126,0.00021965888,0.000017185725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015765376,0.0008389033,0.416333,0.00017323096,0.00071876385,0.0003317012,0.0053422996,0.000002372968,0.47973353,0.0006596045,0.0019575607,0.07814368],"study_design_scores_gemma":[0.008861374,0.0010353641,0.94234174,0.00015450137,0.000055389213,0.00057499926,0.00061109284,0.000031465377,0.038163528,0.0005659651,0.007092919,0.00051163527],"about_ca_topic_score_codex":0.0005198893,"about_ca_topic_score_gemma":0.00011930916,"teacher_disagreement_score":0.5260088,"about_ca_system_score_codex":0.000018126448,"about_ca_system_score_gemma":0.00005227944,"threshold_uncertainty_score":0.9323504},"labels":[],"label_agreement":null},{"id":"W2133005406","doi":"10.3324/haematol.2009.019943","title":"Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Salvage therapy; Refractory (planetary science); Chemotherapy; Transplantation; Internal medicine; Surgery; Lymphoma; Oncology; Cohort","score_opus":0.0058981634693385555,"score_gpt":0.22754268173314432,"score_spread":0.22164451826380577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133005406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943797,0.00004659309,0.0000030287608,0.0043221912,0.00008798462,0.0009098131,0.000051697894,0.00007550582,0.00012348106],"genre_scores_gemma":[0.9965776,0.000041484833,0.0006642833,0.0024294988,0.000009568048,0.00011534671,0.000035528108,0.000027517292,0.00009915598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985854,0.00008390057,0.0002821518,0.00043276467,0.00028484117,0.0003309127],"domain_scores_gemma":[0.9988622,0.00031760047,0.00007907308,0.00043308214,0.000063367,0.0002446986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012725388,0.00030619127,0.000678817,0.00015637751,0.000068585774,0.000022665381,0.000090512614,0.00017604048,0.00009742907],"category_scores_gemma":[0.00012183921,0.00017033539,0.0000702962,0.000096476666,0.000081772,0.000048650432,0.000031071435,0.00012306978,0.00002477727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0104086725,0.002417034,0.98076785,0.000031232794,0.00008905185,0.0007286133,0.0004992643,1.03811466e-7,0.0020343,0.00005923158,0.000086555185,0.002878103],"study_design_scores_gemma":[0.012427477,0.0026115824,0.9801887,0.00011193993,0.00006054632,0.0000816248,0.00005112024,0.0000016867076,0.0033873038,0.000016021699,0.00085019384,0.0002117863],"about_ca_topic_score_codex":0.000063036474,"about_ca_topic_score_gemma":0.00011686394,"teacher_disagreement_score":0.0026663167,"about_ca_system_score_codex":0.0000809744,"about_ca_system_score_gemma":0.00004906626,"threshold_uncertainty_score":0.69460756},"labels":[],"label_agreement":null},{"id":"W2133225333","doi":"10.3324/haematol.2013.100263","title":"Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench story","year":2014,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Posaconazole; Hematology; Bench to bedside; Medicine; Antifungal; Intensive care medicine; Internal medicine; Medical physics; Voriconazole; Dermatology","score_opus":0.03588883364448356,"score_gpt":0.28773611860322,"score_spread":0.25184728495873643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133225333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75153565,0.0007518324,0.0028340702,0.00052759104,0.2348383,0.003690782,0.00017089614,0.00042814927,0.005222695],"genre_scores_gemma":[0.9665237,0.000028302384,0.0011995265,0.00021864807,0.031062596,0.000097001684,0.0004904053,0.00009007034,0.00028974732],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9952341,0.00043352944,0.00078911247,0.0014277697,0.0011796965,0.0009358353],"domain_scores_gemma":[0.9966011,0.0009358756,0.00037051222,0.0010375769,0.000617137,0.00043778826],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00089723733,0.00067760964,0.002082247,0.0004922318,0.00025157398,0.00006961806,0.00040666942,0.0014823023,0.00023639906],"category_scores_gemma":[0.0030986792,0.00050810195,0.00016938508,0.00047288497,0.00031669685,0.00021730352,0.00015375594,0.0019187636,0.00008731352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026817843,0.000971064,0.29597095,0.0017562783,0.00011712503,0.0011294706,0.0005881157,0.0000061868077,0.0000790736,0.00086219003,0.69558364,0.000254101],"study_design_scores_gemma":[0.034126148,0.079331614,0.46591055,0.022498237,0.0019086715,0.00069495913,0.011320611,0.00059822126,0.0014624535,0.005298511,0.36530298,0.011547036],"about_ca_topic_score_codex":0.00010305495,"about_ca_topic_score_gemma":0.0013730042,"teacher_disagreement_score":0.3302807,"about_ca_system_score_codex":0.0008737302,"about_ca_system_score_gemma":0.00068919087,"threshold_uncertainty_score":0.999814},"labels":[],"label_agreement":null},{"id":"W2133581509","doi":"10.3324/haematol.13044","title":"Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Studienstiftung des Deutschen Volkes","keywords":"Myeloid leukemia; Leukemia; Downregulation and upregulation; Cancer research; Myeloid; Biology; Microarray analysis techniques; Cell growth; Molecular biology; Cell culture; Gene expression; Gene; Immunology; Genetics","score_opus":0.053897946218395276,"score_gpt":0.2971970424751597,"score_spread":0.24329909625676444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133581509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924701,0.00059067114,0.0007931656,0.00073437375,0.00006509446,0.0004829969,0.000008446384,0.000090481844,0.004764704],"genre_scores_gemma":[0.99405557,0.00018171247,0.004594908,0.0001738024,0.00006909165,0.000052055628,0.000050144685,0.000026031805,0.0007966927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99783146,0.000135409,0.0006055149,0.00040327103,0.00057582074,0.00044852644],"domain_scores_gemma":[0.99902797,0.00016536252,0.00013956572,0.0003726988,0.00014908453,0.00014534322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028906183,0.00021119467,0.0006372896,0.0003337409,0.00010681719,0.000008036625,0.00019302526,0.0002552138,0.0004804821],"category_scores_gemma":[0.00022862581,0.00017710529,0.00014605926,0.0004549321,0.00039371348,0.00017199137,0.000061018436,0.0004186839,0.000076458535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025676792,0.00081704604,0.17848131,0.0007667927,0.00012599553,0.002304836,0.004298838,0.0005573361,0.7937885,0.00443888,0.0065660784,0.0052867224],"study_design_scores_gemma":[0.006167791,0.00048765214,0.88482666,0.00070369773,0.00005281332,0.004538927,0.00050229736,0.00563108,0.09288912,0.0010261018,0.002752889,0.00042096502],"about_ca_topic_score_codex":0.000070785136,"about_ca_topic_score_gemma":0.000014251878,"teacher_disagreement_score":0.7063454,"about_ca_system_score_codex":0.00031843572,"about_ca_system_score_gemma":0.00039387378,"threshold_uncertainty_score":0.7222144},"labels":[],"label_agreement":null},{"id":"W2134625781","doi":"10.3324/haematol.2010.023614","title":"Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Central retinal vein occlusion; Visual acuity; Cochrane Library; Low molecular weight heparin; Randomized controlled trial; Ophthalmology; Branch retinal vein occlusion; Meta-analysis; Fluorescein angiography; Surgery; Heparin; Internal medicine; Macular edema","score_opus":0.13824677480320632,"score_gpt":0.418206579188262,"score_spread":0.27995980438505563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134625781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013931423,0.9765451,0.00012749917,0.00025918728,0.000025312924,0.022572437,0.000361344,0.0000124600665,0.00008270556],"genre_scores_gemma":[0.000118964,0.99252653,0.0005747557,0.000078519966,0.000009398629,0.006159181,0.0002431642,0.000025711279,0.000263783],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931891,0.002307351,0.0034310452,0.00048016352,0.00038968475,0.00020267595],"domain_scores_gemma":[0.98773956,0.0070149405,0.003756829,0.0011177935,0.00024165925,0.00012921664],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0028356055,0.00062220305,0.047469757,0.00022352692,0.00006446804,0.0000136481685,0.00020241145,0.0002704865,0.00039045882],"category_scores_gemma":[0.0034561658,0.00021069481,0.019371893,0.0004740319,0.00022536678,0.000012238399,0.000045678906,0.00010217076,0.0000041944563],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016714754,0.0005052022,4.773884e-7,0.6186754,0.3767265,0.000119170545,0.000012333605,4.780522e-8,1.547075e-7,0.00048617437,0.000028710821,0.0017743562],"study_design_scores_gemma":[0.009516181,0.00042863007,4.3158795e-7,0.032122333,0.9513708,0.00020601478,0.0000036227707,0.000012062107,0.0000074446007,0.000051596682,0.0061394623,0.00014143929],"about_ca_topic_score_codex":0.000016823373,"about_ca_topic_score_gemma":0.000001990052,"teacher_disagreement_score":0.58655304,"about_ca_system_score_codex":0.0000320809,"about_ca_system_score_gemma":0.000115171584,"threshold_uncertainty_score":0.99044883},"labels":[],"label_agreement":null},{"id":"W2135067956","doi":"10.3324/haematol.2009.021766","title":"Vascularization predicts overall survival and risk of transformation in follicular lymphoma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Fundação para a Ciência e a Tecnologia; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Follicular lymphoma; Follicular phase; Lymphoma; Medicine; Internal medicine; CD34; Pathology; Angiogenesis; Microvessel; Prognostic variable; Survival analysis; Oncology; Multivariate analysis; Biology","score_opus":0.010060671104852398,"score_gpt":0.23402911254233863,"score_spread":0.22396844143748623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135067956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966612,0.00019332445,0.00016294689,0.00020626129,0.00006698213,0.00037493318,0.000008490838,0.000027130904,0.0022987556],"genre_scores_gemma":[0.9986005,0.0006624675,0.00061493524,0.000025412539,0.000010738298,0.000034633493,0.00003784505,0.0000053209064,0.000008159148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931,0.000043278586,0.00023443314,0.00014244077,0.00015719567,0.00011263768],"domain_scores_gemma":[0.99961144,0.000058569356,0.00007895027,0.00015175843,0.000042801712,0.00005649655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000171118,0.0000941417,0.00029860917,0.00006703047,0.000030301977,0.0000081676,0.000027819597,0.00012231321,0.000032569566],"category_scores_gemma":[0.000101022684,0.000065890476,0.000065291904,0.00009013431,0.000045059962,0.0000777195,0.000011234585,0.000048874463,0.000004410802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011514647,0.0006103471,0.96950746,0.000117832824,0.000107900014,0.00008881736,0.000511744,0.0000066298335,0.00095636427,0.01897329,0.00002105064,0.0089834],"study_design_scores_gemma":[0.0045407047,0.00017051851,0.98534316,0.000049156206,0.00014268338,0.00013943035,0.000046573983,0.0007774841,0.007486699,0.00077680557,0.00046290067,0.00006390325],"about_ca_topic_score_codex":0.00024343398,"about_ca_topic_score_gemma":0.00014202554,"teacher_disagreement_score":0.018196486,"about_ca_system_score_codex":0.000015750453,"about_ca_system_score_gemma":0.000030909927,"threshold_uncertainty_score":0.26869357},"labels":[],"label_agreement":null},{"id":"W2136504668","doi":"10.3324/haematol.2013.092411","title":"Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Myeloid leukemia; Leukemia; Proteasome; Bortezomib; Proteasome inhibitor; Medicine; Acute lymphocytic leukemia; Myeloid; Cancer research; Acute leukemia; Immunology; Pharmacology; Multiple myeloma; Biology; Lymphoblastic Leukemia; Biochemistry","score_opus":0.027865285506768995,"score_gpt":0.25698354417133096,"score_spread":0.22911825866456195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136504668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388474,0.00017969859,0.00087599445,0.00014734684,0.00030544936,0.0024286832,0.00023073042,0.000030228257,0.001917097],"genre_scores_gemma":[0.99531436,0.000037252004,0.003546875,0.00010335462,0.00015691877,0.00040794237,0.00005436161,0.000024506657,0.00035443477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980492,0.00016813664,0.00056929525,0.00052391604,0.00028848168,0.00040098192],"domain_scores_gemma":[0.9984802,0.00007585067,0.00047755396,0.00050600444,0.00026964408,0.00019073878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035286383,0.00031845886,0.00057423924,0.00012695436,0.000091324466,0.000019594481,0.0002681851,0.00038226938,0.00017411259],"category_scores_gemma":[0.00027966805,0.00027161563,0.00018756685,0.000265942,0.00030108978,0.00001639574,0.0003317636,0.00019430644,0.00019282341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004047929,0.00017573607,0.00082973647,0.00011483714,0.00014269844,0.000016305114,0.00010968338,0.000015166965,0.99588925,0.001289054,0.0007934643,0.00021930704],"study_design_scores_gemma":[0.0012755585,0.0008615707,0.0042694095,0.000031149477,0.00006839756,0.00003558202,0.00006349579,0.000008175257,0.99218076,0.00007946159,0.00079916086,0.00032726434],"about_ca_topic_score_codex":0.00017147552,"about_ca_topic_score_gemma":0.0000045186093,"teacher_disagreement_score":0.0037084434,"about_ca_system_score_codex":0.00003957587,"about_ca_system_score_gemma":0.00040664783,"threshold_uncertainty_score":0.9999736},"labels":[],"label_agreement":null},{"id":"W2138597400","doi":"10.3324/haematol.2010.025767","title":"The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Lymphoma; B cell; Germinal center; Biology; Cancer research; Chromosomal translocation; Immunoglobulin light chain; Diffuse large B-cell lymphoma; Pathology; Haematopoiesis; Antibody; Immunology; Medicine; Stem cell; Gene; Genetics","score_opus":0.0173749675604189,"score_gpt":0.23917187742203694,"score_spread":0.22179690986161804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138597400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932713,0.0032133842,0.00022168097,0.0015539473,0.001963624,0.0021191128,0.000111163725,0.00037081886,0.0011191529],"genre_scores_gemma":[0.98140657,0.00017237957,0.00025141754,0.00028174353,0.000033268516,0.0010486633,0.00020122508,0.00005399781,0.01655076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969392,0.00047072084,0.0007278578,0.0007067902,0.00007742952,0.001078016],"domain_scores_gemma":[0.9963114,0.0022935646,0.00040826524,0.00071736303,0.00021698556,0.000052420823],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00075411296,0.00045419566,0.000669307,0.00009323543,0.0012324783,0.000095917254,0.0008844316,0.0011208608,0.0018126288],"category_scores_gemma":[0.0014547546,0.00030602326,0.00034140836,0.00026322872,0.0007187687,0.00011485097,0.0001496207,0.0007936911,0.0013420167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049983873,0.0005126508,0.001921744,0.00006134743,0.00029590027,0.000013689098,0.0005028252,2.4373523e-7,0.9785438,0.000942888,0.015566752,0.0011383134],"study_design_scores_gemma":[0.0035270883,0.00036909516,0.0021556893,0.00007150931,0.00013877076,0.00014782479,0.00023575549,0.00001320636,0.8251873,0.0015581213,0.16609715,0.0004984355],"about_ca_topic_score_codex":0.00010036842,"about_ca_topic_score_gemma":0.00020412533,"teacher_disagreement_score":0.15335646,"about_ca_system_score_codex":0.000042605952,"about_ca_system_score_gemma":0.00012517096,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W2138924647","doi":"10.3324/haematol.13827","title":"In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodies","year":2009,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Antibody; Medicine; Pregnancy; Immunology; Intervention (counseling); Biology; Fetus; Genetics; Psychiatry","score_opus":0.0308254490250642,"score_gpt":0.27945766250538584,"score_spread":0.24863221348032163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138924647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9079465,0.0024771607,0.0000016918138,0.08608498,0.000099848185,0.0016563471,0.00014329322,0.00013367736,0.0014564684],"genre_scores_gemma":[0.9153545,0.0023913383,0.00012044457,0.079197556,0.00007211622,0.00015734995,0.00068897026,0.000098323915,0.0019194145],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99540687,0.00039695675,0.0009528527,0.0010392967,0.0006885275,0.0015155093],"domain_scores_gemma":[0.9977329,0.00033938928,0.0006100976,0.0010437422,0.00012570679,0.00014815909],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002577663,0.0009955154,0.0030099254,0.00058835634,0.00027656308,0.00009025004,0.0005463595,0.0012049188,0.0003172795],"category_scores_gemma":[0.00038034475,0.00060861645,0.00025622113,0.0008536943,0.00031582135,0.00019693766,0.00016217546,0.0021838536,0.00008259134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025763165,0.0049309414,0.40222213,0.0019874389,0.0031279472,0.51072454,0.00468344,0.000009055981,0.0015593973,0.000043981014,0.06737912,0.0007556742],"study_design_scores_gemma":[0.019379437,0.001029533,0.9544321,0.011578207,0.0005499982,0.004280986,0.00039216081,0.000040095558,0.0014827925,0.0005857397,0.004670607,0.0015783516],"about_ca_topic_score_codex":0.00032126324,"about_ca_topic_score_gemma":0.00007265115,"teacher_disagreement_score":0.55221,"about_ca_system_score_codex":0.00033192136,"about_ca_system_score_gemma":0.00025649098,"threshold_uncertainty_score":0.99963653},"labels":[],"label_agreement":null},{"id":"W2139026714","doi":"10.3324/haematol.11168","title":"Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Cyclophosphamide; Internal medicine; Total body irradiation; Regimen; Chemotherapy; Randomized controlled trial; Surgery; Oncology","score_opus":0.06266984780719237,"score_gpt":0.3249320796119417,"score_spread":0.26226223180474934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139026714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409705,0.00022750837,0.000095703464,0.00017779139,0.0002526135,0.004116983,0.000044289063,0.000055902983,0.0009321616],"genre_scores_gemma":[0.9984769,0.000045267705,0.0003484789,0.00004804835,0.000058108446,0.00031089567,0.00014376715,0.000029831888,0.00053869677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726564,0.00029567516,0.0006625444,0.0005365165,0.0005610821,0.0006785598],"domain_scores_gemma":[0.9980128,0.0007171734,0.0002692409,0.0005595528,0.00017411668,0.00026715844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034048292,0.00041835356,0.0011185465,0.00021379013,0.00015589457,0.00002161145,0.00023870454,0.0001733813,0.00014539127],"category_scores_gemma":[0.00037498737,0.0002075694,0.00022226272,0.0005403687,0.000484914,0.00009586599,0.00011318157,0.0002968524,0.00003279834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13023335,0.0027698562,0.85578406,0.00008539207,0.00056538417,0.002548349,0.0027237711,0.0000040300583,0.0011708499,0.000102350234,0.000061267245,0.003951356],"study_design_scores_gemma":[0.14467849,0.0051721497,0.8313649,0.00029165993,0.00012749706,0.00017800015,0.0007902069,0.00014165956,0.017003415,0.00001604424,0.00003963054,0.0001963423],"about_ca_topic_score_codex":0.00040936176,"about_ca_topic_score_gemma":0.0079005575,"teacher_disagreement_score":0.024419148,"about_ca_system_score_codex":0.00034666064,"about_ca_system_score_gemma":0.00018135988,"threshold_uncertainty_score":0.8464435},"labels":[],"label_agreement":null},{"id":"W2139663853","doi":"10.3324/haematol.2014.117457","title":"The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Janeway Children's Health and Rehabilitation Centre; McMaster University; McMaster Children's Hospital; Alberta Health; University of Alberta; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; Queen's University; Centre Hospitalier Universitaire Sainte-Justine; Population Health Research Institute; Children's Hospital of Western Ontario; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; Alberta Children's Hospital; Izaak Walton Killam Health Centre; University of Saskatchewan; Hospital for Sick Children; Health Sciences Centre; CancerCare Manitoba; BC Children's Hospital; Montreal Children's Hospital; University of Toronto","funders":"","keywords":"Bone marrow failure; Cytogenetics; Myelodysplastic syndromes; Cytopathology; Myeloid; Bone marrow; Myeloid leukemia; Somatic evolution in cancer; Medicine; Hematopathology; Pathology; Leukemia; Neoplastic transformation; Immunology; Oncology; Internal medicine; Biology; Cancer; Haematopoiesis; Stem cell; Genetics; Cytology; Chromosome; Carcinogenesis","score_opus":0.04833145918210546,"score_gpt":0.3331537975892342,"score_spread":0.28482233840712873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139663853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967353,0.0016833153,0.00002249795,0.00087057496,0.000007680655,0.00052346877,0.000005569383,0.000010042899,0.00014158644],"genre_scores_gemma":[0.99759704,0.00044282337,0.001874049,0.000014847253,0.0000036161905,0.00003046036,0.00001433597,0.000008308016,0.00001452554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888283,0.00012591573,0.00037650793,0.00017502996,0.00022304316,0.00021664896],"domain_scores_gemma":[0.9994245,0.00010811189,0.00011952512,0.00012840981,0.00009917939,0.00012028136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059901417,0.00013535596,0.00041837306,0.00014166109,0.000050493225,0.000009522919,0.000053582702,0.0001481999,0.0000032567955],"category_scores_gemma":[0.00013792574,0.00007256431,0.000022523749,0.00014662616,0.00034456042,0.00003708982,0.00006447873,0.00016955665,7.341391e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007007073,0.00064267305,0.7838757,0.0016295632,0.00020297682,0.0016420155,0.018564623,0.000023151812,0.09910253,0.0027373403,0.0007784067,0.08379395],"study_design_scores_gemma":[0.005995244,0.0048036375,0.8925035,0.0005989998,0.000044623703,0.009878553,0.0031629638,0.0009432815,0.08050009,0.0007999499,0.0005062635,0.00026287386],"about_ca_topic_score_codex":0.000025986017,"about_ca_topic_score_gemma":0.000026569,"teacher_disagreement_score":0.108627826,"about_ca_system_score_codex":0.00006776974,"about_ca_system_score_gemma":0.00022062521,"threshold_uncertainty_score":0.29590866},"labels":[],"label_agreement":null},{"id":"W2139931147","doi":"10.3324/haematol.2012.082065","title":"Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health; Translational Cancer Research Network; Harvard Catalyst; New England Research Institutes; University Health Network; U.S. Food and Drug Administration; American University of Beirut; Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago; University College London; Children's Hospital of Philadelphia","keywords":"Sildenafil; Medicine; Pulmonary hypertension; Internal medicine; Cardiology; Doppler echocardiography; Adverse effect; Population; Diastole; Anesthesia; Blood pressure","score_opus":0.020634911660184052,"score_gpt":0.23973257404994378,"score_spread":0.21909766238975972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139931147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959734,0.0005177295,0.0000025690972,0.00052179815,0.00002340387,0.0011031354,0.000013886379,0.00004827464,0.0017957955],"genre_scores_gemma":[0.9978834,0.0006919639,0.00080507883,0.00022952103,0.000007764089,0.00012442222,0.000077469624,0.000020786647,0.00015959775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839175,0.00011611498,0.00031266976,0.0003485544,0.00045071277,0.00038019381],"domain_scores_gemma":[0.99878657,0.0001799449,0.00013316504,0.00042046534,0.00028958768,0.0001902769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089220994,0.00021579927,0.00061674754,0.00017617912,0.00006174088,0.0000084087715,0.00011205701,0.00013351797,0.0004909833],"category_scores_gemma":[0.00015043322,0.000114305774,0.00008670031,0.0003155899,0.00012302192,0.00011375356,0.00005589259,0.00022639742,0.00016435851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008907807,0.0022762201,0.9872399,0.00003080512,0.00008711775,0.0017088219,0.000012537584,0.000001400337,0.0013792675,0.000014194675,0.0010451137,0.00531386],"study_design_scores_gemma":[0.0036050207,0.0013232641,0.9925616,0.0001330474,0.00002922826,0.00047020603,0.00005035245,0.0002967291,0.0010562997,0.00023595359,0.000115778275,0.00012253075],"about_ca_topic_score_codex":0.00051809556,"about_ca_topic_score_gemma":0.0000072946036,"teacher_disagreement_score":0.005321709,"about_ca_system_score_codex":0.000027923767,"about_ca_system_score_gemma":0.000053867952,"threshold_uncertainty_score":0.5375923},"labels":[],"label_agreement":null},{"id":"W2140996066","doi":"10.3324/haematol.12352","title":"Safety and efficacy of pegylated interferon  -2a and ribavirin for the treatment of hepatitis C in patients with thalassemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Hepatitis C virus research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Center for Research Resources; National Institutes of Health; National Heart, Lung, and Blood Institute; New England Research Institutes; Deutsches Krebsforschungszentrum","keywords":"Ribavirin; Medicine; Neutropenia; Pegylated interferon; Gastroenterology; Thalassemia; Internal medicine; Liver biopsy; Hepatitis C; Hepatitis C virus; Immunology; Biopsy; Virus; Chemotherapy","score_opus":0.03172767783409712,"score_gpt":0.2944683417804853,"score_spread":0.2627406639463882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140996066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978588,0.00041850435,0.000045950463,0.00017204545,0.000009134456,0.001200583,0.000029348133,0.000008988382,0.00025664727],"genre_scores_gemma":[0.9967975,0.0027416248,0.00032637827,0.000012134454,0.0000035877235,0.00004120824,0.00001766175,0.000009245417,0.000050639104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919677,0.000050795505,0.00026821345,0.00017053462,0.00015604247,0.00015762878],"domain_scores_gemma":[0.9991477,0.00044326633,0.00008047153,0.00018555211,0.000090387985,0.000052596617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007694105,0.00010608216,0.00044088182,0.00006956407,0.000046904162,0.0000024218064,0.00004455644,0.00006519527,0.000026441072],"category_scores_gemma":[0.00012677598,0.000055088207,0.000030370407,0.00011467812,0.00027738378,0.000027612698,0.000024951032,0.00005940269,8.7358586e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026229376,0.00051491376,0.98068976,0.0000755774,0.00006613885,0.000031858654,0.00075408525,0.0000014286941,0.00005264691,0.000046192446,0.00003766276,0.01510682],"study_design_scores_gemma":[0.006203044,0.005628026,0.9855592,0.00011490882,0.000034699042,0.00002345385,0.000026452786,0.00020113259,0.0015101515,0.0000068341133,0.00063994835,0.000052099942],"about_ca_topic_score_codex":0.0003542744,"about_ca_topic_score_gemma":0.00019655263,"teacher_disagreement_score":0.0150547195,"about_ca_system_score_codex":0.000041520692,"about_ca_system_score_gemma":0.000036502264,"threshold_uncertainty_score":0.22464319},"labels":[],"label_agreement":null},{"id":"W2142866011","doi":"10.3324/haematol.11366","title":"Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute; U.S. Public Health Service; University of British Columbia; Deutsche Forschungsgemeinschaft; Genome British Columbia; National Cancer Institute; National Institutes of Health; Michael Smith Health Research BC","keywords":"Aldehyde dehydrogenase; Cord blood; Stem cell; Haematopoiesis; Biology; Population; Myeloid; Molecular biology; Immunology; Chemistry; Biochemistry; Cell biology; Medicine; Enzyme","score_opus":0.02816526969184888,"score_gpt":0.2653788334748141,"score_spread":0.23721356378296524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142866011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719869,0.000050367107,0.02402666,0.00031227217,0.00011111927,0.0011333805,0.000023976729,0.00020887014,0.0021464892],"genre_scores_gemma":[0.9975923,0.000017572453,0.0019158089,0.00025145657,0.000020824666,0.00004228557,0.00003227329,0.000037053058,0.00009043131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979038,0.00012296475,0.0006582727,0.00047963043,0.00039169425,0.0004436385],"domain_scores_gemma":[0.9979337,0.00059333583,0.00036964967,0.0007202659,0.00016424668,0.00021879963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000788516,0.0003099193,0.0007045149,0.00023100714,0.000079973266,0.000010967756,0.00016238708,0.0002989013,0.00015113308],"category_scores_gemma":[0.000042311465,0.00023421856,0.00020308839,0.00044003772,0.00013072028,0.000054556684,0.000014130216,0.00024767377,0.00007370672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012936089,0.00088064175,0.0013528208,0.0009584238,0.000054804477,0.00018200591,0.00038486568,0.000027636801,0.9925111,0.000520307,0.000056869896,0.001776939],"study_design_scores_gemma":[0.0016429034,0.00051462045,0.0033538444,0.0002852785,0.000104583065,0.00019587281,0.00021289232,0.00579314,0.9875304,0.00005522472,0.000101020494,0.0002102312],"about_ca_topic_score_codex":0.000015586153,"about_ca_topic_score_gemma":0.000006836621,"teacher_disagreement_score":0.025605429,"about_ca_system_score_codex":0.00007672668,"about_ca_system_score_gemma":0.00010431063,"threshold_uncertainty_score":0.95511556},"labels":[],"label_agreement":null},{"id":"W2144716232","doi":"10.3324/haematol.2013.095257","title":"The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Genentech; GlaxoSmithKline; Pfizer","keywords":"Follicular lymphoma; Lymphoma; Flow cytometry; Pathology; Medicine; Biomarker; Immunophenotyping; Tumor microenvironment; Tissue microarray; Cytometry; Immunohistochemistry; Oncology; Biology; Immunology; Immune system","score_opus":0.012448043695978454,"score_gpt":0.2525029391425586,"score_spread":0.24005489544658015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144716232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963623,0.00084026565,0.000010816199,0.0013599147,0.00006582414,0.0011265439,0.000023488843,0.000012042111,0.00019876724],"genre_scores_gemma":[0.9994394,0.000054053082,0.000070549504,0.00015113661,0.000007418667,0.00022923392,0.000024462339,0.000008600755,0.000015139996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976183,0.0005578655,0.0007940011,0.0003820514,0.0004300487,0.00021770688],"domain_scores_gemma":[0.9968653,0.0012233313,0.00044537883,0.0013642545,0.00005787443,0.00004390396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077455415,0.00020539088,0.0007649129,0.000052174135,0.00015130734,0.000013413688,0.00034386473,0.00007728744,0.00006458953],"category_scores_gemma":[0.0005587104,0.00008439259,0.00044739686,0.00055004563,0.00047127513,0.000019286374,0.00018930538,0.000045047163,0.0000055796972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035497267,0.00331689,0.98869336,0.000013291579,0.0010759147,0.000020713462,0.00043585812,0.000021151482,0.004173036,0.0001223466,0.00022169475,0.0015507867],"study_design_scores_gemma":[0.0029167773,0.00014683188,0.96814734,0.000045205234,0.0021559598,0.000014936971,0.0005389747,0.00046355178,0.024796385,0.00012052696,0.000571009,0.0000825286],"about_ca_topic_score_codex":0.0012957795,"about_ca_topic_score_gemma":0.00006774396,"teacher_disagreement_score":0.020623349,"about_ca_system_score_codex":0.00024692257,"about_ca_system_score_gemma":0.00005883296,"threshold_uncertainty_score":0.344143},"labels":[],"label_agreement":null},{"id":"W2146185798","doi":"10.3324/haematol.2009.015917","title":"Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Complete response; Dexamethasone; Multiple myeloma; Refractory (planetary science); Adverse effect; Internal medicine; Progressive disease; Surgery; Chemotherapy; Materials science","score_opus":0.0662267828043679,"score_gpt":0.375866646101104,"score_spread":0.3096398632967361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146185798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680424,0.0000059238923,0.000029629466,0.001096528,0.00005954717,0.0017680883,0.00010545766,0.00006877463,0.00006183938],"genre_scores_gemma":[0.9898026,0.0000022999313,0.008696597,0.0008347682,0.000011490481,0.00013550786,0.000059134825,0.00003748951,0.00042011624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625814,0.00083011034,0.000990953,0.00062648766,0.0007119495,0.00058238755],"domain_scores_gemma":[0.99357796,0.004336001,0.00044142012,0.0008234562,0.00039105563,0.00043009166],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0017144344,0.0003298937,0.0015503571,0.00022891154,0.00007670811,0.000016286875,0.00021397458,0.0003526994,0.0002458835],"category_scores_gemma":[0.01538218,0.00017199708,0.00015591361,0.00038476088,0.00032299347,0.00009704478,0.00011009777,0.00075141457,0.000035421202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13208336,0.0021078542,0.861692,0.000037693764,0.0003998291,0.0003492804,0.00020310038,2.2698207e-7,0.0014816688,0.0000021987007,0.000103627644,0.0015391309],"study_design_scores_gemma":[0.03879621,0.0055001965,0.9533721,0.0001443989,0.00006300391,0.00001056987,0.00006913742,0.000040396306,0.0016798277,0.0000065504983,0.00009583777,0.00022178188],"about_ca_topic_score_codex":0.00033274878,"about_ca_topic_score_gemma":0.0019159549,"teacher_disagreement_score":0.09328714,"about_ca_system_score_codex":0.00012978147,"about_ca_system_score_gemma":0.0003345487,"threshold_uncertainty_score":0.9929117},"labels":[],"label_agreement":null},{"id":"W2146586379","doi":"10.3324/haematol.2011.050724","title":"Atypical autoimmune hemolytic anemia","year":2011,"lang":"fi","type":"letter","venue":"Haematologica","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Hemolytic anemia; Anemia; Immunology; Internal medicine","score_opus":0.03271697741986876,"score_gpt":0.24754423359562192,"score_spread":0.21482725617575316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146586379","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28135374,0.031935167,0.0007820461,0.48873267,0.0090223905,0.005921307,0.00020151629,0.0018416044,0.18020958],"genre_scores_gemma":[0.74919647,0.0023207108,0.0020678916,0.2142307,0.0030470164,0.00018107933,0.000879733,0.00027806684,0.027798312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947328,0.00029304472,0.0013028132,0.0014263412,0.00074591907,0.0014990969],"domain_scores_gemma":[0.9971038,0.00032082704,0.0004176419,0.0016307948,0.0001739902,0.00035293022],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0003475568,0.0011365854,0.0026917972,0.00026277162,0.00035063928,0.00006004883,0.00074261666,0.003802871,0.018208276],"category_scores_gemma":[0.00015881546,0.00084389694,0.0008195739,0.00039094625,0.00066651404,0.00008879455,0.0002702153,0.004516853,0.009285018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029548034,0.0024044192,0.009493391,0.008513847,0.0011477757,0.08446048,0.0014407408,3.8928047e-7,0.0012288395,0.007296924,0.8638776,0.017180786],"study_design_scores_gemma":[0.004517987,0.0020474067,0.05235902,0.003019091,0.002923267,0.012535101,0.00008957221,0.000058707046,0.0010816548,0.0019278335,0.9178069,0.0016334136],"about_ca_topic_score_codex":0.00017018175,"about_ca_topic_score_gemma":0.000008698207,"teacher_disagreement_score":0.46784276,"about_ca_system_score_codex":0.00010019503,"about_ca_system_score_gemma":0.0002241901,"threshold_uncertainty_score":0.99940115},"labels":[],"label_agreement":null},{"id":"W2147426382","doi":"10.3324/haematol.2009.016220","title":"Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Genetics","funders":"Medical Research Council; National Research Foundation; Amgen; European Commission; Les Laboratories Pierre Fabre; Gilead Sciences; F. Hoffmann-La Roche","keywords":"Transplantation; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Immunology; Myeloid leukemia; Medicine; Biology","score_opus":0.012753935256534158,"score_gpt":0.25878793689998686,"score_spread":0.2460340016434527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147426382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997456,0.000055079414,0.00010115355,0.000010496363,0.0001193484,0.0016636136,0.00030621293,0.00007396481,0.00021413011],"genre_scores_gemma":[0.9988086,0.000031610685,0.00058860553,0.000018029255,0.000029655668,0.00016894069,0.00019355264,0.00005259713,0.00010836323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982992,0.000039012106,0.00050275837,0.0004429695,0.00028920922,0.0004268421],"domain_scores_gemma":[0.99858254,0.00023883155,0.00037155312,0.0005331575,0.00009937386,0.00017456998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008735115,0.00038219788,0.0007459603,0.00013163153,0.00007790187,0.0000118277185,0.00013392033,0.00023919078,0.00035298732],"category_scores_gemma":[0.00001784639,0.00022666062,0.00031821345,0.00010005011,0.00010891733,0.00006650677,0.000016715361,0.00034128685,0.00006855065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022160385,0.0004389821,0.9937727,0.00064327236,0.00017002087,0.00004477776,0.00051474356,0.000062922896,0.0014972946,0.000023423232,0.00003037421,0.00058548513],"study_design_scores_gemma":[0.008132937,0.004129516,0.9781493,0.00008005353,0.0005002111,0.000053868476,0.000026102347,0.000071436356,0.008563642,0.000023509752,0.000027959617,0.00024148775],"about_ca_topic_score_codex":0.00012991265,"about_ca_topic_score_gemma":0.000058363952,"teacher_disagreement_score":0.015623389,"about_ca_system_score_codex":0.0010161134,"about_ca_system_score_gemma":0.0004036892,"threshold_uncertainty_score":0.9242952},"labels":[],"label_agreement":null},{"id":"W2147758514","doi":"10.3324/haematol.2009.010264","title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Instituto de Salud Carlos III; Julius-Maximilians-Universität Würzburg","keywords":"Mantle cell lymphoma; Cyclin D1; Cancer research; Lymphoma; BCL10; Biology; Cyclin D2; Pathology; Medicine; Cell; Cell cycle; Immunology; Genetics","score_opus":0.025375690484738173,"score_gpt":0.2710360779570358,"score_spread":0.24566038747229765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147758514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860298,0.0026335027,0.000036832895,0.0055954712,0.00015617855,0.0007939684,0.000021490814,0.00006468784,0.004668078],"genre_scores_gemma":[0.9951396,0.0010241028,0.0012370641,0.0011892015,0.00006663938,0.00009462278,0.000015856893,0.000010169971,0.001222724],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989875,0.000035827397,0.00023180021,0.00034011935,0.0001627862,0.00024196021],"domain_scores_gemma":[0.9991141,0.00030889217,0.0001146222,0.0003170132,0.000060870425,0.00008448202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087742395,0.00018474937,0.00036278716,0.0000412461,0.00023590599,0.000051902174,0.00009087946,0.00010570851,0.00011394878],"category_scores_gemma":[0.0000444199,0.00009652131,0.00011564971,0.00008046292,0.000100895,0.000056383826,0.000037793594,0.000038858234,0.000093616174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037646957,0.007997562,0.055399127,0.00056363153,0.00034081432,0.0019592287,0.008570842,0.0000017318656,0.05063878,0.018631699,0.78542763,0.066704266],"study_design_scores_gemma":[0.006113937,0.00095169205,0.23543581,0.00019808524,0.00016662868,0.0002937433,0.0010445677,0.000033972767,0.71621865,0.01027024,0.029024348,0.00024830794],"about_ca_topic_score_codex":0.000013482983,"about_ca_topic_score_gemma":0.0000032897349,"teacher_disagreement_score":0.75640327,"about_ca_system_score_codex":0.00003898825,"about_ca_system_score_gemma":0.000024102828,"threshold_uncertainty_score":0.3936025},"labels":[],"label_agreement":null},{"id":"W2148382458","doi":"10.3324/haematol.2014.109280","title":"Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Sahlgrenska Universitetssjukhuset; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Rigshospitalet; Fondazione IRCCS Policlinico San Matteo; Ege Üniversitesi; Centro Nazionale Sangue; Helsingin Yliopisto; Akdeniz Üniversitesi; King Faisal Specialist Hospital and Research Centre; National Institute for Health and Care Research","keywords":"Medicine; Cumulative incidence; Umbilical cord; Transplantation; Umbilical Cord Blood Transplantation; Surgery; Regimen; Incidence (geometry); Internal medicine; Gastroenterology; Hematopoietic stem cell transplantation; Immunology","score_opus":0.022457058221704757,"score_gpt":0.26271965016207777,"score_spread":0.240262591940373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148382458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98206264,0.000113466485,0.015262632,0.00056237803,0.00004434018,0.0005884702,0.000023341208,0.00011441819,0.0012283316],"genre_scores_gemma":[0.9750855,0.000032457247,0.024299718,0.00029308372,0.000044688215,0.00006187178,0.0001211904,0.000024106495,0.00003740767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985116,0.00014717368,0.00038829356,0.00039510336,0.00027155492,0.00028623707],"domain_scores_gemma":[0.99915856,0.0002695206,0.00012278173,0.00020054539,0.00008876643,0.00015979788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016526348,0.00022547688,0.0004484789,0.000099125384,0.00010075643,0.000037671027,0.000047318546,0.00019169835,0.00014770754],"category_scores_gemma":[0.0000622964,0.00019134118,0.00006920519,0.00013951573,0.00017049293,0.000082014325,0.000013069775,0.00016449652,0.00001551091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071898433,0.0044100783,0.14389722,0.009616485,0.0014450605,0.006687143,0.027526418,0.00016909595,0.7709908,0.02121321,0.0005216562,0.0063330294],"study_design_scores_gemma":[0.02270511,0.010189041,0.22001293,0.0055151936,0.007456871,0.04120227,0.0032553952,0.0082534505,0.66907966,0.0063955854,0.0035584285,0.0023760665],"about_ca_topic_score_codex":0.000015592055,"about_ca_topic_score_gemma":0.00002465745,"teacher_disagreement_score":0.10191111,"about_ca_system_score_codex":0.00003355508,"about_ca_system_score_gemma":0.000019725885,"threshold_uncertainty_score":0.7802667},"labels":[],"label_agreement":null},{"id":"W2149546612","doi":"10.3324/haematol.2014.111245","title":"A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"U.S. Public Health Service; National Institutes of Health; Université de Montréal; Jewish General Hospital; Centre National de la Recherche Scientifique; McGill University; Leukemia and Lymphoma Society","keywords":"Cytarabine; Medicine; Refractory (planetary science); Ribavirin; Myeloid leukemia; Internal medicine; Acute leukemia; Myeloid; Gastroenterology; Oncology; Pharmacology; Leukemia; Virology; Biology","score_opus":0.036414860354981995,"score_gpt":0.31857175451332226,"score_spread":0.2821568941583403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149546612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9078553,0.0015947487,0.00017674842,0.0827881,0.000117977426,0.0069294353,0.00026814794,0.000070908725,0.0001986363],"genre_scores_gemma":[0.81062526,0.037871946,0.008887674,0.11257359,0.0044192257,0.0063621015,0.004367559,0.000765514,0.01412711],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704665,0.0002494759,0.0008420584,0.0007378977,0.0005578679,0.00056603836],"domain_scores_gemma":[0.99565995,0.0021461302,0.00072502194,0.0010211134,0.0003048923,0.00014292226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045189715,0.00059925177,0.0022315253,0.00025677544,0.00012433053,0.000021388376,0.00025604182,0.00095460226,0.0000483124],"category_scores_gemma":[0.00030656366,0.0003017232,0.00024208115,0.00022856648,0.001015805,0.000048502603,0.000071128234,0.00091320585,0.0000041226526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44127634,0.0028906849,0.00013365883,0.0040004444,0.0059369863,0.0044152443,0.0009773517,0.0000016870134,0.02188105,0.0001024032,0.5007424,0.017641768],"study_design_scores_gemma":[0.4026166,0.08129947,0.00014348523,0.0008645496,0.004087464,0.0020673305,0.00009507796,0.0008041319,0.01570415,0.00010901406,0.4915768,0.00063194946],"about_ca_topic_score_codex":0.00011107707,"about_ca_topic_score_gemma":0.000007022759,"teacher_disagreement_score":0.09723001,"about_ca_system_score_codex":0.00035596717,"about_ca_system_score_gemma":0.00064994156,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W2150839845","doi":"10.3324/haematol.13690","title":"Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Ligue Contre le Cancer; Fondation de France; Association pour la Recherche sur le Cancer","keywords":"Programmed cell death; Chronic lymphocytic leukemia; Cell biology; Biology; Apoptosis; Caspase; Cell; Leukemia; Immunology; Biochemistry","score_opus":0.014411454275946058,"score_gpt":0.23636434257031955,"score_spread":0.22195288829437348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150839845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837924,0.007840285,0.000008205978,0.00022574242,0.00019437927,0.0005711544,0.0000021678836,0.00004537342,0.0027334504],"genre_scores_gemma":[0.9991488,0.00017417848,0.000018197761,0.000113145084,0.00001390905,0.000027765636,0.00001705559,0.000008797182,0.000478186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856585,0.00029305543,0.00041220256,0.000258015,0.00006835807,0.00040250766],"domain_scores_gemma":[0.99905664,0.00009906371,0.00027424298,0.0005042706,0.000051397205,0.000014380278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027278453,0.00019337574,0.00039809736,0.00005324008,0.00019123324,0.00001343623,0.00045523088,0.00030597628,0.00012649348],"category_scores_gemma":[0.00005351085,0.00010289677,0.00013448515,0.00027934546,0.0001447237,0.000056398327,0.000101127465,0.00031882746,0.00008457317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042944902,0.00019692381,0.0027775383,0.00004057307,0.000071115355,0.00001650612,0.0010667654,0.0006099072,0.9775366,0.0049754465,0.00061062287,0.011668515],"study_design_scores_gemma":[0.0028027606,0.00064498803,0.095591106,0.00009421695,0.00007235052,0.00036141387,0.00044603285,0.00043241924,0.888412,0.0011751686,0.009706084,0.00026147423],"about_ca_topic_score_codex":0.0005354848,"about_ca_topic_score_gemma":0.00012556576,"teacher_disagreement_score":0.09281357,"about_ca_system_score_codex":0.0009568834,"about_ca_system_score_gemma":0.0006136487,"threshold_uncertainty_score":0.41960084},"labels":[],"label_agreement":null},{"id":"W2153333353","doi":"10.3324/haematol.10963","title":"Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports","year":2007,"lang":"en","type":"review","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Pancreatitis; Acute pancreatitis; Etiology; Internal medicine; Gastroenterology; Platelet","score_opus":0.02529547746938631,"score_gpt":0.3088290440220717,"score_spread":0.28353356655268536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153333353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004892593,0.9835067,0.000026298547,0.0000077585255,0.0004260776,0.010049855,0.0003431512,0.00008620263,0.00066136813],"genre_scores_gemma":[0.03904558,0.95720464,0.00025394716,0.000018484137,0.0000056584836,0.0007849426,0.002317786,0.00008544074,0.00028349325],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9896532,0.0011167845,0.0070231096,0.0011158425,0.00043161132,0.000659445],"domain_scores_gemma":[0.98142445,0.001332594,0.01362908,0.0025788667,0.0009632797,0.000071748196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018507149,0.000960138,0.01420122,0.0004545501,0.00014553452,0.000028547256,0.0010189291,0.0006650591,0.00086825254],"category_scores_gemma":[0.0032619191,0.00061281834,0.0012651706,0.00097394246,0.00060160947,0.00021221566,0.0004538041,0.00045238016,0.000029350036],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002370197,0.0004078153,0.0011444836,0.989716,0.0050927764,0.0015047572,0.000034420147,1.3279599e-7,0.000006230372,0.000092749004,0.0016849268,0.00029201192],"study_design_scores_gemma":[0.00048770284,0.00055248756,0.00029223596,0.9337254,0.019520286,0.04323296,0.000042078154,7.9276155e-8,0.00008572562,0.000049708524,0.0014236136,0.0005876816],"about_ca_topic_score_codex":0.00008715857,"about_ca_topic_score_gemma":0.000009382778,"teacher_disagreement_score":0.05599055,"about_ca_system_score_codex":0.00018048745,"about_ca_system_score_gemma":0.00052331074,"threshold_uncertainty_score":0.9996323},"labels":[],"label_agreement":null},{"id":"W2153524572","doi":"10.3324/haematol.2011.047050","title":"Family-directed umbilical cord blood banking","year":2011,"lang":"en","type":"review","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu; University of Cape Town; Università degli Studi di Torino; Hospital for Sick Children; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Sahlgrenska Universitetssjukhuset; Akdeniz Üniversitesi; Medizinischen Hochschule Hannover; Hacettepe Üniversitesi; Rigshospitalet; Radboud Universiteit; Institut National de la Santé et de la Recherche Médicale; Imperial College London; King Faisal Specialist Hospital and Research Centre; Fondazione IRCCS Policlinico San Matteo; Universität Heidelberg; Friedrich-Schiller-Universität Jena; Helsingin Yliopisto; National Institute for Health and Care Research; Ankara Universitesi; Ege Üniversitesi","keywords":"Cord blood; Umbilical cord; Medicine; Transplantation; Sibling; Haematopoiesis; Hematopoietic stem cell transplantation; Stem cell; Immunology; Intensive care medicine; Surgery; Biology; Psychology","score_opus":0.12528113140216768,"score_gpt":0.3488847944632607,"score_spread":0.22360366306109303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153524572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022263492,0.9559007,0.000098030374,0.000012957782,0.0002956844,0.0016791862,0.000027063305,0.00078559935,0.040978126],"genre_scores_gemma":[0.00018672571,0.9947036,0.0037185308,0.000116050425,0.000102275844,0.00028089675,0.00031641003,0.000098197335,0.00047731076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687326,0.00028706485,0.001154776,0.00080789166,0.00033761718,0.0005393736],"domain_scores_gemma":[0.99795777,0.0004834629,0.00041561082,0.00078527024,0.000102569684,0.00025531853],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028661417,0.0006413552,0.0037403894,0.0002470231,0.00009050251,0.00002347779,0.00030217323,0.00101149,0.0015012486],"category_scores_gemma":[0.00016551166,0.00045169235,0.0007557953,0.0004737869,0.00014672629,0.000033852542,0.00006331381,0.00072870357,0.0012768543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014509623,0.0007767896,0.00015224291,0.12225955,0.001076387,0.0057638646,0.00016996897,7.991786e-9,0.000009422547,0.005364517,0.0020567866,0.86222535],"study_design_scores_gemma":[0.0006929391,0.00037601066,0.00010081696,0.033742398,0.007070076,0.020007689,0.000015252583,0.0000021512337,0.000028247696,0.00018036421,0.93720615,0.00057788123],"about_ca_topic_score_codex":0.00001958741,"about_ca_topic_score_gemma":0.0000021886435,"teacher_disagreement_score":0.9351494,"about_ca_system_score_codex":0.0000480225,"about_ca_system_score_gemma":0.00027087747,"threshold_uncertainty_score":0.99979347},"labels":[],"label_agreement":null},{"id":"W2153616582","doi":"10.3324/haematol.2013.090142","title":"High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Università degli Studi del Piemonte Orientale; Fondazione Umberto Veronesi; Università di Catania","keywords":"IRF4; Multiple myeloma; Bortezomib; XBP1; Transcription factor; Cancer research; Bone marrow; Monoclonal antibody; Antibody; Interferon regulatory factors; Medicine; Molecular biology; Immunology; Internal medicine; Biology; Gene","score_opus":0.028084629137060443,"score_gpt":0.27910227334030424,"score_spread":0.2510176442032438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153616582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769425,0.00002206688,0.0000361231,0.00033954583,0.000019645538,0.0007207596,0.000027316257,0.00004842861,0.0010918409],"genre_scores_gemma":[0.9956668,0.000006879602,0.0034878145,0.0003556172,0.00001244035,0.0001059517,0.0001037796,0.00002325612,0.0002374473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982163,0.00013050191,0.00044075365,0.00038270347,0.00042090437,0.00040888553],"domain_scores_gemma":[0.9988615,0.00018940476,0.00015146327,0.0004518863,0.00012330864,0.0002224184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012682135,0.00023338772,0.00070987,0.0001847163,0.000051160783,0.0000089309215,0.00011405383,0.00014551799,0.00052446086],"category_scores_gemma":[0.0003632152,0.00013385856,0.00008689902,0.00021532248,0.00011160852,0.00006864401,0.000072558934,0.00016818664,0.000073501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019103758,0.00075977127,0.9915092,0.0001291138,0.000057648464,0.00021581005,0.00007038079,4.996395e-7,0.0008271834,0.000013307806,0.0005327773,0.0039739516],"study_design_scores_gemma":[0.0101321805,0.0008898943,0.96736103,0.00022238035,0.000033092343,0.00002514486,0.000017749682,0.00025793086,0.02058261,0.000030505153,0.0003138591,0.00013363361],"about_ca_topic_score_codex":0.0002528678,"about_ca_topic_score_gemma":0.0000344933,"teacher_disagreement_score":0.024148162,"about_ca_system_score_codex":0.000051556774,"about_ca_system_score_gemma":0.000023974231,"threshold_uncertainty_score":0.57424784},"labels":[],"label_agreement":null},{"id":"W2154092055","doi":"10.3324/haematol.2014.108530","title":"Markedly perturbed hematopoiesis in acid ceramidase deficient mice","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Neurological Disorders and Stroke; University of Toronto","keywords":"Ceramide; Sphingolipid; Inflammation; Disease; Biochemistry; Haematopoiesis; Cancer; Diabetes mellitus; Chemistry; Cancer research; Internal medicine; Biology; Medicine; Endocrinology; Cell biology; Apoptosis; Stem cell","score_opus":0.02243007129139411,"score_gpt":0.24663201643177401,"score_spread":0.22420194514037992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154092055","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7427145,0.047051087,0.00087802403,0.18393067,0.0030923751,0.0020414249,0.0003561756,0.000261038,0.019674705],"genre_scores_gemma":[0.36686033,0.0007226252,0.0031700032,0.6174301,0.004970631,0.0003422514,0.0027934045,0.00022169415,0.0034889271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997143,0.00028047524,0.0005529361,0.00092556427,0.00037926124,0.0007188065],"domain_scores_gemma":[0.99867123,0.000048038077,0.00025035182,0.00076362595,0.00015475837,0.000111979956],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004724216,0.0005340938,0.0008322276,0.00010197308,0.00008027,0.00007004102,0.0006170182,0.0015276565,0.00012357705],"category_scores_gemma":[0.00048468047,0.00044805396,0.0002615475,0.00019213033,0.00013498252,0.0000044545786,0.0003064212,0.0008398791,0.000101875106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103193524,0.00006640981,0.00024386351,0.00021934984,0.000054199874,0.0009280452,0.00010069002,0.000018501018,0.017778102,0.00004319363,0.9802482,0.00019621261],"study_design_scores_gemma":[0.0007927822,0.00009528928,0.000081876155,0.000104201215,0.00006535197,0.00054559653,0.000092267765,0.00004604765,0.032133035,0.00025957846,0.96504086,0.0007431253],"about_ca_topic_score_codex":0.000046262856,"about_ca_topic_score_gemma":0.000016046837,"teacher_disagreement_score":0.43349946,"about_ca_system_score_codex":0.000038822185,"about_ca_system_score_gemma":0.00017532909,"threshold_uncertainty_score":0.9997971},"labels":[],"label_agreement":null},{"id":"W2154610817","doi":"10.3324/haematol.2011.049676","title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Etablissement Français du Sang; GIS-Institut des Maladies Rares","keywords":"ADAMTS13; Thrombotic thrombocytopenic purpura; Medicine; Purpura (gastropod); Thrombocytopenic purpura; Internal medicine; Immunology; Pediatrics; Platelet","score_opus":0.08371613946296001,"score_gpt":0.2979102285476568,"score_spread":0.21419408908469678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154610817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472654,0.0020009952,0.001703436,0.00004301864,0.00012638222,0.0010470526,0.00007827818,0.00004050276,0.00023382067],"genre_scores_gemma":[0.9989474,0.000023981374,0.0003460989,0.000034264864,0.000003394487,0.00050109654,0.00008454432,0.000008856001,0.00005040121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983245,0.00027670275,0.00054863864,0.00030644317,0.00008191089,0.00046177764],"domain_scores_gemma":[0.9991003,0.00020959046,0.00030679078,0.00025906294,0.00009711443,0.00002711252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052260683,0.00019879409,0.00046521425,0.00006254471,0.0002367548,0.00001267361,0.00031718897,0.00016759483,0.0000683278],"category_scores_gemma":[0.0002689318,0.0001335671,0.00004942327,0.00012886169,0.00018217166,0.00018177071,0.00020555219,0.000090947506,0.000013073545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043217512,0.0021085679,0.9002657,0.00043547386,0.00028879938,0.000004685037,0.058981434,0.00033201702,0.02532609,0.010442431,0.0007771954,0.0006054246],"study_design_scores_gemma":[0.0029932947,0.0002991657,0.95703423,0.0006016853,0.00012220499,0.00016228888,0.0054943603,0.0016848749,0.029866485,0.0010577672,0.00015678008,0.000526847],"about_ca_topic_score_codex":0.000037534428,"about_ca_topic_score_gemma":0.000079715624,"teacher_disagreement_score":0.05676854,"about_ca_system_score_codex":0.000098524,"about_ca_system_score_gemma":0.00010320535,"threshold_uncertainty_score":0.5446708},"labels":[],"label_agreement":null},{"id":"W2154663549","doi":"10.3324/haematol.2011.060657","title":"Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre","funders":"","keywords":"Deep vein; D-dimer; Thrombosis; Medicine; Value (mathematics); Internal medicine; Cardiology; Surgery; Statistics; Mathematics","score_opus":0.06642581865203963,"score_gpt":0.336319196925367,"score_spread":0.2698933782733274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154663549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957657,0.00029335645,0.00004104549,0.00039434712,0.00021146165,0.0009632544,0.000013069115,0.000052828414,0.002264966],"genre_scores_gemma":[0.9970344,0.00016948563,0.0008754154,0.0016520619,0.00007141643,0.000079855294,0.000050067163,0.000037716705,0.000029599267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976694,0.0003187662,0.00056156504,0.00034056674,0.0005156923,0.0005939998],"domain_scores_gemma":[0.99871016,0.00014100052,0.00025113736,0.0005999532,0.00009509738,0.00020263925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048670152,0.0002836022,0.0009021313,0.000105909,0.00018513938,0.00003457122,0.00025046134,0.00016107614,0.00066596805],"category_scores_gemma":[0.00016522288,0.00018506176,0.00013665363,0.0002540252,0.00021235396,0.00017221298,0.00023221456,0.00020913931,0.000030174955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057985144,0.007589158,0.981414,0.00017842876,0.0002441509,0.000062155785,0.0048556994,0.000061491206,0.00042382415,0.003152271,0.0010579586,0.0009028852],"study_design_scores_gemma":[0.0014105183,0.00015987347,0.9929597,0.00021743636,0.00042122338,0.00004096564,0.0014204977,0.00013040693,0.0022015986,0.00020745743,0.00057795306,0.00025237046],"about_ca_topic_score_codex":0.0057790405,"about_ca_topic_score_gemma":0.0008678433,"teacher_disagreement_score":0.0115457075,"about_ca_system_score_codex":0.00010926565,"about_ca_system_score_gemma":0.00005017249,"threshold_uncertainty_score":0.87362194},"labels":[],"label_agreement":null},{"id":"W2156365530","doi":"10.3324/haematol.13071","title":"Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health; National Cancer Institute; Instituto de Salud Carlos III; Julius-Maximilians-Universität Würzburg; Comisión Interministerial de Ciencia y Tecnología","keywords":"Comparative genomic hybridization; Biology; Lymphoma; Gene; Gene expression; Genetics; Burkitt's lymphoma; Cancer research; Genome; Immunology","score_opus":0.03160698927732969,"score_gpt":0.2620339191997436,"score_spread":0.23042692992241393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156365530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717134,0.0010267142,0.00024326621,0.00016075352,0.000043529417,0.00055130397,0.00004259352,0.000061658255,0.0006988591],"genre_scores_gemma":[0.99566185,0.00018997218,0.0035234643,0.000085892934,0.000020174035,0.00017238245,0.00028738918,0.000011861803,0.00004699827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987156,0.00008570727,0.00047835594,0.0003117595,0.0001872498,0.00022134106],"domain_scores_gemma":[0.99924135,0.00012765765,0.00017886392,0.00026514588,0.00009148905,0.000095486306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044459775,0.00019198576,0.0005931772,0.00011352432,0.00011760424,0.0000073344577,0.00007730232,0.000099403645,0.00014745072],"category_scores_gemma":[0.000051770487,0.00014623784,0.00008631087,0.00024186529,0.00011784634,0.00006946451,0.000031714004,0.00004294534,0.000042798438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005607496,0.004078132,0.46469653,0.000076679135,0.00014374021,0.0013446773,0.0019990583,0.0000827115,0.52044845,0.00052575074,0.0056218626,0.00042166314],"study_design_scores_gemma":[0.003675059,0.00034556517,0.42082566,0.00007399484,0.000037860274,0.00084442296,0.000070728114,0.00035029836,0.573422,0.00003764993,0.00018782218,0.00012890015],"about_ca_topic_score_codex":0.000094871706,"about_ca_topic_score_gemma":0.000018464294,"teacher_disagreement_score":0.052973602,"about_ca_system_score_codex":0.00014457914,"about_ca_system_score_gemma":0.0001117889,"threshold_uncertainty_score":0.59634066},"labels":[],"label_agreement":null},{"id":"W2157045826","doi":"10.3324/haematol.2008.001743","title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":430,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Genentech; Ipsen; American Heart Association; Novo Nordisk; Grifols; Bayer HealthCare","keywords":"Medicine; Intensive care medicine; Rituximab; Coagulation; Prothrombin complex concentrate; Autoantibody; Coagulopathy; Recombinant factor VIIa; Factor IX; Pediatrics; Internal medicine; Warfarin; Immunology; Antibody","score_opus":0.061380283113684174,"score_gpt":0.32598292267929685,"score_spread":0.2646026395656127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157045826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94721687,0.00003829357,0.0000014460335,0.046465717,0.000020402844,0.00047400716,0.000015280597,0.000016053886,0.005751939],"genre_scores_gemma":[0.99848974,0.00047521267,0.0003168522,0.0002672801,0.000015457657,0.00006928146,0.000052516694,0.0000033763718,0.00031027073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946713,0.00002748189,0.00011159564,0.00013151442,0.00016130858,0.0001009632],"domain_scores_gemma":[0.9995445,0.00015105742,0.000041373063,0.00014963708,0.00006419269,0.000049209873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003422745,0.00008472564,0.00017310788,0.000053616055,0.000068426205,0.000008053006,0.000045012748,0.00003398712,0.00038942497],"category_scores_gemma":[0.000049790262,0.00003560031,0.000035714882,0.00008012217,0.00007148127,0.000021869093,0.000009112937,0.000024847714,0.000011764886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010731262,0.0043559666,0.8697253,0.0000102797785,0.00023220098,0.0000712038,0.0004657517,4.0690932e-7,0.000045207118,0.004911117,0.0029310181,0.11617845],"study_design_scores_gemma":[0.0031621559,0.0067683486,0.97101176,0.000103950275,0.000074040116,0.000021050611,0.00009759305,0.000028671038,0.0039002346,0.0004957566,0.014252212,0.00008425682],"about_ca_topic_score_codex":0.000003226474,"about_ca_topic_score_gemma":0.000001318041,"teacher_disagreement_score":0.116094194,"about_ca_system_score_codex":0.00003464078,"about_ca_system_score_gemma":0.00001296153,"threshold_uncertainty_score":0.42639303},"labels":[],"label_agreement":null},{"id":"W2158156680","doi":"10.3324/haematol.2011.047811","title":"European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myelofibrosis; Medicine; Essential thrombocythemia; Thrombocytosis; Bone marrow; Internal medicine; Pathology; Polycythemia vera; Platelet","score_opus":0.07262760918209814,"score_gpt":0.2989729651666889,"score_spread":0.22634535598459077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158156680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923045,0.00015083433,0.0002623908,0.0015268336,0.00035890503,0.0020331312,0.000032940734,0.00014663304,0.0062578525],"genre_scores_gemma":[0.9867098,0.000050331542,0.011755933,0.0008219063,0.00018229963,0.000076518045,0.00025372242,0.00005250717,0.0000970347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965688,0.0005251242,0.0008655512,0.0013359638,0.00034692948,0.00035765325],"domain_scores_gemma":[0.9976814,0.00017076202,0.0004055588,0.001378748,0.00012610189,0.00023747735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083501625,0.0003264515,0.0011119003,0.00015472216,0.0001578065,0.000029155324,0.00014830376,0.000073667434,0.0009323213],"category_scores_gemma":[0.00066123146,0.00023835717,0.00013510551,0.00047889812,0.00010105098,0.00007020713,0.00017882041,0.00016836388,0.0000955593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13973889,0.026023693,0.65560895,0.002755091,0.0014564339,0.0012144914,0.025320098,0.0000070921255,0.078854695,0.013430176,0.020262823,0.03532758],"study_design_scores_gemma":[0.012804236,0.004465329,0.85822177,0.0013411372,0.00027008553,0.00004609028,0.0001353605,0.0000044622916,0.12147406,0.0006581339,0.00022936211,0.00034995802],"about_ca_topic_score_codex":0.0001832913,"about_ca_topic_score_gemma":0.0000627635,"teacher_disagreement_score":0.20261285,"about_ca_system_score_codex":0.00016600195,"about_ca_system_score_gemma":0.00007708657,"threshold_uncertainty_score":0.999981},"labels":[],"label_agreement":null},{"id":"W2158196950","doi":"10.3324/haematol.13151","title":"Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphocytosis; Dasatinib; Natural killer cell; Lymphocyte; Immunology; CD16; CD3; Biology; Medicine; Cytotoxicity; Myeloid leukemia; CD8; Imatinib; Immune system","score_opus":0.03405269464848501,"score_gpt":0.2943099288139732,"score_spread":0.2602572341654882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158196950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890337,0.003939864,0.00012965409,0.0013413602,0.00069295027,0.003335123,0.000089754576,0.00048021442,0.0009574058],"genre_scores_gemma":[0.9868779,0.001028567,0.0013966567,0.0025469726,0.00025909132,0.00044096014,0.0008584897,0.00014625242,0.006445088],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950731,0.00023672945,0.0007829298,0.0011247201,0.0011684392,0.0016140772],"domain_scores_gemma":[0.9965366,0.0012182569,0.00039166363,0.0008403934,0.00060159963,0.0004114521],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046559246,0.00076987105,0.0015923077,0.00026260203,0.00073652086,0.000055966295,0.00053431874,0.00059213873,0.0006261076],"category_scores_gemma":[0.0007681739,0.00046462548,0.00046867636,0.0008973517,0.0006934403,0.00023242099,0.00018166697,0.00079458806,0.00009790689],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.18494268,0.017962113,0.021810813,0.0045160055,0.01211153,0.11873836,0.025896858,0.00032658817,0.052328806,0.0042704977,0.5543073,0.0027884415],"study_design_scores_gemma":[0.5276347,0.018055389,0.050628807,0.0028597792,0.0012626057,0.038619343,0.0019174115,0.08099233,0.22310102,0.00023247543,0.04879929,0.0058968724],"about_ca_topic_score_codex":0.00013406994,"about_ca_topic_score_gemma":0.000057034576,"teacher_disagreement_score":0.505508,"about_ca_system_score_codex":0.009295838,"about_ca_system_score_gemma":0.0065834275,"threshold_uncertainty_score":0.99978054},"labels":[],"label_agreement":null},{"id":"W2158290056","doi":"10.3324/haematol.2010.022459","title":"Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Leukemia; Medicine; Immunology; Hematology; Acute lymphocytic leukemia; Single-nucleotide polymorphism; Oncology; Lymphoblastic Leukemia; Internal medicine; Cancer research; Biology; Gene; Genetics; Genotype","score_opus":0.0038423789808905624,"score_gpt":0.21861258787334326,"score_spread":0.21477020889245269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158290056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513,0.0000775409,0.0025436003,0.00015381281,0.00003861773,0.00011850347,0.0000117766585,0.000014951624,0.0019112203],"genre_scores_gemma":[0.9986212,0.000058341044,0.00067163975,0.00013182539,0.000037934908,0.000025606096,0.00009959964,0.00000738814,0.00034642528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992485,0.00003390718,0.00018356186,0.00027135442,0.0001360104,0.00012664509],"domain_scores_gemma":[0.9989221,0.00003104862,0.00027693456,0.00062337785,0.000118438365,0.000028068345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021149535,0.00009585836,0.0001830863,0.000025435706,0.000075221455,0.000014752774,0.00018495791,0.00015183636,0.000027021817],"category_scores_gemma":[0.00009840511,0.00005663517,0.00010345053,0.00018800671,0.000054079395,0.000001820837,0.000034486173,0.00009327532,0.0000055019573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015304408,0.00021415259,0.045580544,0.000030475529,0.0016255489,0.000003818174,0.00023951862,0.0020719252,0.9452643,0.00065950636,0.0025648933,0.0015923105],"study_design_scores_gemma":[0.0015513133,0.0004441767,0.08241441,0.000015636573,0.001861173,0.0000997165,0.00013536455,0.0045078467,0.90233785,0.00026749377,0.0059738015,0.00039121526],"about_ca_topic_score_codex":0.00003151474,"about_ca_topic_score_gemma":0.000115494586,"teacher_disagreement_score":0.042926416,"about_ca_system_score_codex":0.000018820685,"about_ca_system_score_gemma":0.00009404073,"threshold_uncertainty_score":0.23095152},"labels":[],"label_agreement":null},{"id":"W2159601358","doi":"10.3324/haematol.2011.043422","title":"Familial myelodysplastic syndromes: a review of the literature","year":2011,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Myelodysplastic syndromes; Platelet disorder; Medicine; RUNX1; Myeloid leukemia; Transplantation; Hematopoietic stem cell transplantation; Leukemia; Immunology; Disease; Internal medicine; Stem cell; Genetics; Haematopoiesis; Biology; Bone marrow; Platelet","score_opus":0.08086625824052283,"score_gpt":0.35863915398657736,"score_spread":0.2777728957460545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159601358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000054193933,0.9890464,0.0000030840843,0.00016949487,0.0002678575,0.0029081004,0.00009879671,0.00006525665,0.0074356208],"genre_scores_gemma":[0.0000068126037,0.9962464,0.00027902372,0.0005052479,0.00009601492,0.00031145356,0.000118921576,0.00006519548,0.0023709047],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99664676,0.0005751859,0.0011583365,0.0005959788,0.0005277614,0.0004959875],"domain_scores_gemma":[0.9967729,0.0004383469,0.0006929423,0.0016269732,0.00028627418,0.00018256434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005216133,0.0006039277,0.004676589,0.00020243794,0.000080247475,0.000013347728,0.0009965195,0.0007831916,0.0008378382],"category_scores_gemma":[0.0021420044,0.0002690004,0.0015234802,0.001386713,0.0003702885,0.000037933107,0.0005191752,0.0017043572,0.0004751504],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019988149,0.00008752203,0.0000039835036,0.7752614,0.00032517425,0.00082740735,0.000048119404,1.4585283e-9,2.05312e-7,0.00093919126,0.028182255,0.19430476],"study_design_scores_gemma":[0.00012577459,0.00010217813,0.000007204279,0.41076365,0.0013105896,0.009059554,0.0000030240556,1.8533409e-7,7.7361847e-7,0.000031273084,0.5784562,0.00013958692],"about_ca_topic_score_codex":0.0000061071823,"about_ca_topic_score_gemma":6.238941e-7,"teacher_disagreement_score":0.55027395,"about_ca_system_score_codex":0.00018511058,"about_ca_system_score_gemma":0.0012772359,"threshold_uncertainty_score":0.9999762},"labels":[],"label_agreement":null},{"id":"W2160076308","doi":"10.3324/haematol.11579","title":"SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Population Health Research Institute; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Apoptosis; Gene knockdown; Programmed cell death; Cancer research; Bone marrow; Small hairpin RNA; Biology; Cell biology; Immunology; Genetics","score_opus":0.03756747326322372,"score_gpt":0.24872298310449462,"score_spread":0.2111555098412709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160076308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823886,0.0016368419,0.00047110044,0.00053838454,0.000157291,0.00027952038,0.000018051775,0.000039867944,0.014470313],"genre_scores_gemma":[0.9965977,0.0007662036,0.00045599008,0.0010052362,0.000032829856,0.000059617036,0.000072162526,0.00001718669,0.0009930704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889505,0.00007272578,0.00019413374,0.00038143652,0.00013736283,0.00031927624],"domain_scores_gemma":[0.9993376,0.000018739362,0.0000871303,0.0004529983,0.000054289325,0.00004921026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044149743,0.00020626442,0.00020429715,0.0000138421065,0.00038896909,0.000023405686,0.00026979644,0.00017204104,0.00008644037],"category_scores_gemma":[0.000022404774,0.00012372095,0.00013107069,0.00013532094,0.00017953111,0.0000039651227,0.00013333924,0.00008528808,0.00014209675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095006434,0.008103284,0.024923595,0.0001635294,0.002165857,0.000537532,0.003297853,0.001167481,0.6421441,0.018086785,0.2904004,0.008059551],"study_design_scores_gemma":[0.00092742976,0.00036578625,0.0006979453,0.0000073181873,0.00003767184,0.00015537809,0.000354902,0.000014341335,0.9268101,0.0005067078,0.069834076,0.00028838497],"about_ca_topic_score_codex":0.00004980752,"about_ca_topic_score_gemma":0.000018077219,"teacher_disagreement_score":0.284666,"about_ca_system_score_codex":0.00000767599,"about_ca_system_score_gemma":0.000054264223,"threshold_uncertainty_score":0.5045194},"labels":[],"label_agreement":null},{"id":"W2161021913","doi":"10.3324/haematol.2014.115840","title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Stanford Cancer Institute; National Heart, Lung, and Blood Institute; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; University of California, Los Angeles; Monash University; Hollings Cancer Center, Medical University of South Carolina; Northwestern University; Incyte; NIH Clinical Center; Townsville Hospital and Health Service; Emory University; Huntsman Cancer Institute; University of Toronto; Tower Cancer Research Foundation; London Health Sciences Centre; Barbara Ann Karmanos Cancer Institute; Rush University; University of Louisville; Georgetown University; National Cancer Institute; Wake Forest University; Kaiser Permanente; Cleveland Clinic; George Washington University; University of Pennsylvania; Vanderbilt University; University of Southern California; Park Nicollet Foundation","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Surgery; Bone marrow","score_opus":0.025920741236176364,"score_gpt":0.25619804275661573,"score_spread":0.23027730152043938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161021913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395883,0.00007313224,0.000007690863,0.00039388548,0.000036382113,0.00083622476,0.00009902887,0.000020628817,0.004574178],"genre_scores_gemma":[0.99788445,0.000061758066,0.0017868229,0.000032812546,0.000009205371,0.000035544723,0.000119426826,0.000016268725,0.00005368002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998366,0.00009325219,0.0005138778,0.00031845583,0.00046151906,0.00024688657],"domain_scores_gemma":[0.9987329,0.00024320882,0.00026303632,0.00029076007,0.00025501146,0.00021504826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002471001,0.00021386347,0.0009332069,0.00011389812,0.000026303213,0.000005878685,0.000068888745,0.00009999642,0.000021281512],"category_scores_gemma":[0.00024457937,0.00012133138,0.000041753607,0.0002340451,0.00023188133,0.00004763173,0.00005050325,0.000105487896,0.0000043743244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024872076,0.0009852959,0.97097677,0.000103119586,0.00015219033,0.000086726446,0.0009409885,0.0000042220204,0.000003276826,0.0010447737,0.00017404913,0.00065653655],"study_design_scores_gemma":[0.047560323,0.0066100466,0.9425319,0.00071028847,0.00014156546,0.000033158605,0.00055401557,0.000008781849,0.0013836755,0.000048382717,0.00026928392,0.0001486013],"about_ca_topic_score_codex":0.00017233855,"about_ca_topic_score_gemma":0.0004300684,"teacher_disagreement_score":0.02844487,"about_ca_system_score_codex":0.000034975234,"about_ca_system_score_gemma":0.00012229086,"threshold_uncertainty_score":0.494775},"labels":[],"label_agreement":null},{"id":"W2161183750","doi":"10.3324/haematol.2010.026989","title":"Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McMaster University","funders":"National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Post-thrombotic syndrome; Medicine; Prospective cohort study; Venous thrombosis; Confidence interval; Internal medicine; Thrombosis; Quality of life (healthcare); Intensive care medicine; Pediatrics","score_opus":0.10753807877910042,"score_gpt":0.34602681321829165,"score_spread":0.23848873443919122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161183750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013071176,0.98027843,0.000011603693,0.000015163617,0.00011116289,0.0061533246,0.0002682653,0.00003217437,0.000058712943],"genre_scores_gemma":[0.12764135,0.87166923,0.00031090443,0.000026983742,0.0000033435015,0.00013111443,0.00018923772,0.000023774188,0.0000040896193],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99486226,0.00062762335,0.0031831039,0.00045956622,0.0006024944,0.0002649618],"domain_scores_gemma":[0.9955412,0.00053842197,0.0026284908,0.0008313276,0.000323639,0.00013691344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011352252,0.0005421497,0.010108635,0.00043802182,0.0000233236,0.0000051448806,0.00032799528,0.0005790841,0.00010183904],"category_scores_gemma":[0.0036707043,0.00033768124,0.0006853717,0.00061664573,0.00022775815,0.000049559156,0.00009720962,0.00058892067,0.0000071981462],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011763356,0.0003447273,0.020877697,0.97668153,0.00025364745,0.000022883947,0.000021646141,4.210652e-9,0.0000044498865,0.0012008365,0.0000020963714,0.000589324],"study_design_scores_gemma":[0.00035173565,0.00057295995,0.0127917025,0.9740265,0.009245142,0.0024502247,0.000013642919,4.0500777e-7,0.000019848858,0.00014331291,0.000046641337,0.00033787597],"about_ca_topic_score_codex":0.000032958567,"about_ca_topic_score_gemma":0.0000069249813,"teacher_disagreement_score":0.11457017,"about_ca_system_score_codex":0.00002566381,"about_ca_system_score_gemma":0.00022767067,"threshold_uncertainty_score":0.9999075},"labels":[],"label_agreement":null},{"id":"W2164059454","doi":"10.3324/haematol.2011.040840","title":"TET2 mutations in secondary acute myeloid leukemias: a French retrospective study","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Myeloid leukemia; Medicine; Chromosomal translocation; Myeloid; Retrospective cohort study; Internal medicine; Karyotype; Mutation; Hematology; Oncology; Gastroenterology; Immunology; Cancer research; Gene; Biology; Genetics; Chromosome","score_opus":0.04183800821531778,"score_gpt":0.3073875758651325,"score_spread":0.2655495676498147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164059454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.910556,0.00013122043,0.00006354149,0.00030412897,0.00008235556,0.0015425202,0.000021638689,0.00019984796,0.0870987],"genre_scores_gemma":[0.9943637,0.0000425678,0.0032382226,0.00023502653,0.000042736723,0.0003733318,0.000032447224,0.000035612524,0.0016363553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975359,0.00019951304,0.0005367769,0.000670467,0.00043967,0.000617693],"domain_scores_gemma":[0.99866354,0.000103899925,0.00012223821,0.00068038964,0.00020488513,0.00022505454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048616756,0.00028560925,0.0007896269,0.0004460152,0.00014291449,0.000021804364,0.00032563,0.00022735239,0.002450719],"category_scores_gemma":[0.00043931013,0.00022374027,0.0001225291,0.0009021771,0.00025872845,0.00016846042,0.00022520921,0.0010760573,0.0005850122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007489757,0.0030768707,0.93121856,0.00011497205,0.00072931923,0.024506735,0.025787864,7.8885313e-7,0.0022099286,0.0015814914,0.005458135,0.004566345],"study_design_scores_gemma":[0.0041529397,0.0017794681,0.9812566,0.00005893995,0.0001490828,0.0014581063,0.0051979907,0.000073137395,0.002541567,0.0027799131,0.00027293927,0.00027932838],"about_ca_topic_score_codex":0.0008537724,"about_ca_topic_score_gemma":0.00044460708,"teacher_disagreement_score":0.085462354,"about_ca_system_score_codex":0.00072424766,"about_ca_system_score_gemma":0.0005972291,"threshold_uncertainty_score":0.9984612},"labels":[],"label_agreement":null},{"id":"W2164667231","doi":"10.3324/haematol.2014.120121","title":"Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Vancouver General Hospital; University of Calgary; Hôpital Notre-Dame; London Health Sciences Centre","funders":"Celgene","keywords":"Thalidomide; Lenalidomide; Medicine; Melphalan; Prednisone; Dexamethasone; Multiple myeloma; Internal medicine; Oncology; Surgery; Gastroenterology","score_opus":0.11451472248451337,"score_gpt":0.3505249363184556,"score_spread":0.23601021383394222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164667231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908274,0.0008671063,0.000018698856,0.0025662673,0.00016311514,0.005020028,0.000044388617,0.00007213355,0.00042085288],"genre_scores_gemma":[0.99752134,0.00006793462,0.0012270395,0.0003245847,0.000026608164,0.000557265,0.00021041586,0.000039119433,0.000025712581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455446,0.0013139643,0.0014890169,0.000609764,0.0011789984,0.00085381605],"domain_scores_gemma":[0.9946414,0.003175741,0.00062891253,0.0008294825,0.00021380736,0.00051066204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020897042,0.00041268737,0.0018170234,0.000325054,0.00010845153,0.00003288472,0.00040109866,0.0002438865,0.000043039778],"category_scores_gemma":[0.0077409977,0.00024165939,0.00016359809,0.0008897132,0.0002688808,0.00015323864,0.00011713284,0.0005121717,0.00005659657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34102625,0.0028976377,0.6508899,0.00023824134,0.0002051749,0.000628488,0.0022031995,0.00015542032,0.0000014906783,0.00012458723,0.0005628499,0.0010667868],"study_design_scores_gemma":[0.41327423,0.0035323533,0.5811116,0.00032384644,0.000032509324,0.000016222672,0.0010042101,0.00029624574,0.000039553863,0.000052585256,0.00011130759,0.00020532317],"about_ca_topic_score_codex":0.008699695,"about_ca_topic_score_gemma":0.008236278,"teacher_disagreement_score":0.07224796,"about_ca_system_score_codex":0.00040595434,"about_ca_system_score_gemma":0.0007361203,"threshold_uncertainty_score":0.99790144},"labels":[],"label_agreement":null},{"id":"W2165746197","doi":"10.3324/haematol.2009.020636","title":"Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Health and Medical Research Council; Medical Research Council; Fondation de France","keywords":"Myeloid leukemia; Imatinib mesylate; Imatinib; microRNA; Medicine; Leukemia; TaqMan; Cancer research; Oncology; Real-time polymerase chain reaction; Internal medicine; Biology; Gene; Genetics","score_opus":0.008674175181232518,"score_gpt":0.2498548977066989,"score_spread":0.24118072252546638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165746197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951954,0.000069660586,0.000011613877,0.0009378324,0.00016682569,0.0014324593,0.000017126578,0.00015797341,0.0020111066],"genre_scores_gemma":[0.99143815,0.0000083014,0.0069442363,0.00053869374,0.00004730157,0.00015574902,0.000048320264,0.00005105479,0.0007681968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977083,0.00010645016,0.00047759825,0.00062648195,0.00039978503,0.00068136706],"domain_scores_gemma":[0.99834985,0.00019532644,0.00014954766,0.00086294446,0.000117949996,0.0003244049],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003416444,0.00037127352,0.00071771466,0.0002644234,0.00009045773,0.000026387352,0.00024294999,0.00025388176,0.0007917587],"category_scores_gemma":[0.00042992097,0.00025786672,0.00008678312,0.00046425185,0.0001337478,0.00009188577,0.00013044722,0.0006155786,0.0008982752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03095866,0.0013234337,0.8375561,0.00036725786,0.00029398006,0.0027984874,0.0013718508,0.000052072322,0.10350693,0.00032136403,0.0043701218,0.01707971],"study_design_scores_gemma":[0.0141538875,0.0021778303,0.95371497,0.0002992223,0.000072367206,0.00026974172,0.000027529666,0.00004901888,0.020884324,0.000049519243,0.007898018,0.00040354714],"about_ca_topic_score_codex":0.00010738225,"about_ca_topic_score_gemma":0.00026391196,"teacher_disagreement_score":0.11615886,"about_ca_system_score_codex":0.0015013445,"about_ca_system_score_gemma":0.000942663,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W2168801827","doi":"10.3324/haematol.2013.102897","title":"Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; University of Toronto; Canadian Blood Services","keywords":"Immune thrombocytopenia; Platelet; Antibody; Pulmonary hemorrhage; Glycoprotein; Immunology; Medicine; Immune system; Platelet membrane glycoprotein; Glycoprotein Ib; Isoantibodies; Hematology; Internal medicine; Chemistry; Biochemistry; Lung","score_opus":0.013333537695772469,"score_gpt":0.2381136306282262,"score_spread":0.22478009293245374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168801827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95517915,0.0012078598,0.000034263194,0.038983684,0.000064637505,0.0021014134,0.00007673516,0.0001291682,0.0022230914],"genre_scores_gemma":[0.9539078,0.00017739764,0.0010934009,0.038278162,0.00009310444,0.00017516188,0.0060366895,0.00008445708,0.00015385797],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997373,0.00014283061,0.0006047568,0.00081344973,0.0004471676,0.0006187807],"domain_scores_gemma":[0.99888414,0.00015262055,0.0002895571,0.0005047373,0.00006554271,0.00010340266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000105512176,0.00066832505,0.0019300418,0.0002555644,0.00011727229,0.000048426828,0.00014030488,0.001029027,0.00019969846],"category_scores_gemma":[0.00006150351,0.00044266958,0.00011209719,0.00027494718,0.00017242889,0.00012289152,0.000101915866,0.0011665962,0.00012461244],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036901517,0.0011427486,0.014311641,0.0031463776,0.00071232417,0.9307246,0.0004908333,0.000008760593,0.0031054036,0.000023817593,0.031425383,0.011217938],"study_design_scores_gemma":[0.046314664,0.014911634,0.082216956,0.010278258,0.0022345923,0.655259,0.0006487833,0.0041377833,0.010256117,0.0016052709,0.16435948,0.007777419],"about_ca_topic_score_codex":0.00028855432,"about_ca_topic_score_gemma":0.000027638976,"teacher_disagreement_score":0.27546558,"about_ca_system_score_codex":0.00009223251,"about_ca_system_score_gemma":0.000091322305,"threshold_uncertainty_score":0.99980253},"labels":[],"label_agreement":null},{"id":"W2169866483","doi":"10.3324/haematol.10696","title":"Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically III children","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Hospital for Sick Children; Austrian Science Fund","keywords":"Partial thromboplastin time; Medicine; Heparin; Coagulation; Prospective cohort study; Anticoagulant; Internal medicine; Anesthesia; Intensive care medicine","score_opus":0.10266072720110964,"score_gpt":0.41214702071004633,"score_spread":0.3094862935089367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169866483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969343,0.000097107215,0.00013221263,0.00024733334,0.00004855327,0.0007020907,0.000006830913,0.000049887658,0.0017816967],"genre_scores_gemma":[0.99689937,0.00021734805,0.0027194708,0.000027603724,0.000049839527,0.000017965796,0.000028319351,0.000017835953,0.000022261484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997976,0.000109613364,0.0008933076,0.00042277316,0.00023820816,0.00036009974],"domain_scores_gemma":[0.99864876,0.0006368299,0.00015506046,0.00024993854,0.00011713528,0.00019228579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006945964,0.00022054127,0.0010869848,0.00022484754,0.000047718142,0.000012658126,0.00005601102,0.00029432954,0.0000324488],"category_scores_gemma":[0.00025209528,0.00016403888,0.0000606911,0.00034893886,0.00018603745,0.00010582575,0.000049498427,0.00035690336,0.000009938272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009354796,0.00038743246,0.9887196,0.000027356295,0.000097978766,0.00023921217,0.00014282607,0.0000064851724,0.00023094396,0.00033198245,0.0000031988009,0.008877542],"study_design_scores_gemma":[0.0054815724,0.0018486809,0.9893718,0.00027580606,0.00013368028,0.00016955963,0.00010918668,0.000045957928,0.0021434275,0.00021456536,0.00004629836,0.00015947086],"about_ca_topic_score_codex":0.00083974085,"about_ca_topic_score_gemma":0.00046673004,"teacher_disagreement_score":0.008718071,"about_ca_system_score_codex":0.000220591,"about_ca_system_score_gemma":0.00014901492,"threshold_uncertainty_score":0.6689311},"labels":[],"label_agreement":null},{"id":"W2169979115","doi":"10.3324/haematol.2010.029702","title":"Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds De La Recherche Scientifique - FNRS; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Fondation contre le Cancer; Terry Fox Foundation","keywords":"Fludarabine; Total body irradiation; Medicine; Transplantation; Cyclophosphamide; Hematopoietic stem cell transplantation; Stem cell; CD8; Internal medicine; Gastroenterology; Lymphocyte; Immunology; Immune system; Chemotherapy; Biology","score_opus":0.009655898165566076,"score_gpt":0.2318726510811421,"score_spread":0.22221675291557602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169979115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941573,0.000019942929,0.0017234446,0.0001463788,0.00014511416,0.0010564264,0.00010387131,0.000064176566,0.0025833067],"genre_scores_gemma":[0.9913091,0.000046733367,0.0074217035,0.0005800026,0.000020995489,0.00014758078,0.00026087207,0.00004188154,0.0001711167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982379,0.0000554594,0.0004974412,0.00044548785,0.0004320023,0.00033168026],"domain_scores_gemma":[0.9988744,0.00018725652,0.0002067013,0.00036379253,0.00018612425,0.0001816892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013867658,0.00026097734,0.0005708822,0.0002296323,0.000056761623,0.000020856427,0.00011839626,0.00023545584,0.00050355674],"category_scores_gemma":[0.00002948688,0.00021689683,0.00011960492,0.00033887086,0.000125,0.0001440885,0.000014629831,0.00026428516,0.00017505963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008613559,0.00162926,0.7365119,0.004337893,0.00045526482,0.006174098,0.03461947,0.000058556187,0.20577745,0.00023233147,0.00049583946,0.0010943677],"study_design_scores_gemma":[0.0022538186,0.00095833844,0.8649598,0.0006512099,0.0003602632,0.00038345423,0.00024869925,0.000011301489,0.12967613,0.000120936784,0.000058846606,0.0003172309],"about_ca_topic_score_codex":0.00004826986,"about_ca_topic_score_gemma":0.000060305498,"teacher_disagreement_score":0.12844786,"about_ca_system_score_codex":0.000025259797,"about_ca_system_score_gemma":0.00006427267,"threshold_uncertainty_score":0.88447964},"labels":[],"label_agreement":null},{"id":"W2170974745","doi":"10.3324/haematol.2014.118927","title":"Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Montpellier; Institut Gustave-Roussy; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Calreticulin; Essential thrombocythemia; Myelofibrosis; Exon; Myeloproliferative Disorders; Mutation; Biology; Cancer research; Genetics; Polycythemia vera; Gene; Immunology","score_opus":0.05822365109552091,"score_gpt":0.2963325217382911,"score_spread":0.2381088706427702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170974745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6622666,0.0029513312,0.000025994565,0.32853535,0.00024745212,0.0022517275,0.0003245052,0.00019632523,0.0032006884],"genre_scores_gemma":[0.9529591,0.0006061386,0.00091820175,0.04038489,0.00097076735,0.0005017445,0.002883417,0.00007266632,0.00070308003],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688864,0.0003030022,0.000753118,0.00073171,0.0007001848,0.0006233215],"domain_scores_gemma":[0.99736595,0.0013808702,0.00045758672,0.00034010469,0.00029306015,0.0001624022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032973802,0.00056558196,0.0018031669,0.00028352364,0.00016214405,0.00008354423,0.00012676015,0.0012873642,0.00012927786],"category_scores_gemma":[0.00065761554,0.00043831312,0.0001685158,0.00027312,0.0001912205,0.00008005364,0.000104720486,0.0013119711,0.00010767192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002070103,0.00072335475,0.4947909,0.0012041096,0.003086559,0.016743131,0.0023725205,0.000026269747,0.000087796594,0.0006046174,0.4797408,0.00041293996],"study_design_scores_gemma":[0.059344333,0.01391619,0.28140947,0.0070522656,0.03470513,0.016536219,0.0027676472,0.0012613904,0.040842965,0.033074513,0.5003439,0.00874597],"about_ca_topic_score_codex":0.0002497398,"about_ca_topic_score_gemma":0.00015849812,"teacher_disagreement_score":0.29069248,"about_ca_system_score_codex":0.0010457892,"about_ca_system_score_gemma":0.000465871,"threshold_uncertainty_score":0.9998069},"labels":[],"label_agreement":null},{"id":"W2173631987","doi":"10.3324/haematol.2015.126938","title":"Gene-expression and in vitro function of mesenchymal stromal cells are affected in juvenile myelomonocytic leukemia","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Leids Universitair Medisch Centrum; Stichting Kinderen Kankervrij; Universiteit Leiden","keywords":"Mesenchymal stem cell; Biology; Haematopoiesis; Stromal cell; Juvenile myelomonocytic leukemia; Cancer research; Bone marrow; Chronic myelomonocytic leukemia; Leukemia; Stem cell; Immunology; Cell biology; Myelodysplastic syndromes","score_opus":0.0343891697055586,"score_gpt":0.28186470427964533,"score_spread":0.24747553457408672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173631987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786365,0.00044355507,0.00007230437,0.00016247241,0.00006871304,0.00055021147,0.000008428505,0.000046911366,0.000783762],"genre_scores_gemma":[0.99722105,0.00004067532,0.0024275437,0.000058951864,0.000031688476,0.000048021357,0.000027429076,0.00001800332,0.00012664802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823725,0.00021728111,0.0004204646,0.00038291886,0.00035100718,0.00039106954],"domain_scores_gemma":[0.99910253,0.00013320372,0.00015138433,0.00030537657,0.00009918929,0.00020828769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046691488,0.00018530503,0.0006961538,0.0003409592,0.000025253394,0.000010198231,0.00011286106,0.00026806165,0.00004164692],"category_scores_gemma":[0.00037379633,0.00014405871,0.00004979366,0.00042975415,0.00014113207,0.000099469515,0.00016137806,0.0004382527,0.000024918665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003732664,0.00018941879,0.035650432,0.00025814326,0.000016926026,0.0012500178,0.0003576363,0.000082913655,0.9559494,0.000016095839,0.0015146865,0.0009816411],"study_design_scores_gemma":[0.0065622916,0.0006288149,0.16283727,0.00027918527,0.000032898435,0.00032675973,0.0010689874,0.0034462817,0.8243152,0.000179939,0.00012336104,0.00019902912],"about_ca_topic_score_codex":0.00012915982,"about_ca_topic_score_gemma":0.00003687292,"teacher_disagreement_score":0.13163424,"about_ca_system_score_codex":0.0005447814,"about_ca_system_score_gemma":0.00038464065,"threshold_uncertainty_score":0.5874544},"labels":[],"label_agreement":null},{"id":"W2174938993","doi":"10.3324/haematol.2015.125864","title":"Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Lenalidomide; Medicine; Internal medicine; Thalidomide; Refractory (planetary science); Multiple myeloma; Tolerability; Oncology; Gastroenterology; Adverse effect; Biology","score_opus":0.12101848918118802,"score_gpt":0.3982900003491797,"score_spread":0.2772715111679917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174938993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370164,0.00080088194,0.000016665732,0.00005353562,0.00010627725,0.0050775656,0.00004525266,0.00005255008,0.0001456445],"genre_scores_gemma":[0.9975103,0.00011905835,0.001821256,0.0000057766997,0.000017451366,0.00039412998,0.000045315435,0.000046694782,0.00004001441],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9932887,0.0032296607,0.0012864298,0.0007563398,0.00070844416,0.0007304279],"domain_scores_gemma":[0.9902246,0.0077133896,0.00050897506,0.00079099275,0.0001781575,0.0005839027],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030086313,0.00058340706,0.0035812703,0.0008885887,0.000056803518,0.000019984991,0.00019977898,0.00023208585,0.00004034241],"category_scores_gemma":[0.009772493,0.0003896847,0.00032897887,0.0006511734,0.00042627918,0.00010531185,0.0001524974,0.00039393973,0.000012765685],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69027466,0.013346421,0.28446618,0.00006983807,0.0007737429,0.002737547,0.0024096158,0.00019900873,0.001983945,0.000011162787,0.000005535966,0.0037223392],"study_design_scores_gemma":[0.58414996,0.01713908,0.39201197,0.0002408161,0.00019027617,0.000055391276,0.0011893623,0.002481338,0.0023208314,0.000015733309,0.0000016466438,0.00020359043],"about_ca_topic_score_codex":0.0073629636,"about_ca_topic_score_gemma":0.0019929502,"teacher_disagreement_score":0.10754579,"about_ca_system_score_codex":0.0010697158,"about_ca_system_score_gemma":0.0006663607,"threshold_uncertainty_score":0.9998555},"labels":[],"label_agreement":null},{"id":"W2181099113","doi":"10.3324/haematol.2015.131573","title":"Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"KWF Kankerbestrijding; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Biology; Ribosome biogenesis; Progenitor cell; Myeloid; Haematopoiesis; Stem cell; Cancer research; Cell biology; Immunology; Genetics; Gene; Ribosome; RNA","score_opus":0.016953925153084592,"score_gpt":0.2511868862908955,"score_spread":0.2342329611378109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181099113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897411,0.009641766,0.0000035733792,0.00006901735,0.000034810568,0.0004404994,0.00001675411,0.0000048850434,0.000047629615],"genre_scores_gemma":[0.9992357,0.00018236796,0.0004248743,0.0000318805,0.000006083396,0.00007397614,0.000013515821,0.000011071172,0.000020552954],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989047,0.00012873483,0.00031961768,0.00031214356,0.00010878478,0.00022600155],"domain_scores_gemma":[0.9995904,0.000019987025,0.00013384376,0.00017862333,0.000032165197,0.00004495997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001560394,0.00015280531,0.0002596173,0.000048593873,0.000029859619,0.000012114357,0.00016663151,0.00014330498,0.0000011120186],"category_scores_gemma":[0.000035071556,0.00009991276,0.000036015037,0.00022472013,0.00009431007,0.0000053602303,0.00017265609,0.00006165135,0.0000017275654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079304125,0.00054170657,0.57429814,0.00007951732,0.000010145578,0.000030234898,0.00027972154,0.000021686106,0.42378968,0.000012519296,0.00006836848,0.0007889564],"study_design_scores_gemma":[0.0012327498,0.00019196149,0.009677518,0.000077409415,0.000012051623,0.000030177209,0.0004585433,0.000042578562,0.98807645,0.000023198487,0.000046252964,0.00013110673],"about_ca_topic_score_codex":0.00010761831,"about_ca_topic_score_gemma":0.00024057573,"teacher_disagreement_score":0.5646207,"about_ca_system_score_codex":0.0000125801525,"about_ca_system_score_gemma":0.00005046022,"threshold_uncertainty_score":0.4074324},"labels":[],"label_agreement":null},{"id":"W2189254605","doi":"10.3324/haematol.2015.126870","title":"Mice are poor heme absorbers and do not require intestinal Hmox1 for dietary heme iron assimilation","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Hemoglobin; Heme; Anemia; Myoglobin; Iron deficiency; Chemistry; Iron-deficiency anemia; Food science; Biochemistry; Physiology; Internal medicine; Biology; Medicine","score_opus":0.06218688890852884,"score_gpt":0.29882415835511444,"score_spread":0.2366372694465856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189254605","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027985333,0.013367769,0.0010789622,0.9413497,0.0013285737,0.0044797533,0.00047338297,0.0005578789,0.009378645],"genre_scores_gemma":[0.04597013,0.00057587,0.015878577,0.9204407,0.004422503,0.00071885,0.0028443234,0.00024409036,0.008904977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746126,0.00009578927,0.0005556122,0.00080377114,0.00049503247,0.00058856356],"domain_scores_gemma":[0.99836797,0.00027388055,0.00047071194,0.0004501477,0.0002590299,0.00017827783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003183824,0.0005473708,0.0012068648,0.00018855729,0.00014810968,0.000054305456,0.00020236014,0.0010172268,0.00016323323],"category_scores_gemma":[0.00060374103,0.00042370617,0.00021610504,0.00012770378,0.00027252018,0.00015597204,0.0001091637,0.0009403536,0.00006700201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000555285,0.000064496366,0.00097216846,0.0035404507,0.00003422718,0.00072686083,0.00013180963,9.3638135e-7,0.00012819117,0.00008597007,0.9919299,0.0018297426],"study_design_scores_gemma":[0.0029183219,0.0005271845,0.0019780702,0.0005950249,0.0007610938,0.0012341272,0.00046307038,0.000086712505,0.00012812234,0.0015410325,0.9889997,0.0007675321],"about_ca_topic_score_codex":0.000021904618,"about_ca_topic_score_gemma":0.0000073711435,"teacher_disagreement_score":0.020909024,"about_ca_system_score_codex":0.00005597767,"about_ca_system_score_gemma":0.00011908367,"threshold_uncertainty_score":0.9998215},"labels":[],"label_agreement":null},{"id":"W2189263041","doi":"10.3324/haematol.2015.128066","title":"Comment on: \"The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes\"","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytopathology; Cytogenetics; Transformation (genetics); Myeloid; Bone marrow; Medicine; Malignant transformation; Pathology; Somatic evolution in cancer; Immunology; Cancer research; Biology; Genetics; Internal medicine; Cancer; Cytology; Chromosome; Gene","score_opus":0.05633848446140335,"score_gpt":0.32228155396511143,"score_spread":0.2659430695037081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189263041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7915644,0.0007689392,0.000008719342,0.20622315,0.000014951733,0.0012231851,0.000043681128,0.000012814515,0.00014017119],"genre_scores_gemma":[0.97786,0.0004242945,0.0013943975,0.019782983,0.00003417961,0.00014138596,0.00029283733,0.00003558313,0.00003436535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976508,0.00035243554,0.00069278333,0.00038915864,0.00052793336,0.00038686217],"domain_scores_gemma":[0.99886197,0.00025686447,0.0003160199,0.00030546496,0.0001452458,0.00011446255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007845742,0.00037345558,0.0010988723,0.00037498353,0.000059486923,0.000014698761,0.000125508,0.0007448554,0.000025241401],"category_scores_gemma":[0.00010868891,0.00020963937,0.00006027093,0.00018791288,0.0004757498,0.000028487033,0.00012195237,0.0010967897,0.0000023885373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006872888,0.0013200436,0.06267399,0.0111011,0.0008474806,0.017634844,0.014053258,0.000013070071,0.011802832,0.0010321722,0.8506137,0.022034613],"study_design_scores_gemma":[0.03980683,0.053456843,0.32433817,0.021347724,0.000960508,0.09030754,0.004835134,0.0017780492,0.09881551,0.0030817525,0.357011,0.0042609423],"about_ca_topic_score_codex":0.000032076074,"about_ca_topic_score_gemma":0.000007105252,"teacher_disagreement_score":0.4936027,"about_ca_system_score_codex":0.00022954783,"about_ca_system_score_gemma":0.0003500225,"threshold_uncertainty_score":0.8548845},"labels":[],"label_agreement":null},{"id":"W2191867422","doi":"10.3324/haematol.2015.133629","title":"Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Thalidomide; Internal medicine; Prednisone; Melphalan; Renal function; Urology; Gastroenterology; Surgery","score_opus":0.09147771662842669,"score_gpt":0.3836690187173586,"score_spread":0.2921913020889319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191867422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859937,0.00013384657,0.000012986641,0.0004286235,0.00002038763,0.013048508,0.00009294349,0.000016945807,0.00025210256],"genre_scores_gemma":[0.9971665,0.00006789438,0.0006955885,0.00005577009,0.000013900265,0.0018317994,0.00012067788,0.000020483003,0.000027392247],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99712145,0.0006011237,0.0006596169,0.0004481873,0.0006870257,0.00048260644],"domain_scores_gemma":[0.9976046,0.0013122025,0.0002443621,0.0004242378,0.00011480784,0.00029977201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011753677,0.00040641337,0.0019138164,0.0002707871,0.000060067912,0.00005061593,0.00020617695,0.000102125,0.000018682187],"category_scores_gemma":[0.0005588778,0.00015636152,0.00012099603,0.00034208797,0.00021985348,0.0001154244,0.00003928441,0.00017549095,0.0000048300426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7369293,0.017027082,0.24290688,0.000024122039,0.00046609028,0.00082107773,0.001080496,0.000019007775,0.000002164952,0.000010684849,0.00006740763,0.00064571796],"study_design_scores_gemma":[0.90311366,0.062460717,0.033179294,0.00023627581,0.00020635579,0.000074179836,0.0001565412,0.0002785891,0.00008475041,0.000033218093,0.000018199058,0.00015820157],"about_ca_topic_score_codex":0.0027884985,"about_ca_topic_score_gemma":0.0015759451,"teacher_disagreement_score":0.20972759,"about_ca_system_score_codex":0.00029593872,"about_ca_system_score_gemma":0.00040109022,"threshold_uncertainty_score":0.6376238},"labels":[],"label_agreement":null},{"id":"W2196382270","doi":"10.3324/haematol.2014.121475","title":"The international prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes in non-surgical bleeding episodes in Glanzmann thrombasthenia patients","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"Novo Nordisk","keywords":"Medicine; Glanzmann's thrombasthenia; Thrombasthenia; Platelet; Platelet transfusion; Adverse effect; Antifibrinolytic; Surgery; Tranexamic acid; Recombinant DNA; Internal medicine; Gastroenterology","score_opus":0.022912696941329136,"score_gpt":0.28742698207640455,"score_spread":0.2645142851350754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196382270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888338,0.00040527125,0.0000023131852,0.0025190855,0.00014559232,0.00078431616,0.000022970657,0.000042932756,0.007243744],"genre_scores_gemma":[0.99850327,0.00031465723,0.00021209854,0.000075786025,0.000022878752,0.00018967163,0.00005093586,0.00001689401,0.00061383937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843574,0.000055125478,0.00039094847,0.00040510372,0.00033457798,0.0003785069],"domain_scores_gemma":[0.9992574,0.00017434261,0.0001282719,0.00023681311,0.00007964507,0.00012355181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000195184,0.00028852158,0.0007055443,0.00010846738,0.00010209092,0.00006593415,0.00015015177,0.00012769009,0.00001546623],"category_scores_gemma":[0.00012385295,0.0001589655,0.00007784546,0.00013017358,0.00020092007,0.00012287959,0.000099523335,0.00015885753,0.000021918819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005860676,0.0008788901,0.99248064,0.00001285705,0.00015158758,0.0011571228,0.0017643016,0.0000041520166,0.0000031482132,0.0016005911,0.00016851377,0.0011921615],"study_design_scores_gemma":[0.013513161,0.0010440852,0.9723101,0.0001429847,0.000052079755,0.00044596038,0.0024006718,0.0004229545,0.00011218988,0.007979692,0.0013378096,0.00023830167],"about_ca_topic_score_codex":0.0005707613,"about_ca_topic_score_gemma":0.0006874384,"teacher_disagreement_score":0.020170497,"about_ca_system_score_codex":0.00031136503,"about_ca_system_score_gemma":0.00005712457,"threshold_uncertainty_score":0.64824253},"labels":[],"label_agreement":null},{"id":"W2256505962","doi":"10.3324/haematol.2015.139717","title":"Acute myeloid leukemia patients clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Flow cytometry; Mdm2; Biomarker; Medicine; Myeloid leukemia; Clinical trial; Oncology; Internal medicine; Cancer research; Immunology; Biology; Cell culture","score_opus":0.0318626593060773,"score_gpt":0.3298666151708328,"score_spread":0.29800395586475553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256505962","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80137354,0.00007382564,0.000030502753,0.18961164,0.00016947942,0.007188801,0.00062257156,0.00034186005,0.0005877937],"genre_scores_gemma":[0.26124486,0.00072610984,0.0052630953,0.60948014,0.0022102066,0.008664541,0.0027409121,0.0010252638,0.10864486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887075,0.0024886865,0.002065939,0.0025640475,0.0019773825,0.0021964577],"domain_scores_gemma":[0.9935635,0.0020119622,0.0009624091,0.0021572043,0.00060769037,0.00069726526],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0014810448,0.0014524075,0.0033936754,0.0010028046,0.00019755647,0.00007431915,0.0009921953,0.0037487394,0.00056273624],"category_scores_gemma":[0.0026208477,0.0008557798,0.00055505906,0.00096005027,0.00048562876,0.00018040511,0.00068693043,0.0038945465,0.0012804959],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035383508,0.0006996516,0.01264328,0.00020984157,0.000900554,0.023142431,0.00038893925,0.0000012852557,0.0062298174,9.745648e-7,0.91517097,0.005228772],"study_design_scores_gemma":[0.041569386,0.024491329,0.07079144,0.012585238,0.00078631233,0.0007430437,0.000052330077,0.00006590953,0.032543063,0.00009811322,0.81353873,0.0027350811],"about_ca_topic_score_codex":0.000076970675,"about_ca_topic_score_gemma":0.000032959117,"teacher_disagreement_score":0.54012865,"about_ca_system_score_codex":0.009816486,"about_ca_system_score_gemma":0.0029821072,"threshold_uncertainty_score":0.99982256},"labels":[],"label_agreement":null},{"id":"W2264688301","doi":"10.3324/haematol.2015.134049","title":"Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Internal medicine; Population; Melphalan; Cohort; Oncology; Transplantation; Malignancy; Myelodysplastic syndromes; Cancer; Bone marrow","score_opus":0.05383425820085901,"score_gpt":0.30255229735905703,"score_spread":0.248718039158198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264688301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803243,0.00009041673,0.0000065441627,0.011179637,0.00029794252,0.0059519736,0.00026666795,0.00014345108,0.0017390325],"genre_scores_gemma":[0.95897967,0.000004843956,0.00052527356,0.031046622,0.00023759983,0.0011861301,0.005711439,0.00010442705,0.0022040154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99460953,0.00060698355,0.0009604113,0.0011201281,0.0016743195,0.0010286338],"domain_scores_gemma":[0.99707687,0.0006218516,0.0003406024,0.000926389,0.00073804526,0.00029624294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058797403,0.00070634903,0.0019866049,0.0005797129,0.0001421999,0.00006250243,0.00035422356,0.0009031773,0.00077671354],"category_scores_gemma":[0.0019244748,0.00053558423,0.00017582189,0.00062983565,0.00009415969,0.000085846325,0.00016475642,0.0013526811,0.00034165112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034836825,0.00093898625,0.83187455,0.00033322288,0.00024170184,0.007448686,0.00010355678,0.0000014330923,4.4316496e-7,0.0000010370507,0.15844764,0.00026035155],"study_design_scores_gemma":[0.008743224,0.0008186238,0.96232516,0.00029761624,0.000103337174,0.000033846234,0.00007140741,0.00013836987,0.00001210657,0.000025016703,0.026956925,0.00047435315],"about_ca_topic_score_codex":0.0014190862,"about_ca_topic_score_gemma":0.002188409,"teacher_disagreement_score":0.13149072,"about_ca_system_score_codex":0.0006863765,"about_ca_system_score_gemma":0.00064630166,"threshold_uncertainty_score":0.99970955},"labels":[],"label_agreement":null},{"id":"W2276396753","doi":"10.3324/haematol.2015.129866","title":"Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicin","year":2015,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Daunorubicin; Myeloid leukemia; HL60; Cell culture; Leukemia; Chemistry; Cancer research; Myeloid; Internal medicine; Medicine; Biology; Genetics","score_opus":0.02170130638992337,"score_gpt":0.24829060731921426,"score_spread":0.2265893009292909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276396753","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19188426,0.0013921072,0.00038703074,0.7577978,0.004148511,0.0047404002,0.0018320808,0.0012512476,0.036566615],"genre_scores_gemma":[0.045685023,0.0007718784,0.0037927092,0.91320306,0.0020966611,0.00018047525,0.003163921,0.00021691376,0.030889329],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966773,0.00031560942,0.00061724987,0.0011120838,0.000531202,0.00074657315],"domain_scores_gemma":[0.99778044,0.00027757278,0.00032633115,0.0009314563,0.00024912113,0.00043507022],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00024922562,0.0006933896,0.0017348564,0.0003485523,0.00016428067,0.000041100364,0.00028249933,0.0017136488,0.0003226076],"category_scores_gemma":[0.00017385425,0.0005396004,0.00018904489,0.00029068382,0.00038020787,0.00005172457,0.00021845012,0.0018609331,0.0002683275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025116804,0.000030303694,0.000030721978,0.0008405824,0.00052440533,0.004950957,0.00018044631,0.000008313027,0.01192111,0.00007827679,0.9786632,0.00026000725],"study_design_scores_gemma":[0.0026873439,0.0022472648,0.00019774468,0.0004718185,0.0016339906,0.0024298406,0.00021442195,0.0010806439,0.0050130994,0.00010136055,0.98305225,0.00087022095],"about_ca_topic_score_codex":0.00024916595,"about_ca_topic_score_gemma":0.000116017254,"teacher_disagreement_score":0.15540534,"about_ca_system_score_codex":0.00031455825,"about_ca_system_score_gemma":0.00043476996,"threshold_uncertainty_score":0.99970555},"labels":[],"label_agreement":null},{"id":"W2288284178","doi":"10.3324/haematol.2015.139741","title":"Response to: Dietary and pharmacological factors affecting iron absorption in mice and man","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Heme; Biochemistry; Extracellular; Iron deficiency; Chemistry; Bioavailability; Intracellular; Gastrointestinal tract; Heme oxygenase; Hemeprotein; DMT1; Iron-deficiency anemia; Biology; Transporter; Anemia; Enzyme; Pharmacology; Internal medicine; Medicine","score_opus":0.01908079783030485,"score_gpt":0.2722747238041162,"score_spread":0.25319392597381135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288284178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93843085,0.0006184484,0.000013511058,0.060220893,0.00011402995,0.00035127447,0.000032766053,0.000025569727,0.00019264451],"genre_scores_gemma":[0.90144104,0.00039693693,0.00016719174,0.09683605,0.00037802116,0.000044325094,0.00009952411,0.000032778957,0.000604153],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801975,0.0004311322,0.00026047073,0.00073011365,0.0001185561,0.00043999476],"domain_scores_gemma":[0.9994073,0.0001683752,0.00010297399,0.00019215675,0.00002088962,0.00010832094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003584067,0.00034252752,0.0004050709,0.000102651815,0.000067580775,0.000029660718,0.0001530487,0.00093425997,0.00003582672],"category_scores_gemma":[0.00019461874,0.00024213793,0.00007276496,0.000056299872,0.00010821132,0.0000040813875,0.00023868015,0.00043081472,0.000011839413],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006237001,0.000020248355,0.0024884313,0.00009502127,0.000034556928,0.0006057065,0.00007970874,5.168728e-7,0.8541088,0.0000010369869,0.14104219,0.00090007554],"study_design_scores_gemma":[0.0018463974,0.0017887079,0.049635652,0.0002926192,0.00012093912,0.00060533953,0.00025107677,0.000007942657,0.22929595,0.00009181457,0.7144166,0.0016469602],"about_ca_topic_score_codex":0.000016337432,"about_ca_topic_score_gemma":0.000017940225,"teacher_disagreement_score":0.62481284,"about_ca_system_score_codex":0.000023548811,"about_ca_system_score_gemma":0.000023509514,"threshold_uncertainty_score":0.98740983},"labels":[],"label_agreement":null},{"id":"W2292251821","doi":"10.3324/haematol.2015.137380","title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Asparaginase; Medicine; Lymphoblastic Leukemia; Antibody; Immunology; Intensive care medicine; Leukemia","score_opus":0.056859683970737984,"score_gpt":0.34078537270542647,"score_spread":0.2839256887346885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292251821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96337765,0.00011638719,0.012580216,0.022421021,0.00004164731,0.0008456714,0.000024644802,0.000031811305,0.00056097127],"genre_scores_gemma":[0.9917821,0.00055795105,0.0071705733,0.00010167523,0.000010114652,0.00010293356,0.000012697346,0.0000064407936,0.00025551117],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993334,0.000041247487,0.00018978812,0.00020879746,0.00010769049,0.00011910862],"domain_scores_gemma":[0.9991821,0.0003946762,0.00008907915,0.00015769641,0.000116104675,0.000060321916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020745298,0.00007253928,0.00018567513,0.000067338144,0.00006027752,0.0000066817147,0.000022594717,0.000051091938,0.000012458263],"category_scores_gemma":[0.00017838208,0.000046711506,0.000020692363,0.00006276596,0.00015785429,0.000038553615,0.00004570267,0.00002529958,0.000003602154],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032593193,0.00096443034,0.006102022,0.0024200238,0.00064046466,0.00032472736,0.001260483,5.879379e-7,0.39768067,0.08202347,0.035303228,0.47002056],"study_design_scores_gemma":[0.029071644,0.002144471,0.30277863,0.0031551223,0.00065212644,0.0038852552,0.008033942,0.0048399568,0.60039884,0.009773438,0.034347326,0.0009192191],"about_ca_topic_score_codex":0.000013879525,"about_ca_topic_score_gemma":0.0000013986249,"teacher_disagreement_score":0.46910134,"about_ca_system_score_codex":0.00008899382,"about_ca_system_score_gemma":0.000026142534,"threshold_uncertainty_score":0.19048399},"labels":[],"label_agreement":null},{"id":"W2295530774","doi":"10.3324/haematol.2015.135418","title":"Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto East General Hospital; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Leukemia and Lymphoma Society of Canada; University of Toronto; Leukemia and Lymphoma Society","keywords":"Ruxolitinib; Idelalisib; Janus kinase; Myelofibrosis; Venetoclax; Medicine; Chronic lymphocytic leukemia; Ibrutinib; Oncology; STAT protein; Internal medicine; Janus kinase 1; Clinical trial; stat; Clinical endpoint; Cancer research; Tolerability; STAT3; Leukemia; Signal transduction; Chemistry; Adverse effect; Receptor; Bone marrow","score_opus":0.046861909385239535,"score_gpt":0.3334470027006804,"score_spread":0.28658509331544085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295530774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928566,0.00072330894,0.0000047839503,0.060063448,0.0007600832,0.004146463,0.00054578535,0.00007817121,0.0051119574],"genre_scores_gemma":[0.9788432,0.00021936595,0.000043633823,0.012990018,0.0029064377,0.00034555755,0.00009603145,0.00009605511,0.0044596912],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99355257,0.0007279603,0.001777542,0.001069716,0.0016170219,0.0012552071],"domain_scores_gemma":[0.994089,0.0017170551,0.0013455088,0.0023969393,0.0002908282,0.00016069002],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011105661,0.0006764985,0.0026141305,0.0004678233,0.00011624161,0.000013722894,0.00096489233,0.0020961754,0.00023815819],"category_scores_gemma":[0.003153115,0.00038106204,0.0007867721,0.0007234257,0.001341094,0.0000892126,0.00088528456,0.0020979245,0.00004986729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.15113541,0.0008686632,0.000006303547,0.0072155413,0.00046616525,0.011902723,0.00045737159,0.000012305932,0.01109516,0.00011593143,0.8091332,0.007591263],"study_design_scores_gemma":[0.6766503,0.0077508776,0.000017610124,0.005311877,0.0003591494,0.0014843774,0.000021810503,0.0009524267,0.10135784,0.00026029366,0.20523937,0.0005940896],"about_ca_topic_score_codex":0.002073592,"about_ca_topic_score_gemma":0.00008622481,"teacher_disagreement_score":0.6038938,"about_ca_system_score_codex":0.08504891,"about_ca_system_score_gemma":0.07700219,"threshold_uncertainty_score":0.9998641},"labels":[],"label_agreement":null},{"id":"W2297856459","doi":"10.3324/haematol.2015.140335","title":"Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Quality of life (healthcare); Psychosocial; International Prognostic Scoring System; Medicine; Cohort; Myelodysplastic syndromes; Scale (ratio); Gerontology; Internal medicine; Psychology; Psychiatry","score_opus":0.040397248204170844,"score_gpt":0.34331150305323793,"score_spread":0.3029142548490671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297856459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869746,0.000022768527,0.00015966072,0.004819572,0.000069451744,0.00042829337,0.00001604562,0.000014956399,0.0074946256],"genre_scores_gemma":[0.99897206,0.000025566873,0.00044905223,0.00007111482,0.000022163238,0.00003171945,0.0000028508928,0.0000060652915,0.00041943192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998599,0.00017610067,0.00047541995,0.00018194102,0.0004303741,0.0001371782],"domain_scores_gemma":[0.99888325,0.00030129153,0.00023525288,0.0003011684,0.00023357992,0.00004544011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061070354,0.00007679971,0.000351717,0.00009092391,0.000018283597,0.0000026092057,0.00023144999,0.000092881186,0.0003131542],"category_scores_gemma":[0.0022767233,0.00003673006,0.00008206375,0.0002341465,0.00026221928,0.000060939048,0.00013687182,0.00012273013,0.00002382339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051520055,0.00017026793,0.9513213,0.00007936179,0.000036980193,0.0000046619184,0.0002869532,0.0000011659391,0.040936347,0.005550163,0.00043030837,0.00066728547],"study_design_scores_gemma":[0.0016925326,0.000074063195,0.8357778,0.00015164567,0.000007120976,0.000021810007,0.00016919221,0.000016872915,0.1604922,0.0014506849,0.000100145735,0.00004590503],"about_ca_topic_score_codex":0.000090761154,"about_ca_topic_score_gemma":0.000030575684,"teacher_disagreement_score":0.119555846,"about_ca_system_score_codex":0.0001481195,"about_ca_system_score_gemma":0.00019764686,"threshold_uncertainty_score":0.3428819},"labels":[],"label_agreement":null},{"id":"W2304098313","doi":"10.3324/haematol.2015.132712","title":"Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Cancer Research UK","keywords":"Adoptive cell transfer; Immunology; Receptor; Biology; Cell therapy; T cell; Chimeric antigen receptor; Antigen; Graft-versus-host disease; Endogeny; Cancer research; Receptor expression; Immune system; Stem cell; Cell biology; Endocrinology","score_opus":0.03489163423556973,"score_gpt":0.29882062272251286,"score_spread":0.26392898848694313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304098313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958638,0.0008869236,0.00018617933,0.00062311697,0.00005184554,0.0011579687,0.000011779078,0.000027007352,0.0011914072],"genre_scores_gemma":[0.9949921,0.0014084087,0.00095023663,0.000041993477,0.000032158336,0.0001237939,0.0000016901544,0.00002010885,0.0024295244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984865,0.0001810239,0.0003800155,0.0003668806,0.0003164472,0.0002690857],"domain_scores_gemma":[0.99891186,0.00013189836,0.000266589,0.00041176332,0.0001613646,0.00011652378],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038210815,0.00016861946,0.00054895354,0.00009994259,0.000048998336,0.0000041781864,0.0001282692,0.00012696562,0.00114754],"category_scores_gemma":[0.00012820293,0.00009289338,0.00008354828,0.00015051693,0.0002675607,0.000036519363,0.00006596371,0.00013127204,0.0000117997115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002198636,0.00051857525,0.0010099738,0.00025577217,0.000011713776,0.000017599525,0.00022496902,8.333073e-8,0.98479915,0.000009497691,0.00026922888,0.010684833],"study_design_scores_gemma":[0.0022412122,0.0016773028,0.00065098447,0.0003265037,0.000009158845,0.00008517919,0.00008357231,0.0000021312615,0.99339855,0.00010403284,0.0013118669,0.000109531895],"about_ca_topic_score_codex":0.00005224184,"about_ca_topic_score_gemma":0.000005015976,"teacher_disagreement_score":0.010575301,"about_ca_system_score_codex":0.0000440725,"about_ca_system_score_gemma":0.00009667871,"threshold_uncertainty_score":0.9997656},"labels":[],"label_agreement":null},{"id":"W2333810059","doi":"10.3324/haematol.2015.139931","title":"Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed","year":2016,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Novo Nordisk; Bayer HealthCare; CSL Behring; Baxalta; Sick Kids Foundation; Biogen; Pfizer","keywords":"Reimbursement; Haemophilia; Business; Medicine; Cost–benefit analysis; Health care; Intensive care medicine; Medical emergency; Political science; Surgery","score_opus":0.031195118780093522,"score_gpt":0.2879831488459305,"score_spread":0.256788030065837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333810059","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077185635,0.011417653,0.00023700655,0.004522982,0.9154036,0.0036769316,0.035163164,0.00020164036,0.021658452],"genre_scores_gemma":[0.2019147,0.0066444976,0.0019458435,0.005137479,0.7729836,0.004610944,0.0034555749,0.0005944546,0.0027129212],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99624825,0.00003883249,0.0015070118,0.0011949715,0.00010193542,0.00090897904],"domain_scores_gemma":[0.99648446,0.00049631123,0.0017675107,0.0006866686,0.0002640413,0.00030099176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003179964,0.00064845197,0.0018066354,0.00029498799,0.00028959417,0.00018322562,0.0005923602,0.0009941468,0.00041167627],"category_scores_gemma":[0.0007367318,0.0006028713,0.00045177084,0.00016090077,0.00013356049,0.00014615935,0.0003044214,0.00045147713,0.0005488395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001980409,0.000093352086,0.00007999908,0.0004583482,0.0002447754,0.00003360523,0.0005598289,0.0000039408014,0.0000018272015,0.021690734,0.97617567,0.00045991063],"study_design_scores_gemma":[0.0018247608,0.0002752613,0.0000121695375,0.00021456646,0.000042353342,0.000003118481,0.00023108066,0.00003981481,0.00030131623,0.015855396,0.9804829,0.0007172651],"about_ca_topic_score_codex":0.000074039104,"about_ca_topic_score_gemma":0.00006478792,"teacher_disagreement_score":0.19419613,"about_ca_system_score_codex":0.0005994294,"about_ca_system_score_gemma":0.00013790661,"threshold_uncertainty_score":0.99964225},"labels":[],"label_agreement":null},{"id":"W2335826388","doi":"10.3324/haematol.2015.137083","title":"Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Refractory (planetary science); Lenalidomide; Multiple myeloma; Creatinine; Internal medicine; Urology; Gastroenterology; Materials science","score_opus":0.052192227517079505,"score_gpt":0.35049796612858714,"score_spread":0.2983057386115076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335826388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970041,0.00047702526,0.000043293418,0.00012825783,0.000059146554,0.0020893132,0.000092868235,0.000046230758,0.00005979727],"genre_scores_gemma":[0.99730015,0.00043138524,0.0017642049,0.000020330202,0.000017078542,0.00026737564,0.000053409414,0.000033693235,0.000112345355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953314,0.0008256442,0.001415399,0.0008917892,0.00081564573,0.0007201257],"domain_scores_gemma":[0.99478596,0.0030575024,0.0006081203,0.0009803604,0.00016642325,0.00040165146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001136753,0.00045539188,0.002289797,0.00159444,0.000063448264,0.00001220936,0.00024861222,0.00029369985,0.0005073211],"category_scores_gemma":[0.002802926,0.0002700529,0.00022147536,0.0017689683,0.00036350897,0.00019777381,0.00022091535,0.00036027253,0.00000811557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24621618,0.04017391,0.5966774,0.00033764294,0.004991922,0.010074462,0.002871206,0.000037162547,0.058001127,0.000025797131,0.00007326098,0.040519904],"study_design_scores_gemma":[0.20608456,0.01666036,0.7645317,0.0005497833,0.001179959,0.000055307224,0.0018513643,0.00074465416,0.0079248035,0.00001801765,0.000040841613,0.0003586977],"about_ca_topic_score_codex":0.0027357785,"about_ca_topic_score_gemma":0.004567581,"teacher_disagreement_score":0.16785422,"about_ca_system_score_codex":0.00037260412,"about_ca_system_score_gemma":0.00022663185,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W2336872381","doi":"10.3324/haematol.2014.117077","title":"Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Discontinuation; Multiple myeloma; Gastroenterology; Surgery; Oncology; Biology","score_opus":0.05052684580106229,"score_gpt":0.2953094141086336,"score_spread":0.2447825683075713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336872381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977414,0.000935117,0.000025377652,0.000047246936,0.000016361302,0.0009938312,0.000054936067,0.00005259949,0.00013312174],"genre_scores_gemma":[0.9964265,0.00036716083,0.00280313,0.000029100718,0.00001332735,0.000041033014,0.00010548473,0.000039290644,0.00017497774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981192,0.00018392934,0.00032347863,0.00050467683,0.0004782772,0.0003904477],"domain_scores_gemma":[0.9980614,0.00044013534,0.00020828485,0.0003824708,0.00030564208,0.0006020521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018510423,0.00032828402,0.0008035602,0.00014597364,0.00008623362,0.000026101983,0.00006939431,0.00017509086,0.000026917778],"category_scores_gemma":[0.00052731344,0.00017989476,0.000026326832,0.00018450372,0.0005679932,0.000112210284,0.000104878,0.00019784359,0.0000032316304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022485448,0.00079996197,0.96901137,0.00027653904,0.00028519076,0.0013327287,0.00021033072,3.6366723e-7,0.00048463602,0.0000053896915,0.00001797301,0.0050900932],"study_design_scores_gemma":[0.024747683,0.0067960466,0.9651556,0.00028101375,0.00019151843,0.0003245059,0.00015256905,0.000040602343,0.0020425878,0.000005388726,0.000044588545,0.00021787248],"about_ca_topic_score_codex":0.000079752266,"about_ca_topic_score_gemma":0.00021608887,"teacher_disagreement_score":0.0059960843,"about_ca_system_score_codex":0.00005094036,"about_ca_system_score_gemma":0.00013139853,"threshold_uncertainty_score":0.73358953},"labels":[],"label_agreement":null},{"id":"W2396715364","doi":"10.3324/haematol.2016.146126","title":"Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Blood groups and transfusion","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Helse Sør-Øst RHF; Kreftforeningen","keywords":"Cold agglutinin disease; Antibody; Immunoglobulin light chain; Cold Agglutinin; Immunoglobulin heavy chain; Gene; Disease; Immunology; Medicine; Biology; Genetics; Pathology; Autoantibody","score_opus":0.008607088845290645,"score_gpt":0.20575633550386352,"score_spread":0.19714924665857286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396715364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4985623,0.009445472,0.000027295118,0.48995116,0.00012279385,0.0010575233,0.0002910859,0.00016458436,0.00037778766],"genre_scores_gemma":[0.7707947,0.0029904598,0.00037571084,0.22050476,0.00059369864,0.00014371956,0.00043297355,0.00010902113,0.004054995],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979036,0.00014884205,0.0002642791,0.0008213527,0.00035956845,0.00050238107],"domain_scores_gemma":[0.9986951,0.00016584522,0.0002631406,0.0005453469,0.00007511342,0.00025547674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013310704,0.0005578303,0.0012163377,0.00012535065,0.00031124824,0.00004004712,0.00011179243,0.0009788703,0.000061192346],"category_scores_gemma":[0.000041273364,0.00031506128,0.00010734408,0.00012679251,0.00031180063,0.00006432283,0.00014650502,0.001389127,0.000009925482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009404084,0.0005629281,0.037234098,0.0030356871,0.00084432436,0.04488244,0.00020920727,1.1425886e-7,0.0019658923,0.000047113837,0.8984447,0.0033694166],"study_design_scores_gemma":[0.009559117,0.0023443294,0.5382325,0.006522366,0.0022607907,0.0120279975,0.00002362324,0.000008299249,0.0036112778,0.00015040358,0.42374194,0.001517356],"about_ca_topic_score_codex":0.00003230439,"about_ca_topic_score_gemma":0.000010780812,"teacher_disagreement_score":0.5009984,"about_ca_system_score_codex":0.000041264302,"about_ca_system_score_gemma":0.00012126757,"threshold_uncertainty_score":0.99993014},"labels":[],"label_agreement":null},{"id":"W2414354258","doi":"10.3324/haematol.2016.143271","title":"Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Human leukocyte antigen; Transplantation; Hazard ratio; Medicine; Hematopoietic stem cell transplantation; Immunology; Graft-versus-host disease; Histocompatibility; Hematopoietic cell; Antigen; Haematopoiesis; Internal medicine; Biology; Stem cell; Genetics","score_opus":0.023069867335561305,"score_gpt":0.2601794026681586,"score_spread":0.2371095353325973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414354258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941133,0.0012251331,0.0009489963,0.0017819834,0.00032619078,0.0007252331,0.0002588974,0.00009254057,0.0005277045],"genre_scores_gemma":[0.9967132,0.0005713468,0.00038716558,0.0001427858,0.00003485406,0.0002445105,0.000481104,0.000029541552,0.0013954693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978476,0.00040227204,0.00049242977,0.0006209145,0.00009629674,0.00054046843],"domain_scores_gemma":[0.9984825,0.0007153562,0.00016368234,0.00034411045,0.00026122187,0.000033127366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048624733,0.0002851802,0.00043198437,0.00010480223,0.0004300915,0.000042080486,0.00036462254,0.00038263013,0.0006010091],"category_scores_gemma":[0.00004121014,0.00014149926,0.000100702244,0.00010045719,0.0006663995,0.0001365065,0.00006714309,0.00037304845,0.00008312204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022111614,0.0002850375,0.052180972,0.000048916634,0.00061427464,0.00063138,0.0041192104,3.556945e-7,0.9388318,0.00034656786,0.00057071325,0.00015961874],"study_design_scores_gemma":[0.015552917,0.0012193386,0.06139967,0.00096788304,0.00054488896,0.006337242,0.0021765388,0.0000017055552,0.8864604,0.005772767,0.018607076,0.000959526],"about_ca_topic_score_codex":0.00028425624,"about_ca_topic_score_gemma":0.0002920218,"teacher_disagreement_score":0.05237134,"about_ca_system_score_codex":0.000024378096,"about_ca_system_score_gemma":0.000042700703,"threshold_uncertainty_score":0.6580628},"labels":[],"label_agreement":null},{"id":"W2418937816","doi":"10.3324/haematol.2016.143677","title":"Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Open label; Snapshot (computer storage); Oncology; Internal medicine; Clinical trial; Phases of clinical research; Bone marrow; Computer science","score_opus":0.08403487765658953,"score_gpt":0.3716524044608081,"score_spread":0.2876175268042186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418937816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929414,0.000034182747,0.0000017207161,0.0001302136,0.000047781807,0.0066105067,0.000063930245,0.0000072204184,0.00016308176],"genre_scores_gemma":[0.9992145,0.000037415404,0.00014141973,0.00008500392,0.00000801836,0.0004274425,0.0000689041,0.00001486269,0.0000024809435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973664,0.00050364615,0.00094112154,0.0004952954,0.00038687023,0.00030663828],"domain_scores_gemma":[0.99845827,0.00051223295,0.00037699495,0.00041507187,0.00014499662,0.00009246709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003926274,0.00027253,0.00103926,0.00020343547,0.00004300961,0.000032157823,0.00031296696,0.00008812783,0.00007494278],"category_scores_gemma":[0.0003461734,0.00012879049,0.000027192375,0.0003311593,0.00014597556,0.0002592885,0.00017558584,0.00011546969,0.0000010052354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09324611,0.11287243,0.78703237,0.000048320682,0.00004505996,0.00004963908,0.0020087848,3.0321223e-7,0.00003624918,0.000043792945,0.000009091007,0.004607868],"study_design_scores_gemma":[0.3047995,0.029969836,0.663419,0.0005923272,0.000053123124,0.0000015606721,0.00037716355,0.00000414376,0.0006588114,0.000011027234,0.000007205577,0.000106269516],"about_ca_topic_score_codex":0.00019676768,"about_ca_topic_score_gemma":0.00071392197,"teacher_disagreement_score":0.2115534,"about_ca_system_score_codex":0.000071530136,"about_ca_system_score_gemma":0.000050254814,"threshold_uncertainty_score":0.5251924},"labels":[],"label_agreement":null},{"id":"W2423969118","doi":"10.3324/haematol.2016.144550","title":"Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Rituximab; Medicine; CHOP; Pathological; Internal medicine; Oncology; Chemotherapy; Vincristine; Pathology; Cyclophosphamide","score_opus":0.008859314499504379,"score_gpt":0.2305589043802064,"score_spread":0.221699589880702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423969118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93198025,0.0005189253,0.000022713668,0.06460206,0.00028630867,0.001704305,0.00004978436,0.00006722764,0.0007684117],"genre_scores_gemma":[0.8976563,0.0008361458,0.0015361741,0.09787902,0.00033714887,0.0004780135,0.0002860821,0.00011200793,0.0008791127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731,0.000093600356,0.0005260056,0.0009094959,0.00049634144,0.0006645502],"domain_scores_gemma":[0.99850106,0.0001588083,0.0006118495,0.00053111673,0.000079537516,0.000117601994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008394665,0.0006612845,0.0014782882,0.00024690034,0.000116695715,0.000056352408,0.00015779193,0.0005054391,0.00007215052],"category_scores_gemma":[0.00002945612,0.00032898076,0.00018126068,0.00020310808,0.00016556153,0.00012536971,0.00008994571,0.00044757625,0.000042980228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005310895,0.0037890952,0.73591757,0.0009384458,0.00072982203,0.04318193,0.00035908024,2.022582e-7,0.000063995125,0.000011594153,0.1834254,0.026271982],"study_design_scores_gemma":[0.13537085,0.004723166,0.73442924,0.015817882,0.00076009927,0.0023488032,0.00008211247,0.000009592719,0.0022403498,0.00011188721,0.10241214,0.0016938499],"about_ca_topic_score_codex":0.00007484516,"about_ca_topic_score_gemma":0.000012543625,"teacher_disagreement_score":0.13005996,"about_ca_system_score_codex":0.00040336268,"about_ca_system_score_gemma":0.00013051639,"threshold_uncertainty_score":0.9999162},"labels":[],"label_agreement":null},{"id":"W2462762289","doi":"10.3324/haematol.2016.148809","title":"Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Oncology; Classical Hodgkin lymphoma; Hodgkin's lymphoma; Internal medicine","score_opus":0.07290797828020769,"score_gpt":0.33914493590097056,"score_spread":0.2662369576207629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462762289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9359936,0.0071799955,0.00012883813,0.04674677,0.00029914366,0.002045946,0.000071098,0.0000524705,0.0074821063],"genre_scores_gemma":[0.98237276,0.01053219,0.0012617774,0.004845577,0.0001069998,0.0006635276,0.00006720057,0.0000162437,0.00013373361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979533,0.00017292416,0.0006957331,0.00041944746,0.00049000775,0.00026858202],"domain_scores_gemma":[0.9973337,0.0014566398,0.0003760488,0.0006427449,0.00015091425,0.000039928054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005808541,0.00025443142,0.0005876577,0.00012852793,0.000096625474,0.000029785422,0.0004937312,0.00009045625,0.00018111177],"category_scores_gemma":[0.0005884716,0.000102183614,0.00018181883,0.0004928054,0.0001508078,0.00009284351,0.00011170295,0.000044753375,0.00010273703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000578972,0.0022389055,0.5245442,0.0010882718,0.0005403545,0.0018137896,0.0013188001,1.5635865e-7,0.00089423556,0.013200118,0.093068086,0.36071414],"study_design_scores_gemma":[0.0035546962,0.00018144613,0.91748315,0.012252359,0.0001761509,0.00075088115,0.00041192712,0.000034160214,0.0037016436,0.00034249196,0.060895395,0.00021570147],"about_ca_topic_score_codex":0.0006142946,"about_ca_topic_score_gemma":0.00030424917,"teacher_disagreement_score":0.39293897,"about_ca_system_score_codex":0.00033973262,"about_ca_system_score_gemma":0.00038088352,"threshold_uncertainty_score":0.41669267},"labels":[],"label_agreement":null},{"id":"W2477939303","doi":"","title":"The Maintenance of Tolerance After Successful Immune Tolerance Induction in Hemophilia A and B: The North American Registry","year":2000,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Immune tolerance; Clotting factor; Cohort; Surgery; Maintenance therapy; Internal medicine; Pediatrics; Immune system; Chemotherapy; Immunology","score_opus":0.011121283941567502,"score_gpt":0.26148005343697495,"score_spread":0.2503587694954074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477939303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849363,0.0025854274,0.0000015334302,0.010018468,0.000031318148,0.00052324845,0.0000032532046,0.000018549274,0.0018818923],"genre_scores_gemma":[0.9938818,0.0037764725,0.00008441184,0.00018922215,0.000035891135,0.00015605475,0.000002608789,0.000008565173,0.00186498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987491,0.00012903928,0.00034100402,0.00024345632,0.00022834439,0.0003090857],"domain_scores_gemma":[0.99914855,0.00018577493,0.00010696835,0.00044505857,0.00006018528,0.00005343771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028414303,0.00013934512,0.00046567907,0.000034130095,0.00012916679,0.000019086883,0.00016224185,0.000049552993,0.000074851756],"category_scores_gemma":[0.0001022043,0.000061183586,0.00007645569,0.00043529636,0.0015340132,0.00004933855,0.000036543788,0.0002895634,0.00002041117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011568724,0.00031672526,0.89665586,0.00020489703,0.0000802326,0.0006569114,0.0012060677,0.00002132885,0.00016221926,0.0006653468,0.00046419376,0.08799747],"study_design_scores_gemma":[0.002563534,0.00016078827,0.9920138,0.00017527567,0.000023071709,0.00043229997,0.00030390522,0.0002967241,0.0007014465,0.00023636805,0.0029873182,0.00010543567],"about_ca_topic_score_codex":0.00028410152,"about_ca_topic_score_gemma":0.00030501958,"teacher_disagreement_score":0.09535795,"about_ca_system_score_codex":0.000025658406,"about_ca_system_score_gemma":0.00003837356,"threshold_uncertainty_score":0.56521356},"labels":[],"label_agreement":null},{"id":"W2497935705","doi":"10.3324/haematol.2016.142810","title":"Innovative approach to older patients with malignant hemopathies","year":2016,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Frailty in Older Adults","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Internal medicine; Gerontology; Intensive care medicine","score_opus":0.011568700071233647,"score_gpt":0.2597224867590249,"score_spread":0.24815378668779123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497935705","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012040199,0.00031484693,0.0021883794,0.0021659716,0.90884465,0.0070296023,0.0013121543,0.00088831893,0.065215856],"genre_scores_gemma":[0.053161208,0.00009457511,0.027475512,0.0023534968,0.88013715,0.002213658,0.004924538,0.00054233975,0.029097516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995975,0.00009412539,0.00062195066,0.0011132297,0.0014863156,0.0007093362],"domain_scores_gemma":[0.99590904,0.00045308526,0.00038306406,0.0009741139,0.001926876,0.00035382962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021324935,0.0007137774,0.001557743,0.00032840137,0.000111062924,0.000043730277,0.0004167563,0.0011250802,0.0001788061],"category_scores_gemma":[0.00293457,0.00037795698,0.00010653926,0.00067339285,0.0002577559,0.00008836046,0.0002655095,0.00083334534,0.00047844579],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006375358,0.0005914349,0.0020630276,0.00058518077,0.00017862559,0.00018298617,0.00040769763,1.6264377e-7,0.000004879412,0.00020062261,0.9937874,0.0013604658],"study_design_scores_gemma":[0.005080394,0.001957868,0.003975839,0.004147294,0.00018363132,0.00008159288,0.000107731415,9.1221807e-7,0.00028727023,0.000071877,0.98315936,0.0009462498],"about_ca_topic_score_codex":0.00001613662,"about_ca_topic_score_gemma":0.0000033244512,"teacher_disagreement_score":0.04112101,"about_ca_system_score_codex":0.00018599092,"about_ca_system_score_gemma":0.00045798603,"threshold_uncertainty_score":0.99986726},"labels":[],"label_agreement":null},{"id":"W2504660737","doi":"10.3324/haematol.2016.145847","title":"The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Ferritin; Medicine; Albumin; Internal medicine; Myelodysplastic syndromes; Transplantation; Myeloid leukemia; C-reactive protein; Gastroenterology; Hematopoietic stem cell transplantation; Biomarker; Immunology; Acute leukemia; Population; Serum albumin; Leukemia; Bone marrow; Biology; Biochemistry","score_opus":0.015946926581086724,"score_gpt":0.27295262317914226,"score_spread":0.25700569659805556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504660737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98690885,0.00019089076,0.0070874095,0.0023753694,0.000045892757,0.00309693,0.00012073032,0.00005270016,0.0001212441],"genre_scores_gemma":[0.9944772,0.00030227876,0.0042490033,0.00007910876,0.000015998054,0.0005692699,0.0000117053505,0.000024265864,0.0002711778],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860746,0.000076876495,0.00041079827,0.0003738278,0.00021425524,0.00031681423],"domain_scores_gemma":[0.9981354,0.001260168,0.00013842438,0.0001833523,0.00012812078,0.00015453671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027338092,0.00021331363,0.00046286528,0.00008163387,0.00016046892,0.00001896477,0.000085405554,0.00013728245,0.000008774324],"category_scores_gemma":[0.00028952563,0.00011482419,0.000056236688,0.00010813106,0.00020103606,0.00007184238,0.000018437357,0.00006936601,0.0000069371335],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006158286,0.00021874679,0.06135273,0.0067604687,0.0011825159,0.00073868857,0.0044420213,0.000004337032,0.8610601,0.023166806,0.00017610521,0.034739196],"study_design_scores_gemma":[0.0056291083,0.002690807,0.5021166,0.003424994,0.0017002887,0.008071591,0.0005268292,0.00013807458,0.4725856,0.0022764956,0.00036984181,0.00046977235],"about_ca_topic_score_codex":0.000006968776,"about_ca_topic_score_gemma":0.000014801206,"teacher_disagreement_score":0.44076386,"about_ca_system_score_codex":0.00004327666,"about_ca_system_score_gemma":0.000106827174,"threshold_uncertainty_score":0.46823946},"labels":[],"label_agreement":null},{"id":"W2509658736","doi":"10.3324/haematol.2016.149740","title":"CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"ETV6; Biology; Cancer research; Gene silencing; Chromatin immunoprecipitation; Gene; Cell biology; Chromosomal translocation; Gene expression; Genetics","score_opus":0.01792296124747704,"score_gpt":0.2739570040392629,"score_spread":0.2560340427917858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509658736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768644,0.00021116341,0.011485547,0.0033877261,0.00019422178,0.00096093427,0.000081718266,0.0003091632,0.006505132],"genre_scores_gemma":[0.9850775,0.00019489776,0.0115689095,0.001246065,0.00015042572,0.00017222931,0.000026718237,0.00006566231,0.0014975911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99662495,0.000085045845,0.0006842321,0.0008148322,0.00069146144,0.0010994831],"domain_scores_gemma":[0.9978862,0.000598044,0.00015404448,0.00078806776,0.0001397636,0.00043390968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036010967,0.00040968574,0.0009525311,0.0003665989,0.00009711519,0.000025746327,0.00043078736,0.00041480685,0.000857871],"category_scores_gemma":[0.0011113975,0.00023931311,0.00019562087,0.000603014,0.00032844621,0.00014901657,0.0003249464,0.0003026775,0.001268663],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00882762,0.006733605,0.15949321,0.000861331,0.0025264525,0.04312198,0.002517171,0.000097342345,0.6678669,0.018760052,0.05340757,0.035786774],"study_design_scores_gemma":[0.09433716,0.0044002132,0.61914355,0.003001779,0.00073094777,0.05395797,0.00034495673,0.005886998,0.18509664,0.0061793798,0.023939267,0.00298118],"about_ca_topic_score_codex":0.000052937896,"about_ca_topic_score_gemma":0.000011357701,"teacher_disagreement_score":0.48277026,"about_ca_system_score_codex":0.0017628975,"about_ca_system_score_gemma":0.0014487085,"threshold_uncertainty_score":0.999509},"labels":[],"label_agreement":null},{"id":"W2511586498","doi":"10.3324/haematol.2016.151449","title":"The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Incyte","keywords":"Ruxolitinib; Myelofibrosis; Polycythemia vera; Medicine; Anemia; Internal medicine; Overall survival; Myeloproliferative neoplasm; Gastroenterology; Bone marrow","score_opus":0.03352389522912173,"score_gpt":0.3046890616389881,"score_spread":0.2711651664098664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511586498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9386419,0.00020690417,1.9022116e-7,0.056751452,0.000029106077,0.0018940594,0.00013697449,0.000020716905,0.0023186863],"genre_scores_gemma":[0.98181576,0.0003867538,0.000027746724,0.016613109,0.000110037145,0.0005681841,0.00023498114,0.00004105282,0.00020238696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973713,0.00039507847,0.00052804715,0.00048066562,0.00065854087,0.0005663707],"domain_scores_gemma":[0.99687034,0.0018583126,0.00039068007,0.000649706,0.00018767777,0.000043275453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025186635,0.0005730406,0.0014453428,0.0001490748,0.00011419218,0.00002514399,0.00022578452,0.0003147773,0.00004483529],"category_scores_gemma":[0.00010623105,0.00016612199,0.00017015864,0.00023123139,0.0003620953,0.000036817986,0.00004169017,0.00068973814,0.00001091372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002640665,0.0004863478,0.92849374,0.00012910215,0.00055334665,0.0010081156,0.0003176317,0.0000027134995,4.2492013e-7,0.00015314369,0.06587719,0.00033756203],"study_design_scores_gemma":[0.006302748,0.008036373,0.9797146,0.0019892165,0.00017718779,0.000052389067,0.000120677,8.059859e-7,0.000069372574,0.00008311128,0.0031941694,0.00025939464],"about_ca_topic_score_codex":0.00024687548,"about_ca_topic_score_gemma":0.0001434919,"teacher_disagreement_score":0.062683016,"about_ca_system_score_codex":0.00026368245,"about_ca_system_score_gemma":0.00011276266,"threshold_uncertainty_score":0.6774258},"labels":[],"label_agreement":null},{"id":"W2513682947","doi":"10.3324/haematol.2016.147116","title":"Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute for Health and Care Research","keywords":"Medicine; Lymphoma; Cancer; Malignancy; Hodgkin lymphoma; Internal medicine; Ataxia-telangiectasia; Incidence (geometry); Pediatrics; Epidemiology; Non-Hodgkin's lymphoma; Cumulative incidence; Oncology; Cohort","score_opus":0.03482524352224295,"score_gpt":0.34146321822440817,"score_spread":0.30663797470216525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513682947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997694,0.00034878877,0.000009267412,0.0011495133,0.00005720075,0.00049692305,0.00004411434,0.00003818145,0.0001620209],"genre_scores_gemma":[0.99800503,0.0011532548,0.00027034397,0.00040435145,0.00005330059,0.000036088495,0.000017935517,0.00001204886,0.000047654303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869,0.00005196534,0.00050550944,0.00040707013,0.0001028826,0.00024256045],"domain_scores_gemma":[0.99926126,0.00021445144,0.00014153482,0.0001855659,0.000018538665,0.00017862517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019587483,0.00018600038,0.0006094301,0.00006881196,0.00007471869,0.000027048463,0.00003995812,0.0001400907,0.000025744477],"category_scores_gemma":[0.00026510502,0.00011017369,0.000042781314,0.00005321716,0.00023750792,0.00005802046,0.00010237655,0.000057975943,0.000017618966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011451679,0.0003947536,0.9834503,0.0000598543,0.000038722206,0.0003223079,0.000040843788,2.493056e-9,0.000018176392,0.00043190017,0.00008281595,0.015045795],"study_design_scores_gemma":[0.00574468,0.0003360418,0.9914194,0.00065864925,0.000082016406,0.0011599811,0.000012686588,0.000012880278,0.000079806516,0.00028531044,0.00007150044,0.00013708883],"about_ca_topic_score_codex":0.000043154352,"about_ca_topic_score_gemma":0.000015864362,"teacher_disagreement_score":0.014908706,"about_ca_system_score_codex":0.000041308045,"about_ca_system_score_gemma":0.000023448774,"threshold_uncertainty_score":0.44927529},"labels":[],"label_agreement":null},{"id":"W2514277111","doi":"10.3324/haematol.2016.145821","title":"Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantation","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Children's Hospital of Eastern Ontario; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Azacitidine; Medicine; Myelodysplastic syndromes; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Leukemia; Myeloid leukemia; Oncology; Gastroenterology; Bone marrow; Surgery; Biology","score_opus":0.012551107800142756,"score_gpt":0.2570567888220094,"score_spread":0.24450568102186662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514277111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906531,0.000050504317,0.002220517,0.0040772017,0.000011950393,0.0026337134,0.000038420883,0.00012577804,0.00018880276],"genre_scores_gemma":[0.99288946,0.00006551951,0.004867772,0.00025973632,0.000007833163,0.0006258305,0.000012287098,0.00004841348,0.0012231431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978301,0.00016403936,0.00032927183,0.00064178417,0.00042674664,0.0006080746],"domain_scores_gemma":[0.9985643,0.00037816502,0.00006754697,0.00047822262,0.00008305247,0.0004287171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021978655,0.00033403796,0.00067705946,0.00039319764,0.000070873466,0.000016350186,0.00015963848,0.0001058685,0.00010236511],"category_scores_gemma":[0.00003331298,0.00016384466,0.000044566536,0.0006200377,0.00008281365,0.000090071575,0.00003010858,0.00012155428,0.00041626085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26314452,0.0026926557,0.41405618,0.0008998896,0.00063832727,0.04394442,0.0090881735,0.00035491976,0.21653232,0.0003452649,0.00031521835,0.047988135],"study_design_scores_gemma":[0.024827693,0.03715254,0.78380185,0.0023796542,0.00024936095,0.03550705,0.0005519948,0.000014776758,0.114114165,0.000017318436,0.00059156975,0.0007920424],"about_ca_topic_score_codex":0.00002160875,"about_ca_topic_score_gemma":0.00005244378,"teacher_disagreement_score":0.36974567,"about_ca_system_score_codex":0.0005788841,"about_ca_system_score_gemma":0.00028858698,"threshold_uncertainty_score":0.6681391},"labels":[],"label_agreement":null},{"id":"W2514747241","doi":"10.3324/haematol.2016.146894","title":"Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Myeloid; Cancer research; Pharmacology; Leukemia; Chemistry; Medicine; Immunology","score_opus":0.017470193773265478,"score_gpt":0.2635668604704489,"score_spread":0.24609666669718344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514747241","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05926455,0.0019913001,0.00013394239,0.92989975,0.001113575,0.0021407271,0.00036645294,0.000448688,0.0046410332],"genre_scores_gemma":[0.06870414,0.001609939,0.0010414398,0.9010054,0.010031602,0.0014615026,0.00043908236,0.0003693104,0.015337622],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949689,0.00043497872,0.0009234885,0.0012725276,0.0010876316,0.0013124901],"domain_scores_gemma":[0.9964715,0.0008505464,0.00069965573,0.0015786263,0.00019799575,0.00020164369],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00047399077,0.001049995,0.0019084238,0.0004360633,0.00018463343,0.000077568526,0.00070732407,0.0016353854,0.0012125046],"category_scores_gemma":[0.00006308601,0.0005275659,0.00038743173,0.0006085088,0.0008962943,0.0001462265,0.0001726508,0.0032682645,0.00075461785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014563864,0.000056520483,0.00009585348,0.00029825265,0.00036626298,0.013917593,0.00020884402,0.000001967442,0.013406163,0.00004365084,0.9695746,0.0005739049],"study_design_scores_gemma":[0.00498735,0.0007678213,0.00005814265,0.0018339492,0.00033825135,0.0032370219,0.00004462414,0.0000102692,0.097494215,0.0001804695,0.89025915,0.0007887265],"about_ca_topic_score_codex":0.00009011568,"about_ca_topic_score_gemma":0.00002633917,"teacher_disagreement_score":0.08408805,"about_ca_system_score_codex":0.00073102117,"about_ca_system_score_gemma":0.00071671256,"threshold_uncertainty_score":0.9997176},"labels":[],"label_agreement":null},{"id":"W2521045502","doi":"10.3324/haematol.2016.148924","title":"A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"National Cancer Institute; Gilead Sciences; European Hematology Association; American Society of Hematology","keywords":"Myelofibrosis; Medicine; Administration (probate law); Phase (matter); Phases of clinical research; Open label; Ruxolitinib; Internal medicine; Adverse effect; Clinical trial; Chemistry; Political science; Bone marrow","score_opus":0.18015390891044974,"score_gpt":0.4582531616756482,"score_spread":0.2780992527651985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521045502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932799,0.000104758605,0.00004494976,0.0018020271,0.000046473986,0.002446552,0.00002169431,0.000036934063,0.002216735],"genre_scores_gemma":[0.9959566,0.000040745064,0.0028683897,0.00013590432,0.000019138191,0.00074727356,0.000012335706,0.000016359443,0.00020323948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979676,0.00023434169,0.00070474687,0.00047003385,0.00035643709,0.00026682403],"domain_scores_gemma":[0.9986172,0.0004374604,0.0002817723,0.00037746585,0.0001701267,0.00011603057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059678615,0.00022286702,0.00079459866,0.00012917619,0.00007041837,0.00002743896,0.00017088605,0.00009296211,0.00039929728],"category_scores_gemma":[0.0006359984,0.0001268474,0.000049039038,0.0002860152,0.00007194824,0.00014338354,0.000119125056,0.0000835176,0.000067667504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012588023,0.123967506,0.69313407,0.0002600153,0.0005017899,0.0015906988,0.0026053174,8.44848e-7,0.054069053,0.004247289,0.0008190935,0.10621631],"study_design_scores_gemma":[0.2124568,0.152447,0.4518912,0.0022617246,0.0007120573,0.0006021943,0.002932763,0.0004000111,0.17391764,0.0011293001,0.00043491775,0.0008143795],"about_ca_topic_score_codex":0.000049447473,"about_ca_topic_score_gemma":0.00009899439,"teacher_disagreement_score":0.24124284,"about_ca_system_score_codex":0.00007457449,"about_ca_system_score_gemma":0.00017696776,"threshold_uncertainty_score":0.51726866},"labels":[],"label_agreement":null},{"id":"W2528750776","doi":"10.3324/haematol.2016.147835","title":"Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Radboud Universitair Medisch Centrum; Erasmus Medisch Centrum; Vrije Universiteit Amsterdam; Radboud Universiteit","keywords":"Myelodysplastic syndromes; Flow cytometry; Cohort; Medicine; International Prognostic Scoring System; Dysplasia; Internal medicine; Confidence interval; Pathology; Oncology; Immunology; Bone marrow","score_opus":0.03187328569843767,"score_gpt":0.28627629038101154,"score_spread":0.2544030046825739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528750776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289435,0.0010072881,0.0011632418,0.0020710377,0.00011078841,0.00046874926,0.000019801519,0.00007302697,0.0021916903],"genre_scores_gemma":[0.99765575,0.0002050219,0.0013985455,0.00020465642,0.00004344178,0.00007898433,0.00005729749,0.000026170714,0.00033014442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971701,0.0002246934,0.00088674744,0.0005973329,0.0005763584,0.0005447673],"domain_scores_gemma":[0.9961527,0.0020914588,0.00033407184,0.0011988276,0.0001049639,0.00011795015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007943761,0.00025819393,0.00119942,0.0004523466,0.00008800983,0.000019211284,0.0004463514,0.0002317526,0.0010011089],"category_scores_gemma":[0.0016132204,0.00012658988,0.00030240935,0.0020069934,0.00040679105,0.00007358423,0.0002515181,0.00038864388,0.00010826012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013566582,0.00037062302,0.9435418,0.000074645366,0.0036613783,0.013484095,0.0006208831,0.000020719077,0.024376014,0.0019583178,0.0018282156,0.008706614],"study_design_scores_gemma":[0.002092551,0.0001913364,0.98976177,0.0006329232,0.0013168671,0.0016100676,0.00031331286,0.0005358229,0.00073686184,0.00088569376,0.0016797058,0.00024306029],"about_ca_topic_score_codex":0.0005365302,"about_ca_topic_score_gemma":0.00028276155,"teacher_disagreement_score":0.04621996,"about_ca_system_score_codex":0.00028735714,"about_ca_system_score_gemma":0.00018264585,"threshold_uncertainty_score":0.9999121},"labels":[],"label_agreement":null},{"id":"W2544907814","doi":"10.3324/haematol.2016.151126","title":"Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"Myelofibrosis; Open label; Medicine; Ruxolitinib; Internal medicine; Oncology; Clinical trial; Pharmacology","score_opus":0.02871582059334091,"score_gpt":0.3091379193859089,"score_spread":0.28042209879256796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544907814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960045,0.000052115298,0.0000315136,0.00032910708,0.000028139355,0.0019961414,0.00011892908,0.0000156949,0.0014238289],"genre_scores_gemma":[0.9977571,0.000040634164,0.0015932358,0.00010154302,0.000009880278,0.0003544536,0.00006810826,0.000013415635,0.00006167738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998142,0.00013809596,0.0006637048,0.00043451216,0.00038652032,0.00023518961],"domain_scores_gemma":[0.9984889,0.00029582522,0.00043682425,0.00035491656,0.0003211321,0.0001024011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019884539,0.00023518951,0.001571082,0.0004286576,0.000056688477,0.0000072874277,0.00014313663,0.00012301673,0.00013432342],"category_scores_gemma":[0.0002090252,0.0001195426,0.000113701295,0.0011856756,0.00014971399,0.0001223232,0.00016586506,0.00007936088,0.0000039111023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1604449,0.04479516,0.7740943,0.00010860522,0.0031033836,0.00006500406,0.0005664085,8.3047394e-7,0.001808173,0.000777623,0.00043902243,0.013796597],"study_design_scores_gemma":[0.4078527,0.049212772,0.5030409,0.0007219176,0.0024509733,0.000005587334,0.000041679607,0.000016660117,0.036189687,0.00010109596,0.000095606694,0.00027039586],"about_ca_topic_score_codex":0.00007566993,"about_ca_topic_score_gemma":0.000070747694,"teacher_disagreement_score":0.27105337,"about_ca_system_score_codex":0.00012563303,"about_ca_system_score_gemma":0.00017494496,"threshold_uncertainty_score":0.48748058},"labels":[],"label_agreement":null},{"id":"W2547656462","doi":"10.3324/haematol.2016.152421","title":"Decreased numbers of dense granules in fetal and neonatal platelets","year":2016,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Platelet; Fetus; Andrology; Medicine; Obstetrics; Pregnancy; Biology; Internal medicine; Genetics","score_opus":0.015596495565175995,"score_gpt":0.25120670938209816,"score_spread":0.23561021381692215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547656462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9040454,0.0024521716,0.000012253507,0.09041234,0.00008192862,0.00052968814,0.000107980886,0.000046622816,0.0023116155],"genre_scores_gemma":[0.90330905,0.0012058717,0.00083809544,0.09292193,0.00016564538,0.000072028335,0.00047935697,0.000066454726,0.00094154465],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850595,0.000056932655,0.00039149783,0.0004170353,0.00024229728,0.00038626764],"domain_scores_gemma":[0.9991589,0.0002078614,0.00024161422,0.00027273162,0.00003579988,0.00008306267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000670364,0.00032823646,0.0011970673,0.00019638265,0.00003064235,0.000007968759,0.00009227645,0.0007225533,0.00020580436],"category_scores_gemma":[0.000105140076,0.00020738105,0.00014454816,0.00008707716,0.00023308776,0.000038867747,0.000051644518,0.00045234113,0.00005303488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016340503,0.00038490817,0.06547938,0.0021366852,0.00088754774,0.4477495,0.00033311755,9.963562e-8,0.0001456959,0.0001405785,0.42198578,0.059122656],"study_design_scores_gemma":[0.038805712,0.0020488063,0.033767015,0.008083541,0.0014664694,0.08740233,0.00024062149,0.0000383939,0.0042152163,0.011185684,0.81032234,0.002423869],"about_ca_topic_score_codex":0.00016210269,"about_ca_topic_score_gemma":0.00005442482,"teacher_disagreement_score":0.38833654,"about_ca_system_score_codex":0.00003151828,"about_ca_system_score_gemma":0.00006286287,"threshold_uncertainty_score":0.8456754},"labels":[],"label_agreement":null},{"id":"W2573426943","doi":"10.3324/haematol.2016.150375","title":"<i>Gfi1b</i> controls integrin signaling-dependent cytoskeleton dynamics and organization in megakaryocytes","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; Megakaryocyte; Cytoskeleton; Biology; Integrin; Actin; Actin cytoskeleton; Tubulin; Microtubule; Genetics; Cell; Stem cell; Haematopoiesis","score_opus":0.013149097644713248,"score_gpt":0.26288720468522525,"score_spread":0.249738107040512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573426943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468553,0.00026994717,0.00021997228,0.0017523261,0.00005210726,0.00035941825,0.000009181742,0.00005148853,0.00260004],"genre_scores_gemma":[0.99887615,0.00024147776,0.00032020922,0.00023460294,0.000011342335,0.000014068203,0.000055148572,0.000014475807,0.00023253514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919796,0.000024426015,0.00020411397,0.00025218466,0.00012341428,0.0001978767],"domain_scores_gemma":[0.99938357,0.000055060824,0.00013275084,0.000279821,0.00007258688,0.00007618529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009740879,0.00014857211,0.00045564753,0.00005959232,0.00017283516,0.00006957,0.00010291145,0.0001321858,0.00007088391],"category_scores_gemma":[0.00042604015,0.00010894404,0.000026088956,0.00006305278,0.000085561966,0.00010589111,0.000076686054,0.00013792266,0.000029740795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023117907,0.00040162267,0.98239607,0.00008637277,0.00009126705,0.003835956,0.00015146907,0.0000049736277,0.002345477,0.0055064545,0.00010537962,0.004843786],"study_design_scores_gemma":[0.021611085,0.0012643383,0.9232501,0.00066782784,0.00038811626,0.00468136,0.000878904,0.005619733,0.03353662,0.0068203225,0.00045534116,0.00082629506],"about_ca_topic_score_codex":0.00020874054,"about_ca_topic_score_gemma":0.0003878191,"teacher_disagreement_score":0.059146006,"about_ca_system_score_codex":0.000058927686,"about_ca_system_score_gemma":0.00003404585,"threshold_uncertainty_score":0.4442609},"labels":[],"label_agreement":null},{"id":"W2580493818","doi":"10.3324/haematol.2016.154377","title":"Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pharmacyclics; Servier","keywords":"Medicine; Follicular lymphoma; Adverse effect; Internal medicine; Neutropenia; Lymphoma; Histone deacetylase inhibitor; Gastroenterology; Chronic lymphocytic leukemia; Oncology; Pharmacology; Histone deacetylase; Immunology; Leukemia; Chemotherapy; Biology","score_opus":0.01595690113616621,"score_gpt":0.3266580733588823,"score_spread":0.3107011722227161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580493818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965594,0.0017756482,0.000019790648,0.00005240285,0.00006346823,0.000914087,0.00009370747,0.000011501033,0.00051004277],"genre_scores_gemma":[0.99884254,0.0006236501,0.00016354033,0.000011510779,0.000049298917,0.00004093824,0.00003871266,0.000026541935,0.0002032923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975151,0.00019169209,0.0008352414,0.00074072415,0.0002883212,0.0004289212],"domain_scores_gemma":[0.99802834,0.000108988585,0.0005113621,0.0010717422,0.00012650237,0.00015307432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073684205,0.00030200792,0.000762294,0.00016167597,0.00033288542,0.00002593728,0.00039292744,0.0002924651,0.0000049500673],"category_scores_gemma":[0.0011573905,0.0002723509,0.00008777915,0.0001201872,0.00092914345,0.000015437281,0.000801625,0.000143009,0.0000026534462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015279784,0.003002647,0.0017469347,0.00052482437,0.00021299449,0.0007567033,0.002401515,0.00005940403,0.9371756,0.00006074591,0.0012879091,0.037490953],"study_design_scores_gemma":[0.066840135,0.014323296,0.024228945,0.00034082736,0.00007604164,0.00031246358,0.0004928813,0.0007302588,0.8905186,0.000018968356,0.001553558,0.000564045],"about_ca_topic_score_codex":0.0011093012,"about_ca_topic_score_gemma":0.0009976287,"teacher_disagreement_score":0.05156035,"about_ca_system_score_codex":0.00042988866,"about_ca_system_score_gemma":0.000934879,"threshold_uncertainty_score":0.9999729},"labels":[],"label_agreement":null},{"id":"W2583258861","doi":"10.3324/haematol.2016.159905","title":"Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Institut National Du Cancer","keywords":"CD22; Refractory (planetary science); Regimen; Medicine; Salvage therapy; Oncology; Internal medicine; B cell; Immunology; Biology; Chemotherapy; Antibody","score_opus":0.016730707934114904,"score_gpt":0.2785180608918325,"score_spread":0.2617873529577176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583258861","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67078334,0.005634399,0.00025508183,0.12508307,0.0032725413,0.033862226,0.0029784471,0.0018980816,0.15623282],"genre_scores_gemma":[0.19253159,0.0011802113,0.0073311976,0.44908884,0.005701123,0.0072968095,0.016995056,0.0019516959,0.3179235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917679,0.00032938932,0.0010498045,0.0024451746,0.002128991,0.0022787561],"domain_scores_gemma":[0.9920118,0.0013726013,0.0013893392,0.0035541686,0.0011442485,0.00052783696],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00044644094,0.0015447263,0.0029655558,0.00048409333,0.00071486935,0.00029546383,0.0015371349,0.0032712119,0.00037839572],"category_scores_gemma":[0.0008961463,0.0011021295,0.0007494856,0.0002641459,0.0011033867,0.00047006336,0.0005450425,0.0031089361,0.0015819686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006609362,0.00031772806,0.00009764653,0.002080717,0.001493143,0.017928833,0.00038480447,0.000002154172,0.00005113967,0.000043737728,0.970386,0.00060473196],"study_design_scores_gemma":[0.09414532,0.0091316085,0.00036474923,0.0029388687,0.004006635,0.006868388,0.00006750629,0.00045718142,0.0021784033,0.0002964659,0.87724525,0.0022996538],"about_ca_topic_score_codex":0.0006043867,"about_ca_topic_score_gemma":0.000012075362,"teacher_disagreement_score":0.47825173,"about_ca_system_score_codex":0.060000382,"about_ca_system_score_gemma":0.03586366,"threshold_uncertainty_score":0.9997301},"labels":[],"label_agreement":null},{"id":"W2584734171","doi":"10.3324/haematol.2016.159087","title":"Genetic polymorphism at <i>BCL2</i> as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Public Health Ontario; University of Toronto; Simon Fraser University; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Terry Fox Research Institute; Genome Canada; Canadian Institutes of Health Research; Genome British Columbia","keywords":"Rituximab; Prednisone; Vincristine; Cyclophosphamide; Medicine; Lymphoma; Doxorubicin; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Cancer research; Chemotherapy","score_opus":0.008323216266862688,"score_gpt":0.22480587435944302,"score_spread":0.21648265809258033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584734171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95755464,0.0046746023,0.000006772664,0.030900858,0.00025605984,0.0047498983,0.0008623326,0.00015217415,0.0008426556],"genre_scores_gemma":[0.91627693,0.0006289879,0.0014233555,0.0744524,0.0005174384,0.0015716384,0.0020628755,0.00020486144,0.0028615117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956708,0.000096218595,0.000828171,0.0014958364,0.00071092363,0.0011980582],"domain_scores_gemma":[0.99683714,0.00047117306,0.0007654875,0.0014194074,0.0001832606,0.00032352287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011612451,0.0010524116,0.0022760085,0.00023638947,0.00041032204,0.0001026544,0.00037998465,0.0011610894,0.000107483866],"category_scores_gemma":[0.00023171087,0.0007159999,0.00028521556,0.0001147246,0.00032158272,0.000079226964,0.000359822,0.00038203772,0.00012424977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039889966,0.025800098,0.49631858,0.001587819,0.00048331794,0.011720544,0.00018008762,1.382959e-7,0.000008276229,0.0000267516,0.4587699,0.0011154788],"study_design_scores_gemma":[0.17433509,0.0034302096,0.6022343,0.0011951048,0.0012538808,0.00075642066,0.000006282059,0.000016391281,0.00035746014,0.00007447055,0.21547179,0.0008685798],"about_ca_topic_score_codex":0.00022957851,"about_ca_topic_score_gemma":0.000036956244,"teacher_disagreement_score":0.24329811,"about_ca_system_score_codex":0.0004724599,"about_ca_system_score_gemma":0.00022050255,"threshold_uncertainty_score":0.9995291},"labels":[],"label_agreement":null},{"id":"W2586723043","doi":"10.3324/haematol.2016.157495","title":"Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; University of Toronto; Helsingin Yliopisto","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Mutation; Biology; Internal medicine; Genetics; Oncology; Medicine; Immunology; Gene","score_opus":0.02855342721875413,"score_gpt":0.2795198590606242,"score_spread":0.25096643184187006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586723043","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43124944,0.0025651571,0.00002122946,0.504655,0.001402278,0.002546243,0.0010157154,0.00041904475,0.056125928],"genre_scores_gemma":[0.8295366,0.00045761652,0.00038858844,0.15829696,0.00095807126,0.0007893636,0.0029622505,0.00010415535,0.0065063806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701124,0.00016641652,0.00061449443,0.0008245013,0.0005534467,0.0008299153],"domain_scores_gemma":[0.99778813,0.00039718306,0.00040943373,0.0011434471,0.00010030055,0.00016148781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001837858,0.0005923824,0.0014725387,0.00027200993,0.00025011465,0.000095698306,0.00039257162,0.0011949678,0.00027990804],"category_scores_gemma":[0.00024924974,0.00043008526,0.0004057663,0.00011611344,0.00016259194,0.000080041886,0.0001718562,0.0005318237,0.0007659688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082583334,0.008738088,0.046934918,0.00051635096,0.00021448369,0.06713458,0.00012496515,1.4675297e-7,0.000003049732,0.00015690968,0.87528664,0.00080726104],"study_design_scores_gemma":[0.036959637,0.0004852208,0.07341741,0.0007048537,0.00073846476,0.001822451,0.00006973095,0.00007267162,0.00025069126,0.0003312915,0.88447773,0.0006698628],"about_ca_topic_score_codex":0.00026955415,"about_ca_topic_score_gemma":0.00010663727,"teacher_disagreement_score":0.39828718,"about_ca_system_score_codex":0.0003158785,"about_ca_system_score_gemma":0.0003124622,"threshold_uncertainty_score":0.9998151},"labels":[],"label_agreement":null},{"id":"W2591816604","doi":"10.3324/haematol.2016.158808","title":"A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Wiskott–Aldrich syndrome; Umbilical Cord Blood Transplantation; Umbilical cord; Transplantation; Cumulative incidence; Internal medicine; Cord blood; Gastroenterology; Hematopoietic stem cell transplantation; Hematology; Surgery; Immunology; Biology","score_opus":0.01884460750505398,"score_gpt":0.28319939833069274,"score_spread":0.2643547908256388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591816604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917363,0.00005760943,0.005902538,0.00014534863,0.000037122354,0.0011200741,0.0007128002,0.00007471732,0.00021347913],"genre_scores_gemma":[0.99510604,0.00012985973,0.0042334963,0.00003932653,0.0000049404093,0.00013327041,0.0002391274,0.000023663793,0.00009024739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985204,0.000053566608,0.0004798534,0.0003825069,0.00030294125,0.00026076954],"domain_scores_gemma":[0.99838626,0.00024427488,0.0005060519,0.000616998,0.00013770959,0.00010871556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014819975,0.00024313848,0.0010440917,0.00026811403,0.00017013942,0.000028391067,0.00017218491,0.00019547743,0.0002176963],"category_scores_gemma":[0.00009284269,0.00016003675,0.00029657834,0.00023230864,0.00014428346,0.00010229915,0.0000093477465,0.00013476892,0.000010942579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011850385,0.00021129152,0.99230677,0.0002891779,0.0047479016,0.00028287873,0.0004608664,0.000011619406,0.0001576907,0.00008732509,0.0000031534926,0.0002562998],"study_design_scores_gemma":[0.003362908,0.00067611085,0.97391266,0.00015710955,0.017931111,0.000924988,0.000031605618,0.00013261565,0.002640124,0.000040435356,0.00000197721,0.00018834134],"about_ca_topic_score_codex":0.000113903756,"about_ca_topic_score_gemma":0.00012940726,"teacher_disagreement_score":0.018394083,"about_ca_system_score_codex":0.000012285146,"about_ca_system_score_gemma":0.000035964156,"threshold_uncertainty_score":0.65261096},"labels":[],"label_agreement":null},{"id":"W2592957633","doi":"10.3324/haematol.2016.159053","title":"Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Arsenic trioxide; Aldehyde dehydrogenase; Cancer research; Haematopoiesis; Myelodysplastic syndromes; Stem cell; Myeloid leukemia; Cyclophosphamide; Leukemia; Myeloid; Biology; Immunology; Chemistry; Medicine; Chemotherapy; Internal medicine; Apoptosis; Bone marrow; Biochemistry; Cell biology; Enzyme","score_opus":0.08955761268395121,"score_gpt":0.3647987528107573,"score_spread":0.2752411401268061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592957633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942789,0.00077522034,0.00038995477,0.0012135326,0.000083745945,0.0015875081,0.000196587,0.000073647585,0.0014009239],"genre_scores_gemma":[0.99003446,0.0011487006,0.0075607924,0.00024695424,0.000057377554,0.00018939121,0.00012793219,0.000048443093,0.0005859494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777216,0.00010030578,0.0005478909,0.0004913956,0.00052488456,0.00056338945],"domain_scores_gemma":[0.9969255,0.00028487266,0.0006930711,0.001537549,0.00032962114,0.00022943763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005287846,0.00030538754,0.0011446327,0.00016309074,0.0002705167,0.000025932595,0.0007604415,0.00036144673,0.0002863219],"category_scores_gemma":[0.0005429491,0.0002072295,0.00037954905,0.00011103389,0.0005728935,0.00016324512,0.00025336776,0.0002951886,0.000025502586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006864341,0.00049251365,0.027942035,0.0006215917,0.0005314316,0.00048361195,0.00062525104,0.0000029643168,0.9360998,0.0006413501,0.023435403,0.0022596698],"study_design_scores_gemma":[0.005999026,0.00090526004,0.012752088,0.00024833423,0.00011397568,0.00024375827,0.00013562247,0.00033102016,0.97513855,0.000649759,0.0032784669,0.00020414278],"about_ca_topic_score_codex":0.00008548786,"about_ca_topic_score_gemma":0.0000068330824,"teacher_disagreement_score":0.03903871,"about_ca_system_score_codex":0.00010399384,"about_ca_system_score_gemma":0.0003672041,"threshold_uncertainty_score":0.8450574},"labels":[],"label_agreement":null},{"id":"W2595098826","doi":"10.3324/haematol.2016.156356","title":"Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern era","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Genentech; Health Resources and Services Administration; Swedish Orphan Biovitrum; Otsuka Pharmaceutical; Astellas Pharma; Otsuka America; bluebird bio; Janssen Scientific Affairs; Telomere Diagnostics; Sunesis; Medac; Jazz Pharmaceuticals; Medical College of Wisconsin; Takeda Oncology; University of Minnesota; Spectrum Pharmaceuticals; Alexion Pharmaceuticals; U.S. Navy; Celgene; National Center for Advancing Translational Sciences; HistoGenetics; WellPoint; Onyx Pharmaceuticals; U.S. Department of Defense; Sanofi; Bristol-Myers Squibb; AstraZeneca; U.S. Department of Health and Human Services; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Patient-Centered Outcomes Research Institute; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Graft-versus-host disease; Acute leukemia; Disease; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Cohort; Myelodysplastic syndromes; Myeloid leukemia; Regimen; Gastroenterology; Surgery; Leukemia; Immunology; Bone marrow","score_opus":0.034571677387496114,"score_gpt":0.3014838367217284,"score_spread":0.2669121593342323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595098826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98409426,0.0002460347,0.0002919869,0.008889229,0.0003745961,0.0009201978,0.000056467652,0.00007094693,0.00505626],"genre_scores_gemma":[0.99766743,0.00031789587,0.00036890677,0.0007690964,0.00005972721,0.00063612225,0.000031170064,0.00002089145,0.00012878457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985318,0.0001092283,0.00030280225,0.00037400617,0.00032425995,0.00035789973],"domain_scores_gemma":[0.9983474,0.00031612188,0.00012547159,0.0009997799,0.00004774767,0.00016345766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028571143,0.00021769546,0.0004151205,0.000050853523,0.0002029595,0.00009847167,0.00037282132,0.000120292956,0.00016839565],"category_scores_gemma":[0.00019781456,0.00013443599,0.00014819631,0.0000668991,0.00017069084,0.00013283148,0.00005690121,0.0002544452,0.00009483889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011274565,0.0013892115,0.95320636,0.0010384399,0.00038381093,0.019216254,0.0049803024,0.0000023246453,0.0019493814,0.0026549364,0.0014624718,0.0024419518],"study_design_scores_gemma":[0.0062272376,0.00027749522,0.9867943,0.00035802447,0.00075677596,0.0002262645,0.00024115366,0.00072128285,0.0018522085,0.0012492975,0.00089719257,0.00039880158],"about_ca_topic_score_codex":0.00007201137,"about_ca_topic_score_gemma":0.00014593372,"teacher_disagreement_score":0.033587918,"about_ca_system_score_codex":0.000025643783,"about_ca_system_score_gemma":0.00005817417,"threshold_uncertainty_score":0.5482141},"labels":[],"label_agreement":null},{"id":"W2597657343","doi":"10.3324/haematol.2017.164459","title":"Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Globulin; Aplastic anemia; Medicine; Horse; Transplantation; Bone marrow; Immunosuppression; Immunology; Internal medicine; Gastroenterology; Biology","score_opus":0.018319121319967914,"score_gpt":0.3011277074789704,"score_spread":0.28280858615900245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597657343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928357,0.000049804552,0.0034738865,0.00025374885,0.0001273308,0.0010391638,0.0000764782,0.000045674708,0.002098194],"genre_scores_gemma":[0.99794906,0.000060816426,0.0016098083,0.00003849007,0.00001578892,0.000046962406,0.000060974304,0.000019835334,0.0001982798],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987016,0.000073010844,0.0004832838,0.00025516623,0.00028106713,0.0002058772],"domain_scores_gemma":[0.99793315,0.0010481382,0.00042273433,0.00044662066,0.00007742224,0.00007196135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003803637,0.00020104011,0.0009226479,0.000090212285,0.00011307659,0.000010325857,0.00013519343,0.00017820415,0.00007802732],"category_scores_gemma":[0.00041241327,0.00014090595,0.00020395352,0.000043276683,0.0001421248,0.00005281173,0.000009165169,0.00009339511,0.000020698906],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028322164,0.000785461,0.7979484,0.05787771,0.00053877005,0.0009286261,0.0016677035,0.0002305661,0.09429672,0.0034244542,0.00057843723,0.013400967],"study_design_scores_gemma":[0.011163734,0.0046668286,0.28331742,0.0019536496,0.0011691013,0.0014024123,0.00005465643,0.00043564278,0.6953426,0.000118977216,0.00008036351,0.00029457826],"about_ca_topic_score_codex":0.00001931649,"about_ca_topic_score_gemma":0.0000049443847,"teacher_disagreement_score":0.6010459,"about_ca_system_score_codex":0.000015273252,"about_ca_system_score_gemma":0.000030329862,"threshold_uncertainty_score":0.5745978},"labels":[],"label_agreement":null},{"id":"W2602665283","doi":"10.3324/haematol.2017.164012","title":"Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Cumulative incidence; Transplantation; Thrombosis; Venous thrombosis; Incidence (geometry); Hematopoietic stem cell transplantation; Surgery; Confidence interval; Proportional hazards model; Body mass index","score_opus":0.024099723906466638,"score_gpt":0.2667924689432085,"score_spread":0.24269274503674187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602665283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953177,0.00060567574,0.00004969634,0.00070966856,0.00016153463,0.0011815574,0.00010815535,0.00011897035,0.0017470234],"genre_scores_gemma":[0.9971923,0.0010214986,0.00010140925,0.0011358635,0.00004031419,0.00027490343,0.00008261119,0.000045954137,0.00010514007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979373,0.00008135627,0.00037259146,0.0006561532,0.00045489427,0.00049766747],"domain_scores_gemma":[0.99809325,0.00009057855,0.00034552978,0.00093448634,0.00010337314,0.00043276406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023959283,0.00039640366,0.001102266,0.00008008284,0.00051506044,0.00014176527,0.00023194986,0.00017849574,0.00017554713],"category_scores_gemma":[0.000034308883,0.00029755456,0.00015044134,0.00008160561,0.00032935207,0.00018722631,0.00010286852,0.00019790807,0.000048859543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010149423,0.016416764,0.8934021,0.008213436,0.006012845,0.037318606,0.014153056,0.00001768701,0.003587968,0.0020395922,0.0071873525,0.0015011799],"study_design_scores_gemma":[0.0042793476,0.0006575687,0.989387,0.0004922393,0.002946242,0.000059903774,0.00020794281,0.000049297025,0.001287622,0.00012439652,0.00011086966,0.00039757873],"about_ca_topic_score_codex":0.00028427792,"about_ca_topic_score_gemma":0.0001897289,"teacher_disagreement_score":0.095984906,"about_ca_system_score_codex":0.00005534589,"about_ca_system_score_gemma":0.00008845253,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W2604831554","doi":"10.3324/haematol.2016.160754","title":"Bleeding risk of surgery and its prevention in patients with inherited platelet disorders","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pontificia Universidad Católica de Chile; Universitair Ziekenhuis Gent; Universidad de Murcia; Universiteit Gent; Queen's University; Ain Shams University; Inselspital, Universitätsspital Bern; Instituto de Salud Carlos III; European Hematology Association; Fondazione Umberto Veronesi; University of Pennsylvania","keywords":"Medicine; Platelet disorder; Platelet; Bleeding diathesis; Bernard–Soulier syndrome; Incidence (geometry); Surgery; Blood Platelet Disorders; Desmopressin; Internal medicine; Pediatrics; Platelet aggregation","score_opus":0.026208891038710422,"score_gpt":0.2644127558795973,"score_spread":0.23820386484088685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604831554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867064,0.00020108552,0.0000037345017,0.000097476,0.000025178626,0.00035044953,0.0000083699415,0.000015535334,0.00062753103],"genre_scores_gemma":[0.9993866,0.0004101103,0.000114248614,0.0000093644785,0.0000022866627,0.000014404454,0.000024730616,0.000008150173,0.000030092271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993492,0.000024773271,0.00018579655,0.00017431533,0.000115193194,0.00015074351],"domain_scores_gemma":[0.9994524,0.00005520089,0.0002505947,0.00016397831,0.000033536697,0.000044287994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096111195,0.00010640303,0.00042610845,0.00008268721,0.00010191059,0.000012056405,0.000042181866,0.00007591493,0.000022965258],"category_scores_gemma":[0.0001844374,0.000071693314,0.000037663092,0.000054139844,0.00005978383,0.00011166356,0.000032505865,0.0000804056,0.0000031222282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004154298,0.00039248177,0.9927392,0.00007972433,0.00007746539,0.00008480867,0.00005236898,6.466444e-7,0.0000064939154,0.000031246105,0.000023269151,0.006096841],"study_design_scores_gemma":[0.002864054,0.0002580515,0.9958903,0.0002386571,0.000053226122,0.00001709929,0.000030222687,0.00005411388,0.00015745709,0.00033436425,0.000027056733,0.00007540117],"about_ca_topic_score_codex":0.00006513538,"about_ca_topic_score_gemma":0.00007509075,"teacher_disagreement_score":0.0060214396,"about_ca_system_score_codex":0.000008856061,"about_ca_system_score_gemma":0.0000149062,"threshold_uncertainty_score":0.29235685},"labels":[],"label_agreement":null},{"id":"W2606755458","doi":"10.3324/haematol.2017.165415","title":"Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Genentech; Celgene; Teva Pharmaceutical Industries; GlaxoSmithKline; Pfizer","keywords":"Follicular lymphoma; Lymphoma; Tissue microarray; Medicine; Rituximab; BCL6; Oncology; Internal medicine; Biomarker; CD163; Diffuse large B-cell lymphoma; Pathology; Cancer research; Immunology; Immunohistochemistry; Biology; Germinal center; B cell","score_opus":0.02448926550737075,"score_gpt":0.2778355668725093,"score_spread":0.2533463013651386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606755458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335223,0.0035253062,0.000002633741,0.0007317286,0.000025933196,0.0017904156,0.000019447802,0.000020115327,0.000532187],"genre_scores_gemma":[0.99907804,0.00034762322,0.00014067556,0.00006655191,0.000004464593,0.00028031095,0.0000074741342,0.000015927864,0.00005891509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850196,0.00011020094,0.00044456046,0.00040886065,0.00027439577,0.00026004098],"domain_scores_gemma":[0.99826723,0.0004300725,0.0004197976,0.00069780514,0.000089107736,0.000095955445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002734663,0.00025422487,0.0008923719,0.000064650245,0.00016516424,0.000032436954,0.00016264718,0.00009533029,0.000017313841],"category_scores_gemma":[0.00040713805,0.00013510171,0.00005546941,0.00011901489,0.0007360255,0.00006950205,0.0001401292,0.00003457051,0.0000015381878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097592693,0.0035192454,0.98694986,0.00020122371,0.00032054223,0.0011178654,0.0004123939,2.0090107e-7,0.0006396467,0.00025991624,0.0003434293,0.0052597565],"study_design_scores_gemma":[0.01632892,0.0028015315,0.9737068,0.00044726502,0.00035580588,0.000754396,0.0005406407,0.0001151252,0.004544437,0.00012598066,0.00012353569,0.00015556545],"about_ca_topic_score_codex":0.00038949764,"about_ca_topic_score_gemma":0.0000917145,"teacher_disagreement_score":0.015352992,"about_ca_system_score_codex":0.000041527834,"about_ca_system_score_gemma":0.00008100183,"threshold_uncertainty_score":0.5509288},"labels":[],"label_agreement":null},{"id":"W2613829040","doi":"10.3324/haematol.2016.155671","title":"Extracellular glycine is necessary for optimal hemoglobinization of erythroid cells","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McGill University; Spartan Bioscience (Canada); Jewish General Hospital; University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Glycine; Heme; Biochemistry; Chemistry; Hemoglobin; Extracellular; Amino acid; Biology; Enzyme","score_opus":0.023632248585831368,"score_gpt":0.28655490434815895,"score_spread":0.2629226557623276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613829040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785582,0.0032832872,0.005491113,0.005759857,0.00033465747,0.0009617662,0.00003713524,0.00008207818,0.005491909],"genre_scores_gemma":[0.98934555,0.0005229324,0.007689004,0.00023079896,0.000046501067,0.000022803915,0.000035697063,0.000022496662,0.0020842094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888265,0.000015779353,0.00037585243,0.00028732652,0.00016876882,0.00026961594],"domain_scores_gemma":[0.9987308,0.000047083453,0.00033623053,0.00061428186,0.00016743058,0.00010417072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015484571,0.00016823635,0.0005243982,0.00005493151,0.00029023763,0.00002472812,0.00020335044,0.00027366422,0.00028066366],"category_scores_gemma":[0.00018529691,0.00012481402,0.00017619917,0.0000640236,0.0002309465,0.00009143682,0.0000708556,0.00012740867,0.00003835868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008372026,0.006155131,0.09020946,0.010584995,0.0017444916,0.0021275952,0.0051024733,0.0007945402,0.49256325,0.038875587,0.29245025,0.051020205],"study_design_scores_gemma":[0.01751113,0.0039356872,0.013605147,0.0012425153,0.0011603619,0.0012415968,0.0027040583,0.016184207,0.8177516,0.0028025364,0.120666325,0.0011948355],"about_ca_topic_score_codex":0.000020329888,"about_ca_topic_score_gemma":8.075607e-7,"teacher_disagreement_score":0.32518837,"about_ca_system_score_codex":0.000013812774,"about_ca_system_score_gemma":0.00005758082,"threshold_uncertainty_score":0.50897676},"labels":[],"label_agreement":null},{"id":"W2624005914","doi":"10.3324/haematol.2016.163436","title":"Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Austrian Science Fund","keywords":"Cancer research; Myeloid leukemia; Tyrosine kinase; K562 cells; Haematopoiesis; Chemistry; Biology; Stem cell; Leukemia; Pharmacology; Signal transduction; Cell biology; Immunology","score_opus":0.027134315873230307,"score_gpt":0.2831470672737546,"score_spread":0.2560127514005243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624005914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860904,0.0011221771,0.00022407352,0.00061437185,0.00005492098,0.0009747165,0.00002882416,0.000055363907,0.010835154],"genre_scores_gemma":[0.9774661,0.00015410694,0.020738406,0.00011266178,0.000026919653,0.000094454124,0.00003105679,0.000028802102,0.0013474835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980185,0.00004610713,0.0005427785,0.00057270925,0.00031814544,0.00050177815],"domain_scores_gemma":[0.9983841,0.00013452093,0.00034587644,0.0008625742,0.00007252545,0.00020040186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038304116,0.00027877907,0.00090866286,0.00013384531,0.00018501004,0.000037606915,0.00030062394,0.00012751241,0.00003722185],"category_scores_gemma":[0.0005299693,0.00022782302,0.000072502815,0.00013545556,0.00024420503,0.00012943405,0.00027771154,0.00027454627,0.000015674648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014385597,0.005667004,0.6744941,0.018551806,0.0015023234,0.0036518143,0.027268803,0.000499922,0.13478796,0.07722605,0.035291757,0.006672909],"study_design_scores_gemma":[0.033695817,0.00090844935,0.9336041,0.0022631001,0.00021849854,0.00023613572,0.0009996637,0.0025786224,0.015871914,0.001721111,0.0068521732,0.001050407],"about_ca_topic_score_codex":0.0006197622,"about_ca_topic_score_gemma":0.0003047807,"teacher_disagreement_score":0.25911003,"about_ca_system_score_codex":0.001562103,"about_ca_system_score_gemma":0.00060953014,"threshold_uncertainty_score":0.92903537},"labels":[],"label_agreement":null},{"id":"W2692859861","doi":"10.3324/haematol.2017.168815","title":"Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute","keywords":"Medicine; Adverse effect; Myeloid leukemia; Clinical trial; Oncology; Internal medicine; Event (particle physics); Pediatric oncology; Center (category theory); Pediatrics; Cancer","score_opus":0.5675975619002257,"score_gpt":0.5693340134520334,"score_spread":0.0017364515518076828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2692859861","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69677544,0.00018948225,0.10817607,0.14308268,0.017523605,0.028841002,0.004305592,0.0002933078,0.0008128383],"genre_scores_gemma":[0.03568246,0.00054540875,0.9128032,0.030455297,0.016075274,0.0032465926,0.00077163236,0.00021872274,0.00020145018],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9757267,0.0050472445,0.015877685,0.0016984997,0.0008113231,0.00083849725],"domain_scores_gemma":[0.77740777,0.19251643,0.027610263,0.0021472762,0.00022724945,0.0000910374],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.027759617,0.0006372075,0.0049075987,0.00021130314,0.0001470917,0.000036756104,0.0014945624,0.0036993586,0.000098968085],"category_scores_gemma":[0.69393206,0.00043639357,0.0013581006,0.00022554015,0.00033798767,0.0001073893,0.00063025934,0.0040920586,0.000010208126],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046256952,0.005718794,0.10068389,0.001736607,0.0023347922,0.043439943,0.0008867104,0.000003971173,0.000009896277,0.0057888576,0.77313524,0.020004315],"study_design_scores_gemma":[0.073875844,0.0017544153,0.12998994,0.0007473717,0.0023080658,0.001089236,0.00003393387,0.00011949434,0.000008727001,0.7783873,0.0106585575,0.0010271318],"about_ca_topic_score_codex":0.00039807937,"about_ca_topic_score_gemma":0.00016386286,"teacher_disagreement_score":0.8046271,"about_ca_system_score_codex":0.00046858037,"about_ca_system_score_gemma":0.0010208472,"threshold_uncertainty_score":0.9998088},"labels":[],"label_agreement":null},{"id":"W2728246735","doi":"10.3324/haematol.2017.166827","title":"Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Molecular biology; Medicine; Cancer research; Biology; Pathology","score_opus":0.13163995836435766,"score_gpt":0.3298766199857031,"score_spread":0.19823666162134546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728246735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8475608,0.028652942,0.0009733799,0.110823624,0.0019240357,0.004286142,0.0020212075,0.00025961333,0.00349825],"genre_scores_gemma":[0.9080786,0.0072447546,0.0122999195,0.06167728,0.0029395223,0.00065038603,0.0053130803,0.00022090756,0.0015755543],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955392,0.0008948898,0.0012904889,0.0009115565,0.00075836247,0.0006055396],"domain_scores_gemma":[0.9927388,0.0020249095,0.0024878047,0.0023859409,0.00024836397,0.000114182425],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011833301,0.0006476698,0.0025159763,0.0001427093,0.0004962085,0.00011954023,0.00060034526,0.0014696075,0.00034805606],"category_scores_gemma":[0.0010561113,0.00034904058,0.0006918051,0.00011196465,0.00022295088,0.000093675124,0.00021218836,0.00032408326,0.0001032315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040594803,0.003793378,0.017031975,0.00039598765,0.0004938294,0.0018149929,0.00017955653,7.3535085e-7,0.017763063,0.00009745676,0.9567518,0.0012712637],"study_design_scores_gemma":[0.020076526,0.00026596003,0.017995892,0.0022148541,0.0025937846,0.00043520535,0.00010612458,0.00013357037,0.13290152,0.0005929963,0.8219402,0.000743391],"about_ca_topic_score_codex":0.00053499243,"about_ca_topic_score_gemma":0.0000056152016,"teacher_disagreement_score":0.13481164,"about_ca_system_score_codex":0.0003179945,"about_ca_system_score_gemma":0.00036817734,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W2732727228","doi":"10.3324/haematol.2016.162230","title":"High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Myeloid leukemia; Temsirolimus; Leukemia; Cancer research; Tumor microenvironment; PI3K/AKT/mTOR pathway; Biology; Bone marrow; Signal transduction; Immunology; Cell biology","score_opus":0.025313561182599316,"score_gpt":0.29439122386803,"score_spread":0.2690776626854307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732727228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900718,0.00028410842,0.005890938,0.0019919472,0.00014207384,0.0013043825,0.000014513742,0.000058165773,0.00024210176],"genre_scores_gemma":[0.9749948,0.0003251959,0.023627559,0.00040619395,0.00003534722,0.00014757275,0.000060898445,0.00003972317,0.00036272916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976914,0.00013859171,0.00058395683,0.0005684087,0.0004764979,0.0005411589],"domain_scores_gemma":[0.9983477,0.0001529372,0.00039287214,0.0008693563,0.00010549432,0.00013163545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007137422,0.00027604055,0.0007405552,0.00021361858,0.0003295859,0.00007588962,0.0005418312,0.00023802657,0.0000773355],"category_scores_gemma":[0.00019953829,0.00023649407,0.00012149064,0.0001786876,0.0002751891,0.00017848838,0.00021719422,0.00042655217,0.000031293355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005120105,0.00047977784,0.012734353,0.0003671141,0.00023392565,0.0017600984,0.00057783304,0.00085515046,0.9642856,0.010863406,0.00071773573,0.0020048972],"study_design_scores_gemma":[0.0044854837,0.00046945427,0.027909592,0.00046245978,0.00004954336,0.000037943606,0.0001949005,0.0030896042,0.9607393,0.002218105,0.00007063608,0.0002729678],"about_ca_topic_score_codex":0.00013236345,"about_ca_topic_score_gemma":0.000048872887,"teacher_disagreement_score":0.017736621,"about_ca_system_score_codex":0.0005985243,"about_ca_system_score_gemma":0.00016164493,"threshold_uncertainty_score":0.96439487},"labels":[],"label_agreement":null},{"id":"W2737663958","doi":"10.3324/haematol.2017.170340","title":"Mutational status of <i>IGHV</i> is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi del Piemonte Orientale; Institute for Oil Sands Innovation, University of Alberta; Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute","keywords":"IGHV@; Trisomy; Chronic lymphocytic leukemia; Leukemia; Aneuploidy; Medicine; Oncology; Internal medicine; Biology; Chromosome; Genetics; Gene","score_opus":0.0332763963390192,"score_gpt":0.30400975155762583,"score_spread":0.27073335521860664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737663958","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26048076,0.049042407,0.00012533594,0.42869207,0.003010174,0.024650574,0.0012668879,0.0008161287,0.23191565],"genre_scores_gemma":[0.56148815,0.0058972193,0.0012266845,0.3648925,0.0036180862,0.0028140962,0.0027353608,0.00054819626,0.056779698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99367166,0.00028145692,0.0012818455,0.0010902501,0.001783058,0.0018917623],"domain_scores_gemma":[0.99431664,0.001971299,0.0008868072,0.0022353986,0.0003711959,0.00021864171],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00071447424,0.0007109012,0.0018204749,0.00039449707,0.00026946448,0.00010325317,0.0011404454,0.0015426408,0.0014920167],"category_scores_gemma":[0.0018127167,0.00046036745,0.00039300747,0.00044001627,0.0012390224,0.00013051723,0.00046000947,0.0024659224,0.00046017344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00043915721,0.00005039851,0.0014091774,0.0033396464,0.00028898788,0.013728064,0.0002034054,0.00008510383,0.000019852534,0.000065381806,0.979552,0.0008188515],"study_design_scores_gemma":[0.018971108,0.0006089476,0.002002532,0.0025756883,0.00047192973,0.0063501694,0.00006653724,0.0150886765,0.00046472315,0.00072769594,0.9519973,0.0006746921],"about_ca_topic_score_codex":0.004861803,"about_ca_topic_score_gemma":0.00013762635,"teacher_disagreement_score":0.3010074,"about_ca_system_score_codex":0.07071165,"about_ca_system_score_gemma":0.09377173,"threshold_uncertainty_score":0.99983543},"labels":[],"label_agreement":null},{"id":"W2739393823","doi":"10.3324/haematol.2017.171041","title":"Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute; Pharmacyclics","keywords":"Ibrutinib; Medicine; Internal medicine; Discontinuation; Mantle cell lymphoma; Atrial fibrillation; Cumulative incidence; Adverse effect; Chronic lymphocytic leukemia; Hazard ratio; Oncology; Confidence interval; Leukemia; Lymphoma; Cohort","score_opus":0.08473874912293827,"score_gpt":0.384229192574077,"score_spread":0.29949044345113873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739393823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912586,0.00007046918,0.00027326803,0.0007693705,0.00025511696,0.004833202,0.0000060761254,0.00003632193,0.002497541],"genre_scores_gemma":[0.9983,0.00030088148,0.0002420448,0.000016987062,0.00019888715,0.00006377079,0.00014857092,0.000011142225,0.0007177105],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959578,0.0009116168,0.0020992726,0.0003002155,0.0005139425,0.00021716492],"domain_scores_gemma":[0.99489045,0.001222743,0.0028736219,0.00071422197,0.0002267787,0.00007219461],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0069155563,0.00015814452,0.003025692,0.00017012644,0.000104550396,0.00001678625,0.0001281772,0.00023710326,0.00019702397],"category_scores_gemma":[0.047761947,0.00010514201,0.0006761196,0.00009300716,0.00019091547,0.00016679104,0.00005136739,0.00010918035,0.000015519192],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95735276,0.000091521055,0.008079634,0.00029536724,0.00066434115,0.00043720994,0.00025116475,0.000046346515,0.029322628,0.0018261786,0.000049116483,0.001583732],"study_design_scores_gemma":[0.96513903,0.00013372401,0.011081661,0.00032232635,0.00041024794,0.00025044035,0.000021131435,0.015716141,0.006076631,0.00057117024,0.00015680474,0.000120675286],"about_ca_topic_score_codex":0.0002531418,"about_ca_topic_score_gemma":0.000021371345,"teacher_disagreement_score":0.040846393,"about_ca_system_score_codex":0.00066491455,"about_ca_system_score_gemma":0.0015641693,"threshold_uncertainty_score":0.96025914},"labels":[],"label_agreement":null},{"id":"W2740395975","doi":"10.3324/haematol.2017.170118","title":"Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone <i>vs</i> . placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Takeda Oncology","keywords":"Ixazomib; Lenalidomide; Medicine; Multiple myeloma; Placebo; Internal medicine; Thalidomide; Dexamethasone; Population; Oncology; Carfilzomib; Pathology","score_opus":0.03835956097297118,"score_gpt":0.3196807159182124,"score_spread":0.28132115494524124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740395975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956052,0.00029935435,0.000009933191,0.00050994835,0.000038945695,0.0030548049,0.00008754183,0.00002924556,0.00036505456],"genre_scores_gemma":[0.9980601,0.00045076048,0.0011444417,0.00008137833,0.000018325722,0.00011135896,0.00003779413,0.000050676128,0.000045147048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996386,0.00061481475,0.0009128694,0.0006368098,0.0007499446,0.00069957186],"domain_scores_gemma":[0.9947994,0.002554984,0.00080708787,0.0013342381,0.00023590875,0.0002684259],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001229312,0.00050568563,0.0015845955,0.00032747333,0.00020816948,0.000040969066,0.00046650213,0.000267844,0.0001847386],"category_scores_gemma":[0.0036359197,0.00026323425,0.00021999166,0.0002701,0.0007473209,0.0001991906,0.00018529716,0.0006471641,0.0000118187645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11347523,0.0029427437,0.86892414,0.0000885855,0.00038153032,0.00021796579,0.00041874973,0.000027919687,0.0009885065,0.00004556297,0.00008282147,0.012406216],"study_design_scores_gemma":[0.07330441,0.0053539267,0.91551095,0.0006844443,0.0000462969,0.00002661172,0.00006244531,0.00015186719,0.0045388727,0.000032306467,0.000054897904,0.00023297666],"about_ca_topic_score_codex":0.0014990276,"about_ca_topic_score_gemma":0.0002673493,"teacher_disagreement_score":0.04658678,"about_ca_system_score_codex":0.00017460696,"about_ca_system_score_gemma":0.0002199666,"threshold_uncertainty_score":0.999982},"labels":[],"label_agreement":null},{"id":"W2745596189","doi":"10.3324/haematol.2017.169581","title":"Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Transplantation; Disease; Hematopoietic stem cell transplantation; Medicine; Intensive care medicine; Health care; Haematopoiesis; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.20365176892538828,"score_gpt":0.42149493632411034,"score_spread":0.21784316739872206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745596189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952781,0.0014514378,0.0010514602,0.0010972165,0.00007533092,0.0007287806,0.000052912288,0.0000090482345,0.0002556765],"genre_scores_gemma":[0.9962189,0.0025370603,0.000940134,0.00017850935,0.000014166541,0.000017205411,0.000068841175,0.000007436874,0.00001772751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906504,0.00011325504,0.00036257762,0.00019804854,0.00011434991,0.00014672674],"domain_scores_gemma":[0.99915856,0.00017555385,0.00021920938,0.0003205582,0.000046784186,0.000079321275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036079984,0.00009376075,0.00029539727,0.00003414511,0.00021444248,0.000011867607,0.00009158055,0.000087539614,0.000013606753],"category_scores_gemma":[0.00017655312,0.000058102793,0.00007031086,0.00004482547,0.00016562192,0.00005996365,0.000017550963,0.00012125505,0.0000014287787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008769305,0.0006024439,0.99000627,0.004514238,0.000012590761,0.00015568349,0.0010859197,0.000028216005,0.00029363582,0.0012860461,0.00016758274,0.0009704222],"study_design_scores_gemma":[0.0064842575,0.00043650783,0.977722,0.0010459613,0.0007177017,0.000094473726,0.0023805345,0.005173793,0.0035733054,0.0010796678,0.0009883362,0.0003034445],"about_ca_topic_score_codex":0.00025045653,"about_ca_topic_score_gemma":0.00016024827,"teacher_disagreement_score":0.012284274,"about_ca_system_score_codex":0.000004955076,"about_ca_system_score_gemma":0.00006078539,"threshold_uncertainty_score":0.23693632},"labels":[],"label_agreement":null},{"id":"W2759397991","doi":"10.3324/haematol.2017.170928","title":"CD56 <sup>bright</sup> natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- <i>versus</i> -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Vancouver General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; McMaster University; Hospital for Sick Children; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Toronto; Dalhousie University; Hamilton Health Sciences; BC Children's Hospital; CancerCare Manitoba; Health Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Filgrastim; Immunology; Bone marrow; Medicine; Apheresis; Graft-versus-host disease; Myeloid; Immune system; Natural killer cell; Granulocyte colony-stimulating factor; Transplantation; Cytotoxic T cell; Internal medicine; Biology; Chemotherapy; Platelet","score_opus":0.017809653360701127,"score_gpt":0.24700774741147366,"score_spread":0.22919809405077254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759397991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836069,0.0018439001,0.00000388996,0.0050298837,0.0005909963,0.0077140075,0.00014322846,0.00013886685,0.000928361],"genre_scores_gemma":[0.9964192,0.00045830745,0.00039103077,0.00017295753,0.0001608344,0.00049137743,0.00021002008,0.000071870854,0.001624393],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949045,0.0007843979,0.0012089686,0.0013120057,0.0007408489,0.0010492449],"domain_scores_gemma":[0.99592066,0.00088346994,0.0004943723,0.0018614087,0.00016022852,0.00067984],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019219104,0.0007079734,0.0016791138,0.0002778664,0.0010260049,0.00022704856,0.0006562958,0.00032176301,0.00013138284],"category_scores_gemma":[0.0006816298,0.00041668967,0.00022974923,0.0002764425,0.00095738756,0.00022830053,0.00007522513,0.0007027916,0.00003108864],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8020929,0.0061968407,0.0571336,0.008756151,0.0065144696,0.06766206,0.02236261,0.00016953419,0.016449068,0.003938026,0.007581813,0.0011429058],"study_design_scores_gemma":[0.71307087,0.0017983019,0.24752346,0.0034249525,0.009272994,0.0033103523,0.0010206954,0.0019207773,0.014523291,0.0002238585,0.0018526077,0.00205782],"about_ca_topic_score_codex":0.0088428585,"about_ca_topic_score_gemma":0.08070744,"teacher_disagreement_score":0.19038986,"about_ca_system_score_codex":0.00015005037,"about_ca_system_score_gemma":0.0008068893,"threshold_uncertainty_score":0.9998285},"labels":[],"label_agreement":null},{"id":"W2766129023","doi":"10.3324/haematol.2017.176719","title":"Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple <i>TP53</i> alterations","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"Centre Hospitalier Universitaire de Nantes; Science for Life Laboratory; Radiumhemmets Forskningsfonder; Cancerfonden","keywords":"Myeloid leukemia; Myelodysplastic syndromes; Clinical significance; Somatic cell; Myeloid; Cancer research; Mutation; Leukemia; Karyotype; Medicine; Biology; Immunology; Internal medicine; Genetics; Gene; Bone marrow; Chromosome","score_opus":0.03837447523164675,"score_gpt":0.2796043368568231,"score_spread":0.24122986162517637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766129023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7626293,0.0010943655,0.0015509188,0.21673445,0.00037125373,0.0036548614,0.00066241506,0.0005059024,0.012796528],"genre_scores_gemma":[0.8828035,0.00054540206,0.01456887,0.09027861,0.0010614789,0.00043032484,0.0017173463,0.00034763676,0.008246852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962027,0.00017684138,0.0007275268,0.00106439,0.0008832244,0.0009453011],"domain_scores_gemma":[0.9963936,0.00074781844,0.0007088789,0.0014887273,0.00041273233,0.0002482423],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00023796466,0.00074309926,0.001992342,0.0004354166,0.00043792918,0.00015766856,0.0005873619,0.001159009,0.00011534678],"category_scores_gemma":[0.00061854935,0.00053393334,0.00021258194,0.00022829542,0.0011367636,0.00020315843,0.0003634211,0.002392803,0.000067171284],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008845699,0.00014651201,0.002923862,0.0050787865,0.0031884308,0.096844524,0.00069784746,0.000013327462,0.07619485,0.00012721663,0.8131759,0.0007241801],"study_design_scores_gemma":[0.02288008,0.01439732,0.0048881457,0.016416825,0.012221556,0.27890846,0.00060731324,0.005862186,0.21386157,0.00069156283,0.42297417,0.0062908363],"about_ca_topic_score_codex":0.00015267354,"about_ca_topic_score_gemma":0.000029782039,"teacher_disagreement_score":0.39020175,"about_ca_system_score_codex":0.0007810191,"about_ca_system_score_gemma":0.0015134668,"threshold_uncertainty_score":0.99990875},"labels":[],"label_agreement":null},{"id":"W2766663088","doi":"10.3324/haematol.2017.179309","title":"A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Toronto; Alberta Health Services; Queen's University; University of Calgary; University of Saskatchewan","funders":"Canadian Cancer Society Research Institute; Alberta Cancer Foundation","keywords":"BCL6; Tissue microarray; Immunohistochemistry; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Fluorescence in situ hybridization; Lymphoma; Gene expression profiling; Cancer research; Biology; Pathology; Gene expression; Medicine; Gene; Antibody; Immunology; B cell; Germinal center","score_opus":0.08115966950695878,"score_gpt":0.34242491001075404,"score_spread":0.26126524050379524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766663088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564856,0.00091102516,0.00003831498,0.00064178417,0.00013239995,0.00068297994,0.000026362957,0.000079428675,0.0018391666],"genre_scores_gemma":[0.99719316,0.00024548115,0.0018074174,0.00040642772,0.000039087925,0.000085432635,0.000011609071,0.000025827241,0.00018557742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812764,0.000059760183,0.000548558,0.0005401096,0.00024969463,0.00047425876],"domain_scores_gemma":[0.9984129,0.00024956162,0.00028059582,0.00074732443,0.000044857057,0.0002647583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002634447,0.00028057076,0.00081059797,0.00009672659,0.00028384477,0.00007199271,0.00017513786,0.00030022892,0.000018287586],"category_scores_gemma":[0.0008648888,0.00019479563,0.00013278727,0.000049864862,0.00019947061,0.00010297869,0.00025523655,0.00013572995,0.000043116444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002036189,0.009638239,0.98600864,0.00015868466,0.00004093802,0.0022654072,0.00014431201,0.000003862913,0.00006972742,0.0005093276,0.00012518643,0.00083203707],"study_design_scores_gemma":[0.038963225,0.0005924182,0.93123585,0.00039852117,0.00031703003,0.00042953226,0.00008093042,0.026498666,0.00027926711,0.00053136295,0.00036134588,0.00031183148],"about_ca_topic_score_codex":0.000059291047,"about_ca_topic_score_gemma":0.000027453523,"teacher_disagreement_score":0.05477279,"about_ca_system_score_codex":0.000121808946,"about_ca_system_score_gemma":0.00012567872,"threshold_uncertainty_score":0.79435354},"labels":[],"label_agreement":null},{"id":"W2766970124","doi":"10.3324/haematol.2017.172353","title":"Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"Celgene","keywords":"Lenalidomide; Medicine; Azacitidine; Myelodysplastic syndromes; Internal medicine; Myeloid leukemia; Oncology; Adverse effect; Multiple myeloma; Bone marrow","score_opus":0.03213945077736108,"score_gpt":0.3138549973378398,"score_spread":0.2817155465604787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766970124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941774,0.0003759487,0.00004141312,0.0007861122,0.00007843668,0.0038163692,0.000063090105,0.000083002975,0.0005782366],"genre_scores_gemma":[0.9954938,0.0010166215,0.0016532326,0.00020105184,0.00009370229,0.00035033087,0.000029668461,0.00007040303,0.0010911615],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99608546,0.00054129714,0.00095145823,0.00094062474,0.0007142671,0.00076685805],"domain_scores_gemma":[0.9966709,0.0010665766,0.0006534101,0.001033381,0.00019209473,0.00038362792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014215839,0.0005546743,0.0031027626,0.00045241992,0.00030414728,0.00017160451,0.00042086726,0.00031643774,0.00029397375],"category_scores_gemma":[0.0014517454,0.00035976173,0.00015408032,0.00026870536,0.0016154095,0.0003439369,0.00049858895,0.0007241829,0.000009060265],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8083564,0.0016783909,0.10389778,0.00079650985,0.003394753,0.055476528,0.0060080118,0.000023762115,0.011474292,0.0013396102,0.0035279482,0.0040260307],"study_design_scores_gemma":[0.8578602,0.003521511,0.12466612,0.0007359929,0.0013947403,0.003677224,0.0032457486,0.0006974635,0.0030301455,0.0002024465,0.00023783078,0.0007305459],"about_ca_topic_score_codex":0.004583437,"about_ca_topic_score_gemma":0.0015074491,"teacher_disagreement_score":0.051799305,"about_ca_system_score_codex":0.0002274925,"about_ca_system_score_gemma":0.0004912551,"threshold_uncertainty_score":0.99988544},"labels":[],"label_agreement":null},{"id":"W2769684200","doi":"10.3324/haematol.2017.175380","title":"Survival adjusting for crossover: phase 3 study of ibrutinib <i>vs</i> . chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Chronic lymphocytic leukemia; Internal medicine; Medicine; Leukemia; Lymphoma; Oncology; Hematology; Chemotherapy; Immunology; Cyclophosphamide","score_opus":0.04148799816424028,"score_gpt":0.3180868482053957,"score_spread":0.2765988500411554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769684200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842675,0.0006879927,0.00003912746,0.0017624192,0.0005943272,0.01078834,0.00041838008,0.00030152834,0.0011404397],"genre_scores_gemma":[0.9814235,0.00009360893,0.00025745595,0.010776588,0.0010900941,0.0015546385,0.0020784473,0.00046275745,0.002262908],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9894912,0.00044459745,0.002376665,0.0026160988,0.0022825042,0.0027889218],"domain_scores_gemma":[0.99076766,0.0018567193,0.0021381562,0.0035574867,0.0012653865,0.000414611],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009652935,0.0017612297,0.0049538175,0.0008706938,0.00053798227,0.00025132808,0.00177084,0.002205448,0.00019157014],"category_scores_gemma":[0.0017218895,0.001353421,0.00057727104,0.0008025891,0.0010387291,0.00025143672,0.0007191461,0.001271279,0.000081406084],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.1501828,0.02098585,0.05277113,0.08590695,0.011583146,0.15433055,0.008068313,0.0029008575,0.00015520303,0.000098241035,0.48675287,0.026264079],"study_design_scores_gemma":[0.89518523,0.024613215,0.006128399,0.008195023,0.0033538204,0.0024942225,0.0006321558,0.023994833,0.0013238455,0.000050923376,0.030675579,0.0033527808],"about_ca_topic_score_codex":0.007522261,"about_ca_topic_score_gemma":0.0007381428,"teacher_disagreement_score":0.7450024,"about_ca_system_score_codex":0.1442935,"about_ca_system_score_gemma":0.07321973,"threshold_uncertainty_score":0.9995133},"labels":[],"label_agreement":null},{"id":"W2772537975","doi":"10.3324/haematol.2017.167973","title":"Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Assistance publique-Hôpitaux de Paris; Institut Gustave-Roussy; Institut National Du Cancer; Campbell Family Institute for Breast Cancer Research; Fondation pour la Recherche Médicale; Université Paris-Sud; Centre Hospitalier Universitaire Vaudois","keywords":"5-Hydroxymethylcytosine; Epigenetics; Biology; Peripheral T-cell lymphoma; Peripheral; Cancer research; Genetics; DNA methylation; T cell; Medicine; Immunology; Internal medicine; Immune system; Gene; Gene expression","score_opus":0.02077635458514958,"score_gpt":0.2801925643707508,"score_spread":0.2594162097856012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772537975","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19855693,0.009275132,0.000046405286,0.7080888,0.0008944551,0.00187106,0.00026488525,0.00015348254,0.08084881],"genre_scores_gemma":[0.74370587,0.0011327456,0.00023751121,0.24594997,0.00046299852,0.00013482795,0.0002689422,0.00008288947,0.008024236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973002,0.00011115675,0.0007359455,0.0006356798,0.00056930195,0.00064772216],"domain_scores_gemma":[0.9980117,0.000055564487,0.00079391804,0.0009375381,0.00011117472,0.00009009667],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020248815,0.0004860345,0.001746378,0.00021458823,0.00008815352,0.000027469676,0.00042154052,0.0014202215,0.0013310196],"category_scores_gemma":[0.00011759409,0.00038725915,0.0005101098,0.00014777358,0.00028119216,0.000052994004,0.00010904283,0.0011026267,0.00008506977],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001827924,0.00026358888,0.010484142,0.001239133,0.00015133034,0.0056724986,0.0004015993,0.000004929385,0.00018816676,0.000022520324,0.98088354,0.0005057506],"study_design_scores_gemma":[0.0090842685,0.00095948024,0.002519962,0.0014653667,0.0003948862,0.00043865683,0.0001374251,0.00008341564,0.0027784253,0.0016150018,0.97968996,0.0008331336],"about_ca_topic_score_codex":0.0009516842,"about_ca_topic_score_gemma":0.000037918013,"teacher_disagreement_score":0.54514897,"about_ca_system_score_codex":0.00040179412,"about_ca_system_score_gemma":0.0004088116,"threshold_uncertainty_score":0.99987614},"labels":[],"label_agreement":null},{"id":"W2775826629","doi":"10.3324/haematol.2017.177485","title":"Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Leukemia; Myeloid; Cancer research; Medicine; Internal medicine; Chemistry","score_opus":0.029660900517050837,"score_gpt":0.3095504216536833,"score_spread":0.27988952113663246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775826629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97790307,0.00036636068,0.000043106582,0.004539414,0.000119031836,0.00083529984,0.00011326427,0.000107414366,0.015973045],"genre_scores_gemma":[0.9864347,0.0005033829,0.007467215,0.0013484545,0.00006765174,0.00008867617,0.000028993863,0.00005519455,0.0040057576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691516,0.00013299166,0.00068994256,0.0007693757,0.0006165091,0.00087600714],"domain_scores_gemma":[0.99713635,0.00016816914,0.00042294554,0.0017466245,0.00022927171,0.0002966594],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058565714,0.0004036288,0.0014537205,0.00033658918,0.00027940192,0.000067539295,0.0009938051,0.00046863704,0.00092522474],"category_scores_gemma":[0.0008908643,0.00031252526,0.0003087241,0.00025054297,0.00075733144,0.00023081571,0.00069940696,0.0007604844,0.00045209765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031975203,0.00048121516,0.17639206,0.0007340948,0.00077847636,0.012623299,0.002166383,0.0000031323614,0.75679725,0.00058739854,0.04295781,0.003281342],"study_design_scores_gemma":[0.0053270003,0.0004874411,0.1603195,0.00037984404,0.00017802777,0.0013984542,0.00020431442,0.0006895322,0.81946397,0.0003570474,0.010715304,0.00047957522],"about_ca_topic_score_codex":0.00056267175,"about_ca_topic_score_gemma":0.000050865994,"teacher_disagreement_score":0.062666684,"about_ca_system_score_codex":0.00056452677,"about_ca_system_score_gemma":0.00065956195,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W2777262489","doi":"10.3324/haematol.2017.181404","title":"Emergence and evolution of <i>TP53</i> mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"Institut National Du Cancer","keywords":"Lenalidomide; Myelodysplastic syndromes; Disease; Library science; Medicine; Political science; Internal medicine; Multiple myeloma; Computer science; Bone marrow","score_opus":0.011336250537362402,"score_gpt":0.2666876846676132,"score_spread":0.2553514341302508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777262489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844264,0.00072548393,0.000088371,0.012137198,0.000040672152,0.0018684134,0.0003683758,0.000044288085,0.00030081967],"genre_scores_gemma":[0.996991,0.0001619734,0.00087097316,0.0008197955,0.000066809436,0.00019654691,0.00057814183,0.0000532581,0.0002615258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735093,0.00023352845,0.00046790065,0.00064029515,0.0008591122,0.0004482441],"domain_scores_gemma":[0.997101,0.00024082907,0.0011314705,0.00072889973,0.00062399736,0.0001737901],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014706867,0.00042845737,0.0011135228,0.0004132993,0.00015161723,0.000018425442,0.0002727857,0.0004765338,0.000054601074],"category_scores_gemma":[0.0008079729,0.00025139848,0.000085585445,0.00032804193,0.00082886184,0.00012156686,0.00011630221,0.0011970317,0.0000049370115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006620836,0.0003429821,0.9226521,0.0020531446,0.00018420986,0.0028729436,0.000092147115,0.000019796518,0.000026207434,0.000010041738,0.06474959,0.00037596654],"study_design_scores_gemma":[0.0059566055,0.0021353143,0.9819399,0.0070169284,0.0009443203,0.00014520243,0.00010092248,0.00015863245,0.00020908024,0.00007538978,0.0008937034,0.00042398713],"about_ca_topic_score_codex":0.00025722344,"about_ca_topic_score_gemma":0.000087100736,"teacher_disagreement_score":0.06385589,"about_ca_system_score_codex":0.00014089636,"about_ca_system_score_gemma":0.0004399514,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W2781841028","doi":"10.3324/haematol.2017.180059","title":"Desmopressin in moderate hemophilia A patients: a treatment worth considering","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institute for Clinical Evaluative Sciences; SickKids Foundation; St. Paul's Hospital; Hospital for Sick Children","funders":"Novo Nordisk","keywords":"Desmopressin; Medicine; Von Willebrand factor; Internal medicine; Risk factor; Gastroenterology; Endocrinology","score_opus":0.061702825560276085,"score_gpt":0.3276232791043853,"score_spread":0.26592045354410926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781841028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847382,0.00019313814,0.000013559384,0.0010469211,0.000055305634,0.00066217786,0.0000021735088,0.00008635599,0.013202171],"genre_scores_gemma":[0.9969804,0.00008245445,0.0011381268,0.0002127465,0.00005200537,0.00010948514,0.00002078296,0.000016599117,0.0013873422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865454,0.00006583642,0.00027191872,0.00036005685,0.00020461007,0.0004430128],"domain_scores_gemma":[0.99931324,0.00007135423,0.00004483785,0.0003069572,0.00010218429,0.00016140717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008673294,0.00019885463,0.00047123176,0.0001571876,0.00011481662,0.000023858413,0.00006280261,0.00012348397,0.00040934424],"category_scores_gemma":[0.000096050775,0.00012431796,0.00008124399,0.00022779875,0.00021937094,0.00006173782,0.000053023494,0.00011177176,0.0002944216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013571224,0.0020736584,0.9774933,0.00007935044,0.00012569307,0.0022734152,0.00092307857,0.0000023256075,0.00060601823,0.0006352103,0.0007874514,0.013643408],"study_design_scores_gemma":[0.039840434,0.015328008,0.6749397,0.0016024584,0.00032685118,0.0013743829,0.0006909243,0.00732823,0.22944534,0.006541223,0.021122469,0.0014599916],"about_ca_topic_score_codex":0.00006189779,"about_ca_topic_score_gemma":0.00010189628,"teacher_disagreement_score":0.30255356,"about_ca_system_score_codex":0.00014620286,"about_ca_system_score_gemma":0.00009611672,"threshold_uncertainty_score":0.5069539},"labels":[],"label_agreement":null},{"id":"W2792280225","doi":"10.3324/haematol.2017.178368","title":"Iron overload in transfusion-dependent survivors of hemoglobin Bart’s hydrops fetalis","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; McMaster Children's Hospital; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"Thalassemia Foundation of Canada; University of Toronto; McMaster University; Hospital for Sick Children; University of Ottawa","keywords":"Hydrops fetalis; Medicine; Hemoglobin; Fetal hemoglobin; Obstetrics; Pregnancy; Internal medicine; Fetus; Biology; Genetics","score_opus":0.013377859969676246,"score_gpt":0.24128775231931307,"score_spread":0.22790989234963682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792280225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.617395,0.0031778482,0.000032778273,0.33531636,0.0013985748,0.0021243994,0.00021515686,0.00022540016,0.0401145],"genre_scores_gemma":[0.6014204,0.008383599,0.0006599306,0.37509367,0.0013348738,0.00019703814,0.0017314492,0.0003209788,0.010858052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962514,0.00025029902,0.0010955638,0.0008356279,0.00079405605,0.0007730576],"domain_scores_gemma":[0.99839514,0.00015278539,0.00034520685,0.00084725965,0.00012422439,0.00013540125],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035889042,0.0006139576,0.001808581,0.00041261382,0.000079813195,0.000016485854,0.00036091334,0.002653462,0.0024364737],"category_scores_gemma":[0.0001459298,0.0004527528,0.00046940023,0.00044442993,0.0004546472,0.000055816912,0.00010840853,0.0020972965,0.00027221945],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004732633,0.00060943456,0.007174435,0.0032034412,0.00022278675,0.012504729,0.0009208034,0.0000092046275,0.0007699576,0.000071641734,0.9728086,0.0012316796],"study_design_scores_gemma":[0.0072645796,0.0022865348,0.0030069326,0.003917818,0.0008818333,0.0043485668,0.0009409072,0.00019253526,0.0039409497,0.0009018387,0.97045535,0.0018621294],"about_ca_topic_score_codex":0.0021837316,"about_ca_topic_score_gemma":0.0004435462,"teacher_disagreement_score":0.039777316,"about_ca_system_score_codex":0.00012243584,"about_ca_system_score_gemma":0.000180787,"threshold_uncertainty_score":0.9997924},"labels":[],"label_agreement":null},{"id":"W2792952263","doi":"10.3324/haematol.2018.187773","title":"Impact of age on genetics and treatment efficacy in follicular lymphoma","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Lymphoma; Medicine; Oncology; Internal medicine; Follicular phase","score_opus":0.04232993865396901,"score_gpt":0.3164919456697417,"score_spread":0.2741620070157727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792952263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97429,0.0015663636,2.3393434e-7,0.021409761,0.00006149739,0.0009416202,0.000052615294,0.000032144235,0.0016457255],"genre_scores_gemma":[0.96938163,0.0018441349,0.00031237197,0.027264882,0.00036917513,0.00015963175,0.00032672475,0.000048005,0.00029346853],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983506,0.00008451389,0.0004088799,0.00052607874,0.00025408692,0.000375833],"domain_scores_gemma":[0.99882066,0.00023663543,0.00019722276,0.0006052238,0.000045720204,0.00009453324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004682274,0.0004737436,0.0013403625,0.00021788932,0.000032481832,0.000016459198,0.000086911365,0.00067502377,0.00011835792],"category_scores_gemma":[0.000047362515,0.00027089036,0.00040383995,0.00012352133,0.00017046707,0.000010053794,0.000044112807,0.00011579853,0.00006397291],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086999,0.009671912,0.24492188,0.00044422832,0.0027589109,0.10730961,0.00055827113,0.0000045195347,0.00006320466,0.000076800105,0.5924153,0.040905397],"study_design_scores_gemma":[0.011631973,0.013070335,0.8520554,0.0008091659,0.000709309,0.0013338992,0.0000075315993,0.0000137541365,0.0013483685,0.00007361192,0.1185455,0.00040119642],"about_ca_topic_score_codex":0.00024966817,"about_ca_topic_score_gemma":0.000013394767,"teacher_disagreement_score":0.60713345,"about_ca_system_score_codex":0.0004987166,"about_ca_system_score_gemma":0.00012912178,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W2799608052","doi":"10.3324/haematol.2018.189852","title":"Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Dexamethasone; Immunology; Medicine; Internal medicine; Antibody; Immune system; Immune tolerance; Factor IX; Antigen; Endocrinology; Pharmacology","score_opus":0.04584113112229286,"score_gpt":0.3029143180218155,"score_spread":0.25707318689952263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799608052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99007064,0.00083636015,0.0006003519,0.0027768642,0.00017171698,0.0011328694,0.000008177923,0.00017071296,0.0042322767],"genre_scores_gemma":[0.9902655,0.00021363253,0.007005096,0.00024326419,0.00012391483,0.00010973427,0.000015248549,0.00003275968,0.0019908343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997713,0.000121959725,0.00040402822,0.0006201375,0.0004206979,0.0007201661],"domain_scores_gemma":[0.99887633,0.00016173234,0.00008549882,0.0005010535,0.00015346841,0.00022189265],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027488716,0.0002985289,0.0007109971,0.0002193362,0.00016435687,0.000033582404,0.00023109774,0.0002694705,0.0020239633],"category_scores_gemma":[0.00014250207,0.0002037341,0.00012312028,0.0005845374,0.00027887846,0.00010610583,0.000091519556,0.00035497453,0.0018529219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021538334,0.0026631227,0.047325704,0.0006029665,0.00019031299,0.0045985766,0.0022310296,0.0000010633736,0.9176873,0.004027873,0.0033712091,0.015146987],"study_design_scores_gemma":[0.005446357,0.0023727918,0.04511319,0.0006351007,0.000050146722,0.0019737873,0.00028154973,0.001162871,0.92493397,0.011899816,0.0054301564,0.0007002331],"about_ca_topic_score_codex":0.00004849453,"about_ca_topic_score_gemma":0.000041234845,"teacher_disagreement_score":0.014446753,"about_ca_system_score_codex":0.00011687836,"about_ca_system_score_gemma":0.00007914399,"threshold_uncertainty_score":0.99892426},"labels":[],"label_agreement":null},{"id":"W2800708348","doi":"10.3324/haematol.2017.180844","title":"GFI1 is required for <i>RUNX1/ETO</i> positive acute myeloid leukemia","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Art; Theology; Art history; Philosophy; Medicine; Internal medicine","score_opus":0.03831771610229713,"score_gpt":0.3187925590230001,"score_spread":0.28047484292070296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800708348","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006163511,0.0008205173,0.0009422203,0.95109725,0.0009983685,0.0059637544,0.002032101,0.0007496237,0.031232646],"genre_scores_gemma":[0.0012217899,0.00058988837,0.010736416,0.9075162,0.0077091483,0.0012063446,0.004173323,0.00036853075,0.06647838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99311554,0.0002546515,0.0011182803,0.0020212727,0.00129767,0.0021925713],"domain_scores_gemma":[0.99484414,0.0009577242,0.0006190354,0.0020410232,0.0011297775,0.00040830765],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.000591847,0.0012001522,0.00277231,0.0005390928,0.00046632922,0.00014251008,0.0011837693,0.003822218,0.0015155196],"category_scores_gemma":[0.0006084994,0.0009317207,0.0010565895,0.00057511823,0.0010729687,0.00017986682,0.0005880915,0.0036034759,0.002903768],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010786034,0.00004894608,0.000043606673,0.00087851135,0.0013057746,0.009592928,0.00026925994,4.751421e-8,0.0009701958,0.00011399705,0.98492056,0.0007775765],"study_design_scores_gemma":[0.0032928186,0.0019045306,0.000101172016,0.0006982301,0.0012667715,0.0056292983,0.000048948154,0.000115569215,0.0131651275,0.0011572362,0.9716194,0.0010008863],"about_ca_topic_score_codex":0.00009005838,"about_ca_topic_score_gemma":0.0000044636013,"teacher_disagreement_score":0.043581076,"about_ca_system_score_codex":0.001968654,"about_ca_system_score_gemma":0.0019109508,"threshold_uncertainty_score":0.9993972},"labels":[],"label_agreement":null},{"id":"W2804990894","doi":"10.3324/haematol.2017.171249","title":"Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Bosutinib; Medicine; Cumulative incidence; Internal medicine; Nausea; Myeloid leukemia; Adverse effect; Imatinib; Gastroenterology; Rash; Mucositis; Oncology; Dasatinib; Surgery; Toxicity; Cohort","score_opus":0.03689671586753953,"score_gpt":0.344653472804586,"score_spread":0.3077567569370465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804990894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933725,0.0012529835,0.000095789714,0.00018648009,0.00012659177,0.0033085644,0.00063561817,0.00008640571,0.00093504426],"genre_scores_gemma":[0.99662673,0.00012988976,0.0010624526,0.00005154603,0.00031870944,0.00011320621,0.00021041179,0.000047992304,0.0014390526],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966335,0.00011569953,0.0013379293,0.000868134,0.00040739987,0.0006373165],"domain_scores_gemma":[0.99742067,0.0004010431,0.0007024599,0.00095509656,0.00028271665,0.00023801514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005630155,0.00047411348,0.0015691668,0.00019756936,0.0002557736,0.000012448707,0.0002511628,0.0002583883,0.0012943208],"category_scores_gemma":[0.00056603237,0.00036967473,0.00026378356,0.00033149714,0.0007021684,0.00009815677,0.0002495567,0.00027958682,0.00002209384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45885292,0.07794955,0.005193154,0.0102974195,0.008958185,0.0027564324,0.036366634,0.00007065897,0.17421351,0.0032311794,0.028929153,0.19318122],"study_design_scores_gemma":[0.6422958,0.23128974,0.016158912,0.0013270455,0.0019316555,0.001132631,0.001215888,0.0042241774,0.05491415,0.00009265947,0.044496305,0.00092108635],"about_ca_topic_score_codex":0.0000987876,"about_ca_topic_score_gemma":0.0002376446,"teacher_disagreement_score":0.19226013,"about_ca_system_score_codex":0.0011969372,"about_ca_system_score_gemma":0.0017422138,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W2807339320","doi":"10.3324/haematol.2017.185165","title":"Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"European Hematology Association","keywords":"Platelet; Medicine; Chemotherapy; Multiple myeloma; Internal medicine; Malignancy; Cancer; Phosphatidylserine; Platelet activation; Gastroenterology; Immunology; Biology","score_opus":0.024890600824630186,"score_gpt":0.2906062416423515,"score_spread":0.2657156408177213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807339320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586505,0.00006576092,0.000062105326,0.0005586306,0.00080558215,0.0010157166,0.000010268755,0.00017087482,0.0014460031],"genre_scores_gemma":[0.9981552,0.0000826264,0.00059650047,0.00059711456,0.0002395521,0.00022155768,0.000018523742,0.000031448904,0.00005750276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983417,0.00011544314,0.00032818218,0.00047672392,0.0003037126,0.00043425066],"domain_scores_gemma":[0.99912745,0.000102055186,0.00017366768,0.00033485598,0.00012588597,0.00013611009],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012461029,0.0002499514,0.0005095721,0.0001493116,0.0001559905,0.00002666707,0.00013272354,0.00024680907,0.0010484064],"category_scores_gemma":[0.00019737001,0.00020567361,0.00012874095,0.00031212726,0.00020729745,0.00018451455,0.000069224065,0.0001823387,0.000114949755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008337487,0.0013006476,0.95361704,0.00027317798,0.00026855108,0.00020082937,0.0006977605,0.00000111186,0.01211383,0.000085887026,0.0080460515,0.015057659],"study_design_scores_gemma":[0.010184426,0.0009742517,0.9099667,0.0003746201,0.000071210656,0.000043338227,0.00009683077,0.00028418849,0.076195784,0.00021968734,0.0012203836,0.00036858176],"about_ca_topic_score_codex":0.00005560705,"about_ca_topic_score_gemma":0.00029110967,"teacher_disagreement_score":0.06408195,"about_ca_system_score_codex":0.00032456077,"about_ca_system_score_gemma":0.00018975807,"threshold_uncertainty_score":0.99986476},"labels":[],"label_agreement":null},{"id":"W2810970248","doi":"10.3324/haematol.2017.185991","title":"A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"Takeda Oncology","keywords":"Ixazomib; Medicine; Melphalan; Prednisone; Multiple myeloma; Maintenance therapy; Internal medicine; Adverse effect; Surgery; Lenalidomide; Chemotherapy; Carfilzomib","score_opus":0.08065535250103235,"score_gpt":0.3476845975581068,"score_spread":0.2670292450570745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810970248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439824,0.00020104786,0.00036123773,0.0010725221,0.00021355324,0.0030059798,0.000066053726,0.00026987641,0.00041148596],"genre_scores_gemma":[0.9955547,0.00005679845,0.0027591016,0.00027258822,0.00011924804,0.0005163488,0.00043234034,0.000055646855,0.0002332606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960208,0.0003828724,0.00091204525,0.00094911736,0.00070632406,0.0010288672],"domain_scores_gemma":[0.9981769,0.0002792483,0.0002797658,0.00056086073,0.00018527695,0.00051794853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005707502,0.00050714856,0.0009783105,0.0003464924,0.0003727189,0.00007208395,0.00024597024,0.00027552203,0.00016424998],"category_scores_gemma":[0.0009529699,0.00039979123,0.00016390425,0.0006963434,0.0002705406,0.00030237588,0.00011349944,0.00042526127,0.000120812445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009119419,0.029484352,0.6853674,0.00021417446,0.0006368076,0.0042780396,0.00878144,0.000017544853,0.21788241,0.000039641647,0.0073008714,0.0368779],"study_design_scores_gemma":[0.2558529,0.048469745,0.4914957,0.0018004203,0.0007990853,0.0013440957,0.006000483,0.028449722,0.15981577,0.0004095495,0.003485723,0.002076812],"about_ca_topic_score_codex":0.0011682012,"about_ca_topic_score_gemma":0.0013766221,"teacher_disagreement_score":0.24673347,"about_ca_system_score_codex":0.00031037195,"about_ca_system_score_gemma":0.00011363393,"threshold_uncertainty_score":0.9998454},"labels":[],"label_agreement":null},{"id":"W2845051690","doi":"10.3324/haematol.2018.188219","title":"N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Queen's University","funders":"","keywords":"Chinese hamster ovary cell; Immunogenicity; Antibody; Biology; Immunoglobulin G; Baby hamster kidney cell; Hamster; Glycosylation; Molecular biology; Mesocricetus; Immune system; Immunology; Biochemistry; Receptor","score_opus":0.0582808155778413,"score_gpt":0.33817069374960423,"score_spread":0.2798898781717629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2845051690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567467,0.00024794487,0.000006075861,0.0016880074,0.00009548832,0.0006297935,0.0000029365879,0.00003675423,0.0016183403],"genre_scores_gemma":[0.99895513,0.00006507443,0.00018128465,0.000052888627,0.00003990553,0.00002517028,0.00001680141,0.000010563177,0.00065318734],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987742,0.00011136934,0.00036855708,0.00023060656,0.00023628681,0.0002790194],"domain_scores_gemma":[0.9992145,0.00012738076,0.00010370849,0.000360109,0.00013938882,0.000054913224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025819486,0.00013757627,0.00039873016,0.0001074661,0.00015141694,0.000009441398,0.00016501073,0.00014455082,0.00042202618],"category_scores_gemma":[0.0001680323,0.00007297181,0.00010824122,0.00029828498,0.00030726526,0.00004423263,0.0000773906,0.00019071682,0.00012240205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002144503,0.0023284026,0.44806632,0.0003957367,0.00033767187,0.0003907551,0.0036665434,0.0000022685565,0.5276056,0.004346011,0.0010105261,0.009705648],"study_design_scores_gemma":[0.0036292188,0.001511402,0.7893284,0.00027524828,0.000064597676,0.00021861859,0.00020142863,0.0012130133,0.19736676,0.0051913154,0.0007836985,0.00021629385],"about_ca_topic_score_codex":0.00024188073,"about_ca_topic_score_gemma":0.000086174114,"teacher_disagreement_score":0.34126207,"about_ca_system_score_codex":0.000057522742,"about_ca_system_score_gemma":0.000044812736,"threshold_uncertainty_score":0.46208906},"labels":[],"label_agreement":null},{"id":"W2861492704","doi":"10.3324/haematol.2017.187385","title":"CD16<sup>+</sup>NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Université de Sherbrooke; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; CD16; Cancer research; Monoclonal antibody; Antibody; Cytotoxic T cell; Stem cell; Leukemia; Immunology; NK-92; Fc receptor; Antigen; Biology; Interleukin 21; In vitro; CD8; Cell biology","score_opus":0.01430704504637206,"score_gpt":0.2574949571213214,"score_spread":0.24318791207494936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2861492704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908797,0.0007492198,0.00008167492,0.00026783542,0.00100914,0.00042513278,0.000010450193,0.00021115279,0.006365696],"genre_scores_gemma":[0.99481446,0.00024395797,0.00014409996,0.00053679664,0.0000620678,0.00003886761,0.00050547114,0.000027714585,0.0036265738],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977306,0.00037269943,0.00058652565,0.00063592504,0.00006836663,0.0006058985],"domain_scores_gemma":[0.99915206,0.00012409463,0.00021767218,0.00033007236,0.00013444101,0.000041646817],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00036683984,0.00035795747,0.00068065856,0.0002681119,0.00045157576,0.0000488143,0.0002760432,0.00054669805,0.0012135352],"category_scores_gemma":[0.00006451294,0.00030477947,0.0001139916,0.00027985955,0.00062315044,0.00026952237,0.00021690475,0.00062541576,0.0010307119],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010884943,0.0003083947,0.04071364,0.00008050064,0.00030820834,0.0001206617,0.0012940812,0.0000038291028,0.9453368,0.0010973118,0.00881486,0.0008332229],"study_design_scores_gemma":[0.010454876,0.0031422365,0.5063097,0.00039995884,0.00033989834,0.0054032193,0.0025736082,0.00036811552,0.30095452,0.0004624491,0.16755429,0.0020371624],"about_ca_topic_score_codex":0.00026170062,"about_ca_topic_score_gemma":0.000037278547,"teacher_disagreement_score":0.6443823,"about_ca_system_score_codex":0.00011641278,"about_ca_system_score_gemma":0.00007574012,"threshold_uncertainty_score":0.99994045},"labels":[],"label_agreement":null},{"id":"W2866628310","doi":"10.3324/haematol.2018.196782","title":"Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Interim; Stage (stratigraphy); Lymphoma; Hodgkin lymphoma; Oncology; Chemotherapy; Internal medicine; Cyclophosphamide; Vincristine; Biology","score_opus":0.04868299079263632,"score_gpt":0.28875085606207046,"score_spread":0.24006786526943413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2866628310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8847225,0.0008441224,0.0000038448147,0.09227506,0.00018101788,0.0020638553,0.00010714932,0.000802841,0.018999623],"genre_scores_gemma":[0.69789344,0.0012605307,0.0010112289,0.29148963,0.0007935312,0.00092447415,0.0016835505,0.00018457013,0.0047590234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964872,0.00030333092,0.00071397173,0.0011231746,0.00053507544,0.00083722424],"domain_scores_gemma":[0.998079,0.00028417338,0.00041366255,0.0008422488,0.00024079184,0.00014013334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012602027,0.0009362242,0.0019190891,0.00052231125,0.000095726675,0.00012022258,0.00032164654,0.0009276725,0.000804736],"category_scores_gemma":[0.00008548835,0.00056847534,0.00028127033,0.0005524625,0.00028917668,0.00010554975,0.00008835912,0.0005227689,0.00034124876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027014718,0.0022282093,0.03789993,0.00033853654,0.0011422685,0.29161558,0.0002744358,2.2724053e-7,0.00007861018,0.00003344805,0.6568335,0.0068537774],"study_design_scores_gemma":[0.02802513,0.013013777,0.18509007,0.0037063458,0.0006120373,0.020313563,0.00012442196,0.00005906435,0.0071901293,0.000060235725,0.739961,0.0018442075],"about_ca_topic_score_codex":0.0005065905,"about_ca_topic_score_gemma":0.00009791081,"teacher_disagreement_score":0.271302,"about_ca_system_score_codex":0.00043650507,"about_ca_system_score_gemma":0.00028365402,"threshold_uncertainty_score":0.99967664},"labels":[],"label_agreement":null},{"id":"W2886320425","doi":"10.3324/haematol.2018.188987","title":"Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Dasatinib; Medicine; Internal medicine; Imatinib; Pleural effusion; Myeloid leukemia; Oncology; Philadelphia chromosome; Population; Gastroenterology; Chromosomal translocation","score_opus":0.02326542935298994,"score_gpt":0.2916060793368093,"score_spread":0.2683406499838194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886320425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774724,0.00016898896,0.00002144031,0.00009679937,0.00011883964,0.0014560423,0.000062110055,0.00004692597,0.00028163177],"genre_scores_gemma":[0.99824876,0.00034037657,0.0010648862,0.00009588029,0.000031788066,0.00006155731,0.0000967194,0.000025025383,0.000034998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983354,0.00009828777,0.0005185353,0.00043628342,0.00026545284,0.0003460342],"domain_scores_gemma":[0.9985346,0.00052484137,0.00035670417,0.00031530324,0.00016086116,0.0001076635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020185017,0.00027945585,0.00078684126,0.00015971359,0.00012230714,0.000009875234,0.000116815456,0.0002015224,0.0001055124],"category_scores_gemma":[0.00062102923,0.00018702289,0.0001069388,0.00021332769,0.00025087298,0.00010393252,0.00009084346,0.00018309585,0.000006620289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006940494,0.00022206588,0.99456596,0.000054439566,0.00010286617,0.000011839227,0.0010913772,8.3353694e-7,0.00030595434,0.000034388086,0.0001871092,0.002729103],"study_design_scores_gemma":[0.009301106,0.0023279488,0.9799579,0.00025559674,0.000065160464,0.00001658925,0.000115832016,0.00019907739,0.0073728897,0.00014620475,0.00007384059,0.00016788983],"about_ca_topic_score_codex":0.00041975867,"about_ca_topic_score_gemma":0.00009146169,"teacher_disagreement_score":0.01460811,"about_ca_system_score_codex":0.00047267423,"about_ca_system_score_gemma":0.00015234541,"threshold_uncertainty_score":0.7626572},"labels":[],"label_agreement":null},{"id":"W2886835568","doi":"10.3324/haematol.2018.194951","title":"Incidence of upper-extremity deep vein thrombosis in western France: a community-based study","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Deep vein; Incidence (geometry); Thrombosis; Medicine; Post-thrombotic syndrome; Surgery","score_opus":0.049415793721863874,"score_gpt":0.3218901565234817,"score_spread":0.2724743628016178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886835568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91762686,0.00026209466,0.00008530868,0.07742038,0.00027381894,0.002529759,0.000022844626,0.00012850361,0.0016503972],"genre_scores_gemma":[0.7492124,0.00006832362,0.0005089773,0.24923243,0.0002515531,0.00037306803,0.00014845523,0.000059996655,0.00014478962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959534,0.0009837867,0.0010152882,0.0006275352,0.0007924282,0.00062755955],"domain_scores_gemma":[0.99676156,0.00054854515,0.0005802822,0.0018023557,0.00022176297,0.000085494394],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009826975,0.0005719357,0.002754386,0.00046005563,0.00017853867,0.000033965804,0.000842299,0.00082621025,0.0005174471],"category_scores_gemma":[0.00024993718,0.00046341,0.00028877295,0.00048839266,0.0003583301,0.000070185364,0.00044409372,0.0025172853,0.00014619669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054266686,0.005305761,0.75741756,0.0028663008,0.00030097947,0.0014209384,0.0028029312,0.000004893563,0.000017912662,0.000010846941,0.22956432,0.00023330681],"study_design_scores_gemma":[0.002820536,0.0030313123,0.8977039,0.0027868133,0.000845609,0.000041906307,0.0011412625,0.000048556405,0.00018841423,0.00020705888,0.09045498,0.00072968204],"about_ca_topic_score_codex":0.001502079,"about_ca_topic_score_gemma":0.0007333281,"teacher_disagreement_score":0.17181204,"about_ca_system_score_codex":0.00012804451,"about_ca_system_score_gemma":0.00011976559,"threshold_uncertainty_score":0.99978393},"labels":[],"label_agreement":null},{"id":"W2889930434","doi":"10.3324/haematol.2018.192823","title":"Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood properties and coagulation","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Tissue transglutaminase; Acute promyelocytic leukemia; Retinoic acid; Tretinoin; Cancer research; Tumor necrosis factor alpha; Cytokine; Biology; Molecular biology; Chemistry; Immunology; Cell biology; Biochemistry; Enzyme","score_opus":0.055657010177624845,"score_gpt":0.29626468350112345,"score_spread":0.2406076733234986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889930434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994721,0.000054786567,0.001200975,0.0009496494,0.000085095,0.0020536329,0.0000058782066,0.00018764593,0.00074133725],"genre_scores_gemma":[0.9955288,0.000040634437,0.0030104103,0.00036007637,0.00009007732,0.00037470533,0.00006623076,0.00003375828,0.0004952607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818647,0.000097204786,0.0004966989,0.00047965616,0.0002659084,0.00047407162],"domain_scores_gemma":[0.9992623,0.000026799606,0.00012982043,0.00036740166,0.00008398852,0.00012972762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118801865,0.00030581528,0.0005332565,0.0000917459,0.00012715087,0.00004151158,0.00011080111,0.00021116497,0.00015008182],"category_scores_gemma":[0.000021268865,0.00021502732,0.00011174277,0.00026956588,0.00009927107,0.00016450872,0.00002874948,0.00016902818,0.000051472292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030909053,0.0012440989,0.023734128,0.00088129286,0.00052990846,0.00054427417,0.029021326,0.000040005376,0.87577975,0.000496189,0.00015653815,0.06448157],"study_design_scores_gemma":[0.00307653,0.0037645018,0.017432237,0.00053187273,0.00028879405,0.00006943587,0.00083614513,0.0011027892,0.9680236,0.0000966239,0.004398337,0.00037916252],"about_ca_topic_score_codex":0.00012612701,"about_ca_topic_score_gemma":0.00013306907,"teacher_disagreement_score":0.092243806,"about_ca_system_score_codex":0.00037064636,"about_ca_system_score_gemma":0.00012759707,"threshold_uncertainty_score":0.87685597},"labels":[],"label_agreement":null},{"id":"W2890347208","doi":"10.3324/haematol.2018.196568","title":"Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in <i>in vivo</i> preclinical models of hematopoietic reconstitution and severe colitis","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Christian ministry; Mesenchymal stem cell; Bone marrow; Internal medicine; Oncology; Cancer research; Pathology; Political science","score_opus":0.03588783827418238,"score_gpt":0.2718389579882562,"score_spread":0.23595111971407381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890347208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868544,0.0005539117,0.000022476612,0.0048877453,0.00039864064,0.0027955046,0.0011772449,0.00007597529,0.0032340977],"genre_scores_gemma":[0.9900408,0.0012191933,0.0011230585,0.005354746,0.00043952707,0.00023510562,0.0004419144,0.00009627169,0.0010493777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992451,0.0011038268,0.0023522906,0.0015949488,0.0013515893,0.0011463098],"domain_scores_gemma":[0.9956949,0.0011287418,0.0013941497,0.0011009009,0.00035387167,0.00032746868],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010051363,0.0008134682,0.0031082332,0.0005083329,0.00011741457,0.00006168089,0.0004705114,0.0026703023,0.00057511043],"category_scores_gemma":[0.00031362145,0.0007052486,0.0003212169,0.00038584368,0.0011112308,0.00024263067,0.00038889644,0.0031646993,0.00008067683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004125359,0.001019913,0.5243978,0.008817281,0.00083593186,0.032603417,0.0009585019,0.000066392204,0.003266491,0.00015667557,0.42298338,0.0007688879],"study_design_scores_gemma":[0.09370924,0.013531266,0.5652744,0.070946924,0.005851408,0.010657089,0.00269359,0.0159467,0.12920511,0.016283326,0.06132094,0.014579997],"about_ca_topic_score_codex":0.00055674085,"about_ca_topic_score_gemma":0.0003699163,"teacher_disagreement_score":0.36166242,"about_ca_system_score_codex":0.00045633045,"about_ca_system_score_gemma":0.00076930143,"threshold_uncertainty_score":0.99953985},"labels":[],"label_agreement":null},{"id":"W2890977830","doi":"10.3324/haematol.2018.194282","title":"Daratumumab plus lenalidomide and dexamethasone <i>versus</i> lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; University of British Columbia; University of Alberta; Queen Elizabeth II Health Sciences Centre; Université Laval; Dalhousie University","funders":"Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Yale University","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Medicine; Hazard ratio; Multiple myeloma; Internal medicine; Oncology; Confidence interval; Gastroenterology","score_opus":0.06103873061989124,"score_gpt":0.341154983171765,"score_spread":0.2801162525518738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890977830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955787,0.0015452865,0.00013433072,0.00043937896,0.000076701384,0.0008643709,0.000093226845,0.00008542723,0.0011825633],"genre_scores_gemma":[0.9904757,0.000562291,0.008133018,0.00016393884,0.000041333366,0.00006844001,0.00014167436,0.000036646346,0.0003769275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965365,0.00044714025,0.000845135,0.0008777263,0.00055485714,0.00073867344],"domain_scores_gemma":[0.9965798,0.0016215913,0.00034855635,0.00072244764,0.0002635043,0.0004640696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007639809,0.00044121937,0.0018811128,0.000996228,0.00018986619,0.000038805967,0.00019001839,0.000350978,0.0005529944],"category_scores_gemma":[0.0027741704,0.00030639276,0.00018916193,0.0018597458,0.0009777272,0.00015176463,0.00024356964,0.0004176896,0.000026402608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20778868,0.0027691638,0.6884001,0.000763532,0.012582911,0.0071662785,0.0031298923,0.000025843534,0.045402132,0.0005845175,0.0023775126,0.029009474],"study_design_scores_gemma":[0.1186279,0.0068933913,0.79777163,0.0005640023,0.004828904,0.00080066477,0.002358753,0.01791076,0.046197984,0.00014535172,0.0027800545,0.0011206206],"about_ca_topic_score_codex":0.0011269832,"about_ca_topic_score_gemma":0.0033996294,"teacher_disagreement_score":0.10937154,"about_ca_system_score_codex":0.00018017708,"about_ca_system_score_gemma":0.00020587823,"threshold_uncertainty_score":0.99993885},"labels":[],"label_agreement":null},{"id":"W2891400988","doi":"10.3324/haematol.2018.196295","title":"Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; University of Toronto; University Health Network","funders":"Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg; School of Medicine, Emory University; Universität Heidelberg; Children's Healthcare of Atlanta; University of Vermont; McMaster University; St. Jude Children's Research Hospital; University of Missouri; Ohio State University; Weill Cornell Medical College; University of Pennsylvania; Children's Hospital of Michigan; Children's Mercy Hospital; Wayne State University; Perelman School of Medicine, University of Pennsylvania; Nationwide Children's Hospital; Children's Hospital of Philadelphia; University of Toronto; Albert-Ludwigs-Universität Freiburg; Emory University; Aflac","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; PKM2; Dihydrolipoyl transacetylase; Pyruvate dehydrogenase complex; Natural history; Pyruvate decarboxylation; Medicine; Chemistry; Glycolysis; Biochemistry; Internal medicine; Enzyme","score_opus":0.03026470639958197,"score_gpt":0.26360454569800684,"score_spread":0.23333983929842486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891400988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613442,0.015449396,0.0000069456437,0.016794104,0.001556926,0.001908204,0.00003313727,0.000099189674,0.002807929],"genre_scores_gemma":[0.91105056,0.002995939,0.00044974824,0.07950736,0.0005150929,0.00027075174,0.000254329,0.0000647644,0.0048914677],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9962907,0.00037559876,0.0009785524,0.0012001232,0.0006150762,0.00053998304],"domain_scores_gemma":[0.9974289,0.00027960213,0.0007440421,0.0013387327,0.0001407988,0.0000679211],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000539641,0.00052927557,0.0010858864,0.0001927724,0.00012460825,0.000013337466,0.0004150845,0.00052694324,0.00044968975],"category_scores_gemma":[0.00018487482,0.00033926262,0.00017566988,0.00025309564,0.0007691554,0.00006547311,0.0003611292,0.0013088685,0.00006185284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010467764,0.0014907051,0.08100949,0.006115638,0.00018136733,0.06543675,0.0023340161,0.0000024774522,0.0018152073,0.0001519531,0.83952445,0.0008911908],"study_design_scores_gemma":[0.004747165,0.0032817128,0.7385386,0.0033470963,0.0017151182,0.0012279089,0.0013736982,0.00007517635,0.00024822084,0.00061030965,0.24344707,0.0013879222],"about_ca_topic_score_codex":0.00038802382,"about_ca_topic_score_gemma":0.00004789572,"teacher_disagreement_score":0.6575291,"about_ca_system_score_codex":0.00023886819,"about_ca_system_score_gemma":0.00011851096,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W2892342442","doi":"10.3324/haematol.2018.203224","title":"<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"Lymphoma; Somatic hypermutation; JUNB; Pathology; Histiocyte; Cancer research; BCL6; B cell; Germinal center; Biology; Medicine; Immunology; Genetics; Gene; Gene expression","score_opus":0.012321291891290267,"score_gpt":0.24434431335100992,"score_spread":0.23202302145971965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892342442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486403,0.0061335536,0.00003286041,0.001579442,0.00031653562,0.0011476048,0.00010586784,0.00033984196,0.041703984],"genre_scores_gemma":[0.9898757,0.0015081175,0.0013152155,0.005689355,0.00016751695,0.00027416248,0.00011959107,0.00008000994,0.00097036705],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958946,0.00019294157,0.0009198112,0.0012253176,0.00055746,0.0012098575],"domain_scores_gemma":[0.9975686,0.0003416149,0.00043361937,0.000874044,0.00025451195,0.0005276243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039599757,0.0007279982,0.0013860232,0.00026432512,0.00035529237,0.00010006228,0.0002866305,0.00047764706,0.0002709933],"category_scores_gemma":[0.00017943679,0.0005783011,0.00022180882,0.0008029763,0.0004416687,0.00019102411,0.00025124138,0.00023831753,0.00074772775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001992846,0.027245205,0.8268629,0.0014232016,0.00035625295,0.017826624,0.0018576564,0.000002782192,0.016735723,0.002474335,0.097861595,0.0053609014],"study_design_scores_gemma":[0.09014786,0.0036175277,0.17836301,0.0013110895,0.0010894035,0.005201539,0.0019146929,0.00034000084,0.51709384,0.0012145863,0.1970941,0.0026123486],"about_ca_topic_score_codex":0.00027148082,"about_ca_topic_score_gemma":0.000235433,"teacher_disagreement_score":0.64849985,"about_ca_system_score_codex":0.00034251937,"about_ca_system_score_gemma":0.00022635043,"threshold_uncertainty_score":0.99966687},"labels":[],"label_agreement":null},{"id":"W2892431967","doi":"10.3324/haematol.2018.201194","title":"Highly sensitive methods are required to detect mutations in histiocytoses","year":2018,"lang":"en","type":"letter","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Mutation; Erdheim–Chester disease; Genetics; Medicine; Cancer research; Computational biology; Biology; Histiocytosis; Internal medicine; Gene","score_opus":0.05598754510934373,"score_gpt":0.359167103244918,"score_spread":0.3031795581355743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892431967","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04152735,0.0010781414,0.008697747,0.8970752,0.0014199171,0.004373411,0.0003942147,0.00067757996,0.044756476],"genre_scores_gemma":[0.09962181,0.00006680222,0.18625201,0.6958991,0.0011026356,0.0007857696,0.0011910883,0.00017729924,0.014903457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975895,0.0003297038,0.000516056,0.00074759795,0.00030005164,0.00051707414],"domain_scores_gemma":[0.99840325,0.0004336425,0.0002510012,0.0005684527,0.00021314403,0.00013053414],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019322705,0.00044099236,0.0012768153,0.0004596109,0.0001238806,0.000026891292,0.00013693944,0.00078142947,0.00019006977],"category_scores_gemma":[0.0010473864,0.0003483641,0.00019882516,0.00044180662,0.00021152195,0.000036330366,0.00007477653,0.00062871334,0.0009210447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001772734,0.00012215672,0.00028306164,0.0002779416,0.0002466357,0.026884353,0.0004345485,0.0000015707094,0.000052337633,0.00004974546,0.9664144,0.0050559537],"study_design_scores_gemma":[0.0020324735,0.0010011366,0.003772192,0.0012066127,0.0006891169,0.0016769641,0.00022310506,0.000035979894,0.0014666925,0.0019648527,0.9852443,0.00068662636],"about_ca_topic_score_codex":0.00015182291,"about_ca_topic_score_gemma":0.00009914613,"teacher_disagreement_score":0.20117603,"about_ca_system_score_codex":0.00036633242,"about_ca_system_score_gemma":0.00017174268,"threshold_uncertainty_score":0.9998968},"labels":[],"label_agreement":null},{"id":"W2899225691","doi":"10.3324/haematol.2018.202093","title":"Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Epigenetics; Exome sequencing; Cancer research; Hematologic malignancy; Bromodomain; Malignancy; Exome; Epigenesis; Biology; Medicine; Gene; Genetics; Mutation; DNA methylation; Internal medicine; Gene expression","score_opus":0.01868401955377211,"score_gpt":0.2812417373954823,"score_spread":0.26255771784171017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899225691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594571,0.0014369874,0.0023159862,0.0007726009,0.00018979388,0.0012516186,0.0000118290645,0.00018026301,0.034383815],"genre_scores_gemma":[0.9906836,0.00016458094,0.00392336,0.0015989067,0.00015345216,0.00009901116,0.00007363215,0.00006852556,0.0032349266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973254,0.00020700047,0.00048593336,0.00064712035,0.0005824012,0.00075215],"domain_scores_gemma":[0.99829525,0.00038607715,0.00013114084,0.00057342346,0.000332917,0.00028121425],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023058944,0.0003565958,0.0006586801,0.00023216684,0.00031867553,0.00006689164,0.0002578486,0.0002528853,0.0019948904],"category_scores_gemma":[0.0002656121,0.0003006143,0.00015623034,0.00037838577,0.00057185744,0.000064596476,0.00014101257,0.00027711893,0.0028889554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016011652,0.0066171438,0.26402104,0.0046362476,0.0014997609,0.010762195,0.008142255,0.00043255466,0.63494736,0.00687348,0.014853311,0.03120301],"study_design_scores_gemma":[0.01995505,0.01718898,0.17590177,0.0007557282,0.0012525746,0.07398028,0.002743479,0.05351777,0.5390845,0.051887874,0.05983552,0.0038965023],"about_ca_topic_score_codex":0.000021613992,"about_ca_topic_score_gemma":0.000024265024,"teacher_disagreement_score":0.09586288,"about_ca_system_score_codex":0.00029773483,"about_ca_system_score_gemma":0.000553252,"threshold_uncertainty_score":0.99994457},"labels":[],"label_agreement":null},{"id":"W2901234593","doi":"10.3324/haematol.2018.199356","title":"Trypsin-encoding <i>PRSS1-PRSS2</i> variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Environmental Health Sciences; Barncancerfonden; Blood Cancer UK; Rigshospitalet; Børnecancerfonden; Kræftens Bekæmpelse","keywords":"Asparaginase; Lymphoblastic Leukemia; Medicine; Pancreatitis; Oncology; Internal medicine; Toxicity; Leukemia; Gastroenterology; Pediatrics","score_opus":0.011335035741701556,"score_gpt":0.2438319169626636,"score_spread":0.23249688122096204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901234593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934265,0.0002189213,0.0010502781,0.00016246736,0.00006218138,0.0007680982,0.000046057317,0.00011791629,0.0041475827],"genre_scores_gemma":[0.99792355,0.00024613267,0.0012230702,0.00021617737,0.00003941769,0.0001756433,0.00006874326,0.000021004293,0.000086231856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781775,0.00031185008,0.00059858104,0.00051638193,0.000296904,0.00045851484],"domain_scores_gemma":[0.99810284,0.0004044011,0.0006511426,0.0005931393,0.00015092595,0.000097575634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005010476,0.00030398177,0.00082893606,0.00012799556,0.00037044042,0.000022065946,0.00018906542,0.0002523901,0.000033179174],"category_scores_gemma":[0.00078826194,0.00018684135,0.00011421524,0.0006519936,0.0005703216,0.000116693,0.000085380685,0.00035481135,0.00001932292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025036914,0.00028873037,0.99241775,0.000008874158,0.0007645747,0.0035960076,0.000370624,0.000039238686,0.00043396078,0.0016100729,0.00004085213,0.00017893265],"study_design_scores_gemma":[0.0023150712,0.00086057547,0.97815233,0.00046634086,0.0011372423,0.014478747,0.000036130412,0.00018349584,0.0015852842,0.0005842484,0.0000132386285,0.00018730822],"about_ca_topic_score_codex":0.001391719,"about_ca_topic_score_gemma":0.0011731379,"teacher_disagreement_score":0.014265445,"about_ca_system_score_codex":0.00029777354,"about_ca_system_score_gemma":0.00023291691,"threshold_uncertainty_score":0.7619169},"labels":[],"label_agreement":null},{"id":"W2905400988","doi":"10.3324/haematol.2018.195172","title":"The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Biology; Mitochondrial DNA; Oxidative phosphorylation; Respiratory chain; Mitochondrial respiratory chain; Myeloid leukemia; Mitochondrion; Molecular biology; Polymerase; DNA polymerase; Cellular differentiation; Cell biology; Cancer research; Biochemistry; DNA; Gene","score_opus":0.016604256531932135,"score_gpt":0.2778918988496143,"score_spread":0.26128764231768214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905400988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995554,0.0007196229,0.0002082904,0.006632602,0.00016659356,0.001640937,0.000017170676,0.00010093372,0.00055828836],"genre_scores_gemma":[0.99765205,0.0005529752,0.000490231,0.00041957299,0.00024328296,0.0001793527,0.00006929658,0.000035414705,0.0003578482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736124,0.00033283935,0.0005982818,0.0005738926,0.0004889922,0.0006447769],"domain_scores_gemma":[0.9980186,0.0007249289,0.00026279315,0.000596916,0.00022441793,0.00017230296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052541716,0.00034483604,0.0005351642,0.00017764731,0.0006498057,0.00013207246,0.0003048235,0.00023430587,0.00009696316],"category_scores_gemma":[0.0010243781,0.000178338,0.00010844981,0.00068328186,0.00082605414,0.00020968803,0.0002861241,0.0005864895,0.00009353158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013356369,0.00053601805,0.06663831,0.0002416129,0.0014164739,0.0006998018,0.008580456,0.0000090795575,0.84981924,0.0067375326,0.017693464,0.03427163],"study_design_scores_gemma":[0.007718467,0.0025800732,0.39329323,0.0003366368,0.0004584727,0.0008537477,0.0016343746,0.016603174,0.56939995,0.005132923,0.0013285337,0.00066038925],"about_ca_topic_score_codex":0.00035404437,"about_ca_topic_score_gemma":0.00048537116,"teacher_disagreement_score":0.3266549,"about_ca_system_score_codex":0.0004871324,"about_ca_system_score_gemma":0.000299613,"threshold_uncertainty_score":0.7272413},"labels":[],"label_agreement":null},{"id":"W2905627019","doi":"10.3324/haematol.2018.205096","title":"Mogamulizumab <i>versus</i> investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Regimen; Hazard ratio; Lymphoma; Adult T-cell leukemia/lymphoma; Chemotherapy regimen; Oncology; Chemotherapy; Gastroenterology; T-cell leukemia; Confidence interval","score_opus":0.01946078763361982,"score_gpt":0.24664039158622283,"score_spread":0.227179603952603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905627019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96811354,0.0036621608,0.0000063332245,0.00036995337,0.00089283584,0.00026319025,0.000015576941,0.00012278224,0.026553646],"genre_scores_gemma":[0.99620163,0.00055768754,0.00026095854,0.0008110044,0.000054936536,0.0000340797,0.000015459513,0.000026054075,0.0020381657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981263,0.00021159869,0.0005413909,0.00050100224,0.000070843904,0.00054881955],"domain_scores_gemma":[0.99862117,0.0003379558,0.00034937912,0.00048455878,0.00015206964,0.00005487365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015555357,0.00032589323,0.0007230503,0.00014702602,0.00020653388,0.0000068887553,0.0004326009,0.00056250126,0.0003297198],"category_scores_gemma":[0.00038505503,0.00024968933,0.0001395389,0.00029385864,0.0013351333,0.00006577679,0.00016279393,0.00028428997,0.000675292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005384844,0.0017236042,0.03813432,0.00035841027,0.00061911874,0.000114061026,0.007680023,0.000004206998,0.79306424,0.005878544,0.13850647,0.00853216],"study_design_scores_gemma":[0.018491013,0.0022420788,0.008592948,0.00016181558,0.00007020236,0.00006228008,0.0014902581,0.000008549818,0.8135345,0.00045369842,0.1542189,0.0006737644],"about_ca_topic_score_codex":0.0008615294,"about_ca_topic_score_gemma":0.00043106312,"teacher_disagreement_score":0.029541373,"about_ca_system_score_codex":0.00013518783,"about_ca_system_score_gemma":0.00019930943,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2907285051","doi":"10.3324/haematol.2018.209114","title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":322,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universitätsklinikum Köln; Tianjin Medical University; University College London Hospitals NHS Foundation Trust; Medizinische Universität Wien; National and Kapodistrian University of Athens; Università degli Studi di Roma Tor Vergata; Universitair Medisch Centrum Groningen; Cleveland Clinic; University College London; University of Toronto; University of Oklahoma Health Sciences Center; Universität Wien; Cardiff University; University of Washington; University of Oklahoma; Samsung; Pusan National University; University of Ottawa; Ohio State University","keywords":"Medicine; Ambulatory; Internal medicine; Incidence (geometry); Framingham Risk Score; Meta-analysis; Venous thromboembolism; Thrombosis; Disease","score_opus":0.16741654481687118,"score_gpt":0.3819672575359277,"score_spread":0.2145507127190565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907285051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010794496,0.982436,0.000011184722,0.00023224339,0.00008568964,0.016561674,0.0004922864,0.000023718423,0.00014643473],"genre_scores_gemma":[0.00019095863,0.99126726,0.000038243656,0.00036121398,0.000012543709,0.0077437516,0.00020808337,0.00003666762,0.00014126382],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966407,0.00033195823,0.0017934433,0.00055493333,0.00034840542,0.000330572],"domain_scores_gemma":[0.9968723,0.00056062534,0.0014185951,0.0008562436,0.00022208621,0.000070151145],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00091997354,0.0004737205,0.017882925,0.0002842105,0.0000967728,0.000025448646,0.00027944896,0.00024105785,0.000085582076],"category_scores_gemma":[0.00038105765,0.00022307519,0.002400628,0.000757108,0.000096223426,0.000042550902,0.00011450645,0.00020862705,0.000008166454],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031436198,0.00041190148,0.000011778508,0.89049786,0.10563591,0.000003633916,0.00003991283,4.819272e-7,3.3521261e-9,0.00061816775,0.0010681945,0.0017089917],"study_design_scores_gemma":[0.00019943263,0.0002998425,0.0001414113,0.07073305,0.89996725,0.000009522507,0.000017868308,0.000004679791,7.112517e-8,0.000040112456,0.028427545,0.00015919007],"about_ca_topic_score_codex":0.00007467785,"about_ca_topic_score_gemma":0.00006736792,"teacher_disagreement_score":0.81976485,"about_ca_system_score_codex":0.00009720891,"about_ca_system_score_gemma":0.0001043668,"threshold_uncertainty_score":0.9966976},"labels":[],"label_agreement":null},{"id":"W2907895732","doi":"10.3324/haematol.2018.205948","title":"Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come","year":2018,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Myeloid leukemia; Calicheamicin; Medicine; Leukemia; Oncology; Internal medicine; CD33; Biology; Genetics; Stem cell","score_opus":0.015626789455013577,"score_gpt":0.31325345522887643,"score_spread":0.2976266657738629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907895732","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3686375,0.0007953639,0.00016126959,0.009204883,0.5739288,0.009480243,0.00094211724,0.0012015514,0.035648335],"genre_scores_gemma":[0.0222101,0.0013239476,0.007974071,0.0021408012,0.9354142,0.0010859993,0.002724887,0.00060031965,0.026525678],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99256694,0.00025171685,0.0010436804,0.0019283708,0.0024157353,0.001793564],"domain_scores_gemma":[0.99492747,0.0010203135,0.00038002638,0.0020192382,0.0008696097,0.0007833617],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00086490513,0.0011806128,0.003133982,0.0011308718,0.00020706942,0.000117983975,0.0013499045,0.0029147537,0.001020236],"category_scores_gemma":[0.0019731773,0.00082026294,0.0002970335,0.0013474794,0.0007133721,0.00015431695,0.0008476549,0.004480217,0.0020860462],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005829018,0.00015039496,0.00070203125,0.0007473897,0.00042326824,0.012848453,0.00053826754,0.0000027907242,0.00017808624,0.000035686808,0.9779478,0.000596856],"study_design_scores_gemma":[0.0062947427,0.005017527,0.0015102419,0.001923045,0.0004780984,0.00161719,0.00036761427,0.000068651236,0.0005707173,0.00005128366,0.98097664,0.0011242261],"about_ca_topic_score_codex":0.00052651175,"about_ca_topic_score_gemma":0.00035834708,"teacher_disagreement_score":0.36148545,"about_ca_system_score_codex":0.004813927,"about_ca_system_score_gemma":0.0048205964,"threshold_uncertainty_score":0.99989295},"labels":[],"label_agreement":null},{"id":"W2908171531","doi":"10.3324/haematol.2018.209031","title":"Convergence of risk prediction models in follicular lymphoma","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Follicular lymphoma; Lymphoma; Internal medicine; Medicine; Oncology; Follicular phase","score_opus":0.024587332290219584,"score_gpt":0.24158274211294123,"score_spread":0.21699540982272164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908171531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87005115,0.006498161,0.00018660497,0.10842739,0.0011777056,0.0029588714,0.00073534873,0.00020630324,0.00975845],"genre_scores_gemma":[0.9268378,0.0025507133,0.00050925894,0.06861453,0.00024294003,0.00023536422,0.00060296006,0.000040754338,0.00036566972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802315,0.00011645844,0.00059530605,0.00052259327,0.00041713184,0.00032535163],"domain_scores_gemma":[0.99858195,0.0002612325,0.0003852014,0.0006407334,0.00008970098,0.000041202624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001249987,0.0003231548,0.0011715454,0.0002001361,0.000025692845,0.0000074314585,0.00014103825,0.0009212374,0.00018415938],"category_scores_gemma":[0.00009009559,0.00022994856,0.00030552575,0.00018263834,0.00008070621,0.000056119283,0.000060625756,0.00029559873,0.00015735158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016528103,0.000750634,0.19980904,0.0009744812,0.00041604505,0.0065867635,0.00021399188,0.00010729148,0.000009256395,0.0004157326,0.78893656,0.0016148885],"study_design_scores_gemma":[0.025016095,0.002748831,0.41281492,0.0058482066,0.0035609656,0.0040637855,0.00018213115,0.01129489,0.004993677,0.008790679,0.5190074,0.0016784668],"about_ca_topic_score_codex":0.00038451512,"about_ca_topic_score_gemma":0.0000068408176,"teacher_disagreement_score":0.26992923,"about_ca_system_score_codex":0.0001924961,"about_ca_system_score_gemma":0.00014480532,"threshold_uncertainty_score":0.9377031},"labels":[],"label_agreement":null},{"id":"W2908902338","doi":"10.3324/haematol.2018.211235","title":"Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital","funders":"","keywords":"Imatinib; Persistence (discontinuity); Myeloid leukemia; Medicine; Cohort; Chronic myeloid leukaemia; Oncology; Internal medicine; Cohort study; Leukemia","score_opus":0.039788586859992175,"score_gpt":0.27108964129736374,"score_spread":0.23130105443737156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908902338","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7547837,0.00378706,0.0005168826,0.18572077,0.0011922732,0.04219423,0.00033302006,0.0012765471,0.010195553],"genre_scores_gemma":[0.40172058,0.00061170245,0.019403895,0.48047787,0.0062376587,0.019147472,0.006184789,0.0011376926,0.06507836],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99480176,0.0001624035,0.0008616113,0.0018583867,0.0010444759,0.0012713857],"domain_scores_gemma":[0.9962011,0.00051908335,0.0007285132,0.0021039394,0.0003021325,0.00014521886],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003193543,0.0011411514,0.0030484805,0.00024742758,0.00021216516,0.000072791685,0.00060562027,0.0013354464,0.0006967537],"category_scores_gemma":[0.00014440446,0.0007699041,0.0005170607,0.00035941345,0.00025558926,0.000089023306,0.00018683705,0.001864973,0.0007367447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066371815,0.00047147457,0.047243,0.004554394,0.003348245,0.0093994895,0.00046114385,0.000027164933,0.00008916423,0.0000073381884,0.9332115,0.000523379],"study_design_scores_gemma":[0.049947783,0.0300438,0.055997305,0.003707687,0.01651414,0.022665674,0.0015996426,0.0018390798,0.00072046154,0.00007916612,0.8121696,0.004715651],"about_ca_topic_score_codex":0.000118995755,"about_ca_topic_score_gemma":0.00003638765,"teacher_disagreement_score":0.3530631,"about_ca_system_score_codex":0.0056310077,"about_ca_system_score_gemma":0.003065775,"threshold_uncertainty_score":0.999961},"labels":[],"label_agreement":null},{"id":"W2910217751","doi":"10.3324/haematol.2018.200378","title":"Mechanisms of thrombocytopenia in platelet-type von Willebrand disease","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi di Perugia; Queen's University; Fondazione Cariplo","keywords":"Platelet; GPVI; Megakaryocyte; Thrombopoiesis; Megakaryocytopoiesis; Von Willebrand factor; Von Willebrand disease; Chemistry; Immunology; Platelet Glycoprotein GPIb-IX Complex; Bone marrow; Ristocetin; Platelet membrane glycoprotein; Endocrinology; Cell biology; Internal medicine; Haematopoiesis; Biology; Medicine; Stem cell","score_opus":0.01584517417583293,"score_gpt":0.2616321639105532,"score_spread":0.2457869897347203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910217751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935992,0.0003890835,0.000013131398,0.0003061769,0.00009055949,0.0005409,0.000006345626,0.000030652278,0.0050239787],"genre_scores_gemma":[0.99889123,0.000100855184,0.00037223645,0.00021094191,0.0000024396327,0.000009628453,0.000033304204,0.000011033836,0.00036830222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918157,0.00002318171,0.00021853075,0.00022622047,0.00015255652,0.00019796437],"domain_scores_gemma":[0.99951816,0.000037107675,0.00006911285,0.0002507781,0.000030388366,0.00009442904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060415667,0.00012913876,0.00060985994,0.00007706342,0.000016930402,0.000004102211,0.00006991226,0.00008419584,0.00086058205],"category_scores_gemma":[0.00004233343,0.00009002877,0.00006604039,0.00017122601,0.000032352516,0.000050390296,0.000035887766,0.00008547055,0.00030852685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008782311,0.0039235298,0.86798567,0.0014306123,0.0004809369,0.021425083,0.00059702044,0.000049719023,0.034656454,0.054720495,0.001500029,0.0044481363],"study_design_scores_gemma":[0.022636583,0.0032839156,0.84660816,0.0010874161,0.00029193965,0.001219448,0.0004666716,0.000773539,0.053484455,0.066493556,0.0028525768,0.00080172264],"about_ca_topic_score_codex":0.000021516846,"about_ca_topic_score_gemma":0.000008095204,"teacher_disagreement_score":0.021377493,"about_ca_system_score_codex":0.000017974327,"about_ca_system_score_gemma":0.0000475747,"threshold_uncertainty_score":0.942277},"labels":[],"label_agreement":null},{"id":"W2910821491","doi":"10.3324/haematol.2018.203943","title":"Resolution of celiac disease, IgA deficiency and platelet refractoriness after allogeneic bone marrow transplantation for acute leukemia","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Transplantation; Stem cell; Immunology; Hematology; Immune system; Disease; Bone marrow; Leukemia; Acute leukemia; Platelet; Internal medicine","score_opus":0.02151216357234776,"score_gpt":0.29430982506398956,"score_spread":0.2727976614916418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910821491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9037053,0.0112136835,0.0009982025,0.07569226,0.00075048325,0.005165833,0.0016515572,0.0001665364,0.0006561639],"genre_scores_gemma":[0.8863603,0.010309002,0.00290438,0.08255737,0.0013905363,0.0016755803,0.007071193,0.00026613066,0.007465542],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688923,0.00010646995,0.00069712056,0.0008458462,0.00074390613,0.00071744673],"domain_scores_gemma":[0.9980176,0.00050360465,0.00033501704,0.0007330689,0.0002687683,0.00014192071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028541835,0.0004553618,0.0012018138,0.00028570087,0.00007560065,0.00002768927,0.000217576,0.001033882,0.00011083442],"category_scores_gemma":[0.00017212974,0.00035263525,0.0002694053,0.0002110172,0.00028498765,0.00009900322,0.00008335228,0.0007355178,0.000037785176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021151148,0.00024100223,0.0020572867,0.0491031,0.00086617994,0.031903777,0.00047738015,0.00003610912,0.004008887,0.00023419486,0.8878058,0.0021150964],"study_design_scores_gemma":[0.059233546,0.0035286439,0.015880594,0.0063134963,0.008391152,0.01849953,0.000081976636,0.006249578,0.011122918,0.0016608298,0.86580765,0.0032301012],"about_ca_topic_score_codex":0.00008724072,"about_ca_topic_score_gemma":0.0000073517117,"teacher_disagreement_score":0.042789605,"about_ca_system_score_codex":0.0027039084,"about_ca_system_score_gemma":0.0030637379,"threshold_uncertainty_score":0.9998926},"labels":[],"label_agreement":null},{"id":"W2913401942","doi":"10.3324/haematol.2018.211433","title":"Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Stroke (engine); Hazard ratio; Thrombophilia; Internal medicine; Risk factor; Population; Confidence interval; Pediatrics; Factor V Leiden; Antithrombin; Proportional hazards model; Surgery; Thrombosis; Heparin; Venous thrombosis","score_opus":0.015405589626881525,"score_gpt":0.27481494102433085,"score_spread":0.2594093513974493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913401942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234974,0.0003097701,0.000034450975,0.0005391832,0.00035826015,0.0004383414,0.000022212049,0.000032898148,0.005915159],"genre_scores_gemma":[0.9992199,0.00007691407,0.00027901612,0.00012124171,0.000053384447,0.000016518188,0.000045053115,0.000007846307,0.00018015965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989617,0.0000575495,0.0003271686,0.00018725019,0.00030707757,0.0001592713],"domain_scores_gemma":[0.9994496,0.00005387479,0.00016210989,0.00023653868,0.00006247582,0.00003536287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023813579,0.00009930032,0.000306444,0.00013260564,0.000026201817,0.000008323407,0.0001321379,0.00009659909,0.00086892536],"category_scores_gemma":[0.00006695744,0.00006513327,0.000091460635,0.0001607132,0.000012765672,0.000056615234,0.00006494562,0.00016544625,0.000092047216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008033583,0.0003433276,0.94139904,0.00003587681,0.000030508272,0.0000037460452,0.00016607597,0.0000070910824,0.0023880934,0.054477807,0.000045100183,0.0010230205],"study_design_scores_gemma":[0.001419077,0.00023099416,0.98920494,0.00004194971,0.00005740651,0.00003027818,0.00043150855,0.002026149,0.002005367,0.0036336451,0.0008241688,0.00009448398],"about_ca_topic_score_codex":0.000021337133,"about_ca_topic_score_gemma":0.00002396167,"teacher_disagreement_score":0.05084416,"about_ca_system_score_codex":0.000026778285,"about_ca_system_score_gemma":0.000021807411,"threshold_uncertainty_score":0.9514124},"labels":[],"label_agreement":null},{"id":"W2913806361","doi":"10.3324/haematol.2018.205526","title":"IgG4-related disease: what a hematologist needs to know","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; IgG4-related disease; Retroperitoneal fibrosis; Rituximab; Autoimmune pancreatitis; Lymphoplasmacytic Lymphoma; Lymphoma; Pathology; Disease; Eosinophilia; Bone marrow; Lymphoproliferative disorders; Fibrosis; Hypergammaglobulinemia; Waldenstrom macroglobulinemia","score_opus":0.05655250605357538,"score_gpt":0.34915730279394286,"score_spread":0.2926047967403675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913806361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020259414,0.9870087,0.0000065615072,0.0008322264,0.0012493922,0.0042185136,0.00009473106,0.000810107,0.005577177],"genre_scores_gemma":[0.0002459822,0.98818564,0.00009607533,0.00090089464,0.00013737744,0.0005998221,0.0008481038,0.00018713842,0.008798941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994928,0.00034426004,0.0017980131,0.00120057,0.00064566225,0.0010834947],"domain_scores_gemma":[0.9954062,0.00038365353,0.0007052611,0.0019310055,0.00020447622,0.0013693867],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0002805933,0.0013090664,0.00595431,0.0009402965,0.00020186095,0.00023326138,0.00070866174,0.0013031302,0.0021725579],"category_scores_gemma":[0.0007561853,0.0008926917,0.0019951237,0.0015143665,0.00026115373,0.00033456198,0.00039671522,0.0010813979,0.020011056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036384902,0.0010033128,0.00024454418,0.14296858,0.001707877,0.009941279,0.00019021895,0.000004164355,7.541924e-7,0.0183167,0.12006765,0.7051911],"study_design_scores_gemma":[0.00054285,0.00022476426,0.000025590622,0.075098135,0.0048024403,0.0020233167,0.00013484436,0.000007136358,0.0000014272651,0.00010918306,0.91609836,0.0009319798],"about_ca_topic_score_codex":0.0000032068756,"about_ca_topic_score_gemma":6.0943023e-7,"teacher_disagreement_score":0.7960307,"about_ca_system_score_codex":0.00021724853,"about_ca_system_score_gemma":0.0010370484,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W2914988374","doi":"10.3324/haematol.2018.207837","title":"ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Bijzonder Onderzoeksfonds UGent; Universiteit Gent; Vlaamse regering; National Health and Medical Research Council; Swiss Bridge Foundation; European Hematology Association","keywords":"Biology; Cancer research; Progenitor cell; Transcription factor; Haematopoiesis; Cell biology; Cellular differentiation; Stem cell; Leukemia; Immunology; Genetics; Gene","score_opus":0.007954733886676247,"score_gpt":0.23922216608475683,"score_spread":0.23126743219808057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914988374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777815,0.0005536146,0.0058979257,0.00048401605,0.00027696128,0.0012013522,0.000020562456,0.0002641646,0.013519922],"genre_scores_gemma":[0.99089867,0.00008137402,0.0039928257,0.0006579059,0.000080667945,0.00006572493,0.000054161042,0.000067496825,0.004101166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970385,0.000113892274,0.0004772641,0.0008503391,0.0006921282,0.00082789146],"domain_scores_gemma":[0.99786806,0.0005578851,0.0001845823,0.00075530267,0.0001639304,0.00047023155],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027391803,0.00044764872,0.0009644104,0.00017912661,0.00015084146,0.00005363856,0.00031556928,0.00050392223,0.0011709114],"category_scores_gemma":[0.00023992716,0.00032145128,0.00018661916,0.00035848015,0.00023592376,0.000105391344,0.00038989694,0.0005036444,0.0024181423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011704768,0.0017107902,0.024963098,0.006592816,0.0012907453,0.018243691,0.0022101593,0.00008966171,0.85910004,0.027466299,0.03356864,0.01305928],"study_design_scores_gemma":[0.09985559,0.019025117,0.18721247,0.0036909676,0.0035141413,0.10451924,0.0041086073,0.1476123,0.3358339,0.056526307,0.030352537,0.0077488255],"about_ca_topic_score_codex":0.000057301117,"about_ca_topic_score_gemma":0.000005069389,"teacher_disagreement_score":0.52326614,"about_ca_system_score_codex":0.0008823026,"about_ca_system_score_gemma":0.0006946984,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2916869227","doi":"10.3324/haematol.2018.214593","title":"Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"National Key Research and Development Program of China; Chinese Academy of Medical Sciences Initiative for Innovative Medicine; National Natural Science Foundation of China","keywords":"Myeloid leukemia; Thrombopoiesis; Bone marrow; Haematopoiesis; Leukemia; Medicine; Immunology; Cancer research; Acute leukemia; Myeloid; Megakaryocyte; Stem cell; Biology; Cell biology","score_opus":0.01190285207895406,"score_gpt":0.2531779952257883,"score_spread":0.24127514314683426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916869227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862509,0.00036104332,0.000033153032,0.0016277472,0.00019640014,0.0012445614,0.000035623096,0.00009185394,0.010158751],"genre_scores_gemma":[0.9949222,0.00010626496,0.00086183555,0.0016806104,0.000012679945,0.00008993856,0.00005919345,0.000024416602,0.0022428478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984732,0.00004546477,0.00037237105,0.00045336143,0.00017532082,0.00048025697],"domain_scores_gemma":[0.99928313,0.00007482347,0.00008860585,0.0003646167,0.000049649796,0.00013919121],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000101175254,0.0002673527,0.001076705,0.00016239357,0.000045021137,0.000029827293,0.00015512585,0.00018139005,0.0006292257],"category_scores_gemma":[0.00005065217,0.00019648303,0.00012328783,0.00023467676,0.00004931551,0.000071912924,0.00011723933,0.0002137229,0.0021744177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052877376,0.0012873336,0.19033292,0.00030339148,0.0006442234,0.022838904,0.0013965964,0.000019769626,0.7620739,0.0015201581,0.010943604,0.0033514882],"study_design_scores_gemma":[0.050544806,0.004308259,0.22387646,0.0010818861,0.00064603955,0.0045908894,0.0016170722,0.00035653097,0.6757419,0.0029555531,0.032766227,0.0015143857],"about_ca_topic_score_codex":0.00009708702,"about_ca_topic_score_gemma":0.000073347896,"teacher_disagreement_score":0.08633199,"about_ca_system_score_codex":0.00021905164,"about_ca_system_score_gemma":0.000106472915,"threshold_uncertainty_score":0.9986025},"labels":[],"label_agreement":null},{"id":"W2917196540","doi":"10.3324/haematol.2019.216796","title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada; Baxalta; National Science Foundation; National Institutes of Health; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"ADAMTS13; Compound heterozygosity; Medicine; Thrombotic thrombocytopenic purpura; Gastroenterology; Internal medicine; Disease; Genotype; Allele; Age of onset; Pediatrics; Genetics; Biology; Gene; Platelet","score_opus":0.022099107912404194,"score_gpt":0.25729035820357293,"score_spread":0.23519125029116875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917196540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694229,0.0030182695,0.0000062346744,0.0033292603,0.0039006216,0.0007722905,0.00006820291,0.00014518014,0.019337077],"genre_scores_gemma":[0.98413986,0.00013720659,0.000027612845,0.0003056822,0.00004155656,0.00009543904,0.0002034245,0.000015977985,0.015033224],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982378,0.000176966,0.0004633853,0.0004919199,0.00013539453,0.00049453723],"domain_scores_gemma":[0.99836016,0.0004468063,0.00024319842,0.0008459365,0.000070863156,0.00003301838],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033405534,0.0002539291,0.00044389663,0.000048007336,0.0005285309,0.00007338753,0.0012444423,0.00017386854,0.010429805],"category_scores_gemma":[0.000147178,0.0001636717,0.00018323165,0.0000780989,0.00026849506,0.00010521642,0.000780104,0.00021198376,0.01188384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044796846,0.00024122844,0.12050255,0.0000780034,0.000897891,0.00014376918,0.00030854833,0.000011844067,0.03756012,0.019432656,0.8201365,0.00023890485],"study_design_scores_gemma":[0.0033488872,0.00040312015,0.16341387,0.00023748816,0.00013850577,0.0024899538,0.0015361927,0.000026988133,0.015875466,0.0020554266,0.8097452,0.00072893803],"about_ca_topic_score_codex":0.00004335115,"about_ca_topic_score_gemma":0.000063654334,"teacher_disagreement_score":0.042911317,"about_ca_system_score_codex":0.00017449743,"about_ca_system_score_gemma":0.00006167026,"threshold_uncertainty_score":0.9904748},"labels":[],"label_agreement":null},{"id":"W2917444309","doi":"10.3324/haematol.2018.209619","title":"Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grifols; Skånes universitetssjukhus; Lunds Universitet; Institut National de la Santé et de la Recherche Médicale; Helsingin ja Uudenmaan Sairaanhoitopiiri; Pfizer; Hospital for Sick Children; Great Ormond Street Hospital for Children; Swedish Orphan Biovitrum; Aix-Marseille Université; Institut National de la Recherche Agronomique; Baxalta; CSL Behring; Helsingin Yliopisto; Bayer","keywords":"Medicine; Vaginal delivery; Intracranial Hemorrhages; Incidence (geometry); Obstetrics; Cesarean delivery; Pediatrics; Pregnancy; Surgery","score_opus":0.03410179109182764,"score_gpt":0.31381053151399274,"score_spread":0.2797087404221651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917444309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653304,0.0009948775,0.000027479055,0.00067644485,0.000071543065,0.00088223524,0.000037037247,0.0000297845,0.00074755744],"genre_scores_gemma":[0.9975573,0.00033658004,0.0015906213,0.000117912685,0.00006740649,0.00003708201,0.000013276636,0.000018112565,0.00026170796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891776,0.000052250707,0.00025254872,0.0003228273,0.0001754469,0.000279175],"domain_scores_gemma":[0.99939966,0.00018548021,0.000064195905,0.00017129027,0.000081278784,0.000098119795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018560224,0.00017078425,0.0005085065,0.00018406424,0.000057374127,0.000012667415,0.000055816854,0.00020762422,0.000094736126],"category_scores_gemma":[0.000034846507,0.00012344861,0.00006313088,0.00012380234,0.00013919095,0.00007546167,0.00005383916,0.00018349133,0.0000076253887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031423334,0.00047851898,0.95759517,0.0018002351,0.00023412096,0.00045112174,0.00076136424,0.000019707728,0.026018465,0.0002954902,0.00030762184,0.0088958265],"study_design_scores_gemma":[0.06380284,0.012638831,0.6357438,0.0025213005,0.002134397,0.008365858,0.0067448854,0.084834926,0.16948482,0.008364102,0.0029687546,0.0023954904],"about_ca_topic_score_codex":0.00032600353,"about_ca_topic_score_gemma":0.000068549816,"teacher_disagreement_score":0.3218514,"about_ca_system_score_codex":0.00003505671,"about_ca_system_score_gemma":0.000046553312,"threshold_uncertainty_score":0.5034088},"labels":[],"label_agreement":null},{"id":"W2918035369","doi":"10.3324/haematol.2018.207548","title":"Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Skånes universitetssjukhus; University of Aberdeen; Universiteit Leiden; Newcastle University; Hospital for Sick Children; Royal Devon and Exeter NHS Foundation Trust; Wellcome Trust; James Cook University; University of Nottingham","keywords":"Lymphoproliferative disease; Immunosuppression; Virology; Cytotoxic T cell; Immunology; Medicine; Epstein–Barr virus; Virus; Disease; Lymphoproliferative disorders; Term (time); Biology; Lymphoma; Pathology; Genetics","score_opus":0.019045199998360504,"score_gpt":0.26200250503100203,"score_spread":0.2429573050326415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918035369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81726086,0.04234376,0.00011989199,0.123016976,0.0028458324,0.008909503,0.0027761708,0.0007785061,0.001948502],"genre_scores_gemma":[0.6821917,0.0058868006,0.00011601249,0.28913525,0.001166529,0.0031476622,0.0044537014,0.0003362194,0.013566103],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948307,0.0003353086,0.0010193925,0.0015969168,0.0008293376,0.0013883377],"domain_scores_gemma":[0.99677867,0.00059903436,0.00081848964,0.0011183346,0.0003568412,0.00032862928],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00028343822,0.0012355534,0.0025060782,0.00030188548,0.00043375482,0.0002325541,0.0004275429,0.0021296376,0.0005508249],"category_scores_gemma":[0.0004480125,0.00093762873,0.0009780693,0.0002622307,0.00040128766,0.00022781178,0.00024708972,0.0011358984,0.00022837761],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063652718,0.00024337838,0.04142709,0.0013496667,0.0009889795,0.0019980522,0.00042746784,0.000001421665,0.00048826623,0.000026161353,0.9462228,0.00046144426],"study_design_scores_gemma":[0.10873111,0.006222937,0.22728361,0.013665841,0.007624792,0.00071377977,0.0006501691,0.000483507,0.0061629103,0.0050059333,0.6137533,0.0097021],"about_ca_topic_score_codex":0.000049155144,"about_ca_topic_score_gemma":0.000028524315,"teacher_disagreement_score":0.3324695,"about_ca_system_score_codex":0.00091558124,"about_ca_system_score_gemma":0.00076612405,"threshold_uncertainty_score":0.99930745},"labels":[],"label_agreement":null},{"id":"W2921220965","doi":"10.3324/haematol.2018.202283","title":"Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Amgen","keywords":"Romiplostim; Immune thrombocytopenia; Medicine; Platelet; Term (time); Immune system; Thrombopoietin; Immunology; Pediatrics; Biology","score_opus":0.015680505865902944,"score_gpt":0.2567007271871789,"score_spread":0.24102022132127596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921220965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927785,0.0038540931,0.0000020368639,0.0003853367,0.00001473614,0.0021896889,0.000035918154,0.00009024889,0.00064946845],"genre_scores_gemma":[0.996368,0.0018137693,0.0003791822,0.000045133245,0.000011942678,0.0001677239,0.00014800968,0.00003944962,0.0010267977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984691,0.000057487323,0.00025611033,0.00058111275,0.00017498013,0.00046118343],"domain_scores_gemma":[0.9989224,0.00010327725,0.00011465932,0.0007080475,0.000023005487,0.00012862026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042238466,0.00044268635,0.001204736,0.00014244043,0.000082753184,0.000034612665,0.000113131646,0.00013923689,0.00024230046],"category_scores_gemma":[0.00001080211,0.00023118162,0.000066271736,0.00017846524,0.00014599455,0.00011283267,0.00005246644,0.00010223461,0.000116553405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041859825,0.0010894621,0.9822953,0.00003043372,0.00086230645,0.004734812,0.00014192623,0.000005650574,0.00032096353,0.000045633158,0.000006878909,0.0062806914],"study_design_scores_gemma":[0.027813012,0.01819508,0.9415464,0.00025590614,0.000281428,0.007745984,0.00003052874,0.000014626738,0.0037476325,0.000026165582,0.00006231813,0.0002809655],"about_ca_topic_score_codex":0.00041342143,"about_ca_topic_score_gemma":0.0009771996,"teacher_disagreement_score":0.040748905,"about_ca_system_score_codex":0.0003164954,"about_ca_system_score_gemma":0.00017864216,"threshold_uncertainty_score":0.9427313},"labels":[],"label_agreement":null},{"id":"W2922443156","doi":"10.3324/haematol.2018.209924","title":"Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Ottawa Hospital; Thrombosis and Atherosclerosis Research Institute","funders":"Bayer","keywords":"Vignette; Venous thromboembolism; Anticoagulant therapy; Medicine; Anticoagulant; Fractional factorial design; Internal medicine; Intensive care medicine; Factorial experiment; Mathematics; Thrombosis; Statistics","score_opus":0.07872900564231253,"score_gpt":0.3621470513603932,"score_spread":0.2834180457180807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922443156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6773668,0.0012609093,0.00020362114,0.29459345,0.008978679,0.012997735,0.000114055554,0.00059729046,0.0038874687],"genre_scores_gemma":[0.55103225,0.0007351236,0.0002580561,0.4429287,0.0036575354,0.00052037835,0.00050201727,0.00013702265,0.00022893006],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99367225,0.000760628,0.0016221738,0.001605991,0.0012606513,0.0010783054],"domain_scores_gemma":[0.9964229,0.0010009131,0.0007283207,0.0015249361,0.00018763264,0.00013529763],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00090374926,0.00090118306,0.004887901,0.00047956168,0.00013780534,0.00010293034,0.00057792146,0.0016067352,0.001445717],"category_scores_gemma":[0.000277896,0.00068059086,0.000673986,0.00036380408,0.00016754596,0.000089054316,0.00016062916,0.0030961912,0.0006971511],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048954814,0.014573616,0.049635112,0.00041225893,0.0010283783,0.010834585,0.00018022626,0.00001632325,0.000021430196,0.000065409746,0.92151695,0.0012261369],"study_design_scores_gemma":[0.009280612,0.0077626845,0.5108578,0.00052403484,0.00059323333,0.00012338629,0.00014197688,0.00009427372,0.000030031411,0.00030562948,0.4693196,0.00096667645],"about_ca_topic_score_codex":0.00025341185,"about_ca_topic_score_gemma":0.000024788427,"teacher_disagreement_score":0.46122274,"about_ca_system_score_codex":0.00020770755,"about_ca_system_score_gemma":0.00048250702,"threshold_uncertainty_score":0.9996894},"labels":[],"label_agreement":null},{"id":"W2926348605","doi":"10.3324/haematol.2018.206540","title":"Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Frank A. Campini Foundation","keywords":"Medicine; Aplastic anemia; Internal medicine; Anemia; Hematopoietic stem cell transplantation; Refractory (planetary science); Gastroenterology; Pediatrics; Surgery; Transplantation; Bone marrow","score_opus":0.01735950502544225,"score_gpt":0.2738170451576972,"score_spread":0.25645754013225497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926348605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268234,0.0005519316,0.00049598754,0.00012455502,0.00048626482,0.0049412213,0.00006957674,0.0002750641,0.0003730795],"genre_scores_gemma":[0.99697477,0.000620017,0.00094264885,0.0002024199,0.00025603586,0.0005822159,0.00013090264,0.00007319962,0.00021777563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678826,0.00016920004,0.00086873054,0.00086511875,0.0005627645,0.0007459144],"domain_scores_gemma":[0.9963548,0.0019140103,0.00053777377,0.0006717327,0.0002635276,0.0002581528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023243825,0.00050631067,0.0012498243,0.00034553377,0.00016376932,0.00004408626,0.0003010869,0.00017274385,0.00035598417],"category_scores_gemma":[0.00028535578,0.00038946042,0.00021998104,0.0008813211,0.00011967205,0.00009591523,0.00004548322,0.000407767,0.0005432816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016121,0.0010333124,0.9931822,0.0011571188,0.00008214878,0.00044592103,0.0009636631,0.00004360206,0.0002680444,0.000040526324,0.0010146354,0.00015673503],"study_design_scores_gemma":[0.0098421825,0.0066938596,0.9775628,0.0000376396,0.0012507976,0.0015602959,0.0014864948,0.00019552725,0.0005613688,0.000028319404,0.00011483199,0.00066590315],"about_ca_topic_score_codex":0.000032601994,"about_ca_topic_score_gemma":0.000017334696,"teacher_disagreement_score":0.015619413,"about_ca_system_score_codex":0.00006647654,"about_ca_system_score_gemma":0.00025337577,"threshold_uncertainty_score":0.99985576},"labels":[],"label_agreement":null},{"id":"W2926630840","doi":"10.3324/haematol.2018.209528","title":"THROMBOTECT takes the lead","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lead (geology); Medicine; Intensive care medicine; Biology","score_opus":0.06572114236027245,"score_gpt":0.28877072286259026,"score_spread":0.22304958050231782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926630840","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010050031,0.0006654586,0.00027583513,0.9481996,0.0009840042,0.0010448096,0.000013272468,0.00030754606,0.04750445],"genre_scores_gemma":[0.031611163,0.000061267805,0.0005935662,0.9515036,0.0013225429,0.000067828485,0.0001793234,0.00006661273,0.014594115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805695,0.00015821471,0.00035380354,0.0004921519,0.00051401416,0.00042484293],"domain_scores_gemma":[0.9982953,0.00029109235,0.00023439362,0.0010549581,0.000091602305,0.00003262244],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017981365,0.00037473027,0.0010091023,0.000090495785,0.00014433496,0.00004986332,0.00034348384,0.0011480227,0.0018796102],"category_scores_gemma":[0.00012023291,0.00019886688,0.0003524069,0.00017247829,0.00014700906,0.00003143091,0.00006393657,0.0018790915,0.0035932276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010813575,0.000031549593,0.00005580498,0.00022421728,0.0001614242,0.00043446448,0.00006298817,2.70826e-7,0.00020873724,0.0013377615,0.9970986,0.00037332793],"study_design_scores_gemma":[0.0004749268,0.00026415446,0.00059030787,0.00022417809,0.00037343858,0.0011618524,0.00006235865,0.00004642699,0.0013044978,0.0013355928,0.99387544,0.00028683472],"about_ca_topic_score_codex":0.0000123954105,"about_ca_topic_score_gemma":0.0000020244436,"teacher_disagreement_score":0.032910336,"about_ca_system_score_codex":0.000029692648,"about_ca_system_score_gemma":0.000088325316,"threshold_uncertainty_score":0.9990328},"labels":[],"label_agreement":null},{"id":"W2928049355","doi":"10.3324/haematol.2018.211086","title":"Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Autoantibody; Glycoprotein; Antigen; Platelet; Avidity; Antibody; Platelet membrane glycoprotein; Immunology; Monoclonal antibody; Medicine; Immune system; Immune thrombocytopenia; Molecular biology; Biology","score_opus":0.006762883703364924,"score_gpt":0.2206216580224373,"score_spread":0.21385877431907238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928049355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161166,0.0006460157,0.0000054009465,0.0006079718,0.00005457205,0.0014640267,0.000011988056,0.00005738071,0.0055409716],"genre_scores_gemma":[0.9969838,0.00003698569,0.0017055363,0.00030215827,0.0000035352023,0.00005760514,0.000087260574,0.000024124101,0.0007989423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861866,0.000031583804,0.00034162746,0.00037070102,0.00026485842,0.000372546],"domain_scores_gemma":[0.99925554,0.000025319718,0.00012631464,0.0004659337,0.000057701465,0.00006917021],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000077165016,0.00023194322,0.00094248896,0.00008967107,0.00004491529,0.000013515934,0.00011536818,0.00013196198,0.001436337],"category_scores_gemma":[0.00002614556,0.00014319485,0.000082776634,0.00023040935,0.000051680472,0.000092941315,0.00006421385,0.00019791539,0.0010076368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023531674,0.0016468414,0.99171275,0.00014084122,0.00018582435,0.0015050747,0.00034918002,0.0000020680106,0.00070647406,0.00028585378,0.00023510122,0.0008768301],"study_design_scores_gemma":[0.012537532,0.002010651,0.97811234,0.00034438775,0.000049016024,0.00015634994,0.00008266983,0.00003799305,0.004488311,0.0005124818,0.0014028803,0.0002653792],"about_ca_topic_score_codex":0.00014347876,"about_ca_topic_score_gemma":0.0000073975257,"teacher_disagreement_score":0.013600395,"about_ca_system_score_codex":0.000054869502,"about_ca_system_score_gemma":0.000046646357,"threshold_uncertainty_score":0.99977016},"labels":[],"label_agreement":null},{"id":"W2938912331","doi":"10.3324/haematol.2018.213512","title":"ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Oncology; Lymphoma; Internal medicine; Anaplastic lymphoma kinase; Cancer research","score_opus":0.014647189949418797,"score_gpt":0.2568785740166578,"score_spread":0.24223138406723901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938912331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617326,0.0002744272,0.000006032633,0.000049556238,0.00007392567,0.00077138084,0.0012147414,0.000029815033,0.0014068368],"genre_scores_gemma":[0.9937215,0.000046648736,0.00039125825,0.0003078808,0.0000063583893,0.000041326904,0.005458174,0.000013892632,0.000012954808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780047,0.00013246437,0.00057765434,0.00066064927,0.00046276895,0.00036600005],"domain_scores_gemma":[0.99822676,0.00021151813,0.00029213203,0.0009800342,0.00013219581,0.00015736782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013793525,0.00024602364,0.0009650434,0.0004202686,0.000037490852,0.000015429378,0.00028813718,0.00014853243,0.00028489184],"category_scores_gemma":[0.00010597166,0.0001771882,0.00013745505,0.00079729647,0.00004515758,0.0001561077,0.00029098126,0.000059906684,0.000083892635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007518401,0.013009258,0.97728586,0.00008865729,0.0012273384,0.0002508808,0.0010200633,0.000015170378,0.000007812441,0.00013820681,0.00022034167,0.005984567],"study_design_scores_gemma":[0.011911871,0.002720052,0.9787358,0.00020772628,0.0024487083,0.000010897695,0.00065828906,0.0022199792,0.0007376078,0.0000107608175,0.00014734961,0.00019095521],"about_ca_topic_score_codex":0.00023978719,"about_ca_topic_score_gemma":0.0002654363,"teacher_disagreement_score":0.011160031,"about_ca_system_score_codex":0.00010684327,"about_ca_system_score_gemma":0.00007816535,"threshold_uncertainty_score":0.7225525},"labels":[],"label_agreement":null},{"id":"W2941404034","doi":"10.3324/haematol.2018.214957","title":"Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Epigenetics; Genetics; Biology; DNA sequencing; Computational biology; Evolutionary biology; Gene","score_opus":0.13369967544279251,"score_gpt":0.31145699692775386,"score_spread":0.17775732148496134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941404034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8906359,0.035265837,0.00024430655,0.07188604,0.0002583678,0.0010642927,0.00003671968,0.000040708288,0.0005677972],"genre_scores_gemma":[0.8184945,0.009128614,0.0034971589,0.16664757,0.0006175967,0.00012532866,0.00091502495,0.000060000293,0.0005142413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802035,0.00011433366,0.00060095,0.0005450624,0.0004287416,0.00029058792],"domain_scores_gemma":[0.99828094,0.00032922212,0.00044045222,0.00071384,0.00017542753,0.00006012492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008233398,0.0004254162,0.0010171987,0.00012435768,0.0001308056,0.000058798516,0.00018304071,0.0007126724,0.000049102266],"category_scores_gemma":[0.00007594633,0.0002390181,0.00018666197,0.00017423244,0.00021998404,0.000034571814,0.0001187548,0.0002167413,0.00002531069],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066721026,0.0005623464,0.010270062,0.0013511032,0.00183995,0.0011746899,0.0018264408,0.0000555143,0.11080902,0.00016838139,0.8608672,0.011008589],"study_design_scores_gemma":[0.0075634513,0.002277418,0.010804844,0.0009808688,0.004997191,0.0019738884,0.000530982,0.00862375,0.30484056,0.00036162804,0.65558237,0.0014630684],"about_ca_topic_score_codex":0.00032579192,"about_ca_topic_score_gemma":0.000033035874,"teacher_disagreement_score":0.20528483,"about_ca_system_score_codex":0.00020081903,"about_ca_system_score_gemma":0.00024229684,"threshold_uncertainty_score":0.9746875},"labels":[],"label_agreement":null},{"id":"W2945827479","doi":"10.3324/haematol.2018.215202","title":"Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; Health Resources and Services Administration; Office of Naval Research; U.S. Department of Defense; National Heart, Lung, and Blood Institute; U.S. Navy","keywords":"Medicine; Hazard ratio; Transplantation; Internal medicine; Myeloid leukemia; Graft-versus-host disease; Sibling; Leukemia; Gastroenterology; Surgery; Immunology; Confidence interval","score_opus":0.01952168664170772,"score_gpt":0.28401988166212866,"score_spread":0.26449819502042093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945827479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918881,0.000023514396,0.0037871914,0.00010891227,0.00039543386,0.0026061386,0.00008046608,0.00014099703,0.00096921186],"genre_scores_gemma":[0.9946404,0.00017985427,0.0034934015,0.00021785806,0.000029667479,0.0001974831,0.00061179197,0.00004702727,0.00058249023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976948,0.00011925077,0.0007421309,0.00055987627,0.00040865416,0.00047528485],"domain_scores_gemma":[0.99885297,0.00039377896,0.00019556603,0.00029442183,0.000117488285,0.00014575238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002801006,0.00029532847,0.00080301164,0.00022815348,0.000051614017,0.000036494934,0.00017540631,0.00033454024,0.0003744006],"category_scores_gemma":[0.000079463396,0.00023411424,0.00015590084,0.00028741997,0.00006857963,0.00019480896,0.000017848351,0.0003045795,0.00035274625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031548582,0.0011938397,0.9136434,0.004040148,0.0013908265,0.0028985674,0.018813457,0.0002453302,0.020293836,0.0035656425,0.0006863523,0.001680021],"study_design_scores_gemma":[0.029603258,0.0019110636,0.93720204,0.0015205105,0.0011126571,0.00089041394,0.00063783536,0.0026288165,0.022613542,0.0009961606,0.00013283119,0.00075084664],"about_ca_topic_score_codex":0.00013150617,"about_ca_topic_score_gemma":0.000113640715,"teacher_disagreement_score":0.02355867,"about_ca_system_score_codex":0.00030695822,"about_ca_system_score_gemma":0.00014854429,"threshold_uncertainty_score":0.95469016},"labels":[],"label_agreement":null},{"id":"W2945961964","doi":"10.3324/haematol.2019.216986","title":"High activation of STAT5A drives peripheral T-cell lymphoma and leukemia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"STAT5; Cancer research; Lymphoma; CD8; T cell; Haematopoiesis; Biology; Anaplastic large-cell lymphoma; Cytokine; Immunology; Medicine; Stem cell; Signal transduction; Immune system; Cell biology","score_opus":0.0072399445658656286,"score_gpt":0.19987590946208345,"score_spread":0.19263596489621782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945961964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939974,0.0016374701,0.00002677135,0.00009677714,0.000271171,0.00015669553,0.000009457851,0.00004632404,0.0037579283],"genre_scores_gemma":[0.99578,0.0002399073,0.00017654525,0.00006691034,0.0000068876125,0.000008156223,0.000018740287,0.000006964861,0.0036958687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992893,0.000071519426,0.00019386645,0.0002174705,0.000025071886,0.00020281813],"domain_scores_gemma":[0.9995706,0.000102440914,0.0001300031,0.00014962275,0.0000363401,0.000010974244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054211676,0.00013343405,0.000365813,0.00004285763,0.00010078592,0.000005316287,0.00009273283,0.00018321845,0.00040021125],"category_scores_gemma":[0.000018836408,0.000091443755,0.0000486286,0.000056788347,0.00024027356,0.000053904187,0.00009531196,0.00007912619,0.00016960087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002557179,0.00015352934,0.039961826,0.000132875,0.00012186076,0.0000053645895,0.0010111271,0.0000071006875,0.94689107,0.0061591067,0.0019693547,0.0033310389],"study_design_scores_gemma":[0.003834559,0.00068772404,0.088843614,0.000056185956,0.00004092444,0.00009023257,0.0019522491,0.0000063415564,0.8877612,0.0010051371,0.015404664,0.00031718644],"about_ca_topic_score_codex":0.00014109407,"about_ca_topic_score_gemma":0.0000066626462,"teacher_disagreement_score":0.059129916,"about_ca_system_score_codex":0.0000266554,"about_ca_system_score_gemma":0.00003015871,"threshold_uncertainty_score":0.43820325},"labels":[],"label_agreement":null},{"id":"W2946604950","doi":"10.3324/haematol.2018.212266","title":"Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Galway; Health Research Board; Massachusetts General Hospital; National Institute of General Medical Sciences; Maine Medical Center Research Institute; American Cancer Society","keywords":"Bortezomib; Sialyltransferase; Multiple myeloma; In vivo; Proteasome inhibitor; Cancer research; Stromal cell; Plasma cell; Tumor microenvironment; Bone marrow; Chemistry; Immunology; Medicine; Immune system; Pharmacology; Biology; Sialic acid; Biochemistry","score_opus":0.012338106528150105,"score_gpt":0.25625402471220426,"score_spread":0.24391591818405417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946604950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974168,0.00003506707,0.0012178381,0.00011641767,0.000010596488,0.00062624615,0.000025671558,0.000013039166,0.00053831603],"genre_scores_gemma":[0.9986352,0.000018001476,0.00078296126,0.00007560877,0.000010402019,0.00006722881,0.00006620311,0.000014981111,0.00032945556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990422,0.00006621249,0.00022047767,0.00035190023,0.0001217624,0.00019743471],"domain_scores_gemma":[0.9995741,0.000025768295,0.000056145334,0.0001675626,0.00009433875,0.00008205924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001345645,0.00013910461,0.00021267204,0.00013032729,0.00006325709,0.000024444511,0.000042040923,0.000084838124,0.000016465718],"category_scores_gemma":[0.000055250508,0.00011796344,0.000028025133,0.00012572986,0.00007092152,0.000015024613,0.000062725085,0.00012793134,0.0000040813497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036504542,0.00012068357,0.01762727,0.00010362817,0.0000055311834,0.0000061209107,0.00010322053,0.00020668452,0.9811838,0.00013149483,0.000030310346,0.00011620237],"study_design_scores_gemma":[0.0014184528,0.0007488402,0.004769174,0.00003901311,0.0000051486622,0.000032508295,0.00017566218,0.0016626387,0.9908765,0.000045525794,0.00006417737,0.00016235064],"about_ca_topic_score_codex":0.00007899617,"about_ca_topic_score_gemma":0.0009616995,"teacher_disagreement_score":0.0128580965,"about_ca_system_score_codex":0.00001121723,"about_ca_system_score_gemma":0.000031831103,"threshold_uncertainty_score":0.48104095},"labels":[],"label_agreement":null},{"id":"W2950359233","doi":"10.3324/haematol.2019.217448","title":"Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; Dexamethasone; Medicine; Lenalidomide; Internal medicine; Hazard ratio; Neutropenia; Bortezomib; Multiple myeloma; Progression-free survival; Confidence interval; Oncology; Gastroenterology; Surgery; Chemotherapy","score_opus":0.02860394486689076,"score_gpt":0.3202406490927045,"score_spread":0.2916367042258137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950359233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642867,0.0015639411,0.0000013697037,0.00018062125,0.00004592891,0.0015756902,0.000067442124,0.000018246901,0.00011809918],"genre_scores_gemma":[0.99939513,0.00009145527,0.0001864047,0.00005489819,0.0000036450128,0.00008752567,0.000027233895,0.0000130462495,0.00014063896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817574,0.00035509068,0.00044522344,0.0004199273,0.0003319986,0.00027202352],"domain_scores_gemma":[0.9980096,0.0008138458,0.0003750857,0.00048320755,0.00020467231,0.000113564594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020044835,0.00023033023,0.0012427055,0.00034813883,0.00007636758,0.000007780452,0.00008297532,0.00012740609,0.000046721827],"category_scores_gemma":[0.00074607786,0.00012261623,0.00012782383,0.00081941235,0.00034461022,0.000037913887,0.00010460589,0.00020284441,0.0000027512456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014169518,0.001958462,0.9628875,0.0010044381,0.0027835513,0.0017257978,0.0022189508,0.00004087749,0.009681999,0.000035218516,0.00014761927,0.0033460448],"study_design_scores_gemma":[0.02026547,0.0037414236,0.93590766,0.00078542286,0.00090241525,0.00004482837,0.0026377046,0.0036094177,0.03174491,0.0000098596265,0.00015293898,0.00019796506],"about_ca_topic_score_codex":0.00020677417,"about_ca_topic_score_gemma":0.0007474688,"teacher_disagreement_score":0.026979879,"about_ca_system_score_codex":0.0000983599,"about_ca_system_score_gemma":0.00005726762,"threshold_uncertainty_score":0.5000144},"labels":[],"label_agreement":null},{"id":"W2952692503","doi":"10.3324/haematol.2019.220475","title":"Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Celgene","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Distribution (mathematics); Variable (mathematics); Medicine; Pathology; Mathematics; Mathematical analysis","score_opus":0.027482284971366486,"score_gpt":0.2800336963888145,"score_spread":0.25255141141744797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952692503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796336,0.0012065187,0.00012526498,0.011527517,0.00035125445,0.002269095,0.0030362871,0.000039930535,0.0018104878],"genre_scores_gemma":[0.9794216,0.0001065574,0.00022941556,0.015865719,0.00020272928,0.00018465039,0.0037344391,0.000023826145,0.0002310645],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99726534,0.00026428155,0.00083990954,0.0006165465,0.00053179846,0.00048209654],"domain_scores_gemma":[0.9975926,0.0006079292,0.00061124197,0.0010260544,0.000108617765,0.00005353739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023512916,0.0004599983,0.0016301105,0.000044800036,0.00006068421,0.000020348609,0.00035740124,0.00064448715,0.00020944659],"category_scores_gemma":[0.00007271301,0.0002690777,0.00026144285,0.00033959514,0.000088472676,0.000039430888,0.0001747887,0.0002965658,0.000067682966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007863306,0.08009653,0.26747835,0.0004992472,0.0004514356,0.0040980084,0.00027960882,0.0000038677545,0.000028959717,0.00032572795,0.64575404,0.00019790442],"study_design_scores_gemma":[0.42897698,0.006036938,0.14633825,0.0019193565,0.0054804073,0.0002956144,0.0015465918,0.00038802242,0.0029596644,0.00061509537,0.40399224,0.0014508542],"about_ca_topic_score_codex":0.0021825747,"about_ca_topic_score_gemma":0.000043341894,"teacher_disagreement_score":0.42819065,"about_ca_system_score_codex":0.00038821902,"about_ca_system_score_gemma":0.0002726609,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W2954881683","doi":"10.3324/haematol.2019.222828","title":"Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Confidence interval; Meta-analysis; Internal medicine; Venous thromboembolism; Anticoagulant therapy; Thrombosis","score_opus":0.06730849768831643,"score_gpt":0.33285654658064,"score_spread":0.2655480488923236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954881683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067182365,0.97802335,0.0000015558722,0.00010587804,0.00007801143,0.014469525,0.00043531682,0.000022585935,0.0001455335],"genre_scores_gemma":[0.06208388,0.93585837,0.00003839277,0.0001189683,0.000005415043,0.0016134639,0.00021139154,0.000053403215,0.000016737657],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9932392,0.001490533,0.0030590533,0.0008891257,0.0008411782,0.00048090037],"domain_scores_gemma":[0.99133486,0.00060770405,0.0059315516,0.0016734792,0.0003602244,0.00009217829],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0013595567,0.0007963754,0.024144366,0.00058953353,0.00007414928,0.000024573157,0.00062824064,0.00040214587,0.0001515437],"category_scores_gemma":[0.0009495868,0.0004103678,0.0016637758,0.0025903762,0.00019658284,0.000097922864,0.00020745509,0.00068241666,0.000006546271],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013051601,0.0048439396,0.0018199111,0.9089705,0.08027454,0.000011698504,0.0004261737,0.000013980313,4.813517e-8,0.00039915112,0.00014766406,0.0030793587],"study_design_scores_gemma":[0.00062375545,0.000619525,0.042072527,0.13775364,0.8180776,0.000007039379,0.000051720745,0.0000052518803,8.9977823e-7,0.00005222869,0.00032002822,0.00041577886],"about_ca_topic_score_codex":0.0010549652,"about_ca_topic_score_gemma":0.0011951254,"teacher_disagreement_score":0.77121687,"about_ca_system_score_codex":0.00026118965,"about_ca_system_score_gemma":0.0003944363,"threshold_uncertainty_score":0.99983484},"labels":[],"label_agreement":null},{"id":"W2954898755","doi":"10.3324/haematol.2019.219725","title":"Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tertiary care; Hematology; Medicine; Internal medicine; Retrospective cohort study; Center (category theory); Hypergammaglobulinemia; Polyclonal antibodies; Oncology; Disease; Immunology; Chemistry; Antibody","score_opus":0.006137392419775965,"score_gpt":0.23758539949813892,"score_spread":0.23144800707836297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954898755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278146,0.0007271748,0.000001146559,0.0012686212,0.00013755007,0.002038844,0.00039063866,0.00018543123,0.002469127],"genre_scores_gemma":[0.9973762,0.000009347396,0.000019579162,0.0011851249,0.000029739158,0.00020877019,0.0009905827,0.00003319862,0.00014743659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750966,0.00039300745,0.0005387596,0.00062816346,0.00045821568,0.00047217935],"domain_scores_gemma":[0.9985896,0.0002098998,0.00021127913,0.00061216176,0.00017236553,0.00020473095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012446193,0.00036016657,0.00076278206,0.00015000011,0.00016667489,0.00003371423,0.00025422472,0.00022261764,0.0011316288],"category_scores_gemma":[0.0002663536,0.00021278924,0.00017751427,0.00041830976,0.00019568624,0.00012687362,0.000071427734,0.0006723308,0.0003007276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006379155,0.001772051,0.98802036,0.000034677687,0.0003398907,0.0050447434,0.002150403,0.000008168718,0.000040057905,0.000951954,0.000984147,0.00001564967],"study_design_scores_gemma":[0.0061931927,0.0005138625,0.98581606,0.00040983388,0.00042201113,0.00024859724,0.0055582216,0.00007369135,0.000021073341,0.0003938452,0.000078024925,0.00027159773],"about_ca_topic_score_codex":0.00008702861,"about_ca_topic_score_gemma":0.00014518201,"teacher_disagreement_score":0.005555277,"about_ca_system_score_codex":0.00015703432,"about_ca_system_score_gemma":0.00021612342,"threshold_uncertainty_score":0.9997815},"labels":[],"label_agreement":null},{"id":"W2956022946","doi":"10.3324/haematol.2018.207811","title":"CD117<sup>hi</sup> expression identifies a human fetal hematopoietic stem cell population with high proliferation and self-renewal potential","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Paris; Institute of Cancer Research; Institut National Du Cancer; Association Française de la Maladie de Fanconi; Université Pierre et Marie Curie; Ligue Contre le Cancer; Université Paris Descartes; Commissariat à l'Énergie Atomique et aux Énergies Alternatives; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale","keywords":"Stem cell; Haematopoiesis; Biology; Cell biology; CD117; Population; Cell growth; Hematopoietic stem cell; Cancer research; Immunology; Genetics; CD34; Medicine","score_opus":0.025311903528613303,"score_gpt":0.29389452068653593,"score_spread":0.26858261715792264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956022946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96028954,0.001376785,0.00008784526,0.033603862,0.00018394495,0.0036799987,0.000041760813,0.00036428368,0.00037196567],"genre_scores_gemma":[0.95892864,0.00010780342,0.00065616606,0.033617362,0.0011001267,0.00036429343,0.001164717,0.00015054464,0.0039103585],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99488646,0.00048294882,0.00084803096,0.0011847586,0.001751731,0.00084604655],"domain_scores_gemma":[0.9979355,0.00018256577,0.0005023933,0.0008607769,0.00028957572,0.00022921455],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041498514,0.000646781,0.0013168699,0.00044602423,0.00045953746,0.00022334963,0.00028946027,0.0013549547,0.00022297305],"category_scores_gemma":[0.00003886965,0.00046212776,0.00014276407,0.00022210354,0.00016212197,0.0002529587,0.00026020422,0.0019364392,0.00019023474],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006039001,0.002652066,0.030763054,0.15920818,0.0009656342,0.050562683,0.00410988,0.00025156862,0.024446087,0.0006308682,0.7169587,0.0034122542],"study_design_scores_gemma":[0.07123678,0.040107384,0.043933738,0.03448511,0.0071535762,0.053462688,0.003492312,0.006922461,0.17522387,0.0067791482,0.54076356,0.016439386],"about_ca_topic_score_codex":0.000119411736,"about_ca_topic_score_gemma":0.000011461163,"teacher_disagreement_score":0.17619519,"about_ca_system_score_codex":0.00019964864,"about_ca_system_score_gemma":0.00028063302,"threshold_uncertainty_score":0.99994147},"labels":[],"label_agreement":null},{"id":"W2958122699","doi":"10.3324/haematol.2018.213348","title":"Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Biotechnology and Biological Sciences Research Council; RWTH Aachen University; British Heart Foundation","keywords":"Prostacyclin; Platelet activation; Endocrinology; Internal medicine; CD36; Platelet; Cyclic adenosine monophosphate; Phosphodiesterase; Signal transduction; Chemistry; Medicine; Biochemistry; Receptor; Enzyme","score_opus":0.012808694681206238,"score_gpt":0.24818343581369018,"score_spread":0.23537474113248394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958122699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936539,0.0025623138,0.0000186873,0.0005294183,0.00014790082,0.0014073447,0.00009266637,0.000113000315,0.0014747513],"genre_scores_gemma":[0.9983777,0.00036712203,0.0001767169,0.00078787346,0.00007581731,0.000056408917,0.000047944006,0.000030388208,0.00008005313],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809045,0.0002303752,0.00036022183,0.00046997727,0.0004518392,0.00039713795],"domain_scores_gemma":[0.99829406,0.00044560357,0.00018525518,0.00079888676,0.00013293594,0.00014328244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032701332,0.0002980142,0.00093028694,0.000045021075,0.00012391918,0.000024980209,0.00020116637,0.00019163519,0.00022397794],"category_scores_gemma":[0.00022287719,0.00018177893,0.00046094277,0.00030197887,0.00016103886,0.00015553935,0.00012582459,0.00030025604,0.00030615876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01254748,0.0048820395,0.50760096,0.00096682634,0.005253698,0.0018070766,0.007734955,0.00020090907,0.36685917,0.0018142919,0.00063262467,0.08969997],"study_design_scores_gemma":[0.002673342,0.00097211625,0.07597053,0.0003664021,0.00037751306,0.0010833147,0.0036535426,0.00007250095,0.8961079,0.00033929522,0.017813737,0.0005697872],"about_ca_topic_score_codex":0.000079371384,"about_ca_topic_score_gemma":0.0000123751515,"teacher_disagreement_score":0.5292488,"about_ca_system_score_codex":0.00002708091,"about_ca_system_score_gemma":0.00009383,"threshold_uncertainty_score":0.741273},"labels":[],"label_agreement":null},{"id":"W2966280182","doi":"10.3324/haematol.2019.222695","title":"Predicting risk for recurrence of arterial ischemic stroke in children: thrombophilia as another piece of the puzzle","year":2019,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thrombophilia; Arterial Ischemic Stroke; Medicine; Ischemic stroke; Stroke (engine); Internal medicine; Cardiology; Ischemia; Thrombosis","score_opus":0.015423507242443695,"score_gpt":0.2742938251090765,"score_spread":0.25887031786663284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966280182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.719427,0.00033288338,0.00008335157,0.0001076047,0.2744901,0.0027522843,0.0010017751,0.000049658065,0.0017553744],"genre_scores_gemma":[0.9422784,0.00017583437,0.0006159529,0.000041663636,0.05617557,0.0001017553,0.00018462983,0.000054768323,0.00037141473],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977454,0.00012877567,0.00077955116,0.00047717488,0.00058950053,0.00027961156],"domain_scores_gemma":[0.9973459,0.00053136604,0.0011478575,0.0007092415,0.00022579264,0.00003982958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045180728,0.0003031564,0.001278268,0.000106163214,0.000059151906,0.000009389002,0.0003940474,0.0009190473,0.00016146807],"category_scores_gemma":[0.0019151955,0.00020482334,0.00032469237,0.00018328197,0.00014642678,0.00004311073,0.00013152722,0.000630419,0.000011830949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017007897,0.001625608,0.17375122,0.0026300717,0.0011235194,0.0000047537505,0.0009291289,0.000015312266,0.035356205,0.0014228533,0.78055745,0.0008831136],"study_design_scores_gemma":[0.05082128,0.009024787,0.11735498,0.018514106,0.006310997,0.000268382,0.001097985,0.0009825963,0.46867248,0.006127012,0.3176128,0.003212617],"about_ca_topic_score_codex":0.000110478715,"about_ca_topic_score_gemma":0.000025224203,"teacher_disagreement_score":0.46294463,"about_ca_system_score_codex":0.000033912027,"about_ca_system_score_gemma":0.00027359222,"threshold_uncertainty_score":0.8352453},"labels":[],"label_agreement":null},{"id":"W2967499714","doi":"10.3324/haematol.2018.211201","title":"Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Deutsche Krebshilfe; Medizinischen Hochschule Hannover; Deutsche Forschungsgemeinschaft; European Commission","keywords":"Cancer research; Myeloid leukemia; Leukemia; Biology; Myeloid; MCL1; Haematopoiesis; Acute leukemia; Progenitor cell; Immunology; Stem cell; Cell biology; Gene; Genetics","score_opus":0.029336498116598806,"score_gpt":0.305588594474818,"score_spread":0.2762520963582192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967499714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702727,0.00033856646,0.0004950888,0.0027600317,0.0003590861,0.003140875,0.000108291824,0.00041552258,0.022109818],"genre_scores_gemma":[0.9509726,0.00015671834,0.014099593,0.0024766435,0.00023669719,0.0004401211,0.00030249922,0.000114136084,0.031201003],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960894,0.00011291121,0.0007292909,0.0010521242,0.0007182624,0.0012980254],"domain_scores_gemma":[0.99723494,0.000460094,0.00026392797,0.001228568,0.00035277827,0.000459662],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000719345,0.00053519715,0.0014169142,0.0003407002,0.00025309453,0.000086438,0.00059951044,0.0006567211,0.0020331412],"category_scores_gemma":[0.00039022774,0.0004166349,0.0004981538,0.00063037605,0.00018458968,0.00020851284,0.00030305746,0.0007774876,0.003392227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007391439,0.0003565307,0.021807969,0.001987496,0.0024124053,0.0028262436,0.0020451895,0.000034509583,0.23972821,0.005214127,0.7101458,0.0060500856],"study_design_scores_gemma":[0.025648788,0.00412762,0.012484459,0.00067119213,0.0010944902,0.005660423,0.0016001423,0.013538082,0.62893575,0.0012034538,0.30309713,0.001938441],"about_ca_topic_score_codex":0.00009365108,"about_ca_topic_score_gemma":0.000011463368,"teacher_disagreement_score":0.40704867,"about_ca_system_score_codex":0.0013700873,"about_ca_system_score_gemma":0.0011417494,"threshold_uncertainty_score":0.9998286},"labels":[],"label_agreement":null},{"id":"W2967535150","doi":"10.3324/haematol.2019.221093","title":"Hemophilia A and B: molecular and clinical similarities and differences","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Factor IX; Coagulation; Medicine; Coagulopathy; Gene; Hematology; Genetics; Internal medicine; Biology","score_opus":0.19487917312064362,"score_gpt":0.4379213097387315,"score_spread":0.24304213661808788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967535150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020139515,0.9768437,0.0000012335842,0.00055599364,0.00005681095,0.0010771258,0.000016765867,0.00004047198,0.0012683565],"genre_scores_gemma":[0.002775329,0.9956595,0.00028762477,0.00011029141,0.000045333858,0.000043644068,0.000028810746,0.000023896257,0.0010255851],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981714,0.00022115372,0.00048963865,0.0006094115,0.00021080211,0.00029763076],"domain_scores_gemma":[0.9986258,0.0006669904,0.00011595644,0.00029975834,0.000036306763,0.00025515966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002723582,0.00037109296,0.002778529,0.00012608792,0.00007988414,0.000048880887,0.00007555907,0.00059906655,0.00005404298],"category_scores_gemma":[0.00025373732,0.00020278932,0.00021382072,0.00008969623,0.0006211977,0.000027550275,0.0002501775,0.00051134365,0.0000264985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047995996,0.00017712351,0.01532114,0.06405332,0.0006942394,0.002248076,0.000041882628,3.1016176e-10,3.8584147e-7,0.0019803396,0.0004642664,0.91497123],"study_design_scores_gemma":[0.001984463,0.0021883245,0.0037567834,0.025051834,0.004886115,0.0075305947,0.000111564514,0.000017596383,0.0000032076837,0.001051273,0.95262736,0.0007908533],"about_ca_topic_score_codex":0.0000051086386,"about_ca_topic_score_gemma":0.0000012196779,"teacher_disagreement_score":0.9521631,"about_ca_system_score_codex":0.000011978837,"about_ca_system_score_gemma":0.00011354109,"threshold_uncertainty_score":0.82695085},"labels":[],"label_agreement":null},{"id":"W2969992885","doi":"10.3324/haematol.2019.224204","title":"Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Chimeric antigen receptor; Multiple myeloma; Medicine; Cell therapy; Clinical trial; Antigen; Daratumumab; Monoclonal antibody; Immunology; Targeted therapy; Bortezomib; Cancer research; Immunotherapy; Oncology; Cancer; Internal medicine; Antibody; Cell; Biology","score_opus":0.04202163171986532,"score_gpt":0.2957468530958976,"score_spread":0.25372522137603226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969992885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761751,0.0028550122,0.00012772932,0.0027051864,0.00043475095,0.003801261,0.000072000155,0.00017671248,0.013652198],"genre_scores_gemma":[0.98597,0.0011401601,0.004617668,0.0016837727,0.0005176121,0.00015195641,0.00022823446,0.000094342475,0.0055962047],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972047,0.00058865943,0.0005004529,0.00058815046,0.00040138784,0.000716626],"domain_scores_gemma":[0.9972471,0.0013591702,0.00020904136,0.0008855684,0.00013175797,0.00016738888],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010549902,0.0003077604,0.00063207076,0.000041305924,0.0002289487,0.000056033485,0.0003823304,0.00010453002,0.005338923],"category_scores_gemma":[0.00011473225,0.00018279959,0.00025640742,0.00026309985,0.00017791163,0.000024722707,0.0001287961,0.00031059288,0.0012120493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075389566,0.0010199989,0.20847858,0.00015673031,0.00094249204,0.00029194538,0.002081981,0.00007443768,0.39781958,0.00019941006,0.27446985,0.10692603],"study_design_scores_gemma":[0.009588081,0.0015143217,0.09896063,0.00012540986,0.000046791592,0.00007493817,0.00079070893,0.00066635956,0.020989409,0.00024871502,0.8665464,0.00044823717],"about_ca_topic_score_codex":0.00010573251,"about_ca_topic_score_gemma":0.000016980683,"teacher_disagreement_score":0.59207654,"about_ca_system_score_codex":0.000054124554,"about_ca_system_score_gemma":0.0000907484,"threshold_uncertainty_score":0.9995656},"labels":[],"label_agreement":null},{"id":"W2970999010","doi":"10.3324/haematol.2019.223073","title":"Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Astellas Pharma; Gilead Sciences; Pfizer","keywords":"Medicine; Hematopoietic stem cell transplantation; Human herpesvirus 6; Disease; Transplantation; Encephalitis; Hematologic disease; Stem cell; Immunology; Population; Hematopoietic stem cell; Intensive care medicine; Human immunodeficiency virus (HIV); Haematopoiesis; Internal medicine; Viral disease; Herpesviridae; Biology; Virus","score_opus":0.12334746218705059,"score_gpt":0.35608406905288476,"score_spread":0.23273660686583417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970999010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44292793,0.5447697,0.00019791798,0.00015974292,0.00012724799,0.008328371,0.00031548526,0.000054762397,0.003118846],"genre_scores_gemma":[0.12211024,0.87685335,0.00016935544,0.00005449337,0.000011375561,0.00047346562,0.00015709523,0.000030367812,0.00014024995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806356,0.00022855199,0.0007586758,0.00044990345,0.00024667272,0.00025262672],"domain_scores_gemma":[0.99884826,0.00028191617,0.00031529542,0.00037475862,0.00013529854,0.00004449381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035513836,0.00032369202,0.0013163376,0.00023112129,0.00005091172,0.000031096533,0.00012466761,0.00018470651,0.000033675497],"category_scores_gemma":[0.000015316686,0.00017568965,0.00014381965,0.0002610677,0.00010015128,0.000052858824,0.00005718358,0.00030740479,0.000035604007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003718845,0.0029290365,0.4148307,0.29827255,0.00073965173,0.0011837615,0.0017098243,0.000030634357,0.0000027731792,0.004679475,0.0016452739,0.27025747],"study_design_scores_gemma":[0.017527515,0.0051969266,0.49010047,0.2639991,0.0045663035,0.0005989926,0.00052172714,0.00008701868,0.00006309103,0.00066516985,0.21457548,0.0020981818],"about_ca_topic_score_codex":0.0000965348,"about_ca_topic_score_gemma":0.00023048761,"teacher_disagreement_score":0.33208367,"about_ca_system_score_codex":0.0000683453,"about_ca_system_score_gemma":0.00007161444,"threshold_uncertainty_score":0.7164416},"labels":[],"label_agreement":null},{"id":"W2974306493","doi":"10.3324/haematol.2019.219790","title":"Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Donor lymphocyte infusion; Minimal residual disease; Transplantation; Hematopoietic stem cell transplantation; Human leukocyte antigen; Lymphocyte; Immunology; Leukemia; Disease; Acute leukemia; Oncology; Intensive care medicine; Internal medicine; Antigen","score_opus":0.04367591063350241,"score_gpt":0.3336190730132487,"score_spread":0.2899431623797463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974306493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926265,0.00018739527,0.0013175574,0.0026777708,0.00032007153,0.0012433415,0.00016314839,0.000057374993,0.0014068233],"genre_scores_gemma":[0.9934786,0.00039004066,0.005054037,0.00061865436,0.000081432794,0.00007500915,0.00020640493,0.00001881935,0.00007703441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751145,0.0004128015,0.0011139865,0.0004103965,0.00033779824,0.00021355167],"domain_scores_gemma":[0.9955668,0.0026163172,0.0005176616,0.0010483478,0.0001397373,0.00011113764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050305785,0.0001840736,0.00067495723,0.00003775848,0.00013753638,0.00001761349,0.0004024346,0.00026110286,0.00062437356],"category_scores_gemma":[0.00014692103,0.0001042821,0.00024664635,0.00027606037,0.00035803407,0.000039601447,0.0001136836,0.00031065225,0.00012523019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084894925,0.00056495133,0.958685,0.00013170735,0.00056926697,0.000023140132,0.0017636048,0.000017694432,0.017536903,0.0045855613,0.0014755534,0.013797658],"study_design_scores_gemma":[0.008492145,0.00045006495,0.90842575,0.00217662,0.0026587017,0.0003283716,0.0032123737,0.0030756644,0.04983461,0.006732471,0.014072396,0.0005408147],"about_ca_topic_score_codex":0.00046243094,"about_ca_topic_score_gemma":0.00015095051,"teacher_disagreement_score":0.050259244,"about_ca_system_score_codex":0.000067004396,"about_ca_system_score_gemma":0.00026068703,"threshold_uncertainty_score":0.68364525},"labels":[],"label_agreement":null},{"id":"W2974456904","doi":"10.3324/haematol.2019.227561","title":"Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Agence Nationale de la Recherche","keywords":"Immunology; Haematopoiesis; Hematopoietic stem cell transplantation; Transplantation Chimera; Transplantation; Progenitor cell; Stem cell; Biology; Disease; Medicine; Hematopoietic cell; Internal medicine; Genetics","score_opus":0.00567557052555529,"score_gpt":0.22191001822212508,"score_spread":0.2162344476965698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974456904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929298,0.0026351633,0.0012020557,0.0002565776,0.000046443274,0.002814628,0.000060729784,0.000030130685,0.000024482431],"genre_scores_gemma":[0.99395275,0.0007094289,0.0039024472,0.00040035433,0.000008017132,0.00052186893,0.00042878423,0.000023900498,0.00005247399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883306,0.0000338907,0.00029919672,0.0004271596,0.00015380383,0.00025288342],"domain_scores_gemma":[0.99932945,0.00009484123,0.00009961798,0.00023319639,0.00012091186,0.000121981175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078594945,0.00022705583,0.00057716836,0.00018115927,0.00006383546,0.000013298624,0.000050049777,0.0001453156,0.00003865774],"category_scores_gemma":[0.000013210196,0.00014244515,0.00016528743,0.00023413588,0.000059710612,0.00005343767,0.000011414188,0.000074376425,0.0000032363707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01819873,0.0016459005,0.9687546,0.0012194332,0.001053194,0.000120878554,0.0043004258,0.00035970187,0.002543281,0.000044882498,0.000049345046,0.0017096172],"study_design_scores_gemma":[0.016469274,0.0014538651,0.96343744,0.000114465416,0.0013646755,0.000007468628,0.00039361636,0.001450983,0.014175742,0.00010085123,0.0006381441,0.00039348166],"about_ca_topic_score_codex":0.000015500427,"about_ca_topic_score_gemma":0.00002410076,"teacher_disagreement_score":0.01163246,"about_ca_system_score_codex":0.000021983336,"about_ca_system_score_gemma":0.000029728757,"threshold_uncertainty_score":0.58087444},"labels":[],"label_agreement":null},{"id":"W2974951843","doi":"10.3324/haematol.2019.227876","title":"Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Fondazione Umberto Veronesi; Université de Strasbourg; Università degli Studi di Padova; Università degli Studi di Milano; Università degli Studi di Pavia; European Hematology Association","keywords":"Medicine; Antithrombotic; Low molecular weight heparin; Incidence (geometry); Thrombosis; Orthopedic surgery; Venous thromboembolism; Surgery; Anticoagulant; Venous thrombosis; Heparin; Intensive care medicine; Internal medicine","score_opus":0.009453632389824723,"score_gpt":0.2252449972851209,"score_spread":0.21579136489529618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974951843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901819,0.000114608665,0.000016914315,0.00035708217,0.0002856506,0.008535089,0.00003915725,0.00013625446,0.0003332984],"genre_scores_gemma":[0.99877584,0.00011190362,0.00009360013,0.0002997537,0.000022640215,0.00047397398,0.000118859134,0.00006177362,0.000041645973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997334,0.00024739647,0.0005786894,0.00065420556,0.00051081646,0.00067489524],"domain_scores_gemma":[0.9981572,0.0004700099,0.0003899083,0.00073506415,0.00015678686,0.00009102305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069049245,0.00038090145,0.0017379579,0.000198631,0.00022964031,0.000056876885,0.00025312396,0.00017008971,0.00016409931],"category_scores_gemma":[0.0003617985,0.00022053867,0.0001718276,0.00062603987,0.00011726232,0.00010810408,0.00012409006,0.00036178384,0.00009386915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036425938,0.01207343,0.98197806,0.00017516396,0.00053839036,0.00003999684,0.0011452065,0.000049997107,0.000002169278,0.00010339438,0.0012722271,0.0022576905],"study_design_scores_gemma":[0.0048,0.0056633097,0.98711294,0.00017154579,0.00028620937,0.0000034654718,0.0008858775,0.00008196943,0.000012565128,0.00021508383,0.00045573566,0.00031132431],"about_ca_topic_score_codex":0.0005832776,"about_ca_topic_score_gemma":0.00068666943,"teacher_disagreement_score":0.008593904,"about_ca_system_score_codex":0.00009834512,"about_ca_system_score_gemma":0.00007202497,"threshold_uncertainty_score":0.8993306},"labels":[],"label_agreement":null},{"id":"W2975917046","doi":"10.3324/haematol.2019.220756","title":"Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; BC Children's Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Adaptive Biotechnologies; Astellas Pharma; Daiichi-Sankyo; Janssen Scientific Affairs; Incyte; bluebird bio; Chimerix; Medical College of Wisconsin; Bristol-Myers Squibb; CSL Behring; Janssen Biotech; HistoGenetics; Celgene; Karyopharm Therapeutics; Atara Biotherapeutics; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; GlaxoSmithKline; Health Resources and Services Administration; U.S. Department of Health and Human Services; Astellas Pharma US; Amgen; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Hazard ratio; Transplantation; Internal medicine; Monosomy; Medicine; Cytogenetics; Leukemia; Hematopoietic stem cell transplantation; Oncology; Acute lymphocytic leukemia; Acute leukemia; Karyotype; Confidence interval; Biology; Lymphoblastic Leukemia; Genetics","score_opus":0.026895934963424233,"score_gpt":0.31202471121886705,"score_spread":0.2851287762554428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975917046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951398,0.00013822266,0.000071818664,0.00041800822,0.0001371444,0.0028018937,0.00094151206,0.000016530339,0.00033509685],"genre_scores_gemma":[0.99883395,0.0002565284,0.00011205453,0.00010715379,0.000027115526,0.00031952903,0.000037518035,0.000041896026,0.00026426194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963324,0.00044507353,0.00092920626,0.0004932707,0.0012496912,0.0005503707],"domain_scores_gemma":[0.995679,0.0023545553,0.00038778756,0.0006870591,0.00077605504,0.00011553666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005877314,0.00037903053,0.0009989148,0.00022902105,0.00012743672,0.00002671346,0.00072407135,0.00019854867,0.00008600746],"category_scores_gemma":[0.000091480455,0.00019587639,0.00039867611,0.00035329067,0.0006918495,0.00006701312,0.00015963004,0.0003884147,0.0000049922423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011436541,0.001174384,0.9532884,0.0013041586,0.004331161,0.0001773413,0.015656484,0.00014077908,0.011576187,0.00022746353,0.0005763763,0.00011071847],"study_design_scores_gemma":[0.042491097,0.011545896,0.7491695,0.00291082,0.0039479285,0.0021562716,0.009038971,0.0015902022,0.1759545,0.00040051495,0.00002823946,0.00076602655],"about_ca_topic_score_codex":0.00015118868,"about_ca_topic_score_gemma":0.000032457556,"teacher_disagreement_score":0.20411886,"about_ca_system_score_codex":0.0004522729,"about_ca_system_score_gemma":0.0006065092,"threshold_uncertainty_score":0.7987607},"labels":[],"label_agreement":null},{"id":"W2978153272","doi":"10.3324/haematol.2019.232884","title":"Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Department of Medicine, Ottawa Hospital; National Institute for Health and Care Research; Ottawa Hospital Research Institute; University of Ottawa; Heart and Stroke Foundation of Canada","keywords":"Medicine; Venous thromboembolism; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.03411553747755935,"score_gpt":0.2876161270903636,"score_spread":0.25350058961280425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978153272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820829,0.0006085124,0.00004194985,0.01169874,0.00033704977,0.0027532964,0.00014767825,0.00002431183,0.0023055396],"genre_scores_gemma":[0.979138,0.0007887696,0.0005208553,0.019130465,0.00009721069,0.00003804763,0.00020364719,0.000052501662,0.000030466408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687004,0.0003031954,0.001025971,0.00047093042,0.0008324112,0.0004974301],"domain_scores_gemma":[0.9969127,0.0008328383,0.0010999804,0.0009390474,0.00018529138,0.000030103321],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004115384,0.0004350909,0.0038330075,0.00032292743,0.000044441847,0.0000089679215,0.00046365906,0.0005099551,0.00006674374],"category_scores_gemma":[0.00018705719,0.00025432737,0.00025564275,0.00044520415,0.00031467885,0.00005179116,0.00016218513,0.00066519796,0.0000073765736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028920388,0.018090073,0.5652758,0.029657567,0.013788864,0.014645416,0.0114023555,0.00067153067,0.0008210196,0.0014316499,0.3381489,0.0031748025],"study_design_scores_gemma":[0.007348968,0.008389322,0.92841786,0.021314725,0.014067346,0.00063717633,0.00088883773,0.00017645699,0.0030305644,0.00034587074,0.014035304,0.0013475494],"about_ca_topic_score_codex":0.00054093637,"about_ca_topic_score_gemma":0.000022623162,"teacher_disagreement_score":0.36314207,"about_ca_system_score_codex":0.000058921447,"about_ca_system_score_gemma":0.000120469536,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2978446598","doi":"10.3324/haematol.2019.220434","title":"A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Haematopoiesis; Stromal cell; Myostatin; Stem cell; Myeloid leukemia; CD34; Cancer research; Myeloid; Cytokine; Regulator; Bone marrow; Cell biology; STAT5; Leukemia; Immunology; Signal transduction; Endocrinology; Genetics; Muscle hypertrophy","score_opus":0.016825982131862684,"score_gpt":0.24041571984963858,"score_spread":0.2235897377177759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978446598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385387,0.00046536207,0.00008633813,0.0004380369,0.0001403366,0.0013706322,0.00005306586,0.00008927613,0.0035030935],"genre_scores_gemma":[0.99380606,0.00008957179,0.001559495,0.00021674648,0.00010213075,0.000038463608,0.00009051089,0.00003665837,0.0040603443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795085,0.00008151565,0.0006134058,0.0005084463,0.00044011266,0.00040567588],"domain_scores_gemma":[0.9985492,0.00016551561,0.00038023567,0.0004196823,0.0003355784,0.00014978996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024555056,0.0002993869,0.0010205975,0.00012843817,0.000064093,0.000023758354,0.00016356078,0.00018288588,0.0012049122],"category_scores_gemma":[0.00013600662,0.00021539797,0.00024609477,0.00023243057,0.00018723667,0.00010283101,0.00014084975,0.0002730401,0.00034661422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007574261,0.00014562721,0.002403833,0.00047503953,0.00024488286,0.00019680709,0.0005543326,0.000023850476,0.99014306,0.002834163,0.0010770794,0.0011438695],"study_design_scores_gemma":[0.002248115,0.0013700424,0.015246088,0.0011079023,0.00015075023,0.00027748104,0.0006741105,0.00009781945,0.9779937,0.00017465062,0.00040425887,0.00025503116],"about_ca_topic_score_codex":0.0004865849,"about_ca_topic_score_gemma":0.000015262585,"teacher_disagreement_score":0.012842255,"about_ca_system_score_codex":0.00033831203,"about_ca_system_score_gemma":0.00035736925,"threshold_uncertainty_score":0.9997081},"labels":[],"label_agreement":null},{"id":"W2981831649","doi":"10.3324/haematol.2019.231407","title":"Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fogarty International Center; Canadian Institute for Advanced Research; Cincinnati Children's Hospital Medical Center","keywords":"Transcranial Doppler; Medicine; Cohort; Stroke (engine); Sickle cell anemia; Anemia; Internal medicine; Pediatrics; Disease","score_opus":0.007784249854740441,"score_gpt":0.21219948069863767,"score_spread":0.20441523084389723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981831649","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26605275,0.0043934784,0.00007599846,0.6647233,0.0013570441,0.004832533,0.00031438962,0.00025169752,0.057998803],"genre_scores_gemma":[0.10411615,0.0026188153,0.00035589014,0.8347703,0.0011880851,0.00027086443,0.00060949713,0.0001643668,0.055905998],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721354,0.00012605716,0.00054911,0.000751369,0.0006434974,0.00071642885],"domain_scores_gemma":[0.99865067,0.00023573516,0.00017359952,0.0007113375,0.00008624266,0.00014241933],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002471546,0.00061114057,0.0012571552,0.00011686085,0.00020055246,0.00006283264,0.00032676666,0.0014653896,0.0008592012],"category_scores_gemma":[0.000033679415,0.00035317877,0.00031922854,0.00014916265,0.00030703834,0.000044401222,0.00012739176,0.0022587557,0.00033954898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024320252,0.0001263911,0.0009918278,0.0014584688,0.00018670272,0.0015932742,0.0004969342,0.000008677088,0.00029495556,0.000010835884,0.9942338,0.0003549156],"study_design_scores_gemma":[0.0015011744,0.0006995919,0.0018032244,0.0003257175,0.0007170107,0.0011609823,0.00017838503,0.000015671447,0.00025010627,0.000041952044,0.99274534,0.00056085055],"about_ca_topic_score_codex":0.000059907572,"about_ca_topic_score_gemma":0.0000034145983,"teacher_disagreement_score":0.17004703,"about_ca_system_score_codex":0.0000950503,"about_ca_system_score_gemma":0.0002389136,"threshold_uncertainty_score":0.999892},"labels":[],"label_agreement":null},{"id":"W2987067520","doi":"10.3324/haematol.2019.227892","title":"Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Provincial Health Services Authority","funders":"F. Hoffmann-La Roche","keywords":"Cell of origin; Diffuse large B-cell lymphoma; Biology; Lymphoma; Large-cell lymphoma; Somatic cell; Proportional hazards model; Large cell; Cancer research; Mutation; Hazard ratio; Gene; Oncology; Cancer; Internal medicine; Pathology; Genetics; Adenocarcinoma; Medicine; Immunology; Confidence interval","score_opus":0.059598015126062255,"score_gpt":0.3559190621808619,"score_spread":0.2963210470547996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987067520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964051,0.00056074397,0.000015144694,0.00017850625,0.000031247917,0.0022082329,0.00025599907,0.000018639807,0.00032637198],"genre_scores_gemma":[0.99923754,0.000015561749,0.0003185202,0.00004067702,0.0000075321514,0.0001020004,0.00023274017,0.000010512299,0.000034921402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875855,0.00012441953,0.0004336201,0.00030861874,0.00019016898,0.00018464614],"domain_scores_gemma":[0.9974594,0.00141656,0.00017772656,0.0008196479,0.00003705006,0.00008960948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021114184,0.00015615419,0.0005173294,0.00007999079,0.00005280405,0.000014206988,0.00018577205,0.00005728115,0.00009696431],"category_scores_gemma":[0.00025866175,0.00008646988,0.000059381236,0.00023293828,0.000039301547,0.00006991196,0.00015154171,0.000050620423,0.00007192906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015988169,0.023727642,0.9729652,0.000061610954,0.00008104472,0.0000964802,0.0023135825,0.0000026074356,0.00009322553,0.000087759116,0.00023867976,0.00017227465],"study_design_scores_gemma":[0.032078512,0.0012350669,0.9632302,0.00013127533,0.00032593706,0.000020855734,0.0018883224,0.0006247894,0.00020875272,0.00015062191,0.000019707933,0.000085949025],"about_ca_topic_score_codex":0.00055409997,"about_ca_topic_score_gemma":0.00012893451,"teacher_disagreement_score":0.03191863,"about_ca_system_score_codex":0.00005239287,"about_ca_system_score_gemma":0.00011789391,"threshold_uncertainty_score":0.35261396},"labels":[],"label_agreement":null},{"id":"W2988993561","doi":"10.3324/haematol.2019.225086","title":"Novel evidence for a greater burden of ambient air pollution on cardiovascular disease","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Air pollution; Environmental health; Life expectancy; Particulates; Cardiovascular health; Disease; Coronary artery disease; Diabetes mellitus; Air pollutants; Particulate pollution; Heart failure; Adverse effect; Burden of disease; Disease burden; Intensive care medicine; Cardiology; Internal medicine; Population; Endocrinology","score_opus":0.30372845814452265,"score_gpt":0.39400743196921234,"score_spread":0.09027897382468969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988993561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009896272,0.993765,0.0017936812,0.000686338,0.0001947159,0.002970636,0.00018643653,0.000042724063,0.00026149568],"genre_scores_gemma":[0.002033094,0.9956477,0.0008652688,0.0006838653,0.00006712645,0.00033279695,0.000032561813,0.00002890514,0.0003086296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754804,0.00021148993,0.0006221446,0.0006540095,0.0005229697,0.00044137205],"domain_scores_gemma":[0.9981274,0.0002692128,0.00039772273,0.00093867804,0.000013432682,0.0002535555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078767503,0.0003479198,0.0017783899,0.000059832633,0.00011132575,0.0000102290505,0.0004144347,0.00027528565,0.00023516448],"category_scores_gemma":[0.00048760182,0.00023398802,0.0011415629,0.00018851727,0.00017420518,0.00009974856,0.00019157265,0.00017983688,0.0007706505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003148365,0.00031833313,0.000045836394,0.10027463,0.0005293072,0.00005145903,0.00036523357,0.004294832,0.0000012266319,0.0013715087,0.011988366,0.8804444],"study_design_scores_gemma":[0.0001922429,0.00024253396,0.00033465898,0.011210613,0.00095562765,0.000032828815,0.000008737952,0.00007506862,0.0000023035843,0.000076653145,0.9865707,0.00029799368],"about_ca_topic_score_codex":0.00025743985,"about_ca_topic_score_gemma":0.0000021157928,"teacher_disagreement_score":0.9745824,"about_ca_system_score_codex":0.00028329308,"about_ca_system_score_gemma":0.000102203485,"threshold_uncertainty_score":0.99054104},"labels":[],"label_agreement":null},{"id":"W2990275983","doi":"10.3324/haematol.2019.227579","title":"Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"CD47; Multiple myeloma; Bortezomib; Cancer research; Phagocytosis; Apoptosis; Downregulation and upregulation; Drug resistance; In vivo; Medicine; Biology; Immunology","score_opus":0.011304713301687702,"score_gpt":0.21718373684767736,"score_spread":0.20587902354598966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990275983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98291093,0.015735647,0.000021978114,0.00035829202,0.00017317814,0.00040843574,0.000026030371,0.000045212804,0.00032027645],"genre_scores_gemma":[0.99824184,0.0007993555,0.00040140573,0.000077587516,0.0000060990596,0.000032942426,0.000073476855,0.000016025015,0.00035127442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983955,0.00023932559,0.00052492425,0.00045795066,0.000057490262,0.00032479689],"domain_scores_gemma":[0.99915075,0.00025584156,0.00031868287,0.00019368457,0.00006278135,0.000018244584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027375796,0.00023565124,0.0006535843,0.00010383576,0.00013608468,0.00001707882,0.000118674,0.00021679947,0.00008581708],"category_scores_gemma":[0.00017177197,0.00019998214,0.00005517676,0.0002204785,0.00024654553,0.00035343613,0.00013061512,0.00022757046,0.000022797713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027899613,0.00013427608,0.07006872,0.00021009262,0.00005817406,0.0000023007867,0.00097620214,0.0000010627723,0.92439514,0.0008267271,0.002629357,0.00041894644],"study_design_scores_gemma":[0.0021089988,0.000085883876,0.03892646,0.0002063176,0.000025919087,0.00007943062,0.0008679039,0.000010929306,0.95433,0.00057044066,0.0025052372,0.00028245503],"about_ca_topic_score_codex":0.00011771766,"about_ca_topic_score_gemma":0.000023983132,"teacher_disagreement_score":0.031142259,"about_ca_system_score_codex":0.000033471715,"about_ca_system_score_gemma":0.000016801907,"threshold_uncertainty_score":0.8155035},"labels":[],"label_agreement":null},{"id":"W2991451501","doi":"10.3324/haematol.2019.222596","title":"Dominant negative Gfi1b mutations cause moderate thrombocytopenia and an impaired stress thrombopoiesis associated with mild erythropoietic abnormalities in mice","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Thrombopoiesis; Haematopoiesis; Thrombopoietin; Biology; Allele; Megakaryocyte; Platelet; Cancer research; Erythropoiesis; Molecular biology; Internal medicine; Immunology; Cell biology; Genetics; Medicine; Stem cell; Gene; Anemia","score_opus":0.015762680940316222,"score_gpt":0.26064543078487523,"score_spread":0.24488274984455902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991451501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981806,0.00047424648,0.000014803141,0.00012778155,0.000030058882,0.00048338826,0.00009428616,0.000018477129,0.00057632296],"genre_scores_gemma":[0.998856,0.00016668276,0.0003586543,0.000107775326,0.000006946134,0.00006978688,0.00025360312,0.000021225465,0.00015934282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987817,0.00014713239,0.00021398359,0.00043894793,0.000106715335,0.00031151573],"domain_scores_gemma":[0.9994465,0.000044923065,0.00012084719,0.00024165545,0.000072991235,0.00007307072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007901705,0.0002385689,0.00040849918,0.000044971606,0.00013118095,0.00005102827,0.0001141365,0.00017127271,0.000032553722],"category_scores_gemma":[0.000038266844,0.00017598121,0.000040510142,0.00011349956,0.00020227075,0.000024069046,0.00007511808,0.00008449549,0.000007670773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020504922,0.003971546,0.94784826,0.00025929225,0.002014228,0.00043386084,0.008422309,0.0010850099,0.03100264,0.0019558677,0.0004908255,0.00046569467],"study_design_scores_gemma":[0.015899306,0.005326869,0.5906562,0.00042137387,0.0005039763,0.0002151834,0.015980022,0.0013146125,0.36396965,0.0039770175,0.00004596662,0.0016897732],"about_ca_topic_score_codex":0.00048038753,"about_ca_topic_score_gemma":0.004396185,"teacher_disagreement_score":0.35719198,"about_ca_system_score_codex":0.000017104907,"about_ca_system_score_gemma":0.000059690716,"threshold_uncertainty_score":0.71763057},"labels":[],"label_agreement":null},{"id":"W2991725433","doi":"10.3324/haematol.2019.231753","title":"Are we ready to use precision medicine in chronic myeloid leukemia practice?","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Precision medicine; Medicine; Internal medicine; Oncology; Intensive care medicine; Pathology","score_opus":0.09269146297885146,"score_gpt":0.36623405593882224,"score_spread":0.2735425929599708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991725433","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007967963,0.002160022,0.00009353137,0.9739749,0.00065605476,0.004412154,0.00006835139,0.00028844384,0.010378611],"genre_scores_gemma":[0.0053148353,0.0049510035,0.0029779738,0.938186,0.004254159,0.00055241433,0.00097546086,0.00031453627,0.042473633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99226,0.0008050684,0.0013900615,0.0018594795,0.00204367,0.0016417608],"domain_scores_gemma":[0.99058264,0.004840502,0.0009998888,0.002578741,0.0006595967,0.00033864178],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0012837645,0.0009865582,0.002988454,0.0014120367,0.0001080447,0.00008835884,0.0010020664,0.0029085528,0.0015094087],"category_scores_gemma":[0.012182016,0.00069366983,0.00022985665,0.0012055214,0.0003314436,0.00036723874,0.0007230471,0.0075576846,0.0052792723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008189331,0.000049986236,0.0007083002,0.00136078,0.00013596748,0.03669171,0.0002200345,0.000017926644,0.00038246042,0.00003863173,0.9580493,0.0015259451],"study_design_scores_gemma":[0.0028915415,0.0014390078,0.0026727484,0.0054169116,0.0002309756,0.004427203,0.00019728593,0.00015435138,0.00016735915,0.00007721561,0.98165995,0.000665456],"about_ca_topic_score_codex":0.0009721997,"about_ca_topic_score_gemma":0.00011609883,"teacher_disagreement_score":0.035788886,"about_ca_system_score_codex":0.008027962,"about_ca_system_score_gemma":0.002196516,"threshold_uncertainty_score":0.9995515},"labels":[],"label_agreement":null},{"id":"W2994869882","doi":"10.3324/haematol.2019.223040","title":"Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Memorial University of Newfoundland; Izaak Walton Killam Health Centre; University of Ottawa; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Institute; Terry Fox Research Institute; Hope Foundation; Beatrice Hunter Cancer Research Institute; Nova Scotia Health Research Foundation","keywords":"Zebrafish; Xenotransplantation; Biology; Haematopoiesis; Leukemia; Homing (biology); Myeloid leukemia; Stem cell; Progenitor cell; Cancer research; Hematopoietic stem cell; Immunology; Transplantation; Cell biology; Medicine; Genetics; Internal medicine; Gene","score_opus":0.014546826255976702,"score_gpt":0.27035309105827543,"score_spread":0.25580626480229873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994869882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935143,0.00023120435,0.0004182142,0.00030659587,0.000058260157,0.00060973776,0.0000364641,0.00005328017,0.0047719167],"genre_scores_gemma":[0.99612993,0.00013307958,0.00047893572,0.00017940362,0.00005047081,0.000053457767,0.00012936418,0.000020679834,0.0028246976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980744,0.00010933719,0.00026136567,0.00070316484,0.00037890152,0.00047280526],"domain_scores_gemma":[0.99892044,0.00003988931,0.0001238191,0.0005610868,0.00009992811,0.00025486486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031023868,0.00022672374,0.0003523796,0.000046277495,0.00037890679,0.000050516424,0.00053969875,0.00027347336,0.00023569237],"category_scores_gemma":[0.000026490934,0.00019932687,0.00010015355,0.0001391663,0.0003111576,0.000009078541,0.0013325874,0.00023472354,0.00020288104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109723995,0.00015436328,0.0045958883,0.00015679441,0.0001018582,0.000045701025,0.000114417766,4.46828e-7,0.9880298,0.0020541884,0.0039914977,0.00064534147],"study_design_scores_gemma":[0.0027336446,0.0012615158,0.019474842,0.00005968387,0.000089797126,0.00019220375,0.0003465149,0.00006697882,0.94391364,0.0020795998,0.028832741,0.0009488355],"about_ca_topic_score_codex":0.00002339738,"about_ca_topic_score_gemma":0.000024165593,"teacher_disagreement_score":0.044116136,"about_ca_system_score_codex":0.000038886275,"about_ca_system_score_gemma":0.00008765775,"threshold_uncertainty_score":0.81283134},"labels":[],"label_agreement":null},{"id":"W2995710548","doi":"10.3324/haematol.2019.236737","title":"Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Splenectomy; Immune thrombocytopenia; Medicine; Term (time); Pediatrics; Immune system; Internal medicine; Immunology; Platelet; Spleen","score_opus":0.043182101686548686,"score_gpt":0.3010163514763502,"score_spread":0.2578342497898015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995710548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8874561,0.0004849933,0.000002623093,0.10701846,0.0001238057,0.0038585623,0.00082560355,0.000052295447,0.0001775078],"genre_scores_gemma":[0.8606111,0.000079366495,0.000027209593,0.12917748,0.00014719705,0.00029767904,0.009335552,0.000065537424,0.00025889077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968269,0.00047554311,0.00052532693,0.0012005925,0.00048222247,0.00048944965],"domain_scores_gemma":[0.99589854,0.0003808497,0.00031348664,0.0033240146,0.000041441286,0.000041643438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022228829,0.00074388087,0.0018528784,0.00006823138,0.00014632415,0.00016060675,0.001454152,0.0004169381,0.0008053498],"category_scores_gemma":[0.00006265339,0.0002936689,0.00012756491,0.0001497169,0.0002554412,0.00020074949,0.0006546524,0.0019483699,0.00035232992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006693066,0.0012145924,0.93881875,0.00001680153,0.0017991847,0.011143753,0.0003060343,1.3464653e-7,0.0000017168915,0.0000047312465,0.045949575,0.00007541478],"study_design_scores_gemma":[0.004815805,0.0010349571,0.99028873,0.0004170606,0.0006754044,0.000757756,0.00035042237,0.0000043947953,0.0000097484635,0.000011040556,0.0012483071,0.00038635137],"about_ca_topic_score_codex":0.00094464107,"about_ca_topic_score_gemma":0.0019945716,"teacher_disagreement_score":0.051469997,"about_ca_system_score_codex":0.0000646012,"about_ca_system_score_gemma":0.00006149829,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W2995858855","doi":"10.3324/haematol.2019.226795","title":"The novel L-nucleoside analogue, 5-Fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia","year":2019,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Nucleoside analogue; Medicine; Nucleoside; Leukemia; Myeloid; Cancer research; Pharmacology; Chemistry; Immunology; Stereochemistry","score_opus":0.026645746346510693,"score_gpt":0.28190972480066717,"score_spread":0.2552639784541565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995858855","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039977368,0.0018712409,0.0005395714,0.9155141,0.0015453884,0.0060237083,0.0006518965,0.00080890715,0.033067804],"genre_scores_gemma":[0.020101061,0.004897733,0.0032686961,0.9106417,0.0052607865,0.00078335986,0.0055334843,0.00065299694,0.0488602],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914566,0.0003566212,0.0014955632,0.0019226157,0.0020968136,0.0026717752],"domain_scores_gemma":[0.99251175,0.0022753482,0.00077233353,0.0035041412,0.0005469366,0.0003894984],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0008418379,0.0014607257,0.0026562226,0.00048370732,0.0008456334,0.0003352303,0.0021882097,0.0027819246,0.00019597146],"category_scores_gemma":[0.0011249997,0.0008740009,0.0012020903,0.0008520112,0.0010378885,0.00016802856,0.001089865,0.008538342,0.004014306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000536741,0.00011118086,0.0001904928,0.0004669383,0.0014150618,0.010373962,0.000060433467,0.000014949266,0.0028299002,0.00032583438,0.9807413,0.0029331953],"study_design_scores_gemma":[0.004056327,0.00057871814,0.0035708451,0.00057537877,0.0008538472,0.0041210484,0.000057089455,0.0008525116,0.00068791053,0.00007095908,0.98350215,0.001073229],"about_ca_topic_score_codex":0.00012265258,"about_ca_topic_score_gemma":0.000014956397,"teacher_disagreement_score":0.019876307,"about_ca_system_score_codex":0.0020697976,"about_ca_system_score_gemma":0.001798482,"threshold_uncertainty_score":0.9998142},"labels":[],"label_agreement":null},{"id":"W2997127334","doi":"10.3324/haematol.2019.235721","title":"Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Myeloid leukemia; Medicine; Internal medicine; Minimal residual disease; Oncology; Chemotherapy; Leukemia; Gastroenterology; Pathology","score_opus":0.04661541952459586,"score_gpt":0.28505376704147734,"score_spread":0.23843834751688148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997127334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368495,0.00012533997,0.000028740411,0.002987623,0.000039494495,0.00260732,0.00012058008,0.0001021244,0.0003038544],"genre_scores_gemma":[0.9976002,0.000026967837,0.001397434,0.00041456253,0.000060441675,0.0002080303,0.000058270572,0.000034091954,0.00020003297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964938,0.00030955163,0.0006057071,0.0006974029,0.0012102267,0.00068330544],"domain_scores_gemma":[0.99812436,0.00031811077,0.00023170639,0.0006242226,0.0002515652,0.0004500392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052739005,0.00035369152,0.00078909576,0.00018225095,0.00016096389,0.000040389266,0.00061632827,0.00016053603,0.00014661589],"category_scores_gemma":[0.0015612489,0.00020383243,0.00011374526,0.0009672848,0.00020406007,0.00013793196,0.0003152983,0.0007615493,0.00023438846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01175993,0.0020953908,0.9451541,0.0009501654,0.0003227825,0.00389641,0.005697236,0.00038994694,0.022512505,0.00010699258,0.005809289,0.0013052848],"study_design_scores_gemma":[0.00493299,0.0048147324,0.96146566,0.00076719443,0.00035297027,0.00009279146,0.001272433,0.00060885836,0.024306629,0.000060123446,0.00065447827,0.00067117164],"about_ca_topic_score_codex":0.00005143846,"about_ca_topic_score_gemma":0.000002463844,"teacher_disagreement_score":0.016311564,"about_ca_system_score_codex":0.0006395291,"about_ca_system_score_gemma":0.0005366827,"threshold_uncertainty_score":0.83120453},"labels":[],"label_agreement":null},{"id":"W2998593800","doi":"10.3324/haematol.2019.235291","title":"The long non-coding RNA &lt;i&gt;Cancer Susceptibility 15&lt;/i&gt; (&lt;i&gt;CASC15&lt;/i&gt;) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Universität Ulm; Helmholtz Zentrum München; School of Medicine, Stanford University; Ludwig-Maximilians-Universität München","keywords":"Isocitrate dehydrogenase; IDH1; Molecular biology; Long non-coding RNA; RNA; Cancer research; Chemistry; Biology; Gene; Mutation; Enzyme; Biochemistry","score_opus":0.012620415396468233,"score_gpt":0.2663825028896349,"score_spread":0.25376208749316664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998593800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8593558,0.01507728,0.0058224257,0.10754768,0.0011140475,0.0057109115,0.002963663,0.00034510772,0.002063062],"genre_scores_gemma":[0.9115128,0.011315422,0.0007216476,0.067596704,0.0011486548,0.0012223315,0.0046205455,0.0004185084,0.0014434076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99146545,0.0009999747,0.0013643058,0.0029144236,0.0011346858,0.002121176],"domain_scores_gemma":[0.9957195,0.0002140634,0.00078515185,0.0020184878,0.0006847296,0.000578062],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0007302768,0.0014803599,0.001511327,0.00029005742,0.001081165,0.0004703326,0.0017726958,0.0035247442,0.00023173318],"category_scores_gemma":[0.000497379,0.0012797645,0.0006408947,0.0009569242,0.0008756648,0.000057579047,0.0009848588,0.003368341,0.00007654292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045368963,0.000090691625,0.000007938932,0.0002908523,0.0007228211,0.0012683752,0.00043745004,0.000045448953,0.84970194,0.00025965204,0.14571506,0.0010060943],"study_design_scores_gemma":[0.004460329,0.0015117627,0.00027182046,0.000572466,0.000906613,0.00059587136,0.00021854466,0.0029984384,0.77263504,0.0016853511,0.2104842,0.0036595697],"about_ca_topic_score_codex":0.0000837153,"about_ca_topic_score_gemma":0.0022727572,"teacher_disagreement_score":0.07706691,"about_ca_system_score_codex":0.0007161897,"about_ca_system_score_gemma":0.0013582951,"threshold_uncertainty_score":0.99979454},"labels":[],"label_agreement":null},{"id":"W2998875317","doi":"10.3324/haematol.2019.226126","title":"HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; European Hematology Association","keywords":"HES1; Haematopoiesis; Biology; Progenitor cell; Notch signaling pathway; Cell biology; Myeloid; Lineage (genetic); Gene knockdown; Lymphopoiesis; Stem cell; T cell; Cellular differentiation; Psychological repression; Genetics; Cancer research; Gene; Signal transduction; Gene expression; Immune system","score_opus":0.010141834932139385,"score_gpt":0.21842311657948688,"score_spread":0.2082812816473475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998875317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981124,0.00031849995,0.00009547869,0.00012458581,0.000019737881,0.00014903852,0.0000045124684,0.0000130672515,0.0011627246],"genre_scores_gemma":[0.9977401,0.00003657304,0.0018415519,0.000094867755,0.000026505368,0.000014218078,0.00007570159,0.000008451565,0.00016201157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913913,0.000029051229,0.00025764672,0.00032398532,0.000072181334,0.00017803031],"domain_scores_gemma":[0.9996533,0.0000053858435,0.00010870656,0.0001173556,0.00003239058,0.00008289398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006101351,0.00015004002,0.00021669778,0.000023151062,0.000130177,0.000009483681,0.000114395625,0.00016781093,0.00001866022],"category_scores_gemma":[0.000013091221,0.0001251649,0.000041772644,0.000039899536,0.00012021276,0.000003434045,0.00015986229,0.00005764534,0.0000120704035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008790429,0.00004649857,0.07074309,0.00007929727,0.00003794733,0.000011233479,0.000407409,0.0000030270178,0.92781264,0.00004222051,0.00007753859,0.00065118726],"study_design_scores_gemma":[0.00039150033,0.00015903529,0.17033772,0.00001415529,0.0000071343957,0.000026598247,0.00009750601,0.0000037607465,0.827981,0.000029476989,0.0008067368,0.00014535525],"about_ca_topic_score_codex":0.0000049312002,"about_ca_topic_score_gemma":0.000017017186,"teacher_disagreement_score":0.099831626,"about_ca_system_score_codex":0.0000054018133,"about_ca_system_score_gemma":0.00003347529,"threshold_uncertainty_score":0.5104076},"labels":[],"label_agreement":null},{"id":"W2999855906","doi":"10.3324/haematol.2019.229989","title":"Innate immune cells, major protagonists of sickle cell disease pathophysiology","year":2020,"lang":"en","type":"review","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"Agence Nationale de la Recherche","keywords":"Pathophysiology; Disease; Immunology; Inflammation; Immune system; Innate immune system; Medicine; Pathology","score_opus":0.0189284851360099,"score_gpt":0.2765282941016702,"score_spread":0.25759980896566026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999855906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011716579,0.99398184,0.000007750547,0.00037708765,0.0002644847,0.0026121328,0.00013757857,0.00013673663,0.0023652187],"genre_scores_gemma":[0.00077793805,0.9972258,0.0003101492,0.00018734367,0.000057334957,0.00026340288,0.00028731604,0.000079869766,0.00081084657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971621,0.0002652906,0.0011696438,0.0006843374,0.00024268271,0.00047592592],"domain_scores_gemma":[0.99793965,0.00008973299,0.00077348144,0.00072115805,0.00009018886,0.00038579458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000113619535,0.00062169856,0.0040614237,0.00013935972,0.0000878073,0.00001038695,0.00034451758,0.0007288939,0.0003869143],"category_scores_gemma":[0.00013180995,0.0003946235,0.0011228989,0.0004729439,0.00030166758,0.00002305934,0.0002618718,0.0008594672,0.0006475665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005461495,0.0017396213,0.000011046943,0.3498061,0.000686809,0.009679829,0.00020148589,0.0000011756576,0.0004180672,0.0007847525,0.0056361184,0.6304888],"study_design_scores_gemma":[0.0006775205,0.00043445636,0.000005886349,0.00724731,0.0018647263,0.00013707024,0.00004201125,0.000009549001,0.0001149094,0.00020346796,0.9888558,0.0004072882],"about_ca_topic_score_codex":0.00000968165,"about_ca_topic_score_gemma":1.7104794e-7,"teacher_disagreement_score":0.9832197,"about_ca_system_score_codex":0.00004450765,"about_ca_system_score_gemma":0.0006233163,"threshold_uncertainty_score":0.9998506},"labels":[],"label_agreement":null},{"id":"W3000359647","doi":"10.3324/haematol.2019.239160","title":"Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Skånes universitetssjukhus; Medizinische Universität Wien; Hospital for Sick Children; Great Ormond Street Hospital for Children; Lunds Universitet; Institut National de la Recherche Agronomique; Institut National de la Santé et de la Recherche Médicale; University of Bern; Universität Wien; Helsingin Yliopisto","keywords":"Medicine; Incidence (geometry); Cumulative incidence; Internal medicine; Prospective cohort study; Cohort; Gastroenterology; Missense mutation; Haemophilia; Pediatrics; Mutation; Biology; Genetics; Gene","score_opus":0.02725189121489065,"score_gpt":0.28972216537662665,"score_spread":0.262470274161736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000359647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962722,0.00006304497,0.0000016446762,0.0003868788,0.000010963587,0.0029034882,0.000009544095,0.00008440253,0.00026783132],"genre_scores_gemma":[0.9993582,0.000013870008,0.00019362516,0.00011562898,0.000020484025,0.00009002466,0.00012936033,0.000021744145,0.000057108835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998012,0.00020848837,0.0003972981,0.00048886787,0.0005451434,0.00034819715],"domain_scores_gemma":[0.99892664,0.00006265241,0.0001078385,0.00032214407,0.0002997674,0.00028095444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014133888,0.00022195635,0.0007114416,0.00012002078,0.00004952189,0.000012332547,0.00015563802,0.00011626067,0.00013999945],"category_scores_gemma":[0.00026257476,0.00013699023,0.000041143576,0.000829549,0.00011324824,0.00008146834,0.00006900382,0.00024037041,0.000027225846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023634122,0.0023873483,0.9916772,0.00013007697,0.000097465105,0.00096254697,0.0017448238,0.0000048978195,0.00014145864,0.0000053206377,0.0001779662,0.00030744806],"study_design_scores_gemma":[0.0055429577,0.011517515,0.98106116,0.00015569678,0.00011399048,0.000050255123,0.0003665161,0.0001194489,0.00089191215,0.000009128196,0.000014203165,0.00015721806],"about_ca_topic_score_codex":0.00009090164,"about_ca_topic_score_gemma":0.00017126568,"teacher_disagreement_score":0.010616077,"about_ca_system_score_codex":0.00004978052,"about_ca_system_score_gemma":0.00017308249,"threshold_uncertainty_score":0.55862993},"labels":[],"label_agreement":null},{"id":"W3003971267","doi":"10.3324/haematol.2019.237230","title":"Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Children's Hospital of Philadelphia","keywords":"Medicine; Internal medicine; Vincristine; Minimal residual disease; Bone marrow; Calla; Chemotherapy; Oncology; Acute lymphocytic leukemia; Induction chemotherapy; Randomization; Hematopoietic stem cell transplantation; Transplantation; Leukemia; Clinical trial; Lymphoblastic Leukemia; Cyclophosphamide; Immunology; Antibody","score_opus":0.013167492933858207,"score_gpt":0.2657685661765715,"score_spread":0.2526010732427133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003971267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371135,0.00058870536,0.00027510896,0.0020558317,0.000208725,0.0025158743,0.00013484032,0.00024303845,0.0002665491],"genre_scores_gemma":[0.99774307,0.00006528487,0.0005043168,0.0010312966,0.00018187088,0.00023180083,0.00009245406,0.000067724104,0.00008219664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955054,0.0004319934,0.001327434,0.0010230257,0.00087082083,0.00084135093],"domain_scores_gemma":[0.9969053,0.0008514437,0.0005776988,0.0009267153,0.00013785543,0.00060096965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043483233,0.0005400816,0.002007861,0.00010150026,0.00018810801,0.000053699994,0.00041119434,0.00039852277,0.00010589699],"category_scores_gemma":[0.0006953456,0.00032953473,0.00028743088,0.0004107666,0.00047970275,0.00013485328,0.0006144144,0.0006757454,0.000053745025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01504151,0.0030286647,0.8327819,0.00030994587,0.004423584,0.12610336,0.011352291,0.000014554754,0.0011159537,0.00019002624,0.0034196028,0.0022186206],"study_design_scores_gemma":[0.02967651,0.0041255793,0.95094526,0.00020110581,0.0017844777,0.010402644,0.00152578,0.0006703023,0.00012839779,0.000029987461,0.00013327727,0.00037667574],"about_ca_topic_score_codex":0.0009544751,"about_ca_topic_score_gemma":0.000038470553,"teacher_disagreement_score":0.11816336,"about_ca_system_score_codex":0.00072846306,"about_ca_system_score_gemma":0.00077782775,"threshold_uncertainty_score":0.99991566},"labels":[],"label_agreement":null},{"id":"W3004873674","doi":"10.3324/haematol.2019.220962","title":"Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Bortezomib; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Myeloid leukemia; Oncology; Induction chemotherapy; Multiple myeloma; Leukemia; Surgery","score_opus":0.020542026871820936,"score_gpt":0.29994620438021874,"score_spread":0.2794041775083978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004873674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414054,0.00011750514,0.0029112366,0.048453018,0.000057932575,0.0054807737,0.00094558956,0.00032289914,0.00030560207],"genre_scores_gemma":[0.9555148,0.0004298998,0.027104288,0.013234195,0.00045462488,0.001513101,0.0010026686,0.00014890205,0.00059755356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652445,0.0001178458,0.0006530553,0.0012185274,0.0006642603,0.00082184875],"domain_scores_gemma":[0.99729097,0.0005325047,0.00045497212,0.0010780183,0.00020671073,0.00043682446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028813726,0.00065470586,0.0017285743,0.000058662936,0.00031951797,0.000075203345,0.0004815269,0.00034044828,0.00017788592],"category_scores_gemma":[0.00019333205,0.00025714902,0.00030470264,0.00025387175,0.00048472846,0.00010700535,0.00011909874,0.0005699922,0.000027304679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05492407,0.0007763179,0.8624781,0.00007251358,0.016007697,0.008219437,0.004841451,0.000008693867,0.0066185296,0.00042444712,0.014027917,0.03160085],"study_design_scores_gemma":[0.07259815,0.046583977,0.7633582,0.0001630868,0.0040426925,0.015032729,0.001614739,0.00027547716,0.06206899,0.00028174257,0.03236258,0.0016176812],"about_ca_topic_score_codex":0.0009522591,"about_ca_topic_score_gemma":0.000305354,"teacher_disagreement_score":0.09911992,"about_ca_system_score_codex":0.0016493894,"about_ca_system_score_gemma":0.0015327816,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W3006606775","doi":"10.3324/haematol.2019.245167","title":"SIRPαFc treatment targets human acute myeloid leukemia stem cells","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Trillium Therapeutics (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"Hospital for Sick Children; University of Toronto; Government of Canada; Government of Ontario; Department of Medicine, University of Toronto; Ontario Genomics Institute; Genome Canada","keywords":"Myeloid leukemia; Stem cell; Myeloid cells; Myeloid; Medicine; Cancer research; Immunology; Leukemia; Biology; Cell biology","score_opus":0.031970253949090525,"score_gpt":0.24696602981415194,"score_spread":0.2149957758650614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006606775","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.123211846,0.047455523,0.0002526966,0.791921,0.009254948,0.0057178307,0.0017804366,0.00292294,0.017482787],"genre_scores_gemma":[0.36568385,0.0030116662,0.00025113384,0.5235277,0.0017309593,0.0007565972,0.013567287,0.00035258444,0.09111822],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969239,0.00045651573,0.00075179385,0.0009637587,0.0000888133,0.00081521337],"domain_scores_gemma":[0.9984128,0.00014166204,0.00057674275,0.0007660947,0.00006551793,0.00003721431],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006789974,0.0008050695,0.0016140788,0.0001450955,0.00052387983,0.000056155943,0.0006041459,0.002038391,0.0013580895],"category_scores_gemma":[0.000005799339,0.0005992284,0.00055890623,0.00013683572,0.00029478973,0.00009035279,0.00020325332,0.0013340907,0.0046158144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048542868,0.00005408173,0.000016527234,0.00007165534,0.0010100038,0.0010447653,0.00020455077,0.0000012052285,0.14811955,0.00009904654,0.8477752,0.0015548272],"study_design_scores_gemma":[0.00084193336,0.000600877,0.000052148214,0.000051270996,0.00036978468,0.00033554793,0.000025908157,0.0000020459318,0.23240218,0.00014132763,0.7646725,0.0005044889],"about_ca_topic_score_codex":0.00006412754,"about_ca_topic_score_gemma":0.0000038053731,"teacher_disagreement_score":0.2683933,"about_ca_system_score_codex":0.00043147575,"about_ca_system_score_gemma":0.00014356349,"threshold_uncertainty_score":0.9996459},"labels":[],"label_agreement":null},{"id":"W3007168498","doi":"10.3324/haematol.2020.248385","title":"FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; Department of Medicine, University of Toronto; Health Canada; National Cancer Institute; University of Rochester; University of Toronto; National Center for Research Resources; Medical Center, University of Rochester; Amgen; Lunds Universitet; National Institutes of Health; Toronto General Hospital Research Institute, University Health Network; Universiteit van Amsterdam; Canadian Blood Services; Amsterdam University Medical Centers; Australian Government; Pfizer","keywords":"Autoantibody; Immune thrombocytopenia; Opsonin; Phagocytosis; Platelet; Immunology; Immune system; Antibody; Glycoprotein; Platelet Glycoprotein GPIb-IX Complex; Platelet membrane glycoprotein; Medicine; Biology; Molecular biology","score_opus":0.023574175739878318,"score_gpt":0.27163567722217674,"score_spread":0.2480615014822984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007168498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.851059,0.005457175,0.0000032962243,0.13944712,0.00022754958,0.0022269327,0.00024347314,0.00018317117,0.0011522354],"genre_scores_gemma":[0.9317477,0.0044345567,0.0006700849,0.061423264,0.00017356205,0.00016269367,0.00090317,0.0001402961,0.00034468455],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99562335,0.00024913083,0.0012532903,0.0012421536,0.0007150959,0.0009169934],"domain_scores_gemma":[0.99787617,0.0003426158,0.0007391399,0.0007792726,0.00008272896,0.00018008285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001830868,0.0010021206,0.004591527,0.00044767442,0.00013277799,0.000049132588,0.00040661328,0.0012614987,0.00069652905],"category_scores_gemma":[0.0002393043,0.00075648946,0.00040759015,0.00051569345,0.00038257978,0.000100502475,0.00027599267,0.0019704152,0.000267678],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005866246,0.0026508695,0.012801748,0.009728976,0.004600688,0.61394286,0.0015218386,0.000005202378,0.031726327,0.00020268529,0.30953225,0.007420304],"study_design_scores_gemma":[0.14666687,0.021057718,0.15732925,0.023457527,0.008139221,0.032884017,0.0006764177,0.0009689774,0.3544808,0.005894536,0.23800024,0.010444425],"about_ca_topic_score_codex":0.0002292057,"about_ca_topic_score_gemma":0.000015553802,"teacher_disagreement_score":0.58105886,"about_ca_system_score_codex":0.00009711432,"about_ca_system_score_gemma":0.00017293288,"threshold_uncertainty_score":0.9994886},"labels":[],"label_agreement":null},{"id":"W3008822255","doi":"10.3324/haematol.2018.204040","title":"Human leukocyte antigen-G upregulates immunoglobulin-like transcripts and corrects dysfunction of immune cells in immune thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China; Shandong University","keywords":"Antigen; Immunology; Immune system; Immunoglobulin G; Antibody; Biology; Human leukocyte antigen; CD80; Autoantibody; Cytotoxic T cell; CD40; In vitro","score_opus":0.025642566777456216,"score_gpt":0.25114915522725645,"score_spread":0.22550658844980023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008822255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913463,0.0063844905,0.000024932364,0.00048264084,0.00014419513,0.00061591814,0.000008528151,0.000072232615,0.00092075166],"genre_scores_gemma":[0.9984959,0.00083033025,0.00026864564,0.00020417696,0.000009384315,0.000016668848,0.000053215193,0.000021534783,0.00010019666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985064,0.000059071623,0.00059281365,0.00037457366,0.00017110711,0.0002960093],"domain_scores_gemma":[0.9994016,0.000031928324,0.00017700627,0.00024183965,0.000046337806,0.00010126548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000974391,0.00025754378,0.0011608988,0.00007809239,0.00009446542,0.000016248772,0.000107889784,0.0001734397,0.00017121153],"category_scores_gemma":[0.000022257815,0.0002055698,0.00013878474,0.00026019546,0.00015696397,0.000099807454,0.000054594453,0.00019708443,0.00003428209],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011502765,0.00074958307,0.028422097,0.0004702096,0.00029939663,0.0018627157,0.0018975189,0.000020400092,0.96245235,0.00021786573,0.00030876082,0.0021488543],"study_design_scores_gemma":[0.009708293,0.002118694,0.56025213,0.00042307875,0.00022262573,0.0006330718,0.00079321134,0.0003452895,0.4239821,0.00026920997,0.0008599322,0.0003923625],"about_ca_topic_score_codex":0.00025482295,"about_ca_topic_score_gemma":0.000020936208,"teacher_disagreement_score":0.5384702,"about_ca_system_score_codex":0.0000263018,"about_ca_system_score_gemma":0.000034760345,"threshold_uncertainty_score":0.8382893},"labels":[],"label_agreement":null},{"id":"W3011365044","doi":"10.3324/haematol.2019.244160","title":"Low incidence of &lt;i&gt;EPOR&lt;/i&gt; mutations in idiopathic erythrocytosis","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Université de Recherche Paris Sciences et Lettres; Centre Hospitalier Universitaire de Nantes; Centre National de la Recherche Scientifique; Alberta Health Services; Université de Bourgogne; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; University of Alberta","keywords":"Erythropoietin receptor; Incidence (geometry); Proband; Medicine; Mutation; Internal medicine; Genetics; Biology; Erythropoietin; Gene","score_opus":0.027471021382167452,"score_gpt":0.2705137380996264,"score_spread":0.24304271671745897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011365044","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21715681,0.006110394,0.00018677591,0.7663305,0.00045019604,0.0031192251,0.00024819456,0.00028137327,0.0061165174],"genre_scores_gemma":[0.8310754,0.0012304742,0.0014184134,0.16409224,0.00042832934,0.0008883997,0.00051876873,0.00007301601,0.00027498687],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959693,0.00031055644,0.0013002201,0.0009964289,0.00082960323,0.00059389864],"domain_scores_gemma":[0.9974887,0.00061685627,0.0007169153,0.00070217624,0.00029491985,0.00018042774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020535817,0.000674936,0.0023902673,0.00038985355,0.00012488518,0.00003219091,0.00030553716,0.0009596689,0.00055690535],"category_scores_gemma":[0.0009826345,0.0005245153,0.00042229763,0.00066588225,0.00036000757,0.0000897739,0.0001643204,0.001309023,0.00036782929],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031277022,0.0015422839,0.027067687,0.005213721,0.0007984406,0.072191045,0.0017332331,0.000026358512,0.0032568623,0.0025344365,0.88405573,0.0012674452],"study_design_scores_gemma":[0.014482742,0.009648421,0.09895772,0.026543401,0.004862216,0.012987192,0.00031831246,0.0008760767,0.089866236,0.008537847,0.7280595,0.0048603727],"about_ca_topic_score_codex":0.000023050987,"about_ca_topic_score_gemma":0.00010832103,"teacher_disagreement_score":0.61391854,"about_ca_system_score_codex":0.00021964226,"about_ca_system_score_gemma":0.0004793724,"threshold_uncertainty_score":0.99972063},"labels":[],"label_agreement":null},{"id":"W3011696612","doi":"10.3324/haematol.2019.240846","title":"The variable manifestations of disease in pyruvate kinase deficiency and their management","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Pyruvate kinase deficiency; Medicine; Extramedullary hematopoiesis; Disease; Pyruvate kinase; Anemia; Immunology; Stem cell; Bioinformatics; Internal medicine; Haematopoiesis; Glycolysis; Biology; Genetics","score_opus":0.02466773587017328,"score_gpt":0.24474196986468363,"score_spread":0.22007423399451034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011696612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98416173,0.0007560751,0.0008874694,0.0049969363,0.000052222833,0.0003471449,0.000008140359,0.000036602894,0.008753646],"genre_scores_gemma":[0.9977333,0.00045625484,0.00063636847,0.0010406583,0.00000804863,0.000025118534,0.000007347544,0.000003645918,0.00008929249],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99951047,0.000040018895,0.0001532151,0.00014061254,0.00004711396,0.00010855469],"domain_scores_gemma":[0.99964166,0.0000923167,0.000042787142,0.00012431844,0.000021042815,0.0000778557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006647781,0.00006390901,0.0001447545,0.00002355543,0.00006739836,0.0000042904812,0.000045036868,0.000023008575,0.000058471047],"category_scores_gemma":[0.00008027081,0.000035093297,0.000023611487,0.00015853818,0.00009020633,0.000016047476,0.000045760113,0.000063907886,0.000012957883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043729395,0.0010722012,0.09591315,0.0032188266,0.00013017596,0.0027721676,0.003546314,0.00041123264,0.017699784,0.85290724,0.006380271,0.011575685],"study_design_scores_gemma":[0.006065949,0.0022186667,0.85674375,0.00044089535,0.00028727643,0.00021869608,0.0088271815,0.011759279,0.0019060906,0.0588696,0.052083176,0.0005794103],"about_ca_topic_score_codex":0.0000051444504,"about_ca_topic_score_gemma":0.0000019679642,"teacher_disagreement_score":0.79403764,"about_ca_system_score_codex":0.000004772116,"about_ca_system_score_gemma":0.000016882086,"threshold_uncertainty_score":0.14310631},"labels":[],"label_agreement":null},{"id":"W3015129246","doi":"10.3324/haematol.2020.246603","title":"Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Hemolysis; Oxidative stress; Red blood cell; Glutathione; Antioxidant; Biology; Internal medicine; Immunology; Biochemistry; Medicine; Enzyme","score_opus":0.04113521748334037,"score_gpt":0.274631982799414,"score_spread":0.2334967653160736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015129246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438816,0.002530206,0.00077367824,0.0011429401,0.00009168747,0.0006412863,0.00009633444,0.00014169015,0.0001940095],"genre_scores_gemma":[0.994785,0.0013609767,0.0016003272,0.0020298234,0.000043768297,0.00004463352,0.00003636897,0.000027196731,0.00007187941],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980099,0.00031051514,0.00036757818,0.000692069,0.00017393706,0.00044599903],"domain_scores_gemma":[0.99900794,0.00014631564,0.0001900036,0.0002736442,0.000034826317,0.00034724813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022600911,0.0003644034,0.0011007799,0.000049996117,0.00012219913,0.000022322783,0.000083264094,0.00029558028,0.00020931994],"category_scores_gemma":[0.00017400389,0.0002708851,0.00012311562,0.0002539896,0.00016161257,0.00015797772,0.0001257103,0.0004033569,0.000012225149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015273752,0.0005084418,0.0009836531,0.00021390177,0.00011300687,0.0020568324,0.0012719373,0.000004178159,0.9917664,0.00019382212,0.0009802534,0.00038019932],"study_design_scores_gemma":[0.008205402,0.0015818907,0.029894548,0.00006451039,0.0002892805,0.00054717396,0.00036727428,0.00058186543,0.95524913,0.0009867928,0.0017306599,0.00050148246],"about_ca_topic_score_codex":0.00013337831,"about_ca_topic_score_gemma":0.000023249371,"teacher_disagreement_score":0.036517277,"about_ca_system_score_codex":0.000021119316,"about_ca_system_score_gemma":0.00005234154,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W3015964023","doi":"10.3324/haematol.2019.242206","title":"Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; King's Health Partners; Blood Cancer UK; University of Southampton; BC Cancer Agency; Engineering and Physical Sciences Research Council; European Hematology Association; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; King's College London; Queen Mary University of London","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Positron emission tomography; Cancer research; Medicine; Biology; Pathology; Nuclear medicine","score_opus":0.01638253983460799,"score_gpt":0.24610225658477844,"score_spread":0.22971971675017044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015964023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7511609,0.0015417698,0.000014809132,0.2451043,0.00027364146,0.0009933222,0.00047710483,0.00021363767,0.00022049583],"genre_scores_gemma":[0.7324179,0.00052735227,0.00023328567,0.26420388,0.000363461,0.00041605387,0.0012349149,0.000098378136,0.0005047845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953554,0.00071072305,0.0008845503,0.0013339561,0.000674949,0.0010404016],"domain_scores_gemma":[0.99783194,0.00045894997,0.00035041492,0.0009891089,0.00006153874,0.00030803087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000090778834,0.0009228446,0.0019966436,0.000247798,0.00013250638,0.00007847396,0.0003970822,0.00091605034,0.000406355],"category_scores_gemma":[0.00012776765,0.0006782011,0.0005406957,0.00029447128,0.00013079643,0.000036946833,0.00028205404,0.0006306686,0.0007230899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002074441,0.008566576,0.009116327,0.0004247745,0.00023843267,0.108196594,0.000075636744,3.825278e-8,0.00056088937,0.000006287488,0.8705965,0.00014346096],"study_design_scores_gemma":[0.05050744,0.001945298,0.06534146,0.00041252922,0.00087353983,0.002844922,0.000018528437,0.00010201897,0.010533377,0.00005263456,0.8661697,0.0011985413],"about_ca_topic_score_codex":0.000073000934,"about_ca_topic_score_gemma":0.000013151981,"teacher_disagreement_score":0.10535167,"about_ca_system_score_codex":0.0004374898,"about_ca_system_score_gemma":0.00019577505,"threshold_uncertainty_score":0.9995669},"labels":[],"label_agreement":null},{"id":"W3021433538","doi":"10.3324/haematol.2019.230771","title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Partial thromboplastin time; Autoantibody; Rituximab; Cyclophosphamide; Internal medicine; Recombinant factor VIIa; Factor IX; Coagulation; Prothrombin time; Immunology; Gastroenterology; Antibody; Chemotherapy","score_opus":0.15131201299746294,"score_gpt":0.36058468039560293,"score_spread":0.20927266739814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021433538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.707924,0.00010477677,0.0000028593136,0.28460604,0.00002839375,0.00033870427,0.000014115086,0.000021470067,0.0069596292],"genre_scores_gemma":[0.99662775,0.0018088672,0.00028509882,0.00080808246,0.000046279576,0.000121302204,0.00002282542,0.0000046818122,0.00027513312],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994795,0.000036307258,0.00012703842,0.00014167947,0.00012571043,0.00008977056],"domain_scores_gemma":[0.9994792,0.0002589389,0.000034578163,0.00011315895,0.000034864075,0.00007925614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003736937,0.000076347766,0.00018770201,0.00003007282,0.000058944115,0.000007952478,0.000054964057,0.000037204885,0.0011035815],"category_scores_gemma":[0.00015869174,0.000036430258,0.000058859725,0.00008812614,0.00008598899,0.00001578598,0.000027014423,0.000022710312,0.00004846241],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024425348,0.005247166,0.60127,0.00016630268,0.0016121694,0.00095023535,0.006987702,0.0000023913988,0.004750073,0.03501547,0.06644088,0.27511504],"study_design_scores_gemma":[0.010206222,0.016775625,0.1371073,0.0004084255,0.00045247236,0.00039609117,0.0024895745,0.0019404055,0.16428544,0.001751222,0.6637168,0.00047045105],"about_ca_topic_score_codex":0.0000053839863,"about_ca_topic_score_gemma":8.580849e-7,"teacher_disagreement_score":0.5972759,"about_ca_system_score_codex":0.00002239067,"about_ca_system_score_gemma":0.000015860154,"threshold_uncertainty_score":0.99980956},"labels":[],"label_agreement":null},{"id":"W3022331569","doi":"10.3324/haematol.2019.240705","title":"Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Rising Tide Foundation; Applebaum Foundation","keywords":"Dasatinib; Myeloid leukemia; Medicine; PTPN11; Cancer research; Leukemia; Oncology; Gene expression profiling; Internal medicine; Gene expression; Gene; Biology; Cancer; KRAS; Imatinib; Genetics","score_opus":0.023620898027407133,"score_gpt":0.2867136705403618,"score_spread":0.26309277251295465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022331569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827668,0.0004248906,0.00091097393,0.013893214,0.000019699639,0.0010709892,0.00004860277,0.00020837424,0.0006564324],"genre_scores_gemma":[0.9826905,0.00021560724,0.012630371,0.0036874695,0.000027312917,0.00012644034,0.00011437763,0.00004759078,0.00046034466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976223,0.0003995537,0.00041606542,0.0006744254,0.00041443095,0.00047321746],"domain_scores_gemma":[0.9984012,0.0004821322,0.00014049016,0.00039823458,0.00016069833,0.00041722695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034675898,0.00031462242,0.00066959823,0.00021448873,0.00014796338,0.000037634298,0.00020638504,0.00047088886,0.00030539415],"category_scores_gemma":[0.0006690535,0.0002180779,0.000060771126,0.000905004,0.00027567372,0.00013444765,0.00019161939,0.0011718449,0.00007399931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059369773,0.0002448338,0.031108743,0.00041586685,0.00038262174,0.027950088,0.017563662,0.0001860575,0.8355619,0.00034792305,0.025572756,0.001295801],"study_design_scores_gemma":[0.035118684,0.010562008,0.16990012,0.002168684,0.0007398704,0.01491666,0.006411498,0.03110934,0.71404374,0.0007944508,0.012063378,0.0021715777],"about_ca_topic_score_codex":0.000040258794,"about_ca_topic_score_gemma":0.0000065153904,"teacher_disagreement_score":0.13879137,"about_ca_system_score_codex":0.00025622163,"about_ca_system_score_gemma":0.0007090466,"threshold_uncertainty_score":0.8892959},"labels":[],"label_agreement":null},{"id":"W3022745897","doi":"10.3324/haematol.2019.243063","title":"Immunological consequences of extramedullary erythropoiesis: immunoregulatory functions of CD71<sup>+</sup> erythroid cells","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Erythropoiesis; Ineffective erythropoiesis; Transferrin receptor; Immunology; Iron Isotopes; Medicine; Transferrin; Anemia; Internal medicine; Physics","score_opus":0.03414929395453651,"score_gpt":0.2531330761790776,"score_spread":0.2189837822245411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022745897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98719376,0.004504518,0.0005984928,0.0035783867,0.00025793133,0.0005071556,0.000060176444,0.00021966951,0.003079889],"genre_scores_gemma":[0.9947249,0.00085616426,0.0025904402,0.0013866118,0.00008704904,0.00003573678,0.00005415133,0.000022707853,0.00024218534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976638,0.00024310999,0.00091083045,0.0005025295,0.00030706063,0.00037269987],"domain_scores_gemma":[0.99835676,0.00026098278,0.00040587678,0.0005129337,0.00027179063,0.00019163599],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016865853,0.0003151627,0.0012761455,0.00012319762,0.00012380526,0.0000065729437,0.00023033412,0.00042347136,0.003015483],"category_scores_gemma":[0.00033132394,0.00023579923,0.00040654722,0.00047833676,0.00210808,0.00008021077,0.0001322179,0.0004328394,0.00021514177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028115672,0.0008826322,0.004633154,0.0009795468,0.00054653967,0.00032615758,0.001423642,0.0003340552,0.9691653,0.0037369584,0.013349503,0.0018109302],"study_design_scores_gemma":[0.007962813,0.016344165,0.035846263,0.0008722669,0.0012633171,0.0037320636,0.02472167,0.0013634828,0.8557441,0.002443345,0.048205014,0.0015015056],"about_ca_topic_score_codex":0.000027216745,"about_ca_topic_score_gemma":7.253728e-7,"teacher_disagreement_score":0.11342122,"about_ca_system_score_codex":0.000027789192,"about_ca_system_score_gemma":0.00022510874,"threshold_uncertainty_score":0.9978959},"labels":[],"label_agreement":null},{"id":"W3025072273","doi":"10.3324/haematol.2019.238675","title":"Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Rituximab; Prednisone; Internal medicine; Cyclophosphamide; Oncology; Lymphoma; Vincristine; Regimen; B-cell lymphoma; CD30; Gastroenterology; Surgery; Chemotherapy","score_opus":0.010123700756752741,"score_gpt":0.22607936747927676,"score_spread":0.21595566672252403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025072273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923426,0.0009170971,0.00008963701,0.0024962549,0.000026284888,0.0029018046,0.00008031206,0.00008242172,0.0010636089],"genre_scores_gemma":[0.9940879,0.00020568402,0.0037650976,0.000780478,0.000017940449,0.00060784206,0.00041931026,0.00003418715,0.000081577986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998407,0.000043847216,0.0003334563,0.0006079279,0.0002581957,0.00034957475],"domain_scores_gemma":[0.9990737,0.00017179028,0.00017931843,0.00019448179,0.00014944836,0.00023125803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042021922,0.00036966172,0.0008370081,0.00006862287,0.000105283965,0.000032436117,0.0000578528,0.00011389608,0.000034581073],"category_scores_gemma":[0.000042351065,0.0002214681,0.00006868303,0.00019227725,0.00010412276,0.00009375325,0.000034344295,0.000055004588,0.00002527591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011181117,0.019734116,0.9577095,0.00021295826,0.00027227143,0.00066705985,0.0011594407,0.000008398819,0.00004499089,0.001023495,0.00033151943,0.007655157],"study_design_scores_gemma":[0.16582738,0.036654156,0.7797129,0.00039385605,0.0006355682,0.000138196,0.00033080406,0.00054231356,0.013893166,0.00018637013,0.00122269,0.0004625673],"about_ca_topic_score_codex":0.0002005495,"about_ca_topic_score_gemma":0.00005118127,"teacher_disagreement_score":0.17799653,"about_ca_system_score_codex":0.00026894262,"about_ca_system_score_gemma":0.00011732187,"threshold_uncertainty_score":0.9031207},"labels":[],"label_agreement":null},{"id":"W3031629527","doi":"10.3324/haematol.2019.242735","title":"Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Context (archaeology); Health care; Regimen; Intensive care medicine; Family medicine; Surgery; Political science","score_opus":0.15696893263582237,"score_gpt":0.36237707985624673,"score_spread":0.20540814722042436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031629527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98640996,0.0017907907,0.00017793712,0.008237444,0.000032247375,0.0029370293,0.000120178265,0.00006172546,0.00023270954],"genre_scores_gemma":[0.99475974,0.00028157968,0.004591831,0.00013692881,0.00005101807,0.000039643674,0.000063212385,0.00002490798,0.00005115897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851644,0.00015517604,0.0003935504,0.00040512413,0.00024968793,0.0002800322],"domain_scores_gemma":[0.9990292,0.00015917595,0.00016814073,0.00017965183,0.00029158973,0.00017223171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013605965,0.00023654856,0.00069174403,0.000050068666,0.00013679473,0.000024547206,0.000045863962,0.00006259836,0.0000683044],"category_scores_gemma":[0.0002881041,0.00014585203,0.00007440964,0.00013092047,0.000284252,0.000037700138,0.000029246234,0.000045773668,0.0000044558897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051553804,0.0050468515,0.40594795,0.008579687,0.005797641,0.0016531678,0.049366474,0.00009035558,0.43066746,0.003222985,0.0021544262,0.035919208],"study_design_scores_gemma":[0.034237012,0.033658195,0.06341285,0.0006843832,0.0009812227,0.00028890272,0.0069267433,0.008514602,0.8433039,0.00067762664,0.006366011,0.00094851473],"about_ca_topic_score_codex":0.0000067926067,"about_ca_topic_score_gemma":6.063062e-7,"teacher_disagreement_score":0.41263646,"about_ca_system_score_codex":0.00006918906,"about_ca_system_score_gemma":0.00024097256,"threshold_uncertainty_score":0.59476733},"labels":[],"label_agreement":null},{"id":"W3033337455","doi":"10.3324/haematol.2020.249243","title":"Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; BC Cancer Agency","funders":"BC Cancer Agency; Université Paris-Est Créteil Val-de-Marne; Université Paris-Sud; Terry Fox Research Institute; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"Myeloid leukemia; Epigenetics; Genetically engineered; Cancer research; Leukemia; Biology; Medicine; Computational biology; Bioinformatics; Immunology; Genetics; Gene","score_opus":0.0364780637644815,"score_gpt":0.27953285423043717,"score_spread":0.24305479046595568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033337455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98471117,0.004652275,0.0027238694,0.0065894374,0.000020294287,0.00085970125,0.000025473424,0.000083764244,0.0003340066],"genre_scores_gemma":[0.99373543,0.0012399243,0.0041941414,0.00048470043,0.0000619362,0.000117806994,0.000053193486,0.000030527706,0.0000823394],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982536,0.00006848307,0.00037036208,0.00046775723,0.00040456513,0.00043524368],"domain_scores_gemma":[0.99918306,0.00010768749,0.00008638174,0.00022803647,0.000089698086,0.00030515142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017048254,0.00022429758,0.00059431395,0.0001177851,0.000040442817,0.000011029286,0.00013020798,0.0002483678,0.00016624754],"category_scores_gemma":[0.00024312382,0.00017347331,0.000057161582,0.00031209915,0.00021995614,0.000039257902,0.00016681492,0.0003888564,0.000019205647],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011692081,0.00018606421,0.003641129,0.0010263214,0.00007312269,0.0001652856,0.000454654,0.00087200775,0.97660613,0.00045147087,0.0042642276,0.011090381],"study_design_scores_gemma":[0.0072449613,0.0032653606,0.014466858,0.00037760174,0.00009874339,0.00027548874,0.00014760638,0.76693225,0.20505007,0.00028865543,0.0013702352,0.00048218813],"about_ca_topic_score_codex":0.000008834105,"about_ca_topic_score_gemma":0.0000074360737,"teacher_disagreement_score":0.7715561,"about_ca_system_score_codex":0.00025027033,"about_ca_system_score_gemma":0.000527028,"threshold_uncertainty_score":0.7074036},"labels":[],"label_agreement":null},{"id":"W3039887493","doi":"10.3324/haematol.2020.252916","title":"ABL-class fusion positive acute lymphoblastic leukemia: can targeting ABL cure ALL?","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"ABL; Lymphoblastic Leukemia; Medicine; Cancer research; Class (philosophy); Leukemia; Immunology; Internal medicine; Computer science; Tyrosine kinase; Receptor; Artificial intelligence","score_opus":0.021530595997862858,"score_gpt":0.274821907016485,"score_spread":0.2532913110186222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039887493","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005578349,0.00080505625,0.0008016055,0.9746033,0.0009378269,0.0025763242,0.0007286972,0.0009911082,0.012977721],"genre_scores_gemma":[0.028652556,0.0010031005,0.003790538,0.94677514,0.0050312057,0.00036615942,0.006282153,0.00044711086,0.0076520178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913531,0.0005215025,0.0013419803,0.002196311,0.0022800243,0.0023070811],"domain_scores_gemma":[0.99517834,0.0015045464,0.00075093337,0.0011843157,0.0006077406,0.0007741195],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00030171534,0.0014704902,0.0029680326,0.0004883067,0.00046159446,0.00017525555,0.0011271073,0.003214078,0.0012294854],"category_scores_gemma":[0.0013295818,0.0011130939,0.00074723427,0.00086360256,0.00068138057,0.00013139028,0.0011389884,0.0058480506,0.0018760136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050017325,0.000059951697,0.00006470103,0.0010636606,0.0010836741,0.12539418,0.00038541688,0.0000060612915,0.0015829386,0.000061801446,0.8694945,0.00030295734],"study_design_scores_gemma":[0.005445354,0.0017804283,0.00012426586,0.001828003,0.0026653456,0.01649061,0.00023926212,0.00516135,0.002932151,0.00049193745,0.96099997,0.0018413183],"about_ca_topic_score_codex":0.00031845632,"about_ca_topic_score_gemma":0.000010267794,"teacher_disagreement_score":0.108903565,"about_ca_system_score_codex":0.0051664105,"about_ca_system_score_gemma":0.003821393,"threshold_uncertainty_score":0.99980444},"labels":[],"label_agreement":null},{"id":"W3043245960","doi":"10.3324/haematol.2020.247023","title":"Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma","year":2020,"lang":"en","type":"review","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Lymphoma; Genome-wide association study; Immunology; Population; Genetic association; Biology; Case-control study; Chemokine; Genetic variation; Genetics; Oncology; Medicine; Single-nucleotide polymorphism; Genotype; Internal medicine; Gene; Environmental health; Inflammation","score_opus":0.02416659836648613,"score_gpt":0.2900074486349837,"score_spread":0.2658408502684976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043245960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033957483,0.9842402,0.00026682497,0.001462851,0.00026188028,0.004361243,0.00025122936,0.0005208581,0.0052392115],"genre_scores_gemma":[0.011494693,0.9835155,0.0011884825,0.001747251,0.000086533226,0.0003917496,0.0006276833,0.0001753741,0.0007727043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960569,0.00033193492,0.001118319,0.0011862769,0.0006077567,0.00069882284],"domain_scores_gemma":[0.99757725,0.00018373378,0.00085021235,0.00071343424,0.00022109541,0.00045429927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030975544,0.00079482584,0.0038999668,0.00015076344,0.00022423436,0.00008891664,0.00033602706,0.0011592312,0.00081014755],"category_scores_gemma":[0.0006893337,0.00056418526,0.0006649254,0.0015794411,0.00013028987,0.000053731655,0.00012784963,0.000510492,0.001141107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005292631,0.00095721724,0.0020881796,0.0109314965,0.0039976533,0.0019303149,0.0023013838,0.00002346228,0.0000031078214,0.00009888979,0.06172265,0.91541636],"study_design_scores_gemma":[0.0043685734,0.0020514184,0.0069721946,0.011647915,0.0054152543,0.0003107114,0.00010404429,0.00031378042,0.0000017057995,0.00014970083,0.96739805,0.0012666524],"about_ca_topic_score_codex":0.00011397685,"about_ca_topic_score_gemma":0.00004026393,"teacher_disagreement_score":0.9141497,"about_ca_system_score_codex":0.00087102124,"about_ca_system_score_gemma":0.0012359452,"threshold_uncertainty_score":0.99968094},"labels":[],"label_agreement":null},{"id":"W3049070288","doi":"10.3324/haematol.2020.255950","title":"Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"BC Cancer Foundation; Princess Margaret Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; European Hematology Association; Genome Canada; Hospital for Sick Children; Genome British Columbia","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Central nervous system; Medicine; Pathology; Internal medicine","score_opus":0.02799313388997275,"score_gpt":0.24356126216853355,"score_spread":0.2155681282785608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049070288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79142076,0.017665472,0.00006562454,0.18632811,0.00040805148,0.0022003148,0.00019573342,0.00047165202,0.0012442904],"genre_scores_gemma":[0.8922903,0.00046314712,0.00013411274,0.10600338,0.00017766036,0.00026929114,0.00048732088,0.00007836104,0.000096414136],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99654514,0.00027242207,0.0007550576,0.0009863217,0.0004603028,0.0009807824],"domain_scores_gemma":[0.99849635,0.00026252988,0.00033491885,0.00059037266,0.000053635016,0.0002621942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009712804,0.0006822424,0.0018647964,0.00019020037,0.000121644356,0.0000882726,0.0002031872,0.0009862025,0.000012107366],"category_scores_gemma":[0.00007870068,0.0005130636,0.00030118274,0.00025105308,0.000076522345,0.000048373677,0.0001924273,0.0005564783,0.00012002193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002207271,0.003534999,0.04843001,0.018843394,0.0006192683,0.58938706,0.000584106,0.0000022521533,0.00018659612,0.0014433577,0.33603895,0.0007093209],"study_design_scores_gemma":[0.24492875,0.005137934,0.08422129,0.04832096,0.009998317,0.15753737,0.0057841726,0.0038289647,0.0057467744,0.0004962425,0.42592898,0.008070251],"about_ca_topic_score_codex":0.00011001234,"about_ca_topic_score_gemma":0.000005312492,"teacher_disagreement_score":0.43184966,"about_ca_system_score_codex":0.0007368976,"about_ca_system_score_gemma":0.00016489417,"threshold_uncertainty_score":0.9997321},"labels":[],"label_agreement":null},{"id":"W3086465642","doi":"10.3324/haematol.2021.279046","title":"Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research","year":2021,"lang":"en","type":"erratum","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Defense; National Heart, Lung, and Blood Institute; University of Minnesota; U.S. Navy; Health Resources and Services Administration","keywords":"Hazard ratio; Internal medicine; Transplantation; Medicine; Monosomy; Cytogenetics; Hematopoietic stem cell transplantation; Leukemia; Oncology; International Prognostic Scoring System; Acute lymphocytic leukemia; Myelodysplastic syndromes; Acute leukemia; Karyotype; Bone marrow; Confidence interval; Biology; Lymphoblastic Leukemia; Genetics","score_opus":0.03173605185265883,"score_gpt":0.319849606834028,"score_spread":0.2881135549813692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086465642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875983,0.0010701588,0.000081238,0.0006651584,0.0012491766,0.0037417202,0.004553187,0.000025761796,0.0010153274],"genre_scores_gemma":[0.9927418,0.0021231251,0.00011280557,0.00013803957,0.00014740384,0.000737462,0.0004097498,0.00010081059,0.003488752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935627,0.0009074937,0.0016043099,0.0008852315,0.0022058429,0.00083443907],"domain_scores_gemma":[0.9930985,0.0030162476,0.0008434295,0.0011241364,0.0017334367,0.0001842644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007523456,0.0007767766,0.0021132317,0.00040925381,0.00023393512,0.00005804151,0.0012423068,0.0006640756,0.000112720205],"category_scores_gemma":[0.00024035125,0.00042128775,0.0008731936,0.00057497236,0.0012860732,0.00006427896,0.00033374692,0.0012515701,0.000002292375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046509597,0.0085817315,0.5870742,0.020948626,0.05958183,0.00525629,0.07646625,0.00027112997,0.008143103,0.00047059645,0.18614605,0.00055059255],"study_design_scores_gemma":[0.12302846,0.03617329,0.5431929,0.04111637,0.044413127,0.016318014,0.034522515,0.0027625856,0.15115935,0.0010144452,0.001397794,0.004901137],"about_ca_topic_score_codex":0.0002488078,"about_ca_topic_score_gemma":0.000116955925,"teacher_disagreement_score":0.18474826,"about_ca_system_score_codex":0.00097281695,"about_ca_system_score_gemma":0.002442157,"threshold_uncertainty_score":0.99982387},"labels":[],"label_agreement":null},{"id":"W3093120364","doi":"10.3324/haematol.2020.259093","title":"The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Dalhousie University; Saint John Regional Hospital; Princess Margaret Cancer Centre; Vancouver General Hospital; McGill University; CancerCare Manitoba; Ottawa Hospital; Université de Montréal; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"Dalhousie University; University of Alberta; Celgene; Sanofi; Amgen; Pfizer; McGill University","keywords":"Lenalidomide; Multiple myeloma; Medicine; Database; Oncology; Internal medicine; Computer science","score_opus":0.33194027255700204,"score_gpt":0.4670194784622977,"score_spread":0.13507920590529565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093120364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97859526,0.00024949678,0.000027981518,0.009854796,0.00002367248,0.0006415128,0.007188259,0.000019115427,0.0033999088],"genre_scores_gemma":[0.9950163,0.00020914999,0.00039947536,0.000118944015,0.0000641836,0.000022317796,0.004105324,0.000011599207,0.000052754986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654377,0.00078356423,0.00041894402,0.00046849917,0.0012617769,0.00052344304],"domain_scores_gemma":[0.9951481,0.0021843258,0.00016543487,0.0013659358,0.00060540024,0.00053077546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022401253,0.00014755856,0.0005935224,0.00023058131,0.00039243547,0.000048453614,0.0010955251,0.000049625294,0.0004068799],"category_scores_gemma":[0.00389918,0.00006841526,0.00017272212,0.0019245113,0.00074318855,0.00012239866,0.00035349972,0.00036307663,0.00002654182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024015137,0.00022620507,0.96618366,0.000028600343,0.0038202698,0.00044841453,0.0002634528,0.000024238518,0.00058894145,0.0082217045,0.016270446,0.0015225599],"study_design_scores_gemma":[0.0008984822,0.00030060293,0.9786303,0.000031552096,0.00025990268,0.000006010916,0.00042372156,0.018197877,0.000114468414,0.0002031282,0.0008651317,0.00006879549],"about_ca_topic_score_codex":0.61350375,"about_ca_topic_score_gemma":0.8946185,"teacher_disagreement_score":0.28111473,"about_ca_system_score_codex":0.0002200536,"about_ca_system_score_gemma":0.0011103668,"threshold_uncertainty_score":0.46679643},"labels":[],"label_agreement":null},{"id":"W3093257661","doi":"10.3324/haematol.2020.253740","title":"Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Interleukin-3 receptor; RUNX1; Myeloid; CD34; Myeloid leukemia; Chronic myelomonocytic leukemia; Phenotype; Plasmacytoid dendritic cell; Cancer research; Leukemia; Biology; Immunology; Immunophenotyping; Gene; Haematopoiesis; Flow cytometry; Dendritic cell; Antigen; Bone marrow; Myelodysplastic syndromes; Stem cell; Genetics","score_opus":0.012032518843336238,"score_gpt":0.21571780718578654,"score_spread":0.2036852883424503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093257661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526256,0.0022606417,0.00030608897,0.0006823382,0.00011911325,0.0004883115,0.000035017063,0.00020601963,0.000639894],"genre_scores_gemma":[0.99791044,0.00018082018,0.00020563924,0.0006578092,0.000012251824,0.000070622984,0.00026007177,0.000020541409,0.0006818051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878883,0.0002848501,0.0002586477,0.00031642552,0.000046901605,0.00030434947],"domain_scores_gemma":[0.9994048,0.00020964614,0.00015415749,0.00012679098,0.000077653705,0.000026988706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011196872,0.00021214005,0.00037658896,0.0000500769,0.00028906335,0.000040648403,0.00012250002,0.0002739822,0.00046017696],"category_scores_gemma":[0.00012932676,0.00015527925,0.000041696876,0.00017177104,0.00017038129,0.00014529658,0.0000409911,0.00028464964,0.00031319915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059749093,0.00017372692,0.0021810567,0.00008267831,0.0010133063,0.00033334008,0.0034218607,0.00003063809,0.9780353,0.0009454064,0.004818844,0.0029889452],"study_design_scores_gemma":[0.005727692,0.0027374742,0.009814175,0.00010668538,0.00026224356,0.0011243704,0.00079817534,0.00037851906,0.9741191,0.000113256865,0.0042090127,0.00060928153],"about_ca_topic_score_codex":0.0000062851136,"about_ca_topic_score_gemma":0.000006369755,"teacher_disagreement_score":0.0076331184,"about_ca_system_score_codex":0.000028080569,"about_ca_system_score_gemma":0.00011110013,"threshold_uncertainty_score":0.6332104},"labels":[],"label_agreement":null},{"id":"W3094388801","doi":"10.3324/haematol.2020.260158","title":"Recapitulation of erythropoiesis in congenital dyserythropoietic anemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Biotechnology and Biological Sciences Research Council; University of Oxford; Wellcome Trust; Academy of Medical Sciences; Medical Research Council; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research","keywords":"Erythropoiesis; Ineffective erythropoiesis; Nucleolus; Biology; Chromatin; Pathognomonic; Cell biology; Erythroblast; Abnormality; Cellular differentiation; Genetics; Gene; Cancer research; Anemia; Haematopoiesis; Pathology; Disease; Stem cell; Medicine; Internal medicine","score_opus":0.029735586862759796,"score_gpt":0.25875963826862114,"score_spread":0.22902405140586135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094388801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760795,0.00077626965,0.000031923766,0.00068718975,0.00013262322,0.00026861992,0.0000035830872,0.000044009197,0.0004478327],"genre_scores_gemma":[0.99893564,0.00045105955,0.00019338705,0.00029639545,0.000027152731,0.000008932242,0.000042701926,0.00001053206,0.000034227505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895304,0.0001286653,0.00038677396,0.00024704987,0.00012086134,0.00016360036],"domain_scores_gemma":[0.99950945,0.00011595952,0.00011819122,0.00012027538,0.0000724577,0.00006365784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009510778,0.00013299257,0.0004676505,0.00013768335,0.00003380968,0.000009506071,0.000040314248,0.00016252749,0.00034055253],"category_scores_gemma":[0.00031540214,0.00011508564,0.00004464244,0.00029976878,0.00018302647,0.00010880518,0.000046604633,0.00016229195,0.000025002308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019580475,0.00029380497,0.8932169,0.0015238218,0.000055363318,0.00027804045,0.008262037,0.00006510533,0.089487776,0.0037692823,0.00053688604,0.00055291894],"study_design_scores_gemma":[0.0017253987,0.0007984186,0.9825326,0.00013110954,0.00006157996,0.00009054929,0.002871451,0.0008339922,0.009923963,0.0007773074,0.00008115001,0.00017244334],"about_ca_topic_score_codex":0.00007286999,"about_ca_topic_score_gemma":0.00012913687,"teacher_disagreement_score":0.08931572,"about_ca_system_score_codex":0.000022849938,"about_ca_system_score_gemma":0.0000285636,"threshold_uncertainty_score":0.46930563},"labels":[],"label_agreement":null},{"id":"W3097563180","doi":"10.3324/haematol.2020.261107","title":"Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Celgene; MorphoSys; F. Hoffmann-La Roche; Pharmacyclics; Genentech; Gilead Sciences; BeiGene; Sanofi; Servier; Amgen; Pfizer; GlaxoSmithKline","keywords":"Bendamustine; Ven; Tumor lysis syndrome; Medicine; Venetoclax; Tolerability; Obinutuzumab; Neutropenia; Internal medicine; Chronic lymphocytic leukemia; Gastroenterology; Discontinuation; Rituximab; Leukemia; Toxicity; Chemotherapy; Lymphoma; Adverse effect","score_opus":0.12996967499448986,"score_gpt":0.3799866589269263,"score_spread":0.25001698393243643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097563180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266297,0.0009431345,0.00007476561,0.00047280823,0.00012262554,0.0031975987,0.0001148005,0.00028064862,0.0021306498],"genre_scores_gemma":[0.99724966,0.0001481073,0.0007283254,0.0004111172,0.00029493807,0.00027041903,0.00011653081,0.00008330139,0.0006975926],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99368507,0.00031916954,0.0019579662,0.0013976074,0.0013453498,0.0012948625],"domain_scores_gemma":[0.9966302,0.00075908465,0.0005036208,0.0011661975,0.00029564375,0.0006452534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007712902,0.0006683404,0.0022904973,0.0003915589,0.00014194837,0.000043881228,0.0007875754,0.00043758805,0.0007623316],"category_scores_gemma":[0.0032114217,0.00050480425,0.00028577368,0.0018281236,0.0004623002,0.00015592002,0.0006080669,0.00091057195,0.00028816372],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.4249458,0.006202132,0.00095982244,0.022970095,0.00269673,0.2896259,0.041490976,0.08574905,0.019712044,0.0013416373,0.07913541,0.025170391],"study_design_scores_gemma":[0.41213617,0.01881225,0.00034506634,0.00090217276,0.00043696366,0.0041651884,0.0026996268,0.54834515,0.00643883,0.00004045579,0.004895814,0.0007823063],"about_ca_topic_score_codex":0.0032462871,"about_ca_topic_score_gemma":0.00056095293,"teacher_disagreement_score":0.46259612,"about_ca_system_score_codex":0.17154606,"about_ca_system_score_gemma":0.1343386,"threshold_uncertainty_score":0.99974036},"labels":[],"label_agreement":null},{"id":"W3114964641","doi":"10.3324/haematol.2020.265827","title":"Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC)","year":2020,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council","keywords":"Medicine; Disease; Cerebral infarction; Genome-wide association study; Internal medicine; Genetics; Biology; Gene; Ischemia; Genotype; Single-nucleotide polymorphism","score_opus":0.012474983673794293,"score_gpt":0.22541386323852364,"score_spread":0.21293887956472934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114964641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7245122,0.00088075973,0.0000023707232,0.27237424,0.00012567652,0.0011519776,0.000020558247,0.000055388322,0.0008768284],"genre_scores_gemma":[0.87682533,0.00035700403,0.000023476452,0.121798225,0.00013919969,0.000056873618,0.00021253257,0.000030428491,0.00055689586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998123,0.00018968369,0.00053139136,0.00043957616,0.0004057817,0.00031055885],"domain_scores_gemma":[0.9990136,0.00018042397,0.00037750817,0.00023897679,0.00006654979,0.0001229154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011653125,0.00026760195,0.0008232175,0.00016343314,0.000054331693,0.000015318885,0.00008991433,0.0005636635,0.00013925925],"category_scores_gemma":[0.000321123,0.00021174544,0.00013159816,0.0002309044,0.000047424986,0.000039600454,0.00009430569,0.0012210329,0.00003273654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031385332,0.0010953399,0.73089695,0.0020691603,0.00024455594,0.0037730797,0.0021479782,0.000023836983,0.00004669941,0.0000032281364,0.25930554,0.00007979612],"study_design_scores_gemma":[0.008749072,0.0027203918,0.8095422,0.00058333843,0.0017542875,0.000046221994,0.003775285,0.00017438513,0.000036456822,0.0004912346,0.17122875,0.00089837034],"about_ca_topic_score_codex":0.000117625474,"about_ca_topic_score_gemma":0.000012302905,"teacher_disagreement_score":0.15231317,"about_ca_system_score_codex":0.00014538359,"about_ca_system_score_gemma":0.00008470883,"threshold_uncertainty_score":0.8634728},"labels":[],"label_agreement":null},{"id":"W3115671232","doi":"10.3324/haematol.2020.267757","title":"Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Ontario Ministry of Health and Long-Term Care; Amgen; McMaster University; Cancer Care Ontario; Celgene; Sanofi","keywords":"Medicine; Multiple myeloma; Cohort; Internal medicine; Population; Oncology; Environmental health","score_opus":0.021667831886878514,"score_gpt":0.27253379591813964,"score_spread":0.25086596403126116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115671232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490476,0.000041233856,0.000082876504,0.0007678773,0.000020072697,0.0037336443,0.00004778044,0.00015730619,0.00024446694],"genre_scores_gemma":[0.9978071,0.000006935036,0.00081083825,0.00027728963,0.00002961297,0.0004573552,0.0005630514,0.00003056064,0.000017285658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977994,0.00013452131,0.000392155,0.00057225936,0.00063400285,0.00046768205],"domain_scores_gemma":[0.9988239,0.00029715282,0.00008792234,0.00031107356,0.000101759615,0.00037823032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009903809,0.00028065182,0.0007084123,0.0001467041,0.0000963471,0.00002747832,0.00014515928,0.00009856401,0.00018054414],"category_scores_gemma":[0.00030788637,0.00018702637,0.000076112876,0.00045928388,0.000038993705,0.000075613774,0.000027712447,0.00022140946,0.0000991745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030958408,0.0015779402,0.99136883,0.000099237805,0.00014169206,0.002425493,0.00045458303,0.00018217908,0.000010698477,0.000005372495,0.00006702944,0.0005710946],"study_design_scores_gemma":[0.023140438,0.001582328,0.97122663,0.000106738255,0.00009741838,0.00000869273,0.00013420646,0.0033929052,0.000078411496,0.000003967483,0.000038002352,0.00019024443],"about_ca_topic_score_codex":0.0016789472,"about_ca_topic_score_gemma":0.00055881526,"teacher_disagreement_score":0.020142192,"about_ca_system_score_codex":0.00008353753,"about_ca_system_score_gemma":0.000091038215,"threshold_uncertainty_score":0.76267135},"labels":[],"label_agreement":null},{"id":"W3115869600","doi":"10.3324/haematol.2020.271908","title":"CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science Foundation Ireland; Irish Cancer Society; Health Research Board; Health Service Executive; Wellcome Trust; Canadian Institute for Theoretical Astrophysics","keywords":"CD38; Chimeric antigen receptor; Myeloid leukemia; Cancer research; Leukemia; Interleukin 12; Lymphokine-activated killer cell; Biology; Cytotoxic T cell; Immunology; Immunotherapy; Interleukin 21; Antigen; Cell biology; Stem cell; Immune system; CD8; CD34; In vitro; Biochemistry","score_opus":0.011177358172089646,"score_gpt":0.22384499296343946,"score_spread":0.2126676347913498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115869600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875085,0.0018225068,0.0010951877,0.00042663526,0.005704547,0.00073623314,0.000013780107,0.00057675893,0.0021158974],"genre_scores_gemma":[0.98800606,0.000250557,0.0057043247,0.0011625923,0.00010993902,0.0000633536,0.00069883926,0.0000642878,0.0039400253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692816,0.00075720047,0.0006086448,0.0008859905,0.000108457214,0.0007115578],"domain_scores_gemma":[0.9985055,0.00021397475,0.00051134324,0.00047840897,0.00016809386,0.0001227235],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001795069,0.00057188125,0.0009649014,0.00014023758,0.00059132435,0.00010946872,0.00051960873,0.000510951,0.00562018],"category_scores_gemma":[0.00009924623,0.0004191185,0.00023930971,0.00041237968,0.00023778938,0.0005021891,0.0001637682,0.001086285,0.0024478605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036940419,0.00016010716,0.00023677619,0.00004502882,0.00027788826,0.00005380988,0.00071881287,0.00018752592,0.9448867,0.000006847345,0.049392633,0.00033983708],"study_design_scores_gemma":[0.0029417928,0.0010766382,0.0007699432,0.000051780702,0.00014533386,0.00017428456,0.0005090483,0.00023842807,0.94874096,0.0000030639505,0.044707943,0.0006407984],"about_ca_topic_score_codex":0.00008184361,"about_ca_topic_score_gemma":0.0000020326365,"teacher_disagreement_score":0.0055946074,"about_ca_system_score_codex":0.00010363184,"about_ca_system_score_gemma":0.0001577276,"threshold_uncertainty_score":0.9998261},"labels":[],"label_agreement":null},{"id":"W3118040066","doi":"10.3324/haematol.2020.270595","title":"Molecular and phenotypic diversity of &lt;I&gt;CBL&lt;/I&gt;-mutated juvenile myelomonocytic leukemia","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; York University; European Hematology Association","keywords":"Juvenile myelomonocytic leukemia; Phenotype; Cancer research; Juvenile; Biology; Genetics; Molecular biology; Gene; Haematopoiesis","score_opus":0.029000979285829294,"score_gpt":0.26218188366792006,"score_spread":0.23318090438209077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118040066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98675084,0.0021123658,0.00070016517,0.0028320132,0.000040285307,0.0006677213,0.000023692613,0.00019839595,0.0066745025],"genre_scores_gemma":[0.99646294,0.0002706486,0.0018013894,0.0011347508,0.000037003618,0.000017217717,0.000039296443,0.00003269249,0.00020407097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770087,0.00015786495,0.00045662044,0.00060405023,0.0005465686,0.0005340487],"domain_scores_gemma":[0.99848026,0.00018209175,0.00018107543,0.00045154375,0.00020637558,0.00049866294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024838265,0.00029796822,0.0009693925,0.00013503345,0.00019931782,0.000018454823,0.00035619127,0.00027621878,0.000386408],"category_scores_gemma":[0.0007184518,0.00025098328,0.00016110526,0.00056605996,0.00047089547,0.00009210285,0.001009916,0.00042261195,0.00018515914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046582846,0.00046099012,0.019190568,0.003235,0.001235189,0.015650788,0.007247072,0.0002454869,0.8721762,0.022416016,0.041237585,0.012246867],"study_design_scores_gemma":[0.041678734,0.009389429,0.11365497,0.0013585546,0.00320302,0.0053647887,0.0024268706,0.06300199,0.6717481,0.0073947166,0.076959416,0.0038193988],"about_ca_topic_score_codex":0.000030738487,"about_ca_topic_score_gemma":0.0000052495066,"teacher_disagreement_score":0.20042804,"about_ca_system_score_codex":0.00029923115,"about_ca_system_score_gemma":0.00040568502,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W3118088258","doi":"10.3324/haematol.2020.271619","title":"Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hôpital Maisonneuve-Rosemont; Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval; Hôpital de l'Enfant-Jésus; Institute for Research in Immunology and Cancer","funders":"Université de Montréal; CHU Sainte-Justine Foundation; Molson Foundation","keywords":"Biology; Epigenetics; Epigenome; Genetics; Cancer research; DNA methylation; Chromatin; Regulation of gene expression; Epigenomics; Transcription factor; Demethylase; Histone; Gene expression; Gene","score_opus":0.05493851507936829,"score_gpt":0.2996878199912756,"score_spread":0.2447493049119073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118088258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877459,0.00043196607,0.00014241345,0.008736578,0.000031603126,0.00079765153,0.000010089009,0.0002364887,0.0018673558],"genre_scores_gemma":[0.9958345,0.00028262296,0.0012638276,0.0011566831,0.00012782865,0.00015724517,0.000022435377,0.00006570974,0.0010891317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972342,0.00013504585,0.00048435185,0.0007611426,0.0005590085,0.0008262416],"domain_scores_gemma":[0.998746,0.000065880624,0.0001186489,0.0005097158,0.000090194844,0.0004695972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002031124,0.00035132762,0.0008426815,0.00026251737,0.00017486542,0.000023217977,0.00042840355,0.00031156515,0.00028566679],"category_scores_gemma":[0.00021566701,0.00029476604,0.0001419618,0.00060676254,0.00011630935,0.000081565326,0.00034585758,0.000536248,0.0002835862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021319843,0.00065694796,0.24841595,0.0022004943,0.0004314885,0.012036457,0.006059415,0.0019890987,0.7166159,0.0026400879,0.00504036,0.0017818309],"study_design_scores_gemma":[0.012910641,0.0018091853,0.4316602,0.0005698949,0.00025783334,0.0009186616,0.00043168792,0.026760805,0.52070904,0.0012723133,0.0012045939,0.001495132],"about_ca_topic_score_codex":0.00015002875,"about_ca_topic_score_gemma":0.000080690086,"teacher_disagreement_score":0.19590683,"about_ca_system_score_codex":0.000550928,"about_ca_system_score_gemma":0.0002459546,"threshold_uncertainty_score":0.99995047},"labels":[],"label_agreement":null},{"id":"W3119553533","doi":"10.3324/haematol.2020.271106","title":"Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"GlaxoSmithKline; Amgen","keywords":"Medicine; Evans syndrome; Hazard ratio; Confidence interval; Pediatrics; Thrombocytopenic purpura; Internal medicine; Proportional hazards model; Autoimmune hemolytic anemia; Cohort; Anemia; Prospective cohort study; Platelet","score_opus":0.022778601063894725,"score_gpt":0.2802806230786389,"score_spread":0.25750202201474415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119553533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476,0.0033666168,0.000020865695,0.0005788639,0.000100307225,0.00035942922,0.00007076751,0.00006244046,0.00068071677],"genre_scores_gemma":[0.9950238,0.0027488377,0.00086896814,0.00005326618,0.000015698539,0.000060476345,0.00024765317,0.000013350656,0.0009679779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881446,0.00007190089,0.00032386498,0.00036286836,0.00016615118,0.00026073077],"domain_scores_gemma":[0.9992659,0.00012984725,0.00011047299,0.0003026939,0.00007764626,0.000113420865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005083044,0.00021510725,0.0006710093,0.00007573206,0.00011059231,0.00001698781,0.000055238823,0.0001474691,0.00028982406],"category_scores_gemma":[0.00008702971,0.00014921531,0.00012836822,0.00016142138,0.000089078,0.00004667132,0.000046723515,0.00008875935,0.000047961264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038019108,0.001965509,0.8100389,0.00031436744,0.00055763364,0.1780569,0.00087185757,0.0000026043583,0.0007126136,0.00051649875,0.00027243767,0.006310469],"study_design_scores_gemma":[0.00504009,0.001390894,0.94490737,0.00006194848,0.00079589436,0.045481477,0.00030858812,0.0000077155955,0.0010519192,0.00071587815,0.000055006338,0.0001832296],"about_ca_topic_score_codex":0.000060983282,"about_ca_topic_score_gemma":0.000025234629,"teacher_disagreement_score":0.13486844,"about_ca_system_score_codex":0.000040487354,"about_ca_system_score_gemma":0.00008411957,"threshold_uncertainty_score":0.60848236},"labels":[],"label_agreement":null},{"id":"W3120252752","doi":"10.3324/haematol.2020.269944","title":"Reversible switching of leukemic cells to a drug-resistant, stem-like subset via IL-4-mediated cross-talk with mesenchymal stroma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"College of Medicine, Catholic University of Korea; Seoul National University","keywords":"Mesenchymal stem cell; Stroma; Stromal cell; Cancer research; Biology; Cell biology; Progenitor cell; Cell; Stem cell; Immunology; Genetics","score_opus":0.01705753678729018,"score_gpt":0.25828674109819205,"score_spread":0.24122920431090186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120252752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356896,0.00019735553,0.002540336,0.00036829535,0.00015468436,0.0006300531,0.000082737926,0.00013153428,0.0023260678],"genre_scores_gemma":[0.991477,0.000038476228,0.0068118228,0.00031362555,0.000023223129,0.00003389451,0.00009615128,0.000039245464,0.001166526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974917,0.00013570378,0.0006758481,0.00059063465,0.0006098472,0.0004962301],"domain_scores_gemma":[0.998204,0.00035420273,0.00023651891,0.0005874736,0.0003164799,0.0003013169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030574322,0.000305337,0.00088948023,0.00015768148,0.00011131084,0.000034083132,0.00018243001,0.00017938207,0.0004606928],"category_scores_gemma":[0.000056537723,0.00024128701,0.00013894385,0.0006946568,0.000083085484,0.00010268997,0.000057165387,0.0002624883,0.00013046255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013101741,0.00026098161,0.026843192,0.0018173686,0.00018306606,0.0057901577,0.0016370943,0.00005634022,0.96085805,0.00018326861,0.0009690781,0.00009125702],"study_design_scores_gemma":[0.0037916806,0.000659688,0.024617478,0.0014230012,0.00033042743,0.0035897081,0.0020692612,0.0002176206,0.96162546,0.000055761215,0.0011478636,0.00047205295],"about_ca_topic_score_codex":0.00011892857,"about_ca_topic_score_gemma":0.00012834033,"teacher_disagreement_score":0.0042714863,"about_ca_system_score_codex":0.00009633071,"about_ca_system_score_gemma":0.0003252015,"threshold_uncertainty_score":0.9839398},"labels":[],"label_agreement":null},{"id":"W3120771996","doi":"10.3324/haematol.2020.268656","title":"Comparison of CD38 antibodies &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;ex vivo&lt;/i&gt; mechanisms of action in multiple myeloma","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Calcium signaling and nucleotide metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Servier; Celgene; Sanofi; Bristol-Myers Squibb; Amgen","keywords":"Ex vivo; In vivo; Antibody; CD38; In vitro; Multiple myeloma; Chemistry; Cancer research; Molecular biology; Biology; Medicine; Internal medicine; Immunology; Genetics; Biochemistry; Stem cell","score_opus":0.03111439075457691,"score_gpt":0.27740873787342607,"score_spread":0.24629434711884915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120771996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96778655,0.022684896,0.0012681442,0.0051147207,0.0008817739,0.00083284127,0.00038263472,0.00006374081,0.0009846762],"genre_scores_gemma":[0.98861825,0.0026146376,0.0028710426,0.003539994,0.00042381286,0.00007249214,0.0011271713,0.000107401625,0.0006251857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99494153,0.00065817696,0.0015673481,0.0013796372,0.00059606956,0.0008572357],"domain_scores_gemma":[0.99728495,0.00026841983,0.001036588,0.0009999288,0.00028293516,0.00012716574],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006340364,0.00085371867,0.0024912488,0.00048386332,0.00013039132,0.000054314045,0.000579072,0.0020525414,0.00012739787],"category_scores_gemma":[0.00048532608,0.0008126403,0.0005185275,0.00040095978,0.00047528578,0.000017096707,0.00049611373,0.0008318254,0.000011766187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034925382,0.00029755294,0.00037521718,0.0007674874,0.00017447193,0.00026383065,0.00016272305,0.000038758848,0.9538496,0.00042798047,0.042524308,0.0007688267],"study_design_scores_gemma":[0.0013948865,0.00027434347,0.0016732756,0.00034820734,0.00016377127,0.0001637852,0.00006453351,0.00038838809,0.80645657,0.00037062494,0.1879183,0.0007833179],"about_ca_topic_score_codex":0.0000330853,"about_ca_topic_score_gemma":0.00037717386,"teacher_disagreement_score":0.14739303,"about_ca_system_score_codex":0.00004406187,"about_ca_system_score_gemma":0.00013877067,"threshold_uncertainty_score":0.99943244},"labels":[],"label_agreement":null},{"id":"W3126189506","doi":"10.3324/haematol.2020.260059","title":"Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Platelet; Platelet activation; Chemistry; Platelet membrane glycoprotein; Glycoprotein; Molecular biology; Phenotype; Platelet Glycoprotein GPIb-IX Complex; Immunology; Pharmacology; Biochemistry; Biology; Gene","score_opus":0.06964216701490133,"score_gpt":0.3171490339214843,"score_spread":0.24750686690658297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126189506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898594,0.0037583907,0.00034158537,0.00039167903,0.00011026847,0.0006348652,0.0000263199,0.00019166397,0.004685847],"genre_scores_gemma":[0.98946613,0.0023404532,0.0075671086,0.00014242463,0.000032459655,0.000045357454,0.00019128478,0.00004057075,0.00017422522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976826,0.00012725427,0.0007534994,0.00053119106,0.00037302438,0.00053247553],"domain_scores_gemma":[0.998568,0.00014700589,0.00043346063,0.00052598125,0.00019606599,0.00012950516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001685093,0.00038609636,0.0011889698,0.00013262367,0.00026573875,0.000048064263,0.00013877086,0.00027301782,0.00032733407],"category_scores_gemma":[0.00012908604,0.0003120673,0.0002605654,0.00047411732,0.00019381841,0.00040326855,0.000100243815,0.00030077307,0.00009235458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012274618,0.001582525,0.0008748164,0.0012008845,0.0005744127,0.04838007,0.0017031754,0.000056253706,0.8906116,0.0055445256,0.00073406124,0.04751021],"study_design_scores_gemma":[0.003156351,0.00037563292,0.00088992756,0.0006403967,0.00007419007,0.0070799845,0.0004138745,0.00013621368,0.97836757,0.0035267298,0.0050265864,0.00031257357],"about_ca_topic_score_codex":0.000064146494,"about_ca_topic_score_gemma":0.00001206984,"teacher_disagreement_score":0.08775593,"about_ca_system_score_codex":0.000096590236,"about_ca_system_score_gemma":0.00007081561,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W3128469796","doi":"10.3324/haematol.2020.266791","title":"An early start of Coup-TFII promotes γ-globin gene expression in adult erythroid cells","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Globin; Gene expression; Gene; Biology; Molecular biology; Cell biology; Genetics","score_opus":0.015347205408942355,"score_gpt":0.24273877922147968,"score_spread":0.22739157381253733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128469796","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87475044,0.003187357,0.00015153179,0.11711329,0.00057533395,0.0017667692,0.00014898475,0.00019908033,0.0021072368],"genre_scores_gemma":[0.44253018,0.007424417,0.03642092,0.49979013,0.0017074037,0.00047977056,0.0051887343,0.00055817945,0.0059002726],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967911,0.00026500996,0.0008836463,0.00083593273,0.00058348424,0.0006407945],"domain_scores_gemma":[0.9981561,0.00009913012,0.00039081476,0.0009169219,0.00029479447,0.00014227061],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0001738206,0.0005045352,0.0015528823,0.00024688183,0.00006700615,0.000027868367,0.00029100518,0.0021696321,0.0006173675],"category_scores_gemma":[0.00010435589,0.0003694168,0.00026808452,0.00037703238,0.00019394774,0.000075829616,0.000112241534,0.001989423,0.00006425686],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003249411,0.0013602767,0.005351651,0.00363283,0.00018458963,0.027665699,0.0014088678,0.00002488522,0.18293692,0.00002695311,0.7762961,0.00078629743],"study_design_scores_gemma":[0.008456225,0.004648688,0.002977163,0.012013803,0.00074239663,0.0029537084,0.0019435614,0.00057128095,0.8111496,0.0005017158,0.15155788,0.0024839877],"about_ca_topic_score_codex":0.00018633789,"about_ca_topic_score_gemma":0.000013713429,"teacher_disagreement_score":0.6282127,"about_ca_system_score_codex":0.00006295683,"about_ca_system_score_gemma":0.00023127881,"threshold_uncertainty_score":0.9998758},"labels":[],"label_agreement":null},{"id":"W3132517371","doi":"10.3324/haematol.2020.261354","title":"The &lt;i&gt;EBF1-PDGFRB&lt;/i&gt; T681I mutation is highly resistant to imatinib and dasatinib &lt;i&gt;in vitro&lt;/i&gt; and detectable in clinical samples prior to treatment","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group; Frank A. Campini Foundation; American Lebanese Syrian Associated Charities; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Dasatinib; PDGFRB; In vitro; Imatinib; Cancer research; Mutation; Medicine; Molecular biology; Internal medicine; Pharmacology; Biology; Genetics; Gene; Myeloid leukemia","score_opus":0.03705287857448447,"score_gpt":0.3001651211904886,"score_spread":0.26311224261600413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132517371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7249769,0.015236231,0.000055952332,0.2517817,0.00044863563,0.0039786682,0.00035714902,0.00015362918,0.003011144],"genre_scores_gemma":[0.7420456,0.0149794165,0.024587788,0.19546026,0.0013555386,0.0036875424,0.0016004369,0.000514595,0.015768848],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99189305,0.000987015,0.0025470268,0.0021323161,0.0009996137,0.0014409595],"domain_scores_gemma":[0.99388486,0.0032190338,0.0006567045,0.0014888297,0.00024926302,0.0005012823],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015263872,0.001171478,0.0032462054,0.00059309404,0.00048388398,0.00032176278,0.00049386726,0.0014045216,0.00025506018],"category_scores_gemma":[0.0019900505,0.00081179646,0.00043138405,0.00084147084,0.0005041362,0.0001326008,0.00040035913,0.0010427177,0.000085165986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008241152,0.0029340684,0.004951822,0.0038102432,0.0018262201,0.0300533,0.012373622,0.00001551149,0.04957169,0.004627956,0.75792366,0.12367073],"study_design_scores_gemma":[0.0055716936,0.0028799826,0.03685646,0.0014980072,0.00048861327,0.001079455,0.0003220415,0.00012236017,0.001038692,0.0013324859,0.94755834,0.0012518832],"about_ca_topic_score_codex":0.00008389823,"about_ca_topic_score_gemma":0.0017712044,"teacher_disagreement_score":0.18963464,"about_ca_system_score_codex":0.00031130257,"about_ca_system_score_gemma":0.0004603362,"threshold_uncertainty_score":0.9998919},"labels":[],"label_agreement":null},{"id":"W3132531164","doi":"10.3324/haematol.2020.271304","title":"Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institutes of Health; Canadian Institutes of Health Research; Centre hospitalier régional universitaire de Lille; Medizinische Universität Wien; Oesterreichische Nationalbank; Universität Wien; Centre Hospitalier Universitaire de Québec; Austrian Science Fund; Institut National de la Santé et de la Recherche Médicale; Broad Institute; Université de Lille; Centre National de la Recherche Scientifique; Österreichischen Akademie der Wissenschaften; Vienna Science and Technology Fund; Université Laval","keywords":"Venetoclax; Ibrutinib; Prolymphocytic leukemia; Medicine; Leukemia; Oncology; Cancer research; Internal medicine; Chronic lymphocytic leukemia","score_opus":0.05991853302489981,"score_gpt":0.31065509164948746,"score_spread":0.25073655862458766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132531164","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24466334,0.023050644,0.00043464973,0.7147248,0.0007007795,0.011865651,0.00013339402,0.000114261864,0.0043125115],"genre_scores_gemma":[0.57273614,0.0027719212,0.002531582,0.402061,0.0015031117,0.00348606,0.002521002,0.00019495367,0.012194245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980938,0.00011730678,0.00050946313,0.0004275808,0.00048974564,0.00036210008],"domain_scores_gemma":[0.99671346,0.0023016343,0.00020985398,0.000502313,0.00023294699,0.000039811806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004085725,0.00022229139,0.00076316635,0.0001495907,0.000073320385,0.000026986088,0.00020024405,0.00065639394,0.00012835274],"category_scores_gemma":[0.00094551843,0.00014876988,0.00014157883,0.0002465311,0.00030854592,0.000032367374,0.00012885012,0.00063684135,0.000008282317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005759968,0.000070346476,0.00022956675,0.0061197225,0.00028475453,0.0023349433,0.00052140595,0.00006847166,0.00018937774,0.0027138623,0.9849963,0.0018952275],"study_design_scores_gemma":[0.06815695,0.0013232456,0.0022872377,0.0028459614,0.0007682632,0.008552593,0.00069254846,0.11411021,0.0073397667,0.0061076307,0.78687656,0.00093901646],"about_ca_topic_score_codex":0.00024083463,"about_ca_topic_score_gemma":0.000028762295,"teacher_disagreement_score":0.32807282,"about_ca_system_score_codex":0.008372967,"about_ca_system_score_gemma":0.012278454,"threshold_uncertainty_score":0.9954337},"labels":[],"label_agreement":null},{"id":"W3133800890","doi":"10.3324/haematol.2020.261842","title":"Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Erasmus Universitair Medisch Centrum Rotterdam; Vrije Universiteit Amsterdam; Servier; Sorbonne Université; Institut National de la Santé et de la Recherche Médicale; Amsterdam University Medical Centers; Sanofi; Université de Lille; Assistance publique-Hôpitaux de Paris; Celgene; Bristol-Myers Squibb; Amgen","keywords":"Daratumumab; Bortezomib; Multiple myeloma; Medicine; Dexamethasone; Internal medicine; Thalidomide; Transplantation; Autologous stem-cell transplantation; Oncology","score_opus":0.058757850347967176,"score_gpt":0.3123871978541202,"score_spread":0.25362934750615307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133800890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803773,0.0010745855,0.000020884983,0.012749469,0.00014477855,0.004645033,0.0002734208,0.000056063545,0.0006584595],"genre_scores_gemma":[0.98516303,0.0013827214,0.00017579304,0.010379746,0.00011887979,0.0009343297,0.0016218042,0.00006674968,0.00015695575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99479294,0.00110686,0.0010181578,0.0011527318,0.000989456,0.00093984534],"domain_scores_gemma":[0.9958767,0.0028467868,0.0002705938,0.00072395446,0.000111800204,0.00017012884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006239017,0.00069635303,0.0015772622,0.0005219103,0.00019750177,0.00014127209,0.00035588548,0.0007485051,0.00009513376],"category_scores_gemma":[0.00018598513,0.00046514758,0.00018362771,0.00064303575,0.00011429661,0.00016059751,0.000052863827,0.0021824653,0.000022411969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004182697,0.007114302,0.7358901,0.0022109775,0.00026695727,0.20556268,0.01280804,0.0000040102227,0.00023554897,9.771697e-7,0.018304793,0.013418899],"study_design_scores_gemma":[0.11127736,0.005418793,0.8604924,0.004040285,0.00096151506,0.0018366216,0.0063819927,0.0003271652,0.00298305,0.000018018114,0.004863256,0.001399524],"about_ca_topic_score_codex":0.0018810434,"about_ca_topic_score_gemma":0.0039153444,"teacher_disagreement_score":0.20372605,"about_ca_system_score_codex":0.00015259738,"about_ca_system_score_gemma":0.00016233248,"threshold_uncertainty_score":0.99978},"labels":[],"label_agreement":null},{"id":"W3135433679","doi":"10.3324/haematol.2020.267914","title":"T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective","year":2021,"lang":"en","type":"review","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Cancer Research UK","keywords":"Epigenetics; Chronic lymphocytic leukemia; Epigenomics; Immunology; T cell; Epigenetic therapy; Immune system; Immune Dysfunction; Tumor microenvironment; Biology; Cell; Immunotherapy; Chimeric antigen receptor; Cancer research; Leukemia; Medicine; DNA methylation; Genetics","score_opus":0.06693291355595138,"score_gpt":0.3874413583571703,"score_spread":0.32050844480121893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135433679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017567778,0.9901394,0.000048993967,0.000023900784,0.00031004654,0.002038356,0.000042442058,0.00019523251,0.0054448387],"genre_scores_gemma":[0.0022721286,0.9940554,0.00034493918,0.00011675168,0.00046427958,0.00053533114,0.00079644803,0.00015972198,0.0012550021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99413836,0.0008331661,0.001240957,0.0018938225,0.0008185709,0.0010751156],"domain_scores_gemma":[0.99629444,0.00074235577,0.00041731328,0.0018301938,0.00025453026,0.0004611445],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00042616666,0.0009130138,0.0046916143,0.0005563981,0.00011416691,0.00008899969,0.0005741197,0.0013807113,0.00199244],"category_scores_gemma":[0.00051389186,0.0007179834,0.0008226936,0.0012085586,0.00029061676,0.00010960684,0.00036369366,0.0012551297,0.0013076016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004543,0.0008459492,0.00002050839,0.0799568,0.00165547,0.061907142,0.0014269322,0.0003574996,0.000037605856,0.0022354934,0.007718181,0.8433841],"study_design_scores_gemma":[0.019949127,0.0014685427,0.000021483416,0.03928336,0.0031297652,0.007387272,0.0009926151,0.0067452798,0.00012531743,0.0004950505,0.91868526,0.0017169409],"about_ca_topic_score_codex":0.0071694837,"about_ca_topic_score_gemma":0.00047146244,"teacher_disagreement_score":0.91096705,"about_ca_system_score_codex":0.3900578,"about_ca_system_score_gemma":0.15075369,"threshold_uncertainty_score":0.9999157},"labels":[],"label_agreement":null},{"id":"W3149640503","doi":"10.3324/haematol.2020.274258","title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Lymphoma; Mantle cell lymphoma; Biology; Follicular lymphoma; Cancer research; Comparative genomic hybridization; B cell; Malignancy; B-cell lymphoma; Non-Hodgkin's lymphoma; Genetics; Gene; Immunology; Genome; Antibody","score_opus":0.02294369896182233,"score_gpt":0.2724843191269026,"score_spread":0.24954062016508025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149640503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848062,0.0043536657,0.000049372247,0.0004406355,0.000064814456,0.00023635235,0.0000074088616,0.000032250013,0.010009331],"genre_scores_gemma":[0.9953013,0.00090087316,0.0030022624,0.0004858114,0.000030310057,0.0000773881,0.000029565635,0.000010662166,0.00016182955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903756,0.000041558164,0.0002462701,0.0003348924,0.00011715225,0.00022254104],"domain_scores_gemma":[0.99944633,0.00010003443,0.0000464864,0.00025763354,0.00004055729,0.00010894764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050366154,0.00014142253,0.0003444383,0.00006988121,0.00007796141,0.0000394411,0.000038223447,0.00008450305,0.000249477],"category_scores_gemma":[0.000026137894,0.000113172326,0.000056042416,0.0001570968,0.000046701876,0.000032518044,0.000041568943,0.00004535989,0.00011995255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098956756,0.0022332491,0.9576556,0.00016394662,0.000052587566,0.012807112,0.0006392355,0.000011155871,0.0029743842,0.001677891,0.0039448305,0.017741058],"study_design_scores_gemma":[0.0048576943,0.00021944314,0.93436444,0.00015340048,0.00005183044,0.0020654134,0.00026275826,0.00023663805,0.04346262,0.00019123488,0.013938475,0.0001960696],"about_ca_topic_score_codex":0.00002996372,"about_ca_topic_score_gemma":0.000032867116,"teacher_disagreement_score":0.040488236,"about_ca_system_score_codex":0.00007147786,"about_ca_system_score_gemma":0.000084998,"threshold_uncertainty_score":0.46150336},"labels":[],"label_agreement":null},{"id":"W3155291105","doi":"10.3324/haematol.2020.270835","title":"The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets","year":2021,"lang":"en","type":"review","venue":"Haematologica","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"Transplantation; Microbiome; Antibiotics; Dysbiosis; Bacteremia; Hematopoietic stem cell transplantation; Hematopoietic cell; Immunology; Medicine; Disease; Gut flora; Biology; Haematopoiesis; Internal medicine; Stem cell; Bioinformatics; Microbiology","score_opus":0.031205789050676804,"score_gpt":0.2878973889872526,"score_spread":0.2566915999365758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155291105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013811529,0.9967886,0.00054212415,0.00017583644,0.00011578853,0.0007110686,0.00015286026,0.000020577687,0.00011194826],"genre_scores_gemma":[0.01696027,0.98033994,0.00035511298,0.000119120334,0.0000393881,0.00007230496,0.0017867128,0.000046155732,0.00028102042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793863,0.00044520514,0.00056478014,0.00056191627,0.0001036892,0.00038577287],"domain_scores_gemma":[0.999054,0.0000908949,0.00028256577,0.0004000059,0.00007755196,0.00009497153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002783029,0.0004232713,0.0008724628,0.000054224045,0.00053094834,0.000082189166,0.00024452573,0.0005401549,0.000016962242],"category_scores_gemma":[0.000009730282,0.00023975088,0.0002565727,0.00012391107,0.00017843152,0.0000036222173,0.000035498197,0.0004136772,0.000018905048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002285121,0.0027475466,0.0062695034,0.3509252,0.006674139,0.0068547097,0.0046546594,0.000025930416,0.06841561,0.012043628,0.00857933,0.5305246],"study_design_scores_gemma":[0.0006808786,0.00039566,0.0005470162,0.0021114205,0.0018272853,0.012503787,0.00018740282,6.8924993e-7,0.0004137175,0.0000239452,0.9804448,0.00086338323],"about_ca_topic_score_codex":0.0000037425011,"about_ca_topic_score_gemma":0.00005211175,"teacher_disagreement_score":0.9718655,"about_ca_system_score_codex":0.000013785301,"about_ca_system_score_gemma":0.00021780899,"threshold_uncertainty_score":0.9776757},"labels":[],"label_agreement":null},{"id":"W3158601594","doi":"10.3324/haematol.2020.271957","title":"MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"European Regional Development Fund; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Institutes of Health; Ministerio de Economía y Competitividad; Generalitat de Catalunya","keywords":"Lymphoma; Biology; Cancer research; Neuroblastoma RAS viral oncogene homolog; Comparative genomic hybridization; Plasmablastic lymphoma; Fluorescence in situ hybridization; MAPK/ERK pathway; PAX5; Mutation; Signal transduction; Gene; Genetics; Immunology; Chromosome; KRAS; Transcription factor","score_opus":0.02286479361307594,"score_gpt":0.24197304219745885,"score_spread":0.2191082485843829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158601594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341345,0.0011494491,0.000022541286,0.0008770446,0.000063740896,0.00017500165,0.0000065155523,0.00004760903,0.00424467],"genre_scores_gemma":[0.9981246,0.00023378729,0.0010431925,0.00032830072,0.000015570677,0.000047756952,0.000044123288,0.000008357507,0.00015432734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915683,0.000039451752,0.00020252165,0.00027996715,0.0001272589,0.00019395504],"domain_scores_gemma":[0.9995121,0.00013899963,0.000043439784,0.00017597119,0.000039662234,0.00008984842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050504186,0.00012474255,0.00033099655,0.000057855108,0.000046678924,0.000021006566,0.000022993567,0.00009091347,0.0001449781],"category_scores_gemma":[0.00011262475,0.0000930658,0.00004315473,0.00015391427,0.000044784334,0.0000414651,0.000046155004,0.000029624725,0.00006746202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036762084,0.0023026944,0.86944586,0.00037874412,0.00014405316,0.02441029,0.0008237945,0.000024386607,0.0022540826,0.038338065,0.0016356359,0.05987479],"study_design_scores_gemma":[0.004034211,0.0001949365,0.97412086,0.00019548077,0.00006516317,0.0025689644,0.00021527545,0.00063939753,0.014239709,0.0016046832,0.0019921195,0.00012921801],"about_ca_topic_score_codex":0.000018087125,"about_ca_topic_score_gemma":0.000049903007,"teacher_disagreement_score":0.104674995,"about_ca_system_score_codex":0.00008550762,"about_ca_system_score_gemma":0.000079534344,"threshold_uncertainty_score":0.3795113},"labels":[],"label_agreement":null},{"id":"W3164370350","doi":"10.3324/haematol.2021.278722","title":"Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Universität Leipzig","keywords":"Acute promyelocytic leukemia; Medicine; Arsenic trioxide; Internal medicine; Confidence interval; Gastroenterology; Surgery; Leukemia; Retinoic acid; Arsenic","score_opus":0.005825080949332106,"score_gpt":0.24143705572774735,"score_spread":0.23561197477841525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164370350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991006,0.00006009206,0.00011190531,0.0000076194096,0.000044234206,0.00038869015,0.00013442751,0.000015345438,0.00013707006],"genre_scores_gemma":[0.9985163,0.00015891547,0.0005589686,0.000029364137,0.000023757717,0.000051792173,0.0005053269,0.00001996282,0.00013560322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871516,0.00012893204,0.00032713905,0.00045712115,0.00019987408,0.00017176704],"domain_scores_gemma":[0.9987306,0.000021339985,0.00031674854,0.00031856456,0.00053641415,0.00007634193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008368279,0.00021682332,0.0003776943,0.000036112604,0.00006595749,0.00003882213,0.00018002391,0.0001178413,0.000021369957],"category_scores_gemma":[0.00012923132,0.00014400335,0.00002921897,0.0001547706,0.0001817884,0.00001439146,0.00010067542,0.00011747791,0.0000015343628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009974237,0.00040882025,0.9938005,0.000047162193,0.00034591331,0.00019355952,0.0001951002,0.000004549431,0.0035931605,0.00001295767,0.000009898194,0.00039092472],"study_design_scores_gemma":[0.0041242703,0.004068604,0.88212055,0.00004941473,0.00030184572,0.000084176005,0.0009171469,0.000051779058,0.10775063,0.000010653067,0.00016436157,0.00035657716],"about_ca_topic_score_codex":0.0000056075005,"about_ca_topic_score_gemma":0.000027449778,"teacher_disagreement_score":0.111679986,"about_ca_system_score_codex":0.000031246207,"about_ca_system_score_gemma":0.00021677717,"threshold_uncertainty_score":0.58722866},"labels":[],"label_agreement":null},{"id":"W3171577343","doi":"10.3324/haematol.2021.278990","title":"Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Texas Children's Hospital; Howard Hughes Medical Institute","keywords":"Haematopoiesis; Germline mutation; Germline; Mutation; Somatic cell; Biology; Somatic evolution in cancer; Immunology; Cancer research; Stem cell; Genetics; Cancer; Gene","score_opus":0.01034443955069764,"score_gpt":0.2404323652131387,"score_spread":0.23008792566244107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171577343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311095,0.0033402187,0.0005967919,0.00054157444,0.000057826455,0.00017796946,0.000015681411,0.000023427754,0.00213553],"genre_scores_gemma":[0.9947613,0.0003845395,0.00378041,0.00026128636,0.000033938297,0.000046592424,0.00024403202,0.000026560161,0.0004613421],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998435,0.00013733174,0.00033253786,0.00054085924,0.00021204614,0.0003422313],"domain_scores_gemma":[0.9991787,0.00004676438,0.00012302658,0.00045272327,0.00010163699,0.00009714659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002071403,0.0002273339,0.00037200408,0.00007214137,0.00007881645,0.000042763746,0.00017726635,0.00024844252,0.00014365847],"category_scores_gemma":[0.00018233118,0.00018382957,0.00008653819,0.00026851543,0.000088866815,0.0000060594916,0.00014669396,0.00012786473,0.000021042266],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022924888,0.0010734549,0.56137055,0.00033440217,0.00036793784,0.002599507,0.0004581743,0.00036176882,0.42537624,0.0052870917,0.0012970668,0.0012445465],"study_design_scores_gemma":[0.0020278706,0.00095517404,0.23607126,0.0001453278,0.000062275794,0.0012016972,0.00032047878,0.00006695931,0.73790556,0.0023133536,0.018070119,0.00085993734],"about_ca_topic_score_codex":0.00001566229,"about_ca_topic_score_gemma":0.00010735911,"teacher_disagreement_score":0.3252993,"about_ca_system_score_codex":0.000014480965,"about_ca_system_score_gemma":0.0000980161,"threshold_uncertainty_score":0.7496352},"labels":[],"label_agreement":null},{"id":"W3171756032","doi":"10.3324/haematol.2021.278770","title":"A &lt;i&gt;Grammastola spatulata&lt;/i&gt; mechanotoxin-4 (GsMTx4)-sensitive cation channel mediates increased cation permeability in human hereditary spherocytosis of multiple genetic etiologies","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Quest Diagnostics; Doris Duke Charitable Foundation","keywords":"Hereditary spherocytosis; Chemistry; Ion channel; Genetics; Biology; Biophysics","score_opus":0.02905353610106688,"score_gpt":0.2488160849502858,"score_spread":0.21976254884921892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171756032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971369,0.0016061768,0.00044899297,0.022548346,0.0008948372,0.0021272597,0.0002859389,0.00029190662,0.00042754252],"genre_scores_gemma":[0.9632461,0.00048715385,0.0018805651,0.024241054,0.0010576935,0.00051662675,0.008314797,0.00008880497,0.00016719589],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99456966,0.0012348398,0.0013953722,0.0014197103,0.0006107176,0.0007696792],"domain_scores_gemma":[0.99600613,0.0011588135,0.0008961542,0.0011543847,0.0006296164,0.00015489002],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004598986,0.0008025742,0.0023458663,0.00048110008,0.00018690112,0.000020201609,0.00029945697,0.0023747387,0.0004456009],"category_scores_gemma":[0.0017741856,0.0007127773,0.00048022522,0.00058129703,0.0005705657,0.000093477305,0.0002232491,0.0014655128,0.000043950782],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018243911,0.0018746578,0.008979407,0.006703831,0.0008324894,0.0077359267,0.0028071238,0.0002609819,0.78901595,0.0002541803,0.17869131,0.0010197376],"study_design_scores_gemma":[0.017805418,0.0076536927,0.68269175,0.0060656085,0.0030999416,0.0063676387,0.0038500985,0.006807581,0.1955341,0.005752161,0.058280498,0.0060915183],"about_ca_topic_score_codex":0.00045445425,"about_ca_topic_score_gemma":0.0013360279,"teacher_disagreement_score":0.6737124,"about_ca_system_score_codex":0.00035903716,"about_ca_system_score_gemma":0.00038334835,"threshold_uncertainty_score":0.99953234},"labels":[],"label_agreement":null},{"id":"W3180995513","doi":"10.3324/haematol.2021.278762","title":"The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"NHLBI Division of Intramural Research; Medical Research Council; University of Texas MD Anderson Cancer Center; Directorate for Biological Sciences; National Institutes of Health; Deutschen Konsortium für Translationale Krebsforschung; National University Health System; Masarykova Univerzita; Canterbury District Health Board; National Health and Medical Research Council; Universidade de São Paulo; Medizinischen Hochschule Hannover; Government of South Australia; Vanderbilt University; University of Chicago; Università degli Studi di Pavia; Sociedade Beneficente Israelita Brasileira Albert Einstein; University of Tokyo; Institut Gustave-Roussy; Semmelweis Egyetem; European Hematology Association; Erasmus Medisch Centrum; University of South Australia; Institut National de la Santé et de la Recherche Médicale; Cancer Research UK; Vanderbilt University Medical Center; Queen Mary University of London; Hospital Research Foundation; Associazione Italiana per la Ricerca sul Cancro; National Cancer Institute; Universität Heidelberg; Australian Cancer Research Foundation; Cancer Council South Australia; Université de Montréal; Ligue Contre le Cancer; Deutsches Krebsforschungszentrum; Royal Adelaide Hospital; Fondazione IRCCS Policlinico San Matteo; Bundesministerium für Bildung und Forschung; Assistance publique-Hôpitaux de Paris; Massachusetts General Hospital","keywords":"Database; RUNX1; Genomics; Medicine; Biology; Computer science; Genetics; Gene; Genome; Transcription factor","score_opus":0.03186096913012081,"score_gpt":0.30008672457718183,"score_spread":0.268225755447061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180995513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850148,0.0038125548,0.0006882072,0.006884211,0.00006340081,0.001674016,0.00055530964,0.00010728007,0.0012002133],"genre_scores_gemma":[0.95857126,0.004821687,0.025516897,0.0021522688,0.00024604428,0.0009516313,0.0052893613,0.00016530907,0.0022855178],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967364,0.00025434242,0.00064886804,0.0009180039,0.0005988377,0.00084351783],"domain_scores_gemma":[0.99636954,0.0006189148,0.00029444133,0.001770707,0.00048672705,0.00045968982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007986312,0.0003860242,0.00075429503,0.00011843672,0.00049906375,0.0001709391,0.00050394447,0.00021579671,0.000090643705],"category_scores_gemma":[0.0015462724,0.0002411711,0.00009132881,0.00053114747,0.00066251395,0.00034494756,0.0005413231,0.00048552608,0.00000814432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06300173,0.010203935,0.026081333,0.008245237,0.0036711784,0.044632174,0.009808304,0.00005322782,0.3444609,0.11408648,0.25268954,0.123065956],"study_design_scores_gemma":[0.016375896,0.0026734301,0.002227778,0.0006476072,0.00026106212,0.012086233,0.02106817,0.0030359342,0.097803764,0.00033578032,0.84238327,0.0011010692],"about_ca_topic_score_codex":0.0002739818,"about_ca_topic_score_gemma":0.00026008152,"teacher_disagreement_score":0.5896937,"about_ca_system_score_codex":0.00015685247,"about_ca_system_score_gemma":0.0012151368,"threshold_uncertainty_score":0.9834672},"labels":[],"label_agreement":null},{"id":"W3185716747","doi":"10.3324/haematol.2021.279052","title":"Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Intensive care medicine; Leukemia; Internal medicine; Biology; Retinoic acid; Genetics","score_opus":0.05607474922266552,"score_gpt":0.282901071275792,"score_spread":0.22682632205312647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185716747","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6529069,0.040497825,0.0002542481,0.28684565,0.0006976793,0.0032194152,0.00074480113,0.00013954219,0.014693938],"genre_scores_gemma":[0.064433865,0.06929947,0.0117226215,0.7517129,0.0030178293,0.0038952767,0.00944684,0.00041557066,0.086055644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786633,0.00010742131,0.00040911106,0.0009217419,0.00023665275,0.0004587566],"domain_scores_gemma":[0.99878454,0.00005431696,0.00020765122,0.00071081705,0.00013695961,0.000105726576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000072530114,0.00048567174,0.000825843,0.000068147594,0.000067946276,0.000048799873,0.00031212388,0.0011891557,0.00031748047],"category_scores_gemma":[0.000072756964,0.00038212395,0.00021540542,0.00011483656,0.00015108832,0.0000031991635,0.00022944661,0.00026584612,0.000042403146],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005254599,0.00006767374,0.00044803802,0.0003676917,0.00066337915,0.0012397367,0.0000680673,0.0000030469855,0.017106263,0.0000069875346,0.97922486,0.000751685],"study_design_scores_gemma":[0.00027817968,0.00088450074,0.000010409885,0.000066418346,0.0003008521,0.00029171104,0.00001120075,0.0000037128832,0.29616514,0.0000149273965,0.7016549,0.00031802105],"about_ca_topic_score_codex":0.000040621373,"about_ca_topic_score_gemma":0.0000067328483,"teacher_disagreement_score":0.588473,"about_ca_system_score_codex":0.00010226268,"about_ca_system_score_gemma":0.0003730425,"threshold_uncertainty_score":0.9998631},"labels":[],"label_agreement":null},{"id":"W3187155906","doi":"10.3324/haematol.2021.279232","title":"Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"","keywords":"Daratumumab; Cytopenia; Medicine; Refractory (planetary science); Oncology; Dermatology; Internal medicine; Lenalidomide; Multiple myeloma; Biology; Bone marrow","score_opus":0.053576595386962134,"score_gpt":0.3268228384538645,"score_spread":0.2732462430669024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187155906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827089,0.0014366639,0.0052545266,0.00019186859,0.0000866228,0.000616855,0.0000274563,0.00017418651,0.009502966],"genre_scores_gemma":[0.88410497,0.00004931138,0.11264783,0.00019794826,0.000028922224,0.00014894205,0.00060407247,0.000024078074,0.0021939103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987818,0.000049787683,0.00025669948,0.00043886853,0.00013581051,0.00033704686],"domain_scores_gemma":[0.999256,0.000057462945,0.00009161495,0.0003663817,0.00010581844,0.00012271876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008889966,0.000207782,0.0006302288,0.000045003508,0.00023500688,0.000035294976,0.00008581859,0.00014878852,0.00019025624],"category_scores_gemma":[0.00010931289,0.00015315546,0.0001387602,0.00013674755,0.00005584069,0.00010724205,0.00003477549,0.00014483943,0.000040147035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077002062,0.087095916,0.35183382,0.0051201303,0.005986796,0.09728611,0.007657551,0.0002561926,0.13965933,0.031545583,0.014425388,0.25143299],"study_design_scores_gemma":[0.11481112,0.012322266,0.36319155,0.001038853,0.0038814754,0.05743415,0.010061988,0.09843014,0.09154756,0.0023921973,0.24027255,0.0046161423],"about_ca_topic_score_codex":0.000025604577,"about_ca_topic_score_gemma":0.000010456486,"teacher_disagreement_score":0.24681684,"about_ca_system_score_codex":0.000045728342,"about_ca_system_score_gemma":0.00011408299,"threshold_uncertainty_score":0.6245498},"labels":[],"label_agreement":null},{"id":"W3193510908","doi":"10.3324/haematol.2021.278663","title":"Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC; University of British Columbia","funders":"Mundipharma EDO; Genentech; EUSA Pharma; Celgene; MorphoSys; H. Lundbeck A/S; Juno Therapeutics; Incyte; F. Hoffmann-La Roche; Bristol-Myers Squibb; AstraZeneca; Kite Pharma; Gilead Sciences; Servier; Amgen","keywords":"Hazard ratio; Standardized uptake value; Medicine; Positron emission tomography; Retrospective cohort study; Internal medicine; Nuclear medicine; Quartile; Proportional hazards model; Diffuse large B-cell lymphoma; Oncology; Confidence interval; Lymphoma","score_opus":0.011200039875509236,"score_gpt":0.2461010715508001,"score_spread":0.23490103167529086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193510908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955359,0.0005472498,0.00000730806,0.00040368648,0.00012464239,0.0021922207,0.000098169214,0.000050077233,0.0010407295],"genre_scores_gemma":[0.9976129,0.000017465805,0.0001869413,0.00052665756,0.000043149303,0.0011113483,0.000118264885,0.000022741731,0.00036053872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981932,0.00018637507,0.0003148362,0.0004539337,0.000430843,0.00042080443],"domain_scores_gemma":[0.99890757,0.00024158039,0.00010544265,0.0004915076,0.00014364382,0.00011024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019164626,0.00025165273,0.00067125564,0.00005098038,0.00012636329,0.000046002846,0.00012790473,0.000060587234,0.00010230799],"category_scores_gemma":[0.00020020948,0.00012979489,0.00013985553,0.00025871486,0.000040565632,0.00005265444,0.00008047267,0.000060331684,0.00006610121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005181037,0.0650111,0.92973137,0.00004766673,0.00015710136,0.0020324523,0.0010455616,2.4690482e-7,0.0000025535978,0.0005662003,0.0006058687,0.00028177717],"study_design_scores_gemma":[0.045835916,0.0023352148,0.9445997,0.000038331505,0.0003858039,0.00020711512,0.0022376364,0.00003154683,0.0001811116,0.000040347357,0.003951554,0.00015575407],"about_ca_topic_score_codex":0.00006997892,"about_ca_topic_score_gemma":0.00010823685,"teacher_disagreement_score":0.06267588,"about_ca_system_score_codex":0.00005779036,"about_ca_system_score_gemma":0.00015439314,"threshold_uncertainty_score":0.5292882},"labels":[],"label_agreement":null},{"id":"W3201791129","doi":"10.3324/haematol.2021.279317","title":"Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers","year":2021,"lang":"en","type":"review","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Medical Research Council; Medical Research Council","keywords":"Myeloid leukemia; Epigenetics; Bioinformatics; Clinical trial; Gene expression profiling; Medicine; Computational biology; Profiling (computer programming); DNA microarray; Oncology; Biology; Gene; Cancer research; Gene expression; Genetics; Computer science","score_opus":0.0483749563130761,"score_gpt":0.34039579600795566,"score_spread":0.2920208396948796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201791129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019898837,0.9765599,0.00040677274,0.00002555536,0.00020684948,0.0022942147,0.00010459563,0.00014707986,0.00035620973],"genre_scores_gemma":[0.01215385,0.9684518,0.017630937,0.000035452427,0.000092988645,0.00060145115,0.00082600384,0.00014698364,0.00006055139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99425673,0.00095947145,0.0016369058,0.0016563664,0.0005561975,0.000934332],"domain_scores_gemma":[0.99615985,0.0011664777,0.0009951488,0.0011760958,0.00009062227,0.00041183343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003756697,0.0012686205,0.004758114,0.000570669,0.00018475592,0.00009444756,0.00037655554,0.0010968448,0.00051839266],"category_scores_gemma":[0.0006415029,0.00087642245,0.0007818268,0.00078568613,0.0002695647,0.00004665856,0.00031434267,0.0013809765,0.000031160176],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000029138697,0.00023628696,0.015255911,0.03044403,0.0010264126,0.004674248,0.00016416122,0.00003321387,0.00013175399,0.000018190516,0.00018410495,0.94780254],"study_design_scores_gemma":[0.021774694,0.0035621782,0.030354876,0.34541693,0.019364929,0.007408683,0.001160013,0.0046120565,0.0045155664,0.00022191147,0.5538632,0.007744931],"about_ca_topic_score_codex":0.00033713103,"about_ca_topic_score_gemma":0.00008745215,"teacher_disagreement_score":0.94005764,"about_ca_system_score_codex":0.007870851,"about_ca_system_score_gemma":0.0080254115,"threshold_uncertainty_score":0.99936867},"labels":[],"label_agreement":null},{"id":"W3205650804","doi":"10.3324/haematol.2021.279928","title":"SARS-CoV-2 infection in aplastic anemia","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK","keywords":"Aplastic anemia; Medicine; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Anemia; Immunology; Internal medicine; Bone marrow; Outbreak; Disease; Infectious disease (medical specialty)","score_opus":0.06549907473900365,"score_gpt":0.3635650253734051,"score_spread":0.29806595063440144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205650804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837036,0.0003856398,0.0001466546,0.00051175075,0.00014180632,0.00021085492,0.0000013364391,0.00012005546,0.014778314],"genre_scores_gemma":[0.98230547,0.000020909936,0.00022369051,0.017282711,0.00005620072,0.000050395745,0.000005110925,0.000014670937,0.000040812793],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986199,0.000096876625,0.0002689479,0.0003665488,0.0002776886,0.00037004956],"domain_scores_gemma":[0.9993157,0.0001804269,0.000043225456,0.00031967257,0.00011744068,0.000023583314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018325,0.00014515442,0.00039592845,0.00017443163,0.00005637285,0.000028786606,0.00007462168,0.00019791054,0.000055299075],"category_scores_gemma":[0.00088745984,0.000119013996,0.00009317431,0.0006398687,0.000083202816,0.000061489925,0.00009107949,0.00037087628,0.0005790101],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030702975,0.0005415983,0.5713261,0.00048111708,0.000032747295,0.00938745,0.00017056466,7.390834e-7,0.41092053,0.0016868361,0.0026507871,0.0024945259],"study_design_scores_gemma":[0.0015007285,0.00024203325,0.07624445,0.00016883248,0.000030352496,0.0025633639,0.000052158968,0.00026616684,0.8458167,0.0010659636,0.07185833,0.00019093936],"about_ca_topic_score_codex":0.00020100953,"about_ca_topic_score_gemma":0.00044790038,"teacher_disagreement_score":0.4950816,"about_ca_system_score_codex":0.00009674839,"about_ca_system_score_gemma":0.00022922273,"threshold_uncertainty_score":0.74421966},"labels":[],"label_agreement":null},{"id":"W3207809849","doi":"10.3324/haematol.2021.279229","title":"Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Sanofi Genzyme; Sanofi","keywords":"Carfilzomib; Medicine; Renal function; Hazard ratio; Internal medicine; Dexamethasone; Multiple myeloma; Population; Confidence interval; Adverse effect; Urology; Gastroenterology; Subgroup analysis; Creatinine; Oncology; Lenalidomide","score_opus":0.022369191073017495,"score_gpt":0.27161218656555364,"score_spread":0.24924299549253615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207809849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582475,0.001972103,0.0000886084,0.0003572,0.000055272532,0.001032208,0.00009887227,0.0000876637,0.000483312],"genre_scores_gemma":[0.9880774,0.00028420374,0.010690842,0.00010063938,0.000024212759,0.0001662462,0.00042489954,0.000042207237,0.00018936323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628687,0.00037872736,0.0005707848,0.0011333574,0.0007339402,0.0008963292],"domain_scores_gemma":[0.99722403,0.0009347415,0.00024394618,0.0006913054,0.00029404432,0.0006119109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003439175,0.0005074542,0.0015386239,0.0005170396,0.00021369563,0.00008237551,0.00012950397,0.00029099995,0.00024546523],"category_scores_gemma":[0.0012468067,0.00037171433,0.0001833654,0.0015488239,0.00035747388,0.00013840769,0.00026647944,0.0004763449,0.000017230086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01214035,0.0010497029,0.9744168,0.00018902069,0.0019392279,0.004226624,0.000630496,0.000020577008,0.00034182682,0.00005092124,0.00007075074,0.0049237097],"study_design_scores_gemma":[0.055158187,0.001832708,0.93622667,0.00015207769,0.0011166938,0.00023041041,0.0005604396,0.0024368612,0.0017383621,0.000029801047,0.00011588056,0.00040193307],"about_ca_topic_score_codex":0.00074637093,"about_ca_topic_score_gemma":0.00289621,"teacher_disagreement_score":0.04301784,"about_ca_system_score_codex":0.0002993964,"about_ca_system_score_gemma":0.00021577346,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W3215635656","doi":"10.3324/haematol.2021.276048","title":"The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Downregulation and upregulation; Myeloid leukemia; Cancer research; Biology; Transcription factor; Gene knockdown; Retinoic acid; Genetics; Gene","score_opus":0.02573987258448401,"score_gpt":0.30085714445774797,"score_spread":0.27511727187326396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215635656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861616,0.0022728723,0.000024221086,0.0073103867,0.00006968427,0.0011667954,0.000050940725,0.00015026912,0.0027932418],"genre_scores_gemma":[0.98822385,0.0030053214,0.0017665525,0.0017576049,0.000036500194,0.00014538124,0.00013488687,0.000070118775,0.0048597585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99649006,0.00047280383,0.00054376625,0.00089119887,0.00074725616,0.0008549041],"domain_scores_gemma":[0.99789214,0.0002501169,0.00018933452,0.0010919272,0.0002928934,0.00028361275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045615478,0.00039939326,0.00080845103,0.00013879167,0.00030583752,0.00011756915,0.0003642995,0.00034415652,0.0010005108],"category_scores_gemma":[0.000262615,0.0002403225,0.00010089259,0.00082029775,0.00051905966,0.00014681103,0.0002678056,0.00085087575,0.000119231765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00964631,0.00061907835,0.27218363,0.0007113999,0.003052481,0.013687353,0.004964752,0.000003214551,0.62829876,0.0010226539,0.056115072,0.009695279],"study_design_scores_gemma":[0.01119909,0.0015769881,0.18723865,0.0008705806,0.00027448096,0.0057460675,0.0011369287,0.0009371165,0.7299907,0.0013353247,0.058704264,0.0009897995],"about_ca_topic_score_codex":0.000058208032,"about_ca_topic_score_gemma":0.000022806284,"teacher_disagreement_score":0.10169193,"about_ca_system_score_codex":0.00053090166,"about_ca_system_score_gemma":0.0006994431,"threshold_uncertainty_score":0.99991274},"labels":[],"label_agreement":null},{"id":"W4200215914","doi":"10.3324/haematol.2021.280366","title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Université François-Rabelais; Universitätsklinikum Hamburg-Eppendorf; Royal College of Surgeons in Ireland; McMaster University","keywords":"Antibody; Monoclonal gammopathy; Monoclonal antibody; Platelet; Immunology; Medicine; Platelet factor 4; Monoclonal","score_opus":0.038727634481298276,"score_gpt":0.2957517276168515,"score_spread":0.2570240931355532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200215914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425733,0.00038719815,0.000028984481,0.0006906624,0.000119198856,0.00047181785,0.000013168016,0.00020931868,0.0038223271],"genre_scores_gemma":[0.99504024,0.00019495167,0.0040919627,0.00039678597,0.00003402553,0.00003516085,0.00012543553,0.000049280792,0.000032166274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973108,0.00020541673,0.0006308334,0.00080776896,0.00033972535,0.00070545974],"domain_scores_gemma":[0.99858975,0.00014017601,0.00022292972,0.0005555856,0.00026796293,0.00022360838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016158067,0.00043788934,0.0013480876,0.00022199462,0.00022525847,0.000071710245,0.00015486125,0.00025445427,0.00025055432],"category_scores_gemma":[0.00020202348,0.00032807514,0.00011818517,0.0006544424,0.00013091421,0.00031230724,0.00016313126,0.00050193054,0.000046006768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005351952,0.0016745531,0.68924224,0.0003857462,0.00027595612,0.017959103,0.00261092,0.000045926135,0.27678823,0.0010449515,0.00009500413,0.009342155],"study_design_scores_gemma":[0.0020437366,0.00091147824,0.6081345,0.0005610811,0.000053173735,0.003705857,0.002452129,0.0003575161,0.3806764,0.00017887264,0.00040380328,0.00052145286],"about_ca_topic_score_codex":0.00016158962,"about_ca_topic_score_gemma":0.00021957626,"teacher_disagreement_score":0.10388818,"about_ca_system_score_codex":0.00010153043,"about_ca_system_score_gemma":0.0002193341,"threshold_uncertainty_score":0.99991715},"labels":[],"label_agreement":null},{"id":"W4200247655","doi":"10.3324/haematol.2021.280238","title":"VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Kelowna General Hospital; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; National Institutes of Health; University of British Columbia","keywords":"Turner syndrome; Turner's syndrome; Medicine; Internal medicine; Pediatrics; Gynecology","score_opus":0.015095158973568078,"score_gpt":0.24230374989350906,"score_spread":0.22720859091994097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200247655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980924,0.0017382596,0.00007757893,0.0019094925,0.0014387881,0.00027339414,0.0000123540485,0.000081513725,0.0135446265],"genre_scores_gemma":[0.99285567,0.00010053719,0.0027162211,0.00070634746,0.0000148417375,0.000046065303,0.000057941605,0.000012795271,0.0034895823],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985821,0.000064957596,0.00030214136,0.00037666474,0.00032614978,0.00034794788],"domain_scores_gemma":[0.99931115,0.00007862577,0.00006899341,0.0002727693,0.000083215156,0.00018523497],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000058185902,0.00017610281,0.0005332585,0.00011129158,0.000075650205,0.000020127029,0.00005842661,0.00018339575,0.0010143387],"category_scores_gemma":[0.00013935455,0.00012355461,0.0000810038,0.00035308194,0.00051379617,0.000055285767,0.000045869205,0.0003323203,0.0002554058],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023472843,0.001603674,0.21919216,0.0004284207,0.00019983538,0.7422839,0.00065792917,0.000025540792,0.00059586583,0.026776152,0.006832684,0.0011691364],"study_design_scores_gemma":[0.0042511486,0.0014751089,0.104563795,0.0025169102,0.00013548264,0.8456771,0.000736062,0.000025131483,0.002441851,0.00046256586,0.037218522,0.00049635355],"about_ca_topic_score_codex":0.00001305804,"about_ca_topic_score_gemma":0.000037524438,"teacher_disagreement_score":0.11462837,"about_ca_system_score_codex":0.00005883937,"about_ca_system_score_gemma":0.00030296814,"threshold_uncertainty_score":0.99989885},"labels":[],"label_agreement":null},{"id":"W4200289889","doi":"10.3324/haematol.2021.279410","title":"Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Vincristine; Palbociclib; Chemotherapy; Oncology; Leukemia; Pharmacology; Cancer research; Internal medicine; Cancer; Cyclophosphamide; Breast cancer; Metastatic breast cancer","score_opus":0.014941036200126738,"score_gpt":0.2913868434496764,"score_spread":0.2764458072495497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200289889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687005,0.00021618066,0.00006104237,0.00579935,0.00006580535,0.00032839688,0.0000073143856,0.00008833057,0.00656355],"genre_scores_gemma":[0.995058,0.000065171735,0.0018571586,0.00043801017,0.0000204014,0.00009839504,0.000054549484,0.000015339798,0.0023929686],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860954,0.00008826667,0.0002429814,0.00032592658,0.0004101065,0.0003231631],"domain_scores_gemma":[0.9991488,0.00024204883,0.00005513684,0.00023772329,0.00018103968,0.00013525717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058456386,0.00013718355,0.0003251051,0.00014102663,0.00008257909,0.00002637574,0.000084683226,0.000011553455,0.0002878257],"category_scores_gemma":[0.0004049165,0.0001013022,0.00004687041,0.00055912137,0.00015060951,0.000120147095,0.00007923388,0.00023274637,0.000105912484],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001980739,0.0037477969,0.3443809,0.00080016267,0.00040362758,0.49672985,0.00059416296,0.0007279722,0.022176363,0.08646992,0.040012132,0.0019764064],"study_design_scores_gemma":[0.035924856,0.0029311883,0.3242314,0.0019329615,0.00038532837,0.19722475,0.003017448,0.0034039512,0.3799844,0.018238442,0.031106403,0.0016188873],"about_ca_topic_score_codex":0.0000143096895,"about_ca_topic_score_gemma":0.00014534293,"teacher_disagreement_score":0.35780805,"about_ca_system_score_codex":0.00016658785,"about_ca_system_score_gemma":0.00057857344,"threshold_uncertainty_score":0.41309837},"labels":[],"label_agreement":null},{"id":"W4205969691","doi":"10.3324/haematol.2021.279012","title":"First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab &lt;i&gt;versus&lt;/i&gt; chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Cilag; Juno Therapeutics; Kite Pharma; Cancer Research UK; Genentech; Horizon Therapeutics; Pfizer; Moderna; Incyte; Pharmacyclics; Agios Pharmaceuticals; BeiGene; Bristol-Myers Squibb; Constellation Pharmaceuticals; Clovis Oncology; Teva Pharmaceutical Industries; AstraZeneca; Barts Charity; Exelixis; Karyopharm Therapeutics; Unum Therapeutics; Daiichi Sankyo Europe; Calithera Biosciences; Gilead Sciences; MorphoSys; Celgene; TG Therapeutics; Amgen; GlaxoSmithKline","keywords":"Obinutuzumab; Ibrutinib; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Internal medicine; Oncology; Hazard ratio; Leukemia; Chemotherapy; Confidence interval; Cyclophosphamide","score_opus":0.04504888166279691,"score_gpt":0.308024079257522,"score_spread":0.2629751975947251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205969691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855472,0.00443143,0.00025189653,0.00018362944,0.00055225176,0.006088244,0.00023807524,0.00015603684,0.002551278],"genre_scores_gemma":[0.992657,0.0011562292,0.00018381735,0.00006653169,0.00017808813,0.0017353637,0.00029452503,0.000083216524,0.0036452159],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99196225,0.000902639,0.0021495232,0.0012676268,0.0024517833,0.0012661822],"domain_scores_gemma":[0.99294424,0.0023682667,0.0015222097,0.002360838,0.0004223564,0.00038209994],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014770685,0.00087838137,0.005260473,0.00080246374,0.0006956901,0.000040380306,0.001053033,0.0003286028,0.002888191],"category_scores_gemma":[0.00078931206,0.0005305194,0.0020805139,0.0034977014,0.0021787824,0.000113604605,0.0006725813,0.0004292452,0.000025454707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.81769836,0.00045146124,0.0000020296407,0.0003904195,0.0072460435,0.0013246214,0.0017977327,0.167874,0.00032906613,0.0015850471,0.00059380423,0.00070743234],"study_design_scores_gemma":[0.5896574,0.008300942,0.0000042704773,0.00010578625,0.006997587,0.00056482526,0.00021636514,0.38808778,0.001565447,0.000030185322,0.004134812,0.00033458596],"about_ca_topic_score_codex":0.0025352826,"about_ca_topic_score_gemma":0.0010639651,"teacher_disagreement_score":0.22804093,"about_ca_system_score_codex":0.33171478,"about_ca_system_score_gemma":0.11571017,"threshold_uncertainty_score":0.9997146},"labels":[],"label_agreement":null},{"id":"W4210686684","doi":"10.3324/haematol.2021.279520","title":"Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Hospital of Philadelphia; U.S. Department of Defense; Rally Foundation; V Foundation for Cancer Research","keywords":"Medicine; Temsirolimus; Etoposide; Mucositis; Internal medicine; Gastroenterology; Cyclophosphamide; Leukemia; Leukopenia; Pharmacology; PI3K/AKT/mTOR pathway; Toxicity; Chemotherapy; Biology","score_opus":0.007659484694420746,"score_gpt":0.24405063521021292,"score_spread":0.23639115051579218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210686684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915053,0.002107867,0.00017853495,0.0001867646,0.0002483028,0.0050245193,0.00012759399,0.00018433573,0.00043674343],"genre_scores_gemma":[0.99505645,0.00065502455,0.0006745888,0.0007194706,0.00010103305,0.0021671888,0.00024882652,0.00011859245,0.00025883692],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99563915,0.00037182562,0.00084362394,0.0009959437,0.0010756789,0.0010737997],"domain_scores_gemma":[0.9966176,0.0016699178,0.0005009312,0.0006468756,0.00020737483,0.00035726235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052346283,0.0006203952,0.0013582553,0.0004572349,0.00061584084,0.000051173844,0.00039019997,0.00025889237,0.00013108597],"category_scores_gemma":[0.00030867732,0.00042545103,0.000120791025,0.0007421233,0.00039739505,0.00028080662,0.00028093098,0.0010824102,0.000019594292],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6729771,0.0068824477,0.30062377,0.0014654555,0.0011666358,0.0032428585,0.0016009529,0.0011294896,0.00010990483,0.0011723143,0.0044311625,0.005197927],"study_design_scores_gemma":[0.67436373,0.07260521,0.23662035,0.000262456,0.00212649,0.001998698,0.0010587482,0.0015288608,0.00021683768,0.0012106057,0.0062718596,0.0017361741],"about_ca_topic_score_codex":0.00007705652,"about_ca_topic_score_gemma":0.000049358,"teacher_disagreement_score":0.06572276,"about_ca_system_score_codex":0.002470777,"about_ca_system_score_gemma":0.0026805245,"threshold_uncertainty_score":0.99981976},"labels":[],"label_agreement":null},{"id":"W4211260249","doi":"10.3324/haematol.2021.279486","title":"A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt;","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"David och Astrid Hageléns Stiftelse; Barncancerfonden; Vetenskapsrådet; Cancerfonden","keywords":"CD34; Stem cell; CD38; Myeloid leukemia; Cancer research; Haematopoiesis; Leukemia; In vivo; Myeloid; Ex vivo; Transplantation; Immunology; Biology; Medicine; Cell biology; Internal medicine","score_opus":0.024029043832638153,"score_gpt":0.25015882293189984,"score_spread":0.22612977909926169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211260249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673061,0.016733337,0.00014765264,0.0005543096,0.00044548925,0.0029652684,0.00028593087,0.00031328737,0.011248651],"genre_scores_gemma":[0.97522473,0.005133606,0.0013898466,0.0006088211,0.00015796282,0.00070852356,0.00009009002,0.00022727638,0.016459117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99098146,0.0010285592,0.0015964942,0.0023480153,0.0018211829,0.0022242847],"domain_scores_gemma":[0.9951641,0.0018140913,0.00046866928,0.0015898257,0.00019699901,0.0007663009],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027844755,0.0011320254,0.0023431692,0.0013184943,0.00077215105,0.00021097854,0.0009465398,0.0006083647,0.0033053444],"category_scores_gemma":[0.00012954428,0.0010462505,0.00041449477,0.0017553907,0.000845565,0.00022039314,0.0012726267,0.0020510734,0.00015437344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002491918,0.00083373906,0.00045732575,0.0003758966,0.0001593398,0.0029725612,0.0019079887,0.00015105821,0.9784522,0.001232513,0.00781035,0.0031550962],"study_design_scores_gemma":[0.021231726,0.0021075702,0.0038823965,0.0003846399,0.00031473069,0.004991431,0.001082971,0.0061165313,0.50952995,0.0001877262,0.4479724,0.0021979446],"about_ca_topic_score_codex":0.00003227347,"about_ca_topic_score_gemma":0.0001209126,"teacher_disagreement_score":0.46892226,"about_ca_system_score_codex":0.0016553705,"about_ca_system_score_gemma":0.0006619863,"threshold_uncertainty_score":0.9991988},"labels":[],"label_agreement":null},{"id":"W4212869919","doi":"10.3324/haematol.2022.280677","title":"NOX2: a determinant of acute myeloid leukemia survival","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Myeloid; Cancer research; Oncology; Internal medicine; Immunology","score_opus":0.037218316194180666,"score_gpt":0.30629860586863217,"score_spread":0.2690802896744515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212869919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13104576,0.0016302362,0.00013819057,0.7991617,0.002192835,0.0045423717,0.0014018955,0.0007844312,0.059102613],"genre_scores_gemma":[0.0413669,0.0030677135,0.006848491,0.86061305,0.0045220563,0.0016459525,0.0060076825,0.0007731478,0.075155005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944291,0.0004723587,0.00106105,0.0010950391,0.0017254335,0.0012170174],"domain_scores_gemma":[0.996531,0.00064949365,0.00061827415,0.0017284106,0.00026874745,0.00020406916],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006125871,0.00072179,0.0026418853,0.0005869462,0.00020394921,0.000029247269,0.0010984659,0.001509563,0.0069974484],"category_scores_gemma":[0.00032916875,0.00055881485,0.00075725064,0.000652467,0.00055060134,0.000064997264,0.0010790435,0.005653754,0.00035627227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058122084,0.00006226757,0.0004796408,0.0011982856,0.00077616225,0.060502615,0.000119009484,5.372171e-7,0.0007686083,0.00008274002,0.9344648,0.0009641099],"study_design_scores_gemma":[0.001756566,0.0014505164,0.0006793767,0.00024299974,0.0009506328,0.010183906,0.00008880552,0.00008909291,0.0021956423,0.00015146009,0.98158574,0.00062526384],"about_ca_topic_score_codex":0.00021508285,"about_ca_topic_score_gemma":0.0000056504364,"teacher_disagreement_score":0.089678854,"about_ca_system_score_codex":0.0013163864,"about_ca_system_score_gemma":0.0018810361,"threshold_uncertainty_score":0.9997867},"labels":[],"label_agreement":null},{"id":"W4213288074","doi":"10.3324/haematol.2021.280394","title":"All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Lenalidomide; Ixazomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine; Carfilzomib","score_opus":0.058924197317112646,"score_gpt":0.32786834550963384,"score_spread":0.2689441481925212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213288074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957966,0.00023064959,0.000007978013,0.000839302,0.000056476158,0.002516938,0.00043218088,0.000021422791,0.000098458506],"genre_scores_gemma":[0.9988616,0.00010208335,0.00027187937,0.00007119231,0.0000054144252,0.0003006077,0.00028232916,0.000014583773,0.00009032393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971604,0.0006455932,0.0007598133,0.00039306786,0.00069349766,0.00034766784],"domain_scores_gemma":[0.99836123,0.0006707043,0.0003234639,0.00040165902,0.0001266321,0.00011630888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006931567,0.00021171925,0.00074868184,0.0002409477,0.00020277993,0.000008608947,0.00022581314,0.000069539296,0.00007813863],"category_scores_gemma":[0.0008096501,0.00014208975,0.00011763868,0.00045751344,0.00013677285,0.00008410025,0.00021688586,0.00029762957,0.00000203776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02094723,0.023151621,0.94324124,0.00014636923,0.0002589659,0.00046193702,0.0032504182,0.00004024061,0.0012212411,0.00006090254,0.0018674232,0.005352408],"study_design_scores_gemma":[0.16476963,0.009673762,0.8175144,0.00010989954,0.00016127052,0.00005887848,0.0010668365,0.0012501172,0.0045760176,0.00011728555,0.0005364351,0.00016545503],"about_ca_topic_score_codex":0.0017012588,"about_ca_topic_score_gemma":0.00058932125,"teacher_disagreement_score":0.1438224,"about_ca_system_score_codex":0.00007374536,"about_ca_system_score_gemma":0.000080723825,"threshold_uncertainty_score":0.57942516},"labels":[],"label_agreement":null},{"id":"W4213418290","doi":"10.3324/haematol.2021.280329","title":"Pseudo-mutant P53 is a unique phenotype of &lt;i&gt;DNMT3A&lt;/i&gt;-mutated pre-leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Weizmann Institute of Science","keywords":"Mutant; Phenotype; Haematopoiesis; Mutation; Leukemia; Cancer research; Biology; Progenitor cell; Gene; Cell biology; Genetics; Stem cell","score_opus":0.020704750609857478,"score_gpt":0.28283286327596885,"score_spread":0.26212811266611136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213418290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97247535,0.0015386957,0.00031750085,0.0035081026,0.00019722368,0.0017466401,0.00017470274,0.00042680034,0.019614967],"genre_scores_gemma":[0.9892397,0.00043796797,0.003108764,0.0016380269,0.00007303613,0.00040160684,0.00015661461,0.00009731372,0.0048469473],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99523354,0.0005285746,0.0009941697,0.00090087345,0.0013186005,0.0010242413],"domain_scores_gemma":[0.9970225,0.00041809166,0.0004215486,0.0013059598,0.0004136002,0.00041828788],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000983525,0.0004780956,0.0013473994,0.00044058613,0.00039870295,0.000026765456,0.0008329697,0.0003267648,0.007063916],"category_scores_gemma":[0.00065023184,0.0003987838,0.00033622058,0.0014784695,0.0004712372,0.00010775149,0.0009826943,0.0011309865,0.0002814487],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005944896,0.0013416538,0.0029931809,0.0011563987,0.0009961992,0.008363549,0.0048430334,0.00024380034,0.7392719,0.031217664,0.19817257,0.005455167],"study_design_scores_gemma":[0.018757919,0.00979278,0.02274513,0.00075659744,0.0011811892,0.017045364,0.0018025013,0.028723184,0.28097543,0.009665275,0.6058079,0.0027467646],"about_ca_topic_score_codex":0.00008987259,"about_ca_topic_score_gemma":0.000016571526,"teacher_disagreement_score":0.45829648,"about_ca_system_score_codex":0.0012837038,"about_ca_system_score_gemma":0.0017181776,"threshold_uncertainty_score":0.9998464},"labels":[],"label_agreement":null},{"id":"W4220862006","doi":"10.3324/haematol.2021.279459","title":"Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"National Cancer Institute; Adaptive Biotechnologies; Regeneron Pharmaceuticals; Janssen Pharmaceuticals; Celgene; Pharmacyclics; Sanofi; Chugai Pharmaceutical; Daiichi-Sankyo; Pfizer; Amgen","keywords":"Daratumumab; Medicine; Internal medicine; Neutropenia; Gastroenterology; Population; Adverse effect; Multiple myeloma; Lenalidomide; Chemotherapy","score_opus":0.037694526573671436,"score_gpt":0.31148603190424057,"score_spread":0.2737915053305691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220862006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974696,0.000026263828,0.0000035957082,0.000020394193,0.00007376283,0.0020484412,0.00014229609,0.000018278515,0.00019739292],"genre_scores_gemma":[0.99950475,0.0000045441116,0.000103256396,0.000011496578,0.0000041880294,0.00017405332,0.000108028384,0.000014127921,0.000075542914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997495,0.00032209707,0.000561426,0.00038645076,0.00089269795,0.0003423423],"domain_scores_gemma":[0.99829286,0.00035736238,0.00035929526,0.00070724264,0.00017322096,0.00011003738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020369538,0.0001985645,0.0010236052,0.00032062846,0.00024197219,0.0000070700844,0.00027860733,0.000063948675,0.0004377549],"category_scores_gemma":[0.0003313803,0.000118867254,0.00014225299,0.0016381578,0.0001557151,0.000037003832,0.00023397643,0.00039985945,0.000001637048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11794135,0.021281365,0.8516452,0.0000576022,0.0019550864,0.0025547384,0.0018295253,0.0001305477,0.000106771804,0.0000037102802,0.000032378568,0.0024617482],"study_design_scores_gemma":[0.06654081,0.031568225,0.8972174,0.000027508988,0.0010141924,0.00004301181,0.0021414573,0.0011402372,0.0001409694,0.0000012873268,0.00003708933,0.00012782504],"about_ca_topic_score_codex":0.0013194359,"about_ca_topic_score_gemma":0.0037372494,"teacher_disagreement_score":0.051400546,"about_ca_system_score_codex":0.00022271214,"about_ca_system_score_gemma":0.00021882443,"threshold_uncertainty_score":0.48472658},"labels":[],"label_agreement":null},{"id":"W4220963583","doi":"10.3324/haematol.2021.279756","title":"The glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage after chemotherapy and irradiation","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; School of Medicine, Shanghai Jiao Tong University; Peking University; Shanghai Jiao Tong University; Institute of Genetics and Developmental Biology, Chinese Academy of Sciences; Chinese Academy of Sciences","keywords":"Haematopoiesis; Cancer research; Bone marrow; Progenitor cell; Stem cell; Endothelial stem cell; Chemistry; In vivo; Cell biology; Biology; In vitro; Immunology; Biochemistry","score_opus":0.005893512811003071,"score_gpt":0.21334663377112423,"score_spread":0.20745312096012117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220963583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869475,0.01105925,0.000029936298,0.00042641154,0.00070243474,0.00040845454,0.000051752482,0.000021738713,0.00035256162],"genre_scores_gemma":[0.994524,0.0013134942,0.00024559177,0.0007105501,0.00064856466,0.00048969,0.000027576903,0.000023123093,0.0020174144],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989809,0.00010474251,0.00018718127,0.00031881372,0.00014290433,0.00026548817],"domain_scores_gemma":[0.9994749,0.00002502768,0.000103592516,0.00030212177,0.000029788851,0.00006458868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017051626,0.0001590757,0.00017917981,0.00002536352,0.00033401273,0.00004619619,0.00017065243,0.00007805702,0.00009106042],"category_scores_gemma":[0.000030975123,0.000118044765,0.00008596326,0.00006504334,0.00010809867,0.0000041822154,0.00014814376,0.00010109719,0.0000055249525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013234703,0.00016078095,0.0023008895,0.000056748067,0.00005780517,0.000040708663,0.0003165587,0.000010262311,0.96897674,0.00013722046,0.012903933,0.013714862],"study_design_scores_gemma":[0.0012221261,0.0003126554,0.004113928,0.0000027190258,0.000035431152,0.0003529603,0.00016601267,0.00008299858,0.12398899,0.00015580584,0.86929584,0.0002705228],"about_ca_topic_score_codex":0.000008953258,"about_ca_topic_score_gemma":0.000023019782,"teacher_disagreement_score":0.8563919,"about_ca_system_score_codex":0.00001166966,"about_ca_system_score_gemma":0.00005238733,"threshold_uncertainty_score":0.48137257},"labels":[],"label_agreement":null},{"id":"W4221132712","doi":"10.3324/haematol.2022.280721","title":"A BAFFling &lt;i&gt;ménage à trois&lt;/i&gt; in mantle cell lymphoma","year":2022,"lang":"fr","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Mantle cell lymphoma; Mantle (geology); Cancer research; Chemistry; Lymphoma; Geology; Internal medicine; Geochemistry; Biology; Medicine","score_opus":0.01933096996494044,"score_gpt":0.24076534449651932,"score_spread":0.22143437453157888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221132712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5797933,0.109846435,0.00003571403,0.12653187,0.007428925,0.0047832658,0.0006879375,0.0005650941,0.17032751],"genre_scores_gemma":[0.8574555,0.008167072,0.0018218083,0.0891387,0.0030781603,0.003298224,0.002109538,0.00037759764,0.0345534],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99140036,0.000874071,0.0017760942,0.0021551736,0.0013373352,0.0024569784],"domain_scores_gemma":[0.995429,0.0014812808,0.0007990082,0.0017207322,0.00010359549,0.0004663891],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0006874068,0.0015737112,0.0032726687,0.0007691766,0.0005307864,0.0001439243,0.00094137236,0.0016366858,0.017259859],"category_scores_gemma":[0.00024398939,0.0013430784,0.0010659586,0.0009366388,0.00040443733,0.00015280131,0.0008194258,0.0010404204,0.0046654423],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056956784,0.008319799,0.013070713,0.0029295937,0.0007169825,0.20958193,0.0013652247,0.00006681467,0.0011813554,0.0052732974,0.74713254,0.009792177],"study_design_scores_gemma":[0.011185735,0.0014077288,0.01670666,0.0014169718,0.001072835,0.0036289478,0.00022274604,0.00031478595,0.0014043233,0.00035548638,0.96094894,0.0013348556],"about_ca_topic_score_codex":0.00021223209,"about_ca_topic_score_gemma":0.00017631815,"teacher_disagreement_score":0.27766225,"about_ca_system_score_codex":0.0025095483,"about_ca_system_score_gemma":0.00055905513,"threshold_uncertainty_score":0.9997011},"labels":[],"label_agreement":null},{"id":"W4224231988","doi":"10.3324/haematol.2021.280404","title":"Persistent DNA damage and oncogenic stress-induced Trem1 promotes leukemia in mice","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Cincinnati Children's Hospital Medical Center; National Institutes of Health; Université Laval; National Heart, Lung, and Blood Institute; University of Pittsburgh","keywords":"FANCA; Myelodysplastic syndromes; Fanconi anemia; Haematopoiesis; Biology; Stem cell; Myeloid leukemia; Cancer research; Leukemia; Immunology; DNA repair; Gene; Cell biology; Bone marrow; Genetics","score_opus":0.022674068464629635,"score_gpt":0.2224568965446786,"score_spread":0.19978282808004896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224231988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507415,0.0009929461,0.000001242833,0.00039427064,0.00017276313,0.00029178424,0.000053168118,0.00005942352,0.0029602638],"genre_scores_gemma":[0.9990056,0.000018919389,0.000044815846,0.0001681562,0.0000062387026,0.00008015518,0.000103605715,0.0000081678345,0.00056431134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987699,0.0003393041,0.0002674212,0.00029863563,0.00003941757,0.00028536058],"domain_scores_gemma":[0.9996059,0.000101891404,0.00011330363,0.0001401411,0.000019344747,0.000019445315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028257654,0.0001446166,0.00027507616,0.00011097806,0.00034509704,0.000013236961,0.00018173418,0.00014030351,0.0011810451],"category_scores_gemma":[0.000042558262,0.00012527357,0.00008359648,0.00014344194,0.0000921222,0.00004673786,0.00020539935,0.0002877366,0.00007565448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028571594,0.00012639204,0.0048325253,0.0000556085,0.00011377991,0.00025376663,0.0026429407,0.0000112712605,0.9858138,0.0023978534,0.0014896889,0.00197664],"study_design_scores_gemma":[0.010528516,0.0032624549,0.09130802,0.0001655131,0.00022537525,0.005828808,0.026590608,0.0005777921,0.7967836,0.0016143826,0.061160117,0.0019547972],"about_ca_topic_score_codex":0.00009867928,"about_ca_topic_score_gemma":0.000068511334,"teacher_disagreement_score":0.1890302,"about_ca_system_score_codex":0.00012479594,"about_ca_system_score_gemma":0.00008158188,"threshold_uncertainty_score":0.999732},"labels":[],"label_agreement":null},{"id":"W4224264729","doi":"10.3324/haematol.2021.280203","title":"The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Chronic myelomonocytic leukemia; Transplantation; KRAS; Hematopoietic stem cell transplantation; Neuroblastoma RAS viral oncogene homolog; International Prognostic Scoring System; Oncology; Hematopoietic cell; Multivariate analysis; Gastroenterology; Bone marrow; Haematopoiesis; Myelodysplastic syndromes; Cancer; Stem cell; Biology; Genetics","score_opus":0.037409176900426035,"score_gpt":0.3581258702767788,"score_spread":0.3207166933763527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224264729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525785,0.0013880389,0.000083517094,0.0012721185,0.00002052016,0.0014886085,0.00021920713,0.000029284472,0.00024085719],"genre_scores_gemma":[0.99633163,0.001902663,0.00011300716,0.00012099193,0.000019088886,0.0007745283,0.0005297419,0.000024641631,0.00018372029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973324,0.00049045525,0.00041905852,0.00052324723,0.0006524702,0.0005823467],"domain_scores_gemma":[0.99767494,0.0017463871,0.0000919878,0.00023388224,0.0001045994,0.00014819398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014547444,0.00022480827,0.0005092402,0.0006460845,0.00059913716,0.0000586667,0.00018047502,0.00010933237,0.00015394046],"category_scores_gemma":[0.000083881525,0.00014547752,0.00016722432,0.0008425552,0.00011770392,0.00006964294,0.000047637397,0.00057110377,0.000006825248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021314979,0.0013166692,0.9033197,0.0061315177,0.003764553,0.0063208733,0.011667858,0.012026898,0.02514261,0.0046687345,0.0010460614,0.00327956],"study_design_scores_gemma":[0.020139173,0.004063719,0.9280553,0.00013804792,0.0018617796,0.0039745714,0.0019142675,0.032165516,0.0059867874,0.0010135153,0.00014525914,0.0005421042],"about_ca_topic_score_codex":0.000052927575,"about_ca_topic_score_gemma":0.00016251807,"teacher_disagreement_score":0.024735574,"about_ca_system_score_codex":0.0006757807,"about_ca_system_score_gemma":0.0005135308,"threshold_uncertainty_score":0.59324014},"labels":[],"label_agreement":null},{"id":"W4229059632","doi":"10.3324/haematol.2021.278802","title":"Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Frailty in Older Adults","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; Dana-Farber/Harvard Cancer Center; Harvard Catalyst; National Cancer Institute; National Institutes of Health; Harvard University; U.S. Department of Veterans Affairs","keywords":"Medicine; Randomized controlled trial; Odds ratio; Confidence interval; Geriatric oncology; Geriatrics; Pediatrics; Internal medicine; Emergency medicine; Cancer","score_opus":0.012822945921910092,"score_gpt":0.27149701798771164,"score_spread":0.25867407206580156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229059632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98404366,0.003596687,0.000117816555,0.00072243356,0.00037619413,0.0068667126,0.00001911424,0.00009406342,0.0041632913],"genre_scores_gemma":[0.9954805,0.0003371836,0.0028406696,0.0000733874,0.000029376559,0.0009666824,0.000081439524,0.000018640825,0.00017215112],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971254,0.0005218159,0.0010619352,0.00044259478,0.000518574,0.00032969404],"domain_scores_gemma":[0.995876,0.0022877187,0.00050039194,0.00037752834,0.000869138,0.00008919389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044451878,0.0002868662,0.0033740695,0.00018762339,0.00004679865,0.000017520446,0.000096780874,0.00023500893,0.00029010023],"category_scores_gemma":[0.006016404,0.0001773677,0.0003310348,0.0005413577,0.0002908164,0.000062266445,0.00004149427,0.00020365318,0.000011957052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9933462,0.00030990032,0.00030930233,0.00061827124,0.00020471723,0.0012816575,0.0025505675,0.0000103312705,0.000046536246,0.0009680854,0.00011214752,0.00024223939],"study_design_scores_gemma":[0.9858728,0.001872425,0.0002470566,0.00080493564,0.00044714974,0.0003314803,0.00610249,0.000048166672,0.0039673336,0.0000744095,0.00003853406,0.00019320306],"about_ca_topic_score_codex":0.000023228122,"about_ca_topic_score_gemma":0.00015058028,"teacher_disagreement_score":0.011436782,"about_ca_system_score_codex":0.00008218018,"about_ca_system_score_gemma":0.00043039056,"threshold_uncertainty_score":0.7232845},"labels":[],"label_agreement":null},{"id":"W4229065705","doi":"10.3324/haematol.2021.279189","title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Core Research for Evolutional Science and Technology; Universitätsspital Basel","keywords":"Latin Americans; Transplantation; Population; Hematopoietic cell; Medicine; Demography; Internal medicine; Haematopoiesis; Stem cell; Political science; Biology; Environmental health; Genetics","score_opus":0.036058196810504796,"score_gpt":0.2567178585938418,"score_spread":0.22065966178333699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229065705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929619,0.00040905146,0.0047143167,0.00088604033,0.00003973285,0.0008033822,0.000015272359,0.000023178136,0.00014714473],"genre_scores_gemma":[0.9979421,0.0007734328,0.0008241897,0.00024433053,0.000008803998,0.00006151275,0.00002169263,0.000019478603,0.00010448433],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833226,0.00010389408,0.0005325295,0.00041296188,0.0003280847,0.00029027162],"domain_scores_gemma":[0.9989982,0.0003753782,0.00014259736,0.0002812663,0.00008324645,0.00011930014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013837445,0.00022042588,0.00073318416,0.00010155877,0.000058669015,0.00007371754,0.00009361086,0.00012518348,0.000033809094],"category_scores_gemma":[0.000009963857,0.00014289067,0.000054344673,0.00023809823,0.00021979016,0.00010866722,0.00005160445,0.00020947536,0.0000021102521],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050399387,0.0034146344,0.43542475,0.01831341,0.000637002,0.007262282,0.014480032,0.000030570078,0.5029411,0.0015647738,0.00024799941,0.010643526],"study_design_scores_gemma":[0.0126640275,0.0012651082,0.5354342,0.004274813,0.0013737855,0.0027139161,0.004307656,0.0010289598,0.436001,0.00012737369,0.0001420673,0.0006671125],"about_ca_topic_score_codex":0.00015967972,"about_ca_topic_score_gemma":0.00026249935,"teacher_disagreement_score":0.10000941,"about_ca_system_score_codex":0.000017127262,"about_ca_system_score_gemma":0.000053988686,"threshold_uncertainty_score":0.58269125},"labels":[],"label_agreement":null},{"id":"W4229083035","doi":"10.3324/haematol.2021.278438","title":"Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute; Takeda Oncology","keywords":"Classical Hodgkin lymphoma; Medicine; Hodgkin lymphoma; Stage (stratigraphy); Lymphoma; Internal medicine; Oncology; Gerontology; Biology","score_opus":0.016657081744397482,"score_gpt":0.28360123698800677,"score_spread":0.26694415524360926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229083035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661183,0.00070775376,0.00006786747,0.00045726384,0.000047303958,0.0015326709,0.00009133028,0.00014149248,0.0003424606],"genre_scores_gemma":[0.9971008,0.00007351346,0.00070862053,0.00053812563,0.000027331209,0.0004464882,0.00058696495,0.000029144134,0.0004890463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973286,0.00035559805,0.0005006087,0.0008218614,0.00054950087,0.00044387192],"domain_scores_gemma":[0.9979399,0.0004212526,0.00023878881,0.0009789912,0.00019646238,0.0002246195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012937307,0.0003814462,0.0012010527,0.00008718037,0.00020166281,0.00007478349,0.0001818085,0.00014023867,0.0009238556],"category_scores_gemma":[0.0001545954,0.00020383945,0.00031492172,0.0010492228,0.00012456272,0.000073301475,0.00012905488,0.00012840495,0.00008234717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015569107,0.01731892,0.9509521,0.000015218391,0.0045637367,0.013653165,0.0017771771,0.000011738359,0.000029047353,0.00003798182,0.00063460704,0.009449389],"study_design_scores_gemma":[0.046478517,0.0015222688,0.94245917,0.00009134437,0.005738031,0.000041830906,0.0016589145,0.00011823653,0.0010044372,0.00000944379,0.00062289013,0.00025491568],"about_ca_topic_score_codex":0.00019394413,"about_ca_topic_score_gemma":0.001299557,"teacher_disagreement_score":0.044921607,"about_ca_system_score_codex":0.00020047821,"about_ca_system_score_gemma":0.00018297885,"threshold_uncertainty_score":0.99998945},"labels":[],"label_agreement":null},{"id":"W4237529142","doi":"10.3324/haematol.2019.234666","title":"Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population","year":2019,"lang":"en","type":"erratum","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thrombophilia; Stroke (engine); Medicine; Population; Pediatric stroke; Physical medicine and rehabilitation; Pediatrics; Physical therapy; Internal medicine; Ischemic stroke; Thrombosis; Environmental health","score_opus":0.01945981740667485,"score_gpt":0.28455484931823705,"score_spread":0.2650950319115622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237529142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.568541,0.024135256,0.00024655333,0.006176324,0.08590217,0.007872125,0.0019635744,0.00050666515,0.30465633],"genre_scores_gemma":[0.9823254,0.0012245213,0.00018893555,0.00018770288,0.000649446,0.000053441574,0.0011924445,0.000035826233,0.014142282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767315,0.00013273956,0.00072910823,0.0004346666,0.0007198826,0.00031044005],"domain_scores_gemma":[0.9985497,0.0000831817,0.0006063502,0.00053975265,0.00015817625,0.00006281105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037532678,0.0003016202,0.00094891543,0.00037200566,0.000051560084,0.000021205875,0.00035361218,0.00062675274,0.000914608],"category_scores_gemma":[0.00019622411,0.00020418843,0.0002743927,0.0002517844,0.000030505647,0.00006238607,0.00017534438,0.0009361622,0.000106301464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070036855,0.003769145,0.648357,0.0017604459,0.00089252315,0.000110194174,0.0011020472,0.000019530955,0.00070211437,0.117579654,0.2187537,0.006253312],"study_design_scores_gemma":[0.004430833,0.0010574746,0.81376386,0.00096403307,0.001034575,0.00018135105,0.00095245964,0.004089721,0.00041174926,0.007988002,0.1642915,0.0008344188],"about_ca_topic_score_codex":0.000047975067,"about_ca_topic_score_gemma":0.00008574724,"teacher_disagreement_score":0.4137844,"about_ca_system_score_codex":0.000085813386,"about_ca_system_score_gemma":0.00013764344,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W4241096387","doi":"10.3324/haematol.2013.092155","title":"Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Hazard ratio; Placebo; Internal medicine; Randomized controlled trial; Confidence interval; Janus kinase 2; Myeloproliferative neoplasm; Anemia; Surgery; Gastroenterology; Bone marrow; Pathology","score_opus":0.012935383039976026,"score_gpt":0.23148396466348847,"score_spread":0.21854858162351246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241096387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948586,0.000045006193,0.000006080428,0.00043224462,0.000025303512,0.0012542229,0.00007461903,0.000019831798,0.0032840655],"genre_scores_gemma":[0.9977701,0.00008117505,0.0018402023,0.000039328912,0.000007167125,0.00008072748,0.000103306695,0.000015830123,0.000062199935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843997,0.00008031667,0.0005347045,0.0003234472,0.00036040452,0.0002611691],"domain_scores_gemma":[0.99877197,0.0003075204,0.00026213698,0.00029418955,0.00021381353,0.00015039933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013840027,0.00021760724,0.0009064147,0.000103088605,0.00003601157,0.000007613349,0.00006599456,0.000100723555,0.00010961078],"category_scores_gemma":[0.00014335552,0.00012023922,0.000047332134,0.00020908364,0.0002320722,0.00006210508,0.000042244646,0.000109168446,0.00000958961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009075544,0.0008751877,0.987075,0.00013620137,0.00016027251,0.000032902175,0.00053707475,0.0000018588769,0.00001172262,0.00081734447,0.00013803534,0.0011388697],"study_design_scores_gemma":[0.02726137,0.003688028,0.9662166,0.00063485344,0.00009803639,0.000017348006,0.00030019772,0.00000937794,0.0015085173,0.000032899658,0.00010437411,0.00012835773],"about_ca_topic_score_codex":0.00032933953,"about_ca_topic_score_gemma":0.00030237573,"teacher_disagreement_score":0.020858347,"about_ca_system_score_codex":0.000024218556,"about_ca_system_score_gemma":0.000059869926,"threshold_uncertainty_score":0.4903213},"labels":[],"label_agreement":null},{"id":"W4281571337","doi":"10.3324/haematol.2022.281114","title":"Durable discontinuation of systemic therapy for chronic graft-&lt;i&gt;versus&lt;/i&gt;-host disease: myth or reality?","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Institutes of Health","keywords":"Discontinuation; Graft-versus-host disease; Systemic therapy; Mythology; Medicine; Systemic disease; Disease; Immunology; Internal medicine; Theology; Philosophy; Cancer","score_opus":0.047726942434693324,"score_gpt":0.2978000384813579,"score_spread":0.25007309604666456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281571337","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10709325,0.04769844,0.0114711225,0.76603717,0.007459587,0.039421674,0.0074609485,0.001976701,0.011381086],"genre_scores_gemma":[0.8020097,0.023643373,0.0021241577,0.09235201,0.004705873,0.0136586325,0.034122065,0.0008839166,0.026500288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952786,0.00043948356,0.0013824969,0.0010338002,0.0010985787,0.0007670695],"domain_scores_gemma":[0.99597555,0.0013530006,0.0010186768,0.0011965379,0.0002764074,0.00017983242],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006336225,0.00068750256,0.0019121174,0.00031961265,0.0002474605,0.000041249405,0.0004636234,0.0007515112,0.0019807215],"category_scores_gemma":[0.0002740392,0.0005065817,0.0006058935,0.0004081278,0.000220122,0.0001197836,0.00005780414,0.0007130809,0.00004833844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01136869,0.00049351685,0.00020149515,0.022612961,0.000990355,0.0029263461,0.00093995646,0.000022081185,0.014661964,0.002693755,0.94258356,0.0005052934],"study_design_scores_gemma":[0.014529355,0.0042226305,0.0009847427,0.005557724,0.0023981638,0.0015103872,0.0002465006,0.00032117858,0.0026455726,0.00031930258,0.9659177,0.0013467303],"about_ca_topic_score_codex":0.000015333453,"about_ca_topic_score_gemma":0.000023035434,"teacher_disagreement_score":0.6949164,"about_ca_system_score_codex":0.0004554372,"about_ca_system_score_gemma":0.000858951,"threshold_uncertainty_score":0.9997386},"labels":[],"label_agreement":null},{"id":"W4283311968","doi":"10.3324/haematol.2022.280900","title":"In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Hospital for Sick Children","keywords":"Lymphoma; Biology; Laser capture microdissection; Pathology; Somatic evolution in cancer; Cancer research; Cancer; Medicine; Genetics; Gene; Immunology","score_opus":0.03622174859452767,"score_gpt":0.32978968303005707,"score_spread":0.2935679344355294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283311968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787915,0.00035096146,0.000020670694,0.00020819079,0.000098050135,0.0004984197,0.00004568822,0.000004339668,0.0008945563],"genre_scores_gemma":[0.9988527,0.00040799522,0.00022032391,0.00013394996,0.000029276194,0.00023283712,0.000082198145,0.000011480523,0.000029227282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987397,0.00023697672,0.0003379754,0.0002617508,0.00018144007,0.00024213722],"domain_scores_gemma":[0.9993497,0.000050497292,0.00015797256,0.00035313694,0.00007017297,0.000018530453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004447855,0.0000964068,0.00022167634,0.00006384149,0.00006774357,0.00000858224,0.00029635418,0.00008584695,0.000020730738],"category_scores_gemma":[0.00007869749,0.00007946198,0.000059697144,0.00031600782,0.00017778717,0.0000051522297,0.00035237413,0.00014883818,0.0000010472372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053865503,0.0020717075,0.018553121,0.0001387837,0.000019450144,0.000066998204,0.000842735,0.00015247408,0.9734115,0.0010269425,0.0004603536,0.0027172624],"study_design_scores_gemma":[0.00237233,0.003685429,0.16990356,0.000046106285,0.0000137613615,0.00008362352,0.00088739337,0.00034716085,0.7628484,0.00073270424,0.058735747,0.00034382037],"about_ca_topic_score_codex":0.00021166488,"about_ca_topic_score_gemma":0.00021994047,"teacher_disagreement_score":0.21056315,"about_ca_system_score_codex":0.000042345324,"about_ca_system_score_gemma":0.00016581756,"threshold_uncertainty_score":0.32403654},"labels":[],"label_agreement":null},{"id":"W4289793368","doi":"10.3324/haematol.2022.280740","title":"Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centre Léon Bérard; Pfizer; Incyte; Amgen","keywords":"Blast Crisis; Myeloid leukemia; Medicine; Complete remission; Internal medicine; Oncology; Chemotherapy","score_opus":0.02280471330544193,"score_gpt":0.269305235348068,"score_spread":0.24650052204262607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289793368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250871,0.0017606192,7.860548e-7,0.065346286,0.00037154753,0.0027890415,0.00054821017,0.00014149294,0.0039549344],"genre_scores_gemma":[0.85725796,0.0058541032,0.0011990516,0.110741735,0.0008865125,0.0024182417,0.013730048,0.00049496663,0.0074173673],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951605,0.0003988092,0.001366621,0.0012114177,0.0009055128,0.0009571434],"domain_scores_gemma":[0.9967776,0.00037321734,0.000668582,0.0019767645,0.000073193565,0.00013066341],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019586128,0.0008378651,0.0023500484,0.0009046876,0.00007703151,0.000012716959,0.00064876064,0.0012682213,0.0035598108],"category_scores_gemma":[0.00035620466,0.00066732056,0.0004157216,0.00074921746,0.00014712785,0.000072795636,0.00049305917,0.001988398,0.00008815548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000796407,0.00078647153,0.063509695,0.001260466,0.00024255263,0.016166093,0.00041287963,0.000033617784,0.00003685163,0.000005136972,0.91481084,0.0019390129],"study_design_scores_gemma":[0.052206054,0.010816782,0.0802477,0.0036405341,0.0009339776,0.0016132506,0.00038260137,0.00021779117,0.002563684,0.00050707086,0.84507203,0.001798529],"about_ca_topic_score_codex":0.0035746756,"about_ca_topic_score_gemma":0.00067641627,"teacher_disagreement_score":0.0697388,"about_ca_system_score_codex":0.025260715,"about_ca_system_score_gemma":0.002589571,"threshold_uncertainty_score":0.9995778},"labels":[],"label_agreement":null},{"id":"W4289855872","doi":"10.3324/haematol.2022.281431","title":"Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Région Occitanie Pyrénées-Méditerranée; Agence Nationale de la Recherche","keywords":"Proteomics; Cohort; Mass spectrometry; Medicine; Amyloid (mycology); Cohort study; Computational biology; Internal medicine; Chemistry; Chromatography; Pathology; Biology","score_opus":0.017322024303209706,"score_gpt":0.2983294327472847,"score_spread":0.28100740844407496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289855872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222994,0.0005132796,0.0024381438,0.0022846651,0.00027177233,0.0009572312,0.0001277821,0.000025333871,0.0011518752],"genre_scores_gemma":[0.9610062,0.00011937654,0.036582455,0.00135659,0.00003237608,0.00051361864,0.00017432541,0.000023719747,0.00019132637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757445,0.0006006772,0.0006832044,0.0005585885,0.00029742526,0.00028563113],"domain_scores_gemma":[0.99831086,0.00037768218,0.0005221632,0.0006367368,0.00008891822,0.0000636586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068503176,0.00020745775,0.00042046202,0.00008040432,0.00013417234,0.000018522838,0.00047721865,0.00013186548,0.00017459554],"category_scores_gemma":[0.0018942301,0.0001697,0.0002210929,0.00034743128,0.00013693482,0.0000073088254,0.00030636013,0.00032615126,0.00002254718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002207279,0.0008104399,0.97724086,0.000013577114,0.00019574679,0.000051227322,0.00003195905,0.00040094793,0.017430319,0.00013760173,0.0032864672,0.00018009887],"study_design_scores_gemma":[0.0033827627,0.0010876387,0.76254916,0.00003811964,0.00021080086,0.00007389467,0.00022618752,0.00033924417,0.19090202,0.001709308,0.038824636,0.0006562254],"about_ca_topic_score_codex":0.00012243904,"about_ca_topic_score_gemma":0.00009775538,"teacher_disagreement_score":0.21469173,"about_ca_system_score_codex":0.000077990764,"about_ca_system_score_gemma":0.0002316902,"threshold_uncertainty_score":0.6920165},"labels":[],"label_agreement":null},{"id":"W4292478418","doi":"10.3324/haematol.2022.280723","title":"High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre; Jewish General Hospital; St. Paul's Hospital; Dr. Georges-L.-Dumont University Hospital Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta; Vancouver General Hospital; Princess Margaret Cancer Centre; CancerCare Manitoba; Saskatchewan Cancer Agency; Ottawa Hospital; Health Sciences Centre; McGill University Health Centre; Juravinski Cancer Centre","funders":"Celgene","keywords":"Medicine; Ferritin; Internal medicine; Gastroenterology; Transferrin saturation; Myelodysplastic syndromes; International Prognostic Scoring System; Univariate analysis; Anemia; Serum ferritin; Multivariate analysis; Bone marrow","score_opus":0.02863820880396554,"score_gpt":0.3032478793550697,"score_spread":0.27460967055110413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292478418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644977,0.000021275786,0.00006664169,0.0016371153,0.00018189702,0.0011797979,0.000033936874,0.00012352545,0.00030602474],"genre_scores_gemma":[0.99780804,0.000013109005,0.00089206686,0.0004891814,0.000020107767,0.00025970052,0.00016990992,0.000027969536,0.0003199349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974236,0.0003222651,0.00062005443,0.00046131873,0.00074597186,0.00042679903],"domain_scores_gemma":[0.99881464,0.00046068686,0.00009362175,0.00037407613,0.000085681255,0.00017128275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042900833,0.0002167577,0.00081507606,0.00023964273,0.00015319546,0.000017857845,0.00021242574,0.00013014898,0.00068656664],"category_scores_gemma":[0.000493415,0.00014654809,0.00010182596,0.0004359094,0.00015882283,0.00009898425,0.00014678431,0.0008964821,0.000050092243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018909194,0.0007466157,0.99417084,0.000050461207,0.00009616479,0.0007321093,0.000116146184,0.0000555191,0.0000063241664,0.00052187697,0.00059958955,0.0010134544],"study_design_scores_gemma":[0.007250883,0.003109949,0.98831546,0.000039574265,0.00005892927,0.00015425673,0.00009326831,0.00013811525,0.00001796366,0.000057265475,0.00059985847,0.00016445457],"about_ca_topic_score_codex":0.00007499763,"about_ca_topic_score_gemma":0.00004253136,"teacher_disagreement_score":0.0058553373,"about_ca_system_score_codex":0.00026636134,"about_ca_system_score_gemma":0.00027599194,"threshold_uncertainty_score":0.7517423},"labels":[],"label_agreement":null},{"id":"W4292478663","doi":"10.3324/haematol.2022.281864","title":"Bence Jones Island in Shepherd Bay, Nunavut: a little known tribute to the legendary physician and chemist’s “thé de voyage”","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bay; Tribute; History; Archaeology; Art history","score_opus":0.008939515093991645,"score_gpt":0.23515372236634458,"score_spread":0.22621420727235292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292478663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129087,0.0021878635,0.00017221505,0.0035298262,0.00006212104,0.00023832468,0.000080198544,0.000015412528,0.0024231637],"genre_scores_gemma":[0.9961265,0.00016459898,0.00022683687,0.0018843482,0.00009475892,0.0001560476,0.000046497156,0.00001193602,0.0012884912],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989742,0.00009379554,0.0001607348,0.0003482187,0.00011151787,0.00031153092],"domain_scores_gemma":[0.9995824,0.000021214952,0.00004713827,0.0002552193,0.000020232364,0.00007377824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021533461,0.00014113502,0.00019527928,0.000023847384,0.00024100044,0.000028291926,0.00030109286,0.000070328344,0.00009910795],"category_scores_gemma":[0.000046779543,0.00010750698,0.000054473137,0.00014805511,0.00006525806,0.0000034064135,0.00041850004,0.00016283347,0.000013780522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081952394,0.00082161516,0.052545816,0.0001862464,0.00019659716,0.00067333184,0.0027414076,0.00057845324,0.6934095,0.0025236232,0.23541969,0.010084211],"study_design_scores_gemma":[0.00085147977,0.0005461605,0.03017811,0.00002276805,0.00002997013,0.0003437003,0.0008024291,0.00011370451,0.07921639,0.00073968363,0.88667804,0.00047759028],"about_ca_topic_score_codex":0.000056168756,"about_ca_topic_score_gemma":0.0009253171,"teacher_disagreement_score":0.65125835,"about_ca_system_score_codex":0.0000180224,"about_ca_system_score_gemma":0.00006685627,"threshold_uncertainty_score":0.43840078},"labels":[],"label_agreement":null},{"id":"W4296629879","doi":"10.3324/haematol.2022.280786","title":"Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; National Research Council Canada","funders":"Centre hospitalier universitaire Sainte-Justine","keywords":"CRISPR; Biology; Cancer research; Lymphoblastic Leukemia; Gene; GPX4; Genome editing; Bystander effect; Genome; Leukemia; Genetics; Oxidative stress; Immunology","score_opus":0.0250091142453089,"score_gpt":0.2948795382554464,"score_spread":0.2698704240101375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296629879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926939,0.0009653532,0.0041220975,0.00042623922,0.00010568686,0.00032486528,0.000055548437,0.000028114675,0.0012781887],"genre_scores_gemma":[0.9972132,0.00016545338,0.00028924423,0.0010965038,0.0000262922,0.00047898365,0.00012130597,0.00002200045,0.00058705395],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983857,0.00015389046,0.00032985062,0.000580365,0.000202949,0.0003472221],"domain_scores_gemma":[0.9991123,0.000035154233,0.00011616039,0.00060492154,0.00005739047,0.00007407454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000288048,0.00019305282,0.00026024875,0.00007493827,0.00029880813,0.000031911775,0.00043278717,0.00011443325,0.0004035857],"category_scores_gemma":[0.00008233421,0.0001788093,0.00013150388,0.00026508907,0.00011072775,0.0000053669346,0.00031027463,0.00019059026,0.000030488354],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057337235,0.00062298274,0.04238191,0.00004471014,0.0002530812,0.00008046683,0.00024394171,0.0035840913,0.94847435,0.0016024291,0.0009307269,0.0012079581],"study_design_scores_gemma":[0.003962628,0.0015042303,0.8079421,0.000023720559,0.00023307197,0.0009191653,0.0018426002,0.0012085782,0.09383103,0.0032132787,0.083775684,0.0015438915],"about_ca_topic_score_codex":0.00015203696,"about_ca_topic_score_gemma":0.00006325236,"teacher_disagreement_score":0.8546433,"about_ca_system_score_codex":0.00018699195,"about_ca_system_score_gemma":0.00021637265,"threshold_uncertainty_score":0.72916317},"labels":[],"label_agreement":null},{"id":"W4302287941","doi":"10.3324/haematol.2022.280653","title":"CD56&lt;sup&gt;bright&lt;/sup&gt;CD16&lt;sup&gt;–&lt;/sup&gt; natural killer cells as an important regulatory mechanism in chronic graft-&lt;I&gt;versus&lt;/i&gt;-host disease","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Manitoba; CancerCare Manitoba; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Children's Hospital","keywords":"Perforin; Immunology; Granzyme B; Population; Biology; Interleukin 21; CD16; Natural killer cell; CD8; Cytotoxic T cell; Cancer research; Immune system; Medicine; CD3; In vitro; Genetics","score_opus":0.0101338901872905,"score_gpt":0.22538859530337085,"score_spread":0.21525470511608036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302287941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9392343,0.026278658,0.00014948267,0.0014729942,0.020739345,0.0032356493,0.00028376357,0.0014800978,0.007125671],"genre_scores_gemma":[0.9490887,0.0017983259,0.00017221703,0.0016513235,0.00037774452,0.0007858961,0.0029170855,0.00030052144,0.042908177],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9869105,0.0026320787,0.0031051165,0.0032965804,0.00087958114,0.0031761015],"domain_scores_gemma":[0.99367374,0.0007240101,0.0015681832,0.0029274381,0.00050106115,0.0006055921],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0017295525,0.0021481717,0.0026690527,0.001381176,0.0025744056,0.00025252334,0.0022278905,0.0017183974,0.031864367],"category_scores_gemma":[0.0004815622,0.00198096,0.0014253828,0.0013784283,0.001129823,0.0012816845,0.001526686,0.003050214,0.004922894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085865725,0.0025149544,0.000226043,0.00029837945,0.0012682623,0.0021847705,0.0021648174,0.0006259319,0.71429276,0.08684354,0.18008058,0.0009133903],"study_design_scores_gemma":[0.0116184745,0.0032865012,0.003618455,0.0003236477,0.00078832917,0.002280978,0.0012735629,0.0035250396,0.038716666,0.0024285126,0.92847407,0.003665787],"about_ca_topic_score_codex":0.00011179632,"about_ca_topic_score_gemma":0.00040878778,"teacher_disagreement_score":0.7483935,"about_ca_system_score_codex":0.0019800342,"about_ca_system_score_gemma":0.0010875291,"threshold_uncertainty_score":0.9995776},"labels":[],"label_agreement":null},{"id":"W4304845645","doi":"10.3324/haematol.2022.281180","title":"Variation and impact of polygenic hematologic traits in monogenic sickle cell disease","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Fondation Charles-Bruneau","keywords":"Acute chest syndrome; Fetal hemoglobin; Locus (genetics); Medicine; Disease; Genotype; Epistasis; Context (archaeology); Mendelian randomization; Genome-wide association study; Sickle cell anemia; Mendelian inheritance; Internal medicine; Biology; Immunology; Genetics; Single-nucleotide polymorphism; Gene; Pregnancy; Genetic variants","score_opus":0.010647031821667477,"score_gpt":0.24875977128370713,"score_spread":0.23811273946203965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304845645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940183,0.0041714264,0.00002132414,0.00045172274,0.00003066364,0.00042053437,0.000020675086,0.000040745534,0.0008246086],"genre_scores_gemma":[0.9993923,0.00020349784,0.00012911638,0.0001146545,0.000004020546,0.000046566667,0.000018681885,0.000010786923,0.00008040621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989373,0.000105674684,0.00031399782,0.00024251155,0.00016500254,0.00023547966],"domain_scores_gemma":[0.9995048,0.000057946156,0.00012193577,0.00015707743,0.000020138099,0.00013811025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015067976,0.00013425328,0.00040665249,0.0001469552,0.00008502311,0.000004383567,0.00007422718,0.00007679872,0.00058005657],"category_scores_gemma":[0.00006881005,0.00009886957,0.00014985412,0.00034202557,0.00006183229,0.00003253748,0.00008772268,0.00022397428,0.0000072515077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004153033,0.0051266965,0.941461,0.001260486,0.0003168594,0.0031757744,0.0064907554,0.0031766302,0.026879016,0.003495298,0.0017101902,0.002754235],"study_design_scores_gemma":[0.0025796194,0.000894953,0.99004185,0.000033551787,0.00013284707,0.0005909408,0.00082564354,0.0024909598,0.00020057012,0.0019542095,0.000060676888,0.00019417246],"about_ca_topic_score_codex":0.0001055314,"about_ca_topic_score_gemma":0.000002482931,"teacher_disagreement_score":0.04858083,"about_ca_system_score_codex":0.000062997366,"about_ca_system_score_gemma":0.00013350927,"threshold_uncertainty_score":0.6351213},"labels":[],"label_agreement":null},{"id":"W4306867613","doi":"10.3324/haematol.2021.280051","title":"Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Institut National Du Cancer; Direction Générale de l’offre de Soins; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; CHIST-ERA; Labex Iron","keywords":"Positron emission tomography; Medicine; Multiple myeloma; Cassiopeia A; Positron Emission Tomography-Computed Tomography; Nuclear medicine; Radiology; Tomography; Internal medicine; Physics; Astronomy","score_opus":0.02303871682484634,"score_gpt":0.27348528004051986,"score_spread":0.25044656321567355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306867613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743818,0.0011040708,0.00001295829,0.015040889,0.000342272,0.007643162,0.0010834063,0.00015405781,0.00023736546],"genre_scores_gemma":[0.98400635,0.00010416055,0.00050040084,0.008757079,0.00018268137,0.0015031049,0.0047680144,0.000104479856,0.00007372461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99295396,0.0014788234,0.0012562699,0.0013289773,0.0018618312,0.0011201614],"domain_scores_gemma":[0.99531436,0.0023797825,0.00055167684,0.0012659022,0.00020669833,0.0002815728],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034476697,0.0008899554,0.0019837567,0.0009722918,0.00039024054,0.000062460385,0.0008917398,0.0007096481,0.00048413567],"category_scores_gemma":[0.00039189516,0.000539908,0.00065272365,0.0014399844,0.00023249547,0.00009077832,0.00037699897,0.0026314345,0.000018453318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021983709,0.004272716,0.91225713,0.0003938533,0.0008874005,0.02258588,0.0010452258,0.0000080002965,0.00007749658,0.0000014526175,0.05492657,0.0013459242],"study_design_scores_gemma":[0.013192368,0.0042563407,0.97165054,0.001070215,0.0007374226,0.00013057025,0.00037356964,0.00031444526,0.00048934843,0.000054894233,0.0071694027,0.0005608968],"about_ca_topic_score_codex":0.0051047057,"about_ca_topic_score_gemma":0.0003130796,"teacher_disagreement_score":0.059393417,"about_ca_system_score_codex":0.00016271211,"about_ca_system_score_gemma":0.00021823705,"threshold_uncertainty_score":0.99970526},"labels":[],"label_agreement":null},{"id":"W4306867618","doi":"10.3324/haematol.2022.280678","title":"Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Gilead Sciences","keywords":"Medicine; Refractory (planetary science); Gastroenterology; Internal medicine; Cytokine release syndrome; Adverse effect; Anemia; Incidence (geometry); Surgery; Chimeric antigen receptor; Immunotherapy","score_opus":0.03940613311196696,"score_gpt":0.3146591669903849,"score_spread":0.27525303387841793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306867618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991781,0.0007700397,0.000036377627,0.00035170553,0.00023316963,0.0006912537,0.00037243046,0.000101294376,0.005662703],"genre_scores_gemma":[0.99717027,0.0005137405,0.00046910916,0.00014729518,0.00013249861,0.000112547925,0.00026982996,0.000044385735,0.0011403005],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969127,0.00022686519,0.0008050349,0.0006422368,0.00088455406,0.00052856724],"domain_scores_gemma":[0.9977136,0.00087561755,0.0002884544,0.00084380567,0.000090035486,0.00018845596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006484463,0.00025360112,0.000839422,0.00045285677,0.00012263801,0.0000126466,0.0004166449,0.00017555282,0.007626355],"category_scores_gemma":[0.00053898187,0.00022113774,0.00019978761,0.0009196349,0.00014277086,0.000064989435,0.00037154442,0.0007877015,0.00013877811],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2054958,0.017534636,0.24339247,0.0012340294,0.0018587315,0.04807472,0.010332991,0.0006518695,0.27915046,0.0030806605,0.1472279,0.04196575],"study_design_scores_gemma":[0.36212197,0.04403969,0.36352667,0.0007169862,0.0029596968,0.0045093987,0.006230586,0.012919946,0.051039174,0.016414704,0.13104047,0.004480709],"about_ca_topic_score_codex":0.0005412946,"about_ca_topic_score_gemma":0.000077987825,"teacher_disagreement_score":0.22811128,"about_ca_system_score_codex":0.0006356744,"about_ca_system_score_gemma":0.00061628723,"threshold_uncertainty_score":0.9932808},"labels":[],"label_agreement":null},{"id":"W4308007975","doi":"10.3324/haematol.2022.281644","title":"What doesn’t kill you makes you stronger – &lt;i&gt;bcl-2&lt;/i&gt; promotes survival independent of proliferation","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Biology; Molecular biology; Chemistry; Internal medicine; Medicine","score_opus":0.02814590347934173,"score_gpt":0.28616002641516736,"score_spread":0.25801412293582565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308007975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128134,0.0021135116,0.00013115529,0.00825912,0.000708957,0.0023225036,0.000069334856,0.00022466773,0.004889411],"genre_scores_gemma":[0.9913674,0.00034343672,0.0008654987,0.00033233556,0.00016393104,0.00057448563,0.0002665481,0.00006285571,0.006023484],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.995324,0.00057644217,0.0007995705,0.00078354555,0.0017390563,0.0007773948],"domain_scores_gemma":[0.99792284,0.00021710251,0.0003444583,0.0008774182,0.00037415556,0.00026402803],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013619607,0.00038358962,0.0010028718,0.00033288056,0.0003576303,0.00009913546,0.00051113195,0.00024965993,0.0024933596],"category_scores_gemma":[0.00052903173,0.00029480466,0.00023403371,0.0005388536,0.00030193516,0.00037943624,0.0006517177,0.0007704024,0.000114899005],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011106293,0.01023215,0.11755188,0.0044642612,0.002688797,0.00903143,0.01472971,0.0006937452,0.6299563,0.10322479,0.065496646,0.03082399],"study_design_scores_gemma":[0.040330093,0.021093132,0.21939929,0.001654062,0.0019328148,0.014446013,0.024248887,0.012539194,0.24174802,0.010443643,0.40683886,0.0053259926],"about_ca_topic_score_codex":0.000015479012,"about_ca_topic_score_gemma":0.000048624857,"teacher_disagreement_score":0.3882083,"about_ca_system_score_codex":0.00047806933,"about_ca_system_score_gemma":0.00055035023,"threshold_uncertainty_score":0.9999504},"labels":[],"label_agreement":null},{"id":"W4308060958","doi":"10.3324/haematol.2022.281146","title":"Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Lymphoblastic Leukemia; Antibody; Medicine; Leukemia; Immunology","score_opus":0.020992387842895987,"score_gpt":0.2955415563074582,"score_spread":0.27454916846456223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308060958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96301216,0.002579297,0.0000904837,0.026680484,0.0003443047,0.003978116,0.00047757826,0.00021493308,0.0026226325],"genre_scores_gemma":[0.9762394,0.00060418167,0.00081408693,0.01653771,0.0007818282,0.00084170385,0.0035525803,0.00014625768,0.00048227824],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99473614,0.0004890045,0.0012244876,0.0009355232,0.0015424156,0.0010724493],"domain_scores_gemma":[0.99659973,0.0015390542,0.0006273834,0.0008582184,0.00020858075,0.00016705113],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003321895,0.0007390431,0.0019202698,0.0009960064,0.0001142949,0.000030078267,0.00054108276,0.001084401,0.0029306451],"category_scores_gemma":[0.00045881292,0.0005615149,0.00071747083,0.00109668,0.00025233554,0.00006846966,0.00044450557,0.0024449818,0.00018005678],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033985805,0.0011514784,0.17736712,0.003739676,0.00088017446,0.05001141,0.00023637833,0.00063299,0.00014538606,0.00003321482,0.7621233,0.00028029762],"study_design_scores_gemma":[0.029902803,0.027988674,0.86681145,0.0025290877,0.0048870007,0.040249266,0.00011023834,0.00814807,0.00042900981,0.00074084074,0.015147359,0.003056177],"about_ca_topic_score_codex":0.0005075123,"about_ca_topic_score_gemma":0.000003477561,"teacher_disagreement_score":0.74697596,"about_ca_system_score_codex":0.010121547,"about_ca_system_score_gemma":0.0046970677,"threshold_uncertainty_score":0.9998564},"labels":[],"label_agreement":null},{"id":"W4309243711","doi":"10.3324/haematol.2022.281926","title":"Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Lymphoblastic Leukemia; Dabrafenib; Medicine; Chemotherapy; Oncology; Leukemia; Cancer research; Immunology; Internal medicine; Melanoma; Vemurafenib","score_opus":0.01658346714027838,"score_gpt":0.3049279870172312,"score_spread":0.2883445198769528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309243711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941324,0.00043770362,0.000020062458,0.004016056,0.00007520872,0.00046019562,0.00001666973,0.000054165743,0.0007875116],"genre_scores_gemma":[0.9955931,0.00018238355,0.0009103187,0.0020935724,0.000005850169,0.00010871406,0.000013595328,0.000017555696,0.0010749225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856794,0.00019481871,0.0004032471,0.0004243674,0.00018120803,0.00022842828],"domain_scores_gemma":[0.9992023,0.00031144888,0.00007192157,0.00020535366,0.00001924697,0.00018970725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042700517,0.00015960545,0.00052467786,0.00014375443,0.00015013783,0.000011497856,0.00006825956,0.000092463815,0.00034716428],"category_scores_gemma":[0.00022732114,0.00013212636,0.00005645476,0.0002577623,0.00012636639,0.000022899336,0.00012170226,0.0001849333,0.000025826123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06206796,0.003312182,0.8361343,0.0001653572,0.001234842,0.01641606,0.004049945,0.00006926141,0.001526814,0.0043963864,0.014776165,0.05585073],"study_design_scores_gemma":[0.021335501,0.0043997914,0.93533593,0.00011018311,0.00030777758,0.0036813056,0.00041936623,0.0011562074,0.00006953276,0.0012762102,0.031500332,0.00040786993],"about_ca_topic_score_codex":0.000039703173,"about_ca_topic_score_gemma":0.0000093804265,"teacher_disagreement_score":0.09920163,"about_ca_system_score_codex":0.00026053563,"about_ca_system_score_gemma":0.00017960738,"threshold_uncertainty_score":0.53879565},"labels":[],"label_agreement":null},{"id":"W4310564872","doi":"10.3324/haematol.2022.282025","title":"&lt;i&gt;DUSP22&lt;/i&gt;-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Disease; Medicine; Anaplastic lymphoma kinase; Cancer research; Oncology; Internal medicine; Lung cancer","score_opus":0.0348352812346705,"score_gpt":0.28881175528688846,"score_spread":0.25397647405221796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310564872","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35343012,0.009661493,0.00043384172,0.52897537,0.0045958543,0.011545671,0.035259046,0.0015624188,0.054536175],"genre_scores_gemma":[0.6184163,0.0005994424,0.002327224,0.3561937,0.0016548443,0.0018986849,0.0055033555,0.0003274499,0.01307899],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99052554,0.0011316782,0.002226871,0.0025558437,0.0016663197,0.0018937408],"domain_scores_gemma":[0.9923048,0.0030418113,0.0009781612,0.0021542122,0.00032437642,0.0011966259],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00068762514,0.0015344324,0.0036072661,0.00031579126,0.00067437615,0.00014494141,0.0007910662,0.0014801618,0.008017145],"category_scores_gemma":[0.0018516972,0.0011635295,0.001494013,0.00043455142,0.000543127,0.000059832175,0.0007889293,0.0012915283,0.0006598489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015677939,0.00707042,0.07532438,0.0011178695,0.0011740802,0.08277472,0.00020395746,0.0000016323834,0.000025347346,0.0005202823,0.82953167,0.0006878632],"study_design_scores_gemma":[0.015588215,0.0025599,0.10799899,0.0003970239,0.0044907616,0.0007993421,0.000055092616,0.00024735287,0.00005358269,0.0006286886,0.86569405,0.0014870181],"about_ca_topic_score_codex":0.00009319261,"about_ca_topic_score_gemma":0.00010665995,"teacher_disagreement_score":0.2649862,"about_ca_system_score_codex":0.0008645343,"about_ca_system_score_gemma":0.0013056236,"threshold_uncertainty_score":0.9998161},"labels":[],"label_agreement":null},{"id":"W4310567835","doi":"10.3324/haematol.2022.282014","title":"Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Primary central nervous system lymphoma; Rituximab; Chemoimmunotherapy; Cytarabine; Medicine; ThioTEPA; Methotrexate; Oncology; Central nervous system; Lymphoma; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.018462106856659277,"score_gpt":0.27964529372819324,"score_spread":0.26118318687153397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310567835","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38988435,0.18558164,0.00058570737,0.38222167,0.0042920504,0.01957483,0.0016538658,0.002454567,0.013751331],"genre_scores_gemma":[0.23981726,0.013650769,0.03692297,0.663001,0.0040467186,0.02691286,0.0065467665,0.00093058794,0.008171058],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99624056,0.000188019,0.00078230683,0.0011993792,0.00059551385,0.0009942065],"domain_scores_gemma":[0.9977979,0.0005109964,0.00045253095,0.0009652901,0.00010127098,0.0001719928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020391637,0.0008259732,0.0022897376,0.00010075161,0.00040854907,0.00010103333,0.0003493383,0.00082642166,0.00058922963],"category_scores_gemma":[0.000054509113,0.00062877656,0.00060137385,0.00013764738,0.00017165845,0.00011651648,0.00019914054,0.0003674611,0.0000144730575],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035744875,0.0034299053,0.0015172994,0.008788584,0.002257473,0.02373459,0.0033020193,0.0000014432796,0.0003078081,0.0011114496,0.82689095,0.125084],"study_design_scores_gemma":[0.012594077,0.001451229,0.01654785,0.0005461736,0.0009119846,0.011033502,0.00100392,0.000077675824,0.00045968592,0.000048702317,0.95436966,0.00095556234],"about_ca_topic_score_codex":0.0011367268,"about_ca_topic_score_gemma":0.00002199926,"teacher_disagreement_score":0.28077936,"about_ca_system_score_codex":0.0020651128,"about_ca_system_score_gemma":0.0002775239,"threshold_uncertainty_score":0.9996164},"labels":[],"label_agreement":null},{"id":"W4312093790","doi":"10.3324/haematol.2022.282191","title":"Under the surface: scratching the acute lymphoblastic leukemia niche","year":2022,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Scratching; Lymphoblastic Leukemia; Niche; Medicine; Leukemia; Immunology; Biology; Materials science","score_opus":0.030239462634373646,"score_gpt":0.29128296734931197,"score_spread":0.2610435047149383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312093790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023523975,0.0013802252,0.0004601695,0.95956105,0.0010784509,0.0021548208,0.00013001848,0.0004093389,0.011301954],"genre_scores_gemma":[0.04013582,0.00050512044,0.00034675124,0.9254231,0.001987343,0.0004568198,0.0005277566,0.00025399218,0.030363282],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99274623,0.0011028171,0.00086249807,0.001187845,0.0025101553,0.0015904362],"domain_scores_gemma":[0.9917027,0.0048820544,0.0004734575,0.0025621497,0.00020467312,0.00017500517],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011303059,0.00089491426,0.001415325,0.00015216634,0.0015277179,0.00023120336,0.0022826733,0.0012351964,0.004941131],"category_scores_gemma":[0.00052620843,0.00041775464,0.00064508105,0.00088543555,0.0011077501,0.000079023666,0.0016805596,0.007399648,0.0011056758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024569972,0.000033595996,0.00006029098,0.00020372741,0.00092404673,0.01036492,0.00022283869,0.00024630068,0.000075743155,0.0004083537,0.9870956,0.00011887249],"study_design_scores_gemma":[0.0018752203,0.00045434464,0.00026641556,0.00019090305,0.0014180982,0.016912615,0.0007649461,0.0025578155,0.000099838166,0.0013472973,0.97347677,0.0006357659],"about_ca_topic_score_codex":0.00027376105,"about_ca_topic_score_gemma":0.000010669798,"teacher_disagreement_score":0.034137934,"about_ca_system_score_codex":0.0035300776,"about_ca_system_score_gemma":0.0037091938,"threshold_uncertainty_score":0.99982744},"labels":[],"label_agreement":null},{"id":"W4312095146","doi":"10.3324/haematol.2022.280482","title":"Adjusted comparison of outcomes between patients from CARTITUDE-1 &lt;i&gt;versus&lt;/i&gt; multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Legend Biotech","keywords":"Medicine; Hazard ratio; Internal medicine; Multiple myeloma; Confidence interval; Dexamethasone; Gastroenterology; Pomalidomide; Cyclophosphamide; Proportional hazards model; Oncology; Bortezomib; Chemotherapy","score_opus":0.03679352061212361,"score_gpt":0.35022404532614887,"score_spread":0.31343052471402527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312095146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088466,0.00014086496,0.000009480077,0.00021860051,0.00016711757,0.007690969,0.0007523683,0.000059703645,0.000076264005],"genre_scores_gemma":[0.99625534,0.0000069362177,0.0019112544,0.00003146726,0.000047572063,0.00044779302,0.0012417379,0.000039199014,0.00001869057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945953,0.0011145098,0.0013166727,0.0007892742,0.0017956469,0.00038858832],"domain_scores_gemma":[0.99439585,0.0027196025,0.0010420061,0.0007428356,0.0008628663,0.00023681992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005800922,0.000385671,0.0013822288,0.0002001933,0.00045573333,0.000028008108,0.00033260245,0.000113771435,0.000060695536],"category_scores_gemma":[0.001739421,0.0002524744,0.0001435416,0.0005125401,0.00024215142,0.00022174587,0.0006175081,0.0005083961,0.000006824445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005973786,0.0134562105,0.9723786,0.00004284441,0.0013468444,0.000023582854,0.0030041141,0.000022169344,0.00024533027,0.000017410533,0.00011910269,0.003370019],"study_design_scores_gemma":[0.028607383,0.0069975606,0.96155,0.00010377848,0.0004432816,6.275961e-7,0.0015083536,0.00006796819,0.00032719635,0.0000053634426,0.00016429267,0.0002241858],"about_ca_topic_score_codex":0.0010659691,"about_ca_topic_score_gemma":0.00057846995,"teacher_disagreement_score":0.022633597,"about_ca_system_score_codex":0.00019429476,"about_ca_system_score_gemma":0.00013795715,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W4315753261","doi":"10.3324/haematol.2022.282265","title":"Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; City of Hope","keywords":"Tumor microenvironment; Diffuse large B-cell lymphoma; Immune system; CD8; T cell; Lymphoma; Cancer research; Biology; Immunology; Medicine","score_opus":0.011364487942087954,"score_gpt":0.22063610256699678,"score_spread":0.20927161462490884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315753261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961053,0.00050747127,8.797103e-7,0.0018015722,0.000029500696,0.0008654789,0.000019955878,0.000051246443,0.0006186111],"genre_scores_gemma":[0.99833775,0.000413271,0.000028945053,0.00062848197,0.0000073088822,0.0002321162,0.00009654715,0.000017781551,0.00023781198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998479,0.00013684209,0.00033348048,0.0003520538,0.00029321725,0.00040537992],"domain_scores_gemma":[0.9993862,0.0001426994,0.0001407163,0.00025647093,0.000013982211,0.000059934235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039568054,0.00021130044,0.0004779471,0.0001032353,0.00007668195,0.000024394662,0.00008787896,0.00008682845,0.000042022613],"category_scores_gemma":[0.000040946932,0.00011605801,0.00006018365,0.00035201586,0.00006959343,0.00003812977,0.00006594654,0.00008234705,0.00009400422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003860275,0.03006709,0.9522235,0.00019405436,0.000066148255,0.010985504,0.0019230758,0.0000013385877,0.0022017704,0.00009549113,0.0011540211,0.00070197845],"study_design_scores_gemma":[0.023731556,0.00053955347,0.9596375,0.00019634303,0.00007509338,0.00017434091,0.0013293435,0.00017863075,0.0136022065,0.000035805373,0.00033625637,0.00016337722],"about_ca_topic_score_codex":0.000101331745,"about_ca_topic_score_gemma":0.00012506603,"teacher_disagreement_score":0.029527536,"about_ca_system_score_codex":0.00014820376,"about_ca_system_score_gemma":0.00004010895,"threshold_uncertainty_score":0.47327083},"labels":[],"label_agreement":null},{"id":"W4315754473","doi":"10.3324/haematol.2022.281955","title":"The E3 ligase TRIM31 regulates hematopoietic stem cell homeostasis and MLL-AF9 leukemia","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Biology; Ubiquitin ligase; Stem cell; Haematopoiesis; Progenitor cell; Myeloid leukemia; Hematopoietic stem cell; Cell biology; Leukemia; Cancer research; Cyclin-dependent kinase; Ubiquitin; Cell cycle; Immunology; Cell; Biochemistry","score_opus":0.01627379435404735,"score_gpt":0.22466568191504063,"score_spread":0.20839188756099328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315754473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133385,0.010900154,0.000012908871,0.0011567897,0.0017570477,0.00025767752,0.000003554722,0.0003988697,0.00417915],"genre_scores_gemma":[0.96126604,0.0026596012,0.000005610477,0.00020178658,0.000013965793,0.0000504109,0.0000436244,0.000016897171,0.03574207],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986772,0.00021645066,0.00034708023,0.0003136554,0.000040583516,0.0004050284],"domain_scores_gemma":[0.99887675,0.0005342955,0.00014965184,0.0003597552,0.000052551866,0.00002698494],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031277863,0.00019679412,0.0003094323,0.00010069981,0.00072464405,0.000060503862,0.00019053527,0.0002575126,0.00040998106],"category_scores_gemma":[0.000054718534,0.00012455179,0.00010588113,0.00025863832,0.0002568278,0.00008461782,0.0001382491,0.0003009729,0.0038792486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008971233,0.00014759114,0.0005332863,0.00020399608,0.0002904281,0.00018872893,0.0022514602,0.000014718049,0.2852371,0.0070349434,0.66245335,0.040747248],"study_design_scores_gemma":[0.0010729942,0.00026131544,0.0024932923,0.000047216938,0.000057647037,0.0008004532,0.004275874,0.000043311502,0.5849706,0.0005770437,0.40511474,0.0002854994],"about_ca_topic_score_codex":0.000025980977,"about_ca_topic_score_gemma":0.000004335434,"teacher_disagreement_score":0.2997335,"about_ca_system_score_codex":0.000039851955,"about_ca_system_score_gemma":0.000035579247,"threshold_uncertainty_score":0.9968963},"labels":[],"label_agreement":null},{"id":"W4318915833","doi":"10.3324/haematol.2022.281806","title":"Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic stem cell transplantation; Transplantation; Medicine; Haematopoiesis; Internal medicine; Stem cell; Oncology; Minimal residual disease; Myeloid leukemia; Myeloid; Malignancy; Immunology; Gastroenterology; Leukemia; Biology; Genetics","score_opus":0.04714548301508147,"score_gpt":0.31095091825305016,"score_spread":0.2638054352379687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318915833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914191,0.00022061371,0.00007169552,0.00493167,0.0003845376,0.0014906784,0.0001295493,0.00035751789,0.0009946491],"genre_scores_gemma":[0.99583113,0.00024096834,0.000390673,0.0009885536,0.00007160652,0.00039119914,0.0002836659,0.00006385791,0.0017383178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956392,0.0005436633,0.0008201969,0.0008803171,0.00116839,0.0009482505],"domain_scores_gemma":[0.9963218,0.002277178,0.00018096411,0.00093233766,0.00007157243,0.00021613041],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011603319,0.0005036147,0.001219084,0.00038179907,0.0002836729,0.00009842683,0.0007543578,0.0003804792,0.0002646438],"category_scores_gemma":[0.00016627785,0.00028400353,0.00066539855,0.0010043045,0.00017130729,0.00016369532,0.00015562876,0.0006893819,0.00089237955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00149008,0.00027011806,0.9577713,0.0010984773,0.00042219,0.022551874,0.007818686,0.000012241411,0.00546291,0.00036036482,0.0023381861,0.000403601],"study_design_scores_gemma":[0.010965447,0.00030304838,0.9563249,0.00057831506,0.00057933416,0.0005702194,0.005825064,0.000056999572,0.023677811,0.00031587057,0.00015090272,0.00065210694],"about_ca_topic_score_codex":0.00021824325,"about_ca_topic_score_gemma":0.0005279391,"teacher_disagreement_score":0.021981653,"about_ca_system_score_codex":0.00017558214,"about_ca_system_score_gemma":0.00022360051,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4319786746","doi":"10.3324/haematol.2022.281958","title":"Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Daiichi-Sankyo; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medical College of Wisconsin; StemCyte; HistoGenetics; Karyopharm Therapeutics; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Amgen; Accenture; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; Astellas Pharma US; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Medac; Jazz Pharmaceuticals; Seagen; Be The Match Foundation","keywords":"Busulfan; Fludarabine; Medicine; Hazard ratio; Internal medicine; Melphalan; Cyclophosphamide; Myelofibrosis; Transplantation; Gastroenterology; Regimen; Surgery; Hematopoietic stem cell transplantation; Hematopoietic cell; Proportional hazards model; Oncology; Chemotherapy; Confidence interval; Bone marrow; Haematopoiesis; Stem cell","score_opus":0.03062084220648969,"score_gpt":0.2970089551485368,"score_spread":0.2663881129420471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319786746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354684,0.00010651155,0.00004287798,0.0051428,0.000032554413,0.00076112064,0.00008754489,0.000021662807,0.00025809932],"genre_scores_gemma":[0.9990121,0.00014829516,0.0002238055,0.00011206689,0.000012364961,0.00017531286,0.000059613438,0.000007201177,0.0002492439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923784,0.00006884857,0.00026264557,0.00013107483,0.00017787017,0.00012173882],"domain_scores_gemma":[0.99794036,0.0015577169,0.00026346804,0.00013559603,0.000079388396,0.00002346505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021159461,0.00009184289,0.00035655967,0.000033309258,0.00012728645,0.000006580199,0.000056483528,0.00007487294,0.000019887257],"category_scores_gemma":[0.00017121127,0.000045405395,0.00010748873,0.00013723239,0.000054851138,0.000022718068,0.000016665084,0.00004796756,0.000004135651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017744089,0.000040811734,0.9969261,0.00029046545,0.00019295175,0.0000011701063,0.0005334293,0.000006659056,0.0006941223,0.0005896103,0.0005924383,0.00011447637],"study_design_scores_gemma":[0.0008168264,0.00013541112,0.9296177,0.00007878923,0.00051368924,0.0000042718,0.00014483956,0.000012806812,0.06802641,0.0004826654,0.00012515797,0.000041435753],"about_ca_topic_score_codex":0.00001640043,"about_ca_topic_score_gemma":0.00000892269,"teacher_disagreement_score":0.06733228,"about_ca_system_score_codex":0.000020942169,"about_ca_system_score_gemma":0.00002052103,"threshold_uncertainty_score":0.18515782},"labels":[],"label_agreement":null},{"id":"W4321598875","doi":"10.3324/haematol.2022.281375","title":"Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"Royal Australasian College of Physicians; BeiGene; AstraZeneca; Celgene; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; International Prognostic Index; Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Prospective cohort study; Cohort; Oncology; Gastroenterology","score_opus":0.037713355729774856,"score_gpt":0.32978408898951506,"score_spread":0.2920707332597402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321598875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896921,0.0001525331,0.000001406855,0.007907785,0.0002372786,0.0009895484,0.00002491611,0.00020530228,0.00078912225],"genre_scores_gemma":[0.99808,0.0001253873,0.00005865063,0.0005128633,0.000028855935,0.0005619984,0.00008918976,0.000016410697,0.0005266354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980657,0.00012966616,0.00038996138,0.00048076612,0.0005453914,0.00038849885],"domain_scores_gemma":[0.9990584,0.00012803302,0.000100835125,0.00053269346,0.00005210654,0.00012791595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030565888,0.00026081863,0.0005412809,0.00008951575,0.00012329427,0.000057210305,0.00034083935,0.00010642829,0.00009367778],"category_scores_gemma":[0.00013845571,0.00014756208,0.00014737032,0.0003780128,0.00008016932,0.000114185656,0.000097594224,0.000051663174,0.00034814767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007384063,0.005499851,0.97962326,0.000011101666,0.0002684491,0.0032924225,0.00052792515,0.000004453828,0.000039949067,0.000559175,0.004998438,0.0051011643],"study_design_scores_gemma":[0.0072125196,0.00041732047,0.9843591,0.00003447142,0.0000797549,0.00026565057,0.001453406,0.000117866526,0.00042637726,0.00015645166,0.005322127,0.00015496598],"about_ca_topic_score_codex":0.00030016399,"about_ca_topic_score_gemma":0.00018178725,"teacher_disagreement_score":0.008387901,"about_ca_system_score_codex":0.0002519884,"about_ca_system_score_gemma":0.00006206209,"threshold_uncertainty_score":0.6017407},"labels":[],"label_agreement":null},{"id":"W4322757874","doi":"10.3324/haematol.2022.281106","title":"Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023","year":2023,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Toronto Public Health","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society; U.S. Department of Defense","keywords":"Medicine; Clinical trial; Intensive care medicine; Myeloid leukaemia; Disease; Orphan drug; Family medicine; Oncology; Internal medicine; Bioinformatics","score_opus":0.07228254196953478,"score_gpt":0.36433259856424816,"score_spread":0.2920500565947134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322757874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013256675,0.9903508,0.0000057831735,0.00041854722,0.0004915321,0.0034843867,0.00012787491,0.00021697299,0.003578457],"genre_scores_gemma":[0.00002606319,0.97559893,0.00027739897,0.00008527844,0.00014584592,0.0005657293,0.00018718271,0.0001562765,0.022957297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994632,0.0005878291,0.0018425741,0.00095003593,0.00095738936,0.0010301596],"domain_scores_gemma":[0.9960959,0.0011225751,0.00081912393,0.0015487572,0.00016137645,0.00025227107],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010825831,0.00072737195,0.0046053696,0.0010160446,0.00010065084,0.000025354682,0.0011599974,0.0009945588,0.00024544506],"category_scores_gemma":[0.0013975789,0.00043537424,0.0011386469,0.004313332,0.00027839025,0.00006431259,0.0009705525,0.0028014507,0.00444387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003428922,0.00058606185,0.0017917419,0.19310795,0.0018682247,0.02076691,0.00023477481,0.0000038068033,0.000010632508,0.00059230207,0.3816531,0.3990416],"study_design_scores_gemma":[0.0013976564,0.00024398921,0.00046067243,0.0118588,0.0022357618,0.002646547,0.000021426447,0.000012138477,0.00001318707,0.0003450087,0.98015547,0.00060932984],"about_ca_topic_score_codex":0.000044956556,"about_ca_topic_score_gemma":0.000037613063,"teacher_disagreement_score":0.5985024,"about_ca_system_score_codex":0.000754471,"about_ca_system_score_gemma":0.0025134247,"threshold_uncertainty_score":0.9998098},"labels":[],"label_agreement":null},{"id":"W4327621016","doi":"10.3324/haematol.2022.281973","title":"The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Novo Nordisk","keywords":"Glanzmann's thrombasthenia; Thrombasthenia; Medicine; Platelet; Pediatrics; Internal medicine; Platelet aggregation","score_opus":0.014870093963736423,"score_gpt":0.23727623536907666,"score_spread":0.22240614140534024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327621016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336674,0.0012413049,0.0000017731232,0.06273509,0.000094630275,0.0016717575,0.0001568176,0.00007244238,0.0003587701],"genre_scores_gemma":[0.9388328,0.021082329,0.00025265056,0.032713294,0.00011935662,0.0002942134,0.0056780796,0.00022613928,0.0008011421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759954,0.00018241796,0.00054131245,0.0005441787,0.0004756219,0.0006569557],"domain_scores_gemma":[0.998448,0.0002986846,0.00045181607,0.00064326194,0.00010528667,0.00005291873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020607111,0.0004887623,0.0012945683,0.00024844424,0.0001209275,0.00003359521,0.0002270487,0.0006244926,0.00003336297],"category_scores_gemma":[0.000069554626,0.00027463533,0.000063038446,0.0004726202,0.00031197656,0.00005628021,0.000092016795,0.0008662039,0.000012916635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058277673,0.0009291351,0.88656396,0.00073549716,0.001009056,0.006605321,0.0022100867,0.000009245263,0.000014257166,0.000118609176,0.08179425,0.014182836],"study_design_scores_gemma":[0.011838965,0.0022579834,0.8757164,0.0011507191,0.00008663882,0.00014762377,0.0002537242,0.000024562873,0.000051863815,0.0005313027,0.10744733,0.00049289135],"about_ca_topic_score_codex":0.00046574583,"about_ca_topic_score_gemma":0.0012785915,"teacher_disagreement_score":0.030021792,"about_ca_system_score_codex":0.00009030601,"about_ca_system_score_gemma":0.0000874857,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W4360599615","doi":"10.3324/haematol.2023.282791","title":"Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; Institute for Research in Immunology and Cancer; McGill University; Jewish General Hospital","funders":"Janssen Pharmaceuticals; Genentech; Fondation de l'Hôpital général juif; Leukemia and Lymphoma Society; Jazz Pharmaceuticals; F. Hoffmann-La Roche; Gilead Sciences; Jewish General Hospital; Sanofi","keywords":"Decitabine; Cytarabine; Myeloid leukemia; Pharmacology; Medicine; Internal medicine; Deoxycytidine kinase; Oncology; Cancer research; Biology; Deoxycytidine; Chemotherapy; Gemcitabine; Biochemistry; Gene expression","score_opus":0.01726773215579263,"score_gpt":0.2759986050334017,"score_spread":0.25873087287760904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360599615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943403,0.0002736859,0.0031324606,0.0001037205,0.00019638681,0.0017511606,0.00012278161,0.00003492683,0.000044579425],"genre_scores_gemma":[0.9983211,0.00018784184,0.0007436563,0.00006494505,0.00003616366,0.0002271981,0.00036397824,0.000039505892,0.000015571391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974309,0.00054508355,0.00088046445,0.00045508388,0.00037918714,0.00030926862],"domain_scores_gemma":[0.99867463,0.00020590183,0.00048792746,0.0003974471,0.0001771161,0.00005695559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047553465,0.00030373936,0.00086779014,0.00013441827,0.000089490495,0.000011830941,0.00030371657,0.00026849768,0.000033799894],"category_scores_gemma":[0.00052066846,0.00019001984,0.00022394196,0.0004596101,0.00023587134,0.000021164216,0.00005993118,0.00019184199,0.0000013322793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48321062,0.0008776219,0.0017027698,0.00015940686,0.00039977834,0.000028428682,0.00086916785,0.0021072559,0.50913775,0.00016426733,0.0000718866,0.0012710391],"study_design_scores_gemma":[0.3675312,0.0032472648,0.00039417975,0.00016437254,0.00019679252,0.0000042415104,0.00005005774,0.0011045943,0.62685287,0.00009182598,0.00007380849,0.00028877013],"about_ca_topic_score_codex":0.00005074747,"about_ca_topic_score_gemma":0.000031410313,"teacher_disagreement_score":0.117715105,"about_ca_system_score_codex":0.0000533664,"about_ca_system_score_gemma":0.00029338573,"threshold_uncertainty_score":0.77487844},"labels":[],"label_agreement":null},{"id":"W4360599974","doi":"10.3324/haematol.2022.282030","title":"Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; Astellas Pharma; Servier; Gilead Sciences; Pfizer","keywords":"Medicine; Internal medicine; Cumulative incidence; KRAS; Gastroenterology; Myeloid leukemia; Hematopoietic stem cell transplantation; White blood cell; Neuroblastoma RAS viral oncogene homolog; Myeloid; Transplantation; Oncology; Cancer; Colorectal cancer","score_opus":0.04069498217841501,"score_gpt":0.3371159216637637,"score_spread":0.2964209394853487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360599974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695355,0.000014868052,0.00004773887,0.00093017815,0.000074290874,0.0010112841,0.000110349385,0.00025708321,0.00060065516],"genre_scores_gemma":[0.99363405,0.00055431237,0.0029567347,0.0006398637,0.000047939677,0.0000655299,0.00029961357,0.00007066153,0.0017312941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970008,0.00013817487,0.0008143625,0.00064351707,0.00074882654,0.0006543008],"domain_scores_gemma":[0.99734914,0.00079727464,0.0003613595,0.0007081003,0.00039310753,0.00039099052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004614775,0.00038633277,0.0015188735,0.00026719176,0.00012836704,0.00003046434,0.0002737243,0.0003135427,0.00016001383],"category_scores_gemma":[0.0007672461,0.00019780974,0.00011656097,0.0007930916,0.0008092337,0.00012566181,0.00030217643,0.00063906505,0.00013292365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004669878,0.0002163689,0.98646456,0.00022271926,0.0007230448,0.0020047175,0.00014210748,3.5371517e-7,0.000022409497,0.00016981951,0.002476766,0.0028872706],"study_design_scores_gemma":[0.0054752612,0.003147096,0.988056,0.00015808156,0.0003976724,0.0002954711,0.00013095932,0.00012900608,0.0001167562,0.000032183674,0.0017842622,0.00027726003],"about_ca_topic_score_codex":0.00004548818,"about_ca_topic_score_gemma":0.000029448023,"teacher_disagreement_score":0.0033195019,"about_ca_system_score_codex":0.00014105553,"about_ca_system_score_gemma":0.00059936696,"threshold_uncertainty_score":0.8066447},"labels":[],"label_agreement":null},{"id":"W4360600096","doi":"10.3324/haematol.2022.282296","title":"Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb","keywords":"Azacitidine; Myeloid leukemia; Medicine; Internal medicine; Receipt; Chemotherapy; Oncology; Subgroup analysis; Complete remission; Maintenance therapy; Confidence interval; Biology; World Wide Web","score_opus":0.05211788543983863,"score_gpt":0.3642380091814488,"score_spread":0.31212012374161013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360600096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9256486,0.00007654244,0.00005986037,0.06954837,0.00022318722,0.003176297,0.0008260027,0.00013223084,0.00030891073],"genre_scores_gemma":[0.85124946,0.0010510661,0.0019648962,0.11364998,0.0013635976,0.0010488693,0.024159206,0.0006688451,0.004844114],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9933657,0.0008418402,0.001510832,0.0012653534,0.0018339786,0.001182313],"domain_scores_gemma":[0.9957039,0.0015724987,0.00091847335,0.0012812477,0.0003528987,0.00017100819],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009018114,0.00094576966,0.0035071322,0.00052299467,0.000109317094,0.00005431566,0.00093053206,0.0012189304,0.00036440912],"category_scores_gemma":[0.0006081602,0.00048085384,0.00026208436,0.0015507407,0.0007035368,0.0001598972,0.00022560587,0.0035586674,0.000028566317],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22766902,0.0009990011,0.05584524,0.00024194666,0.0016380993,0.008724953,0.00044241728,0.00000489792,0.0003494872,0.0000063862576,0.7022981,0.0017804281],"study_design_scores_gemma":[0.8517544,0.012909796,0.054470193,0.0040364973,0.0015066691,0.00015478104,0.0007395261,0.0003452921,0.0032584018,0.0001883299,0.068166226,0.002469848],"about_ca_topic_score_codex":0.005178438,"about_ca_topic_score_gemma":0.0006851381,"teacher_disagreement_score":0.6341319,"about_ca_system_score_codex":0.0011948,"about_ca_system_score_gemma":0.0011376131,"threshold_uncertainty_score":0.9997643},"labels":[],"label_agreement":null},{"id":"W4362656958","doi":"10.3324/haematol.2022.282637","title":"Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Hospital of Philadelphia; Canadian Institutes of Health Research; Leukemia and Lymphoma Society; American Society of Hematology; V Foundation for Cancer Research; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation; U.S. Department of Defense","keywords":"Venetoclax; Azacitidine; Medicine; Refractory (planetary science); Leukemia; Oncology; Internal medicine; Pediatrics; Genetics; Biology; Chronic lymphocytic leukemia","score_opus":0.040125126004362105,"score_gpt":0.31240697663451167,"score_spread":0.27228185063014954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362656958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653591,0.00031279802,0.000002700573,0.031290717,0.00008244063,0.0017217394,0.00009382794,0.00031777108,0.0008189279],"genre_scores_gemma":[0.6755515,0.007788157,0.0034351402,0.262196,0.0050597857,0.0015257561,0.0063003264,0.0012556852,0.036887664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504256,0.0007248405,0.0009422281,0.001319846,0.0009780104,0.0009925079],"domain_scores_gemma":[0.9957389,0.0023369251,0.00042395975,0.0009279386,0.0002982731,0.00027398867],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006591111,0.0006937374,0.0019041292,0.0009370476,0.00010737682,0.000044833516,0.0003200672,0.0018855751,0.00009748199],"category_scores_gemma":[0.0010894908,0.00042620354,0.00012943632,0.0010902297,0.0005895877,0.00009684578,0.00021863688,0.005072873,0.00023091113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004706479,0.00007764491,0.6073534,0.00056949776,0.00012366554,0.024990208,0.000029711191,0.0000010021993,7.5337846e-7,0.0000028456273,0.36171308,0.00043170268],"study_design_scores_gemma":[0.011546281,0.0065022884,0.860078,0.0008087109,0.0005153864,0.00059541076,0.000026958882,0.00003661892,0.0000087354165,0.000022055237,0.11911493,0.00074465194],"about_ca_topic_score_codex":0.00012614198,"about_ca_topic_score_gemma":0.000045863115,"teacher_disagreement_score":0.2898076,"about_ca_system_score_codex":0.0011132729,"about_ca_system_score_gemma":0.0019415291,"threshold_uncertainty_score":0.999819},"labels":[],"label_agreement":null},{"id":"W4362657140","doi":"10.3324/haematol.2022.281894","title":"Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Canada First Research Excellence Fund; Government of Ontario; Princess Margaret Cancer Foundation; University of Toronto; Canadian Institutes of Health Research; Cancer Center, University of Colorado; Leukemia and Lymphoma Society","keywords":"SIRT3; Sirtuin; Myeloid leukemia; Biology; Cancer research; Oxidative phosphorylation; Context (archaeology); Stem cell; Cell biology; Cancer cell; Haematopoiesis; Biochemistry; Cancer; NAD+ kinase; Genetics","score_opus":0.016222287703152396,"score_gpt":0.2506516030337123,"score_spread":0.2344293153305599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965849,0.0013630423,0.00041555197,0.00072264083,0.00010888855,0.000541023,0.000038244405,0.000152937,0.00007279038],"genre_scores_gemma":[0.99635893,0.0024290336,0.00043716197,0.00047515173,0.00005787922,0.000023522525,0.000085152664,0.000024685702,0.00010845608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983557,0.00008716238,0.00045753593,0.00045059389,0.0003250474,0.0003239749],"domain_scores_gemma":[0.99898857,0.00027862284,0.0002119713,0.0002320836,0.00010131609,0.00018746573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033887938,0.00024909587,0.0006708441,0.00019422974,0.00016340702,0.000027952836,0.00005687977,0.00027532788,0.000026247197],"category_scores_gemma":[0.00014391403,0.00018133753,0.000057960227,0.00032942288,0.0002059396,0.00011092984,0.00010632181,0.00030697245,0.0000106890175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018380175,0.000052523523,0.0024698514,0.00040333575,0.00009555057,0.00039790606,0.0009072876,0.000023998098,0.97546417,0.000014823272,0.0010173976,0.018969348],"study_design_scores_gemma":[0.0021948882,0.00076110277,0.006059352,0.00052641396,0.0002055519,0.000569007,0.0012570914,0.0044400287,0.9834006,0.00003912579,0.0003088218,0.00023805554],"about_ca_topic_score_codex":0.00003188274,"about_ca_topic_score_gemma":0.000004015543,"teacher_disagreement_score":0.018731292,"about_ca_system_score_codex":0.0000663316,"about_ca_system_score_gemma":0.000037231563,"threshold_uncertainty_score":0.7394729},"labels":[],"label_agreement":null},{"id":"W4368361225","doi":"10.3324/haematol.2022.281580","title":"Germline loss of function &lt;i&gt;BRCA1&lt;/i&gt; and &lt;i&gt;BRCA2&lt;/i&gt; mutations and risk of &lt;i&gt;de novo&lt;/i&gt; hematopoietic malignancies","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"National Heart, Lung, and Blood Institute","keywords":"Germline; Germline mutation; Mutation; Genetics; Biology; Cancer research; Internal medicine; Medicine; Gene","score_opus":0.014106610951789311,"score_gpt":0.24499447945287703,"score_spread":0.23088786850108772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368361225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8991991,0.056597397,0.0058283573,0.021968888,0.0027441725,0.0034708027,0.004833381,0.00054324884,0.0048146015],"genre_scores_gemma":[0.9306992,0.02655993,0.007993562,0.010677281,0.0028384335,0.0015052478,0.006332116,0.0007924689,0.0126017295],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99002457,0.00095984305,0.0028070835,0.0029035904,0.0014032422,0.0019016876],"domain_scores_gemma":[0.99221486,0.00086321734,0.0025437945,0.0026028468,0.0013232573,0.00045203182],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014679305,0.0019083731,0.00283807,0.00094628293,0.00078067946,0.00019772617,0.0013376997,0.0035371038,0.00042582952],"category_scores_gemma":[0.0013073081,0.0018638583,0.00096105837,0.0012538253,0.00279587,0.000077039265,0.0011349294,0.0012522526,0.00014744824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000428752,0.00044110705,0.0008861116,0.0028426528,0.002047093,0.00071793696,0.0008366935,0.0005783859,0.56921256,0.004367358,0.41667235,0.00096902635],"study_design_scores_gemma":[0.0037839687,0.001667002,0.008337149,0.0011190574,0.002964978,0.0029204886,0.00014021194,0.00043991138,0.05316364,0.005639402,0.9165692,0.003255011],"about_ca_topic_score_codex":0.000017373408,"about_ca_topic_score_gemma":0.00051316636,"teacher_disagreement_score":0.5160489,"about_ca_system_score_codex":0.00030733092,"about_ca_system_score_gemma":0.0010705662,"threshold_uncertainty_score":0.9999179},"labels":[],"label_agreement":null},{"id":"W4376133764","doi":"10.3324/haematol.2022.282411","title":"Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; F. Hoffmann-La Roche","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Oncology; Internal medicine; Clinical trial; Stage (stratigraphy); Phases of clinical research; Pharmacology; Bone marrow; Biology","score_opus":0.03954079516253714,"score_gpt":0.34076388170347427,"score_spread":0.3012230865409371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376133764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996591,0.00013747781,0.000009853968,0.0009229773,0.0000213158,0.0017908822,0.000034943558,0.000028428443,0.00046314314],"genre_scores_gemma":[0.99829036,0.00076054904,0.00032644393,0.000067775065,0.0000067077817,0.00018426767,0.000052168096,0.000012211134,0.0002995066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99867356,0.00011011789,0.00053983566,0.0002645094,0.00020872618,0.00020324803],"domain_scores_gemma":[0.9991092,0.0004156563,0.00019225222,0.00016947064,0.000049784194,0.000063606996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026815964,0.0001595148,0.00077337783,0.00023447847,0.00003596084,0.0000049607443,0.000047212165,0.000091593705,0.00028424186],"category_scores_gemma":[0.00019969018,0.00009827591,0.000045762863,0.0004954966,0.00010231315,0.000044755732,0.00002810049,0.00008897726,0.000004423417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6966456,0.03131032,0.19258364,0.0009738189,0.0004687144,0.0021277776,0.008946468,0.000056286375,0.0033523391,0.029904984,0.00019824665,0.033431813],"study_design_scores_gemma":[0.5875597,0.049545854,0.31620324,0.0012688092,0.00010154633,0.00009441722,0.0013654332,0.00047894535,0.041516725,0.00037460978,0.0012006265,0.00029008105],"about_ca_topic_score_codex":0.00013729976,"about_ca_topic_score_gemma":0.00011304806,"teacher_disagreement_score":0.12361961,"about_ca_system_score_codex":0.000034901444,"about_ca_system_score_gemma":0.000103015635,"threshold_uncertainty_score":0.40075752},"labels":[],"label_agreement":null},{"id":"W4378172267","doi":"10.3324/haematol.2023.282734","title":"Patient-reported treatment response in chronic graft-&lt;i&gt;versus&lt;/i&gt;-host disease","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Pharmacyclics; Genentech; Astellas Pharma; Omeros Corporation; Incyte; CTI Biopharma; Horizon Therapeutics; Regeneron Pharmaceuticals; Syndax Pharmaceuticals; Sanofi; CSL Behring; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Multivariate analysis; Quality of life (healthcare); Prospective cohort study; Observational study; Disease; Clinical trial","score_opus":0.03949272140279008,"score_gpt":0.29741349296268405,"score_spread":0.25792077155989396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378172267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935034,0.0006864388,0.0000436117,0.0014414199,0.00031422015,0.0013625294,0.000039757142,0.0005176626,0.0020909968],"genre_scores_gemma":[0.99766433,0.0005497881,0.00016292371,0.00009586731,0.000038338712,0.0004252087,0.00025536635,0.00004450779,0.00076364377],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99719244,0.0002852407,0.00072279177,0.0006304334,0.0004885666,0.00068052136],"domain_scores_gemma":[0.9979679,0.00067835965,0.00017727043,0.00068719697,0.000071573246,0.0004176765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003748814,0.0003472761,0.0006591093,0.00039168794,0.000111691006,0.000020642907,0.000103888575,0.00018521387,0.00045335921],"category_scores_gemma":[0.00043849883,0.00027293098,0.00020286065,0.0008351517,0.00012996115,0.00007252784,0.00003947132,0.0001250169,0.0009772386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1502939,0.0049859076,0.089332126,0.003456853,0.0016070817,0.23840098,0.013302317,0.00061506586,0.46656775,0.009359651,0.012463539,0.009614824],"study_design_scores_gemma":[0.02946542,0.007819935,0.8798075,0.001777184,0.0011992685,0.0014462936,0.00063646684,0.002875497,0.0246184,0.00044511707,0.048584804,0.001324134],"about_ca_topic_score_codex":0.000013072624,"about_ca_topic_score_gemma":0.000078324294,"teacher_disagreement_score":0.79047537,"about_ca_system_score_codex":0.0006229673,"about_ca_system_score_gemma":0.00054692646,"threshold_uncertainty_score":0.9999723},"labels":[],"label_agreement":null},{"id":"W4378952054","doi":"10.3324/haematol.2023.282781","title":"Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; Amgen; StemCyte; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Department of Health and Human Services","keywords":"Medicine; Population; Confidence interval; Transplantation; Internal medicine; Aplastic anemia; Standardized mortality ratio; Hematopoietic stem cell transplantation; Hematopoietic cell; Surgery; Haematopoiesis; Bone marrow; Stem cell","score_opus":0.024026651734487776,"score_gpt":0.25876444584491914,"score_spread":0.23473779411043136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378952054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673635,0.00005905283,0.0009543928,0.0000489947,0.00007423767,0.00091184874,0.000657507,0.000094918454,0.0004627108],"genre_scores_gemma":[0.99785787,0.0002736348,0.00048444435,0.00002594364,0.000015108606,0.00007259466,0.0011260436,0.000029746518,0.000114591356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981186,0.00015358382,0.00045748596,0.0003553509,0.0006511531,0.00026382203],"domain_scores_gemma":[0.9987341,0.00049843715,0.00019838465,0.00022254836,0.00024249568,0.00010403182],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020981158,0.0002342283,0.0006148002,0.00010550887,0.000102242164,0.000016840582,0.0000630469,0.00013995964,0.0010434955],"category_scores_gemma":[0.00004348098,0.00016429221,0.000064196116,0.0002491157,0.00018571226,0.00010172684,0.000018830431,0.00012409751,0.000037567144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013916283,0.0003866679,0.97486854,0.0032687595,0.00025693787,0.00037466967,0.00275167,0.000042223972,0.0038181872,0.00017034115,0.00009669305,0.000049009595],"study_design_scores_gemma":[0.007862046,0.00049883174,0.97438455,0.0004301385,0.00028838572,0.00011497506,0.00046464463,0.000025617892,0.015607283,0.000082592014,0.000010164665,0.00023079703],"about_ca_topic_score_codex":0.000011442274,"about_ca_topic_score_gemma":0.00003658229,"teacher_disagreement_score":0.0117890965,"about_ca_system_score_codex":0.000035844503,"about_ca_system_score_gemma":0.000091733236,"threshold_uncertainty_score":0.9998697},"labels":[],"label_agreement":null},{"id":"W4378953442","doi":"10.3324/haematol.2023.283106","title":"Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Italfarmaco; Astellas Pharma; Sierra Oncology; CTI Biopharma; Incyte; Jazz Pharmaceuticals; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Bone marrow","score_opus":0.029609548292402355,"score_gpt":0.29878744014817415,"score_spread":0.2691778918557718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378953442","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7545115,0.00005288137,0.000030908628,0.24026228,0.000418486,0.0018742264,0.002497559,0.00015522519,0.00019696004],"genre_scores_gemma":[0.48617712,0.00017125186,0.004089426,0.49856266,0.0011151902,0.0018442885,0.0073001273,0.00019782929,0.0005421195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960693,0.00023875714,0.0012544076,0.0010152785,0.00084207446,0.00058015855],"domain_scores_gemma":[0.99697566,0.0012790831,0.00043296567,0.00072665024,0.00033466323,0.00025094816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001581936,0.00066832895,0.002624571,0.00025315172,0.000058773563,0.000025585185,0.00017850214,0.0009840872,0.0007986449],"category_scores_gemma":[0.00023373359,0.00040768465,0.0005833924,0.00027820308,0.00017859763,0.0000511317,0.00008256871,0.00086866977,0.00073540694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011628739,0.0006664662,0.7378173,0.00026978523,0.0009901006,0.0015594063,0.0002882774,5.4096233e-7,5.4909674e-7,0.000008040263,0.2564248,0.0008118342],"study_design_scores_gemma":[0.0033602929,0.0021327562,0.9565197,0.0008392329,0.00096966483,0.000006419935,0.000029538398,0.0000015319525,0.00011808851,0.00009285043,0.035506923,0.00042296379],"about_ca_topic_score_codex":0.00010345214,"about_ca_topic_score_gemma":0.00002619772,"teacher_disagreement_score":0.26833436,"about_ca_system_score_codex":0.0000630743,"about_ca_system_score_gemma":0.000096664924,"threshold_uncertainty_score":0.9998375},"labels":[],"label_agreement":null},{"id":"W4379769519","doi":"10.3324/haematol.2023.283031","title":"Correcting the aberrant Fanconi anemia transcriptional program by gene therapy","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Fanconi anemia; Genetic enhancement; Anemia; Medicine; Gene; Genetics; Biology; Cancer research; Internal medicine; DNA repair","score_opus":0.02181332958894403,"score_gpt":0.30484142083161403,"score_spread":0.28302809124267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379769519","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3802561,0.060284935,0.012993542,0.5270475,0.008557882,0.0059361923,0.0008828187,0.0015322558,0.0025087344],"genre_scores_gemma":[0.2931894,0.008775587,0.004374108,0.6346682,0.01408909,0.003934563,0.01549747,0.00077385444,0.02469775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833333,0.00008167616,0.00029990936,0.00056042505,0.00022897817,0.00049567485],"domain_scores_gemma":[0.9992772,0.000049665392,0.000102864804,0.00047439194,0.000054506872,0.00004141955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016103726,0.00036964368,0.00033106402,0.000033251345,0.00016894036,0.000061263665,0.00044800658,0.00081702386,0.000061188635],"category_scores_gemma":[0.00003811344,0.00024943048,0.00024557425,0.00011347438,0.000116565294,0.0000013155922,0.00006106853,0.00074690406,0.000043173597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019180341,0.000026256397,0.000047916226,0.000055247467,0.000095167954,0.00009648558,0.000040934876,0.000037467053,0.044497576,0.000002562323,0.94589454,0.009186676],"study_design_scores_gemma":[0.000257048,0.00022538687,0.00012346977,0.00002265674,0.000024758272,0.0006718435,0.00002629431,0.000039976516,0.05316468,0.000027774866,0.94505525,0.00036084547],"about_ca_topic_score_codex":0.000016864908,"about_ca_topic_score_gemma":0.0000078629455,"teacher_disagreement_score":0.10762063,"about_ca_system_score_codex":0.000010490646,"about_ca_system_score_gemma":0.00004468823,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W4381597464","doi":"10.3324/haematol.2023.283510","title":"Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"University of Texas MD Anderson Cancer Center; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Isocitrate dehydrogenase; Myeloid leukemia; Minimal residual disease; Cancer research; IDH1; Disease; RNA splicing; Gene; Residual; Medicine; Mutation; Oncology; Leukemia; Biology; Internal medicine; Genetics; Enzyme; Biochemistry; Computer science","score_opus":0.031026215968207538,"score_gpt":0.30257728020387314,"score_spread":0.2715510642356656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381597464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9291633,0.0017942061,0.000012203804,0.06658731,0.00004962405,0.002095155,0.00015879775,0.000041211442,0.00009822174],"genre_scores_gemma":[0.99059963,0.00071121665,0.000445136,0.0072572264,0.00003952298,0.00035523454,0.00028783374,0.00007923088,0.00022497548],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99643713,0.00043962325,0.00089022267,0.00067258405,0.00093006797,0.00063035364],"domain_scores_gemma":[0.9979599,0.0006415214,0.00039342197,0.0006359233,0.00022849618,0.00014071655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055996486,0.00042137422,0.0011119174,0.0005430117,0.000100593585,0.000029379757,0.00034536535,0.00050257536,0.00003665186],"category_scores_gemma":[0.00058299693,0.0002820794,0.0003169518,0.0006521307,0.0004434378,0.00007001173,0.00036951472,0.0016589133,0.0000059294402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002832708,0.0012557714,0.21494079,0.020225067,0.00525504,0.108966105,0.009821104,0.002176663,0.5933807,0.0003476501,0.03815722,0.002641212],"study_design_scores_gemma":[0.019123727,0.0055527412,0.8038608,0.014067649,0.00717696,0.0025275566,0.012962705,0.03171493,0.09289612,0.0029859468,0.0030368331,0.0040940233],"about_ca_topic_score_codex":0.00052471086,"about_ca_topic_score_gemma":0.000048897495,"teacher_disagreement_score":0.58892,"about_ca_system_score_codex":0.0006318489,"about_ca_system_score_gemma":0.0014944589,"threshold_uncertainty_score":0.99996316},"labels":[],"label_agreement":null},{"id":"W4383302075","doi":"10.3324/haematol.2023.283426","title":"Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Hazard ratio; Internal medicine; Transplantation; Myeloproliferative neoplasm; Myelodysplastic syndromes; Cyclophosphamide; Hematopoietic stem cell transplantation; Confidence interval; Gastroenterology; International Prognostic Scoring System; Graft-versus-host disease; Surgery; Oncology; Myelofibrosis; Chemotherapy; Bone marrow","score_opus":0.023679462404266074,"score_gpt":0.3013200057034748,"score_spread":0.27764054329920873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383302075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706275,0.00002713527,0.004188527,0.0043965853,0.00016855713,0.0019163906,0.0010922368,0.0004680581,0.0006797515],"genre_scores_gemma":[0.9874233,0.000292144,0.007328405,0.0004410058,0.00017714409,0.00054515863,0.0029928999,0.00005547726,0.00074445264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970069,0.00015490114,0.00073607726,0.000813108,0.0006055755,0.0006834399],"domain_scores_gemma":[0.9966817,0.0018714023,0.0002559779,0.00044073025,0.00043290516,0.0003173003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003158345,0.00033679698,0.00080843276,0.00029529652,0.00027428867,0.00010205346,0.00020891445,0.0001688656,0.000044107186],"category_scores_gemma":[0.0011387715,0.00027722056,0.00015317221,0.0015995152,0.000308266,0.00017200217,0.00005940408,0.000347161,0.0007017153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20183325,0.003994264,0.32098612,0.0077140466,0.0026672622,0.020253945,0.073625825,0.0028068977,0.052712213,0.009488161,0.28673932,0.017178686],"study_design_scores_gemma":[0.03853973,0.0071552354,0.7512379,0.00065873534,0.0017410492,0.0011251984,0.01692452,0.055994526,0.11295182,0.0025713483,0.008770766,0.002329156],"about_ca_topic_score_codex":0.0001553605,"about_ca_topic_score_gemma":0.00059860636,"teacher_disagreement_score":0.43025178,"about_ca_system_score_codex":0.00020826812,"about_ca_system_score_gemma":0.00046992255,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W4384119997","doi":"10.3324/haematol.2023.282905","title":"Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McMaster University; Ottawa Hospital","funders":"Hamilton Health Sciences; Sanofi; Pfizer; Prothena; Amgen","keywords":"Medicine; Multiple myeloma; Internal medicine; Retrospective cohort study; Cause of death; Population; Cancer; Cohort; Oncology; Disease; Surgery","score_opus":0.07943408511965692,"score_gpt":0.3647558882724021,"score_spread":0.28532180315274513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384119997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958253,0.000098904704,0.000008562551,0.0002897292,0.00009741935,0.0026999472,0.000050531507,0.00030040857,0.0006292306],"genre_scores_gemma":[0.99816376,0.000052654184,0.000119709315,0.000042285967,0.000036208523,0.0011732639,0.00023028658,0.000022207965,0.00015961024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773484,0.00015966268,0.00037506252,0.00059650274,0.0006360313,0.00049789017],"domain_scores_gemma":[0.99892956,0.00019778758,0.000084393374,0.0005006283,0.00010997564,0.00017764534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040930422,0.00020957261,0.00068188837,0.000290425,0.00014689434,0.000022552858,0.0001136711,0.00010206156,0.00042127335],"category_scores_gemma":[0.00042089264,0.00015966615,0.000101229954,0.0010408753,0.000059614817,0.000052294705,0.000059542926,0.0002412543,0.00024331755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031265544,0.00092125224,0.9948796,0.00003785629,0.00013107735,0.00258563,0.00010361527,0.000043561075,0.00005205401,0.000052494568,0.000327087,0.00055308547],"study_design_scores_gemma":[0.0039483607,0.00029983872,0.99257636,0.000050502695,0.000035224268,0.000010709735,0.0001898125,0.0024458545,0.00014448412,0.00011216402,0.000048261874,0.00013842699],"about_ca_topic_score_codex":0.0047329636,"about_ca_topic_score_gemma":0.003832639,"teacher_disagreement_score":0.003635705,"about_ca_system_score_codex":0.0004248552,"about_ca_system_score_gemma":0.00008750646,"threshold_uncertainty_score":0.7154857},"labels":[],"label_agreement":null},{"id":"W4384120732","doi":"10.3324/haematol.2022.281944","title":"Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Philadelphia chromosome; Term (time); Medicine; Tyrosine kinase; Internal medicine; Genetics; Biology; Nilotinib; Chromosomal translocation; Gene; Receptor","score_opus":0.028718520755449044,"score_gpt":0.33212614158053844,"score_spread":0.3034076208250894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643773,0.0011922948,0.000091858885,0.024986373,0.0003072229,0.0067707873,0.0018651611,0.0003519826,0.00005704222],"genre_scores_gemma":[0.9680761,0.00008094623,0.00038930564,0.020166345,0.0010537027,0.0034384988,0.00438633,0.0002636879,0.002145089],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9937045,0.00017580469,0.0016669654,0.0020547693,0.001191963,0.0012059784],"domain_scores_gemma":[0.995351,0.00060397206,0.0012926387,0.0018068549,0.00069482054,0.0002506966],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00033196155,0.0013244437,0.0043689883,0.0011721492,0.00032457442,0.00008209395,0.00048784248,0.0013281677,0.00058225193],"category_scores_gemma":[0.00022435919,0.000955718,0.0011607626,0.0022400995,0.0006962145,0.00015139877,0.00032568103,0.0015869549,0.00005126847],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042267587,0.021470908,0.28019923,0.014134762,0.09770985,0.24474591,0.0076195034,0.00028504347,0.0009489715,0.000013611073,0.28450334,0.0061012777],"study_design_scores_gemma":[0.18115227,0.091797166,0.5097547,0.013251928,0.15755045,0.0033493557,0.00053912285,0.0020303782,0.01591515,0.000032872755,0.01794127,0.0066853375],"about_ca_topic_score_codex":0.00014872657,"about_ca_topic_score_gemma":0.00017525538,"teacher_disagreement_score":0.26656207,"about_ca_system_score_codex":0.0018508199,"about_ca_system_score_gemma":0.0009851503,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W4384120739","doi":"10.3324/haematol.2023.283225","title":"Down syndrome and leukemia: from basic mechanisms to clinical advances","year":2023,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Cancer Council Western Australia; National Institutes of Health; Ministerio de Ciencia e Innovación; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; European Commission; St. Jude Children's Research Hospital; Children's Hospital of Philadelphia; American Lebanese Syrian Associated Charities; U.S. Department of Defense","keywords":"Down syndrome; Trisomy; Myeloid leukemia; Leukemia; Medicine; Acute leukemia; Population; Lymphoblastic Leukemia; Immunology; Bioinformatics; Oncology; Biology; Genetics; Psychiatry","score_opus":0.14615426216856228,"score_gpt":0.4390545652284838,"score_spread":0.29290030305992154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005153226,0.9940854,0.00019903161,0.0004650292,0.00051722635,0.0026319611,0.00020613581,0.00046971446,0.0009102348],"genre_scores_gemma":[0.000042753494,0.99025774,0.0060806735,0.0005557161,0.00023733126,0.00055607286,0.00028656612,0.00013897469,0.0018441724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950507,0.0004967686,0.0014981303,0.0015173868,0.00063423114,0.000802762],"domain_scores_gemma":[0.9951397,0.0024766268,0.00036638026,0.0011246625,0.00009894093,0.0007936893],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010690249,0.00071656203,0.0057447404,0.0004082882,0.00014047905,0.00006189062,0.0006127284,0.0013234612,0.0005109844],"category_scores_gemma":[0.0019919162,0.00046977456,0.00068171107,0.00084998657,0.00025672518,0.00007864996,0.0009356258,0.0018474553,0.006200745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087921086,0.0000734587,0.000032853357,0.018665582,0.0006880082,0.017100044,0.000027181675,1.0159758e-7,6.715039e-7,0.0013100981,0.012960543,0.9490535],"study_design_scores_gemma":[0.0006231185,0.00072951894,0.00010052587,0.01598542,0.0011497138,0.0049486286,0.00004947517,0.000006533891,0.0000015854175,0.0019801,0.97392446,0.0005009124],"about_ca_topic_score_codex":0.0000664456,"about_ca_topic_score_gemma":0.000020109163,"teacher_disagreement_score":0.9609639,"about_ca_system_score_codex":0.00047901666,"about_ca_system_score_gemma":0.0010958154,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W4384820346","doi":"10.3324/haematol.2022.282469","title":"Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Servier; AstraZeneca","keywords":"Mantle cell lymphoma; Internal medicine; Medicine; Refractory (planetary science); Oncology; Lymphoma; Overall survival; Materials science; Metallurgy","score_opus":0.1030738814372394,"score_gpt":0.31948936529747396,"score_spread":0.21641548386023457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384820346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904676,0.00025963195,0.000001155199,0.0041235653,0.000117035466,0.0026403798,0.002187338,0.00009198985,0.000111285444],"genre_scores_gemma":[0.9880859,0.00014732848,0.00022391826,0.0035521179,0.00010135519,0.00015330019,0.007474733,0.000100391815,0.00016092122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625015,0.00025143792,0.0008043847,0.00134205,0.0008382332,0.0005137443],"domain_scores_gemma":[0.9967366,0.0011107533,0.0007130565,0.0012122252,0.000106104795,0.00012129717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019640721,0.0006955544,0.0016866775,0.00027550236,0.00014703379,0.00003781005,0.0003890791,0.0004989854,0.000037284215],"category_scores_gemma":[0.00015985801,0.0004044694,0.000061206876,0.00027439217,0.00014020807,0.00013602577,0.0004530578,0.0004974283,0.000009385285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012408082,0.024541615,0.9016736,0.00029822375,0.00085431535,0.007825036,0.0021654204,0.0000011596271,0.0000046223718,0.0000010296487,0.049176972,0.0010498977],"study_design_scores_gemma":[0.13125579,0.027202941,0.8301363,0.0017169712,0.0009824075,0.000019598452,0.00063852855,0.00003638693,0.00008248487,0.000013093501,0.007258661,0.00065684645],"about_ca_topic_score_codex":0.001726439,"about_ca_topic_score_gemma":0.0002849795,"teacher_disagreement_score":0.1188477,"about_ca_system_score_codex":0.00015326563,"about_ca_system_score_gemma":0.00020942042,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W4385514316","doi":"10.3324/haematol.2022.281780","title":"Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Swedish Orphan Biovitrum; BioCryst; Apellis Pharmaceuticals; Regeneron Pharmaceuticals; UCB Pharma; Alexion Pharmaceuticals; Amgen","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Medicine; Internal medicine; Anemia","score_opus":0.11289929139092401,"score_gpt":0.3572159072057279,"score_spread":0.24431661581480385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73666424,0.012270958,0.000031221123,0.22480094,0.01010453,0.0047955387,0.0074178153,0.0008397771,0.0030749948],"genre_scores_gemma":[0.87557095,0.0002148639,0.00015359813,0.09349799,0.0015287255,0.0010049383,0.013175474,0.00020241246,0.0146510685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994087,0.0020223132,0.002330663,0.00067247,0.00012477764,0.0007627694],"domain_scores_gemma":[0.99584377,0.0018807533,0.0014485371,0.0007244922,0.00007684402,0.000025613885],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014327347,0.00053481676,0.003018468,0.00050361076,0.00013778495,0.000015966812,0.0008248052,0.0015242685,0.0066766837],"category_scores_gemma":[0.001299939,0.00041116582,0.00060868094,0.00029943875,0.00028942825,0.000041774696,0.00038662873,0.001296916,0.0010845556],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036845487,0.0004149051,0.00039569841,0.00044497394,0.00037396682,0.0013826923,0.0001364232,9.993977e-7,0.0032593831,0.000101072466,0.9927001,0.0004213382],"study_design_scores_gemma":[0.00948854,0.0014071607,0.00027304006,0.00095976074,0.0003357443,0.0007684588,0.00014075871,0.0000017636535,0.0073748464,0.0014124102,0.9771451,0.000692433],"about_ca_topic_score_codex":0.00013803339,"about_ca_topic_score_gemma":0.000038446673,"teacher_disagreement_score":0.1389067,"about_ca_system_score_codex":0.00006837774,"about_ca_system_score_gemma":0.00016911427,"threshold_uncertainty_score":0.999834},"labels":[],"label_agreement":null},{"id":"W4385851839","doi":"10.3324/haematol.2023.283073","title":"Isatuximab plus carfilzomib and dexamethasone in patients with early &lt;i&gt;versus&lt;/i&gt; late relapsed multiple myeloma: IKEMA subgroup analysis","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Sanofi","keywords":"Carfilzomib; Multiple myeloma; Subgroup analysis; Dexamethasone; Oncology; Internal medicine; Medicine; Lenalidomide; Meta-analysis","score_opus":0.024619686835252442,"score_gpt":0.2661916376063397,"score_spread":0.24157195077108723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385851839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963289,0.0003387727,0.000033497217,0.0002792605,0.00008901201,0.0012824469,0.00008074958,0.00024962405,0.0013177593],"genre_scores_gemma":[0.99610597,0.000151445,0.0016825629,0.000046678168,0.000020686624,0.00019983729,0.00042713512,0.000049683716,0.0013159915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645364,0.00023955482,0.00052294193,0.0009163342,0.00085552846,0.0010120085],"domain_scores_gemma":[0.99765456,0.0007157367,0.00022668704,0.0007107554,0.00019982817,0.0004924415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037454872,0.0004528501,0.0013249241,0.0009695379,0.00020968635,0.0000618236,0.00020030314,0.000284527,0.00021494502],"category_scores_gemma":[0.00086646754,0.00032028754,0.00020833436,0.0027499462,0.0002870525,0.00017883301,0.00021714483,0.00035354175,0.00024461854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009098525,0.00057343376,0.9826903,0.000120815144,0.0016041563,0.0022375192,0.00057280174,0.00004537847,0.0003540913,0.00011285521,0.00041623903,0.002173927],"study_design_scores_gemma":[0.03318387,0.0014435239,0.9602155,0.00008315224,0.0006208605,0.000014897765,0.00006664313,0.0034901132,0.00015719121,0.000032085805,0.00036656615,0.00032558068],"about_ca_topic_score_codex":0.00023380145,"about_ca_topic_score_gemma":0.00149624,"teacher_disagreement_score":0.024085341,"about_ca_system_score_codex":0.00022274851,"about_ca_system_score_gemma":0.00010276519,"threshold_uncertainty_score":0.9999249},"labels":[],"label_agreement":null},{"id":"W4386910272","doi":"10.3324/haematol.2023.282884","title":"Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk; Moderna; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; Argenx; Sanofi Genzyme; Incyte; bluebird bio; Ionis Pharmaceuticals; Celgene; Sanofi; Alexion Pharmaceuticals; Amgen; Pfizer; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Bone mineral; Term (time); Medicine; Internal medicine; Pediatrics; Glycolysis; Metabolism; Osteoporosis","score_opus":0.0272006064339276,"score_gpt":0.2528535681545815,"score_spread":0.22565296172065388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386910272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511971,0.00005337479,0.000003528544,0.04613647,0.00053324597,0.0010445318,0.000051504823,0.00022288621,0.0007573932],"genre_scores_gemma":[0.5927602,0.00030361087,0.00023455215,0.39264047,0.00086141477,0.00037819843,0.005010393,0.00015638594,0.0076547614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741536,0.00015198658,0.0004786686,0.0008967496,0.0004031604,0.00065409736],"domain_scores_gemma":[0.9986114,0.00018613225,0.00025029964,0.0006624082,0.00018020294,0.000109565015],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005021171,0.0005982163,0.0012918506,0.00037723838,0.00009656378,0.000015537093,0.00011446465,0.0008634837,0.00017878163],"category_scores_gemma":[0.00011556973,0.0003689646,0.00021223852,0.00035202442,0.00017448998,0.00003100418,0.000055798337,0.0009448772,0.0008608803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003066063,0.0019555413,0.5183839,0.00099096,0.00015346146,0.06610898,0.00021992798,0.000006077107,0.00017149399,0.0000573751,0.4073499,0.0015363214],"study_design_scores_gemma":[0.009462897,0.010650953,0.96634614,0.0012407613,0.00034951788,0.0004879046,0.000025400012,0.000011555776,0.00031559778,0.00005969241,0.010118632,0.00093091466],"about_ca_topic_score_codex":0.000070885246,"about_ca_topic_score_gemma":0.00014744476,"teacher_disagreement_score":0.44796228,"about_ca_system_score_codex":0.00024773736,"about_ca_system_score_gemma":0.00008419342,"threshold_uncertainty_score":0.9999171},"labels":[],"label_agreement":null},{"id":"W4387114848","doi":"10.3324/haematol.2023.283557","title":"Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"National Cancer Institute; Pharmacyclics; Genentech; F. Hoffmann-La Roche; Incyte; H. Lundbeck A/S; BeiGene; CSL Behring; AstraZeneca; MorphoSys; Celgene; Gilead Sciences; Teva Pharmaceutical Industries; Servier; TG Therapeutics; Amgen","keywords":"Bendamustine; Medicine; Obinutuzumab; Follicular lymphoma; Internal medicine; Tolerability; Rituximab; Adverse effect; Phases of clinical research; Gastroenterology; Lymphoma; Chemotherapy","score_opus":0.042731580876233986,"score_gpt":0.328386806788105,"score_spread":0.28565522591187104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387114848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994399,0.0018845455,0.0000018359733,0.0007312044,0.00016394716,0.0017237043,0.00002730377,0.0003876049,0.000680834],"genre_scores_gemma":[0.9977515,0.00035707737,0.00023722237,0.00026407294,0.00005684344,0.0005084445,0.00008236545,0.00004488902,0.0006976355],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973322,0.00014306145,0.0006495504,0.00081561157,0.0004281496,0.0006314248],"domain_scores_gemma":[0.99858344,0.00030509595,0.00016496837,0.0006016797,0.0000663,0.0002785027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028653504,0.00044157758,0.0012387951,0.0003951081,0.0002831887,0.00003886772,0.00015148266,0.00022963675,0.00020342537],"category_scores_gemma":[0.0003985805,0.00029527716,0.00014773534,0.00090395607,0.000120746925,0.00008475776,0.00029280415,0.00016525363,0.00024199214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03130996,0.14500242,0.2552278,0.0016893294,0.0029151614,0.36959764,0.027658263,0.00007823033,0.0012942812,0.0036883445,0.03126434,0.13027424],"study_design_scores_gemma":[0.46369672,0.033938497,0.4445263,0.0011121491,0.0015415057,0.006813007,0.013200072,0.0051577133,0.0013981243,0.0005107884,0.02646418,0.0016409351],"about_ca_topic_score_codex":0.00042801347,"about_ca_topic_score_gemma":0.0002144468,"teacher_disagreement_score":0.43238676,"about_ca_system_score_codex":0.00079925073,"about_ca_system_score_gemma":0.00046882522,"threshold_uncertainty_score":0.99994993},"labels":[],"label_agreement":null},{"id":"W4387357326","doi":"10.3324/haematol.2023.283303","title":"Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Seagen","keywords":"Brentuximab vedotin; Classical Hodgkin lymphoma; Chemotherapy; Medicine; Stage (stratigraphy); Hodgkin lymphoma; Oncology; Internal medicine; Lymphoma; Pediatrics; Biology","score_opus":0.019321271487194744,"score_gpt":0.25608773366937543,"score_spread":0.23676646218218067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387357326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8889869,0.00043574753,0.0000050983363,0.1076416,0.000117537464,0.0021259915,0.000051417752,0.00019966881,0.0004360361],"genre_scores_gemma":[0.92929506,0.00090480293,0.00044327878,0.066099614,0.00023096197,0.00070794876,0.00028927892,0.00015631465,0.0018727395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667025,0.00013630693,0.00059303566,0.001151276,0.0006176053,0.0008315532],"domain_scores_gemma":[0.99878854,0.00014646514,0.00027948525,0.00057492545,0.00006016544,0.00015044004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013892312,0.00075560826,0.0017521456,0.000391944,0.000060202452,0.00006186725,0.00019569084,0.00090166327,0.00007013787],"category_scores_gemma":[0.000041903517,0.0004205865,0.00009731798,0.00056197646,0.0002513666,0.00006555157,0.000092596005,0.0006952087,0.00006355918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012857729,0.0028762226,0.7269962,0.0024122195,0.00033463613,0.15107505,0.0009459682,9.023137e-7,0.000003965162,0.000021695538,0.09169456,0.010780886],"study_design_scores_gemma":[0.07762616,0.00412899,0.8600975,0.01731816,0.0002512322,0.004582033,0.00055707345,0.00016173728,0.00022865992,0.000020437861,0.033874802,0.001153161],"about_ca_topic_score_codex":0.00077333354,"about_ca_topic_score_gemma":0.002459817,"teacher_disagreement_score":0.14649302,"about_ca_system_score_codex":0.00045214884,"about_ca_system_score_gemma":0.00032561805,"threshold_uncertainty_score":0.9998246},"labels":[],"label_agreement":null},{"id":"W4388537425","doi":"10.3324/haematol.2023.283437","title":"Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidase","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Celgene","keywords":"Azacitidine; Myeloid leukemia; Myeloid; Cancer research; Stem cell; Myeloperoxidase; CD34; Leukemia; Pharmacology; Medicine; Immunology; Biology; DNA methylation; Cell biology; Biochemistry; Gene expression","score_opus":0.04790925169331383,"score_gpt":0.30722279638420724,"score_spread":0.2593135446908934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388537425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779594,0.00004571743,0.00039934664,0.0004775482,0.000058457088,0.00071617897,0.00003422928,0.00008029988,0.00039230593],"genre_scores_gemma":[0.99845773,0.00014803147,0.00085650553,0.000057796715,0.000026559503,0.00005125079,0.00005503045,0.000021403332,0.00032569314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810106,0.00012352137,0.0006594684,0.00030109353,0.0005362682,0.00027856682],"domain_scores_gemma":[0.9984611,0.0003180357,0.0003422883,0.00043141752,0.00036368906,0.00008346273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002646343,0.000177421,0.00075198093,0.00030552197,0.000038892595,0.0000052515998,0.00020436957,0.00019203965,0.0001353793],"category_scores_gemma":[0.00025526207,0.00013220792,0.00011753902,0.0010042985,0.00013389533,0.0001257782,0.00014596975,0.00018291801,0.000034829507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005367621,0.00020145881,0.001693412,0.0010407034,0.000088657434,0.000026060561,0.0012766141,0.000047721736,0.9907004,0.00048557494,0.0011292242,0.0027734127],"study_design_scores_gemma":[0.001166818,0.0007411885,0.04358793,0.00047743955,0.00004093226,0.000015989095,0.0013196061,0.0001122625,0.9522112,0.00019212993,0.00003323115,0.000101263315],"about_ca_topic_score_codex":0.00005679241,"about_ca_topic_score_gemma":0.0000022437912,"teacher_disagreement_score":0.04189452,"about_ca_system_score_codex":0.00010453206,"about_ca_system_score_gemma":0.00018080155,"threshold_uncertainty_score":0.53912824},"labels":[],"label_agreement":null},{"id":"W4388732699","doi":"10.3324/haematol.2023.284188","title":"First-line MAPK inhibition in pediatric histiocytosis: are we ready?","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Line (geometry); MAPK/ERK pathway; Medicine; Biology; Genetics; Signal transduction","score_opus":0.06669837523109853,"score_gpt":0.28752932263255937,"score_spread":0.22083094740146084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388732699","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015624207,0.0034617514,0.000049494036,0.97031385,0.00078080926,0.0015012984,0.00024580205,0.00076285907,0.0072599184],"genre_scores_gemma":[0.23179626,0.035572927,0.0009900786,0.6194808,0.006215056,0.0026368408,0.011407311,0.0005884781,0.09131224],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974275,0.00007169397,0.00067342893,0.00076707866,0.00047719735,0.00058307895],"domain_scores_gemma":[0.9987106,0.0001856148,0.0003691257,0.0005477646,0.00009139329,0.000095519514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001145259,0.00050168653,0.001226938,0.00060583255,0.00011173923,0.000025391684,0.00010206806,0.0012062509,0.00034147524],"category_scores_gemma":[0.00021340142,0.00040309914,0.0002182455,0.0006196083,0.000082033715,0.000044753644,0.00008029558,0.0011930284,0.0023051947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006524893,0.00026713774,0.004243889,0.0019269319,0.000057508292,0.04633331,0.000059730948,0.000008555087,2.5484547e-7,0.000035085846,0.9467569,0.0002454737],"study_design_scores_gemma":[0.005073352,0.0007394423,0.008504589,0.0027276317,0.0011770489,0.0014990467,0.00007309151,0.00011481961,0.000023402356,0.003960238,0.9751649,0.0009424621],"about_ca_topic_score_codex":0.00009344007,"about_ca_topic_score_gemma":0.00018191054,"teacher_disagreement_score":0.35083306,"about_ca_system_score_codex":0.00032791815,"about_ca_system_score_gemma":0.00013847274,"threshold_uncertainty_score":0.9998421},"labels":[],"label_agreement":null},{"id":"W4389236480","doi":"10.3324/haematol.2021.280275","title":"Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Anaplastic large-cell lymphoma; Vincristine; Oncology; CHOP; Peripheral T-cell lymphoma; Medicine; Prednisone; Lymphoma; Internal medicine; T cell; Immunology; Cancer research; CD30; Chemotherapy; Cyclophosphamide; Immune system","score_opus":0.05974935561026039,"score_gpt":0.2606493981969898,"score_spread":0.2009000425867294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389236480","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04247128,0.0099050775,0.0000014556979,0.93491954,0.0004444653,0.0013922509,0.000037477395,0.00023520617,0.0105932355],"genre_scores_gemma":[0.39684954,0.005323311,0.0010654632,0.5534596,0.024006333,0.0029924302,0.0017602576,0.0003912691,0.014151814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977201,0.00013822316,0.0003975448,0.0007760061,0.0003832224,0.0005848528],"domain_scores_gemma":[0.9990489,0.00017677026,0.0001435133,0.00050375663,0.000026511025,0.00010055928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009784088,0.00053137646,0.0011068684,0.00017465229,0.00007947098,0.000060666396,0.00015054992,0.0010223321,0.00017737164],"category_scores_gemma":[0.0000040923132,0.00034666035,0.00022003376,0.00020441443,0.00014134712,0.00003533981,0.00012366282,0.00058144,0.00011325296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012538752,0.0006624236,0.047524128,0.0011233923,0.00028539624,0.02145248,0.0004967676,0.0000010897361,0.000005672017,0.00013485349,0.9164239,0.011764485],"study_design_scores_gemma":[0.003336282,0.00040517646,0.05854479,0.0001802732,0.00028815056,0.0014871884,0.00029209306,0.000065727676,0.00009906912,0.00029267865,0.93457675,0.0004318392],"about_ca_topic_score_codex":0.000077131386,"about_ca_topic_score_gemma":0.0000069623206,"teacher_disagreement_score":0.38145998,"about_ca_system_score_codex":0.00019859377,"about_ca_system_score_gemma":0.00010203579,"threshold_uncertainty_score":0.99989855},"labels":[],"label_agreement":null},{"id":"W4389244392","doi":"10.3324/haematol.2023.282719","title":"Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Series (stratigraphy); Computational biology; Characterization (materials science); Lymphoma; Peripheral T-cell lymphoma; Medicine; Computer science; Biology; Pathology; Immunology; T cell; Materials science; Nanotechnology; Immune system","score_opus":0.016698499312848013,"score_gpt":0.26887717057554317,"score_spread":0.25217867126269516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68534416,0.017670397,0.0012760856,0.29005495,0.0002875285,0.0039307727,0.000022583894,0.00025945826,0.0011541011],"genre_scores_gemma":[0.685762,0.30051437,0.0034405496,0.0039743977,0.00023484166,0.0032964442,0.0014467968,0.000034389293,0.0012962084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999072,0.00006619021,0.00026417707,0.0003153475,0.000131707,0.00015059169],"domain_scores_gemma":[0.9995276,0.000014706706,0.000084251216,0.00026096648,0.000056318164,0.000056184912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115848685,0.00013961531,0.00027163763,0.000069589,0.000082905484,0.000020077807,0.000038189053,0.00004024946,0.000085420405],"category_scores_gemma":[0.000055339584,0.00008235031,0.00003698719,0.00046586728,0.000025265559,0.00009306078,0.000022284828,0.000016991695,0.00005086674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016741827,0.0076370295,0.10627835,0.00469082,0.00035702184,0.0012841218,0.0041974997,0.0063570966,0.021150805,0.01324093,0.02562273,0.8075094],"study_design_scores_gemma":[0.0042587607,0.0018660338,0.19904001,0.0009407931,0.00028110063,0.00039536593,0.00061393296,0.0033075784,0.0059608286,0.000039241047,0.7829285,0.0003678123],"about_ca_topic_score_codex":0.0000076114457,"about_ca_topic_score_gemma":0.000009621545,"teacher_disagreement_score":0.8071416,"about_ca_system_score_codex":0.00018971837,"about_ca_system_score_gemma":0.000032430733,"threshold_uncertainty_score":0.3358148},"labels":[],"label_agreement":null},{"id":"W4389244542","doi":"10.3324/haematol.2023.282716","title":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","year":2023,"lang":"en","type":"review","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Lymphoma; Biology; T cell; CD8; NODAL; Epigenetics; Anaplastic lymphoma kinase; Cell of origin; Cancer research; Immunology; Pathology; Medicine; Cell; Genetics; Immune system; Gene","score_opus":0.13516869267368736,"score_gpt":0.36153845979951,"score_spread":0.22636976712582263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002680004,0.99614066,0.0000055246724,0.00010597113,0.000679528,0.00081196416,0.00010465111,0.00012336604,0.0017603191],"genre_scores_gemma":[0.0006064884,0.99845946,0.00012752431,0.000014882791,0.00021467257,0.00024639166,0.0001896024,0.0000374402,0.000103541825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837196,0.00013544108,0.0005735921,0.00048640466,0.00013516164,0.0002974432],"domain_scores_gemma":[0.99893624,0.00025236752,0.0003365576,0.00030744425,0.00003466408,0.00013271207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010680536,0.00040657714,0.0023798407,0.00018517682,0.00011884241,0.000014693079,0.00008361873,0.00040243057,0.00011365628],"category_scores_gemma":[0.000030475418,0.00024883624,0.0004925944,0.0003067821,0.00015109224,0.000019157067,0.0001032167,0.00017424248,0.000042964537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029480594,0.0008421775,0.0009447041,0.03948841,0.00053993176,0.0007258767,0.00021110252,2.4365178e-8,4.2142807e-7,0.0075606974,0.0016041754,0.948053],"study_design_scores_gemma":[0.00079887087,0.00028871515,0.0001465522,0.0059273336,0.0016549914,0.0015372228,0.00020799453,0.0000014541752,0.0000017189687,0.00019772981,0.98901486,0.00022255487],"about_ca_topic_score_codex":0.000012950469,"about_ca_topic_score_gemma":0.000007593218,"teacher_disagreement_score":0.98741066,"about_ca_system_score_codex":0.00036738897,"about_ca_system_score_gemma":0.00023012827,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W4390344090","doi":"10.3324/haematol.2023.283776","title":"LNK/&lt;i&gt;SH2B3&lt;/i&gt; as a novel driver in juvenile myelomonocytic leukemia","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; Deutsche Krebshilfe; Frank A. Campini Foundation; National Cancer Institute; National Institutes of Health; Children's Hospital of Philadelphia; Leukemia and Lymphoma Society","keywords":"Juvenile myelomonocytic leukemia; Cancer research; KRAS; Ruxolitinib; Biology; Myeloid; Haematopoiesis; Neuroblastoma RAS viral oncogene homolog; Internal medicine; Immunology; Mutation; Medicine; Genetics; Stem cell; Bone marrow; Myelofibrosis; Gene","score_opus":0.0365812657277071,"score_gpt":0.3064503753839696,"score_spread":0.2698691096562625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390344090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438055,0.0004795422,0.00012425517,0.0035876967,0.00022816846,0.0012789251,0.000024290011,0.00075666246,0.04971495],"genre_scores_gemma":[0.9794817,0.00048668057,0.0018216366,0.0011754817,0.00015507048,0.00034611527,0.00012409076,0.00009810194,0.01631111],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563754,0.00015764093,0.0008323718,0.0009924866,0.00094025146,0.0014397193],"domain_scores_gemma":[0.99744374,0.0006229626,0.00017787596,0.0010816747,0.00018617464,0.00048755415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00092803483,0.00048805107,0.001260823,0.0008536141,0.0001974496,0.000058638252,0.0006342954,0.00057520793,0.0013496075],"category_scores_gemma":[0.0016245567,0.00040202687,0.00028164368,0.0022295283,0.0004215737,0.00017817151,0.0006112202,0.0009120931,0.010813871],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00260577,0.0013036072,0.015007353,0.001815255,0.0006530309,0.049731683,0.0052022585,0.00045444333,0.4052427,0.068074204,0.43627796,0.013631717],"study_design_scores_gemma":[0.029014176,0.0026503145,0.2401379,0.0018343792,0.00044572967,0.011586001,0.0015604649,0.04003995,0.025902726,0.0088855,0.6350307,0.0029121977],"about_ca_topic_score_codex":0.00009339672,"about_ca_topic_score_gemma":0.00011826251,"teacher_disagreement_score":0.37934,"about_ca_system_score_codex":0.0015995615,"about_ca_system_score_gemma":0.0014277311,"threshold_uncertainty_score":0.9998432},"labels":[],"label_agreement":null},{"id":"W4390484306","doi":"10.3324/haematol.2023.284289","title":"&lt;i&gt;Erratum&lt;/i&gt; to: &lt;i&gt;DUSP22&lt;/i&gt;-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; Anaplastic large-cell lymphoma; Cancer research; Internal medicine","score_opus":0.02840536132505914,"score_gpt":0.298310698904237,"score_spread":0.26990533757917784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390484306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93689287,0.009800225,0.0011456308,0.007209648,0.0022669951,0.003952361,0.0041173194,0.0010767409,0.033538226],"genre_scores_gemma":[0.9824249,0.00058432895,0.0037897632,0.003373277,0.00048416888,0.00089175696,0.00051459024,0.00020686547,0.007730315],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99061006,0.0007129476,0.0023319044,0.0027443862,0.0014571531,0.002143518],"domain_scores_gemma":[0.9917884,0.0025807994,0.000421078,0.0019347721,0.00047348134,0.002801454],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0010610251,0.0014571332,0.0028122272,0.00040801123,0.00062017824,0.00035413032,0.00073130033,0.0008254468,0.0017765292],"category_scores_gemma":[0.0027704241,0.0010861076,0.0012222823,0.001008573,0.0005882536,0.00016572722,0.00065108214,0.0004530064,0.002158707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010273713,0.04636834,0.2311123,0.005032626,0.0059196465,0.1154865,0.0043639587,0.000062575185,0.020033728,0.09550215,0.44690073,0.018943723],"study_design_scores_gemma":[0.023552341,0.0055436594,0.5758166,0.0023023714,0.006142716,0.0012951735,0.00018448448,0.0050371434,0.0016923307,0.004110963,0.37121406,0.0031081764],"about_ca_topic_score_codex":0.000045150642,"about_ca_topic_score_gemma":0.00055756647,"teacher_disagreement_score":0.34470427,"about_ca_system_score_codex":0.0007871697,"about_ca_system_score_gemma":0.0014524453,"threshold_uncertainty_score":0.99981785},"labels":[],"label_agreement":null},{"id":"W4391438115","doi":"10.3324/haematol.2024.285005","title":"&lt;i&gt;Erratum to&lt;/i&gt;: Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","year":2024,"lang":"en","type":"erratum","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Series (stratigraphy); Characterization (materials science); Computational biology; Medicine; Peripheral T-cell lymphoma; Lymphoma; Biology; Internal medicine; Immunology; Nanotechnology; T cell; Materials science","score_opus":0.012532389194545813,"score_gpt":0.2569160452565248,"score_spread":0.24438365606197898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391438115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008667425,0.51838267,0.0021481204,0.40112796,0.018822614,0.017943712,0.00039703012,0.00063270674,0.03187776],"genre_scores_gemma":[0.011889724,0.8378772,0.005834497,0.008460363,0.0026593674,0.011464388,0.013079772,0.00023324159,0.108501405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968893,0.00019100076,0.0008573086,0.0011864714,0.00046473392,0.00041120526],"domain_scores_gemma":[0.9983689,0.000024302039,0.00031429174,0.0008527487,0.00022297546,0.0002167789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023752335,0.00065361697,0.0011422576,0.00026643314,0.00016385077,0.00012267203,0.00016671352,0.00033776686,0.00020285287],"category_scores_gemma":[0.00014472927,0.00041072431,0.00017262432,0.00080270873,0.000067127316,0.00015144607,0.00010543084,0.00014273345,0.000115792274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038846882,0.0020300297,0.00015755254,0.004691971,0.00029238677,0.00059221155,0.0008755635,0.00026811237,0.0024328637,0.0027355526,0.9386304,0.046904914],"study_design_scores_gemma":[0.0009295483,0.0012047185,0.0018122541,0.0029722052,0.0005925006,0.0002974345,0.00005101395,0.00034141602,0.00025992715,0.000023228335,0.9911328,0.00038294197],"about_ca_topic_score_codex":0.000008208464,"about_ca_topic_score_gemma":0.00008396696,"teacher_disagreement_score":0.39266762,"about_ca_system_score_codex":0.0011306283,"about_ca_system_score_gemma":0.00031704077,"threshold_uncertainty_score":0.9998345},"labels":[],"label_agreement":null},{"id":"W4392287332","doi":"10.3324/haematol.2023.283713","title":"Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; University of Calgary","funders":"Loxo Oncology; Adaptive Biotechnologies; Regeneron Pharmaceuticals; Genentech; Celgene; BeiGene; Sanofi; Pfizer; Amgen","keywords":"Lenalidomide; Medicine; Internal medicine; Hazard ratio; Ixazomib; Population; Confidence interval; Dexamethasone; Surgery; Oncology; Carfilzomib","score_opus":0.08382698583699201,"score_gpt":0.375925104901556,"score_spread":0.292098119064564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392287332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948803,0.00038359663,0.0003013675,0.0012647306,0.000032634634,0.002934552,0.000034623703,0.000025595564,0.00014260202],"genre_scores_gemma":[0.99588835,0.000056515943,0.0030951723,0.00018214394,0.00003413131,0.00067259744,0.000024741688,0.000014491708,0.000031849904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982961,0.00020668952,0.0004950778,0.00035833675,0.00034108033,0.0003027607],"domain_scores_gemma":[0.99823713,0.001329036,0.00007030746,0.00021263826,0.00007180753,0.000079072226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001551687,0.0001636229,0.0004918752,0.00014820196,0.000040297637,0.000040072187,0.00010192933,0.000054823744,0.000044803255],"category_scores_gemma":[0.0005700201,0.00008507315,0.000058247268,0.0001854445,0.000058331676,0.000059604645,0.000054586137,0.00019028166,0.0000019391982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025170164,0.004669628,0.8702243,0.0015428264,0.0009850748,0.0041138,0.016199011,0.00008268981,0.007099533,0.0028084358,0.00034782974,0.0667567],"study_design_scores_gemma":[0.02940264,0.029914184,0.89971256,0.0021164576,0.00036450598,0.00027860492,0.027495204,0.0041387547,0.0042523514,0.0013880343,0.00042272758,0.0005139713],"about_ca_topic_score_codex":0.00034397686,"about_ca_topic_score_gemma":0.0014815506,"teacher_disagreement_score":0.06624273,"about_ca_system_score_codex":0.000056343728,"about_ca_system_score_gemma":0.000071449846,"threshold_uncertainty_score":0.34691826},"labels":[],"label_agreement":null},{"id":"W4393265067","doi":"10.3324/haematol.2023.284138","title":"Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Walloon excellence in life sciences and biotechnology; Fonds Wetenschappelijk Onderzoek; Fonds De La Recherche Scientifique - FNRS; Génome Québec; Gilead Sciences; University of Minnesota; Vlaamse regering; European Society for Clinical Nutrition and Metabolism; Pfizer; Université Catholique de Louvain; Fondation Louvain","keywords":"Gut flora; Anorexia; Microbiome; Biology; Metabolome; Internal medicine; Physiology; Immunology; Medicine; Metabolomics; Bioinformatics","score_opus":0.011340949009278492,"score_gpt":0.24594396970166654,"score_spread":0.23460302069238806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393265067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954005,0.0026401759,0.00007579641,0.0009037642,0.000113796224,0.00023877382,0.00019839812,0.00007138387,0.0003573935],"genre_scores_gemma":[0.99643075,0.001007072,0.00024519739,0.00053842115,0.0000485054,0.00008255341,0.0004831986,0.00002579087,0.0011385306],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988781,0.00006152591,0.00019029078,0.00048871327,0.00006256687,0.00031879943],"domain_scores_gemma":[0.999506,0.000033073946,0.00007288162,0.00023157542,0.000057248428,0.000099248704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009201071,0.00020216385,0.00024885577,0.00005514705,0.00025073104,0.000083864266,0.00011478726,0.00023000558,0.000076495206],"category_scores_gemma":[0.000021830301,0.00015188452,0.000060471964,0.00015816721,0.0001403109,0.00000687257,0.00014158833,0.0001124676,0.000040851315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046416502,0.000067641515,0.014134015,0.00013314535,0.00022997484,0.00022792135,0.00015517327,0.0000048651923,0.9509212,0.00026036717,0.033350438,0.00046887016],"study_design_scores_gemma":[0.0020112735,0.0013891481,0.58907706,0.00082432944,0.00053648185,0.0023490891,0.00028684942,0.00013360786,0.18336254,0.00017252022,0.21825375,0.001603327],"about_ca_topic_score_codex":0.000016676788,"about_ca_topic_score_gemma":0.00031508616,"teacher_disagreement_score":0.76755863,"about_ca_system_score_codex":0.00007019419,"about_ca_system_score_gemma":0.000097637254,"threshold_uncertainty_score":0.6193671},"labels":[],"label_agreement":null},{"id":"W4393277437","doi":"10.3324/haematol.2024.285031","title":"Non-myeloma light chain cast nephropathy: a multicenter retrospective study on clinicopathological characteristics","year":2024,"lang":"en","type":"letter","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Multiple myeloma; Medicine; Retrospective cohort study; Multicenter study; Nephropathy; Immunoglobulin light chain; Internal medicine; Oncology; Immunology; Endocrinology","score_opus":0.019856196132632932,"score_gpt":0.2939163035963683,"score_spread":0.2740601074637353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393277437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.846745,0.0007268259,0.000033594824,0.14378776,0.002351968,0.003323777,0.0006903923,0.00027416038,0.0020665238],"genre_scores_gemma":[0.8106666,0.00031358117,0.00015010423,0.1816997,0.0026550903,0.0010825593,0.000959756,0.0001874432,0.0022851413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946131,0.00046031713,0.0010510322,0.0023329328,0.0005608572,0.0009817536],"domain_scores_gemma":[0.99733686,0.000117996395,0.0006098649,0.0015956888,0.00018054873,0.00015904779],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036818613,0.001243757,0.0017220419,0.00021571282,0.00021711091,0.00018141353,0.00080912973,0.0021562562,0.0001584799],"category_scores_gemma":[0.00051706535,0.00091075303,0.0007036643,0.0002097917,0.00024423568,0.000006138092,0.00076339825,0.0019892394,0.0015338134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003322268,0.0018178355,0.16062774,0.00019332107,0.00069614145,0.030727051,0.00040873728,3.3960308e-7,0.0010298989,0.000022041433,0.80375105,0.00039360908],"study_design_scores_gemma":[0.0030533709,0.012077173,0.34392762,0.0005707593,0.0013490621,0.0010043195,0.0006095119,0.000021434927,0.0049653314,0.00008715048,0.62958896,0.002745292],"about_ca_topic_score_codex":0.000008868298,"about_ca_topic_score_gemma":0.000012384406,"teacher_disagreement_score":0.18329988,"about_ca_system_score_codex":0.00016857941,"about_ca_system_score_gemma":0.00009647127,"threshold_uncertainty_score":0.99933434},"labels":[],"label_agreement":null},{"id":"W4394725118","doi":"10.3324/haematol.2024.285041","title":"Unfriendly protein of GATA1 and mechanisms of bone marrow failure","year":2024,"lang":"en","type":"letter","venue":"Haematologica","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Bone marrow; GATA1; Bone marrow failure; Medicine; Cancer research; Immunology; Cell biology; Internal medicine; Haematopoiesis; Biology; Erythropoiesis; Anemia; Stem cell","score_opus":0.010840507314403282,"score_gpt":0.22801900187705562,"score_spread":0.21717849456265234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394725118","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27059153,0.032711297,0.015907265,0.66714835,0.00072147435,0.0036499265,0.0021508501,0.0001274318,0.006991881],"genre_scores_gemma":[0.9553213,0.00040246695,0.0068306685,0.027742548,0.00039153828,0.0003609769,0.0008919568,0.000084252235,0.007974274],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988896,0.000050047194,0.00033032466,0.0004130859,0.00014416037,0.00017275907],"domain_scores_gemma":[0.9991821,0.000007567967,0.00023207391,0.00046572182,0.000086647684,0.000025869687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009818333,0.00020218243,0.00041260174,0.000065142754,0.000024855646,0.000012596182,0.00017147171,0.00069915236,0.00007338573],"category_scores_gemma":[0.000031248834,0.00015838169,0.00012245102,0.000079483245,0.00016743322,0.0000015787181,0.00013229465,0.0002815048,0.0000070895308],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019741643,0.000021734604,0.00000611187,0.0011040675,0.000096419775,0.00008182271,0.000018214705,5.264508e-7,0.40425187,0.0054583964,0.5887349,0.00020613699],"study_design_scores_gemma":[0.00016236881,0.00029693564,0.000011660435,0.00022098198,0.0000791554,0.00016988584,0.000052872212,0.000004953598,0.38358864,0.006789439,0.608363,0.0002601419],"about_ca_topic_score_codex":0.000010498916,"about_ca_topic_score_gemma":0.0000069438347,"teacher_disagreement_score":0.68472975,"about_ca_system_score_codex":0.000004778756,"about_ca_system_score_gemma":0.00006407439,"threshold_uncertainty_score":0.64586174},"labels":[],"label_agreement":null},{"id":"W4394725168","doi":"10.3324/haematol.2024.284967","title":"Oral iron supplementation: new formulations, old questions","year":2024,"lang":"en","type":"review","venue":"Haematologica","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tolerability; Anemia; Iron deficiency; Iron-deficiency anemia; Ferrous; Medicine; Iron supplement; Iron sulfate; Iron supplementation; Pharmacology; Internal medicine; Chemistry; Sulfate; Adverse effect","score_opus":0.08397059795947864,"score_gpt":0.4065818136440817,"score_spread":0.32261121568460305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394725168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000416397,0.99187183,0.00025691892,0.0009320922,0.0004684701,0.0012023405,0.000076577766,0.0002575398,0.0049300366],"genre_scores_gemma":[0.000009384331,0.9761934,0.003780662,0.00036779192,0.000229805,0.00015595919,0.0012607955,0.000049193553,0.017952984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998293,0.00007785301,0.00065487187,0.0004311698,0.00024332409,0.00029977952],"domain_scores_gemma":[0.99913037,0.00006340354,0.0001594217,0.00042374356,0.000034266042,0.00018877187],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012055374,0.00039314196,0.00153987,0.0002618145,0.0001000391,0.00005472843,0.00013408168,0.00033330877,0.0023704323],"category_scores_gemma":[0.00009725684,0.00025694864,0.0005056033,0.0004196985,0.000051294846,0.0001006286,0.000075257514,0.00037183255,0.002365248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008837994,0.00008310851,0.000012319664,0.025780585,0.00006312696,0.00016426426,0.0000574628,2.2085577e-7,6.485041e-8,0.09271627,0.25428265,0.6268311],"study_design_scores_gemma":[0.00033905596,0.00006582174,0.000010983398,0.0036697814,0.0045195725,0.0005653222,0.00003271814,0.000002228553,2.4708044e-7,0.0014690611,0.9890808,0.00024444264],"about_ca_topic_score_codex":0.00006385365,"about_ca_topic_score_gemma":0.000019614548,"teacher_disagreement_score":0.73479813,"about_ca_system_score_codex":0.000054628727,"about_ca_system_score_gemma":0.00042919253,"threshold_uncertainty_score":0.99998826},"labels":[],"label_agreement":null},{"id":"W4394919587","doi":"10.3324/haematol.2024.285257","title":"‘One way, or another, I’m gonna find ya’: miR-221-3p finds its targets via small extracellular vesicles","year":2024,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Extracellular vesicles; Vesicle; Extracellular; Chemistry; Molecular biology; Cell biology; Biophysics; Biology; Biochemistry; Membrane","score_opus":0.02172669775936194,"score_gpt":0.2613766853722104,"score_spread":0.23964998761284848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394919587","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04553691,0.29521498,0.0041763047,0.0008269947,0.643761,0.0028531444,0.002649641,0.00071362953,0.0042674285],"genre_scores_gemma":[0.08103246,0.010882119,0.011228426,0.0006664556,0.7780858,0.0010642151,0.01188916,0.0013454227,0.103805915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99408823,0.0003804797,0.0011582237,0.002273534,0.0008482489,0.0012512818],"domain_scores_gemma":[0.99656266,0.0002899733,0.0005726651,0.001816883,0.0003547814,0.00040302004],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006338524,0.0012299598,0.0013149905,0.00019298906,0.00026497076,0.0002389176,0.0017007111,0.0035785574,0.0009057935],"category_scores_gemma":[0.0015524498,0.0010855657,0.0007266352,0.0003040706,0.00039311912,0.000012636454,0.0009859237,0.0013199135,0.0012860239],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006147402,0.00052039727,0.000007611455,0.0011280497,0.0004430213,0.0015846485,0.000057477242,0.0000068343256,0.20610647,0.000074710355,0.78753436,0.0019216696],"study_design_scores_gemma":[0.0008293449,0.00062750705,0.000020127338,0.0003398861,0.00039200767,0.00009600176,0.000026071868,0.00007090586,0.14421849,0.0005973613,0.8514557,0.0013266003],"about_ca_topic_score_codex":0.000018490697,"about_ca_topic_score_gemma":0.00006267012,"teacher_disagreement_score":0.28433287,"about_ca_system_score_codex":0.000083523904,"about_ca_system_score_gemma":0.0005869915,"threshold_uncertainty_score":0.9994916},"labels":[],"label_agreement":null},{"id":"W4395077641","doi":"10.3324/haematol.2024.285425","title":"Central nervous system prophylaxis: it’s time to start from scratch","year":2024,"lang":"en","type":"editorial","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Scratch; Central nervous system; Medicine; Computer science; Internal medicine; Operating system","score_opus":0.011279503501672075,"score_gpt":0.2530312432106314,"score_spread":0.24175173970895936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395077641","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014854532,0.0037795894,0.000010845154,0.0073125334,0.95568657,0.0033372373,0.0029660377,0.0012458175,0.01080686],"genre_scores_gemma":[0.04207603,0.00023181185,0.0011985615,0.00094277004,0.9319613,0.0014285204,0.004261948,0.00028077228,0.017618302],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99603665,0.00010369357,0.0007268886,0.0012323728,0.001126231,0.00077414344],"domain_scores_gemma":[0.9975721,0.0005422498,0.0001757892,0.0009316156,0.00021906469,0.00055912975],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014454409,0.00072813506,0.001875028,0.0001911745,0.00011185195,0.0001895491,0.000308324,0.0012907719,0.0016895469],"category_scores_gemma":[0.0004032305,0.0004943671,0.00047163334,0.00029664696,0.00006192221,0.00003587592,0.00026187525,0.0006378077,0.019241529],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025698874,0.00038640056,0.00009054238,0.0009691503,0.0006132077,0.009424138,0.00017808804,0.0000015113759,0.000018162387,0.000044117594,0.98556554,0.0024521423],"study_design_scores_gemma":[0.0009397529,0.0014412476,0.0004086562,0.003955608,0.001069468,0.00008459663,0.0001519997,0.000031125244,0.00021283355,0.000094197516,0.99109393,0.0005165537],"about_ca_topic_score_codex":0.0007354589,"about_ca_topic_score_gemma":0.000049919116,"teacher_disagreement_score":0.027221497,"about_ca_system_score_codex":0.001056118,"about_ca_system_score_gemma":0.00069883297,"threshold_uncertainty_score":0.9997508},"labels":[],"label_agreement":null},{"id":"W4396762306","doi":"10.3324/haematol.2024.285002","title":"Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Transplantation; Cord blood; Hematopoietic cell; Population; Hematopoietic stem cell transplantation; Stem cell; Internal medicine; Immunology; Haematopoiesis; Oncology; Biology; Environmental health","score_opus":0.015563875858783244,"score_gpt":0.26814670619031655,"score_spread":0.2525828303315333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396762306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994556,0.00020145545,0.0010943908,0.0014985725,0.00006140997,0.0018625888,0.00000773452,0.00008052867,0.0006373382],"genre_scores_gemma":[0.9989492,0.00022602687,0.00034044046,0.00009522734,0.0000061829146,0.00025105148,0.000025776973,0.000030505005,0.00007555414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978117,0.00011273714,0.00067080883,0.0006829331,0.00026893456,0.0004528909],"domain_scores_gemma":[0.99912417,0.00036602048,0.00006789432,0.000183748,0.000027649934,0.00023053131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034651993,0.00031258704,0.0007927287,0.0006141267,0.000045410332,0.00016679015,0.00009692071,0.00024277039,0.00009430653],"category_scores_gemma":[0.000030981842,0.00024504113,0.000038776594,0.0009119797,0.00011371381,0.00023259803,0.00004717676,0.0005002273,0.000012769575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009690353,0.0015121959,0.8761716,0.009836865,0.00013949529,0.02923103,0.014545941,0.00008694109,0.056063913,0.0007664377,0.00004589522,0.0019093674],"study_design_scores_gemma":[0.014811862,0.0007545783,0.92177796,0.005348907,0.0003573678,0.0027134595,0.00049331493,0.003830304,0.04885331,0.00045466717,0.000014188461,0.00059008686],"about_ca_topic_score_codex":0.0010408283,"about_ca_topic_score_gemma":0.0027583865,"teacher_disagreement_score":0.045606386,"about_ca_system_score_codex":0.000098932316,"about_ca_system_score_gemma":0.00011695866,"threshold_uncertainty_score":0.99924874},"labels":[],"label_agreement":null},{"id":"W4396774026","doi":"10.3324/haematol.2024.285285","title":"Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Leukapheresis; Etoposide; Medicine; Chemotherapy; Internal medicine; Leukocytosis; White blood cell; Leukostasis; Myeloid leukemia; Myeloid; Surgery; Leukemia; Gastroenterology; Stem cell","score_opus":0.03800216772601007,"score_gpt":0.3311627107403944,"score_spread":0.2931605430143843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396774026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95344007,0.0011572958,0.0001579797,0.0025378922,0.00016327693,0.03811887,0.00010901548,0.00024013533,0.00407544],"genre_scores_gemma":[0.95984846,0.002584712,0.012329423,0.00060978194,0.0004928005,0.022346655,0.00008366259,0.00015164421,0.001552836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606884,0.00024890614,0.0011141228,0.00092395436,0.0008483723,0.00079582585],"domain_scores_gemma":[0.9978903,0.00050196843,0.0002592307,0.0010448061,0.00011522474,0.00018850256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009647198,0.0004662251,0.0009590727,0.00032500864,0.00011959168,0.000081970065,0.00065471604,0.00034142434,0.00031775015],"category_scores_gemma":[0.0000977829,0.00028741854,0.0002609989,0.0014762406,0.00025456148,0.00021499782,0.0003374882,0.00085725624,0.00019768935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09945773,0.0041318918,0.26570278,0.023972338,0.014233906,0.068698145,0.020317158,0.0010044592,0.08271563,0.004567442,0.2439526,0.1712459],"study_design_scores_gemma":[0.099573664,0.0035974225,0.57917255,0.012900924,0.0065262164,0.0031719485,0.0072163944,0.056915134,0.1289098,0.004731061,0.092295155,0.004989758],"about_ca_topic_score_codex":0.0006108227,"about_ca_topic_score_gemma":0.000042934033,"teacher_disagreement_score":0.31346974,"about_ca_system_score_codex":0.0008682476,"about_ca_system_score_gemma":0.0006948384,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W4396948326","doi":"10.3324/haematol.2024.285371","title":"Right at your fingertips!","year":2024,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Trade Secret Protection Methods","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.10862637145324554,"score_gpt":0.48010682467096466,"score_spread":0.3714804532177191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396948326","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031572097,0.0026302093,0.0003559092,0.0015269042,0.94462484,0.0014403347,0.0003017211,0.0015386598,0.047265675],"genre_scores_gemma":[0.00012773073,0.00037099805,0.005397204,0.00032329757,0.84928775,0.0012671096,0.0003348631,0.00018773238,0.1427033],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993312,0.0022163116,0.0012367408,0.0011916736,0.0009463807,0.0010969214],"domain_scores_gemma":[0.99295056,0.004847519,0.0006322936,0.0010148983,0.00028404675,0.00027067596],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0018034058,0.0006489238,0.0013726319,0.00030308004,0.001297484,0.00003675353,0.0007064115,0.0050863847,0.013722762],"category_scores_gemma":[0.0053722425,0.00047274158,0.0003741186,0.00041065415,0.00015625531,0.00007146509,0.000855774,0.0068860194,0.026888372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009965443,0.000020123476,0.000020875637,0.0020923228,0.000078974015,0.00040691157,0.0005300181,3.0344896e-7,0.00004372886,0.0013120752,0.99521476,0.0001802726],"study_design_scores_gemma":[0.00034837134,0.00008871574,0.000028557692,0.0010731646,0.00013389118,0.000021585089,0.00011234402,0.000008655987,0.00006717001,0.0071825543,0.99043316,0.00050184096],"about_ca_topic_score_codex":0.000107660635,"about_ca_topic_score_gemma":0.00016318679,"teacher_disagreement_score":0.09543762,"about_ca_system_score_codex":0.0007231075,"about_ca_system_score_gemma":0.0007285268,"threshold_uncertainty_score":0.9997724},"labels":[],"label_agreement":null},{"id":"W4398761348","doi":"10.3324/haematol.2024.285382","title":"Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study","year":2024,"lang":"en","type":"letter","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pulmonary embolism; Retrospective cohort study; Medicine; Cancer; Intensive care medicine; Internal medicine; Emergency medicine","score_opus":0.023155287411070105,"score_gpt":0.2945700972757691,"score_spread":0.271414809864699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398761348","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42468795,0.01376634,0.000028279987,0.43080002,0.0041783545,0.020327348,0.0014245268,0.0007477785,0.10403939],"genre_scores_gemma":[0.94776285,0.0039159646,0.00016066954,0.042061307,0.00030962646,0.0009971678,0.00034570717,0.00012713874,0.004319573],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99612415,0.00016646946,0.0012285446,0.00088223076,0.0010761787,0.000522406],"domain_scores_gemma":[0.99792147,0.000058872163,0.00081757247,0.0008544351,0.00027869284,0.000068953144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036152382,0.0005469035,0.0029022044,0.0003634977,0.00006739377,0.000014843974,0.00036160482,0.000596947,0.00055105373],"category_scores_gemma":[0.0000382784,0.00042095984,0.00049253576,0.00058477634,0.00015913934,0.000030284902,0.0005296427,0.0010702743,0.00004674395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024177185,0.007479682,0.015361,0.009806669,0.010497014,0.014917668,0.0015675338,0.000007503635,0.00000719013,0.0015663574,0.93633074,0.0022168523],"study_design_scores_gemma":[0.003793079,0.007225729,0.64098215,0.014680988,0.021424284,0.00008720932,0.0048268493,0.000066756336,0.0002147931,0.0019743524,0.3032745,0.0014493188],"about_ca_topic_score_codex":0.00060855766,"about_ca_topic_score_gemma":0.000046417903,"teacher_disagreement_score":0.6330563,"about_ca_system_score_codex":0.00042356222,"about_ca_system_score_gemma":0.00007412445,"threshold_uncertainty_score":0.9998242},"labels":[],"label_agreement":null},{"id":"W4399600471","doi":"10.3324/haematol.2024.284968","title":"PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire","year":2024,"lang":"fr","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Hematopoietic stem cell transplantation; Blockade; Lymphoma; Transplantation; Hematopoietic cell; Stem cell; Hodgkin lymphoma; Bone marrow transplantation; Oncology; Haematopoiesis; Immunology; Internal medicine; Biology; Receptor","score_opus":0.013621294772128315,"score_gpt":0.26700380028615983,"score_spread":0.2533825055140315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399600471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697185,0.0060665244,0.000023505185,0.020303426,0.0002598709,0.0017258278,0.00026338574,0.00002654069,0.0016124251],"genre_scores_gemma":[0.9866002,0.00066370645,0.00023070155,0.010904945,0.00013544247,0.0005277465,0.00007482944,0.00006802726,0.00079438713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626744,0.00080153754,0.00092757243,0.0006753508,0.00071256387,0.00061552564],"domain_scores_gemma":[0.99790835,0.0010513791,0.00043447106,0.00041310338,0.00007857122,0.000114126466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007217831,0.00059354183,0.0012860439,0.00026166587,0.00009603845,0.000028409564,0.00029383737,0.00074138265,0.00040187527],"category_scores_gemma":[0.00001793462,0.00040870934,0.0003683464,0.00037024243,0.00027501895,0.000034858862,0.00009861838,0.00044500694,0.00014609263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010059428,0.014946121,0.85703033,0.015166573,0.0018067004,0.012129694,0.04632317,0.0004526329,0.01145006,0.00039376097,0.037680823,0.001614198],"study_design_scores_gemma":[0.014958039,0.0020184268,0.86675435,0.007174418,0.002768964,0.00397586,0.003149372,0.0004478061,0.09543129,0.0013883486,0.0011045411,0.000828559],"about_ca_topic_score_codex":0.0004225371,"about_ca_topic_score_gemma":0.000070021444,"teacher_disagreement_score":0.08398123,"about_ca_system_score_codex":0.0006926156,"about_ca_system_score_gemma":0.0008194094,"threshold_uncertainty_score":0.9998365},"labels":[],"label_agreement":null},{"id":"W4401420883","doi":"10.3324/haematol.2024.285973","title":"A &lt;i&gt;nu&lt;/i&gt; mouse model of diffuse large B-cell lymphoma in constitutional &lt;i&gt;Atm&lt;/i&gt; loss","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Lymphoma; Diffuse large B-cell lymphoma; Chemistry; Medicine; Internal medicine","score_opus":0.019798043463003054,"score_gpt":0.25487065980390505,"score_spread":0.23507261634090199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401420883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95659095,0.015364284,0.0007571866,0.0013723896,0.0004087137,0.001369613,0.00087616115,0.00047389526,0.022786802],"genre_scores_gemma":[0.99065703,0.0023955423,0.0017879119,0.00062528247,0.000116420124,0.0005435034,0.00031371074,0.00007883378,0.0034817602],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99493676,0.00018679112,0.0013464064,0.0013023647,0.0010249623,0.0012026922],"domain_scores_gemma":[0.9973031,0.00056314655,0.00030033724,0.0010693871,0.00024388812,0.0005201276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005049766,0.0008520006,0.0017750784,0.0005472137,0.0002472279,0.000098441575,0.00044660302,0.0006399423,0.00050225743],"category_scores_gemma":[0.0002656422,0.00065430667,0.0006753111,0.0006910154,0.0010209555,0.00026707223,0.0003510692,0.00022855871,0.00080219714],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088305655,0.030593337,0.008344796,0.0016203737,0.0008119714,0.010754372,0.0012210624,0.0003254694,0.06360793,0.85108674,0.02928398,0.0014669355],"study_design_scores_gemma":[0.15486154,0.004268244,0.03431909,0.0067607313,0.0044049127,0.009921715,0.00031100554,0.12805465,0.12975846,0.01897997,0.50232494,0.006034733],"about_ca_topic_score_codex":0.000014413274,"about_ca_topic_score_gemma":0.00014756416,"teacher_disagreement_score":0.83210677,"about_ca_system_score_codex":0.000683247,"about_ca_system_score_gemma":0.0010559228,"threshold_uncertainty_score":0.9999758},"labels":[],"label_agreement":null},{"id":"W4401770046","doi":"10.3324/haematol.2024.285768","title":"Comparing the clinical trial efficacy &lt;i&gt;versus&lt;/i&gt; real-world effectiveness of treatments for multiple myeloma: a population-based study","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; McMaster University; University of Toronto; Sunnybrook Health Science Centre; Eli Lilly (Canada); BC Cancer Agency; Ottawa Hospital","funders":"National Cancer Institute","keywords":"Multiple myeloma; Medicine; Clinical trial; Population; Oncology; World population; Internal medicine; Environmental health","score_opus":0.1593452859384943,"score_gpt":0.4341329201977882,"score_spread":0.27478763425929387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401770046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828566,0.00031963346,0.00015497662,0.00012820229,0.0006384709,0.009375618,0.000058022655,0.00021411998,0.0008253042],"genre_scores_gemma":[0.99723876,0.000020045285,0.00061424525,0.000010356092,0.00015685227,0.0013968906,0.00032465282,0.000045004534,0.0001931802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996289,0.0009894191,0.0009015405,0.0007288491,0.00058175763,0.0005094254],"domain_scores_gemma":[0.98630613,0.012435497,0.00018728517,0.00069290696,0.00015101706,0.00022713386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015084064,0.0003579529,0.0012855687,0.00024531316,0.00027342862,0.0000581286,0.0002455977,0.00014585216,0.00005247073],"category_scores_gemma":[0.0018905138,0.00020595013,0.0006078653,0.0005102338,0.00014672441,0.000064687345,0.00009479378,0.00023417278,0.000048652026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24015258,0.00929944,0.73695374,0.0006271754,0.0032106566,0.0007103721,0.00014071683,0.00007332429,0.00037775934,0.0015976036,0.0002467401,0.0066099046],"study_design_scores_gemma":[0.14927909,0.006464555,0.83541334,0.00033843715,0.0009919256,0.000009975921,0.00003189729,0.006507274,0.00029135955,0.00007046665,0.00043192226,0.00016976782],"about_ca_topic_score_codex":0.00018477488,"about_ca_topic_score_gemma":0.0006979421,"teacher_disagreement_score":0.0984596,"about_ca_system_score_codex":0.00021589713,"about_ca_system_score_gemma":0.00022688443,"threshold_uncertainty_score":0.83984023},"labels":[],"label_agreement":null},{"id":"W4402015336","doi":"10.3324/haematol.2024.285740","title":"Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Systemic mastocytosis; Medicine; Bone marrow; Mast (botany); Mast cell; Pathology; Immunology","score_opus":0.006752401218315513,"score_gpt":0.18823596803731443,"score_spread":0.1814835668189989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402015336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824405,0.0007026653,0.000012348181,0.0000874561,0.00013847789,0.00033142403,0.00010642094,0.00007389718,0.00030324992],"genre_scores_gemma":[0.99859303,0.00006649761,0.000043522105,0.000056397323,0.0000031271818,0.000031100426,0.000111166904,0.00001827442,0.0010768787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897593,0.00010475478,0.00024188969,0.00036714497,0.00005003202,0.0002602204],"domain_scores_gemma":[0.99952126,0.0001685675,0.000104218074,0.0001488034,0.000029440602,0.000027741986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010518163,0.00022266939,0.0005078124,0.0001210453,0.00009645623,0.00003651511,0.00006053512,0.00020747533,0.00015300387],"category_scores_gemma":[0.00002455067,0.00012924697,0.00002053876,0.000095711825,0.00015528411,0.000048329723,0.000058378846,0.000236033,0.00004050875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010328181,0.0004169505,0.9744476,0.00050032896,0.00015660816,0.00032571596,0.00070725,0.0000010974917,0.01999845,0.0004398696,0.00077431626,0.001198987],"study_design_scores_gemma":[0.0032824436,0.0013617796,0.9854727,0.002090929,0.000100164274,0.00013985862,0.00019963253,0.00001228904,0.0052882177,0.000017159575,0.0015785657,0.00045627344],"about_ca_topic_score_codex":0.000011147474,"about_ca_topic_score_gemma":0.000019844652,"teacher_disagreement_score":0.014710233,"about_ca_system_score_codex":0.000029437619,"about_ca_system_score_gemma":0.000013366779,"threshold_uncertainty_score":0.52705383},"labels":[],"label_agreement":null},{"id":"W4402020309","doi":"10.3324/haematol.2024.285648","title":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Takeda Oncology; Health Resources and Services Administration; Centers for Disease Control and Prevention; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Pfizer; Incyte; Kiadis Pharma; TG Therapeutics; Medac; Jazz Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Astellas Pharma; Adaptive Biotechnologies; MorphoSys; California Department of Public Health; Sanofi; GlaxoSmithKline; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Population; Transplantation; Medicaid; Hematopoietic stem cell transplantation; Myeloid leukemia; Young adult; Relative survival; Gerontology; Demography; Internal medicine; Pediatrics; Cancer; Cancer registry; Health care; Environmental health","score_opus":0.024502288346107653,"score_gpt":0.2877900609250132,"score_spread":0.26328777257890557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402020309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994834,0.00013433173,0.0011060648,0.000081953345,0.00004588589,0.0024679138,0.0011602774,0.00012043049,0.000049139002],"genre_scores_gemma":[0.9893695,0.00005895009,0.00050085445,0.00008328737,0.000012816979,0.0002329928,0.009669048,0.00004688078,0.000025678526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974039,0.00024181383,0.00071133743,0.0005962926,0.0006716146,0.00037500457],"domain_scores_gemma":[0.9987455,0.00035119161,0.00015821784,0.00047018158,0.0001302912,0.00014459812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032799062,0.00029853184,0.00067000504,0.00044156855,0.00006929226,0.00003869451,0.00019777835,0.00020896822,0.00013980072],"category_scores_gemma":[0.00003450572,0.00021443955,0.00007338609,0.0008543591,0.0000928294,0.00015042463,0.000037508573,0.00037007945,0.000056990633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010466082,0.0006261038,0.99104923,0.0014282718,0.00012571682,0.0022011485,0.0009715606,0.0011033268,0.0001607072,0.000020132138,0.0004893762,0.0007778261],"study_design_scores_gemma":[0.007883772,0.0012172537,0.9776365,0.00060209713,0.0006092408,0.000049969098,0.0005437897,0.009312697,0.0017530452,0.000022064683,0.00006163553,0.0003079221],"about_ca_topic_score_codex":0.00065418595,"about_ca_topic_score_gemma":0.00040060558,"teacher_disagreement_score":0.013412709,"about_ca_system_score_codex":0.0005103178,"about_ca_system_score_gemma":0.00047954672,"threshold_uncertainty_score":0.87445915},"labels":[],"label_agreement":null},{"id":"W4402259999","doi":"10.3324/haematol.2024.285552","title":"BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Cancer research; Acetylation; Progenitor cell; PTEN; Chemistry; Medicine; Stem cell; Biochemistry; Biology; Cell biology; Gene; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.008330774134721261,"score_gpt":0.23861317385633846,"score_spread":0.23028239972161718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402259999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803664,0.009330223,0.0029515785,0.003913816,0.00028924088,0.00033142776,0.00002684511,0.000043649703,0.002746826],"genre_scores_gemma":[0.9980702,0.00024352966,0.00023293654,0.00059187855,0.00007722715,0.000023609533,0.000029396078,0.000008647896,0.00072260894],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937433,0.000042927004,0.00015538062,0.00022107728,0.00008339102,0.00012292134],"domain_scores_gemma":[0.9996744,0.000017933316,0.000042488286,0.00020332276,0.000029472798,0.000032385356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013833254,0.00009447896,0.00011070426,0.000027584781,0.000066173554,0.00002989129,0.000092449576,0.000113385446,0.00008803685],"category_scores_gemma":[0.00006227108,0.00005843297,0.00007434774,0.00010016455,0.000107639564,0.000003899847,0.00008090972,0.000073760006,0.000014389973],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003019594,0.00014459887,0.002065289,0.00043969354,0.00032612868,0.00004166344,0.0006964435,0.000008978259,0.79280555,0.032115873,0.15227732,0.018776521],"study_design_scores_gemma":[0.00017036921,0.00030940835,0.0006449426,0.000024796858,0.000032036936,0.00007179903,0.00025717026,0.00017449656,0.47696468,0.0014785647,0.5197355,0.0001362352],"about_ca_topic_score_codex":0.000008639433,"about_ca_topic_score_gemma":0.0000028952652,"teacher_disagreement_score":0.3674582,"about_ca_system_score_codex":0.000005707012,"about_ca_system_score_gemma":0.00004507743,"threshold_uncertainty_score":0.23828274},"labels":[],"label_agreement":null},{"id":"W4403497619","doi":"10.3324/haematol.2024.286532","title":"Pirtobrutinib: the ‘brute’ with a softer side","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Brute force; Side channel attack; Computer science; Computer security; Cryptography","score_opus":0.02305823980501282,"score_gpt":0.30563447598735743,"score_spread":0.2825762361823446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403497619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84228146,0.006484087,0.0009811211,0.027505385,0.0002741946,0.0012789303,0.000007213813,0.0009553028,0.1202323],"genre_scores_gemma":[0.9923067,0.00007372198,0.00065779407,0.0017006851,0.00012938541,0.00010785597,0.0000059689446,0.000031009546,0.0049868855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851906,0.00005484506,0.00019272826,0.000359938,0.00044600217,0.00042741996],"domain_scores_gemma":[0.9987895,0.00047441918,0.000022239557,0.00053235056,0.000058846672,0.00012267304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028299246,0.00016204298,0.000288583,0.00006878789,0.00010070212,0.000087406275,0.00018796102,0.000099362325,0.0006466003],"category_scores_gemma":[0.00017133799,0.00006882632,0.000097760174,0.00037185437,0.00032710633,0.000051749157,0.0001084081,0.00034878764,0.0013685508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049259914,0.0008689324,0.004099536,0.006063779,0.0024831635,0.15489374,0.0073259464,0.00006106888,0.0028652232,0.16973118,0.5613943,0.08528715],"study_design_scores_gemma":[0.013509812,0.0021517854,0.0037379884,0.0020152077,0.00060388306,0.1072999,0.0011654109,0.024407612,0.011188198,0.005527754,0.8275854,0.00080702343],"about_ca_topic_score_codex":0.000080204205,"about_ca_topic_score_gemma":0.000023465269,"teacher_disagreement_score":0.26619115,"about_ca_system_score_codex":0.0009985446,"about_ca_system_score_gemma":0.002284804,"threshold_uncertainty_score":0.999409},"labels":[],"label_agreement":null},{"id":"W4403497627","doi":"10.3324/haematol.2024.285893","title":"Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Observational study; Multiple myeloma; Refractory (planetary science); Medicine; Internal medicine; Oncology; Intensive care medicine; Astrobiology; Biology","score_opus":0.19924721023739833,"score_gpt":0.41256001151294147,"score_spread":0.21331280127554314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403497627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207413,0.00027559113,0.000087424,0.0034432064,0.000077524455,0.0034159203,0.000090628295,0.00017630191,0.0003592547],"genre_scores_gemma":[0.9934561,0.00029607533,0.0015190538,0.0005792185,0.000060502654,0.0013428832,0.0007698351,0.00003467993,0.001941639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980211,0.00026807107,0.00042720413,0.00043780953,0.0004206101,0.00042519925],"domain_scores_gemma":[0.99664444,0.002717934,0.00006163255,0.00037949576,0.00009876669,0.0000977185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006023097,0.00023145854,0.00042965042,0.0003953395,0.00015451421,0.00007283851,0.00020185126,0.00008442884,0.00022261383],"category_scores_gemma":[0.0004329758,0.0001171417,0.0001090444,0.0009329893,0.00007419769,0.00008250963,0.00003629847,0.0003085896,0.000057343186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012184064,0.0043069255,0.9469666,0.0004549855,0.0006772958,0.0074372487,0.0049782605,0.000023049932,0.00024968205,0.0020280005,0.014011571,0.0066823103],"study_design_scores_gemma":[0.010846894,0.0031581922,0.9343159,0.0002547098,0.0001015995,0.00016952617,0.0030313241,0.014641964,0.00017921938,0.0006893588,0.032384884,0.00022643329],"about_ca_topic_score_codex":0.0013267301,"about_ca_topic_score_gemma":0.0029073954,"teacher_disagreement_score":0.01837331,"about_ca_system_score_codex":0.00013021388,"about_ca_system_score_gemma":0.00016600285,"threshold_uncertainty_score":0.47769},"labels":[],"label_agreement":null},{"id":"W4404360765","doi":"10.3324/haematol.2024.285647","title":"Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionals","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Haemophilia; Mandate; Medicine; Health care; Universal design; Product (mathematics); Health professionals; Family medicine; Business; Nursing; Medical education; Political science; Pediatrics","score_opus":0.11528854909521859,"score_gpt":0.4207723818345558,"score_spread":0.3054838327393372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92779076,0.015220216,0.0000012377659,0.05123654,0.000058285685,0.0014589468,0.000021292288,0.00011181814,0.004100881],"genre_scores_gemma":[0.99663466,0.0015432034,0.00028466582,0.00010638284,0.000021692693,0.0002303519,0.00006335783,0.00002528309,0.0010904053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981663,0.00017500366,0.0003123721,0.0005153368,0.00043480168,0.000396182],"domain_scores_gemma":[0.99904853,0.00020017207,0.000053635827,0.0002375587,0.0002831242,0.0001769874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022791344,0.0002184398,0.00064152357,0.00031764034,0.000063563166,0.000020157977,0.00014634003,0.00016786065,0.000095364056],"category_scores_gemma":[0.00028408525,0.0001234723,0.00006772087,0.0007629937,0.0000728042,0.000088117304,0.00010307389,0.00023005865,0.00002990479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047905785,0.0067107235,0.7631933,0.00670131,0.0023937698,0.012770273,0.10977799,0.000006067808,0.00070733274,0.009860287,0.0020536643,0.08103469],"study_design_scores_gemma":[0.0041698115,0.0035100912,0.93952733,0.009576888,0.00017254551,0.00022093637,0.031381987,0.00002903124,0.00978633,0.0004543598,0.00073276326,0.0004379233],"about_ca_topic_score_codex":0.000074526004,"about_ca_topic_score_gemma":0.00044728463,"teacher_disagreement_score":0.17633401,"about_ca_system_score_codex":0.00039586227,"about_ca_system_score_gemma":0.00046492837,"threshold_uncertainty_score":0.5035054},"labels":[],"label_agreement":null},{"id":"W4404360795","doi":"10.3324/haematol.2024.285916","title":"Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with high-risk cytogenetics: the IFM 2014-01 study","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute","keywords":"Pomalidomide; Ixazomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Lenalidomide; Internal medicine; Refractory (planetary science); Cytogenetics; Carfilzomib; Biology; Genetics; Chromosome","score_opus":0.035197362417903034,"score_gpt":0.30476384999350237,"score_spread":0.2695664875755993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944193,0.001736152,0.000027497359,0.0008684463,0.00009064757,0.0024911151,0.00004483988,0.0001699865,0.0001520518],"genre_scores_gemma":[0.99570566,0.00092644343,0.0020382807,0.00010970596,0.00006353668,0.00048716847,0.000032530952,0.000051599658,0.0005850964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972513,0.0005510281,0.00045097608,0.00071656227,0.00046614904,0.0005640099],"domain_scores_gemma":[0.9973757,0.0015463169,0.00011408272,0.0006538162,0.000061746105,0.00024829587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006523854,0.00036016415,0.00078500825,0.00023101528,0.0001846735,0.0001044829,0.00018289867,0.0001567107,0.00036594618],"category_scores_gemma":[0.00079149054,0.00016663935,0.00007521283,0.0003872492,0.0002536564,0.000079384525,0.00015021524,0.0005892309,0.00018195288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016056303,0.001533753,0.93645996,0.00023024641,0.0008234708,0.017815601,0.0015245384,0.000002162682,0.0032232627,0.00005387198,0.00039140208,0.021885408],"study_design_scores_gemma":[0.014745299,0.004348467,0.97380924,0.0002914389,0.00027723968,0.0010833426,0.0011569415,0.0006528215,0.002040903,0.00006047198,0.001275274,0.0002585388],"about_ca_topic_score_codex":0.00067270035,"about_ca_topic_score_gemma":0.0010564035,"teacher_disagreement_score":0.037349284,"about_ca_system_score_codex":0.00009291124,"about_ca_system_score_gemma":0.0001581342,"threshold_uncertainty_score":0.67953557},"labels":[],"label_agreement":null},{"id":"W4404360817","doi":"10.3324/haematol.2024.286513","title":"Germline genetics, disease, and exposure to medication influence longitudinal dynamics of clonal hematopoiesis","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Advancing Translational Sciences; National Institute for Occupational Safety and Health; National Center for Research Resources; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Alexander and Margaret Stewart Trust","keywords":"Germline; Genetics; Disease; Biology; Haematopoiesis; Somatic evolution in cancer; Medicine; Internal medicine; Stem cell; Cancer; Gene","score_opus":0.020920657141438388,"score_gpt":0.3146771251211383,"score_spread":0.29375646797969995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98276454,0.004277017,0.0015601129,0.010516268,0.000053230036,0.00041190482,0.00005021528,0.000094735056,0.00027200129],"genre_scores_gemma":[0.994978,0.00049335544,0.0038631056,0.00024742572,0.000053795477,0.000051906092,0.000059163438,0.000017762644,0.0002354999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985571,0.000039016388,0.00034236128,0.00038612323,0.00042934105,0.0002460752],"domain_scores_gemma":[0.9989101,0.00018511388,0.000045478017,0.00034329938,0.00016365865,0.00035232335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024690919,0.00014674127,0.00035844703,0.00018685302,0.000048013782,0.000024187573,0.00014071804,0.00010603562,0.00015522305],"category_scores_gemma":[0.00047569544,0.0001103989,0.000062578845,0.00033883005,0.00025115637,0.000054782813,0.00016948872,0.00020828542,0.00005497779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001453969,0.00043812,0.8758575,0.008183118,0.00061600795,0.0050253654,0.000975786,0.00015499465,0.0062669083,0.06883993,0.01460352,0.01758481],"study_design_scores_gemma":[0.0006599583,0.0006468651,0.97673213,0.0009408425,0.00027986098,0.0012865798,0.0001604353,0.012418547,0.0016452755,0.003286645,0.0016697787,0.00027304806],"about_ca_topic_score_codex":0.000018006069,"about_ca_topic_score_gemma":0.000014987199,"teacher_disagreement_score":0.10087469,"about_ca_system_score_codex":0.00010546772,"about_ca_system_score_gemma":0.0002507324,"threshold_uncertainty_score":0.45019364},"labels":[],"label_agreement":null},{"id":"W4404585739","doi":"10.3324/haematol.2024.286587","title":"Arkadia: a new player in hematopoietic stem and progenitor cell development","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Agricultural Research Institute of Ontario","funders":"","keywords":"Progenitor cell; Haematopoiesis; Stem cell; Progenitor; Hematopoietic stem cell; Biology; Immunology; Cell biology","score_opus":0.016754458777951856,"score_gpt":0.24081958636144776,"score_spread":0.2240651275834959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404585739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671598,0.016700428,0.00013211639,0.011778662,0.00017400694,0.0003631277,3.858008e-7,0.00027112893,0.0034203103],"genre_scores_gemma":[0.994888,0.00029911505,0.0018948045,0.00028337055,0.00001907885,0.000025931608,0.0000018486762,0.000010328374,0.002577536],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992334,0.0000139805015,0.00021171955,0.0002609048,0.00007473827,0.00020523532],"domain_scores_gemma":[0.9997204,0.000042090272,0.000018849674,0.000121706,0.000007870931,0.00008909566],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00008459788,0.00012073669,0.00026233957,0.00013529178,0.0000367306,0.0000134977545,0.000050513274,0.0014264793,0.0001020195],"category_scores_gemma":[0.000009384773,0.00008076944,0.000031348824,0.00020288624,0.00006298171,0.000023609553,0.00004851151,0.0010459474,0.00021753128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017898787,0.0029396603,0.14016853,0.018715587,0.0017757269,0.11033335,0.039295025,0.000007755664,0.03257287,0.15151915,0.13994947,0.36093298],"study_design_scores_gemma":[0.0046494906,0.00095968886,0.017555911,0.003943962,0.0003633494,0.025731789,0.0023993377,0.00048686337,0.5503578,0.0039949734,0.38835117,0.0012056651],"about_ca_topic_score_codex":0.000003600971,"about_ca_topic_score_gemma":0.000005133009,"teacher_disagreement_score":0.51778495,"about_ca_system_score_codex":0.000021735668,"about_ca_system_score_gemma":0.00013697072,"threshold_uncertainty_score":0.9998699},"labels":[],"label_agreement":null},{"id":"W4404588201","doi":"10.3324/haematol.2024.286018","title":"Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Chemotherapy; Daunorubicin; Myeloid leukemia; Leukemia; Drug resistance; Cancer research; Immune system; Cell; Immunology; Biology; Doxorubicin; Medicine; Internal medicine; Genetics","score_opus":0.01313633930100579,"score_gpt":0.2218791358512197,"score_spread":0.2087427965502139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404588201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877245,0.0067924857,0.00059469865,0.0008351279,0.0008116461,0.00063022063,0.00031752238,0.00035962646,0.0008862483],"genre_scores_gemma":[0.99675757,0.0011671401,0.00018600831,0.00038341264,0.000038275826,0.000037231457,0.00041901838,0.00006363642,0.00094773417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99674207,0.00094666786,0.00057597057,0.00085050194,0.00011941069,0.0007653933],"domain_scores_gemma":[0.99828124,0.00088654656,0.00017046963,0.0004948168,0.00008063755,0.00008629302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090427924,0.00058765174,0.0010474446,0.00020411999,0.00047119654,0.00014786975,0.000310849,0.0004454384,0.0004169052],"category_scores_gemma":[0.000020151525,0.00045110608,0.00044593532,0.0003092421,0.00025858157,0.00028533826,0.00013916176,0.0004911762,0.00048725697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006619185,0.00019489364,0.00016899314,0.00011898904,0.00044534542,0.000088585984,0.0021324132,0.00004322465,0.9917407,0.000046018697,0.0022803282,0.0020785586],"study_design_scores_gemma":[0.0010969838,0.00012880324,0.00094421237,0.00027368005,0.00016989307,0.0007699203,0.0006757416,0.00055299595,0.9808243,0.00003602989,0.013954193,0.0005732359],"about_ca_topic_score_codex":0.0011396828,"about_ca_topic_score_gemma":0.00005827452,"teacher_disagreement_score":0.011673865,"about_ca_system_score_codex":0.00019291331,"about_ca_system_score_gemma":0.000107886095,"threshold_uncertainty_score":0.99979407},"labels":[],"label_agreement":null},{"id":"W4404806732","doi":"10.3324/haematol.2024.285874","title":"Intracranial hemorrhage before start of prophylaxis in children with hemophilia: incidence, timing, and potential for prevention","year":2024,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novo Nordisk; Sanofi; Swedish Orphan Biovitrum; CSL Behring; Bayer; Pfizer","keywords":"Medicine; Incidence (geometry); Pediatrics; Cumulative incidence; Population; Intracranial haemorrhage; Surgery; Complication","score_opus":0.018633915529934354,"score_gpt":0.29656158599412163,"score_spread":0.27792767046418726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404806732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679065,0.0005431657,0.00031433342,0.00064140826,0.00003137306,0.0014826513,0.000015590851,0.000048392718,0.00013241947],"genre_scores_gemma":[0.9941307,0.000036918515,0.0050654565,0.000010464567,0.00006033179,0.00010242068,0.00005021477,0.000015603075,0.0005279264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897105,0.000029539056,0.00023618921,0.0003062122,0.00022319726,0.00023379328],"domain_scores_gemma":[0.99966335,0.000032696353,0.0000370975,0.0001382439,0.000056291592,0.00007229031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018865839,0.00013525486,0.0003503052,0.00018382925,0.000046975765,0.000020226958,0.000056162255,0.00013057752,0.00006927838],"category_scores_gemma":[0.00005050045,0.00008107587,0.000068800306,0.00023160689,0.00015263537,0.00008174601,0.000041023464,0.0001724788,0.000006182915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034524156,0.0016107099,0.75449914,0.0054004085,0.00062374293,0.0047797873,0.0011589141,0.000012463872,0.005036307,0.0023976448,0.0002612125,0.22076726],"study_design_scores_gemma":[0.012992082,0.032163095,0.87362736,0.0029194397,0.000897758,0.021917136,0.00050300057,0.01645683,0.024164235,0.013399271,0.00018116653,0.0007785996],"about_ca_topic_score_codex":0.000018881343,"about_ca_topic_score_gemma":0.00002841713,"teacher_disagreement_score":0.21998866,"about_ca_system_score_codex":0.000029748866,"about_ca_system_score_gemma":0.00008807606,"threshold_uncertainty_score":0.33061782},"labels":[],"label_agreement":null},{"id":"W4404888990","doi":"10.3324/haematol.2023.284612","title":"Minor trauma and venous thromboembolism: the threshold for antithrombotic prophylaxis","year":2024,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Ambulatory; Venous thromboembolism; Minor (academic); Antithrombotic; Intensive care medicine; Major trauma; Emergency medicine; Surgery; Internal medicine; Thrombosis","score_opus":0.08985798920612728,"score_gpt":0.37256239612054776,"score_spread":0.28270440691442045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404888990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004078083,0.9870076,0.000020092873,0.0006412859,0.00076877343,0.0072973785,0.000076893004,0.00024324385,0.0035368958],"genre_scores_gemma":[0.0018685828,0.99397093,0.0004885727,0.00042125618,0.00038479574,0.0019510499,0.00009769133,0.0001486934,0.0006684444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969681,0.00008776788,0.0008609382,0.0010356964,0.00035311462,0.00069437973],"domain_scores_gemma":[0.99820584,0.00029442675,0.00029861165,0.0009441336,0.00007825702,0.00017872277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045742284,0.00081753585,0.005266068,0.00024302091,0.0003245081,0.00019330636,0.00041634947,0.0005667676,0.0001106912],"category_scores_gemma":[0.00011499754,0.00040494863,0.0009808184,0.00041755068,0.00038291104,0.000051462554,0.00031129073,0.00066146004,0.00028946408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017116743,0.00096333015,0.000004654214,0.15031613,0.0022396478,0.0005584887,0.0003648888,1.9148065e-7,4.2763915e-7,0.028616192,0.051246297,0.7656726],"study_design_scores_gemma":[0.00030939968,0.0016084516,0.00010076201,0.013347055,0.0140791,0.0013746896,0.00011523122,0.000013128052,0.0000021219573,0.0016450335,0.9669062,0.00049883913],"about_ca_topic_score_codex":0.000021200347,"about_ca_topic_score_gemma":0.000013014427,"teacher_disagreement_score":0.9156599,"about_ca_system_score_codex":0.00009418223,"about_ca_system_score_gemma":0.00017433177,"threshold_uncertainty_score":0.99984026},"labels":[],"label_agreement":null},{"id":"W4407187841","doi":"10.3324/haematol.2024.287056","title":"Context and timing matters in acute myeloid leukemia: females are the superior hosts","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Context (archaeology); Myeloid; Leukemia; Medicine; Biology; Immunology","score_opus":0.034466295304956554,"score_gpt":0.31275989987857,"score_spread":0.27829360457361346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407187841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93640643,0.0017365646,0.000043477758,0.05886198,0.000068078254,0.000685382,0.0000071747904,0.0000764554,0.002114457],"genre_scores_gemma":[0.9859109,0.00058946706,0.00038348758,0.011025164,0.0000208918,0.00011718223,0.000007927879,0.00001665214,0.0019283622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847513,0.00012565657,0.0003260413,0.0004012478,0.00021076604,0.00046112758],"domain_scores_gemma":[0.9989166,0.00042940574,0.00006629914,0.00042411237,0.00006698248,0.00009656304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003434711,0.00021412046,0.00059436803,0.00020857621,0.00017838558,0.00005658211,0.00024575333,0.00020000609,0.000092088085],"category_scores_gemma":[0.00029338172,0.0001298727,0.00007571128,0.0004050152,0.00042858892,0.00007348566,0.00028972427,0.0006003972,0.000082912346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017509115,0.00017922587,0.85932726,0.0012477369,0.00063457724,0.009958879,0.0030766325,0.000006799034,0.012088596,0.0074338624,0.07452885,0.029766686],"study_design_scores_gemma":[0.0070470595,0.0003378142,0.91546124,0.001991946,0.00033927785,0.004224835,0.01985241,0.0013577404,0.01411801,0.00079129945,0.033868928,0.0006094484],"about_ca_topic_score_codex":0.00015372741,"about_ca_topic_score_gemma":0.00012738128,"teacher_disagreement_score":0.05613399,"about_ca_system_score_codex":0.0003273005,"about_ca_system_score_gemma":0.0002482851,"threshold_uncertainty_score":0.5296055},"labels":[],"label_agreement":null},{"id":"W4407188092","doi":"10.3324/haematol.2024.286973","title":"Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Intracranial Hemorrhages; Cohort; Brain hemorrhage; Internal medicine; Surgery; Neurosurgery; Subarachnoid hemorrhage","score_opus":0.011169505612823797,"score_gpt":0.2769404697889744,"score_spread":0.2657709641761506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407188092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744004,0.000033080447,0.0004077916,0.00033426142,0.000037555947,0.0013785453,0.000012911696,0.00002383195,0.00033195643],"genre_scores_gemma":[0.993868,8.3137843e-7,0.0058155274,0.00011994424,0.0000048057163,0.000052705193,0.00008676171,0.000006051922,0.000045363235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988882,0.00013915311,0.00033349067,0.00024479063,0.0002619154,0.00013247153],"domain_scores_gemma":[0.9993194,0.00022792103,0.000115967574,0.00019120575,0.00011611788,0.000029428153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029095227,0.00012338407,0.00045791361,0.00017708952,0.00004547213,0.0000074922673,0.000046172372,0.000040299496,0.00009863589],"category_scores_gemma":[0.00030490747,0.00008280033,0.00003568998,0.00033376654,0.000042851887,0.00005016656,0.000033508004,0.00008362728,0.0000024764634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048190434,0.0038166689,0.989802,0.00007220958,0.00014238042,0.00018903111,0.00008215433,0.00004825188,0.000010513269,0.0002705999,0.00004257232,0.005041738],"study_design_scores_gemma":[0.006456375,0.00090950174,0.99149835,0.00008490687,0.00018949411,0.000015432688,0.00020471589,0.00041694453,0.00009523173,0.000054018517,0.000009914045,0.00006508721],"about_ca_topic_score_codex":0.000093513874,"about_ca_topic_score_gemma":0.00008282873,"teacher_disagreement_score":0.005974471,"about_ca_system_score_codex":0.000041128507,"about_ca_system_score_gemma":0.00003613855,"threshold_uncertainty_score":0.33764997},"labels":[],"label_agreement":null},{"id":"W4408204842","doi":"10.3324/haematol.2024.286019","title":"A machine learning approach for the rapid identification of measurable residual disease in acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Myeloid leukemia; Identification (biology); Minimal residual disease; Residual; Medicine; Disease; Leukemia; Myeloid; Immunology; Computational biology; Computer science; Internal medicine; Biology","score_opus":0.021884079648391796,"score_gpt":0.2579899449668189,"score_spread":0.2361058653184271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408204842","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09123343,0.012106552,0.87744296,0.0045315158,0.0003446948,0.0023575623,0.0000916498,0.000618982,0.011272655],"genre_scores_gemma":[0.99221903,0.000058271205,0.006759312,0.00012470265,0.000005082988,0.00021173956,0.000025026564,0.0000058537353,0.0005909987],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987531,0.000090862166,0.0003572945,0.0003668115,0.00020215251,0.00022978267],"domain_scores_gemma":[0.9988857,0.000282314,0.00015674937,0.0005335468,0.00008987457,0.00005180246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045808376,0.00012443807,0.00022453128,0.00013789903,0.0001444568,0.00017595488,0.0009618965,0.00003223416,0.0000025183695],"category_scores_gemma":[0.0006181724,0.00008675455,0.00009812429,0.00054195133,0.00011208374,0.00037512355,0.00024220718,0.00010500027,0.000003903627],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010474339,0.0019522646,0.073133394,0.0017491138,0.0006370491,0.00014483338,0.0012192575,0.053773694,0.0034760789,0.7151495,0.009005948,0.1387114],"study_design_scores_gemma":[0.0014881291,0.00009065519,0.052887365,0.00013254973,0.0002020515,0.000020673944,0.0001188042,0.90066767,0.010065828,0.031717855,0.0022160409,0.00039237837],"about_ca_topic_score_codex":0.000028682749,"about_ca_topic_score_gemma":0.0000018015171,"teacher_disagreement_score":0.9009856,"about_ca_system_score_codex":0.000041382773,"about_ca_system_score_gemma":0.00016695961,"threshold_uncertainty_score":0.35377482},"labels":[],"label_agreement":null},{"id":"W4408415307","doi":"10.3324/haematol.2024.287057","title":"Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptides","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Agence Nationale de la Recherche","keywords":"Transplacental; Immune tolerance; Immune system; Offspring; Immunology; Antibody; Von Willebrand factor; Fetus; Placenta; Biology; Pregnancy; Platelet; Genetics","score_opus":0.0381505450178042,"score_gpt":0.3281099921600438,"score_spread":0.2899594471422396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408415307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484813,0.0015922002,0.00013974258,0.0013714668,0.00006521797,0.0013368916,0.0001700993,0.000050036244,0.00042620086],"genre_scores_gemma":[0.9953214,0.00039236012,0.00045772785,0.000074521624,0.000008205836,0.000053550266,0.000044808356,0.000017357677,0.0036301014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810874,0.0002103311,0.0006730971,0.00029899416,0.00037745966,0.00033134985],"domain_scores_gemma":[0.9985744,0.0005924304,0.00014905505,0.0004342578,0.00015851653,0.00009136033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020530104,0.00023437107,0.0008257531,0.00028111908,0.000107147374,0.00000955148,0.00018860765,0.0001973043,0.00068975415],"category_scores_gemma":[0.00017066614,0.00014054909,0.00024042786,0.00041028942,0.00023106208,0.0000529187,0.000056067303,0.00014392794,0.000028956338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018705497,0.00060094555,0.014022018,0.00046350394,0.00036053298,0.00007570098,0.00090759277,5.599005e-7,0.9593239,0.00017609655,0.00031640398,0.005047251],"study_design_scores_gemma":[0.003228303,0.0015164189,0.29436564,0.0006611242,0.00011191506,0.000048116875,0.00053991936,0.000029738598,0.69875354,0.000053786756,0.0005510808,0.00014042247],"about_ca_topic_score_codex":0.000071279654,"about_ca_topic_score_gemma":0.000013669049,"teacher_disagreement_score":0.28034365,"about_ca_system_score_codex":0.000095074785,"about_ca_system_score_gemma":0.00021419553,"threshold_uncertainty_score":0.75523245},"labels":[],"label_agreement":null},{"id":"W4408675643","doi":"10.3324/haematol.2024.287200","title":"Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplantineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Lenalidomide; Hazard ratio; Internal medicine; Multiple myeloma; Confidence interval; Adverse effect; Odds ratio; Bortezomib","score_opus":0.03638377731833328,"score_gpt":0.32255061909428157,"score_spread":0.2861668417759483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408675643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328667,0.000559432,0.0012674645,0.00089093554,0.000116187504,0.0031115483,0.00030028546,0.000047614667,0.00041988282],"genre_scores_gemma":[0.9964183,0.00017781656,0.0020510461,0.00038136917,0.000022027056,0.00046550608,0.00021314477,0.000014386655,0.00025640344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979196,0.00016921738,0.00061611313,0.00048901344,0.00035828305,0.00044774325],"domain_scores_gemma":[0.99715894,0.0017270948,0.00020967993,0.00053342636,0.00022410291,0.00014677865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030855287,0.00026369665,0.0012244566,0.0003689747,0.00019721489,0.00002816693,0.00021280923,0.0001693566,0.000054733748],"category_scores_gemma":[0.0019330234,0.00015617465,0.0005468627,0.0010784211,0.00022440038,0.0000616667,0.00008714057,0.00017304474,0.0000023774874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13977677,0.0023780281,0.8350849,0.00076334225,0.0064409515,0.000097392505,0.00043043017,0.000025187319,0.0008918807,0.00070270355,0.002263496,0.011144928],"study_design_scores_gemma":[0.24765043,0.0011146137,0.72799426,0.00023298927,0.004602249,0.000009601648,0.000146458,0.006024304,0.009885661,0.00021466627,0.0018881952,0.00023658943],"about_ca_topic_score_codex":0.00055345986,"about_ca_topic_score_gemma":0.00040587448,"teacher_disagreement_score":0.10787366,"about_ca_system_score_codex":0.00006196275,"about_ca_system_score_gemma":0.00016008329,"threshold_uncertainty_score":0.63686174},"labels":[],"label_agreement":null},{"id":"W4409778054","doi":"10.3324/haematol.2024.287280","title":"Changes in cardiac parameters during venetoclax treatment","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Venetoclax; Medicine; Intensive care medicine; Internal medicine; Oncology; Leukemia","score_opus":0.022309197668820623,"score_gpt":0.28453893987424644,"score_spread":0.26222974220542583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409778054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234265,0.00041087298,0.0000117213085,0.0014946541,0.00010903979,0.0004798603,0.000002563868,0.000070046626,0.005078579],"genre_scores_gemma":[0.99812603,0.00045471903,0.00029845812,0.00035187718,0.000022584421,0.00013514327,0.000010518073,0.0000059596186,0.0005946886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937874,0.00004313645,0.00012197524,0.00020400196,0.00007320294,0.00017891896],"domain_scores_gemma":[0.99967575,0.000047444755,0.000027677883,0.00019588607,0.00001448613,0.0000387613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006543464,0.00010940953,0.0003968053,0.000120217985,0.00003996646,0.000008230549,0.000033680313,0.00011178842,0.00002047332],"category_scores_gemma":[0.000032565866,0.0000866869,0.000105738225,0.0001957909,0.00003528549,0.000017106311,0.000013319837,0.00007534117,0.0000124819835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010114767,0.00041504414,0.167545,0.00073251553,0.0007464324,0.0009546413,0.0019044809,0.00011561466,0.76970845,0.0029799957,0.0005332338,0.053353116],"study_design_scores_gemma":[0.0012803162,0.00015738783,0.08226512,0.0001919827,0.000054448414,0.000041944266,0.00021433244,0.00002320793,0.91360646,0.00026871363,0.0018060628,0.00009000517],"about_ca_topic_score_codex":0.000060848615,"about_ca_topic_score_gemma":0.000056506797,"teacher_disagreement_score":0.14389804,"about_ca_system_score_codex":0.00032948682,"about_ca_system_score_gemma":0.000057960988,"threshold_uncertainty_score":0.35349894},"labels":[],"label_agreement":null},{"id":"W4410414256","doi":"10.3324/haematol.2024.287141","title":"Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND study","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Cohort; Population; Progression-free survival; Retrospective cohort study; Surgery; Overall survival; Multiple myeloma","score_opus":0.10806593627858142,"score_gpt":0.3951758313215723,"score_spread":0.2871098950429909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410414256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341,0.0011384521,0.0000036153524,0.0012891535,0.00023143094,0.0013187333,0.0002293369,0.000054707816,0.0023245565],"genre_scores_gemma":[0.9965003,0.0007194826,0.00037946203,0.00069132174,0.000059239723,0.00010977545,0.0001830591,0.000019147874,0.0013381772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684024,0.00038407888,0.0012029118,0.0008265411,0.00036166032,0.00038455048],"domain_scores_gemma":[0.99398005,0.0031717967,0.00037584812,0.0022810712,0.000078659854,0.00011257652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009433183,0.00030038675,0.0014118245,0.00014094255,0.000105267405,0.000025115138,0.0006902224,0.00016692329,0.00021127508],"category_scores_gemma":[0.0008704516,0.00015794182,0.00016691115,0.0005600296,0.00019312993,0.00006653299,0.0007021858,0.00020596031,0.00007843519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039427495,0.01940353,0.96034074,0.000038950733,0.00050774426,0.0020242454,0.0003938399,4.1516137e-7,0.000008683669,0.00059383345,0.005829655,0.0069156364],"study_design_scores_gemma":[0.036475305,0.00077834015,0.95654464,0.00035279963,0.000607462,0.000014893735,0.0014304313,0.00010014852,0.00013556604,0.0001857382,0.0032283529,0.00014634701],"about_ca_topic_score_codex":0.005050417,"about_ca_topic_score_gemma":0.021324279,"teacher_disagreement_score":0.032532554,"about_ca_system_score_codex":0.00021933788,"about_ca_system_score_gemma":0.00037621846,"threshold_uncertainty_score":0.996534},"labels":[],"label_agreement":null},{"id":"W4410617859","doi":"10.3324/haematol.2024.286963","title":"Anticoagulant treatment for isolated distal deep vein thrombosis: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Fondazione Cariplo","keywords":"Medicine; Deep vein; Thrombosis; Incidence (geometry); Pulmonary embolism; Relative risk; Internal medicine; Surgery; Anticoagulant; Meta-analysis; Post-thrombotic syndrome; Randomized controlled trial; Confidence interval","score_opus":0.13991649110288945,"score_gpt":0.4058915410669656,"score_spread":0.26597504996407617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410617859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.855002e-7,0.9809226,0.00071802473,0.00058402546,0.000037864538,0.016986452,0.00022308198,0.00012259027,0.0004050104],"genre_scores_gemma":[0.000040779414,0.9854079,0.00049169245,0.00088716403,0.000011581384,0.011514195,0.0005662493,0.00004125191,0.0010392013],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962135,0.00038729506,0.0017174184,0.00096763996,0.00024874165,0.0004653898],"domain_scores_gemma":[0.99701697,0.00063216547,0.00088467106,0.0011724804,0.00011953418,0.00017420553],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00046747344,0.0009218336,0.029280376,0.00043304233,0.0001614522,0.00007296278,0.00024159784,0.00032144494,0.00032386684],"category_scores_gemma":[0.0002953574,0.0004696115,0.0060657007,0.0008806517,0.000072376686,0.00003575646,0.00014583128,0.00014301186,0.00003445007],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023228283,0.00042090766,2.550501e-7,0.6994773,0.29781592,0.00005927138,0.00001860308,8.622652e-8,6.8387824e-9,0.00079615443,0.0006409318,0.0007682019],"study_design_scores_gemma":[0.00020789707,0.0004189668,0.0000013295069,0.08240234,0.8761044,0.00010006538,0.000020048681,0.000016737995,1.3312665e-7,0.000025692383,0.040359214,0.0003431818],"about_ca_topic_score_codex":0.00003044761,"about_ca_topic_score_gemma":0.000030238816,"teacher_disagreement_score":0.61707497,"about_ca_system_score_codex":0.00013805853,"about_ca_system_score_gemma":0.000113419206,"threshold_uncertainty_score":0.9997756},"labels":[],"label_agreement":null},{"id":"W4410869236","doi":"10.3324/haematol.2024.287136","title":"T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Rijksinstituut voor Volksgezondheid en Milieu; Leids Universitair Medisch Centrum; Universitair Medisch Centrum Groningen; ZonMw; H2020 European Research Council; Genentech; Celgene; Gilead Sciences; Amsterdam University Medical Centers; Eli Lilly and Company","keywords":"Antibody; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Immunology; Hematologic Neoplasms; 2019-20 coronavirus outbreak; Medicine; Hematology; Biology; Cancer; Infectious disease (medical specialty); Disease; Genetics; Outbreak; Internal medicine","score_opus":0.027397590929468935,"score_gpt":0.3283156643040673,"score_spread":0.30091807337459836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410869236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995925,0.0012746351,0.00009635695,0.00022753337,0.000045365156,0.0009980696,0.000011395411,0.00006757007,0.0013540448],"genre_scores_gemma":[0.9978494,0.00002744162,0.0004969526,0.0015060754,0.0000056389486,0.00006320055,0.0000102487,0.000015941097,0.000025068666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979847,0.00017274784,0.0005570336,0.00048074013,0.00034130743,0.00046347585],"domain_scores_gemma":[0.9989438,0.00020657512,0.00021187241,0.00042221305,0.00019184977,0.000023711722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029395105,0.0002784723,0.00089640124,0.00055963657,0.00009658087,0.000031133986,0.00025366468,0.00020098944,0.0000069213866],"category_scores_gemma":[0.00022538514,0.0001886592,0.00008626184,0.00061542576,0.00029490612,0.00009251169,0.00021824025,0.00028787006,0.000009730011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037355851,0.0006014175,0.6757933,0.000590999,0.0000628204,0.00029005064,0.00008741761,2.0929735e-7,0.31832024,0.00027572952,0.00007311412,0.00016911661],"study_design_scores_gemma":[0.0059813815,0.0006471991,0.50719154,0.00042231515,0.00006879071,0.00007952293,0.00020474853,0.000054712127,0.48458332,0.000269735,0.00031822833,0.0001785272],"about_ca_topic_score_codex":0.00012780387,"about_ca_topic_score_gemma":0.000019045143,"teacher_disagreement_score":0.16860178,"about_ca_system_score_codex":0.00003818635,"about_ca_system_score_gemma":0.00021592352,"threshold_uncertainty_score":0.7693299},"labels":[],"label_agreement":null},{"id":"W4411460229","doi":"10.3324/haematol.2025.288065","title":"Olverembatinib in chronic myeloid leukemia: is less actually better?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Cancer research; Immunology","score_opus":0.02647662499174571,"score_gpt":0.2971282614366661,"score_spread":0.2706516364449204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411460229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539325,0.001652767,0.00008224186,0.0032324297,0.00017156138,0.0007682073,0.000010637709,0.00019621402,0.03995343],"genre_scores_gemma":[0.9901865,0.00028344762,0.0013035202,0.004011426,0.00006893226,0.0001499449,0.000040003804,0.0000253702,0.0039308346],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99777067,0.000072001814,0.00057707273,0.00065841427,0.0002964146,0.0006254094],"domain_scores_gemma":[0.998738,0.00020475547,0.00012635266,0.00074415474,0.00006362367,0.0001231366],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017543105,0.00035737327,0.0008689142,0.00028193902,0.00009585705,0.000026283746,0.00027062822,0.00037795017,0.0010016473],"category_scores_gemma":[0.00015537404,0.00028606714,0.00017767843,0.0005823932,0.00015036577,0.000060374732,0.00018168733,0.00052444066,0.00038804955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023585972,0.0020545728,0.3552573,0.0052967523,0.0021142324,0.014352934,0.004716166,0.00020871537,0.022782924,0.017326415,0.16199172,0.41153967],"study_design_scores_gemma":[0.06809964,0.0030060466,0.635715,0.008063315,0.0013729873,0.003103145,0.0026323714,0.009563877,0.118714534,0.01056215,0.13634497,0.0028219444],"about_ca_topic_score_codex":0.00021451767,"about_ca_topic_score_gemma":0.00021237691,"teacher_disagreement_score":0.40871772,"about_ca_system_score_codex":0.004502568,"about_ca_system_score_gemma":0.0019867586,"threshold_uncertainty_score":0.9999592},"labels":[],"label_agreement":null},{"id":"W4411701092","doi":"10.3324/haematol.2025.288157","title":"Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Erythropoietin; Myelodysplastic syndromes; Medicine; Oncology; Internal medicine; Bone marrow","score_opus":0.042568391868135026,"score_gpt":0.3386231535157654,"score_spread":0.29605476164763034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411701092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96805835,0.0015279291,0.0038878398,0.013190757,0.00034747686,0.0012753848,0.000014198167,0.00027796664,0.011420118],"genre_scores_gemma":[0.99063516,0.0011062288,0.003804226,0.0011678997,0.0000684505,0.00013441729,0.000015752357,0.000043689197,0.0030241713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971466,0.00023589893,0.0006269011,0.00071724656,0.0004750743,0.0007982644],"domain_scores_gemma":[0.99794453,0.0008908132,0.00016012088,0.0006973077,0.00011523854,0.00019196873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053386355,0.0003794121,0.00095856545,0.00050354464,0.00018040447,0.00004901865,0.00032061365,0.00037331035,0.0006690035],"category_scores_gemma":[0.0008536537,0.00029256777,0.0001954684,0.0010221893,0.00025264543,0.00007668344,0.00023360732,0.001076998,0.00032360345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071186656,0.0028972111,0.74801856,0.0027078234,0.0013478892,0.02501325,0.0022865192,0.005388657,0.007742477,0.010403084,0.09631721,0.09075866],"study_design_scores_gemma":[0.046886068,0.006313176,0.6083579,0.0096309725,0.0009455155,0.004611123,0.0049969926,0.15471986,0.009512036,0.014823147,0.1356765,0.0035266725],"about_ca_topic_score_codex":0.00010739009,"about_ca_topic_score_gemma":0.000027423566,"teacher_disagreement_score":0.14933121,"about_ca_system_score_codex":0.00048790485,"about_ca_system_score_gemma":0.0002652173,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W4412178506","doi":"10.3324/haematol.2025.288391","title":"Advancing quality of life research in chronic myeloid leukemia: where do we stand?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Myeloid leukemia; Medicine; Quality of life (healthcare); Internal medicine; Oncology; Nursing","score_opus":0.07511564801604897,"score_gpt":0.3993944169620986,"score_spread":0.3242787689460496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88772357,0.088368736,0.00007643029,0.003950424,0.00011340939,0.0009736548,0.000011854093,0.00009343658,0.018688517],"genre_scores_gemma":[0.98715913,0.010282397,0.0008954956,0.000062725805,0.000045224497,0.00011573752,0.0000056890203,0.000019024457,0.0014145453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663776,0.0004780346,0.00092381827,0.00059187127,0.0006241321,0.00074439857],"domain_scores_gemma":[0.9975966,0.0009650605,0.00017486632,0.0008645935,0.00022287012,0.00017599779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016749613,0.00024110309,0.0011056224,0.00043403183,0.00010690775,0.00001570545,0.00027294326,0.00032809665,0.0004764306],"category_scores_gemma":[0.0010949679,0.00019157038,0.00014532589,0.0011533991,0.00030828477,0.00008264639,0.00026227027,0.0008105519,0.00008130277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008073397,0.002578928,0.6120024,0.04903852,0.0013740944,0.003581498,0.00302541,0.00068790745,0.040825427,0.0919862,0.06710193,0.11972431],"study_design_scores_gemma":[0.08202169,0.0052345535,0.4124309,0.04797193,0.00046133433,0.0005111664,0.015195068,0.002302175,0.06340337,0.035568986,0.3326932,0.002205629],"about_ca_topic_score_codex":0.00062436,"about_ca_topic_score_gemma":0.0006784315,"teacher_disagreement_score":0.26559126,"about_ca_system_score_codex":0.0063228887,"about_ca_system_score_gemma":0.0059038787,"threshold_uncertainty_score":0.9997317},"labels":[],"label_agreement":null},{"id":"W4412178530","doi":"10.3324/haematol.2025.287772","title":"Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Respiratory Research Network","funders":"","keywords":"Medicine; Tolerability; Family medicine; Quality of life (healthcare); Disease; Myeloid leukemia; Internal medicine; Nursing; Adverse effect","score_opus":0.036523565505358006,"score_gpt":0.28499122384251957,"score_spread":0.24846765833716156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381506,0.0031982802,0.00006403183,0.0002490835,0.00011952104,0.00085988926,0.00020054197,0.00005034378,0.0014432403],"genre_scores_gemma":[0.99788225,0.00044516788,0.00018045049,0.0009522776,0.000019733403,0.000043855198,0.00022984964,0.000016361008,0.0002300729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997637,0.00067485997,0.000567889,0.00048314984,0.00031013196,0.000326972],"domain_scores_gemma":[0.99721867,0.0015920016,0.00028772358,0.00071324065,0.0000804772,0.00010788393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000840877,0.00029489605,0.0008158112,0.00009980863,0.00015274457,0.000029848625,0.00016275191,0.00013753198,0.000033032913],"category_scores_gemma":[0.0005471485,0.0001895769,0.00007475922,0.00040571898,0.000253955,0.0000407174,0.00031058313,0.00024284128,0.000009616262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010611033,0.00030480078,0.944618,0.0006284471,0.0008711135,0.000035166886,0.0004296897,0.000011918312,0.00047152129,0.0021511414,0.0026457955,0.046771333],"study_design_scores_gemma":[0.0029815543,0.00036117836,0.9940142,0.00026152647,0.00013306897,0.0000019153822,0.0003002802,0.00016190558,0.0012177905,0.00013862713,0.00026755332,0.00016036881],"about_ca_topic_score_codex":0.016376844,"about_ca_topic_score_gemma":0.0025984787,"teacher_disagreement_score":0.04939626,"about_ca_system_score_codex":0.0006249066,"about_ca_system_score_gemma":0.00031556495,"threshold_uncertainty_score":0.99017316},"labels":[],"label_agreement":null},{"id":"W4412178544","doi":"10.3324/haematol.2025.287777","title":"Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"Astellas Pharma; Alexion Pharmaceuticals; Amgen","keywords":"Myeloid leukemia; Medicine; Internal medicine; Oncology","score_opus":0.019669385114657715,"score_gpt":0.2956154064342636,"score_spread":0.2759460213196059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993105,0.000011517203,0.00019506947,0.00029188488,0.000111952264,0.00482874,0.00005913927,0.00006358815,0.0013331217],"genre_scores_gemma":[0.99775624,0.000038089307,0.0005886671,0.0000793555,0.000020593401,0.00052705605,0.000080539736,0.00001867655,0.0008907672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981104,0.00021875641,0.00051196077,0.00040765852,0.0004458209,0.00030538443],"domain_scores_gemma":[0.99836487,0.0003782356,0.0002686575,0.00063268334,0.00029812122,0.00005744172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040299798,0.000190159,0.0005297616,0.00031478624,0.00015945327,0.000016597678,0.00026247857,0.00012308377,0.000026064237],"category_scores_gemma":[0.00053169037,0.00010965346,0.000079751044,0.0010702622,0.00011654188,0.000090483576,0.00013858851,0.0003805387,0.0000045690267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021872057,0.0006715561,0.99111164,0.00011807507,0.00019854857,0.00001861621,0.0004003849,0.00013933824,0.00006778049,0.0001946533,0.0033675446,0.0015246868],"study_design_scores_gemma":[0.012460475,0.0014421284,0.9824381,0.0002629241,0.0003341084,0.0000026662133,0.00038939685,0.0005443921,0.0017076841,0.00018565268,0.00014453789,0.000087942106],"about_ca_topic_score_codex":0.000843051,"about_ca_topic_score_gemma":0.000723323,"teacher_disagreement_score":0.010273268,"about_ca_system_score_codex":0.00059782784,"about_ca_system_score_gemma":0.0004188434,"threshold_uncertainty_score":0.44715384},"labels":[],"label_agreement":null},{"id":"W4412178557","doi":"10.3324/haematol.2025.288026","title":"&lt;i&gt;CSF3R&lt;/i&gt; mutations and variants in myeloid neoplasms: associated phenotypes, comutations, and survival trends","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Phenotype; Myeloid; Genetics; Biology; Cancer research; Oncology; Medicine; Gene","score_opus":0.018981944478283434,"score_gpt":0.2943129052595669,"score_spread":0.27533096078128344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549103,0.0019367293,0.0003747734,0.0066450937,0.0001435037,0.0005109322,0.000073754556,0.00018658247,0.035218373],"genre_scores_gemma":[0.9925602,0.00045067954,0.0014678875,0.00041765376,0.000020504242,0.00009154164,0.00023290774,0.000022885259,0.004735744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781036,0.00031966204,0.0005030578,0.0005323187,0.000326318,0.0005082578],"domain_scores_gemma":[0.99821055,0.00097462995,0.0001436118,0.00030961746,0.00017380579,0.00018780833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006315761,0.00026033132,0.0007343095,0.0006401637,0.00025412635,0.00006685891,0.00014530745,0.000314851,0.00021465348],"category_scores_gemma":[0.0019778505,0.00022669822,0.000057199548,0.0012867773,0.00033732574,0.00012365406,0.00017296313,0.00042679856,0.0000346754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026492334,0.0034491147,0.39762977,0.0014532098,0.0023951072,0.008971016,0.0074174586,0.00012873675,0.034852218,0.33988202,0.076095454,0.12507668],"study_design_scores_gemma":[0.007676958,0.0003241041,0.9686683,0.00033312166,0.0002668123,0.000511954,0.0005176402,0.005807592,0.00027786833,0.0048097256,0.010386618,0.0004193427],"about_ca_topic_score_codex":0.00007691262,"about_ca_topic_score_gemma":0.0008321596,"teacher_disagreement_score":0.5710385,"about_ca_system_score_codex":0.00023595158,"about_ca_system_score_gemma":0.00034522882,"threshold_uncertainty_score":0.9244485},"labels":[],"label_agreement":null},{"id":"W4412488863","doi":"10.3324/haematol.2025.287351","title":"Bispecific antibody therapy-associated opportunistic infections: cytomegalovirus retinitis and chronic salmonellosis in a non-HIV patient","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cytomegalovirus retinitis; Retinitis; Medicine; Cytomegalovirus; Antibody; Human immunodeficiency virus (HIV); Virology; Immunology; AIDS-Related Opportunistic Infections; Opportunistic infection; Sida; Human cytomegalovirus; Viral disease; Virus; Herpesviridae","score_opus":0.03078206127885176,"score_gpt":0.3291933607798476,"score_spread":0.2984112995009959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412488863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97516197,0.002919817,0.00006910417,0.0013744464,0.00010948623,0.0011232867,0.000045014513,0.00012973095,0.019067159],"genre_scores_gemma":[0.98963827,0.008756087,0.00005817673,0.0004634644,0.000026066818,0.00018254106,0.00009161539,0.000025133897,0.00075864536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978419,0.0001535064,0.0005841878,0.0005532445,0.00029559055,0.0005715748],"domain_scores_gemma":[0.99885064,0.00030168556,0.00012358456,0.00040384856,0.00013985546,0.00018039909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035280452,0.00027958435,0.0007748869,0.00069488375,0.00022549015,0.00008150937,0.00012151402,0.00028809547,0.0005454028],"category_scores_gemma":[0.00034908977,0.00022931835,0.00012592912,0.0011383403,0.00026713012,0.000081191116,0.00014414739,0.0005409305,0.00011770019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019423196,0.0053581004,0.8324036,0.00089190895,0.0007494146,0.0055301087,0.0012025269,0.000008948545,0.03934547,0.0053680004,0.015135672,0.092063904],"study_design_scores_gemma":[0.012169051,0.004310787,0.85156727,0.0024931084,0.0001746192,0.00067687174,0.0008134781,0.0032137206,0.006949294,0.0020069683,0.1145531,0.0010717394],"about_ca_topic_score_codex":0.00034942955,"about_ca_topic_score_gemma":0.00025071664,"teacher_disagreement_score":0.099417426,"about_ca_system_score_codex":0.0003116108,"about_ca_system_score_gemma":0.0003274956,"threshold_uncertainty_score":0.9351331},"labels":[],"label_agreement":null},{"id":"W4412779709","doi":"10.3324/haematol.2025.288041","title":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"Sanofi","keywords":"Medicine; Multiple myeloma; Internal medicine; Hematopoietic cell; Cumulative incidence; Transplantation; Incidence (geometry); Population; Hematopoietic stem cell transplantation; Surgery; Gastroenterology; Haematopoiesis; Stem cell","score_opus":0.0236028157870531,"score_gpt":0.32334170441655197,"score_spread":0.2997388886294989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412779709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970847,0.00024133068,0.000021589029,0.00008328126,0.00004693481,0.0008663342,0.00004473942,0.0000249315,0.0015861691],"genre_scores_gemma":[0.9993726,0.00026849087,0.00006174396,0.000022261278,0.0000038490557,0.00015057839,0.000053997042,0.000007726442,0.00005873557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865323,0.00018788746,0.00033677262,0.0002692085,0.00023970768,0.00031320273],"domain_scores_gemma":[0.998711,0.0007761116,0.00007959563,0.00027979026,0.000057655896,0.00009586623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001727048,0.0001774408,0.00044515263,0.000112200985,0.00007932227,0.000019425426,0.000092368515,0.00010761528,0.000024198214],"category_scores_gemma":[0.00024096521,0.00009847137,0.000109514505,0.00019984337,0.0001653873,0.000037702266,0.000032616455,0.00015554758,0.000006820358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025029636,0.0007641087,0.99185884,0.00029601288,0.00008078734,0.0013087734,0.0002745624,0.0000076041715,0.000079860976,0.00006738119,0.00003742855,0.002721649],"study_design_scores_gemma":[0.0053588287,0.0004935961,0.99159354,0.00015669464,0.000040840103,0.000010857947,0.00008036205,0.00017670357,0.0017659916,0.00024332319,0.0000050704725,0.00007420935],"about_ca_topic_score_codex":0.0006644673,"about_ca_topic_score_gemma":0.000530174,"teacher_disagreement_score":0.0028558648,"about_ca_system_score_codex":0.000057252968,"about_ca_system_score_gemma":0.000060523584,"threshold_uncertainty_score":0.40155458},"labels":[],"label_agreement":null},{"id":"W4412779753","doi":"10.3324/haematol.2025.288227","title":"Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Minimal residual disease; Myeloid leukemia; Medicine; Residual; Window of opportunity; Intervention (counseling); Therapeutic window; Disease; Internal medicine; Oncology; Leukemia; Pediatrics; Computer science; Psychiatry; Algorithm; Pharmacology","score_opus":0.04320646628438361,"score_gpt":0.35392626466955174,"score_spread":0.3107197983851681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412779753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452496,0.00048532605,0.0006145511,0.0016672038,0.00006782735,0.001107948,0.00011612451,0.000026141106,0.0013899407],"genre_scores_gemma":[0.9964112,0.00016936855,0.0022342182,0.000113096736,0.0000136798635,0.00016438839,0.00009115112,0.0000090719805,0.0007938245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829674,0.00014647843,0.00069098425,0.0003208958,0.0002463902,0.00029850105],"domain_scores_gemma":[0.9985998,0.00035197253,0.0002206708,0.00040394044,0.00026242397,0.00016117585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006746781,0.00015023918,0.000673692,0.00036438974,0.000033489683,0.000005150262,0.00024751836,0.00015809087,0.00008693593],"category_scores_gemma":[0.0022664035,0.0001238836,0.000202103,0.00046746756,0.0002826212,0.0000703396,0.0001846272,0.00028976923,0.0000031515071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06573489,0.004833942,0.68898636,0.023350952,0.0014247478,0.0029622763,0.0015507785,0.000037146325,0.036119275,0.04130353,0.05495026,0.078745835],"study_design_scores_gemma":[0.016771998,0.0030024545,0.85638696,0.0055564772,0.00068108033,0.00013198894,0.0013240164,0.002514426,0.100112684,0.010670037,0.002375342,0.00047256524],"about_ca_topic_score_codex":0.000098635464,"about_ca_topic_score_gemma":0.000027420516,"teacher_disagreement_score":0.16740057,"about_ca_system_score_codex":0.00022813617,"about_ca_system_score_gemma":0.0011993669,"threshold_uncertainty_score":0.5051826},"labels":[],"label_agreement":null},{"id":"W4413796318","doi":"10.3324/haematol.2025.288203","title":"Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chimeric antigen receptor; TIGIT; Antigen; Immunology; B cell; Antibody; Multiple myeloma; T cell; CD19; Medicine; Cancer research; Immune system","score_opus":0.02896208532303257,"score_gpt":0.2932672466752372,"score_spread":0.2643051613522046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413796318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462706,0.0005261386,0.0002027224,0.0010135495,0.00027901545,0.0014198549,0.000024444982,0.00014885045,0.0017583924],"genre_scores_gemma":[0.9944666,0.00033463753,0.0006796157,0.0001559091,0.000035475343,0.00019805152,0.00014760841,0.000017563201,0.003964561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799454,0.00018283924,0.00056086556,0.00047480606,0.0003135935,0.00047335634],"domain_scores_gemma":[0.9989107,0.00029414578,0.00013948666,0.00043693208,0.00011071916,0.00010801968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027350808,0.0002562637,0.0006296906,0.00034449826,0.00016488382,0.0000441518,0.00015218156,0.00026394136,0.00019098139],"category_scores_gemma":[0.00045384647,0.00014830598,0.00010363831,0.000491126,0.00008138117,0.00012112587,0.0001057461,0.00032836024,0.00025406925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014685499,0.001611891,0.78511184,0.0020790882,0.0002633966,0.0058431,0.00039625115,0.000010539326,0.17580946,0.0004940497,0.0006278716,0.013067009],"study_design_scores_gemma":[0.010669184,0.00038570893,0.74866885,0.000978767,0.00006607575,0.0008695123,0.0007026712,0.0012749702,0.23560941,0.00007806339,0.0004520221,0.00024473792],"about_ca_topic_score_codex":0.0003585089,"about_ca_topic_score_gemma":0.00023061225,"teacher_disagreement_score":0.05979996,"about_ca_system_score_codex":0.00019875668,"about_ca_system_score_gemma":0.00017300026,"threshold_uncertainty_score":0.60477424},"labels":[],"label_agreement":null},{"id":"W4413798012","doi":"10.3324/haematol.2025.288379","title":"The age of fit-equity: ignoring age and fitness in treatment selection for chronic lymphocytic leukemia","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Chronic lymphocytic leukemia; Selection (genetic algorithm); Leukemia; Equity (law); Medicine; Internal medicine; Oncology; Gerontology; Computer science; Political science; Artificial intelligence","score_opus":0.059695221212627284,"score_gpt":0.37441940071600227,"score_spread":0.314724179503375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413798012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222124,0.00282518,0.00023751485,0.00025259441,0.00009345506,0.0013868741,0.000003504263,0.000055134144,0.0029244788],"genre_scores_gemma":[0.99590874,0.0010899651,0.00024407812,0.00006277824,0.000034410958,0.00039970383,0.000011484168,0.000012352803,0.0022364643],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985833,0.000064439315,0.00037962184,0.00032913074,0.00018922449,0.00045428908],"domain_scores_gemma":[0.99870545,0.0007922096,0.000073978874,0.0003103665,0.00006203103,0.00005598318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037701288,0.0001714442,0.0005282234,0.00014180926,0.00016785336,0.000032767162,0.00013959972,0.0001492634,0.000012913617],"category_scores_gemma":[0.00037345468,0.00010705459,0.00009456536,0.00038096157,0.00025584933,0.00003635318,0.00014395866,0.0001021914,0.0000032647588],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01721387,0.0013572602,0.028996268,0.026578672,0.0031510598,0.008181487,0.005747715,0.00685038,0.073942974,0.1356918,0.010105002,0.6821835],"study_design_scores_gemma":[0.20084561,0.009618582,0.038792323,0.00503082,0.001270878,0.0030495513,0.0021373027,0.38888693,0.2382809,0.021204054,0.089511834,0.0013712008],"about_ca_topic_score_codex":0.0014207824,"about_ca_topic_score_gemma":0.001737244,"teacher_disagreement_score":0.6808123,"about_ca_system_score_codex":0.049603876,"about_ca_system_score_gemma":0.009558349,"threshold_uncertainty_score":0.99605656},"labels":[],"label_agreement":null},{"id":"W4413994504","doi":"10.3324/haematol.2025.288332","title":"Caffeine impairs red blood cell storage quality by dual inhibition of ADORA2b signaling and G6PD activity","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute","keywords":"Caffeine; Red blood cell; Pharmacology; Medicine; Hematocrit; Hemolysis; Oxidative stress; Physiology; Immunology; Internal medicine","score_opus":0.014733884373006404,"score_gpt":0.29853938106728073,"score_spread":0.28380549669427435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413994504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580586,0.0013265113,0.000083662424,0.00095558475,0.000033739954,0.00026369432,0.00005796908,0.000056589306,0.0014163986],"genre_scores_gemma":[0.9988815,0.00006724852,0.00037910623,0.00024004745,0.00001830547,0.000008235275,0.000055348723,0.000005054317,0.00034510958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990033,0.000072345676,0.00029980228,0.0002675378,0.00015302356,0.00020401734],"domain_scores_gemma":[0.9993409,0.00012218945,0.00015513539,0.00018887804,0.000066942,0.00012594968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028948995,0.00013058887,0.00043260356,0.000040395873,0.00007037498,0.000005207942,0.00003115481,0.00018582337,0.000052162057],"category_scores_gemma":[0.00013017526,0.000104073384,0.000057120556,0.00015388409,0.00011162158,0.00003200806,0.00005583104,0.00019812296,0.0000014670325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067860173,0.0005264925,0.004813071,0.0035929978,0.000023131364,0.0001333544,0.00005086675,1.8230546e-7,0.98714286,0.000048627997,0.0019755908,0.0010142275],"study_design_scores_gemma":[0.001683183,0.00028555916,0.006049233,0.00020793627,0.00007762864,0.00008442776,0.00016738588,0.000017750765,0.99105644,0.00011283312,0.00015807069,0.00009956735],"about_ca_topic_score_codex":0.000091699236,"about_ca_topic_score_gemma":0.0000038128821,"teacher_disagreement_score":0.0039135683,"about_ca_system_score_codex":0.000022199736,"about_ca_system_score_gemma":0.00008716414,"threshold_uncertainty_score":0.42439893},"labels":[],"label_agreement":null},{"id":"W4413994539","doi":"10.3324/haematol.2023.283896","title":"CHIP ahoy: charting a decade of discovery in clonal hematopoiesis","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Disease; Clinical trial; Germline; Bioinformatics; Computational biology; Medicine; Genetics; Internal medicine; Gene","score_opus":0.025414745909700998,"score_gpt":0.32885372574500993,"score_spread":0.30343897983530893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413994539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768099,0.00062729855,0.00028596006,0.003929062,0.000045203433,0.00038734655,0.0000052922364,0.000052997017,0.017856933],"genre_scores_gemma":[0.99638593,0.00007001946,0.0015578463,0.0006084192,0.000020960926,0.000058387057,0.00000894489,0.000010703444,0.0012787639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847907,0.00008322425,0.0004897559,0.00030193786,0.00026314965,0.0003828595],"domain_scores_gemma":[0.99908304,0.00034321062,0.00009862992,0.00034329266,0.000065433516,0.000066376444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041516032,0.00014385863,0.00064656825,0.00033386715,0.0000467362,0.0000144228825,0.0001919365,0.00016152057,0.000120822806],"category_scores_gemma":[0.0010585915,0.000108383174,0.00012153542,0.00069584796,0.00017443052,0.00008921675,0.00020063792,0.0003632005,0.000034242654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002249466,0.0011357259,0.7667637,0.0035889063,0.00034049113,0.0026351337,0.0012273653,0.000016343723,0.058997918,0.14316459,0.013804286,0.0060760602],"study_design_scores_gemma":[0.0071606045,0.00045832386,0.6405855,0.0031301656,0.00016009001,0.0010746992,0.0019681407,0.001726364,0.32611927,0.01201732,0.0050710775,0.0005284733],"about_ca_topic_score_codex":0.00007571725,"about_ca_topic_score_gemma":0.000023344583,"teacher_disagreement_score":0.26712137,"about_ca_system_score_codex":0.00012907684,"about_ca_system_score_gemma":0.00030820974,"threshold_uncertainty_score":0.44197375},"labels":[],"label_agreement":null},{"id":"W4414133977","doi":"10.3324/haematol.2025.287910","title":"Blinatumomab restores asparaginase activity in pediatric B-cell acute lymphoblastic leukemia patients with PEG-Asparaginase hypersensitivity","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Sanming Project of Medicine in Shenzhen","keywords":"Blinatumomab; Lymphoblastic Leukemia; Asparaginase; Acute lymphocytic leukemia; Chemotherapy; Leukemia","score_opus":0.008894512271582146,"score_gpt":0.2574623038537237,"score_spread":0.24856779158214157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414133977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862427,0.00019149398,0.00061931496,0.0007528559,0.00018262438,0.001308378,0.00004222078,0.00023374837,0.010426623],"genre_scores_gemma":[0.9968565,0.00011073507,0.00095870375,0.00044255564,0.00005702383,0.00014813653,0.00006160495,0.00005158914,0.001313118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959949,0.0003338669,0.00050226075,0.0011234996,0.0009212757,0.001124182],"domain_scores_gemma":[0.99709976,0.0009172879,0.0002259585,0.0009790105,0.00039931544,0.00037864302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038592226,0.0005933245,0.0011865445,0.00094219006,0.00021220963,0.00006243511,0.00035079435,0.00041066125,0.00004383913],"category_scores_gemma":[0.0006958099,0.00044733583,0.0001572287,0.0019087456,0.00039381476,0.00025213882,0.0003559137,0.0008459029,0.00019569197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016981458,0.005645167,0.92586434,0.0019733033,0.00034556034,0.030036129,0.00030308895,0.00021540895,0.0011541123,0.000870973,0.01261693,0.003993559],"study_design_scores_gemma":[0.021628026,0.0013376293,0.96518433,0.00030448067,0.0006811354,0.0004978039,0.00007339211,0.0035190159,0.005588506,0.00016603952,0.0003785197,0.00064114],"about_ca_topic_score_codex":0.00032010087,"about_ca_topic_score_gemma":0.000105932195,"teacher_disagreement_score":0.039320003,"about_ca_system_score_codex":0.0023828563,"about_ca_system_score_gemma":0.002612227,"threshold_uncertainty_score":0.9997978},"labels":[],"label_agreement":null},{"id":"W4414134014","doi":"10.3324/haematol.2025.289055","title":"HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cyclophosphamide; Human leukocyte antigen; Transplantation; Lymphoblastic Leukemia; Locus (genetics); Acute leukemia; Selection (genetic algorithm); Acute lymphocytic leukemia","score_opus":0.013866531810900964,"score_gpt":0.26896962605014335,"score_spread":0.2551030942392424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414134014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850798,0.00015822715,0.009690963,0.0030316054,0.000049621853,0.0016074155,0.00033814332,0.000015823576,0.000028388],"genre_scores_gemma":[0.99525714,0.0012709589,0.000720515,0.0022032293,0.0000065180984,0.00010543042,0.0004114228,0.000016239288,0.000008540301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817866,0.00038819353,0.00064100284,0.0003119088,0.00022506167,0.00025516347],"domain_scores_gemma":[0.99853015,0.00089011394,0.00028121588,0.00021254168,0.000058002766,0.000027947228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070195185,0.0002484087,0.00047720742,0.00011158752,0.00026333853,0.000030692274,0.00021983279,0.00011443902,0.0000024120122],"category_scores_gemma":[0.000006685479,0.000116586416,0.0003303499,0.00065328856,0.00011884226,0.000066620865,0.000007403816,0.0002236792,1.06674115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013754614,0.0013281993,0.70345,0.0044216425,0.016401008,0.00032060855,0.05311871,0.09693139,0.10468935,0.0029468334,0.00013113239,0.0025064845],"study_design_scores_gemma":[0.019716617,0.0010101746,0.85683227,0.0033210265,0.03994289,0.0010500026,0.0032142093,0.02032747,0.053318158,0.0007116029,0.000043897006,0.00051169656],"about_ca_topic_score_codex":0.0006592178,"about_ca_topic_score_gemma":0.0008208266,"teacher_disagreement_score":0.15338223,"about_ca_system_score_codex":0.00013481583,"about_ca_system_score_gemma":0.000096651376,"threshold_uncertainty_score":0.4754256},"labels":[],"label_agreement":null},{"id":"W4414745045","doi":"10.3324/haematol.2025.288835","title":"Taming neutrophil extravasation: a promising therapeutic approach to dampen inflammation?","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Therapeutic approach; MEDLINE; Neutrophil extracellular traps; Inflammation; Immunotherapy","score_opus":0.02284966986835783,"score_gpt":0.29637316516004747,"score_spread":0.2735234952916896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414745045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8797738,0.000427172,0.023697041,0.0073421737,0.00011734096,0.0017220216,0.0000014281846,0.00038391526,0.08653512],"genre_scores_gemma":[0.9833181,0.00001925584,0.013183693,0.0019867525,0.00006715875,0.00011760159,0.000014345827,0.000020049049,0.0012730374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859226,0.00007774783,0.0003947539,0.00041486055,0.00023189747,0.00028846506],"domain_scores_gemma":[0.9991253,0.000104575636,0.00009616711,0.0004716182,0.00010231448,0.00010003059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026626015,0.00020391759,0.0004402627,0.00020348578,0.00016647895,0.000051655516,0.00016990886,0.00020213837,0.00010548223],"category_scores_gemma":[0.00012892696,0.00016415567,0.00009766325,0.0006206536,0.00006669153,0.0000761959,0.00006172671,0.00026959754,0.00007100174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032241263,0.0028352737,0.04042625,0.0030218677,0.0019745375,0.0003434892,0.019597895,0.0010977078,0.42823744,0.19723107,0.008962455,0.29304788],"study_design_scores_gemma":[0.018975915,0.001371786,0.39826465,0.0035480263,0.0013934866,0.0025237594,0.0043670554,0.018593341,0.41312313,0.040245347,0.09478371,0.0028097914],"about_ca_topic_score_codex":0.000010200259,"about_ca_topic_score_gemma":0.0000012807704,"teacher_disagreement_score":0.3578384,"about_ca_system_score_codex":0.00011369651,"about_ca_system_score_gemma":0.000103620834,"threshold_uncertainty_score":0.66940737},"labels":[],"label_agreement":null},{"id":"W4414745051","doi":"10.3324/haematol.2025.288699","title":"Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Seagen; BeiGene; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Bristol-Myers Squibb","keywords":"Chemoimmunotherapy; International Prognostic Index; Primary central nervous system lymphoma; Central nervous system; Lymphoma; Index (typography)","score_opus":0.005123391789369006,"score_gpt":0.20472902019307018,"score_spread":0.19960562840370116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414745051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948387,0.00019261448,0.000049627837,0.00020828846,0.00007000129,0.0010764768,0.000027427992,0.000051668307,0.003485188],"genre_scores_gemma":[0.9994192,0.000007892954,0.00016674683,0.00015668813,0.0000074155705,0.000119099655,0.000070607464,0.000012970295,0.000039348255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985872,0.00007101134,0.0003715073,0.00030790543,0.00034854963,0.00031381234],"domain_scores_gemma":[0.99917006,0.00011791336,0.0002010728,0.00031366225,0.00014745902,0.000049835468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009288961,0.00021823197,0.00056528446,0.00010048695,0.000067743975,0.000015251139,0.00017041185,0.00009146039,0.000031677027],"category_scores_gemma":[0.00003629916,0.00011244606,0.00008144121,0.00032596182,0.000114130584,0.00004328257,0.000065070526,0.0000842646,0.0000019868176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036627178,0.006508558,0.98354846,0.00023060403,0.00018290861,0.00015235083,0.00015254559,0.0000015270359,0.0000067814485,0.00021019705,0.000022047761,0.0053213155],"study_design_scores_gemma":[0.027786365,0.0004464261,0.96908444,0.0011369695,0.00012204698,0.000056638226,0.00024137918,0.0002497771,0.0007207807,0.0000045752226,0.000053847652,0.00009672726],"about_ca_topic_score_codex":0.000189909,"about_ca_topic_score_gemma":0.000073616604,"teacher_disagreement_score":0.024123646,"about_ca_system_score_codex":0.00024093226,"about_ca_system_score_gemma":0.0002380651,"threshold_uncertainty_score":0.45854175},"labels":[],"label_agreement":null},{"id":"W4414975794","doi":"10.3324/haematol.2025.288780","title":"Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review","year":2025,"lang":"en","type":"review","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Biogen; Gilead Sciences; Leukemia and Lymphoma Society; BeiGene; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Obinutuzumab; Tolerability; Chronic lymphocytic leukemia; Hematology; Ibrutinib; Lymphoma","score_opus":0.03306404265306265,"score_gpt":0.3343913292221242,"score_spread":0.3013272865690616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414975794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009158434,0.9752825,0.000013603552,0.00004757011,0.00021262626,0.0093661845,0.00012454492,0.0001844501,0.0056101047],"genre_scores_gemma":[0.0025296295,0.9940836,0.00049457344,0.0002587032,0.0001483781,0.0009899371,0.00027661998,0.0001432547,0.0010753358],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98883873,0.0012676616,0.0045780013,0.0025711905,0.0010959336,0.0016484587],"domain_scores_gemma":[0.99208975,0.00284059,0.0015714703,0.0024760673,0.00036923247,0.00065289985],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0027592957,0.0017683741,0.011711229,0.0014492595,0.00025088325,0.00007330979,0.0009387375,0.0014751408,0.00020804319],"category_scores_gemma":[0.0023315656,0.0013716045,0.0010218475,0.0029560374,0.0013316448,0.00016556241,0.0018848589,0.00061100075,0.000048165155],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00063632155,0.00008747378,0.000022373753,0.3777682,0.00021918312,0.0012275232,0.000069521724,0.000003886077,0.000002219768,0.00021827102,0.00038473503,0.6193603],"study_design_scores_gemma":[0.05242419,0.0020260466,0.0005938044,0.54415464,0.0051091374,0.009419971,0.000051077495,0.0065003373,0.000054413435,0.00018029001,0.37715027,0.0023358196],"about_ca_topic_score_codex":0.012675285,"about_ca_topic_score_gemma":0.0029141346,"teacher_disagreement_score":0.6170245,"about_ca_system_score_codex":0.3464404,"about_ca_system_score_gemma":0.28140205,"threshold_uncertainty_score":0.9998211},"labels":[],"label_agreement":null},{"id":"W4414975841","doi":"10.3324/haematol.2025.288058","title":"Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experience","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Foundation; Canadian Centre for Applied Research in Cancer Control; Occupational Cancer Research Centre; BC Cancer Agency; BC Children's Hospital","funders":"Seagen; Pfizer","keywords":"ABVD; Young adult; Incidence (geometry); Disease; Risk factor; Cumulative incidence; Hodgkin lymphoma; Radiation therapy; Heart failure","score_opus":0.018417311775531665,"score_gpt":0.27541564926819495,"score_spread":0.25699833749266326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414975841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951641,0.0021161481,0.000006982124,0.0005348082,0.000224355,0.00057800784,0.00001469243,0.000030581763,0.0013303075],"genre_scores_gemma":[0.9978061,0.0013445494,0.000052432188,0.00025830764,0.000015314401,0.00018425222,0.0000087565295,0.00000617688,0.00032412005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987727,0.00011773034,0.00033041424,0.00033887636,0.00019735745,0.00024292812],"domain_scores_gemma":[0.9993289,0.00013265393,0.000078067445,0.00031010472,0.00007656211,0.00007372452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012322968,0.00012095298,0.00056378264,0.000026388561,0.00015107005,0.000110585606,0.0001088643,0.00012029805,0.00003206845],"category_scores_gemma":[0.00016395745,0.00010506278,0.00011184041,0.00022394261,0.00033521085,0.000035420333,0.00012023779,0.000072580595,0.0000030625913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047232294,0.0007823912,0.98452,0.00014161403,0.00004593751,0.00058375066,0.00018278527,8.8152326e-8,0.000029350716,0.00018893965,0.002340939,0.01113698],"study_design_scores_gemma":[0.0016103121,0.00009128095,0.99612206,0.0005901954,0.00007399764,0.00022727124,0.00032226392,0.000017952912,0.00063807744,0.000049588623,0.00016708484,0.00008989646],"about_ca_topic_score_codex":0.026665013,"about_ca_topic_score_gemma":0.0537369,"teacher_disagreement_score":0.027071886,"about_ca_system_score_codex":0.000101714875,"about_ca_system_score_gemma":0.00008061556,"threshold_uncertainty_score":0.9798165},"labels":[],"label_agreement":null},{"id":"W4415787584","doi":"10.3324/haematol.2024.286478","title":"Histiocyte Society blueprint for Langerhans cell histiocytosis research: from cell-of-origin to a more comprehensive cure","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Langerhans cell histiocytosis; Histiocyte; Histiocytosis; Disease; Presentation (obstetrics); Organ dysfunction; Multisystem disease; Myeloid","score_opus":0.12541149878339414,"score_gpt":0.4126545538098677,"score_spread":0.28724305502647357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415787584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96673954,0.0031295754,0.0056135254,0.0060792607,0.0002462695,0.0022204362,0.00027200114,0.0001296601,0.015569739],"genre_scores_gemma":[0.96876705,0.00019189664,0.023505341,0.0012947515,0.000035741195,0.00042759755,0.00014663023,0.000023554132,0.0056074234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983325,0.000057659676,0.00036289706,0.0005265021,0.00031164617,0.00040879071],"domain_scores_gemma":[0.9983461,0.00045904156,0.00009241391,0.00051340053,0.0004229028,0.00016612805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013420651,0.00022181464,0.0006806715,0.00014158261,0.00020118184,0.000015890128,0.00019497286,0.00019421159,0.00014289029],"category_scores_gemma":[0.00010461258,0.0001792397,0.00029549544,0.00039992068,0.0001936945,0.000022118038,0.00012881756,0.0002178808,0.000083941515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002801612,0.0048213326,0.02967848,0.0035161325,0.0011037665,0.00043349495,0.0076572383,0.00013224578,0.02245985,0.008763462,0.91132975,0.007302616],"study_design_scores_gemma":[0.010261076,0.0013958267,0.015396457,0.0008379187,0.0010743042,0.000018601186,0.005467232,0.0010335153,0.06280802,0.0045085475,0.8966106,0.0005878924],"about_ca_topic_score_codex":0.00051493023,"about_ca_topic_score_gemma":0.000021378384,"teacher_disagreement_score":0.04034817,"about_ca_system_score_codex":0.00023291739,"about_ca_system_score_gemma":0.00025139423,"threshold_uncertainty_score":0.7309182},"labels":[],"label_agreement":null},{"id":"W4415952016","doi":"10.3324/haematol.2025.288838","title":"CD19 directed CAR T therapy for intravascular large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Astellas Pharma US; Health Resources and Services Administration; National Institutes of Health; Gilead Sciences; Actinium Pharmaceuticals; Adaptive Biotechnologies; Moonshot Research and Development Program; AstraZeneca; Gateway for Cancer Research; Astellas Pharma; Alexion Pharmaceuticals; Amgen","keywords":"Lymphoma; CD19; Chimeric antigen receptor; Aggressive lymphoma; CAR T-cell therapy; Antibody therapy","score_opus":0.023826367591453696,"score_gpt":0.3159687436674928,"score_spread":0.2921423760760391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95335734,0.005662326,0.0013753413,0.0022503058,0.00026070667,0.0025106561,0.000025202247,0.000525264,0.03403283],"genre_scores_gemma":[0.97316366,0.0013479919,0.0014916367,0.002101981,0.000086292945,0.0004478852,0.0000741755,0.000039366314,0.021246985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998284,0.000115649826,0.0002957998,0.000452754,0.0002752635,0.00057656126],"domain_scores_gemma":[0.9987361,0.00024311745,0.0000523764,0.0006264768,0.00021625267,0.00012570785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043002577,0.00022154069,0.0006350143,0.0001850926,0.00015916344,0.000031486787,0.00022583615,0.0002381786,0.0015319117],"category_scores_gemma":[0.00019496404,0.00016384888,0.0003140663,0.00044514408,0.00009638,0.000030309657,0.000068264024,0.00014440824,0.00007172512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0134387,0.013259407,0.028702505,0.002455554,0.0026167606,0.0015580679,0.0017520257,0.0000034042594,0.46463484,0.020363329,0.17980275,0.27141267],"study_design_scores_gemma":[0.021677982,0.0007436206,0.006043782,0.000112937494,0.00010020967,0.00009346741,0.00032441545,0.0007352885,0.20130487,0.0012636418,0.7673032,0.00029653584],"about_ca_topic_score_codex":0.000033209904,"about_ca_topic_score_gemma":0.0000136983235,"teacher_disagreement_score":0.5875005,"about_ca_system_score_codex":0.000091407725,"about_ca_system_score_gemma":0.00019654412,"threshold_uncertainty_score":0.9993808},"labels":[],"label_agreement":null},{"id":"W4415952024","doi":"10.3324/haematol.2025.288743","title":"&lt;i&gt;IDH2&lt;/i&gt; mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Sun Pharma; MorphoSys; Astellas Pharma; Sierra Oncology; Incyte; Swedish Orphan Biovitrum; Daiichi Sankyo Europe; Oregon Health and Science University; Gilead Sciences; Amgen; Pfizer; Syndax Pharmaceuticals; Foghorn Therapeutics","keywords":"NPM1; Myeloid leukemia; Isocitrate dehydrogenase; IDH1; Hypomethylating agent; Azacitidine; Retrospective cohort study; Cohort; Mutation","score_opus":0.01789843076102343,"score_gpt":0.274959400748029,"score_spread":0.25706096998700556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871018,0.00041921073,0.0023111654,0.0017006426,0.000042788623,0.0034530556,0.000061349536,0.0007793871,0.0041306135],"genre_scores_gemma":[0.98654443,0.00013539997,0.004935741,0.0019755356,0.00003230266,0.00078481756,0.0005522972,0.00015033173,0.004889173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99458545,0.00044429553,0.0009251351,0.0013559633,0.001313766,0.0013753726],"domain_scores_gemma":[0.9956805,0.0011818997,0.0006827873,0.001063595,0.00095844397,0.0004327555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006542176,0.0009275861,0.0018047097,0.00062436826,0.00056529173,0.00017399948,0.00048055267,0.0006028512,0.00035601057],"category_scores_gemma":[0.000570619,0.00056441745,0.00021696022,0.0029821673,0.00063265563,0.0003369299,0.00008864583,0.0009354111,0.00006194274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019943304,0.0018411297,0.9070859,0.00078877405,0.006136804,0.024039492,0.0032293305,0.0013351218,0.012354463,0.00031283527,0.010350491,0.012582377],"study_design_scores_gemma":[0.090206034,0.007830335,0.81407225,0.005418674,0.0018732224,0.00062961516,0.0012117758,0.018717181,0.056699257,0.000051235238,0.0012507632,0.0020396286],"about_ca_topic_score_codex":0.0003124087,"about_ca_topic_score_gemma":0.00048041166,"teacher_disagreement_score":0.0930136,"about_ca_system_score_codex":0.0015289899,"about_ca_system_score_gemma":0.001452784,"threshold_uncertainty_score":0.99968076},"labels":[],"label_agreement":null},{"id":"W4415952046","doi":"10.3324/haematol.2025.289031","title":"Interleukin-6 in Castleman disease subtypes: look to tissues, not just blood","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Nova Scotia Health Authority; University of British Columbia","funders":"","keywords":"Castleman disease; Disease; MEDLINE; Immunopathology; Systemic disease","score_opus":0.022872756364728228,"score_gpt":0.3063727286181574,"score_spread":0.28349997225342916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532444,0.0013171954,0.000052344476,0.015081422,0.00022790469,0.00063233264,0.000016938315,0.00013409289,0.029293362],"genre_scores_gemma":[0.98804307,0.00011098648,0.00018176012,0.006800236,0.000025289659,0.000082740815,0.000020795469,0.000012757698,0.0047223493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987905,0.000042707423,0.00029383216,0.00036797847,0.00015762425,0.00034734647],"domain_scores_gemma":[0.9993348,0.000045529465,0.000050418792,0.00032204195,0.000048891787,0.00019827811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011192572,0.00017726827,0.00046367626,0.00020556455,0.000054661163,0.000021295778,0.00013974679,0.00011386388,0.00034460277],"category_scores_gemma":[0.00031713475,0.00014154383,0.000094899224,0.00044310928,0.000054738364,0.000035931113,0.00008585848,0.00018690138,0.0002140981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063823042,0.0026622345,0.5929717,0.0017901385,0.0005472093,0.01004011,0.0032212895,0.00010162771,0.0019336562,0.031382937,0.3320232,0.016943607],"study_design_scores_gemma":[0.026463099,0.002549473,0.5400215,0.0050322423,0.0019364719,0.00021287709,0.008662837,0.0003609891,0.011081344,0.007316427,0.39439604,0.0019667435],"about_ca_topic_score_codex":0.00023127708,"about_ca_topic_score_gemma":0.0003906721,"teacher_disagreement_score":0.06237284,"about_ca_system_score_codex":0.000100048164,"about_ca_system_score_gemma":0.00016160519,"threshold_uncertainty_score":0.577199},"labels":[],"label_agreement":null},{"id":"W4416166919","doi":"10.3324/haematol.2025.287443","title":"Novel and emerging therapeutic strategies for clonal haematopoiesis","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Epigenetics; Haematopoiesis; Bone marrow; Somatic evolution in cancer; Stem cell; Epigenesis; Leukemia; Hematopoietic stem cell","score_opus":0.04390705616631437,"score_gpt":0.35304966535192706,"score_spread":0.3091426091856127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416166919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8063953,0.0050470633,0.12054185,0.033058457,0.00022849027,0.0022639553,0.00003061787,0.0003981774,0.03203611],"genre_scores_gemma":[0.9845142,0.0001232987,0.011719704,0.0018088031,0.000033396373,0.00018767033,0.000012472562,0.000014751939,0.0015857404],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99893284,0.000023692608,0.00023375866,0.00031370166,0.00014959753,0.00034641128],"domain_scores_gemma":[0.9991742,0.00034697435,0.00004454457,0.00024028472,0.00011857041,0.00007544909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023664201,0.00015679639,0.00043678124,0.00015994132,0.0001805811,0.000054957953,0.00011727071,0.00013663391,0.000082448205],"category_scores_gemma":[0.00015225279,0.000114112896,0.00008774881,0.0002280206,0.00019723474,0.000075384596,0.0000939646,0.00018418302,0.000010052628],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001254904,0.0003310475,0.008915342,0.0022823869,0.00066148053,0.00019277686,0.0006903588,0.0000075413395,0.041514426,0.90522,0.017137261,0.021792501],"study_design_scores_gemma":[0.034429874,0.0030434392,0.16082203,0.002442045,0.0021037466,0.00950096,0.03515897,0.032426164,0.058246713,0.33266768,0.3266552,0.0025031425],"about_ca_topic_score_codex":0.000022827371,"about_ca_topic_score_gemma":0.000008802752,"teacher_disagreement_score":0.57255226,"about_ca_system_score_codex":0.00005517559,"about_ca_system_score_gemma":0.00031188928,"threshold_uncertainty_score":0.4653389},"labels":[],"label_agreement":null},{"id":"W4416397582","doi":"10.3324/haematol.2025.288392","title":"Loss of nuclear myosin 1 causes hemostatic defects and immune dysregulation","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ústav Molekulární Genetiky, Akademie Věd České Republiky; Tamkeen; Akademie Věd České Republiky; York University; New York University Abu Dhabi","keywords":"Immune dysregulation; Immune system; Myosin; Hemostasis; Platelet; Coagulation; Myosin light-chain kinase","score_opus":0.013225077373867793,"score_gpt":0.2690248519532449,"score_spread":0.2557997745793771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416397582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872209,0.0039011238,0.000057223293,0.001188586,0.000078176156,0.00022993056,0.0000030182914,0.000053801774,0.0072672768],"genre_scores_gemma":[0.998658,0.0002706676,0.00052294566,0.00032642123,0.0000069348803,0.000007887775,0.0000036408371,0.000005498873,0.00019802043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942005,0.000032503467,0.00020123977,0.00014664145,0.00008489808,0.00011468132],"domain_scores_gemma":[0.99956334,0.000114192764,0.000061806604,0.00016821224,0.00006678056,0.000025680374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009818573,0.00009166942,0.000441173,0.000072853494,0.00007784656,0.000006287901,0.000028292072,0.000060758317,0.000021333795],"category_scores_gemma":[0.00018928526,0.00007013765,0.000068760855,0.00016400835,0.00019076593,0.000026392612,0.00007030638,0.000058622027,0.0000046447763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033972382,0.0011642277,0.47568256,0.0088649895,0.0017913093,0.0019916163,0.00788107,0.000021932792,0.13146167,0.31580913,0.02622163,0.02571262],"study_design_scores_gemma":[0.0022943898,0.00039256318,0.95322084,0.0009764654,0.0006052839,0.0007506474,0.0017342188,0.00007098523,0.02372493,0.005364809,0.010654115,0.00021076857],"about_ca_topic_score_codex":0.00001487667,"about_ca_topic_score_gemma":0.0000026099149,"teacher_disagreement_score":0.47753826,"about_ca_system_score_codex":0.000012575635,"about_ca_system_score_gemma":0.000018473664,"threshold_uncertainty_score":0.286013},"labels":[],"label_agreement":null},{"id":"W4416397923","doi":"10.3324/haematol.2025.288654","title":"JAK inhibitor selection in challenging scenarios of myelofibrosis: a review","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"MorphoSys; Swedish Orphan Biovitrum; Sierra Oncology; Incyte; Celgene","keywords":"Ruxolitinib; Myelofibrosis; Janus kinase; Context (archaeology); Clinical trial; Constitutional symptoms; Venetoclax; Selection (genetic algorithm)","score_opus":0.015796766915338285,"score_gpt":0.30762751780376535,"score_spread":0.2918307508884271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416397923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76083946,0.19491059,0.00019602042,0.025722213,0.00017421009,0.003085553,0.000008048905,0.00016581021,0.014898078],"genre_scores_gemma":[0.9759256,0.020944018,0.0007661283,0.0018222677,0.000014603533,0.0003040834,0.000008017877,0.000006637585,0.00020861335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896586,0.000066281034,0.00040657335,0.000251979,0.00013002488,0.0001792755],"domain_scores_gemma":[0.9995506,0.000095238975,0.00009406075,0.00013159278,0.000086618864,0.000041907377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015767211,0.00014205149,0.00066272996,0.00015904152,0.00004349302,0.00000448996,0.000043255488,0.00008994968,0.00022455025],"category_scores_gemma":[0.00020819333,0.000101568636,0.00009969075,0.00045935382,0.000033416854,0.00003304721,0.000032365988,0.0001275346,0.000020473753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008699382,0.0053984784,0.8067948,0.036652923,0.00074790366,0.00060205976,0.00078286504,0.000042329702,0.0059908433,0.036802355,0.06991195,0.035403512],"study_design_scores_gemma":[0.010510879,0.0030517797,0.6149482,0.13304037,0.0012064653,0.00077520806,0.000554387,0.0012144018,0.14683755,0.001259212,0.085727975,0.00087354606],"about_ca_topic_score_codex":0.000023494282,"about_ca_topic_score_gemma":0.000026210124,"teacher_disagreement_score":0.21508615,"about_ca_system_score_codex":0.00007180961,"about_ca_system_score_gemma":0.00007585283,"threshold_uncertainty_score":0.4141849},"labels":[],"label_agreement":null},{"id":"W7117871030","doi":"10.3324/haematol.2024.286014","title":"Molecular genetic testing in von Willebrand disease: past, present, and beyond","year":2025,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Genetic testing; Gene; Missense mutation; Molecular genetics; Genetic variation; Genetic analysis","score_opus":0.01282278433244914,"score_gpt":0.26421942424842737,"score_spread":0.2513966399159782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117871030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810874,0.0060462994,0.000057331934,0.0024952814,0.000021616448,0.0003620512,0.0000033083757,0.000037080288,0.009889636],"genre_scores_gemma":[0.99817675,0.000076620985,0.0010355607,0.00046169412,0.000008706233,0.00004256996,0.000009243904,0.0000061331134,0.0001826959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993213,0.000026389536,0.00014828963,0.00023927898,0.00008064905,0.0001841355],"domain_scores_gemma":[0.9996462,0.00007084914,0.000027405826,0.0001521221,0.000019106705,0.00008432304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030559368,0.00011212058,0.00028058546,0.000086635744,0.00004292879,0.000013312475,0.00003763991,0.000051391384,0.000015921356],"category_scores_gemma":[0.000069545305,0.00008445724,0.00002833456,0.00020244966,0.000055217475,0.000020861995,0.00005035024,0.00006980617,0.000005933788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013776583,0.00027971115,0.9752815,0.00021071456,0.000060061542,0.010393325,0.00003421143,0.000019017358,0.00034283422,0.00043193874,0.0010305387,0.011778406],"study_design_scores_gemma":[0.003003204,0.00013364844,0.9838569,0.0002725366,0.00015761532,0.00031165907,0.00004993807,0.001332825,0.00043775485,0.008250831,0.002047306,0.00014577348],"about_ca_topic_score_codex":0.000014327515,"about_ca_topic_score_gemma":0.000002204059,"teacher_disagreement_score":0.01708938,"about_ca_system_score_codex":0.0000113047745,"about_ca_system_score_gemma":0.00002958291,"threshold_uncertainty_score":0.34440663},"labels":[],"label_agreement":null}]}